data_2k8d_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k8d _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.503 HH11 ' HG2' ' A' ' 22' ' ' GLU . 3.5 mmt180 . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 pt -115.18 130.97 23.8 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.668 0.787 . . . . 0.0 109.695 -174.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.14 146.39 57.72 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 N-CA-C 108.993 -1.195 . . . . 0.0 108.993 167.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -124.97 105.75 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 166.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -98.31 101.1 12.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.9 m -67.18 74.45 0.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.478 1.111 . . . . 0.0 109.1 165.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.52 -46.89 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 124.853 1.261 . . . . 0.0 110.712 -168.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.24 -16.99 60.42 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.981 -174.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 150' ' ' ARG . 1.4 mtmp? -99.45 0.47 42.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.101 1.76 . . . . 0.0 110.549 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 39.72 59.44 1.86 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.344 2.658 . . . . 0.0 113.141 -167.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.73 165.83 16.59 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.334 0.654 . . . . 0.0 109.759 171.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -143.38 124.4 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -136.67 112.94 9.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.823 1.649 . . . . 0.0 107.023 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 46.0 ttm -79.5 146.15 32.84 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.775 -1.203 . . . . 0.0 108.855 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.4 t -137.7 157.41 33.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.503 ' HG2' HH11 ' A' ' 7' ' ' ARG . 3.3 mp0 -65.8 165.8 12.21 Favored 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 121.22 -0.925 . . . . 0.0 112.084 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -64.46 174.21 1.8 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.303 -0.873 . . . . 0.0 110.947 165.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.85 103.63 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 169.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -134.95 103.94 5.78 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 166.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -136.85 177.47 7.83 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.856 1.663 . . . . 0.0 106.676 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.5 t -111.46 164.85 12.51 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 159.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.03 -27.32 43.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.579 1.552 . . . . 0.0 111.509 -175.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.21 -26.89 65.04 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 32' ' ' ARG . 62.6 mm-40 -71.62 -43.35 66.34 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.33 1.052 . . . . 0.0 109.316 -177.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -61.87 19.61 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.391 2.677 . . . . 0.0 114.932 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.447 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -136.78 1.1 2.5 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 165.251 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -133.37 -17.28 2.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 118.201 -0.904 . . . . 0.0 113.196 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 pt -110.53 -4.73 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 119.261 0.937 . . . . 0.0 112.491 171.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 mt -78.87 172.59 13.56 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.626 1.171 . . . . 0.0 110.78 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 38' ' ' GLU . 72.6 m-20 -78.52 155.62 78.66 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.084 0.953 . . . . 0.0 110.997 175.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -68.51 16.82 0.15 Allowed 'Trans proline' 0 CA--C 1.546 1.092 1 C-N-CA 126.213 4.608 . . . . 0.0 114.039 168.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.46 ' H ' ' C ' ' A' ' 36' ' ' ASP . 7.2 tt0 -128.1 -31.8 2.33 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 127.376 2.271 . . . . 0.0 110.123 167.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.95 -38.71 83.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.123 0.874 . . . . 0.0 108.793 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -59.09 -45.82 89.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.099 0.408 . . . . 0.0 111.143 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.1 -48.9 31.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 116.718 -1.611 . . . . 0.0 107.922 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.1 t -49.5 -32.28 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 119.868 1.213 . . . . 0.0 110.384 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.46 -25.54 66.1 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 114.05 1.129 . . . . 0.0 114.05 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.78 -27.78 15.61 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.396 0.998 . . . . 0.0 111.865 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -113.35 -0.53 14.49 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -163.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.93 42.12 5.92 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.436 1.094 . . . . 0.0 110.846 -171.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.555 0 C-N-CA 125.479 1.514 . . . . 0.0 111.568 172.997 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 p30 . . . . . 0 N--CA 1.424 -1.768 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.82 173.73 49.93 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.853 -172.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.8 pt -135.79 164.67 31.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.997 1.719 . . . . 0.0 108.696 170.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -72.88 148.09 44.74 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 2.8 tmt_? -141.12 112.71 7.57 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.098 0.959 . . . . 0.0 109.092 175.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.73 95.71 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.403 1.881 . . . . 0.0 109.082 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.2 tt -65.1 -16.22 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.188 0.595 . . . . 0.0 111.117 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.4 m -86.73 1.65 51.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.071 2.148 . . . . 0.0 112.741 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 22.0 p -150.23 -11.05 0.26 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 162.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.8 3.1 62.52 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 118.083 -1.398 . . . . 0.0 114.197 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.3 m -97.61 143.66 28.06 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.591 1.696 . . . . 0.0 111.281 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 11.7 p-10 -97.05 156.1 16.51 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.855 2.062 . . . . 0.0 112.128 177.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.265 0.2 OUTLIER -151.72 -95.79 0.06 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.172 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -60.25 111.07 1.4 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.993 0.917 . . . . 0.0 113.414 -159.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.41 115.92 5.06 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.643 1.577 . . . . 0.0 107.749 166.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.6 m -56.12 -10.63 0.88 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 117.915 2.561 . . . . 0.0 117.915 -162.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -62.92 -25.69 68.45 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.686 1.585 . . . . 0.0 111.827 163.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.9 p -88.51 20.85 3.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.966 2.507 . . . . 0.0 111.817 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.481 ' HG2' ' H ' ' A' ' 81' ' ' PHE . 30.2 tttt -118.51 179.55 4.09 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.878 2.071 . . . . 0.0 108.205 166.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.481 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 16.5 m-85 -113.61 165.26 12.68 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 158.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -146.88 -65.23 0.28 Allowed 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 119.007 0.821 . . . . 0.0 109.466 171.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -57.29 161.64 3.18 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.832 0.825 . . . . 0.0 110.83 166.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.63 -62.74 3.49 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 119.261 -0.744 . . . . 0.0 111.511 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t -152.35 -10.67 0.18 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 47.13 23.64 1.79 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.872 1.701 . . . . 0.0 116.576 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -63.44 156.62 69.48 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 117.707 0.753 . . . . 0.0 111.811 -168.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -79.62 47.72 2.61 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.637 2.891 . . . . 0.0 110.634 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.01 144.57 31.09 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 126.418 1.887 . . . . 0.0 107.95 -176.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -158.8 177.09 11.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.645 1.178 . . . . 0.0 109.339 -161.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -128.62 0.49 5.52 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -165.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -161.48 -177.38 5.92 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.677 1.191 . . . . 0.0 108.079 166.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.4 m -140.87 165.77 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 118.873 0.76 . . . . 0.0 112.303 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 p -60.97 -54.7 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.405 1.482 . . . . 0.0 110.603 174.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.5 t 175.58 165.57 0.34 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.406 2.682 . . . . 0.0 107.921 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -75.61 79.22 2.6 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 162.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -126.82 -51.05 1.46 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.645 0.778 . . . . 0.0 109.967 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -117.13 1.55 12.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.697 1.599 . . . . 0.0 111.168 171.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.67 149.42 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 126.497 1.919 . . . . 0.0 106.942 174.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -134.3 143.21 47.6 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.247 1.419 . . . . 0.0 108.918 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 mp -120.68 152.16 38.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.883 2.073 . . . . 0.0 112.265 170.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.18 126.45 39.25 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 163.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -67.92 143.05 55.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.764 0.826 . . . . 0.0 110.354 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -146.03 173.48 12.13 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 158.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.35 22.13 16.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.442 2.297 . . . . 0.0 110.739 175.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.93 23.27 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.907 2.483 . . . . 0.0 116.843 -165.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 pp -131.13 -5.72 3.88 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.407 -1.433 . . . . 0.0 112.455 162.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.32 1.01 40.99 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 117.387 -1.785 . . . . 0.0 113.089 -167.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 55.4 mtm -140.92 -90.81 0.15 Allowed 'General case' 0 C--N 1.349 0.544 0 CA-C-N 120.383 2.092 . . . . 0.0 108.306 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.2 t -142.87 111.78 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.416 ' HE ' ' CD2' ' A' ' 125' ' ' HIS . 18.9 ttt180 -130.14 88.12 2.61 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.641 1.576 . . . . 0.0 111.047 175.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 7.9 m -89.12 144.09 26.38 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -66.52 162.36 20.94 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.218 0.917 . . . . 0.0 110.182 170.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.2 t -136.88 110.11 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 174.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.4 mt -131.29 160.33 35.25 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.52 1.128 . . . . 0.0 109.64 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.8 t -81.66 118.11 22.55 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.26 -6.31 4.36 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.971 1.308 . . . . 0.0 113.876 -175.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.3 ttt-85 -115.13 -9.94 12.24 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.504 1.922 . . . . 0.0 113.645 171.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 22.5 p -164.37 81.58 0.4 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.46 1.482 . . . . 0.0 109.474 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -70.01 56.23 0.14 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.483 1.513 . . . . 0.0 113.039 -174.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -75.17 -49.5 19.26 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.709 1.204 . . . . 0.0 112.952 -166.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -159.71 -67.46 0.08 Allowed 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 122.981 0.512 . . . . 0.0 109.832 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 mt 44.98 -110.66 0.21 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.25 1.82 . . . . 0.0 110.074 -173.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.55 -123.69 0.86 Allowed Glycine 0 CA--C 1.521 0.441 0 CA-C-N 118.751 0.705 . . . . 0.0 112.636 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.416 ' CD2' ' HE ' ' A' ' 111' ' ' ARG . 42.6 p-80 -158.86 174.06 15.57 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.427 -0.455 . . . . 0.0 111.18 -173.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.4 p -122.83 141.37 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.219 1.408 . . . . 0.0 108.014 172.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -134.89 133.19 39.39 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.604 1.162 . . . . 0.0 108.808 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -65.16 107.36 1.54 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.809 0.844 . . . . 0.0 109.67 172.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -162.28 -5.18 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -161.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -110.4 179.28 20.29 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 119.959 -1.713 . . . . 0.0 112.455 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.2 146.69 41.14 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.038 2.492 . . . . 0.0 110.837 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.5 ptt-85 -59.71 153.23 53.48 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.588 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.86 -41.44 0.9 Allowed 'Cis proline' 0 C--N 1.35 0.618 0 CA-C-N 119.816 0.97 . . . . 0.0 111.573 -6.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.53 71.7 4.03 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 125.968 1.707 . . . . 0.0 109.663 176.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -103.95 5.96 47.04 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 112.372 -2.195 . . . . 0.0 111.291 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.75 157.39 27.13 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 116.661 -2.016 . . . . 0.0 107.189 166.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -132.14 94.54 3.48 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -65.72 143.77 57.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 164.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 12.5 t -142.28 135.19 28.52 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.061 1.745 . . . . 0.0 108.001 159.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -133.1 141.92 48.44 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.71 0.804 . . . . 0.0 109.379 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -140.6 87.52 2.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.859 1.264 . . . . 0.0 108.082 -163.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 80.2 p -153.2 177.15 11.15 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.505 0.722 . . . . 0.0 109.586 173.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.61 -8.19 45.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 170.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.06 -25.7 61.58 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.549 1.14 . . . . 0.0 113.141 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 64.2 mt -76.68 44.62 0.37 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.157 2.583 . . . . 0.0 115.35 -158.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -73.43 155.88 38.84 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 166.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -103.65 160.61 14.61 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.67 0.788 . . . . 0.0 109.233 168.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.9 pt -132.73 165.5 36.01 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.222 1.009 . . . . 0.0 108.713 160.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -50.49 150.74 11.14 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.931 2.421 . . . . 0.0 110.507 159.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.402 ' O ' ' HE2' ' A' ' 15' ' ' LYS . 12.1 mmt180 -40.43 -44.45 2.01 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 126.444 1.898 . . . . 0.0 112.352 -164.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -145.8 -75.3 0.21 Allowed 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.525 1.13 . . . . 0.0 110.112 167.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -146.05 8.92 1.11 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.285 3.034 . . . . 0.0 109.83 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -59.2 -14.3 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.14 -0.975 . . . . 0.0 113.298 167.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.478 0 C-N-CA 128.16 2.791 . . . . 0.0 107.074 163.336 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.0 ptt-85 . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.8 pt -111.88 91.88 16.36 Favored Pre-proline 0 N--CA 1.45 -0.461 0 C-N-CA 125.88 1.672 . . . . 0.0 106.759 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 73.6 Cg_endo -64.91 138.06 55.91 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 N-CA-C 107.413 -1.803 . . . . 0.0 107.413 168.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.9 mt -121.25 152.1 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -173.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -147.0 91.58 2.02 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.229 1.412 . . . . 0.0 107.441 -164.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.4 m -66.43 77.17 0.1 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.809 0.731 . . . . 0.0 109.53 165.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -60.68 -36.58 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.658 1.183 . . . . 0.0 111.546 -170.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.52 -11.53 53.15 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.231 1.012 . . . . 0.0 112.233 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -123.31 10.22 9.24 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.362 1.865 . . . . 0.0 110.798 174.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 27.58 52.01 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.572 3.149 . . . . 0.0 113.332 -161.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.95 169.87 17.27 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 118.846 -1.142 . . . . 0.0 111.173 167.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.52 136.72 43.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 158.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -145.01 107.36 4.37 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.46 1.904 . . . . 0.0 108.427 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 47.8 ttp -82.09 125.41 30.81 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.664 -1.273 . . . . 0.0 111.568 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.4 t -130.89 135.1 60.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -55.81 166.74 0.67 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 166.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.0 mtp-105 -66.23 163.68 17.38 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.413 177.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.413 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 3.2 tt -90.2 122.66 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 169.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -149.33 112.67 4.97 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 167.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.7 mt -136.99 178.4 7.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.052 1.741 . . . . 0.0 108.316 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.31 -177.88 2.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.465 1.906 . . . . 0.0 107.843 159.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.3 -42.88 71.44 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.812 -1.18 . . . . 0.0 109.835 164.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.27 -18.97 30.58 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 128.834 2.853 . . . . 0.0 112.441 -161.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 32' ' ' ARG . 35.7 mt-10 -86.9 -40.71 14.59 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 129.664 3.186 . . . . 0.0 110.378 -168.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -62.25 7.46 0.06 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.269 2.228 . . . . 0.0 114.784 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.433 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -128.85 -4.78 5.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.938 1.695 . . . . 0.0 113.837 177.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -132.01 -18.86 2.61 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.612 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 pt -109.16 8.97 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.096 0.862 . . . . 0.0 111.356 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -115.84 164.94 13.66 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.97 1.308 . . . . 0.0 110.219 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -58.22 149.02 60.13 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 122.932 0.493 . . . . 0.0 110.784 176.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -69.19 4.48 1.93 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.466 2.777 . . . . 0.0 112.249 164.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -93.07 -48.84 6.3 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.101 -1.0 . . . . 0.0 111.277 161.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.405 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -56.58 -44.47 81.07 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 120.274 1.397 . . . . 0.0 111.355 -172.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -58.14 -40.09 80.44 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.887 1.275 . . . . 0.0 112.432 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -80.98 -45.96 15.83 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 118.645 0.657 . . . . 0.0 109.646 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.266 2.0 t -60.28 -24.44 30.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.771 1.228 . . . . 0.0 110.534 -177.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.13 -23.13 66.38 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 169.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -99.94 -40.66 7.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.309 1.413 . . . . 0.0 111.996 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -83.85 5.82 23.79 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.15 0.58 . . . . 0.0 111.791 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.43 49.01 20.54 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.892 1.677 . . . . 0.0 109.882 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.663 0 CA-C-O 119.217 -0.768 . . . . 0.0 114.485 178.643 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.7 t0 . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.45 175.9 50.4 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -158.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.5 pt -141.9 -178.69 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.363 1.065 . . . . 0.0 108.624 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -98.43 162.13 13.32 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 122.307 1.051 . . . . 0.0 110.293 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.84 108.61 9.53 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 17.6 t -68.3 84.54 0.26 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 170.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.1 tt -65.31 -25.89 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 122.062 -0.399 . . . . 0.0 110.204 -168.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.3 m -66.52 -1.87 4.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.37 2.268 . . . . 0.0 113.808 173.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 19.7 p -143.47 21.34 1.86 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.263 1.025 . . . . 0.0 110.843 158.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.63 12.02 51.06 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.588 1.09 . . . . 0.0 113.98 171.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 m -111.48 150.08 30.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.639 1.976 . . . . 0.0 110.636 -158.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -89.65 156.72 18.38 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.228 1.376 . . . . 0.0 113.082 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.06 -168.8 0.14 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.826 2.45 . . . . 0.0 109.361 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.9 t80 39.31 79.66 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 128.99 2.916 . . . . 0.0 112.607 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.7 148.43 49.26 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.92 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.8 t -71.34 -9.19 57.74 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -166.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -63.88 -39.84 95.14 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.732 1.213 . . . . 0.0 112.253 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.3 t -85.95 -18.16 33.4 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.276 0.631 . . . . 0.0 111.514 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.482 ' HG2' ' H ' ' A' ' 81' ' ' PHE . 20.9 tttt -74.41 178.09 5.48 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.587 0.755 . . . . 0.0 109.815 168.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.482 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -131.32 151.72 51.25 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 105.102 -2.185 . . . . 0.0 105.102 158.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -131.93 -57.05 0.98 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.497 1.119 . . . . 0.0 110.038 -167.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.4 t -88.09 177.93 6.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.441 0.639 . . . . 0.0 109.898 163.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 55.86 -97.42 0.05 OUTLIER Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.6 1.571 . . . . 0.0 110.989 -173.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.2 m -60.24 -55.52 32.69 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.724 1.61 . . . . 0.0 110.667 177.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 43.64 44.3 6.73 Favored Glycine 0 C--N 1.343 0.932 0 C-N-CA 127.591 2.519 . . . . 0.0 113.837 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -118.62 152.61 51.47 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.239 1.415 . . . . 0.0 109.992 -169.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.08 46.88 1.85 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.779 2.986 . . . . 0.0 112.969 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.3 p -124.62 150.43 46.01 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.822 0.849 . . . . 0.0 109.501 166.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -141.43 178.56 7.35 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.034 1.334 . . . . 0.0 109.851 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -135.02 -0.62 2.75 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -172.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -159.96 177.81 10.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.452 1.101 . . . . 0.0 110.583 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.14 153.33 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 120.554 1.524 . . . . 0.0 111.544 -174.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.4 t -59.84 -63.43 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 127.976 2.51 . . . . 0.0 110.828 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.4 t -173.03 159.73 4.03 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.148 2.179 . . . . 0.0 106.326 -173.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -82.5 54.46 2.63 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.008 1.323 . . . . 0.0 108.167 173.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.554 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 15.6 p80 -102.8 -64.48 1.07 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 -159.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.554 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 16.3 t-20 -109.47 5.9 23.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.461 1.904 . . . . 0.0 112.33 173.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.1 tt -125.15 152.83 31.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 126.0 1.72 . . . . 0.0 107.22 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -132.6 135.44 45.89 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.172 0.589 . . . . 0.0 109.475 173.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.15 146.38 49.52 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.623 2.369 . . . . 0.0 111.381 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -143.0 113.04 7.11 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 127.183 2.193 . . . . 0.0 107.468 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.56 158.54 20.11 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 122.538 1.161 . . . . 0.0 111.014 -177.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -164.39 176.99 8.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.127 2.571 . . . . 0.0 109.803 -172.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.271 0.0 OUTLIER -109.27 39.02 2.16 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.465 -1.397 . . . . 0.0 111.865 170.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.7 m -73.04 18.62 0.1 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 pp -130.66 0.91 4.42 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.172 -0.955 . . . . 0.0 111.542 158.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.67 1.94 60.08 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 117.747 -1.585 . . . . 0.0 113.665 -170.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.1 mmt -136.99 -95.68 0.22 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.366 1.583 . . . . 0.0 108.626 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.0 t -137.23 113.45 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 18.8 ttt180 -120.71 151.17 39.87 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 165.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 8.6 t -157.37 123.17 4.7 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -171.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -64.77 154.21 37.58 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.349 0.522 . . . . 0.0 110.522 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 78.5 t -134.39 107.91 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mp -129.44 172.45 11.52 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 171.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 42.4 t -66.56 148.35 52.01 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.05 -33.39 73.23 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 119.138 -0.458 . . . . 0.0 110.703 171.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.413 ' HG2' ' H ' ' A' ' 24' ' ' ILE . 10.4 tpt85 -106.23 -83.51 0.52 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 117.336 -1.316 . . . . 0.0 114.016 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 20.6 p -64.49 27.74 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 119.595 3.183 . . . . 0.0 119.595 -157.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 64.28 -19.59 0.07 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 158.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.65 164.32 23.64 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -159.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -38.09 -58.5 0.95 Allowed 'General case' 0 C--N 1.346 0.415 0 C-N-CA 128.42 2.688 . . . . 0.0 113.291 -174.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.502 ' CD2' ' HG ' ' A' ' 142' ' ' SER . 0.4 OUTLIER 45.01 -108.84 0.15 Allowed 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.752 2.021 . . . . 0.0 109.065 -173.36 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.69 -124.68 0.9 Allowed Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.792 170.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.21 166.24 30.0 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 122.953 0.501 . . . . 0.0 110.932 -175.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.3 p -115.38 143.28 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 126.176 1.79 . . . . 0.0 109.457 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -144.77 159.28 43.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.819 0.848 . . . . 0.0 110.906 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -67.86 76.07 0.21 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.109 2.164 . . . . 0.0 111.588 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -157.3 20.72 0.3 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.323 1.449 . . . . 0.0 111.601 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.74 171.44 17.13 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 120.414 -1.429 . . . . 0.0 113.278 -173.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.03 152.77 68.03 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.754 2.303 . . . . 0.0 110.15 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -63.32 151.95 86.06 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 162.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.8 -41.27 1.02 Allowed 'Cis proline' 0 C--N 1.347 0.465 0 CA-C-N 120.626 1.259 . . . . 0.0 113.848 11.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.2 p -67.97 -30.11 69.32 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -169.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.18 -1.89 39.0 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.649 1.118 . . . . 0.0 113.576 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -120.26 147.81 44.5 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.552 1.176 . . . . 0.0 110.011 -168.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -123.4 110.38 15.06 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 126.923 2.089 . . . . 0.0 107.753 -169.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -86.01 137.95 32.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.659 1.984 . . . . 0.0 107.026 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 17.1 t -140.11 138.64 35.44 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 168.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -145.64 153.01 40.56 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.326 0.65 . . . . 0.0 110.558 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -149.47 127.43 11.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.734 1.614 . . . . 0.0 108.827 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.502 ' HG ' ' CD2' ' A' ' 123' ' ' LEU . 97.2 p -166.79 175.17 7.99 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.799 0.84 . . . . 0.0 109.219 166.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.06 -13.89 8.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.872 0.869 . . . . 0.0 112.824 164.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.28 -12.01 60.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.484 1.038 . . . . 0.0 112.693 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 53.5 mt -84.53 81.93 8.63 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.902 1.228 . . . . 0.0 112.144 -170.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -92.42 126.73 37.63 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 162.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -75.72 146.73 39.89 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 162.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.7 pt -144.9 165.38 22.63 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 118.817 0.735 . . . . 0.0 110.868 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -60.21 174.87 1.24 Allowed 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.041 2.494 . . . . 0.0 111.675 159.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -55.02 -25.75 32.5 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -164.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 152' ' ' GLN . 23.9 p-10 -166.14 -61.71 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 128.192 2.597 . . . . 0.0 110.757 159.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.413 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 23.8 mm-40 -153.2 -0.41 0.24 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 130.669 3.587 . . . . 0.0 109.672 -163.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -62.08 -18.53 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.021 0.928 . . . . 0.0 112.003 169.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.404 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 158.968 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.3 pt -138.67 145.13 44.87 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.412 0.685 . . . . 0.0 111.865 -158.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.56 117.33 3.68 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.274 2.649 . . . . 0.0 110.236 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.1 mm -79.56 101.15 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 163.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -108.96 109.54 20.62 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 t -82.88 96.21 8.19 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.72 -34.67 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 120.749 1.613 . . . . 0.0 109.118 173.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.81 -20.99 0.55 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 171.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -131.25 3.06 4.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.861 1.664 . . . . 0.0 112.184 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 t30 37.26 64.1 0.65 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.892 1.677 . . . . 0.0 111.224 -158.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.8 mtp-105 -107.38 157.99 17.52 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 168.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.12 137.32 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 158.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -134.27 156.52 48.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 159.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 33.6 ttm -112.95 131.9 55.56 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 68.9 t -136.08 155.68 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.726 1.611 . . . . 0.0 106.82 -170.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -68.53 154.44 41.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.63 -1.294 . . . . 0.0 111.288 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.86 147.63 52.99 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 162.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.1 tt -60.68 122.12 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.278 0.631 . . . . 0.0 109.484 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -148.19 108.1 4.03 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 104.235 -2.505 . . . . 0.0 104.235 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.4 mt -135.69 177.9 7.47 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.944 1.298 . . . . 0.0 109.361 -173.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 90.2 p -83.45 176.01 9.39 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 159.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -62.2 -48.59 79.33 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.731 -0.606 . . . . 0.0 110.804 176.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.36 -20.71 65.61 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -169.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -58.84 -42.16 88.65 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.804 0.842 . . . . 0.0 111.229 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -61.69 10.99 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.887 2.475 . . . . 0.0 115.852 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.54 -10.22 3.19 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.736 1.215 . . . . 0.0 113.858 171.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -119.99 -17.5 8.41 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.845 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 pt -112.04 4.88 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 119.342 0.974 . . . . 0.0 112.337 168.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -110.57 163.69 13.47 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.457 1.103 . . . . 0.0 110.826 -176.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.92 136.09 79.62 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 163.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.44 -17.08 53.13 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.081 1.854 . . . . 0.0 111.431 173.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -72.58 -41.33 65.79 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 118.53 -0.748 . . . . 0.0 110.114 170.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.32 -45.64 93.59 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 119.7 1.136 . . . . 0.0 110.091 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -55.92 -47.38 77.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.764 0.825 . . . . 0.0 111.588 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -73.26 -47.89 39.37 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 117.643 -1.17 . . . . 0.0 108.051 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 37.0 t -55.43 -29.6 24.31 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 124.516 1.126 . . . . 0.0 110.297 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.09 -22.57 66.95 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.47 -33.18 16.07 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.363 1.438 . . . . 0.0 111.304 175.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -102.02 -1.06 32.56 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 124.429 1.092 . . . . 0.0 112.34 -167.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 41.18 39.97 1.04 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.559 1.544 . . . . 0.0 111.15 -168.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.499 0 CA-C-O 117.568 -1.685 . . . . 0.0 115.054 173.906 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 t70 . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.1 -177.43 33.15 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -164.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.1 pt -133.91 155.29 39.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 121.578 0.704 . . . . 0.0 109.403 176.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -78.86 146.22 33.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 3.8 tmt_? -138.24 109.45 6.86 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.243 1.017 . . . . 0.0 108.45 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.19 101.34 0.4 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.504 1.522 . . . . 0.0 108.194 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.8 tt -63.14 -28.4 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.626 0.77 . . . . 0.0 110.715 -170.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.0 m -83.45 11.87 6.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.478 1.911 . . . . 0.0 112.255 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.4 p -143.39 -7.11 0.79 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.577 0.751 . . . . 0.0 111.859 158.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.31 1.85 83.54 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.369 1.461 . . . . 0.0 113.131 177.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.0 m -119.82 147.57 44.5 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.228 1.514 . . . . 0.0 112.582 -159.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 10.1 p-10 -91.33 155.89 18.18 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.757 1.623 . . . . 0.0 113.221 -173.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.255 0.2 OUTLIER -162.34 -109.63 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.037 1.735 . . . . 0.0 110.013 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -51.62 120.3 5.04 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.338 1.055 . . . . 0.0 112.587 -159.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.31 139.63 48.09 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -20.62 65.82 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.99 -13.2 59.45 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.321 -1.487 . . . . 0.0 113.057 170.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.4 p -84.38 -19.39 33.64 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.991 -1.068 . . . . 0.0 112.564 166.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.28 86.78 2.25 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.707 1.603 . . . . 0.0 107.378 -166.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -135.0 133.52 39.53 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -142.07 114.17 8.15 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 168.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.6 p -70.78 71.93 0.53 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.024 1.729 . . . . 0.0 111.348 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.31 -44.55 1.08 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.098 1.333 . . . . 0.0 111.461 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.29 -46.6 17.42 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.181 0.99 . . . . 0.0 109.551 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 53.83 15.88 5.23 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.662 2.077 . . . . 0.0 115.882 -170.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -50.5 144.64 11.95 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 125.406 1.483 . . . . 0.0 112.782 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.98 65.02 6.06 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.375 3.384 . . . . 0.0 111.827 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.1 p -129.53 142.28 50.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.906 0.883 . . . . 0.0 109.041 164.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.4 167.53 21.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.973 1.709 . . . . 0.0 108.589 -168.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -122.42 -8.69 8.59 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.435 0.694 . . . . 0.0 112.679 -169.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -156.36 179.99 8.72 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.3 m -131.31 162.61 39.0 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-N 119.579 1.081 . . . . 0.0 112.305 -171.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.2 p -55.84 -38.41 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.211 1.405 . . . . 0.0 111.037 166.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.4 m 141.78 154.03 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 1 C-N-CA 132.194 4.198 . . . . 0.0 108.555 -173.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 53.3 mp0 -71.24 59.79 0.27 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.992 1.717 . . . . 0.0 109.914 166.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -105.46 -47.88 3.82 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.763 1.225 . . . . 0.0 108.526 -175.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.96 12.52 7.81 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 125.095 1.358 . . . . 0.0 112.28 170.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.89 145.82 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 125.369 1.468 . . . . 0.0 107.677 169.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -120.07 144.82 47.38 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.174 1.79 . . . . 0.0 108.329 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mp -131.74 157.21 44.4 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.89 1.276 . . . . 0.0 110.484 167.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.42 ' HE ' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -135.27 142.92 46.01 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 130.868 3.667 . . . . 0.0 102.817 164.42 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -126.76 130.76 50.94 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.936 1.294 . . . . 0.0 109.216 -165.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 105' ' ' ARG . 18.1 t70 -144.55 -170.98 3.51 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.528 2.331 . . . . 0.0 108.419 -172.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.443 ' H ' ' CG ' ' A' ' 104' ' ' ASP . 34.1 ptt180 -115.85 6.92 14.39 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.582 2.353 . . . . 0.0 112.119 -178.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -65.98 31.64 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 130.154 3.382 . . . . 0.0 116.968 -163.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 pp -133.08 -7.13 3.05 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.509 1.524 . . . . 0.0 112.278 160.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.44 1.64 35.2 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 117.441 -1.755 . . . . 0.0 113.029 -168.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.3 mtt -141.94 -89.18 0.15 Allowed 'General case' 0 C--N 1.348 0.513 0 CA-C-N 120.322 2.061 . . . . 0.0 109.024 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.3 p -150.41 109.76 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -117.76 124.27 48.03 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.487 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.83 144.61 50.58 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.42 ' CD ' ' HE ' ' A' ' 102' ' ' ARG . 10.3 pt-20 -75.75 157.22 33.8 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 173.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.1 t -136.57 110.73 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -135.82 150.61 49.49 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 51.9 t -72.66 108.13 5.51 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.62 -30.13 67.03 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.225 1.41 . . . . 0.0 112.029 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.02 -21.07 66.37 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 118.805 -0.617 . . . . 0.0 112.422 176.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 5.6 p -121.44 -100.76 0.42 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 165.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.2 p30 156.02 30.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 128.489 2.716 . . . . 0.0 110.606 -165.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.9 166.11 10.95 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.253 1.021 . . . . 0.0 111.844 -167.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -30.35 -78.3 0.02 OUTLIER 'General case' 0 C--N 1.339 0.138 0 C-N-CA 129.585 3.154 . . . . 0.0 116.016 -159.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.2 mt 43.55 -111.55 0.2 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.588 1.555 . . . . 0.0 111.807 -170.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.37 -109.36 0.3 Allowed Glycine 0 C--N 1.336 0.532 0 CA-C-N 119.623 1.101 . . . . 0.0 113.333 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -147.01 179.83 7.33 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 112.147 -166.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.97 144.83 36.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.715 1.606 . . . . 0.0 108.289 159.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -136.0 161.67 35.02 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.446 1.098 . . . . 0.0 110.394 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.11 117.78 14.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.903 0.881 . . . . 0.0 109.538 172.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.57 -28.87 0.11 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.05 155.52 40.65 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.12 -13.98 21.0 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.52 2.147 . . . . 0.0 113.295 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.2 ptt-85 134.57 167.28 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.918 1 C-N-CA 133.97 4.908 . . . . 0.0 106.293 -163.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.94 -58.29 0.12 OUTLIER 'Cis proline' 0 C--N 1.351 0.681 0 CA-C-N 122.314 1.862 . . . . 0.0 111.875 -3.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.4 p -69.69 -25.07 63.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.474 1.51 . . . . 0.0 112.862 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.39 -6.64 28.99 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.961 1.267 . . . . 0.0 113.343 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -115.69 152.52 33.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 120.914 -1.345 . . . . 0.0 110.017 -169.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -122.96 106.07 10.53 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.92 2.088 . . . . 0.0 107.452 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -70.15 133.93 47.61 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 162.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 23.3 t -140.71 129.45 22.97 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 174.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -129.83 147.24 51.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.28 0.632 . . . . 0.0 110.063 -175.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -139.34 99.96 3.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.4 p -138.9 166.88 23.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 162.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.27 -13.51 60.78 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.183 170.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -81.59 0.04 40.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 114.792 1.405 . . . . 0.0 114.792 -165.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 72.4 mt -79.5 54.23 1.71 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.715 1.606 . . . . 0.0 112.116 -164.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -70.59 145.1 50.95 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -85.38 156.31 20.92 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 166.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 30.6 pt -136.91 162.96 52.82 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 158.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.49 168.45 6.61 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.559 1.506 . . . . 0.0 111.238 164.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -31.66 -36.65 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 130.583 3.553 . . . . 0.0 118.21 -169.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -176.14 -57.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.564 1.946 . . . . 0.0 107.5 169.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -157.31 66.48 0.5 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -176.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -121.74 -2.55 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.686 1.194 . . . . 0.0 111.071 161.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 0 C-N-CA 129.369 3.366 . . . . 0.0 105.699 159.685 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 7.0 mmm180 . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.2 pt -126.48 109.24 23.37 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 127.08 2.152 . . . . 0.0 109.383 -174.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.55 101.41 1.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.567 2.178 . . . . 0.0 108.52 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.1 mt -76.78 151.68 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -137.93 101.73 4.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.727 1.611 . . . . 0.0 106.859 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.0 m -68.35 73.74 0.23 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.177 0.899 . . . . 0.0 108.818 159.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.32 -30.8 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 121.772 -0.58 . . . . 0.0 110.438 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.4 -27.88 1.86 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.441 2.296 . . . . 0.0 113.64 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -130.73 15.62 5.34 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.081 2.153 . . . . 0.0 110.819 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 32.59 52.24 0.28 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.805 2.842 . . . . 0.0 113.604 -165.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -86.82 167.44 14.38 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.917 -0.49 . . . . 0.0 109.771 165.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.4 t -143.28 132.81 21.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -145.65 102.19 3.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.988 1.315 . . . . 0.0 108.713 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.3 ttt -82.86 118.99 23.82 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.436 -0.79 . . . . 0.0 111.019 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.2 t -113.78 -177.77 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 128.535 2.734 . . . . 0.0 106.524 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 4.1 pm0 -112.94 160.86 17.65 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.842 1.655 . . . . 0.0 112.103 177.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -56.74 154.86 8.43 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.9 1.28 . . . . 0.0 110.996 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -72.9 124.1 29.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -176.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -148.12 115.7 6.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 163.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.3 mt -138.36 -177.81 5.01 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 128.669 2.788 . . . . 0.0 105.984 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.9 m -167.17 -24.39 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 30' ' ' GLU . 4.4 t70 -91.73 -152.5 0.3 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.119 0.872 . . . . 0.0 109.462 -176.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.91 5.19 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.454 1.902 . . . . 0.0 114.101 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.469 ' H ' ' C ' ' A' ' 28' ' ' ASP . 36.4 mt-10 -60.43 -45.1 94.85 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 126.633 1.973 . . . . 0.0 110.58 -162.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -68.65 42.41 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.468 2.307 . . . . 0.0 113.104 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.9 -34.05 0.09 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.793 1.637 . . . . 0.0 110.634 160.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -91.08 -24.65 19.95 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.012 -0.994 . . . . 0.0 113.451 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 pt -108.43 15.53 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 120.203 1.365 . . . . 0.0 112.464 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.79 175.98 9.12 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.261 1.424 . . . . 0.0 109.837 -167.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.482 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -61.95 135.13 94.51 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 166.352 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -66.31 -12.4 35.47 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.929 1.753 . . . . 0.0 110.886 165.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -76.51 -43.05 41.08 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.367 167.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.482 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -57.38 -47.59 81.28 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 119.541 1.064 . . . . 0.0 109.841 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -48.1 -52.41 20.53 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.669 1.987 . . . . 0.0 111.603 175.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ptt-85 -76.08 -47.98 22.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.383 -0.818 . . . . 0.0 109.206 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.0 t -58.21 -27.11 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 124.91 1.284 . . . . 0.0 109.518 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.44 -13.04 36.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 171.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -112.44 -26.06 8.89 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.417 1.462 . . . . 0.0 112.061 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt -112.48 14.5 20.26 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.989 1.716 . . . . 0.0 112.043 -172.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.67 -12.96 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 130.052 3.341 . . . . 0.0 116.408 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.684 0 C-N-CA 124.908 1.242 . . . . 0.0 113.956 178.042 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 122.254 1.025 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.62 177.51 46.72 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.694 -161.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.3 pt -136.96 171.68 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.44 1.496 . . . . 0.0 108.538 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -96.56 136.04 37.63 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.994 0.518 . . . . 0.0 110.571 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 0.0 OUTLIER -102.32 120.09 39.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 163.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 35.1 t -65.79 90.7 0.13 Allowed 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 169.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.8 tt -66.57 -10.05 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.482 0.713 . . . . 0.0 111.735 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.7 t -77.94 -3.01 39.69 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.638 1.175 . . . . 0.0 111.759 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.3 p -154.68 -5.45 0.15 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 173.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.431 ' C ' ' HG1' ' A' ' 72' ' ' THR . . . 68.21 62.03 4.45 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -174.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.431 ' HG1' ' C ' ' A' ' 71' ' ' GLY . 62.9 m -154.52 137.98 15.9 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 121.035 -1.274 . . . . 0.0 108.523 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 37.1 m-20 -101.19 157.21 16.95 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.942 0.792 . . . . 0.0 110.333 -167.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.25 0.3 OUTLIER -159.72 -103.16 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.377 1.071 . . . . 0.0 112.657 -179.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -52.65 121.2 6.7 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -158.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.07 122.38 15.38 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.628 1.171 . . . . 0.0 108.754 168.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 t -66.61 -15.93 63.81 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -167.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -70.36 -16.8 63.02 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.41 1.084 . . . . 0.0 112.506 173.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.1 p -71.25 -22.64 61.95 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.366 -0.834 . . . . 0.0 111.484 167.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -98.63 -172.57 2.34 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.539 1.536 . . . . 0.0 109.839 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.73 8.14 16.07 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.659 1.183 . . . . 0.0 113.536 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -53.11 134.86 38.42 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 159.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.4 p 111.44 -36.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 1 C-N-CA 132.482 4.313 . . . . 0.0 111.29 -166.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.32 -69.27 0.39 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 -173.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.1 t -118.96 -21.21 7.81 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.722 0.809 . . . . 0.0 111.266 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.08 11.79 13.38 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.69 1.138 . . . . 0.0 114.525 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -62.82 130.84 94.18 Favored Pre-proline 0 C--O 1.237 0.439 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.63 70.03 5.84 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.895 3.063 . . . . 0.0 112.613 -165.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 72.3 p -138.01 154.18 49.34 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.019 1.728 . . . . 0.0 110.055 173.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -145.17 170.21 16.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.645 1.578 . . . . 0.0 109.08 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -128.06 -13.52 5.09 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -175.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -141.42 178.16 7.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 169.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.29 160.89 22.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.918 0.865 . . . . 0.0 111.439 -167.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 p -59.74 -40.15 81.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 125.55 1.54 . . . . 0.0 111.038 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.5 m 156.73 156.65 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.286 1 C-N-CA 131.747 4.019 . . . . 0.0 106.495 -176.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -75.61 48.79 0.47 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.72 2.008 . . . . 0.0 109.794 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -110.4 -46.93 3.34 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.406 -0.808 . . . . 0.0 109.654 -159.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.56 17.69 8.84 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 124.17 0.988 . . . . 0.0 112.118 170.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.38 135.65 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 174.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.439 ' HD2' ' H ' ' A' ' 101' ' ' LEU . 39.0 tptt -108.56 144.24 36.52 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.306 1.842 . . . . 0.0 108.991 -173.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.439 ' H ' ' HD2' ' A' ' 100' ' ' LYS . 54.9 mt -138.39 128.79 26.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 130.355 3.462 . . . . 0.0 107.468 -167.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.39 114.7 13.99 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 128.716 2.806 . . . . 0.0 104.778 163.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -101.73 142.4 33.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 124.283 0.989 . . . . 0.0 110.822 -172.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -148.34 176.68 10.07 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.605 2.362 . . . . 0.0 107.577 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.83 10.24 36.03 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 119.977 -1.702 . . . . 0.0 112.494 172.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.0 t -58.31 16.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 130.157 3.383 . . . . 0.0 119.342 -158.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 pp -128.85 -6.25 5.06 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.694 1.198 . . . . 0.0 112.136 168.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.69 -1.66 32.19 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 117.246 -1.863 . . . . 0.0 113.38 -167.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -141.29 -91.15 0.15 Allowed 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.648 2.224 . . . . 0.0 108.74 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 56.8 t -141.72 114.59 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.439 HH21 ' CE1' ' A' ' 125' ' ' HIS . 22.2 ttt180 -118.86 127.82 53.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.359 1.037 . . . . 0.0 108.512 168.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 23.7 t -127.17 146.25 50.47 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 171.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -68.64 162.3 26.27 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.995 0.816 . . . . 0.0 110.508 172.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.2 t -142.43 100.52 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 174.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mp -130.82 162.22 30.04 Favored 'General case' 0 N--CA 1.461 0.116 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.6 t -71.82 124.52 25.0 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.21 -9.01 20.02 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.396 0.678 . . . . 0.0 111.76 174.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.98 -25.5 15.36 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.54 1.936 . . . . 0.0 113.011 170.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 31.2 p -159.71 95.38 1.2 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.6 1.56 . . . . 0.0 109.514 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.9 32.51 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.004 1 C-N-CA 131.79 4.036 . . . . 0.0 113.068 178.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.91 -63.57 1.25 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -158.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.435 ' H ' HD23 ' A' ' 123' ' ' LEU . 50.7 t-80 -158.0 -64.46 0.09 Allowed 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 174.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.435 HD23 ' H ' ' A' ' 122' ' ' HIS . 2.3 mm? 54.02 -106.32 0.3 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.153 2.181 . . . . 0.0 106.464 173.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 176.62 -120.43 0.74 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.228 -0.986 . . . . 0.0 112.685 167.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.439 ' CE1' HH21 ' A' ' 111' ' ' ARG . 22.6 p-80 -159.69 173.68 15.69 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.749 -0.266 . . . . 0.0 110.761 -168.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.4 p -123.61 143.38 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.579 1.552 . . . . 0.0 107.884 171.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -138.79 151.74 47.31 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.273 1.029 . . . . 0.0 109.413 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -65.83 118.5 9.76 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 170.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -142.57 -47.06 0.33 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.068 0.947 . . . . 0.0 113.511 -168.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -104.45 -179.78 24.77 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.096 1.332 . . . . 0.0 114.566 -159.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.22 147.16 83.22 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.108 2.539 . . . . 0.0 110.186 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -77.43 159.34 77.6 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 118.731 -0.652 . . . . 0.0 109.451 -174.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.35 -49.17 0.24 Allowed 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 120.037 1.049 . . . . 0.0 111.521 0.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.3 p -77.74 76.24 4.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 123.043 1.401 . . . . 0.0 109.907 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -110.0 7.53 31.17 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 128.138 2.78 . . . . 0.0 110.249 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -78.2 138.65 38.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.712 1.756 . . . . 0.0 106.754 163.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.21 101.05 10.56 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 173.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -67.74 143.4 55.91 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 161.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 36.3 t -146.6 137.44 24.07 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.139 1.375 . . . . 0.0 108.497 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -138.43 153.99 48.87 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.759 0.824 . . . . 0.0 111.262 -177.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -156.33 114.76 3.36 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.14 2.176 . . . . 0.0 107.334 173.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.0 p -171.87 177.82 3.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.472 1.509 . . . . 0.0 108.995 174.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.31 21.45 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.113 1.765 . . . . 0.0 113.1 165.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -90.91 -15.88 29.09 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.98 1.264 . . . . 0.0 113.286 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.4 mt -83.46 88.49 6.99 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.376 0.535 . . . . 0.0 111.802 -159.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -127.87 114.32 17.05 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.427 1.091 . . . . 0.0 108.915 167.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -68.86 145.47 53.68 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 163.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.2 pt -137.8 163.4 48.42 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 125.329 1.452 . . . . 0.0 109.382 168.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.18 161.13 11.64 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.232 1.954 . . . . 0.0 111.694 166.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -34.13 -24.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 131.543 3.937 . . . . 0.0 120.273 -167.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -167.42 -82.37 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.253 1.821 . . . . 0.0 107.289 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -141.73 9.63 1.98 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.967 2.107 . . . . 0.0 110.191 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.9 pp -69.81 -16.25 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -167.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 116.783 -2.121 . . . . 0.0 112.077 170.897 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 121.413 0.625 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 pt -122.72 102.57 38.39 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 124.852 1.261 . . . . 0.0 110.447 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.2 99.46 1.01 Allowed 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.375 2.05 . . . . 0.0 109.325 174.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.4 mt -79.85 88.31 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -78.26 97.31 5.5 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -69.55 72.0 0.33 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 160.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.1 t -56.26 -37.98 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 123.677 0.791 . . . . 0.0 111.506 -170.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.09 -12.17 25.07 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -125.54 7.12 7.6 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.248 1.819 . . . . 0.0 111.067 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 31.39 48.31 0.08 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 128.72 2.808 . . . . 0.0 112.81 -161.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -90.18 157.96 17.47 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 168.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.5 t -148.77 92.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 -176.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -100.48 102.96 14.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 32.9 ttm -80.05 87.41 5.44 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.669 173.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 80.8 t -84.47 174.7 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 125.853 1.661 . . . . 0.0 107.001 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -105.74 155.18 19.53 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 120.232 -1.542 . . . . 0.0 110.55 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.54 150.05 41.43 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.24 113.77 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -139.84 105.34 5.09 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 162.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.6 mt -133.12 171.89 13.39 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.492 1.517 . . . . 0.0 109.306 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.6 t -85.32 165.38 17.33 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 158.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.2 -38.8 74.22 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.138 0.881 . . . . 0.0 110.111 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.95 -25.78 65.46 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -170.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -67.56 -45.06 76.7 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.818 1.647 . . . . 0.0 109.846 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -61.2 10.93 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.058 2.143 . . . . 0.0 115.864 -174.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.75 -5.79 4.07 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 173.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -128.7 -18.96 3.79 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.639 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 pt -104.97 4.41 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.88 0.763 . . . . 0.0 111.391 166.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mt -112.36 160.46 17.68 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.85 1.26 . . . . 0.0 110.372 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.4 145.51 75.23 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.65 -4.48 12.21 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.678 2.252 . . . . 0.0 112.33 166.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -77.93 -56.43 4.5 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.725 1.21 . . . . 0.0 109.996 162.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.74 -42.48 71.66 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.571 1.078 . . . . 0.0 111.223 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -58.03 -47.2 83.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.956 1.302 . . . . 0.0 111.613 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -75.69 -38.86 58.32 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 119.458 1.026 . . . . 0.0 110.572 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 t -55.05 -28.61 21.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.943 1.297 . . . . 0.0 111.068 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.88 -20.57 63.88 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 172.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -101.3 -45.11 5.44 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 119.722 1.146 . . . . 0.0 111.807 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -89.93 12.55 17.11 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.591 1.087 . . . . 0.0 112.833 -174.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.37 36.75 1.16 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 128.082 2.553 . . . . 0.0 113.557 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.697 0 CA-C-O 119.883 -0.398 . . . . 0.0 113.688 171.128 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.6 t70 . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 121.803 0.811 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.63 151.83 24.72 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.684 1.611 . . . . 0.0 111.944 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.8 pt -132.85 161.94 40.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 125.171 1.388 . . . . 0.0 108.178 169.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -82.67 142.5 31.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.012 0.434 . . . . 0.0 110.144 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.8 140.33 49.01 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 124.372 1.069 . . . . 0.0 110.2 160.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.2 t -70.6 84.49 0.62 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 162.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.9 tp -59.74 -13.37 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.044 1.338 . . . . 0.0 112.218 172.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.7 t -78.47 1.89 20.78 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.635 1.574 . . . . 0.0 111.737 173.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.6 p -159.02 -9.56 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 170.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.35 64.31 2.67 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -173.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.22 135.23 30.51 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.113 2.165 . . . . 0.0 106.238 176.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -100.13 152.34 20.36 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.555 1.525 . . . . 0.0 112.222 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.283 0.0 OUTLIER -154.51 -107.97 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.387 1.075 . . . . 0.0 112.864 178.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -50.49 121.69 6.06 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.467 1.907 . . . . 0.0 113.622 -160.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -86.95 156.84 19.63 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.139 0.976 . . . . 0.0 111.402 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.1 t -56.8 -17.71 10.17 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -63.55 -26.96 68.94 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.862 1.664 . . . . 0.0 111.43 170.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.1 p -92.05 -47.14 7.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.211 1.405 . . . . 0.0 109.177 174.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.35 112.55 15.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.793 1.237 . . . . 0.0 109.725 -159.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -52.59 145.73 11.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.959 0.904 . . . . 0.0 111.165 173.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -140.93 -69.62 0.38 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.789 1.236 . . . . 0.0 110.287 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.7 m -73.16 120.51 18.88 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.53 -158.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.92 -64.95 3.3 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.6 m -120.37 78.67 1.38 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.734 1.214 . . . . 0.0 108.703 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -77.76 32.84 1.67 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 123.884 0.754 . . . . 0.0 113.895 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -59.54 152.6 55.11 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 125.14 1.376 . . . . 0.0 112.002 -172.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.91 60.09 7.61 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.297 2.665 . . . . 0.0 109.657 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.1 p -145.49 145.92 31.26 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 163.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -153.69 175.45 13.24 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.578 1.151 . . . . 0.0 109.463 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -112.1 -12.87 13.62 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.619 0.768 . . . . 0.0 112.384 -164.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -154.49 -175.86 5.61 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -173.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.75 154.35 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 124.861 1.264 . . . . 0.0 109.478 -163.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.7 p -62.17 -32.34 54.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 122.581 0.352 . . . . 0.0 110.197 164.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.1 m 153.03 165.83 0.01 OUTLIER 'General case' 0 C--O 1.234 0.238 1 C-N-CA 132.943 4.497 . . . . 0.0 106.51 -175.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -107.96 75.97 1.03 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -132.46 -28.8 1.62 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.357 1.463 . . . . 0.0 112.597 -161.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.71 16.57 11.93 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.636 1.175 . . . . 0.0 111.876 167.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.0 tt -132.22 146.18 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 125.94 1.696 . . . . 0.0 108.114 -173.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -127.92 124.47 37.45 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.815 1.246 . . . . 0.0 108.834 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 mp -118.79 139.8 51.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.032 2.133 . . . . 0.0 108.756 -173.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -131.61 116.91 18.0 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.673 1.589 . . . . 0.0 106.715 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -79.19 135.67 36.87 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.693 1.235 . . . . 0.0 112.174 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.496 ' CG ' ' H ' ' A' ' 105' ' ' ARG . 19.2 t70 -143.41 -172.03 3.62 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.351 1.86 . . . . 0.0 110.697 170.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.496 ' H ' ' CG ' ' A' ' 104' ' ' ASP . 0.2 OUTLIER -122.7 7.16 9.41 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.537 2.735 . . . . 0.0 111.838 -173.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -65.65 30.42 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 129.928 3.291 . . . . 0.0 116.905 -161.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pp -131.09 -2.52 4.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.017 1.327 . . . . 0.0 112.023 161.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.14 3.31 51.36 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 117.908 -1.496 . . . . 0.0 112.415 -168.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.5 mtp -140.69 -95.35 0.15 Allowed 'General case' 0 C--N 1.347 0.494 0 CA-C-N 120.01 1.905 . . . . 0.0 107.993 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.8 t -142.64 111.4 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -119.03 100.72 7.53 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.768 1.227 . . . . 0.0 107.966 171.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 36.1 t -100.9 128.07 47.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.62 158.96 22.98 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.968 0.804 . . . . 0.0 110.099 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 95.0 t -141.65 98.95 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.3 mp -126.84 164.26 21.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 174.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.3 m -77.47 145.29 37.15 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.403 -1.436 . . . . 0.0 110.625 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -82.14 -22.89 35.9 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.09 0.956 . . . . 0.0 111.249 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -38.22 54.33 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 117.993 -1.003 . . . . 0.0 111.092 169.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.2 p -147.58 115.72 6.54 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 173.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.53 56.28 0.06 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.411 1.485 . . . . 0.0 111.304 176.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.14 168.38 16.89 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.242 1.817 . . . . 0.0 110.682 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -44.69 -64.04 0.78 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.756 2.022 . . . . 0.0 113.264 -161.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 50.94 -114.29 0.77 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.414 1.886 . . . . 0.0 107.983 174.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.22 -119.65 0.68 Allowed Glycine 0 CA--C 1.522 0.518 0 CA-C-N 118.653 0.66 . . . . 0.0 113.271 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 54.1 p-80 -161.18 170.7 19.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.237 0.615 . . . . 0.0 110.648 -170.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.6 p -115.2 139.61 40.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.161 1.384 . . . . 0.0 108.283 172.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -132.23 150.47 52.15 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 123.593 0.558 . . . . 0.0 110.812 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -66.42 108.59 2.42 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.732 1.213 . . . . 0.0 109.206 174.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.33 -44.47 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.683 1.193 . . . . 0.0 112.257 -170.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.74 -179.65 32.51 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.222 0.915 . . . . 0.0 114.94 -159.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.55 165.25 31.35 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.219 2.613 . . . . 0.0 110.629 171.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.72 154.87 84.14 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 164.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.46 -55.52 0.14 OUTLIER 'Cis proline' 0 C--N 1.348 0.55 0 CA-C-N 120.745 1.302 . . . . 0.0 113.751 10.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 19.1 p -66.7 -31.16 71.64 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.366 1.067 . . . . 0.0 113.149 -166.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 71.81 -2.37 25.08 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.052 0.834 . . . . 0.0 114.797 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -103.38 159.09 15.87 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.3 1.05 . . . . 0.0 108.863 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.4 ttp85 -129.14 99.91 5.43 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.68 1.192 . . . . 0.0 108.856 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -62.5 132.15 51.52 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.656 1.582 . . . . 0.0 107.413 163.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 42.6 t -141.77 144.86 34.19 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.654 1.116 . . . . 0.0 109.386 173.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.5 ptp -149.76 158.19 43.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.457 0.646 . . . . 0.0 110.655 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.17 89.17 1.93 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.566 2.346 . . . . 0.0 106.096 -176.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.433 ' HB3' ' H ' ' A' ' 144' ' ' ALA . 2.8 m -147.2 162.27 39.23 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.31 1.444 . . . . 0.0 108.63 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.7 -20.31 65.62 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.355 1.062 . . . . 0.0 113.072 163.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.433 ' H ' ' HB3' ' A' ' 142' ' ' SER . . . -62.81 29.3 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 130.661 3.584 . . . . 0.0 114.881 -175.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 93.8 mt -132.81 47.41 2.51 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.283 1.833 . . . . 0.0 108.861 -168.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.6 tttt -74.43 122.45 23.01 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -66.95 131.9 46.82 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 165.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 17.2 pt -114.17 164.42 16.27 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 160.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -60.13 173.26 1.94 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 121.657 1.571 . . . . 0.0 110.038 160.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -41.77 -28.34 0.15 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -168.75 -83.53 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 170.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -146.14 26.98 1.18 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.169 1.788 . . . . 0.0 110.244 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -73.28 -12.61 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.97 1.308 . . . . 0.0 112.152 170.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.49 0 N-CA-C 106.977 -2.449 . . . . 0.0 106.977 160.483 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.7 mtt85 . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.0 pt -132.55 128.75 21.13 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.046 0.938 . . . . 0.0 110.395 -164.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.17 132.97 17.27 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.86 1.707 . . . . 0.0 110.256 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.9 mm -101.01 148.77 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 160.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.98 91.49 1.79 Allowed 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.872 1.269 . . . . 0.0 107.869 -169.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.9 m -71.37 80.22 0.76 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.579 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.39 -33.96 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.995 1.271 . . . . 0.0 111.09 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.05 -6.75 4.33 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 173.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -130.02 11.45 5.55 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.306 2.242 . . . . 0.0 110.512 170.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.3 t30 28.11 66.82 0.08 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.821 2.448 . . . . 0.0 112.248 -162.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -114.7 161.44 18.13 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.6 t -144.75 122.5 5.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -141.43 98.87 3.44 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -170.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 44.2 ttm -70.52 133.5 46.84 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.077 -1.014 . . . . 0.0 109.477 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.3 t -121.25 161.33 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 176.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -78.46 167.15 21.74 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.186 -1.571 . . . . 0.0 109.565 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.5 mtm105 -63.24 165.2 7.68 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.669 -0.644 . . . . 0.0 109.96 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.2 tp -70.28 120.61 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 167.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -152.43 118.17 5.39 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 160.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.1 mt -140.4 172.86 12.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.885 1.674 . . . . 0.0 108.442 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.486 ' H ' ' CG ' ' A' ' 30' ' ' GLU . 10.7 p -94.51 168.62 10.75 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.019 1.328 . . . . 0.0 109.67 171.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -77.66 70.05 3.99 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.791 0.805 . . . . 0.0 109.5 164.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -167.14 -26.81 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 125.286 1.435 . . . . 0.0 110.988 158.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.486 ' CG ' ' H ' ' A' ' 27' ' ' SER . 23.1 mm-40 -55.62 -45.24 77.56 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.309 0.644 . . . . 0.0 110.348 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -68.19 37.34 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.275 2.63 . . . . 0.0 112.767 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.406 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -149.56 -34.34 0.19 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.632 1.173 . . . . 0.0 111.402 161.466 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -92.24 -26.37 18.2 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.807 -1.092 . . . . 0.0 113.049 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.2 pt -100.81 23.44 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 120.186 1.357 . . . . 0.0 111.467 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.7 mt -122.25 161.49 23.19 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.443 1.097 . . . . 0.0 112.233 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.49 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -61.54 149.03 85.26 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.082 170.334 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -68.83 5.1 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.419 2.746 . . . . 0.0 112.657 167.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -102.79 -39.82 6.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.672 -1.156 . . . . 0.0 111.441 165.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.49 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -60.78 -43.68 97.75 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 121.421 1.919 . . . . 0.0 111.455 -173.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -57.66 -45.7 85.18 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.929 1.292 . . . . 0.0 111.549 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -76.33 -36.78 58.07 Favored 'General case' 0 C--O 1.221 -0.434 0 O-C-N 121.526 -0.734 . . . . 0.0 111.066 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.2 t -55.0 -27.99 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 120.701 -1.25 . . . . 0.0 111.143 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.45 -22.91 67.16 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -93.84 -41.82 9.43 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.514 1.506 . . . . 0.0 111.537 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -96.13 4.82 52.22 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.302 1.841 . . . . 0.0 112.884 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.04 15.58 1.84 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.939 1.695 . . . . 0.0 113.533 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.792 0 CA-C-O 117.702 -1.61 . . . . 0.0 114.805 -179.779 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.61 172.12 17.39 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 122.206 0.892 . . . . 0.0 114.978 166.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.2 pt -136.2 170.79 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.829 1.651 . . . . 0.0 109.618 176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -96.95 111.04 23.43 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.457 1.103 . . . . 0.0 109.999 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.49 113.73 14.42 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 163.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 20.7 t -65.84 85.32 0.08 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.512 1.525 . . . . 0.0 109.14 166.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.1 tt -66.33 -11.61 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.704 1.602 . . . . 0.0 111.587 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.5 m -82.28 -1.44 49.47 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.309 1.844 . . . . 0.0 113.0 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.8 p -152.17 -16.43 0.18 Allowed 'General case' 0 C--N 1.338 0.104 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 165.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.66 65.84 1.59 Allowed Glycine 0 C--N 1.337 0.616 0 N-CA-C 107.593 -2.203 . . . . 0.0 107.593 -162.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.1 m -143.21 166.63 24.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 172.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -135.53 145.89 47.51 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.57 -102.82 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.666 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -54.4 108.01 0.34 Allowed 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.487 1.115 . . . . 0.0 112.815 -159.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.37 135.86 52.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -10.11 57.31 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.38 0.991 . . . . 0.0 112.949 -171.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.91 -20.8 62.64 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.468 -1.395 . . . . 0.0 112.472 163.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.3 p -86.69 -20.14 28.17 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.659 1.184 . . . . 0.0 112.89 168.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -137.05 86.29 2.19 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.229 1.812 . . . . 0.0 107.471 -169.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -139.06 124.24 19.05 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -144.83 93.62 2.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -176.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.0 m -61.81 124.97 22.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.825 1.25 . . . . 0.0 111.14 -170.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.12 -60.88 4.8 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.79 -49.6 70.04 Favored 'General case' 0 CA--C 1.526 0.039 0 CA-C-N 117.941 0.87 . . . . 0.0 112.285 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 42.35 42.11 4.26 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.918 2.199 . . . . 0.0 115.657 -162.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -61.44 143.81 92.79 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 118.528 1.164 . . . . 0.0 108.874 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.14 70.44 6.69 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.02 2.48 . . . . 0.0 110.895 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.3 p -136.44 150.29 48.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.521 1.129 . . . . 0.0 110.967 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.25 166.77 22.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.901 2.08 . . . . 0.0 107.568 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -127.7 -6.9 5.66 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.393 0.677 . . . . 0.0 112.451 -170.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -151.96 -178.02 6.5 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 167.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.23 158.76 43.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 124.105 0.962 . . . . 0.0 111.825 -176.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 p -51.36 -42.44 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 127.271 2.228 . . . . 0.0 111.444 171.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.6 m 157.14 155.07 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.515 1 C-N-CA 131.959 4.104 . . . . 0.0 106.786 -176.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -74.06 75.51 1.73 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 161.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -114.8 -53.51 2.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.573 1.149 . . . . 0.0 108.991 177.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.82 14.33 7.45 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 173.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.5 tt -106.12 154.25 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 159.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -123.49 134.11 53.94 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 166.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 46.8 mt -117.41 148.97 41.29 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.855 2.062 . . . . 0.0 109.02 172.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.17 115.69 15.34 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 162.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.96 143.44 56.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.221 1.409 . . . . 0.0 110.034 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -147.79 -178.97 6.55 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 158.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.95 14.7 9.95 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.024 2.13 . . . . 0.0 110.377 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.8 m -62.33 -21.81 65.57 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 126.194 1.798 . . . . 0.0 115.692 -158.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 pp -77.08 -14.72 59.77 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.556 1.071 . . . . 0.0 112.231 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.86 0.6 25.73 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 117.316 -1.824 . . . . 0.0 113.012 -168.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.0 mmt -143.31 -85.18 0.15 Allowed 'General case' 0 C--N 1.349 0.553 0 CA-C-N 120.456 2.128 . . . . 0.0 107.9 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.2 t -145.19 114.69 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -129.37 103.44 6.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.305 1.442 . . . . 0.0 110.186 172.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 2.6 m -106.85 151.87 24.64 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -70.43 163.68 26.21 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.354 0.979 . . . . 0.0 110.838 171.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.3 t -137.09 107.51 5.38 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 168.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.49 164.49 18.83 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 167.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 17.0 t -65.47 156.22 33.12 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 162.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.72 -28.91 66.21 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . 0.285 0.0 OUTLIER -116.1 -52.45 2.6 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 179.451 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 15.9 p -77.51 77.68 4.03 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 121.077 1.762 . . . . 0.0 109.227 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -52.86 67.04 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 128.983 2.913 . . . . 0.0 111.071 166.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.4 -178.9 4.51 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.37 2.268 . . . . 0.0 110.264 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -43.75 -57.99 2.94 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.259 2.224 . . . . 0.0 113.366 -165.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 42.54 -112.08 0.19 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.616 1.966 . . . . 0.0 109.422 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -178.29 -125.3 0.91 Allowed Glycine 0 CA--C 1.519 0.328 0 CA-C-N 118.954 0.797 . . . . 0.0 113.767 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -158.46 174.87 14.44 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.076 0.55 . . . . 0.0 110.085 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.85 137.14 58.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 124.285 1.034 . . . . 0.0 108.774 171.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -135.07 147.15 49.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.193 0.597 . . . . 0.0 109.675 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -58.66 111.32 1.22 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.842 1.257 . . . . 0.0 109.442 170.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -153.94 -29.5 0.12 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -78.7 155.8 41.69 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.19 -30.02 7.34 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.141 1.894 . . . . 0.0 112.632 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 179.37 168.58 0.64 Allowed Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 128.744 2.818 . . . . 0.0 106.584 -172.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.11 -51.06 0.16 OUTLIER 'Cis proline' 0 C--N 1.349 0.589 0 CA-C-N 121.081 1.422 . . . . 0.0 111.407 -12.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.0 p -71.13 -23.43 62.08 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.686 1.595 . . . . 0.0 112.44 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.03 -8.85 21.08 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.499 1.523 . . . . 0.0 113.257 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -105.76 152.84 22.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 120.64 -1.506 . . . . 0.0 109.977 -171.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -126.96 97.74 5.07 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.53 1.932 . . . . 0.0 107.033 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -67.74 140.21 56.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 164.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 45.7 t -140.65 149.23 42.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.448 1.099 . . . . 0.0 109.192 170.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.7 ptt? -140.84 148.95 41.35 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.317 1.447 . . . . 0.0 109.337 -176.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -147.65 88.77 1.71 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.999 2.12 . . . . 0.0 107.424 -173.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 88.7 p -165.28 178.44 6.9 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 121.551 -0.718 . . . . 0.0 109.549 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.62 -18.26 63.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.121 1.368 . . . . 0.0 114.169 167.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.82 22.68 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.539 1.936 . . . . 0.0 115.445 -159.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 28.3 mt -121.23 41.03 3.43 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -158.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -75.77 101.59 5.12 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -53.92 137.28 39.38 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 167.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 14.8 pt -136.2 166.59 26.83 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.242 1.417 . . . . 0.0 108.297 167.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.89 168.1 4.74 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.646 2.231 . . . . 0.0 112.435 164.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -18.87 -49.58 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 130.206 3.402 . . . . 0.0 118.118 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -165.42 -81.01 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.218 1.407 . . . . 0.0 107.609 -167.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -144.74 16.64 1.61 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.085 1.754 . . . . 0.0 111.412 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.79 -3.92 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.259 -0.901 . . . . 0.0 112.728 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.475 0 C-N-CA 128.117 2.77 . . . . 0.0 106.554 159.88 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 pt -132.01 112.83 14.73 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.439 1.495 . . . . 0.0 108.856 -162.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.08 106.34 2.01 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.52 2.146 . . . . 0.0 109.274 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.4 mm -78.72 80.69 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 173.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -83.66 89.54 7.14 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.328 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.7 m -71.41 83.57 0.8 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 173.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 p -56.42 -36.62 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.444 1.497 . . . . 0.0 111.842 -171.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -17.86 49.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.665 1.186 . . . . 0.0 112.648 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -129.11 12.44 6.11 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.602 1.961 . . . . 0.0 110.015 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 26.48 58.31 0.07 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 129.104 2.962 . . . . 0.0 111.32 -164.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.9 mtp85 -94.63 175.14 6.78 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 118.569 -1.252 . . . . 0.0 108.881 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -149.8 120.97 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 159.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.41 111.57 22.51 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 167.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.9 ttt -77.42 105.83 8.8 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.819 1.19 . . . . 0.0 108.808 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.94 178.96 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -130.96 168.82 16.69 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 120.292 -1.505 . . . . 0.0 112.516 172.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.89 139.61 57.24 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.659 0.784 . . . . 0.0 111.545 -171.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.427 ' H ' ' HD2' ' A' ' 118' ' ' ARG . 12.9 tt -73.72 115.38 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -175.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -139.0 99.52 3.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.4 mt -133.39 177.41 7.71 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.203 1.801 . . . . 0.0 108.805 -171.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.2 t -84.4 179.77 7.35 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 158.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 30' ' ' GLU . 10.9 t70 -54.19 -36.99 64.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.846 0.748 . . . . 0.0 109.231 158.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.559 ' HA ' ' CZ ' ' A' ' 32' ' ' ARG . 18.6 m-20 -62.82 17.07 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 129.978 3.311 . . . . 0.0 117.269 -169.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 28' ' ' ASP . 48.1 mm-40 -133.04 -46.9 0.85 Allowed 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -172.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -62.36 5.69 0.1 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.601 1.96 . . . . 0.0 114.922 -175.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.559 ' CZ ' ' HA ' ' A' ' 29' ' ' ASP . 3.7 ptt180 -124.75 -10.51 7.27 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.611 1.564 . . . . 0.0 113.869 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -134.66 -11.42 2.37 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.628 0.771 . . . . 0.0 112.19 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pt -119.55 11.39 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.828 0.851 . . . . 0.0 111.283 166.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -113.49 170.78 7.99 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.479 1.111 . . . . 0.0 111.825 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.42 142.41 90.7 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.902 0.881 . . . . 0.0 110.527 172.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.34 -7.2 20.66 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.556 2.837 . . . . 0.0 112.707 170.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -82.85 -45.32 14.41 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.504 1.121 . . . . 0.0 109.671 163.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.41 -42.47 98.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 120.579 1.536 . . . . 0.0 111.461 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -57.89 -45.75 85.92 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.029 0.532 . . . . 0.0 111.196 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -69.85 -49.6 50.88 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 119.304 -0.958 . . . . 0.0 109.642 172.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 t -55.89 -29.11 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 119.544 1.065 . . . . 0.0 111.01 -170.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.3 -28.31 69.64 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 174.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -100.46 -22.6 14.96 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.581 1.082 . . . . 0.0 113.12 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -107.35 3.72 25.63 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.963 0.905 . . . . 0.0 112.712 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.51 49.48 15.96 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.74 1.616 . . . . 0.0 111.047 -172.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.495 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 178.065 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.4 t70 . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.54 178.44 25.41 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.1 pt -135.2 167.5 25.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 125.507 1.523 . . . . 0.0 107.859 167.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -84.07 127.8 34.14 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 122.239 1.019 . . . . 0.0 110.172 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -87.31 130.97 34.4 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 158.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.9 t -75.23 100.59 4.38 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 159.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.6 tt -66.34 -18.59 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.435 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.9 t -82.11 7.62 12.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.653 0.781 . . . . 0.0 111.147 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.9 p -153.49 0.05 0.24 Allowed 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.965 -1.084 . . . . 0.0 113.87 168.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.411 ' C ' ' HG1' ' A' ' 72' ' ' THR . . . 64.82 55.24 23.49 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.411 ' HG1' ' C ' ' A' ' 71' ' ' GLY . 99.4 m -153.8 154.45 34.01 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.067 -1.255 . . . . 0.0 109.259 -173.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -85.95 152.21 23.13 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.07 0.948 . . . . 0.0 112.914 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.29 0.2 OUTLIER -146.89 -101.81 0.09 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.518 168.027 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -66.29 138.29 57.53 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.269 0.941 . . . . 0.0 111.19 -164.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -99.11 152.45 19.84 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.465 1.106 . . . . 0.0 108.63 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.66 -22.05 31.76 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.99 -29.66 57.69 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.706 1.139 . . . . 0.0 112.411 169.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 t -120.78 54.69 1.06 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.453 1.901 . . . . 0.0 109.466 168.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -140.79 162.21 35.98 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.504 -1.373 . . . . 0.0 110.073 159.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -104.23 120.27 40.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 163.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -138.15 -55.54 0.65 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.822 2.049 . . . . 0.0 108.287 -165.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 t -67.11 173.24 3.89 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.063 0.935 . . . . 0.0 110.167 159.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 52.38 -110.03 1.08 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.428 1.489 . . . . 0.0 110.966 -173.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -66.19 -37.76 86.38 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.455 1.102 . . . . 0.0 112.425 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.79 18.34 17.37 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.371 1.462 . . . . 0.0 116.33 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.86 151.09 97.43 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 117.679 0.74 . . . . 0.0 111.836 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.62 62.12 7.06 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.052 3.168 . . . . 0.0 110.968 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.6 p -135.79 155.87 49.69 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.859 0.863 . . . . 0.0 109.29 166.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -156.88 178.29 10.52 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.475 1.11 . . . . 0.0 110.762 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -117.75 -11.44 10.36 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -169.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -149.1 176.86 10.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.631 1.173 . . . . 0.0 110.895 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 m -129.25 156.54 41.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.133 0 O-C-N 121.136 -0.978 . . . . 0.0 111.371 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.1 p -60.94 -34.03 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.768 1.227 . . . . 0.0 111.166 173.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.2 m 164.6 166.4 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 131.614 3.966 . . . . 0.0 106.628 -175.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -96.4 77.2 2.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.152 1.781 . . . . 0.0 107.793 174.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.529 ' CD2' ' H ' ' A' ' 98' ' ' ASN . 5.4 p80 -133.93 -65.23 0.67 Allowed 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.64 -0.663 . . . . 0.0 111.619 -159.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.529 ' H ' ' CD2' ' A' ' 97' ' ' HIS . 0.9 OUTLIER -96.51 16.93 17.35 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.19 1.396 . . . . 0.0 108.935 167.017 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.03 140.64 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 128.315 2.646 . . . . 0.0 107.451 -174.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.418 ' HD3' ' H ' ' A' ' 101' ' ' LEU . 14.4 tppt? -129.24 151.43 49.91 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 128.226 2.61 . . . . 0.0 108.591 -173.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.418 ' H ' ' HD3' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -146.05 154.14 41.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.479 1.911 . . . . 0.0 107.875 -176.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.4 ' HG2' ' CG ' ' A' ' 113' ' ' GLU . 19.3 mmt180 -136.52 121.9 19.37 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -71.04 126.02 28.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.473 1.033 . . . . 0.0 110.274 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.439 ' CG ' ' H ' ' A' ' 105' ' ' ARG . 37.3 t0 -128.4 176.98 7.3 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.866 0.841 . . . . 0.0 109.786 158.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.439 ' H ' ' CG ' ' A' ' 104' ' ' ASP . 0.0 OUTLIER -108.31 14.24 25.02 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.229 2.212 . . . . 0.0 111.542 173.447 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 t -46.96 -40.55 14.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.408 1.883 . . . . 0.0 115.44 -159.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.6 pp -73.36 -11.25 60.42 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 115.11 -4.81 22.11 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.158 1.837 . . . . 0.0 112.957 -169.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -141.61 -85.35 0.18 Allowed 'General case' 0 C--N 1.349 0.584 0 CA-C-N 120.143 1.971 . . . . 0.0 109.753 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.2 t -144.58 111.68 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -129.56 106.56 8.83 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.678 1.591 . . . . 0.0 108.79 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 10.1 m -106.28 141.94 36.78 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.602 -1.189 . . . . 0.0 107.88 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.4 ' CG ' ' HG2' ' A' ' 102' ' ' ARG . 22.2 pt-20 -67.71 160.97 26.98 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.791 1.632 . . . . 0.0 110.691 172.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.7 t -141.64 104.04 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.19 161.26 28.11 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.731 0.812 . . . . 0.0 109.078 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 13.5 m -77.73 106.71 9.72 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.79 -25.1 10.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.259 1.424 . . . . 0.0 113.177 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.427 ' HD2' ' H ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -80.72 -37.29 30.88 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 126.596 1.958 . . . . 0.0 113.149 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 3.9 p -153.82 69.88 0.81 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -161.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.27 58.0 0.25 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 128.086 2.554 . . . . 0.0 113.693 -159.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.7 -147.55 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.738 1.615 . . . . 0.0 112.319 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -70.12 -64.89 0.8 Allowed 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.282 1.433 . . . . 0.0 109.423 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 49.84 -116.84 0.94 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.421 1.889 . . . . 0.0 107.561 -177.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.76 -119.32 0.62 Allowed Glycine 0 CA--C 1.521 0.445 0 CA-C-N 118.501 0.591 . . . . 0.0 112.578 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -158.0 177.57 11.17 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 122.453 -0.44 . . . . 0.0 111.155 -170.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.1 p -124.64 145.02 32.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 124.663 1.185 . . . . 0.0 108.884 170.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -140.05 144.67 36.99 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.584 1.554 . . . . 0.0 108.668 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.08 121.12 19.67 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.403 0.547 . . . . 0.0 109.55 173.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.39 -45.15 0.22 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.624 2.37 . . . . 0.0 111.946 -165.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -90.53 -178.34 44.01 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.404 1.002 . . . . 0.0 112.935 -170.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.93 155.22 69.22 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.829 2.353 . . . . 0.0 111.017 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.89 154.06 95.33 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.908 174.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.07 -36.64 2.45 Favored 'Cis proline' 0 C--N 1.35 0.642 0 CA-C-N 119.506 0.859 . . . . 0.0 111.429 -5.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.51 59.19 1.87 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 127.826 2.451 . . . . 0.0 111.531 -175.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -88.33 -5.79 75.34 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.869 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.29 104.37 16.39 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 119.414 1.607 . . . . 0.0 111.048 -166.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.64 94.06 5.62 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.173 1.789 . . . . 0.0 108.347 -173.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -62.33 130.37 44.98 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 160.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 22.1 t -144.02 130.23 19.71 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.3 ptp -142.8 140.95 31.54 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.445 0.698 . . . . 0.0 110.395 -173.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.91 15.5 28.83 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.991 2.116 . . . . 0.0 110.647 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.2 p -65.96 112.0 3.6 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.023 1.729 . . . . 0.0 110.53 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -54.29 -24.84 20.54 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.54 1.136 . . . . 0.0 112.993 164.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.83 2.29 3.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.317 2.247 . . . . 0.0 116.351 -170.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 90.7 mt -87.26 87.02 7.32 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.091 0.859 . . . . 0.0 109.836 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -87.01 126.44 34.74 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.349 1.06 . . . . 0.0 108.785 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -70.87 135.22 47.89 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.327 0.967 . . . . 0.0 109.453 170.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.2 pt -136.44 163.6 48.76 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.33 1.052 . . . . 0.0 109.764 171.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.21 168.73 7.23 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.592 2.195 . . . . 0.0 111.646 161.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.417 ' HA ' ' HD2' ' A' ' 150' ' ' ARG . 6.8 mmm-85 -62.75 -4.74 2.23 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 119.51 3.152 . . . . 0.0 119.51 -158.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 178.11 -62.58 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.195 1 C-N-CA 132.905 4.482 . . . . 0.0 109.552 161.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -156.73 8.26 0.2 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.973 2.909 . . . . 0.0 110.831 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.9 pp -65.54 -14.54 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.872 1.214 . . . . 0.0 112.936 170.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 159.097 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.4 pt -129.33 136.97 29.97 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.401 1.08 . . . . 0.0 111.901 -168.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.0 120.92 3.87 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.997 2.464 . . . . 0.0 110.454 170.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.83 146.99 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 159.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -126.87 154.81 43.92 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 127.267 2.227 . . . . 0.0 105.621 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.53 91.94 2.53 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 171.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.08 -43.76 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 C-N-CA 123.346 0.659 . . . . 0.0 111.664 -171.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.97 -28.88 58.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.633 0.773 . . . . 0.0 110.904 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 152' ' ' GLN . 7.0 ttmm -87.39 -1.4 57.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.27 1.428 . . . . 0.0 111.091 170.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.8 t30 38.15 65.83 0.55 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 128.915 2.886 . . . . 0.0 112.427 -171.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.43 162.34 28.3 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.69 1.996 . . . . 0.0 109.44 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.7 t -138.9 134.47 42.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 164.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -141.53 97.58 3.19 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.684 1.594 . . . . 0.0 108.311 -172.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.4 ttp -78.94 133.29 36.91 Favored 'General case' 0 C--N 1.339 0.14 0 O-C-N 121.371 -0.831 . . . . 0.0 109.852 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.7 t -137.15 161.27 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.558 1.543 . . . . 0.0 107.063 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -58.32 170.26 0.74 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 123.03 1.395 . . . . 0.0 112.54 164.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 -69.49 176.42 3.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.858 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.537 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 2.4 tt -78.45 128.24 38.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 164.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -158.13 97.17 1.5 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.7 mt -138.29 176.21 8.9 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.936 1.294 . . . . 0.0 108.646 -167.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.454 ' H ' ' CG ' ' A' ' 30' ' ' GLU . 12.8 p -88.11 -159.88 0.58 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 164.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.04 -48.69 56.93 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.888 1.222 . . . . 0.0 109.313 160.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.67 -12.53 16.68 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 126.58 1.952 . . . . 0.0 114.856 -159.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.489 ' C ' ' H ' ' A' ' 32' ' ' ARG . 12.9 mm-40 -85.0 -48.34 9.34 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 127.028 2.131 . . . . 0.0 110.316 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -60.61 8.94 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 128.135 2.574 . . . . 0.0 115.711 -168.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.489 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -139.06 -11.29 1.27 Allowed 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 128.928 2.891 . . . . 0.0 111.878 -164.037 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.9 -16.41 3.27 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 118.369 -0.824 . . . . 0.0 112.081 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pt -110.98 13.33 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 119.472 1.033 . . . . 0.0 111.958 172.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.01 167.94 14.02 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.006 0.923 . . . . 0.0 111.403 -171.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.2 137.8 74.19 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 123.89 0.876 . . . . 0.0 108.761 169.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -70.13 -3.69 12.76 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.398 2.732 . . . . 0.0 113.23 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -95.01 -30.04 14.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 127.233 2.213 . . . . 0.0 110.328 170.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.05 -48.46 81.66 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 120.975 1.716 . . . . 0.0 111.092 -174.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -59.07 -37.8 77.93 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.524 0.729 . . . . 0.0 111.885 -174.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -81.41 -45.81 15.53 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.869 -0.586 . . . . 0.0 109.827 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -58.59 -28.11 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 120.103 1.319 . . . . 0.0 110.005 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.19 -8.29 23.33 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 173.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -119.26 -27.51 5.63 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.429 1.468 . . . . 0.0 111.12 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -105.0 12.35 32.39 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.07 1.748 . . . . 0.0 112.868 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.47 7.92 1.49 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.669 2.788 . . . . 0.0 115.374 171.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.74 0 CA-C-O 118.485 -1.175 . . . . 0.0 114.888 174.33 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 t0 . . . . . 0 C--O 1.234 0.28 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.67 169.78 46.23 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 125.894 1.711 . . . . 0.0 112.402 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.6 pt -128.19 173.32 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 162.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -94.56 119.04 32.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.889 1.275 . . . . 0.0 110.066 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.27 119.98 10.68 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 158.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 2.8 t -74.81 71.44 1.99 Allowed 'General case' 0 C--O 1.236 0.389 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 159.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 tt -62.9 -26.62 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.604 -162.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.6 t -77.65 3.15 14.6 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.334 1.454 . . . . 0.0 112.393 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.3 p -140.54 21.69 2.36 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.318 -0.864 . . . . 0.0 111.464 158.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.35 36.18 52.45 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.2 m -124.3 177.02 6.08 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.381 2.273 . . . . 0.0 106.907 -170.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -138.25 145.65 41.6 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.647 1.112 . . . . 0.0 109.235 -173.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.406 HD13 ' CD2' ' A' ' 75' ' ' PHE 0.305 0.2 OUTLIER -151.18 -102.2 0.06 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 178.377 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.406 ' CD2' HD13 ' A' ' 74' ' ' LEU . 38.8 m-85 -55.27 150.48 11.13 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -158.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -112.7 143.68 43.49 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.895 0.878 . . . . 0.0 110.726 -174.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.4 m -61.15 -16.63 46.54 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -56.7 -23.26 40.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 120.355 1.434 . . . . 0.0 112.18 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.1 t -112.96 -3.73 14.02 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.759 0.823 . . . . 0.0 112.384 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.424 ' C ' ' HE2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -114.8 68.21 0.7 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.958 -1.089 . . . . 0.0 108.134 176.691 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -135.78 49.12 2.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.989 0.916 . . . . 0.0 109.965 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -72.53 95.15 1.77 Allowed 'General case' 0 C--N 1.341 0.206 0 O-C-N 121.626 -0.671 . . . . 0.0 109.505 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.2 t -58.89 134.4 56.89 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.859 0.463 . . . . 0.0 110.287 -175.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.98 -67.93 3.66 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.61 -55.54 17.04 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.03 0.915 . . . . 0.0 111.527 -174.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.02 16.03 12.0 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 129.373 3.368 . . . . 0.0 115.871 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.39 150.62 8.51 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 125.261 1.424 . . . . 0.0 112.137 171.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.71 71.69 4.7 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.77 2.98 . . . . 0.0 110.384 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.4 p -133.89 152.31 51.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 164.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -131.78 176.45 8.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.816 1.246 . . . . 0.0 109.433 -170.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -124.91 -3.08 7.7 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.239 1.015 . . . . 0.0 112.587 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -151.64 -173.26 4.46 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.711 2.004 . . . . 0.0 107.693 -176.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.84 155.34 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 C-N-CA 123.783 0.833 . . . . 0.0 109.304 178.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 p -61.46 -33.34 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.382 0.611 . . . . 0.0 110.486 170.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.8 m 168.02 159.82 0.04 OUTLIER 'General case' 0 C--O 1.234 0.279 1 C-N-CA 132.559 4.343 . . . . 0.0 105.075 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -101.04 80.9 2.18 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.509 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 17.9 p80 -125.43 -67.04 0.91 Allowed 'General case' 0 C--N 1.347 0.484 0 C-N-CA 126.443 1.897 . . . . 0.0 109.345 -165.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.509 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 0.7 OUTLIER -96.9 22.08 8.79 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 122.071 0.938 . . . . 0.0 112.429 179.525 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.9 tt -126.61 147.78 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 128.628 2.771 . . . . 0.0 104.847 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -125.14 138.35 54.15 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 122.803 0.441 . . . . 0.0 110.713 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mp -144.41 130.28 19.32 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.964 1.706 . . . . 0.0 109.07 -164.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.422 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 2.3 mpt_? -131.35 111.95 12.31 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 128.364 2.665 . . . . 0.0 105.345 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -74.41 128.44 35.54 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.629 1.571 . . . . 0.0 110.845 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 105' ' ' ARG . 32.0 t0 -134.2 178.01 7.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.095 1.358 . . . . 0.0 109.156 162.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.414 ' H ' ' CG ' ' A' ' 104' ' ' ASP . 0.0 OUTLIER -113.62 18.39 17.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.995 1.718 . . . . 0.0 110.544 -178.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.18 -30.56 60.16 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -158.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.85 -12.99 60.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.827 0.739 . . . . 0.0 112.617 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.5 -2.5 23.47 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 126.343 1.925 . . . . 0.0 112.936 -169.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 76.6 mtm -143.47 -81.91 0.18 Allowed 'General case' 0 C--N 1.35 0.605 0 CA-C-N 120.484 2.142 . . . . 0.0 109.629 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 42.9 t -143.08 116.6 3.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -125.44 111.2 14.83 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 126.33 1.852 . . . . 0.0 107.845 168.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 38.3 t -129.25 125.45 36.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -170.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 24.1 pt-20 -60.38 159.16 10.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.002 0.819 . . . . 0.0 111.387 -172.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -137.39 106.62 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 171.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.7 mp -120.67 170.28 9.58 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 164.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.1 163.34 12.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 118.927 -1.109 . . . . 0.0 108.592 164.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.46 -20.04 66.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.713 168.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.537 ' HG2' ' H ' ' A' ' 24' ' ' ILE . 30.7 tpt85 -148.46 -48.16 0.15 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -176.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 31.8 p -80.74 65.41 5.87 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.686 1.584 . . . . 0.0 108.453 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.39 57.33 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.217 2.607 . . . . 0.0 112.156 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.98 -47.38 52.55 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.648 0.779 . . . . 0.0 111.941 -164.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -169.07 -69.26 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 125.595 1.558 . . . . 0.0 107.601 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.4 mt 52.13 -114.02 0.79 Allowed 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 126.907 2.083 . . . . 0.0 110.846 -171.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.01 -119.45 0.72 Allowed Glycine 0 CA--C 1.525 0.692 0 CA-C-N 119.09 0.859 . . . . 0.0 112.367 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -159.47 163.55 35.22 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 122.299 -0.53 . . . . 0.0 111.17 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.5 p -101.49 132.96 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 168.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -131.53 155.57 47.22 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.369 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.06 112.7 3.1 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.253 1.021 . . . . 0.0 109.182 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -144.16 -24.45 0.55 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -171.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.45 163.77 13.56 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 123.349 0.5 . . . . 0.0 112.22 -167.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.86 -15.89 10.42 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.831 2.354 . . . . 0.0 114.353 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.5 ptt-85 142.63 165.08 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.945 1 C-N-CA 132.069 4.148 . . . . 0.0 107.181 -159.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.11 -53.11 0.15 OUTLIER 'Cis proline' 0 C--N 1.352 0.752 0 CA-C-N 121.624 1.616 . . . . 0.0 111.269 -9.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.9 p -73.76 -23.72 59.77 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.965 1.306 . . . . 0.0 112.743 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.74 5.37 68.9 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.282 0.944 . . . . 0.0 113.832 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -125.44 162.17 25.44 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 119.647 1.723 . . . . 0.0 111.622 -167.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 ttm105 -125.23 109.53 12.95 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.642 1.577 . . . . 0.0 108.116 173.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -74.59 106.46 6.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.881 1.673 . . . . 0.0 106.977 165.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 18.2 t -121.94 135.55 54.87 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.561 1.073 . . . . 0.0 109.898 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.8 ptp -159.18 161.06 36.14 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.444 0.698 . . . . 0.0 110.754 -171.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -148.29 146.13 28.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.532 0.733 . . . . 0.0 109.426 161.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 91.0 p -171.78 -175.53 1.55 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.572 1.949 . . . . 0.0 107.208 158.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.87 -21.07 62.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.613 1.165 . . . . 0.0 113.163 165.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.53 22.03 0.06 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.735 1.614 . . . . 0.0 114.886 -169.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 88.9 mt -130.64 106.05 8.23 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.701 1.137 . . . . 0.0 110.018 -165.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -137.88 140.07 40.2 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.318 1.047 . . . . 0.0 108.788 174.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -76.95 141.38 40.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.219 0.918 . . . . 0.0 110.341 168.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.0 pt -137.01 170.53 10.54 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.077 1.751 . . . . 0.0 108.754 165.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.19 165.19 4.33 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.73 2.287 . . . . 0.0 112.783 167.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -45.05 -18.77 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 129.006 2.922 . . . . 0.0 118.341 -165.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -164.29 -78.71 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 171.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.4 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 31.8 mm-40 -149.71 42.05 0.87 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.99 2.516 . . . . 0.0 104.637 163.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.9 pp -76.39 -25.12 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 O-C-N 120.802 -1.186 . . . . 0.0 111.907 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 CA-C-O 117.306 -1.83 . . . . 0.0 110.542 175.528 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 . . . . . 0 N--CA 1.447 -0.604 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.448 ' CD1' HD22 ' A' ' 98' ' ' ASN . 1.3 pt -129.35 125.74 22.65 Favored Pre-proline 0 N--CA 1.452 -0.332 0 C-N-CA 125.595 1.558 . . . . 0.0 110.78 174.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.83 143.35 36.91 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.628 1.552 . . . . 0.0 110.384 164.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.8 mt -126.23 98.94 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.4 103.26 14.64 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.073 0.949 . . . . 0.0 108.546 -171.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.7 m -72.83 76.93 1.14 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.826 173.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.8 p -56.31 -39.63 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 118.709 0.686 . . . . 0.0 110.585 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.55 -12.66 10.55 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.301 1.84 . . . . 0.0 113.907 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 151' ' ' ASP . 39.4 mtmt -128.68 7.73 5.74 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.503 1.521 . . . . 0.0 111.639 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.5 t30 32.76 74.0 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.948 2.499 . . . . 0.0 112.801 -159.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.41 167.86 20.55 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.52 142.97 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 164.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -125.15 165.59 17.97 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 158.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 46.7 ttm -132.47 133.97 44.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.4 t -137.98 161.0 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 -171.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -72.87 161.97 30.06 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.774 -1.829 . . . . 0.0 112.429 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.24 142.13 58.4 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 161.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.3 tt -60.48 137.07 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.002 1.321 . . . . 0.0 109.414 -176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -150.44 114.17 5.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 103.396 -2.816 . . . . 0.0 103.396 171.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.2 mt -137.87 -159.54 0.97 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.518 1.527 . . . . 0.0 108.357 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.0 m -144.56 175.31 10.23 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.437 -1.415 . . . . 0.0 107.65 162.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.28 -41.08 60.19 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.341 1.457 . . . . 0.0 113.363 -159.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.404 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 2.1 m-20 -77.06 -18.44 58.05 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -175.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 32' ' ' ARG . 75.0 mm-40 -66.45 -47.27 73.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.965 0.802 . . . . 0.0 109.834 -176.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -62.12 15.23 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.285 2.234 . . . . 0.0 115.889 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.412 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -133.22 -9.41 2.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 170.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -122.63 -17.56 6.88 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.19 0.905 . . . . 0.0 112.619 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 pt -110.75 19.01 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 118.949 0.795 . . . . 0.0 111.483 169.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -127.27 166.58 17.5 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.271 1.028 . . . . 0.0 111.534 -173.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.452 ' CG ' HH12 ' A' ' 66' ' ' ARG . 0.9 OUTLIER -58.62 137.56 86.22 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 163.352 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -67.83 -16.48 45.95 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.334 2.022 . . . . 0.0 112.245 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -73.49 -42.47 61.8 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.753 -0.592 . . . . 0.0 109.856 170.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.51 -38.16 80.21 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.271 0.941 . . . . 0.0 111.125 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -54.92 -56.48 19.09 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.81 0.844 . . . . 0.0 110.824 172.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -63.65 -45.65 89.22 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.683 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.7 t -51.69 -37.8 20.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 125.091 1.356 . . . . 0.0 109.952 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.34 -10.84 18.28 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 176.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.62 -17.22 11.19 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.812 1.187 . . . . 0.0 113.46 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.424 ' C ' ' H ' ' A' ' 47' ' ' GLY . 12.8 ptpt -116.1 8.77 14.57 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.254 1.022 . . . . 0.0 112.028 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.37 -30.77 0.08 Allowed 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 130.241 3.416 . . . . 0.0 113.561 -164.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 45' ' ' LYS . . . . . . . . 0 C--N 1.336 0.582 0 C-N-CA 126.365 1.936 . . . . 0.0 109.486 -170.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 CA--C 1.532 0.261 0 CA-C-O 121.606 0.717 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.66 179.32 41.91 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -173.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.2 pt -122.72 170.9 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.522 0.729 . . . . 0.0 109.617 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -97.89 143.93 27.97 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.144 0.978 . . . . 0.0 109.858 -174.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.452 HH12 ' CG ' ' A' ' 36' ' ' ASP . 34.2 ttt180 -127.62 146.68 50.46 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.669 1.188 . . . . 0.0 109.139 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 10.6 t -102.04 94.42 5.76 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 175.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.2 tt -58.11 -31.07 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.82 1.248 . . . . 0.0 111.371 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.1 t -75.78 5.7 5.95 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.266 1.826 . . . . 0.0 111.906 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.402 ' HB2' ' HE ' ' A' ' 118' ' ' ARG . 26.8 p -144.06 10.63 1.53 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.741 1.216 . . . . 0.0 111.57 162.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.4 11.08 45.93 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.384 1.945 . . . . 0.0 114.712 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.0 m -114.44 142.99 45.65 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.351 1.576 . . . . 0.0 110.646 -159.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 9.7 p-10 -95.53 147.93 23.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.467 1.507 . . . . 0.0 112.584 -178.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.311 0.2 OUTLIER -152.98 -98.16 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.34 1.056 . . . . 0.0 113.666 173.485 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -49.96 131.15 22.71 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -159.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -69.64 132.1 45.66 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.447 -0.783 . . . . 0.0 109.124 171.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.8 m -62.95 -20.57 65.36 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.14 -12.57 41.09 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.202 1.365 . . . . 0.0 113.264 172.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.3 p -74.32 -25.27 59.45 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.552 -0.718 . . . . 0.0 111.886 166.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -121.69 95.07 4.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.321 1.848 . . . . 0.0 109.564 -168.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -141.93 116.07 9.41 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -137.75 110.77 7.75 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 171.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.9 p -63.48 103.16 0.49 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.127 1.371 . . . . 0.0 111.295 -167.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.47 -47.63 1.43 Allowed Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.744 1.164 . . . . 0.0 111.245 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -53.99 25.16 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.401 0.68 . . . . 0.0 110.469 177.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 47.16 23.66 1.84 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.933 2.206 . . . . 0.0 115.196 -167.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -54.66 153.28 11.01 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 118.966 1.383 . . . . 0.0 112.338 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.35 71.71 2.35 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.866 3.044 . . . . 0.0 112.26 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.9 p -133.81 149.97 51.41 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 158.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -147.24 173.46 12.53 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.66 1.184 . . . . 0.0 109.095 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -113.34 -13.6 12.88 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.473 -0.775 . . . . 0.0 112.832 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -155.27 -179.05 7.71 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.222 1.409 . . . . 0.0 108.349 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.07 166.71 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.586 1.554 . . . . 0.0 111.153 -175.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.54 -50.46 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.592 0.757 . . . . 0.0 109.534 168.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.4 m 172.81 162.58 0.12 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 130.518 3.527 . . . . 0.0 106.362 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -85.45 65.88 9.41 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -111.78 -56.78 2.34 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 124.753 1.221 . . . . 0.0 108.173 -173.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.448 HD22 ' CD1' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -100.66 4.15 43.02 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 175.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.32 131.42 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -107.96 140.98 40.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.387 1.475 . . . . 0.0 107.562 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.01 155.33 49.38 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.572 1.549 . . . . 0.0 109.77 175.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.36 131.54 36.5 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 128.561 2.744 . . . . 0.0 104.138 165.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.42 150.15 45.25 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 171.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' A' ' 106' ' ' SER . 53.0 t0 -148.3 140.24 23.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 158.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 16.39 0.07 Allowed 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.644 -1.285 . . . . 0.0 112.355 172.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 104' ' ' ASP . 0.4 OUTLIER -43.51 -61.56 1.34 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 127.419 2.288 . . . . 0.0 113.149 -158.675 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pp -58.95 -14.34 8.95 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.389 1.076 . . . . 0.0 113.618 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 118.83 -4.9 14.25 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 126.651 2.072 . . . . 0.0 111.893 -172.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -141.02 -84.64 0.2 Allowed 'General case' 0 C--N 1.348 0.538 0 CA-C-N 119.645 1.723 . . . . 0.0 109.018 -174.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.2 t -147.13 108.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -173.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.426 ' HE ' ' CD2' ' A' ' 125' ' ' HIS . 44.2 ttt180 -131.17 83.31 2.1 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.478 1.511 . . . . 0.0 110.785 176.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 1.4 m -85.14 137.16 33.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.879 -0.581 . . . . 0.0 109.771 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -67.05 157.33 33.8 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.21 0.914 . . . . 0.0 111.132 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.4 t -133.82 107.13 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -129.81 154.27 47.41 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 27.8 t -69.59 137.0 51.97 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -70.43 -17.37 63.0 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.402 ' HE ' ' HB2' ' A' ' 70' ' ' CYS . 0.0 OUTLIER -104.98 -37.22 7.05 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.205 1.802 . . . . 0.0 112.781 -173.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 29.6 p -135.04 74.64 1.53 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 123.551 1.644 . . . . 0.0 108.337 171.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.82 55.93 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 1 C-N-CA 133.697 4.799 . . . . 0.0 113.462 172.334 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -112.05 -57.95 2.2 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 -159.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -138.54 -89.26 0.22 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.257 0.935 . . . . 0.0 109.678 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 mt 58.94 -120.24 1.08 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.705 2.002 . . . . 0.0 109.88 -176.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -174.96 -125.07 0.84 Allowed Glycine 0 CA--C 1.522 0.509 0 CA-C-N 118.972 0.805 . . . . 0.0 112.962 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.426 ' CD2' ' HE ' ' A' ' 111' ' ' ARG . 31.9 p-80 -161.2 179.07 8.66 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.169 0.587 . . . . 0.0 110.569 -172.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.62 143.24 41.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.767 1.227 . . . . 0.0 108.936 172.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -139.37 154.77 47.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.841 1.256 . . . . 0.0 109.219 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.84 113.76 10.23 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -164.93 -46.97 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.461 1.504 . . . . 0.0 111.48 -168.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -64.52 167.91 27.74 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.249 0.452 . . . . 0.0 112.508 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.55 177.16 7.79 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.594 2.196 . . . . 0.0 110.999 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -57.0 146.48 59.76 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 160.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.18 -52.6 0.16 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.529 0 CA-C-N 120.103 1.073 . . . . 0.0 114.641 15.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 17.5 p -77.95 -24.07 48.29 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -164.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.65 5.72 86.38 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 119.278 -0.734 . . . . 0.0 113.684 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -132.9 159.81 38.83 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.38 1.59 . . . . 0.0 111.787 -168.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.2 ttm105 -125.07 109.17 12.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.759 1.624 . . . . 0.0 106.69 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -72.04 128.45 35.74 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 160.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 17.5 t -135.73 135.88 40.36 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.786 1.234 . . . . 0.0 108.282 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 35.1 ttm -140.04 156.5 46.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 122.276 1.036 . . . . 0.0 109.824 -165.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.58 104.11 4.33 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.469 1.908 . . . . 0.0 105.921 173.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 58.1 p -153.65 157.49 39.69 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 162.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.14 -25.01 54.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.56 4.91 0.91 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.745 2.018 . . . . 0.0 115.855 -159.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 83.4 mt -90.84 87.97 6.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.084 1.354 . . . . 0.0 109.674 -159.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -93.26 133.68 36.24 Favored 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -71.43 146.33 48.72 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 159.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.6 pt -137.84 166.27 27.48 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.818 1.247 . . . . 0.0 107.977 166.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.36 173.3 0.71 Allowed 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.419 2.079 . . . . 0.0 111.696 164.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -52.66 -17.81 1.48 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 -163.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.404 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 5.0 t70 -175.66 -77.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.546 2.338 . . . . 0.0 107.199 170.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -144.4 17.67 1.7 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.353 2.261 . . . . 0.0 110.175 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -74.0 -9.74 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.205 -0.934 . . . . 0.0 112.348 173.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.513 0 N-CA-C 106.935 -2.466 . . . . 0.0 106.935 159.271 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.8 pt -123.46 128.22 25.3 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.953 1.301 . . . . 0.0 110.556 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.58 108.76 2.63 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.29 2.66 . . . . 0.0 109.747 172.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mp -86.84 155.95 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 167.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -135.45 101.53 4.84 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.896 1.279 . . . . 0.0 108.71 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.8 m -65.84 79.61 0.08 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 161.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.5 p -56.21 -41.92 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.041 0.936 . . . . 0.0 110.54 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.07 -12.03 10.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.388 1.475 . . . . 0.0 114.216 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.93 12.47 6.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.387 1.475 . . . . 0.0 110.925 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 33.57 59.15 0.52 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.105 2.562 . . . . 0.0 112.208 -167.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.8 mtp85 -106.48 169.13 8.7 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 173.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.9 t -137.6 97.94 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 168.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -98.89 81.97 2.7 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.882 1.673 . . . . 0.0 108.286 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 43.4 ttp -66.51 127.9 34.12 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.639 -0.663 . . . . 0.0 110.551 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.7 t -129.47 142.42 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.164 1.386 . . . . 0.0 108.278 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -78.99 144.1 35.06 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.399 0.619 . . . . 0.0 110.211 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 mtm105 -65.74 148.16 52.21 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.204 -160.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.91 114.87 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.286 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 168.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -145.84 102.1 3.62 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 102.626 -3.101 . . . . 0.0 102.626 170.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.7 mt -136.65 175.27 9.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.719 0.808 . . . . 0.0 109.72 -168.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.1 t -102.16 163.71 12.09 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 162.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -54.88 -30.89 59.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.04 0.936 . . . . 0.0 111.182 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.91 -27.6 60.96 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.013 2.525 . . . . 0.0 112.634 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 32' ' ' ARG . 67.3 mm-40 -85.51 -45.31 11.92 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.796 1.238 . . . . 0.0 110.68 -170.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -60.61 14.15 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.749 2.42 . . . . 0.0 115.443 -174.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.452 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -127.29 -14.35 5.39 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.143 1.377 . . . . 0.0 113.701 172.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.34 -12.75 4.47 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.43 -172.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 pt -112.82 14.62 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 118.732 0.696 . . . . 0.0 111.356 167.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -117.32 171.84 7.7 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.192 1.397 . . . . 0.0 110.415 -175.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.93 143.01 88.33 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 165.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -70.58 -10.66 28.37 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.974 2.45 . . . . 0.0 111.875 168.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -75.61 -46.62 30.63 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 125.004 1.322 . . . . 0.0 109.889 165.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.89 -41.62 87.61 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 119.859 1.209 . . . . 0.0 110.675 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -57.21 -44.21 83.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.713 1.205 . . . . 0.0 112.014 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -80.1 -41.6 25.21 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 118.79 0.723 . . . . 0.0 110.16 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.9 t -52.75 -31.78 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 126.355 1.862 . . . . 0.0 109.728 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.77 -19.6 64.16 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 173.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.98 -31.85 12.88 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.057 1.299 . . . . 0.0 111.594 173.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 47' ' ' GLY . 15.8 ptpt -103.16 1.48 33.23 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.46 1.104 . . . . 0.0 113.371 -169.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.23 3.08 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.998 2.519 . . . . 0.0 114.712 -168.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 45' ' ' LYS . . . . . . . . 0 C--N 1.338 0.673 0 C-N-CA 125.893 1.711 . . . . 0.0 113.168 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.8 t0 . . . . . 0 C--O 1.235 0.309 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.8 153.13 11.49 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 125.444 1.497 . . . . 0.0 113.031 158.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.7 pt -130.05 154.17 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 162.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.68 126.46 32.37 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -80.36 114.27 19.15 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 158.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 19.7 t -65.11 85.07 0.05 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 162.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.9 tt -66.78 -22.92 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 122.061 -0.399 . . . . 0.0 110.487 -169.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.7 m -61.42 -8.65 4.28 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.797 1.639 . . . . 0.0 113.704 169.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 21.4 p -138.88 15.94 2.67 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.893 1.224 . . . . 0.0 111.647 160.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.99 17.11 21.27 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.293 -1.282 . . . . 0.0 113.961 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.1 m -121.23 143.07 49.34 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.14 1.47 . . . . 0.0 108.95 -164.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.9 167.93 19.99 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 176.08 -160.1 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 131.35 3.86 . . . . 0.0 109.001 172.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 0.14 107.52 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 131.548 3.939 . . . . 0.0 117.023 -165.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.12 144.58 57.0 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.454 1.502 . . . . 0.0 111.13 171.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.8 m -56.46 -30.47 62.93 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.59 -22.14 66.89 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -175.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 p -93.0 -7.37 46.02 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.729 0.695 . . . . 0.0 111.637 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.93 47.63 2.38 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.86 2.064 . . . . 0.0 108.819 -159.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -117.39 60.92 0.75 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.967 0.907 . . . . 0.0 109.666 -167.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -68.3 97.24 0.72 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.0 m -57.3 117.93 4.59 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.147 0.979 . . . . 0.0 112.039 -164.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.88 -49.86 4.29 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.354 0.978 . . . . 0.0 112.102 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.7 -43.97 91.77 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.208 1.004 . . . . 0.0 111.878 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 41.5 35.76 1.38 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 128.833 3.111 . . . . 0.0 114.662 -159.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.5 150.11 5.07 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 126.063 1.745 . . . . 0.0 110.243 175.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.96 69.91 6.1 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.564 2.842 . . . . 0.0 110.769 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.6 p -144.96 152.39 40.1 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.752 1.621 . . . . 0.0 108.821 -177.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.95 168.48 19.61 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.88 1.272 . . . . 0.0 109.085 -176.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -115.84 -9.75 11.8 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 118.811 -0.614 . . . . 0.0 112.445 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -156.64 176.02 13.28 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.846 1.259 . . . . 0.0 107.925 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.6 t -125.99 149.12 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.627 0.771 . . . . 0.0 110.907 -162.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 p -56.54 -54.65 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 126.452 1.901 . . . . 0.0 110.769 171.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.0 m 169.8 164.1 0.06 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 130.669 3.588 . . . . 0.0 107.282 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 mp0 -76.92 64.55 2.45 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.823 1.649 . . . . 0.0 109.508 173.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -115.41 -54.79 2.51 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.879 0.872 . . . . 0.0 109.284 -170.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -121.38 14.24 11.16 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.463 1.105 . . . . 0.0 111.859 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.88 150.77 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.807 1.643 . . . . 0.0 108.846 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -123.27 150.32 43.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.876 2.07 . . . . 0.0 110.771 -174.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.4 mt -145.72 137.14 24.98 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.804 2.442 . . . . 0.0 110.298 -166.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.435 ' HE ' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -139.98 117.25 11.28 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 129.102 2.961 . . . . 0.0 105.879 159.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -104.08 144.26 31.8 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.242 1.017 . . . . 0.0 110.869 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -152.62 179.44 8.61 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.946 2.499 . . . . 0.0 108.11 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.51 27.52 8.29 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.704 -1.248 . . . . 0.0 111.43 173.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.74 -38.9 67.71 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -159.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 pp -75.86 -9.41 58.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.16 6.09 37.03 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 117.579 -1.678 . . . . 0.0 112.781 -168.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 13.3 tpt -145.67 -91.23 0.1 Allowed 'General case' 0 C--N 1.349 0.567 0 CA-C-N 120.298 2.049 . . . . 0.0 109.212 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.3 t -139.37 119.68 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 172.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.433 HH21 ' CE1' ' A' ' 125' ' ' HIS . 17.5 ttt180 -121.83 128.23 51.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 165.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 43.3 t -124.49 142.55 51.24 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 168.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.435 ' CD ' ' HE ' ' A' ' 102' ' ' ARG . 17.4 pt-20 -67.61 162.68 22.98 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.886 170.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 73.2 t -136.81 108.67 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 169.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -125.29 173.09 9.05 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 168.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 39.6 t -71.29 159.59 34.32 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.448 -0.783 . . . . 0.0 108.985 171.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -81.55 -13.89 57.51 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 170.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -115.94 -58.44 2.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 173.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.2 p -94.71 62.39 2.73 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.8 51.29 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 128.362 2.665 . . . . 0.0 113.434 -168.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.38 -71.77 0.59 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.787 1.235 . . . . 0.0 113.359 -167.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -130.79 -83.93 0.53 Allowed 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.761 0.824 . . . . 0.0 109.135 -165.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mt 50.66 -108.88 0.37 Allowed 'General case' 0 C--N 1.338 0.097 0 C-N-CA 126.89 2.076 . . . . 0.0 109.989 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.23 -125.42 0.94 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.586 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.433 ' CE1' HH21 ' A' ' 111' ' ' ARG . 20.3 p-80 -162.42 178.97 8.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.387 -0.478 . . . . 0.0 110.468 -170.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.9 p -129.5 143.25 41.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 124.72 1.208 . . . . 0.0 108.89 172.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -133.79 150.79 51.45 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 124.225 0.953 . . . . 0.0 110.744 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -64.13 106.83 1.14 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.048 1.339 . . . . 0.0 109.333 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -167.57 -48.53 0.02 OUTLIER 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.082 1.353 . . . . 0.0 111.472 -169.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -65.18 172.37 21.8 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.785 0.707 . . . . 0.0 113.408 -170.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -69.83 167.84 23.38 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.253 1.969 . . . . 0.0 111.348 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -61.63 151.6 77.73 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 162.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.33 -47.67 0.3 Allowed 'Cis proline' 0 C--N 1.347 0.472 0 CA-C-N 119.944 1.016 . . . . 0.0 114.182 14.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.2 p -73.96 -26.28 60.4 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -166.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.72 5.62 79.46 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 119.184 0.902 . . . . 0.0 113.678 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -130.23 156.83 43.96 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.983 1.391 . . . . 0.0 111.275 -168.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 14.7 ttt85 -125.27 103.83 8.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.271 1.828 . . . . 0.0 108.234 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -73.89 141.19 46.06 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.105 1.362 . . . . 0.0 107.346 167.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 53.7 t -142.92 136.13 28.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.319 1.847 . . . . 0.0 107.703 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 6.8 ttt -144.71 141.54 29.37 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.744 0.818 . . . . 0.0 108.976 -174.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -148.11 93.48 2.18 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.589 1.156 . . . . 0.0 108.917 -170.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 77.3 p -163.27 -173.41 3.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 167.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.75 -21.31 27.32 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.225 1.41 . . . . 0.0 114.183 168.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.34 26.29 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.725 2.41 . . . . 0.0 115.98 -164.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 62.3 mt -121.33 38.33 4.11 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.744 1.218 . . . . 0.0 111.852 -162.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -75.47 108.99 8.64 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -64.19 140.18 58.84 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.477 -0.764 . . . . 0.0 109.207 163.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.3 pt -128.01 165.25 31.8 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 159.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -53.34 163.08 2.65 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.584 2.856 . . . . 0.0 112.976 166.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -15.76 -53.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 129.669 3.188 . . . . 0.0 114.865 173.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' A' ' 152' ' ' GLN . 4.6 p-10 -157.08 -67.68 0.1 Allowed 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 127.313 2.245 . . . . 0.0 111.283 159.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.421 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 38.4 mt-30 -144.17 1.42 1.1 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.353 1.461 . . . . 0.0 110.9 -163.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.06 -19.03 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.189 1.796 . . . . 0.0 114.56 -170.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.958 0 CA-C-O 116.951 -2.027 . . . . 0.0 109.529 -177.523 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 8.6 ttt85 . . . . . 0 CA--C 1.508 -0.659 0 CA-C-O 121.291 0.567 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.7 pt -136.45 146.94 57.95 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 113.89 -1.505 . . . . 0.0 112.259 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.86 134.12 10.56 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.71 2.94 . . . . 0.0 111.485 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.4 mm -114.58 100.11 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 127.053 2.141 . . . . 0.0 105.737 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -100.4 124.18 45.57 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.9 m -101.8 87.1 3.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -54.01 -39.3 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.679 0.791 . . . . 0.0 111.255 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.65 -25.58 11.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.286 2.234 . . . . 0.0 114.78 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -124.71 7.1 8.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.763 2.025 . . . . 0.0 111.348 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 33.44 63.1 0.37 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.53 2.332 . . . . 0.0 111.638 -161.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.5 mtp-105 -109.87 164.28 12.73 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.1 p -134.85 144.92 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 158.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -136.71 165.55 25.64 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 158.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.7 ttp -127.66 116.98 21.12 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -170.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.76 139.12 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.044 1.738 . . . . 0.0 107.64 -160.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 7' ' ' ARG 0.284 3.5 pm0 -89.53 148.87 23.15 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 122.234 1.016 . . . . 0.0 112.42 -169.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.429 HH11 ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -66.93 146.18 54.66 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.329 -162.503 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.13 118.81 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -167.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -137.73 101.83 4.57 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.487 1.515 . . . . 0.0 107.388 173.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.9 mt -134.15 177.83 7.44 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 127.227 2.211 . . . . 0.0 106.83 166.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.6 t -162.73 -14.84 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -176.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 30' ' ' GLU . 8.4 t70 -118.63 -146.51 0.39 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.623 1.102 . . . . 0.0 109.576 -171.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.7 5.35 0.12 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.841 1.657 . . . . 0.0 113.643 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 28' ' ' ASP . 27.8 mt-10 -62.79 -44.61 95.73 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 125.577 1.551 . . . . 0.0 110.728 -163.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -68.58 45.03 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 128.334 2.654 . . . . 0.0 112.179 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.38 -44.35 0.07 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.469 1.908 . . . . 0.0 108.878 160.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -75.22 -27.19 59.44 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.446 -0.788 . . . . 0.0 112.305 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 pt -110.83 28.18 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 119.377 0.99 . . . . 0.0 111.847 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mt -117.93 166.57 12.34 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 125.133 1.373 . . . . 0.0 111.511 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 5.2 m-20 -61.35 146.76 88.61 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 163.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -67.3 -9.71 26.15 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.471 2.114 . . . . 0.0 112.327 169.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -78.63 -51.83 9.32 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.973 1.709 . . . . 0.0 109.95 163.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.466 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -58.67 -37.93 77.08 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.45 1.477 . . . . 0.0 110.451 -176.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -52.6 -52.9 53.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.896 1.278 . . . . 0.0 111.84 173.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -77.21 -45.08 27.75 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.596 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.9 t -53.72 -31.15 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.56 1.144 . . . . 0.0 110.13 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.59 -18.31 64.77 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 174.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -102.34 -37.03 8.24 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.383 1.447 . . . . 0.0 112.43 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -97.29 2.95 51.34 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.798 1.239 . . . . 0.0 113.2 -176.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.69 13.82 0.55 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.773 2.429 . . . . 0.0 114.437 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.711 0 C-N-CA 125.645 1.593 . . . . 0.0 109.381 177.492 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.8 t0 . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 122.109 0.957 . . . . 0.0 113.088 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.23 154.64 25.53 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 128.558 2.98 . . . . 0.0 110.1 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.6 pt -140.07 174.7 7.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.724 1.21 . . . . 0.0 109.327 173.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -99.79 108.34 20.61 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.564 1.146 . . . . 0.0 110.285 -177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.54 122.96 20.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 158.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.5 t -72.16 90.39 1.21 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 158.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 17.1 tt -65.15 -21.42 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 121.984 -0.447 . . . . 0.0 111.092 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.3 t -72.66 -0.25 12.52 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.12 1.768 . . . . 0.0 111.859 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.7 p -143.82 9.5 1.54 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.427 1.012 . . . . 0.0 113.334 160.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.439 ' C ' ' HG1' ' A' ' 72' ' ' THR . . . 56.76 55.36 30.44 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.439 ' HG1' ' C ' ' A' ' 71' ' ' GLY . 49.2 m -151.95 179.08 8.77 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.75 -1.441 . . . . 0.0 108.467 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.5 141.27 48.7 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.135 1.374 . . . . 0.0 108.487 -163.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.283 0.0 OUTLIER -151.23 -89.55 0.06 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 177.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -54.29 151.65 7.17 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.263 1.025 . . . . 0.0 112.96 -170.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -126.32 150.75 48.31 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.743 1.217 . . . . 0.0 111.099 -166.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.4 t -59.94 -23.06 63.25 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.053 -1.451 . . . . 0.0 113.739 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -60.54 -19.69 57.98 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 120.953 1.706 . . . . 0.0 112.583 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . 0.253 2.2 t -119.65 -3.76 10.32 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.401 1.48 . . . . 0.0 111.035 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -96.51 94.45 7.38 Favored 'General case' 0 C--N 1.344 0.36 0 O-C-N 120.739 -1.226 . . . . 0.0 109.781 -175.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -63.22 127.33 30.78 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 163.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.441 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 1.7 t70 -147.13 -58.92 0.27 Allowed 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 127.474 2.31 . . . . 0.0 107.322 -163.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.8 m -51.89 111.78 0.67 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.519 1.527 . . . . 0.0 111.401 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.07 -43.19 0.64 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.333 1.92 . . . . 0.0 114.743 174.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.3 m -81.93 -72.0 0.46 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.041 1.336 . . . . 0.0 108.88 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 82' ' ' ASP . . . 48.46 45.24 29.21 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 126.467 1.984 . . . . 0.0 114.26 170.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.21 148.07 34.96 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 113.801 -1.199 . . . . 0.0 107.952 166.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.67 68.59 7.03 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.836 2.357 . . . . 0.0 110.574 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.6 p -139.02 150.16 45.5 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.703 1.201 . . . . 0.0 109.222 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -130.04 166.2 20.62 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.629 1.972 . . . . 0.0 107.779 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -123.57 -16.43 6.76 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.31 176.08 9.14 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.55 2.34 . . . . 0.0 106.073 175.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.9 p -145.5 155.86 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 121.681 -0.637 . . . . 0.0 110.982 -168.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 p -60.93 -36.27 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.397 1.479 . . . . 0.0 111.501 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.5 m 140.21 151.84 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 1 C-N-CA 131.794 4.038 . . . . 0.0 108.113 -169.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -75.9 52.17 0.68 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.981 1.712 . . . . 0.0 111.021 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -105.63 -49.1 3.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.274 1.029 . . . . 0.0 109.593 -167.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -125.26 22.97 7.73 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.526 1.13 . . . . 0.0 111.346 165.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.03 125.52 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 163.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.47 148.97 25.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.996 2.118 . . . . 0.0 107.142 -178.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mp -134.58 160.6 37.57 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.576 1.151 . . . . 0.0 108.752 167.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -133.57 130.12 37.97 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 131.336 3.854 . . . . 0.0 102.903 162.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -66.07 140.63 58.26 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.4 0.619 . . . . 0.0 109.592 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -142.69 171.86 13.48 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 103.808 -2.664 . . . . 0.0 103.808 158.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -130.74 18.93 5.13 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.561 2.344 . . . . 0.0 110.281 -173.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 t -54.64 -38.35 66.78 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 128.332 2.653 . . . . 0.0 113.702 -159.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.0 pp -75.69 -8.38 56.68 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.16 4.06 41.43 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.338 1.446 . . . . 0.0 112.55 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 97.2 mtp -140.14 -99.17 0.15 Allowed 'General case' 0 C--N 1.346 0.43 0 CA-C-N 119.382 1.591 . . . . 0.0 107.915 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -143.97 100.98 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.272 0 CA-C-N 120.733 1.606 . . . . 0.0 108.225 -173.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -114.54 61.36 0.67 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.071 1.348 . . . . 0.0 111.085 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 46.7 m -70.07 137.7 51.44 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -64.58 158.32 24.61 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.95 0.796 . . . . 0.0 110.591 173.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.8 t -139.22 102.21 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -132.2 160.17 36.88 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.3 m -70.97 128.24 35.31 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -72.61 -18.84 61.56 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -169.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -78.87 -38.17 38.39 Favored 'General case' 0 CA--C 1.525 0.012 0 C-N-CA 126.483 1.913 . . . . 0.0 111.794 168.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 23.9 p -146.51 89.66 1.87 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.501 1.521 . . . . 0.0 107.846 -166.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.18 55.27 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.323 2.649 . . . . 0.0 112.127 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -74.76 -77.26 0.12 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -158.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.436 ' H ' ' CD2' ' A' ' 123' ' ' LEU . 55.4 t-80 -138.14 -73.19 0.41 Allowed 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.436 ' CD2' ' H ' ' A' ' 122' ' ' HIS . 1.9 mm? 56.83 -112.74 0.71 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.808 2.043 . . . . 0.0 108.228 169.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.72 -126.95 1.27 Allowed Glycine 0 CA--C 1.526 0.72 0 CA-C-N 119.504 1.047 . . . . 0.0 113.959 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -155.59 172.91 17.48 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.349 0.659 . . . . 0.0 111.227 -174.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.1 p -114.3 144.41 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 C-N-CA 124.516 1.126 . . . . 0.0 108.024 170.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -144.89 157.9 43.99 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.191 0.996 . . . . 0.0 110.627 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.15 102.34 2.48 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.378 1.871 . . . . 0.0 109.155 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -165.74 -48.7 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.335 1.054 . . . . 0.0 111.348 -171.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -66.18 173.08 24.81 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 123.173 0.416 . . . . 0.0 112.909 -173.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.42 168.26 24.77 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.698 2.266 . . . . 0.0 111.77 -171.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -61.06 151.44 75.09 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 161.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.44 -42.23 0.84 Allowed 'Cis proline' 0 C--N 1.345 0.383 0 CA-C-N 119.999 1.035 . . . . 0.0 114.655 16.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.3 p -77.29 -30.04 54.05 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -168.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.48 13.55 82.8 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 118.77 0.714 . . . . 0.0 113.767 -174.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -128.71 154.56 46.21 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 119.172 1.486 . . . . 0.0 111.029 -171.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.3 ttm105 -120.82 106.19 11.43 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -71.99 126.98 31.14 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 160.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 23.6 t -135.82 126.85 27.84 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.607 1.094 . . . . 0.0 108.184 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -145.65 147.48 32.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.279 0.632 . . . . 0.0 109.632 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -140.89 130.36 23.88 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.2 p -168.98 174.66 6.22 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.686 1.594 . . . . 0.0 107.941 167.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.91 -9.15 8.72 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.301 1.04 . . . . 0.0 112.972 167.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.27 -20.43 63.05 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.692 1.197 . . . . 0.0 114.202 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.2 mt -83.12 74.38 10.0 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.112 0.869 . . . . 0.0 111.333 -161.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -98.3 119.16 36.49 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.045 0.938 . . . . 0.0 110.006 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.18 147.14 53.77 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.961 0.41 . . . . 0.0 110.192 164.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.7 pt -140.89 170.22 9.92 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 126.516 1.926 . . . . 0.0 108.42 162.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -54.86 177.19 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.541 3.494 . . . . 0.0 113.184 159.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.5 mmt-85 -32.39 -45.42 0.11 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.726 2.411 . . . . 0.0 115.989 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -165.42 -71.85 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.577 0.751 . . . . 0.0 108.988 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.9 9.19 0.77 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.906 1.282 . . . . 0.0 112.799 -176.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.5 pp -67.85 -30.68 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -169.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 CA-C-O 117.191 -1.894 . . . . 0.0 109.478 -175.711 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 119.846 -0.121 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.418 ' HB ' HD22 ' A' ' 98' ' ' ASN . 47.2 pt -122.2 110.25 32.8 Favored Pre-proline 0 CA--C 1.536 0.435 0 O-C-N 120.715 -1.241 . . . . 0.0 110.842 -173.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.03 140.42 34.61 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.42 1.413 . . . . 0.0 109.016 171.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.406 ' HA ' ' HD1' ' A' ' 97' ' ' HIS . 46.6 mt -127.9 149.13 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 172.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -132.06 152.32 51.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -175.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.2 m -126.73 80.13 1.92 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 p -57.05 -39.2 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 123.005 0.522 . . . . 0.0 110.908 -169.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.75 2.81 3.74 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.333 1.053 . . . . 0.0 113.604 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -135.45 5.75 3.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.567 2.347 . . . . 0.0 110.274 171.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 34.09 42.6 0.06 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 128.375 2.67 . . . . 0.0 113.393 -162.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -87.09 161.99 17.82 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.315 -0.866 . . . . 0.0 108.995 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -135.96 132.19 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 167.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -133.83 107.05 7.64 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.868 1.667 . . . . 0.0 106.535 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 40.5 ttp -81.76 136.45 35.43 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.099 -1.001 . . . . 0.0 108.637 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.4 t -129.27 169.77 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.708 2.003 . . . . 0.0 106.067 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -99.95 152.82 19.73 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 120.526 -1.359 . . . . 0.0 110.37 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.402 ' CG ' ' HD3' ' A' ' 118' ' ' ARG . 25.0 ttm180 -68.18 137.2 54.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.02 1.728 . . . . 0.0 110.427 -168.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.2 tt -74.4 125.7 34.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.482 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.9 -170.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -154.37 110.67 3.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.9 mt -138.88 173.77 11.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.591 1.556 . . . . 0.0 109.256 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.63 159.02 21.66 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.042 2.137 . . . . 0.0 107.786 165.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.53 -35.09 76.75 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.562 -0.711 . . . . 0.0 112.607 -172.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.22 -28.62 65.41 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-O 121.051 0.453 . . . . 0.0 112.192 -174.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -59.72 -38.15 80.87 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.011 1.324 . . . . 0.0 110.048 -169.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -61.47 11.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.047 2.539 . . . . 0.0 116.61 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.89 -1.35 2.71 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 166.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -126.73 -20.59 4.25 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.825 -174.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 pt -109.13 -1.64 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.635 0.652 . . . . 0.0 111.704 165.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -101.72 163.72 12.11 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.306 1.042 . . . . 0.0 110.573 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.96 142.62 79.22 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.371 0.668 . . . . 0.0 109.772 168.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -65.84 -16.53 53.3 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.02 1.813 . . . . 0.0 111.453 166.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -71.57 -42.9 67.22 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 121.982 -0.449 . . . . 0.0 110.014 169.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.6 -44.47 96.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 121.225 -0.922 . . . . 0.0 109.912 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -56.8 -45.24 82.32 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.144 0.978 . . . . 0.0 112.336 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -76.44 -49.26 17.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -176.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 74.0 t -54.54 -33.41 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 125.156 1.382 . . . . 0.0 108.685 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.01 -18.95 63.88 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.44 -26.39 14.47 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.244 1.384 . . . . 0.0 112.192 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -108.86 -1.37 19.22 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 124.575 1.15 . . . . 0.0 112.779 -172.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.18 -2.4 0.05 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.18 2.592 . . . . 0.0 115.059 -169.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.744 0 CA-C-N 119.417 1.008 . . . . 0.0 111.94 174.345 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.5 t0 . . . . . 0 C--O 1.238 0.469 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.53 168.41 28.82 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 125.116 1.341 . . . . 0.0 112.167 161.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.6 pt -135.35 164.21 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 113.587 -1.307 . . . . 0.0 108.091 163.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -78.27 122.57 25.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.634 0.73 . . . . 0.0 109.306 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.79 117.48 23.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.234 1.814 . . . . 0.0 106.377 163.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 5.2 t -71.38 69.72 0.58 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.455 1.502 . . . . 0.0 108.746 171.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.4 tt -61.46 -19.39 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 125.512 1.525 . . . . 0.0 112.754 -169.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.1 t -70.89 -1.0 10.36 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.267 1.427 . . . . 0.0 112.617 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 9.6 p -146.19 -7.57 0.54 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.494 1.043 . . . . 0.0 113.246 158.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.9 -8.28 59.45 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.207 -1.329 . . . . 0.0 113.032 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.2 m -64.34 171.79 2.9 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.483 2.713 . . . . 0.0 111.137 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.93 152.43 51.08 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.767 1.627 . . . . 0.0 107.9 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.401 HD13 ' CD2' ' A' ' 75' ' ' PHE 0.28 0.3 OUTLIER -155.34 -98.85 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 178.996 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.401 ' CD2' HD13 ' A' ' 74' ' ' LEU . 28.2 m-85 -61.51 132.42 53.34 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.489 1.041 . . . . 0.0 113.723 -158.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.46 136.6 36.97 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.52 1.128 . . . . 0.0 110.805 173.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 58.7 m -53.02 -33.6 52.48 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.448 1.099 . . . . 0.0 113.527 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.7 -17.48 63.02 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.147 0.979 . . . . 0.0 113.235 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.4 p -76.23 -23.31 54.53 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 121.705 -0.622 . . . . 0.0 112.037 172.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 87' ' ' TRP . 1.3 mtpt -86.96 -169.81 2.79 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.524 1.53 . . . . 0.0 109.806 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -133.18 32.78 3.68 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.847 0.859 . . . . 0.0 113.051 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -54.96 -21.97 13.53 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.407 1.483 . . . . 0.0 112.424 166.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.0 p -66.54 58.67 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.293 2.237 . . . . 0.0 110.802 165.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.95 -32.91 2.8 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.555 1.55 . . . . 0.0 113.615 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.3 m -131.3 -60.41 0.95 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.549 1.674 . . . . 0.0 112.449 -167.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.08 7.29 87.25 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 115.586 0.994 . . . . 0.0 115.586 177.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.412 ' O ' ' HE3' ' A' ' 80' ' ' LYS . 2.8 t90 -67.01 144.9 98.76 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 118.44 1.12 . . . . 0.0 109.147 173.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.48 64.32 6.45 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.207 3.271 . . . . 0.0 112.393 -173.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 61.5 p -133.52 141.64 47.84 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.052 1.741 . . . . 0.0 108.983 173.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.83 168.22 19.14 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.82 1.648 . . . . 0.0 109.208 -175.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -129.4 -9.14 4.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -146.23 175.42 10.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 169.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.81 155.7 27.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 122.232 1.015 . . . . 0.0 111.682 -167.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.76 -36.44 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.898 1.679 . . . . 0.0 111.634 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.2 m 151.04 160.08 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 131.295 3.838 . . . . 0.0 108.642 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -77.26 66.54 3.05 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.151 0.98 . . . . 0.0 108.591 168.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.406 ' HD1' ' HA ' ' A' ' 10' ' ' ILE . 18.6 p80 -109.17 -54.05 2.58 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.163 0.585 . . . . 0.0 110.114 -173.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.418 HD22 ' HB ' ' A' ' 8' ' ' ILE . 1.0 OUTLIER -133.75 23.49 3.96 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 174.336 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.52 138.31 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 125.813 1.645 . . . . 0.0 106.708 172.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -105.35 137.22 43.49 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 127.251 2.22 . . . . 0.0 109.061 -174.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mp -136.71 153.42 50.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.197 1.799 . . . . 0.0 111.101 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -143.88 129.56 19.23 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 131.43 3.892 . . . . 0.0 104.332 164.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -62.18 145.44 53.46 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.559 1.144 . . . . 0.0 110.421 166.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -150.34 175.7 11.58 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 158.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.08 20.22 13.87 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.026 1.33 . . . . 0.0 110.917 175.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.9 m -64.68 26.89 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 129.803 3.241 . . . . 0.0 116.654 -169.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 pp -130.85 -7.29 3.99 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.086 1.354 . . . . 0.0 112.086 162.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.45 -1.73 32.66 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 117.08 -1.955 . . . . 0.0 113.09 -168.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.8 mtm -141.29 -87.59 0.17 Allowed 'General case' 0 C--N 1.35 0.599 0 CA-C-N 120.733 2.266 . . . . 0.0 109.442 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 49.1 t -145.92 113.78 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -123.63 94.36 4.22 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.001 1.72 . . . . 0.0 108.566 174.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 14.6 t -105.91 129.27 54.09 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -174.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -64.44 160.08 19.99 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.114 0.87 . . . . 0.0 112.119 -174.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.5 t -138.73 105.93 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -126.93 173.79 9.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.051 0.94 . . . . 0.0 108.607 170.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.5 t -70.18 149.02 47.96 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.165 -0.959 . . . . 0.0 109.161 165.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.07 -16.48 63.7 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.402 ' HD3' ' CG ' ' A' ' 23' ' ' ARG . 28.2 tpt85 -117.72 -70.07 0.81 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-O 118.27 -0.871 . . . . 0.0 113.243 170.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 17.0 p -68.13 18.72 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 118.664 2.838 . . . . 0.0 118.664 -158.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 61.79 -11.44 0.07 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.955 2.502 . . . . 0.0 116.464 166.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.48 150.12 40.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.924 0.89 . . . . 0.0 112.388 -163.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -33.39 -59.84 0.37 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 128.734 2.814 . . . . 0.0 113.224 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 45.52 -106.01 0.11 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.875 2.07 . . . . 0.0 109.365 -173.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.29 -119.56 0.69 Allowed Glycine 0 CA--C 1.522 0.491 0 CA-C-N 118.081 0.4 . . . . 0.0 112.209 171.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -163.84 172.27 14.29 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.166 0.586 . . . . 0.0 110.412 -172.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.413 HG23 ' HE2' ' A' ' 136' ' ' LYS . 3.5 p -115.45 139.54 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.423 1.489 . . . . 0.0 108.828 171.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -131.29 148.93 52.73 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.214 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.79 82.66 1.63 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.076 1.751 . . . . 0.0 109.991 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -156.51 -0.91 0.13 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.678 1.191 . . . . 0.0 112.682 -166.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.66 179.24 34.28 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 120.382 -1.449 . . . . 0.0 113.116 -169.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.44 158.84 53.14 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.707 2.272 . . . . 0.0 110.731 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 45.9 mtp85 -64.56 154.75 83.64 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 164.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.02 -41.49 0.96 Allowed 'Cis proline' 0 C--N 1.348 0.532 0 CA-C-N 119.922 1.008 . . . . 0.0 113.787 8.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.6 p -69.32 -30.08 68.06 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -168.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.94 3.88 75.71 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.817 0.722 . . . . 0.0 113.455 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.413 ' HE2' HG23 ' A' ' 126' ' ' VAL . 13.2 ptmt -123.27 152.66 41.14 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.458 1.629 . . . . 0.0 111.222 -166.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 27.3 ttm105 -125.56 99.07 5.85 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.968 1.707 . . . . 0.0 106.751 -177.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -70.06 139.17 52.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 163.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 35.1 t -143.66 140.49 30.11 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.5 1.12 . . . . 0.0 108.322 174.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -148.36 157.83 43.72 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.689 0.395 . . . . 0.0 111.312 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -155.96 126.45 6.75 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.599 1.56 . . . . 0.0 108.607 170.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 91.6 p -171.29 -179.8 2.75 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.214 1.406 . . . . 0.0 109.044 163.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.48 -17.17 43.31 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 165.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.79 8.93 0.76 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 120.694 1.588 . . . . 0.0 114.093 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.0 mt -115.6 69.47 0.73 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.63 1.172 . . . . 0.0 110.189 -164.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -97.52 129.69 44.66 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -75.55 145.62 41.11 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.575 0.625 . . . . 0.0 109.55 167.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 28.1 pt -138.13 168.06 17.6 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 126.256 1.823 . . . . 0.0 108.294 167.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -54.07 160.84 5.65 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.657 2.905 . . . . 0.0 112.124 163.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -47.69 -26.27 1.48 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -165.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' A' ' 152' ' ' GLN . 25.4 p-10 -161.45 -70.33 0.06 Allowed 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 128.728 2.811 . . . . 0.0 108.998 159.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.435 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 44.9 mt-30 -148.97 7.58 0.72 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.881 2.472 . . . . 0.0 110.126 -173.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.7 pp -56.77 -24.47 19.72 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 C-N-CA 124.877 1.271 . . . . 0.0 113.938 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 CA-C-O 116.969 -2.017 . . . . 0.0 109.271 174.998 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.7 pt -128.9 117.64 19.39 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 125.831 1.652 . . . . 0.0 108.918 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.99 136.11 22.15 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.488 1.458 . . . . 0.0 108.403 166.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.1 mt -117.93 111.58 34.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -113.52 97.28 6.35 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.149 1.38 . . . . 0.0 108.488 -176.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -68.98 83.39 0.32 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.559 0.744 . . . . 0.0 109.234 170.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.4 p -55.07 -39.12 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 118.41 0.55 . . . . 0.0 111.159 -173.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -14.53 20.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.844 1.258 . . . . 0.0 113.98 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -126.64 2.87 6.81 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 126.318 1.847 . . . . 0.0 111.059 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 36.08 44.11 0.24 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.406 1.882 . . . . 0.0 111.665 -159.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.69 160.4 30.82 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 117.676 -1.609 . . . . 0.0 108.654 168.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.5 t -140.85 128.41 22.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 103.96 -2.607 . . . . 0.0 103.96 162.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -142.67 119.69 11.35 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.441 1.496 . . . . 0.0 107.62 169.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 28.9 ttp -83.58 142.98 30.45 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 172.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.5 t -140.94 177.23 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 129.42 3.088 . . . . 0.0 103.19 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 15.7 pt-20 -108.17 169.4 8.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 120.373 1.442 . . . . 0.0 114.052 174.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.406 HH21 ' CG ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -60.97 171.24 1.28 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.636 0.774 . . . . 0.0 110.038 176.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.32 131.63 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.553 1.141 . . . . 0.0 111.416 -169.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -157.15 99.97 1.83 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.829 0.851 . . . . 0.0 109.357 173.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.6 mt -143.9 169.48 17.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.428 2.291 . . . . 0.0 108.612 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.512 ' H ' ' CG ' ' A' ' 30' ' ' GLU . 0.7 OUTLIER -90.35 164.23 14.41 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 127.098 2.159 . . . . 0.0 109.878 176.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.22 57.9 1.52 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.382 1.087 . . . . 0.0 110.055 160.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.06 -12.06 0.22 Allowed 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 124.694 1.198 . . . . 0.0 111.869 158.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.512 ' CG ' ' H ' ' A' ' 27' ' ' SER . 45.0 mm-40 -81.92 -49.09 10.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.545 -0.722 . . . . 0.0 109.976 -170.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.441 ' CE3' ' CD1' ' A' ' 35' ' ' LEU . 62.5 m95 -60.72 9.37 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.45 1.9 . . . . 0.0 114.9 -175.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.481 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -130.68 -0.66 4.33 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.441 1.497 . . . . 0.0 114.879 177.286 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.97 -23.11 2.01 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.592 173.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 pt -103.33 16.96 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 119.306 0.957 . . . . 0.0 110.517 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.441 ' CD1' ' CE3' ' A' ' 31' ' ' TRP . 3.4 mt -139.67 160.16 40.5 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.078 0.951 . . . . 0.0 112.138 -174.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 2.4 m-20 -59.36 148.52 72.68 Favored Pre-proline 0 C--O 1.238 0.489 0 C-N-CA 124.353 1.061 . . . . 0.0 110.159 172.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -63.08 -18.37 64.79 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.749 1.633 . . . . 0.0 111.328 165.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -72.21 -50.68 25.67 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 119.323 -0.37 . . . . 0.0 110.119 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.445 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -58.14 -44.17 87.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 119.068 0.849 . . . . 0.0 110.509 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -53.95 -51.84 62.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.034 1.334 . . . . 0.0 111.911 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -68.72 -51.11 45.01 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.376 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.7 t -61.15 -28.63 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 118.805 -0.617 . . . . 0.0 109.664 -170.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.5 -17.64 64.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -107.41 -32.37 7.77 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.435 1.016 . . . . 0.0 112.346 174.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -103.74 0.35 30.38 Favored 'General case' 0 C--N 1.343 0.292 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -174.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.29 45.57 7.28 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.031 1.332 . . . . 0.0 111.819 -170.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 168.666 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 C--O 1.236 0.379 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.75 -171.72 39.78 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 124.115 0.864 . . . . 0.0 112.644 171.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.2 pt -140.49 179.04 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 158.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -89.1 147.65 24.11 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.061 -1.024 . . . . 0.0 110.726 169.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -120.39 141.99 49.6 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.978 0.894 . . . . 0.0 111.207 158.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 25.5 t -92.6 93.96 8.79 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 113.48 -1.691 . . . . 0.0 107.214 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.2 tt -63.32 -29.81 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 123.861 0.864 . . . . 0.0 111.322 -164.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.9 m -77.44 0.53 22.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.118 1.767 . . . . 0.0 112.503 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 6.6 p -132.0 -10.41 3.4 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.242 1.017 . . . . 0.0 112.92 163.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.7 6.13 84.49 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.002 1.286 . . . . 0.0 112.71 -172.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.2 m -106.17 132.1 52.63 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 118.442 1.121 . . . . 0.0 109.887 -164.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -75.92 165.23 25.29 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.325 1.85 . . . . 0.0 112.967 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 177.23 -171.96 0.1 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 129.048 2.939 . . . . 0.0 108.775 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 27.3 95.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 129.964 3.305 . . . . 0.0 116.109 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.55 150.43 43.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.328 1.051 . . . . 0.0 111.692 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.6 m -62.19 -24.14 67.04 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -174.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.18 -16.99 63.75 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.3 t -98.64 -9.68 24.38 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.7 -0.625 . . . . 0.0 111.293 169.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.517 ' HE2' ' H ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -84.48 179.1 7.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.12 1.368 . . . . 0.0 108.682 172.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.517 ' H ' ' HE2' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -141.24 -173.57 3.78 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.013 1.725 . . . . 0.0 107.618 174.537 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -158.82 -86.97 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -158.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.6 t -58.39 129.96 44.51 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 166.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.48 -87.68 0.52 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.8 m -81.96 50.06 1.49 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.405 1.097 . . . . 0.0 111.408 -175.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.37 32.23 3.65 Favored Glycine 0 CA--C 1.524 0.649 0 O-C-N 120.025 -1.672 . . . . 0.0 112.07 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -122.33 166.68 16.31 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.764 2.026 . . . . 0.0 108.557 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.32 71.44 6.76 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.559 2.173 . . . . 0.0 113.752 -160.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.6 p -136.86 162.09 34.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.827 1.251 . . . . 0.0 111.236 166.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -145.19 178.45 8.06 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.922 2.489 . . . . 0.0 109.471 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -128.61 -4.64 5.29 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -157.78 178.81 9.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.119 2.167 . . . . 0.0 108.146 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.0 t -134.14 151.09 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 119.182 0.901 . . . . 0.0 110.846 -168.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 p -55.01 -47.4 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.349 1.86 . . . . 0.0 111.546 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.3 m 165.22 170.24 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 131.069 3.748 . . . . 0.0 106.593 -174.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -90.4 97.15 11.01 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 159.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.433 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 11.0 p80 -131.08 -60.36 0.96 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.292 0.637 . . . . 0.0 110.804 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.433 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 30.2 m120 -115.47 18.74 15.83 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.087 1.355 . . . . 0.0 111.388 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.3 tt -130.64 163.93 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.117 2.567 . . . . 0.0 106.98 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.415 ' HD3' ' N ' ' A' ' 101' ' ' LEU . 2.7 tmtm? -135.96 128.79 31.1 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.137 0.975 . . . . 0.0 109.028 174.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.415 ' N ' ' HD3' ' A' ' 100' ' ' LYS . 1.7 mp -114.15 143.95 43.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.792 2.837 . . . . 0.0 111.256 176.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.27 113.85 8.25 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.102 1.761 . . . . 0.0 109.107 168.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -81.31 125.22 30.08 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.423 0.689 . . . . 0.0 111.498 -176.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 105' ' ' ARG . 38.7 t0 -130.62 -175.99 3.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.501 1.921 . . . . 0.0 108.753 172.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.436 ' H ' ' CG ' ' A' ' 104' ' ' ASP . 0.0 OUTLIER -111.95 19.62 17.72 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.518 1.527 . . . . 0.0 111.477 177.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.45 20.73 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 129.102 2.961 . . . . 0.0 118.155 -165.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.6 pp -132.06 -2.17 3.63 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.821 -1.174 . . . . 0.0 112.253 167.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.4 8.68 56.11 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 117.871 -1.516 . . . . 0.0 112.851 -168.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 16.1 tpt -142.23 -92.13 0.13 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 119.867 1.834 . . . . 0.0 108.507 174.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 81.5 t -143.01 114.77 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.401 ' HE ' ' CD2' ' A' ' 125' ' ' HIS . 14.1 ttt180 -119.09 113.8 21.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.646 1.178 . . . . 0.0 108.183 169.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.443 ' HB3' ' CG1' ' A' ' 126' ' ' VAL . 31.5 t -106.15 122.33 45.97 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.03 151.03 44.06 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 172.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 75.6 t -136.46 111.49 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 C-N-CA 125.016 1.326 . . . . 0.0 107.572 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 mp -127.8 164.97 21.02 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.28 1.032 . . . . 0.0 109.195 175.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 18.1 t -71.88 154.2 41.39 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.445 -0.785 . . . . 0.0 109.3 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -82.96 -20.96 34.21 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 122.055 -0.403 . . . . 0.0 112.05 172.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.22 -42.79 3.46 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.639 1.176 . . . . 0.0 112.496 -162.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 27.9 p -123.54 81.08 1.86 Allowed 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 167.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.406 ' CG ' HH21 ' A' ' 23' ' ' ARG . 0.4 OUTLIER -60.49 40.77 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.014 1 C-N-CA 132.533 4.333 . . . . 0.0 114.888 -163.909 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.21 -174.44 3.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.154 2.582 . . . . 0.0 112.434 -170.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -30.4 -70.11 0.06 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 130.012 3.325 . . . . 0.0 114.716 -164.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 mt 42.16 -111.13 0.15 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.277 2.231 . . . . 0.0 109.984 -170.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.59 -114.26 0.46 Allowed Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 118.884 0.765 . . . . 0.0 112.623 171.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.401 ' CD2' ' HE ' ' A' ' 111' ' ' ARG . 56.4 p-80 -164.76 179.08 6.77 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.826 0.45 . . . . 0.0 110.298 -170.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' A' ' 112' ' ' CYS . 2.7 p -124.49 144.93 32.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 124.795 1.238 . . . . 0.0 108.463 167.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -131.48 147.23 52.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 124.109 0.881 . . . . 0.0 109.566 175.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -65.89 115.35 5.89 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.01 -34.36 0.15 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -171.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -83.91 172.32 49.7 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -174.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.7 -84.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.685 2.256 . . . . 0.0 110.353 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.62 169.53 9.88 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 129.062 2.945 . . . . 0.0 104.887 176.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.3 -54.49 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.629 0 CA-C-N 121.572 1.597 . . . . 0.0 111.93 -2.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.8 p -69.35 -25.61 64.28 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.37 0.668 . . . . 0.0 112.442 -174.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 68.22 10.77 60.28 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.895 0.76 . . . . 0.0 113.453 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -130.29 158.57 39.42 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 119.281 1.54 . . . . 0.0 111.561 -169.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.83 103.36 7.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.941 1.696 . . . . 0.0 108.499 -175.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -73.15 135.28 44.65 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 168.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 27.0 t -142.19 133.58 26.47 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.707 1.203 . . . . 0.0 108.5 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 6.9 ptm -133.16 156.25 47.81 Favored 'General case' 0 CA--C 1.528 0.098 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -137.4 97.82 3.56 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.5 m -157.74 158.38 35.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 173.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -77.22 -30.19 54.49 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.07 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.46 54.17 0.57 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.863 2.065 . . . . 0.0 113.183 -170.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.8 mt -120.0 63.59 0.83 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.014 0.926 . . . . 0.0 108.73 -176.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -79.63 101.84 8.57 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -57.8 133.8 55.72 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 165.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.3 pt -136.99 165.72 32.72 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.567 1.147 . . . . 0.0 108.888 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.32 170.94 2.71 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.484 2.123 . . . . 0.0 111.38 162.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -50.09 -11.51 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 128.814 2.846 . . . . 0.0 118.185 -166.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.4 t0 177.31 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 128.675 2.79 . . . . 0.0 107.296 159.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.32 11.89 0.63 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.962 2.105 . . . . 0.0 112.0 -174.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -71.71 -11.58 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 O-C-N 121.186 -0.946 . . . . 0.0 112.328 173.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.543 0 C-N-CA 127.888 2.661 . . . . 0.0 106.532 159.199 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 . . . . . 0 CA--C 1.538 0.491 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.8 pt -136.24 137.28 24.17 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.147 0.979 . . . . 0.0 111.431 -171.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.12 114.31 3.88 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.51 2.14 . . . . 0.0 110.342 170.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.5 mm -87.64 132.29 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 159.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -132.28 96.09 3.8 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 -175.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 m -68.56 61.26 0.09 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 167.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.8 t -52.21 -36.67 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 120.863 -1.148 . . . . 0.0 109.486 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.54 -18.52 65.06 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.83 -174.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -108.53 1.98 21.87 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 129.812 3.245 . . . . 0.0 111.581 169.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.0 t30 37.7 61.57 1.0 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.046 2.538 . . . . 0.0 113.164 -158.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.98 169.11 11.49 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.765 1.226 . . . . 0.0 108.949 169.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -148.39 124.35 2.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 126.401 1.88 . . . . 0.0 106.305 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -144.19 95.15 2.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.032 1.333 . . . . 0.0 107.948 -173.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 12.1 ttt -69.63 137.62 52.39 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.513 -1.367 . . . . 0.0 109.968 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.9 t -135.08 160.02 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.049 1.34 . . . . 0.0 107.385 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -68.22 155.76 39.02 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.045 -1.659 . . . . 0.0 110.961 170.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.532 HH12 ' CD ' ' A' ' 25' ' ' GLU . 41.6 ptt85 -74.93 154.11 38.3 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 121.749 -0.594 . . . . 0.0 109.421 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.61 134.53 25.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.532 ' CD ' HH12 ' A' ' 23' ' ' ARG . 0.3 OUTLIER -162.52 123.56 2.54 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 102.008 -3.33 . . . . 0.0 102.008 159.029 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.1 mt -140.49 -178.96 5.75 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.963 1.705 . . . . 0.0 106.821 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.1 t -161.58 -10.94 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -118.94 -144.22 0.37 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.58 1.082 . . . . 0.0 110.211 -172.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.24 3.02 0.69 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.603 1.161 . . . . 0.0 113.281 175.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -59.47 -46.5 88.6 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 125.994 1.718 . . . . 0.0 110.974 -163.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -69.29 45.64 0.06 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.32 2.248 . . . . 0.0 112.344 174.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.67 -36.25 0.05 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.084 2.154 . . . . 0.0 109.915 159.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -84.68 -25.85 28.16 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.109 -0.948 . . . . 0.0 112.309 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 pt -109.67 18.69 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 119.773 1.17 . . . . 0.0 112.176 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.51 174.91 10.74 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.478 1.111 . . . . 0.0 110.875 -169.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.91 141.78 96.96 Favored Pre-proline 0 C--O 1.237 0.417 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 169.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -68.57 -14.53 39.81 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.744 2.296 . . . . 0.0 111.589 171.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -79.14 -44.04 22.79 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 122.999 0.52 . . . . 0.0 109.97 168.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.98 -39.7 90.62 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.58 1.082 . . . . 0.0 110.64 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -46.9 -58.29 4.09 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.953 2.101 . . . . 0.0 111.175 171.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -72.73 -42.06 64.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.883 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.5 t -52.56 -35.36 20.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 124.595 1.158 . . . . 0.0 110.405 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.71 -8.78 11.29 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -116.23 -38.68 3.53 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.376 0.989 . . . . 0.0 111.936 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -87.15 9.43 20.02 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.304 0.956 . . . . 0.0 113.151 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.58 -36.62 0.23 Allowed 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 129.143 2.977 . . . . 0.0 113.636 -167.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.511 0 C-N-CA 127.023 2.249 . . . . 0.0 108.861 -166.255 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 p30 . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 120.912 0.386 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.39 162.83 12.82 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.875 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.5 pt -143.51 175.21 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 126.274 1.829 . . . . 0.0 109.131 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -93.35 122.51 35.84 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.295 0.569 . . . . 0.0 111.934 173.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.91 115.05 21.61 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 158.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.8 t -70.55 94.53 0.99 Allowed 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 166.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 tt -58.85 -33.0 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.599 1.16 . . . . 0.0 111.155 -165.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.4 t -82.48 5.14 21.62 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.949 1.3 . . . . 0.0 111.891 -169.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.72 18.63 1.83 Allowed 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.43 -0.794 . . . . 0.0 111.557 158.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.7 25.83 56.41 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 123.343 0.497 . . . . 0.0 112.744 174.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.4 m -120.55 124.54 45.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.863 1.265 . . . . 0.0 108.021 -164.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -64.63 145.27 56.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.408 1.083 . . . . 0.0 111.448 170.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.455 HD22 ' H ' ' A' ' 75' ' ' PHE 0.281 0.0 OUTLIER -148.88 -107.42 0.08 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.953 160.657 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.455 ' H ' HD22 ' A' ' 74' ' ' LEU . 19.4 m-85 -54.38 127.15 26.16 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.307 1.443 . . . . 0.0 112.416 -159.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -89.47 150.54 22.43 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.223 1.009 . . . . 0.0 109.494 -176.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.1 m -59.47 -26.83 65.57 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.088 172.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -70.1 -17.78 63.23 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.914 1.234 . . . . 0.0 112.449 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.8 p -96.44 -22.86 16.88 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.809 1.244 . . . . 0.0 112.196 170.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.472 ' HE2' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -125.56 79.09 1.79 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.566 1.946 . . . . 0.0 107.653 -170.482 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -127.43 118.64 24.45 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -135.68 163.65 29.67 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 104.71 -2.329 . . . . 0.0 104.71 159.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.6 t -136.48 135.89 38.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.385 0.993 . . . . 0.0 109.785 -164.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.99 -53.28 1.36 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -164.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.92 -68.96 0.28 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.26 1.424 . . . . 0.0 110.021 168.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 53.7 12.31 2.43 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 126.177 1.846 . . . . 0.0 116.225 -170.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -51.19 155.04 2.44 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 127.021 2.128 . . . . 0.0 112.307 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -73.55 68.09 4.49 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.864 3.042 . . . . 0.0 111.532 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.2 p -131.04 143.76 50.94 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.238 1.415 . . . . 0.0 108.508 167.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.92 160.22 38.97 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.659 1.584 . . . . 0.0 108.035 -171.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -123.27 7.04 9.08 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.453 -171.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -159.61 176.65 11.77 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 159.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -100.64 157.91 4.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 119.1 0.864 . . . . 0.0 110.268 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.3 p -66.25 -45.63 89.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 169.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.6 m -179.81 161.46 0.98 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 129.73 3.212 . . . . 0.0 106.714 167.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -76.74 56.99 1.22 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.03 1.732 . . . . 0.0 110.085 175.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.426 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 9.9 p80 -111.56 -61.51 1.69 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.629 0.772 . . . . 0.0 109.251 -168.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.426 ' H ' ' CG ' ' A' ' 97' ' ' HIS 0.25 0.8 OUTLIER -113.09 21.23 15.57 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 175.48 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.8 tt -111.74 153.21 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 167.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -122.22 145.26 48.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.482 1.113 . . . . 0.0 108.815 169.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.5 mt -149.52 133.34 16.96 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 128.87 2.868 . . . . 0.0 108.602 -159.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.56 101.9 4.47 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 129.105 2.962 . . . . 0.0 108.503 168.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -73.8 143.8 45.84 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.604 0.762 . . . . 0.0 111.899 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -154.94 178.0 10.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 129.407 3.083 . . . . 0.0 107.989 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.13 25.12 9.84 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 120.366 -1.459 . . . . 0.0 113.135 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.45 19.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -166.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.14 2.03 2.76 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.985 -1.072 . . . . 0.0 112.449 165.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.05 -3.55 51.9 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.061 -1.41 . . . . 0.0 113.042 -169.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -139.11 -98.32 0.17 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.416 1.608 . . . . 0.0 109.175 -174.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.6 m -135.12 110.28 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.412 ' HE ' ' CD2' ' A' ' 125' ' ' HIS . 4.8 ttt180 -106.33 142.06 36.63 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 161.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.479 ' HB3' ' CG1' ' A' ' 126' ' ' VAL . 20.8 t -137.39 138.99 40.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 166.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -61.25 153.43 26.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 169.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.3 t -134.09 107.98 10.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -125.43 165.37 18.55 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 172.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 26.8 t -73.92 146.64 43.83 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 168.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.78 -45.46 86.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.745 -0.645 . . . . 0.0 109.337 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.3 tpt85 -84.41 -77.64 0.26 Allowed 'General case' 0 C--N 1.35 0.589 0 CA-C-O 116.257 -1.83 . . . . 0.0 111.775 162.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.6 p -78.34 75.32 4.87 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.859 1.209 . . . . 0.0 110.746 -158.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -59.76 77.22 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.509 1.924 . . . . 0.0 112.536 171.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.26 -155.62 0.45 Allowed 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 112.861 -1.972 . . . . 0.0 109.748 161.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -70.11 -60.6 2.19 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 125.525 1.53 . . . . 0.0 111.296 -168.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 50.24 -113.11 0.64 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.503 1.921 . . . . 0.0 108.511 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 174.11 -128.4 1.46 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 119.815 -1.183 . . . . 0.0 113.664 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.412 ' CD2' ' HE ' ' A' ' 111' ' ' ARG . 38.2 p-80 -157.78 175.65 13.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.01 0.524 . . . . 0.0 110.044 -174.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.479 ' CG1' ' HB3' ' A' ' 112' ' ' CYS . 3.0 p -122.06 143.86 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.288 1.435 . . . . 0.0 108.776 172.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -142.1 164.95 28.78 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.619 1.168 . . . . 0.0 111.516 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -72.06 102.93 3.11 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.468 1.907 . . . . 0.0 109.452 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -162.75 -50.8 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.709 2.004 . . . . 0.0 110.21 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -63.85 157.77 41.85 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 123.311 0.382 . . . . 0.0 112.29 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.12 177.64 8.5 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.651 2.234 . . . . 0.0 112.684 -169.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -50.19 145.62 9.63 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.792 159.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -84.55 -25.36 9.03 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 CA-C-N 119.462 0.844 . . . . 0.0 113.253 18.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.261 0.9 OUTLIER -107.46 -14.01 14.95 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.463 0.705 . . . . 0.0 112.18 -159.182 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.23 16.66 79.31 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 121.465 -0.772 . . . . 0.0 114.974 159.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -146.98 159.37 43.64 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 118.579 1.189 . . . . 0.0 110.486 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 ttm105 -119.56 108.88 15.04 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 126.052 1.741 . . . . 0.0 107.18 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -73.77 138.72 44.74 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 163.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 19.3 t -141.29 133.47 27.91 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.081 0.855 . . . . 0.0 108.74 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -130.18 105.11 7.71 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 122.15 0.976 . . . . 0.0 109.336 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -83.82 68.17 9.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 169.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 p -113.91 142.59 45.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.284 1.433 . . . . 0.0 110.463 -176.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.59 91.44 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.036 0.934 . . . . 0.0 111.907 170.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.73 16.74 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.44 2.696 . . . . 0.0 116.649 -160.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 87.9 mt -92.61 75.68 5.05 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.419 1.088 . . . . 0.0 111.275 -162.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -86.14 110.94 19.9 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -62.83 144.41 56.61 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 164.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 4.9 pt -142.79 169.6 10.45 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 126.179 1.792 . . . . 0.0 108.111 171.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -56.96 177.2 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.903 2.402 . . . . 0.0 111.142 159.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -50.93 8.56 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 119.867 3.284 . . . . 0.0 119.867 -172.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.7 t70 145.08 -72.85 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.159 1 C-N-CA 133.549 4.739 . . . . 0.0 107.308 163.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -154.69 43.02 0.49 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.172 2.589 . . . . 0.0 107.083 -176.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.3 pt -77.19 -19.73 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.076 -1.015 . . . . 0.0 110.562 161.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 1 C-N-CA 130.849 4.071 . . . . 0.0 105.832 171.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 4.2 mtt180 . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 pt -138.93 140.56 27.35 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.801 2.04 . . . . 0.0 109.665 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -80.78 143.0 14.47 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.062 2.508 . . . . 0.0 111.015 174.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.2 mm -135.86 122.02 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 125.816 1.647 . . . . 0.0 107.254 -168.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -132.47 98.51 4.39 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.905 0.775 . . . . 0.0 110.299 -165.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.5 m -69.73 74.84 0.43 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.827 0.851 . . . . 0.0 109.602 170.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.86 -39.24 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.686 1.194 . . . . 0.0 112.074 -174.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.67 -15.64 8.33 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.162 2.185 . . . . 0.0 113.724 175.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -133.1 15.58 4.19 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.738 2.415 . . . . 0.0 110.12 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 24.38 45.58 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 131.133 3.773 . . . . 0.0 114.375 -163.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.2 mtp-105 -90.95 171.63 9.15 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.003 175.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.0 p -140.34 154.4 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 158.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -144.35 170.99 14.96 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 127.984 2.514 . . . . 0.0 106.903 158.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 43.6 ttm -127.46 92.3 3.47 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.757 0.823 . . . . 0.0 109.499 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.6 t -77.16 155.94 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -79.13 174.24 11.77 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.06 -1.025 . . . . 0.0 112.476 175.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -77.86 163.24 26.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.533 0.733 . . . . 0.0 110.413 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.288 2.8 tp -89.15 69.12 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 123.324 1.535 . . . . 0.0 111.784 -169.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.9 89.87 3.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.018 1.727 . . . . 0.0 106.532 -173.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.8 mt -130.33 -176.21 3.88 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.107 2.163 . . . . 0.0 109.952 -175.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.0 t -112.91 162.66 15.58 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.741 1.617 . . . . 0.0 107.885 163.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -52.28 -36.89 54.06 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.14 0.882 . . . . 0.0 111.514 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -46.87 -34.63 5.57 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 129.25 3.02 . . . . 0.0 111.714 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -81.92 -46.88 13.45 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.193 1.797 . . . . 0.0 111.212 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -64.01 40.5 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 129.844 3.258 . . . . 0.0 113.503 -174.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -169.29 -18.68 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.166 2.187 . . . . 0.0 113.24 -170.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -127.24 -13.69 5.53 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.31 -0.852 . . . . 0.0 112.807 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pt -109.31 3.95 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 119.061 0.846 . . . . 0.0 111.906 170.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.3 mt -97.74 170.67 8.83 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.423 1.489 . . . . 0.0 111.014 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.18 144.73 90.95 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 159.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -63.64 -15.01 46.17 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.889 1.726 . . . . 0.0 111.761 166.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -70.94 -41.9 70.53 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 122.523 0.329 . . . . 0.0 110.587 170.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.55 -40.51 97.06 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.29 0.566 . . . . 0.0 109.914 -172.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -53.48 -52.61 59.0 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.576 1.15 . . . . 0.0 112.057 172.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -76.92 -47.07 22.07 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -172.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 p -62.52 -24.39 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.23 -9.51 32.97 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 115.157 1.539 . . . . 0.0 115.157 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.78 -41.28 2.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.881 1.219 . . . . 0.0 110.849 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.424 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -89.08 3.44 51.77 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.623 1.169 . . . . 0.0 113.317 176.346 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.33 2.44 0.09 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.16 2.584 . . . . 0.0 115.663 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 1.022 0 N-CA-C 118.242 2.057 . . . . 0.0 118.242 -163.721 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.3 t0 . . . . . 0 CA--C 1.537 0.475 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.96 169.5 14.76 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.909 1.242 . . . . 0.0 112.63 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.0 pt -138.49 172.41 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.794 1.638 . . . . 0.0 110.427 -172.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -86.6 137.51 32.43 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.893 0.477 . . . . 0.0 111.207 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.51 121.06 44.17 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.671 1.188 . . . . 0.0 109.765 164.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 16.9 t -70.16 87.64 0.59 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.309 174.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 tt -52.89 -26.28 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -171.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.0 t -75.5 -0.86 21.7 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.838 0.855 . . . . 0.0 111.684 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.3 p -149.37 20.29 0.95 Allowed 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.69 -1.256 . . . . 0.0 111.926 161.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.1 -4.93 0.45 Allowed Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.565 1.555 . . . . 0.0 116.021 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.421 HG21 HD21 ' A' ' 98' ' ' ASN . 97.3 m -71.03 142.9 50.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.778 1.631 . . . . 0.0 109.577 -171.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -89.87 135.4 33.65 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.687 0.795 . . . . 0.0 111.739 165.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.326 0.0 OUTLIER -137.26 -92.91 0.23 Allowed 'General case' 0 C--N 1.344 0.336 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 178.17 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -61.59 118.01 6.51 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.554 0.615 . . . . 0.0 110.851 -165.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.5 152.41 44.03 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 168.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.3 m -55.94 -25.8 45.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.217 -1.373 . . . . 0.0 113.565 175.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.59 -25.17 64.38 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 121.426 1.921 . . . . 0.0 111.282 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.3 p -95.87 18.52 13.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.081 1.353 . . . . 0.0 112.129 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -151.27 35.57 0.58 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.82 1.248 . . . . 0.0 111.492 161.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -84.35 57.42 4.26 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.621 0.724 . . . . 0.0 111.421 -164.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -98.75 110.24 22.87 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.169 0.587 . . . . 0.0 109.988 -172.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.6 m -50.04 102.14 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.371 1.868 . . . . 0.0 112.951 -169.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.72 -49.69 3.95 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.6 1.095 . . . . 0.0 112.305 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.9 m -59.52 -45.88 90.46 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.246 1.018 . . . . 0.0 110.967 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 49.58 26.43 7.52 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 128.034 2.73 . . . . 0.0 115.12 171.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -56.81 147.52 52.65 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.237 1.015 . . . . 0.0 111.139 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -78.97 57.62 6.54 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.163 3.242 . . . . 0.0 110.126 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.1 p -160.6 121.28 2.9 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -172.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.88 -160.78 1.1 Allowed 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 124.455 1.102 . . . . 0.0 109.082 -172.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -115.75 4.8 14.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 118.429 0.559 . . . . 0.0 112.074 -161.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -155.35 -179.18 7.84 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.144 0.578 . . . . 0.0 110.359 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 m -137.02 167.17 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 127.287 2.235 . . . . 0.0 110.114 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.5 p -58.48 -51.1 75.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.52 1.128 . . . . 0.0 111.926 -178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.4 m 159.74 151.37 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 129.216 3.006 . . . . 0.0 108.038 -169.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -74.29 79.68 1.84 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.888 0.475 . . . . 0.0 109.842 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -118.92 -56.23 2.12 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.81 0.844 . . . . 0.0 110.919 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.421 HD21 HG21 ' A' ' 72' ' ' THR . 27.9 t-20 -128.28 33.07 4.77 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.14 0.976 . . . . 0.0 111.352 170.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.7 tt -118.78 144.29 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 163.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.426 ' HD3' ' H ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -127.81 141.07 51.67 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.889 1.276 . . . . 0.0 107.698 171.418 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.426 ' H ' ' HD3' ' A' ' 100' ' ' LYS . 1.8 mp -127.85 140.8 51.8 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.452 1.901 . . . . 0.0 107.629 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -120.86 125.68 48.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 171.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -106.9 126.94 52.96 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.237 0.615 . . . . 0.0 110.769 -167.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -132.45 178.59 6.71 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.714 2.006 . . . . 0.0 109.912 176.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -106.63 11.35 30.53 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.423 1.889 . . . . 0.0 112.992 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 m -46.9 -43.44 18.86 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.616 1.566 . . . . 0.0 115.182 -159.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 pp -68.5 -12.2 60.89 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.49 4.95 30.23 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 117.615 -1.659 . . . . 0.0 112.757 -169.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.2 ttp -147.88 -86.94 0.09 Allowed 'General case' 0 C--N 1.348 0.511 0 CA-C-N 120.258 2.029 . . . . 0.0 109.172 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.8 p -148.61 114.32 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -120.56 112.1 18.5 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.221 1.808 . . . . 0.0 107.822 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.01 134.79 54.89 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.41 165.67 23.29 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.495 1.043 . . . . 0.0 110.661 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.62 108.41 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mp -131.17 167.47 19.1 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 167.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.1 t -66.53 149.2 50.8 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.6 -17.4 59.21 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 44.8 tpt85 -111.74 -58.48 2.12 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 118.627 -0.701 . . . . 0.0 111.74 170.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.8 p -84.98 77.13 10.18 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.54 74.99 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.599 1.16 . . . . 0.0 110.01 172.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -97.61 -73.6 0.6 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.909 1.284 . . . . 0.0 112.323 -165.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.68 -80.95 0.17 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.54 1.136 . . . . 0.0 109.674 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt 45.56 -110.88 0.25 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.775 1.63 . . . . 0.0 111.15 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.95 -111.79 0.39 Allowed Glycine 0 C--N 1.332 0.318 0 CA-C-N 118.88 0.764 . . . . 0.0 112.843 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -164.02 -176.45 4.53 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -166.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.88 147.53 29.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 127.163 2.185 . . . . 0.0 108.632 169.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -137.91 143.41 40.81 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.98 0.912 . . . . 0.0 108.63 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.95 111.81 9.46 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -167.82 -45.35 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.977 2.111 . . . . 0.0 110.776 -160.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.31 178.38 38.13 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.391 0.996 . . . . 0.0 113.606 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.76 162.0 42.35 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.664 2.243 . . . . 0.0 111.883 -175.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -60.72 154.37 57.79 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 163.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.66 -42.9 0.71 Allowed 'Cis proline' 0 C--N 1.346 0.432 0 CA-C-N 120.812 1.326 . . . . 0.0 113.693 12.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.2 p -70.88 -30.59 67.0 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.41 10.2 84.5 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.302 -0.721 . . . . 0.0 112.682 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.85 164.01 28.22 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.906 1.353 . . . . 0.0 112.81 -166.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.86 106.89 7.98 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.858 1.663 . . . . 0.0 107.963 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -73.05 148.12 44.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.264 1.826 . . . . 0.0 107.235 167.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 49.7 t -156.16 115.79 3.57 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.399 1.479 . . . . 0.0 108.854 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.94 138.3 33.72 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 123.903 0.881 . . . . 0.0 109.771 -175.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -142.51 126.71 17.51 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.445 1.098 . . . . 0.0 109.416 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 85.2 p -162.7 176.63 10.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 167.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -53.6 -31.43 46.9 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.599 1.559 . . . . 0.0 112.065 163.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -87.62 47.8 1.55 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.237 1.415 . . . . 0.0 112.058 -175.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 88.1 mt -131.3 61.3 1.64 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.794 1.238 . . . . 0.0 108.31 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -88.56 127.09 35.54 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -68.59 144.87 54.38 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 169.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.3 pt -137.44 168.24 17.37 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 126.304 1.842 . . . . 0.0 108.765 171.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -57.87 174.07 0.71 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.78 1.653 . . . . 0.0 110.806 158.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 11.9 mtp85 -46.8 -33.71 4.67 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.126 1.771 . . . . 0.0 113.778 -172.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -151.8 -65.08 0.18 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.583 1.953 . . . . 0.0 108.156 158.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -151.85 1.97 0.37 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 129.546 3.138 . . . . 0.0 110.668 -171.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.7 pp -55.15 -29.94 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 119.665 1.12 . . . . 0.0 113.862 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 116.824 -2.098 . . . . 0.0 109.457 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 . . . . . 0 N--CA 1.436 -1.132 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 pt -131.38 107.69 14.67 Favored Pre-proline 0 C--N 1.324 -0.5 0 C-N-CA 125.813 1.645 . . . . 0.0 108.393 -165.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.85 103.57 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.415 2.743 . . . . 0.0 109.483 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.6 mt -85.28 97.65 5.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -75.47 95.67 3.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.5 m -67.86 67.71 0.1 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.637 0.775 . . . . 0.0 108.92 159.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.11 -34.95 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.584 -0.697 . . . . 0.0 110.822 -170.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.38 -11.72 17.25 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.685 1.194 . . . . 0.0 114.088 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.503 ' HE3' ' HB3' ' A' ' 151' ' ' ASP . 35.9 ttmt -123.32 12.81 9.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.184 1.394 . . . . 0.0 110.66 172.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 30.9 68.21 0.11 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 129.915 3.286 . . . . 0.0 113.157 -164.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 mtp85 -131.5 165.36 23.74 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 172.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.9 t -144.1 98.58 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -92.84 103.47 15.81 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.5 ttt -77.88 89.08 4.08 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.656 0.662 . . . . 0.0 109.665 171.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.06 168.31 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 176.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -92.16 161.66 14.65 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.532 -1.355 . . . . 0.0 108.884 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -60.27 151.78 26.63 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.49 -0.756 . . . . 0.0 110.141 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.529 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 2.9 tp -65.87 130.4 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 172.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -153.95 120.03 5.37 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 129.109 2.964 . . . . 0.0 103.134 165.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.1 mt -143.89 175.29 10.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.542 1.537 . . . . 0.0 109.054 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.468 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 45.8 m -93.68 157.18 16.3 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 161.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.79 -36.24 64.69 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.137 0.975 . . . . 0.0 112.206 -174.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.35 -18.32 63.78 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -178.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' A' ' 27' ' ' SER . 11.3 mm-40 -70.2 -43.75 70.09 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.609 1.164 . . . . 0.0 109.748 -177.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -60.19 10.54 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.118 2.567 . . . . 0.0 115.542 -173.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -130.77 -9.89 3.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 172.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.82 -13.88 5.74 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 118.31 -0.853 . . . . 0.0 113.05 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.3 pt -113.44 -2.67 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.168 0.895 . . . . 0.0 112.45 171.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.23 173.34 7.98 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.074 0.949 . . . . 0.0 111.29 -171.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.47 133.83 70.64 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 162.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.72 -21.1 45.54 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.382 2.055 . . . . 0.0 112.731 -172.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -74.76 -31.29 61.75 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.986 171.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.18 -41.89 84.87 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 120.063 1.301 . . . . 0.0 110.54 -174.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -57.13 -48.4 78.74 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.071 0.948 . . . . 0.0 111.272 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -69.8 -46.5 65.58 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.665 0.666 . . . . 0.0 110.917 175.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.261 6.3 t -58.88 -23.64 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 125.593 1.557 . . . . 0.0 111.364 -177.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.54 70.76 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 168.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.38 -36.46 13.8 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.906 1.23 . . . . 0.0 111.782 177.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -94.75 6.0 50.23 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.473 0.709 . . . . 0.0 112.876 -174.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.11 19.32 0.19 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.258 2.223 . . . . 0.0 113.857 -172.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.771 0 C-N-CA 125.397 1.475 . . . . 0.0 114.652 -179.721 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.4 t0 . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.137 0.494 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.94 -175.57 36.85 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.024 1.297 . . . . 0.0 113.099 174.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.6 pt -125.91 160.24 33.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 165.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -72.96 155.54 39.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 122.424 1.107 . . . . 0.0 109.498 171.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -129.89 109.95 11.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 127.491 2.316 . . . . 0.0 106.228 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.1 t -75.76 73.85 2.72 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.193 1.397 . . . . 0.0 107.983 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.7 tt -58.57 -16.8 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 127.114 2.166 . . . . 0.0 113.002 -170.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.3 t -74.91 -0.51 18.83 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.432 1.493 . . . . 0.0 112.231 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.8 p -152.41 -13.66 0.17 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 158.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.99 10.99 57.03 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 119.805 1.184 . . . . 0.0 113.34 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -63.14 163.23 10.44 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.601 1.16 . . . . 0.0 108.936 160.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -129.2 153.65 47.53 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 169.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -169.33 -163.23 0.39 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.913 1.685 . . . . 0.0 109.426 -173.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 20.54 91.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 130.675 3.59 . . . . 0.0 114.632 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -57.61 137.27 56.56 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.0 1.32 . . . . 0.0 110.286 173.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.8 m -59.52 -21.34 60.05 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -169.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.92 -20.95 64.34 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.647 1.112 . . . . 0.0 112.448 173.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.6 p -75.72 -12.42 60.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.263 1.025 . . . . 0.0 112.549 172.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -133.67 85.34 2.2 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 125.146 1.379 . . . . 0.0 110.219 -165.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -142.8 45.31 1.59 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.639 -0.663 . . . . 0.0 112.454 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.8 98.04 0.06 Allowed 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.8 m -76.3 113.01 13.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.212 0.605 . . . . 0.0 110.57 -158.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.19 -60.61 0.49 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -175.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.25 -53.92 50.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.383 1.073 . . . . 0.0 111.306 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 37.35 35.43 0.18 Allowed Glycine 0 C--N 1.337 0.635 0 C-N-CA 130.632 3.968 . . . . 0.0 114.395 -167.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.9 158.07 13.74 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.728 0.811 . . . . 0.0 110.506 167.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.35 78.45 1.21 Allowed 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.531 2.821 . . . . 0.0 111.102 177.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.1 p -139.95 157.31 45.89 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.487 165.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -136.26 169.84 17.0 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.104 1.762 . . . . 0.0 108.55 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -122.4 -6.71 8.73 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.336 1.054 . . . . 0.0 112.274 174.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -152.25 -179.45 7.55 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.166 1.386 . . . . 0.0 107.676 173.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 m -119.25 164.9 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.853 1.661 . . . . 0.0 111.027 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.4 p -61.81 -49.83 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.466 1.106 . . . . 0.0 109.492 160.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.0 m 168.95 159.94 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 130.515 3.526 . . . . 0.0 107.912 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -70.02 81.97 0.49 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.134 1.373 . . . . 0.0 108.812 162.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -128.08 -60.44 1.14 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.611 0.764 . . . . 0.0 110.99 -175.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.23 26.52 10.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.628 1.171 . . . . 0.0 110.599 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.0 tt -132.74 158.15 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.794 1.638 . . . . 0.0 108.677 -171.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.438 ' HE3' ' OE2' ' A' ' 113' ' ' GLU . 2.9 tmtm? -135.18 119.52 17.87 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.327 1.451 . . . . 0.0 108.323 -171.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.5 mp -136.45 137.37 40.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.89 1.276 . . . . 0.0 111.919 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.436 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 1.9 mpt_? -125.48 119.49 28.37 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.104 2.562 . . . . 0.0 108.666 168.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.07 143.71 41.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.945 0.898 . . . . 0.0 110.64 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -145.9 -178.21 5.99 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.953 2.101 . . . . 0.0 106.915 167.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.44 11.73 18.53 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.173 1.789 . . . . 0.0 110.985 177.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.8 t -55.37 -3.96 0.08 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.836 3.255 . . . . 0.0 118.322 -158.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 pp -101.82 -10.37 19.96 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.68 1.127 . . . . 0.0 111.977 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.41 8.8 34.81 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 117.554 -1.692 . . . . 0.0 113.197 -165.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 43.9 tpp -148.92 -85.96 0.09 Allowed 'General case' 0 C--N 1.349 0.581 0 CA-C-N 120.481 2.141 . . . . 0.0 109.641 176.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.7 t -143.43 115.54 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 176.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -128.7 114.02 16.11 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 124.939 1.296 . . . . 0.0 108.571 171.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 22.7 t -121.87 136.17 54.92 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.387 1.075 . . . . 0.0 108.378 -175.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.438 ' OE2' ' HE3' ' A' ' 100' ' ' LYS . 25.6 pt-20 -65.37 159.79 23.31 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.735 1.152 . . . . 0.0 111.098 175.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 90.0 t -142.14 111.68 2.63 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 C-N-CA 124.961 1.304 . . . . 0.0 107.835 172.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.97 165.72 17.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.776 1.23 . . . . 0.0 108.273 170.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 35.2 t -69.64 162.65 27.23 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 164.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -86.54 -2.92 58.88 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.529 ' HG2' ' H ' ' A' ' 24' ' ' ILE . 28.2 tpt85 -142.64 -52.39 0.39 Allowed 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.322 0.965 . . . . 0.0 112.83 171.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 22.6 p -84.01 65.79 8.87 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 120.181 1.355 . . . . 0.0 108.248 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.61 53.94 0.08 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.598 2.759 . . . . 0.0 112.535 -170.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.43 -178.39 4.6 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.745 1.618 . . . . 0.0 110.802 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -39.38 -60.68 0.89 Allowed 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 128.218 2.607 . . . . 0.0 112.587 -173.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 48.53 -118.31 1.02 Allowed 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.807 1.643 . . . . 0.0 107.559 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.54 -110.11 0.29 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-N 118.124 0.42 . . . . 0.0 112.189 168.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.33 176.99 8.61 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.575 -0.368 . . . . 0.0 111.806 -165.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.411 HG23 ' HE2' ' A' ' 136' ' ' LYS . 3.1 p -127.56 138.58 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 124.826 1.251 . . . . 0.0 109.341 168.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -138.29 161.11 37.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.386 1.074 . . . . 0.0 110.95 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -66.93 112.58 4.39 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.675 1.59 . . . . 0.0 110.527 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -156.1 -28.2 0.1 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -78.12 154.15 40.6 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -173.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.21 -32.88 6.27 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 121.984 1.789 . . . . 0.0 112.15 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 164.07 166.0 0.06 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 131.511 3.925 . . . . 0.0 106.026 -170.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.12 -45.03 0.45 Allowed 'Cis proline' 0 C--N 1.349 0.57 0 CA-C-N 121.245 1.48 . . . . 0.0 112.005 -9.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.0 p -73.59 -22.18 60.12 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.863 1.265 . . . . 0.0 113.215 -172.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.54 -1.67 56.49 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.358 0.98 . . . . 0.0 113.356 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.411 ' HE2' HG23 ' A' ' 126' ' ' VAL . 12.7 ptmt -124.25 158.34 32.73 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 120.811 -1.405 . . . . 0.0 111.522 -162.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -125.98 108.8 11.75 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.824 2.05 . . . . 0.0 107.42 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -80.74 120.79 25.09 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 168.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 42.6 t -133.2 122.57 24.18 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.318 1.447 . . . . 0.0 107.794 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.7 ptp -141.94 161.87 36.88 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.309 1.044 . . . . 0.0 109.675 -176.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.99 132.68 16.87 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 126.816 2.047 . . . . 0.0 106.238 175.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 77.0 p -174.15 176.76 2.45 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.747 1.219 . . . . 0.0 108.604 165.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.95 -14.09 51.12 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.002 0.921 . . . . 0.0 112.972 162.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -75.84 6.71 4.68 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.005 1.275 . . . . 0.0 113.818 -171.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.1 mt -109.31 85.4 2.09 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.471 1.032 . . . . 0.0 110.407 -163.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -112.75 167.13 10.74 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.804 0.842 . . . . 0.0 109.11 171.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -112.86 159.44 19.03 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.352 1.461 . . . . 0.0 108.44 168.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.0 pt -141.15 169.46 11.41 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 126.825 2.05 . . . . 0.0 107.595 163.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -58.26 174.07 0.82 Allowed 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.433 2.088 . . . . 0.0 111.588 160.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -47.02 -25.52 0.83 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.34 2.256 . . . . 0.0 116.744 -164.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.503 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -176.66 -60.03 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.965 1.706 . . . . 0.0 108.258 167.389 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -151.74 19.7 0.7 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.909 2.084 . . . . 0.0 110.266 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.26 -14.07 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 120.639 -1.288 . . . . 0.0 111.669 174.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.913 0 C-N-CA 128.006 2.717 . . . . 0.0 106.444 160.472 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.6 mtt85 . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.42 152.06 77.3 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 119.574 1.079 . . . . 0.0 111.68 170.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.35 124.6 5.96 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.256 1.97 . . . . 0.0 109.734 164.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.4 mm -88.6 147.42 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 159.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -146.3 91.95 2.12 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -171.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 m -71.04 86.59 0.73 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 118.899 -1.12 . . . . 0.0 110.09 172.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.53 -34.78 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 124.002 0.921 . . . . 0.0 110.834 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.44 -15.22 2.46 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.826 2.05 . . . . 0.0 113.769 173.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -131.19 7.8 4.65 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.975 2.11 . . . . 0.0 111.084 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 27.6 66.9 0.08 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 128.258 2.623 . . . . 0.0 111.678 -158.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -112.45 162.07 16.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.927 1.691 . . . . 0.0 108.06 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.2 t -143.48 123.16 8.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -139.59 98.79 3.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.534 1.934 . . . . 0.0 107.265 -174.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.5 ttp -68.72 139.0 55.35 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.636 -1.29 . . . . 0.0 109.817 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 t -135.98 135.18 50.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -62.93 167.77 4.48 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 120.946 -1.096 . . . . 0.0 111.208 165.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 mtm105 -78.01 -166.67 0.84 Allowed 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.448 -0.783 . . . . 0.0 113.031 -169.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.529 ' N ' ' HE ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -86.1 112.88 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 -178.232 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -142.43 98.41 3.3 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 -177.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.9 mt -136.19 172.76 12.53 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 126.652 1.981 . . . . 0.0 109.885 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.96 166.57 21.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.97 2.108 . . . . 0.0 107.936 160.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -62.99 -54.59 35.97 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.493 -0.754 . . . . 0.0 112.196 -175.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.45 -19.01 65.28 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -171.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -56.57 -40.7 75.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.041 0.936 . . . . 0.0 109.575 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -59.3 6.82 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.412 2.285 . . . . 0.0 116.599 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.06 -8.88 3.03 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 120.756 -1.215 . . . . 0.0 114.184 173.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -117.87 -22.45 7.93 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.423 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pt -105.32 -9.5 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.456 1.025 . . . . 0.0 112.338 169.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.55 175.28 6.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.685 0.794 . . . . 0.0 111.135 -170.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.32 140.77 94.53 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 164.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.3 -12.25 27.41 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.337 2.691 . . . . 0.0 112.523 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -81.95 -38.97 24.39 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 126.76 2.024 . . . . 0.0 110.059 167.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.26 -44.5 96.4 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 119.776 1.171 . . . . 0.0 110.323 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -46.55 -57.23 4.94 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.202 1.401 . . . . 0.0 110.703 174.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.453 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 20.0 ptp180 -73.63 -49.52 25.61 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 118.084 -0.96 . . . . 0.0 108.784 -174.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.8 t -53.04 -32.85 18.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 119.08 0.854 . . . . 0.0 110.064 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.61 -28.4 68.49 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.81 -23.98 19.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.438 1.017 . . . . 0.0 112.128 175.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 41' ' ' ARG . 19.0 ptpt -111.26 -1.7 15.99 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -168.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 40.35 43.55 1.48 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.068 1.347 . . . . 0.0 111.002 -167.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.516 0 C-N-CA 125.781 1.658 . . . . 0.0 114.858 167.119 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 161.32 -167.43 36.21 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -164.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.2 pt -130.76 162.55 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.317 1.047 . . . . 0.0 110.25 174.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -79.91 155.25 27.83 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.726 0.811 . . . . 0.0 111.243 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -139.93 152.81 46.67 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.534 1.134 . . . . 0.0 110.197 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.9 t -103.3 93.01 4.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.478 1.511 . . . . 0.0 107.817 169.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.401 HG23 ' HA ' ' A' ' 144' ' ' ALA . 4.0 tt -61.09 -33.91 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 125.426 1.49 . . . . 0.0 111.733 -175.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.0 t -75.77 5.95 5.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.595 1.158 . . . . 0.0 111.613 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.1 p -140.96 15.48 2.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.795 0.838 . . . . 0.0 110.811 158.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.65 11.29 35.05 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.009 1.766 . . . . 0.0 115.271 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.0 m -118.85 137.91 53.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.745 1.773 . . . . 0.0 110.849 -159.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -79.62 164.17 24.01 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.516 1.527 . . . . 0.0 113.481 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.268 0.2 OUTLIER -161.28 -101.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.983 0.913 . . . . 0.0 112.402 174.46 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -61.89 129.32 40.4 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -158.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -74.07 134.19 42.93 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 170.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.7 m -62.51 -18.12 61.24 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.153 0.981 . . . . 0.0 113.439 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -30.68 66.25 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.012 1.278 . . . . 0.0 111.635 172.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.7 p -69.53 -17.13 63.55 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.229 1.012 . . . . 0.0 112.694 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -102.17 -163.73 1.03 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.701 1.6 . . . . 0.0 109.723 -164.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.47 21.66 4.34 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.566 0.951 . . . . 0.0 113.566 -175.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -53.87 118.31 3.87 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.756 1.222 . . . . 0.0 109.015 164.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 m 111.0 -23.5 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 131.621 3.968 . . . . 0.0 110.585 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -99.16 -52.01 1.29 Allowed Glycine 0 C--N 1.34 0.786 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 176.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.4 t -155.43 -6.72 0.13 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 168.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.99 17.69 52.29 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 119.794 1.179 . . . . 0.0 115.351 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -63.15 150.49 88.68 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 118.022 0.911 . . . . 0.0 110.864 176.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -77.89 51.01 3.45 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.747 2.964 . . . . 0.0 111.489 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.4 p -129.74 146.39 51.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.676 0.791 . . . . 0.0 109.785 168.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.72 166.05 25.79 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.004 1.722 . . . . 0.0 108.568 -170.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -116.63 -9.27 11.36 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -172.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -149.65 -174.03 4.57 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 168.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 m -130.79 165.48 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 124.511 1.124 . . . . 0.0 111.475 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.3 p -52.7 -44.95 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.452 1.501 . . . . 0.0 110.877 168.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.4 m 157.14 158.33 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 130.258 3.423 . . . . 0.0 108.76 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -72.8 72.78 1.09 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 164.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.403 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 3.6 p80 -121.41 -56.19 1.9 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.379 1.072 . . . . 0.0 109.191 -174.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.403 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 49.7 t30 -118.01 13.41 13.91 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.363 1.865 . . . . 0.0 110.644 170.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.31 142.3 44.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 O-C-N 119.962 -1.711 . . . . 0.0 107.236 171.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -122.53 145.97 47.84 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.085 1.754 . . . . 0.0 107.963 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mp -128.12 157.37 40.94 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 125.092 1.357 . . . . 0.0 111.771 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.49 133.53 27.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 127.934 2.493 . . . . 0.0 106.094 167.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.491 ' CD ' HH21 ' A' ' 105' ' ' ARG . 6.8 tm-20 -76.94 144.49 38.8 Favored 'General case' 0 N--CA 1.459 0.021 0 C-N-CA 123.245 0.618 . . . . 0.0 110.878 177.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -150.9 177.73 9.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.044 2.138 . . . . 0.0 105.409 158.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.491 HH21 ' CD ' ' A' ' 103' ' ' GLU . 1.1 ptp180 -120.36 27.98 8.28 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.667 1.987 . . . . 0.0 111.072 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.03 21.3 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.961 2.905 . . . . 0.0 116.372 -168.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.64 0.57 3.29 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.539 1.136 . . . . 0.0 112.435 166.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.35 -0.13 55.79 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 117.696 -1.613 . . . . 0.0 112.842 -170.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -139.11 -88.97 0.21 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 119.854 1.827 . . . . 0.0 108.495 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 64.5 t -145.2 107.2 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -176.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -113.56 88.62 2.88 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.892 1.277 . . . . 0.0 108.757 167.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 53.5 m -86.06 133.32 33.9 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.05 159.58 30.55 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.311 0.96 . . . . 0.0 111.285 174.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.7 t -141.65 102.79 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 126.385 1.874 . . . . 0.0 107.163 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -133.09 159.66 39.45 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.551 0.614 . . . . 0.0 111.248 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 43.1 t -79.27 115.32 18.85 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.532 0.733 . . . . 0.0 111.021 -173.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.51 -24.83 65.61 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.671 1.188 . . . . 0.0 113.463 -171.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.529 ' HE ' ' N ' ' A' ' 24' ' ' ILE . 8.3 tpt180 -59.2 -26.97 65.29 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.73 1.15 . . . . 0.0 112.749 175.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 2.8 p -137.71 -94.73 0.2 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -174.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 176.42 16.45 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.99 2.516 . . . . 0.0 112.238 -174.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.83 148.36 44.55 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -158.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -41.18 -65.65 0.41 Allowed 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 128.985 2.914 . . . . 0.0 113.99 -159.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 52.66 -108.1 0.38 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.868 1.667 . . . . 0.0 108.916 176.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.06 -115.51 0.5 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.145 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -160.21 177.15 10.95 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 122.762 -0.257 . . . . 0.0 110.792 -168.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.409 HG22 ' HE2' ' A' ' 136' ' ' LYS . 5.0 p -125.68 137.35 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.265 1.426 . . . . 0.0 108.888 173.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -132.25 159.11 40.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.098 0.959 . . . . 0.0 112.133 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -72.78 84.36 1.2 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.917 2.487 . . . . 0.0 110.942 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -160.04 7.22 0.09 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.355 1.062 . . . . 0.0 112.818 -172.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -97.71 170.36 25.28 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 119.872 -1.768 . . . . 0.0 112.755 -173.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.04 165.09 33.71 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.631 2.221 . . . . 0.0 110.146 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -62.45 151.92 81.57 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 162.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.05 -44.74 0.51 Allowed 'Cis proline' 0 C--N 1.347 0.452 0 CA-C-N 119.992 1.033 . . . . 0.0 113.806 8.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 26.9 p -72.8 -25.72 61.25 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -165.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.58 3.5 62.9 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.094 0.854 . . . . 0.0 113.552 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.409 ' HE2' HG22 ' A' ' 126' ' ' VAL . 9.7 ptmt -128.97 156.76 43.26 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.327 1.563 . . . . 0.0 111.877 -165.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.7 ttm105 -125.11 101.13 6.88 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.675 1.99 . . . . 0.0 107.399 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -67.26 135.48 53.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 162.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 20.9 t -143.81 141.34 30.33 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.704 1.138 . . . . 0.0 108.609 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -141.09 158.61 43.68 Favored 'General case' 0 C--O 1.231 0.079 0 C-N-CA 123.09 0.556 . . . . 0.0 111.494 -173.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -151.17 125.56 9.45 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.95 1.7 . . . . 0.0 108.093 161.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.8 t -149.5 148.97 30.03 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 158.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.24 -19.93 63.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.571 166.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.401 ' HA ' HG23 ' A' ' 68' ' ' ILE . . . -65.78 -12.26 52.62 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.755 1.222 . . . . 0.0 113.436 172.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 89.5 mt -75.45 106.09 6.82 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.946 1.248 . . . . 0.0 109.992 -176.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -109.82 167.62 10.02 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.31 1.444 . . . . 0.0 107.923 170.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -124.39 147.12 48.45 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 23.6 pt -138.77 166.66 23.53 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.287 1.435 . . . . 0.0 107.85 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -54.82 170.24 0.67 Allowed 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.497 2.132 . . . . 0.0 111.652 167.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -52.92 -27.15 17.4 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -171.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -165.05 -83.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 158.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -123.55 12.25 9.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.489 1.116 . . . . 0.0 110.597 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.12 -24.57 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -169.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 CA-C-O 116.939 -2.034 . . . . 0.0 109.597 179.299 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.5 mtt180 . . . . . 0 N--CA 1.439 -1.017 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.0 pt -116.14 113.45 41.51 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 126.882 2.073 . . . . 0.0 106.829 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.66 101.0 1.11 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.03 1.82 . . . . 0.0 107.652 168.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.18 147.01 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 170.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -141.75 160.98 39.07 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.302 1.841 . . . . 0.0 107.228 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.5 t -136.63 113.64 10.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 160.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.8 p -56.91 -45.34 83.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 119.148 0.885 . . . . 0.0 110.046 170.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.37 -31.02 61.43 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.36 1.864 . . . . 0.0 113.057 -174.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -118.75 0.41 11.44 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.059 1.344 . . . . 0.0 112.181 -175.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 41.43 41.12 1.46 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.648 1.579 . . . . 0.0 112.41 -159.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -74.46 150.92 39.7 Favored 'General case' 0 C--N 1.345 0.39 0 O-C-N 121.15 -0.969 . . . . 0.0 109.138 174.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.2 t -142.37 137.84 29.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 159.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -155.49 110.15 2.93 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.052 1.741 . . . . 0.0 109.61 173.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.2 ttt -79.79 129.34 34.4 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 120.34 -1.475 . . . . 0.0 110.192 174.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.0 t -122.8 155.24 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -79.58 162.55 25.26 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.401 -0.812 . . . . 0.0 110.61 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -75.28 160.6 30.16 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.582 -0.699 . . . . 0.0 110.688 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.422 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 7.6 tt -90.92 67.97 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 122.745 1.259 . . . . 0.0 112.133 -161.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -101.38 47.22 0.91 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.393 -169.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.5 mt -78.61 172.72 13.29 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.785 1.278 . . . . 0.0 110.984 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.23 153.57 28.45 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 127.205 2.202 . . . . 0.0 107.011 161.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -59.37 -39.05 82.06 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.216 1.371 . . . . 0.0 111.877 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.61 -22.73 62.24 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -174.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.79 -38.84 83.88 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.481 1.112 . . . . 0.0 109.563 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.6 m95 -62.85 8.3 0.06 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.731 2.412 . . . . 0.0 115.994 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.22 -2.05 3.98 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -129.7 -19.73 3.3 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.456 -0.783 . . . . 0.0 112.617 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 pt -107.31 1.78 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 119.033 0.833 . . . . 0.0 111.645 167.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -108.55 167.19 10.23 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.17 0.988 . . . . 0.0 110.894 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.39 140.04 79.77 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 166.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.17 -18.16 55.74 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.018 1.812 . . . . 0.0 111.49 168.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -70.37 -44.14 68.7 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 118.83 -0.605 . . . . 0.0 109.713 170.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.48 -43.82 93.18 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.18 0.9 . . . . 0.0 110.049 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -59.81 -45.22 93.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.84 0.856 . . . . 0.0 112.007 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -70.19 -48.38 57.44 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 119.095 0.862 . . . . 0.0 108.788 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.1 t -53.92 -32.58 22.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 124.871 1.269 . . . . 0.0 110.065 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.67 -26.35 67.97 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 175.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.5 ptt-85 -88.8 -27.62 20.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.752 1.16 . . . . 0.0 111.912 174.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -110.93 2.64 18.24 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -168.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.04 36.29 1.93 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.479 1.511 . . . . 0.0 111.621 -171.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.451 0 CA-C-O 117.967 -1.463 . . . . 0.0 113.411 174.901 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 CA--C 1.533 0.317 0 CA-C-O 120.769 0.319 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.19 178.31 38.59 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -159.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.6 pt -136.82 160.63 36.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.427 0.691 . . . . 0.0 109.555 173.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.71 158.28 28.36 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.132 0.967 . . . . 0.0 110.693 178.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 5.2 ttt180 -143.51 134.18 25.08 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.481 1.512 . . . . 0.0 110.057 -170.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.7 t -87.03 92.71 9.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 174.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.7 tt -62.01 -25.61 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 O-C-N 122.265 -0.272 . . . . 0.0 110.994 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 57.8 m -70.12 -0.35 7.59 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.267 1.827 . . . . 0.0 113.589 176.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 25.0 p -139.56 15.2 2.54 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.918 0.887 . . . . 0.0 110.606 158.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.11 9.43 5.77 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 118.031 -1.427 . . . . 0.0 114.201 -177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.1 m -110.29 141.57 43.1 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.308 1.554 . . . . 0.0 108.851 -164.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 7.8 p-10 -65.82 163.84 15.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.51 1.124 . . . . 0.0 113.679 176.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.309 0.2 OUTLIER -154.29 -110.01 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.604 165.214 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -52.83 115.65 1.93 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.319 1.448 . . . . 0.0 112.617 -162.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -65.96 151.16 47.41 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 170.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.37 -16.67 64.26 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 176.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -63.61 -13.4 41.73 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.787 1.631 . . . . 0.0 111.828 163.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.425 ' HA ' ' CD2' ' A' ' 90' ' ' PHE . 67.5 p -119.58 12.4 12.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.813 2.445 . . . . 0.0 111.703 172.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -156.16 91.97 1.31 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.021 0.929 . . . . 0.0 110.396 178.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -141.68 147.69 37.88 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.988 1.715 . . . . 0.0 106.456 166.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -149.96 136.93 19.47 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 166.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.2 p -55.47 98.39 0.02 OUTLIER 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.805 2.042 . . . . 0.0 112.96 -158.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.9 11.95 26.75 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.832 1.206 . . . . 0.0 113.7 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.3 m -136.02 -34.45 0.8 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.218 1.007 . . . . 0.0 110.507 -159.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.7 25.82 59.25 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.428 -1.206 . . . . 0.0 114.659 172.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -59.5 140.65 88.6 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 119.223 1.511 . . . . 0.0 109.677 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -78.82 67.8 8.38 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.154 2.569 . . . . 0.0 113.301 -167.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.2 p -145.61 145.48 30.98 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.485 162.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' A' ' 79' ' ' THR . 4.7 t80 -141.94 -156.56 0.69 Allowed 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.464 0.706 . . . . 0.0 110.195 171.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -133.14 4.33 3.75 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.036 0.835 . . . . 0.0 112.184 -172.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.577 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 1.1 t0 -151.38 -176.95 5.79 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.22 158.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.8 m -134.26 164.1 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 126.594 1.958 . . . . 0.0 109.23 173.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -73.1 -17.71 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -167.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.3 m 160.43 171.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 131.121 3.768 . . . . 0.0 108.253 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -91.65 100.67 13.35 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 158.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.564 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 10.6 p80 -141.84 -60.83 0.46 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.334 0.654 . . . . 0.0 109.92 -171.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.564 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 63.1 t30 -114.37 10.72 17.12 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.468 2.307 . . . . 0.0 110.005 171.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.57 150.22 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 127.5 2.32 . . . . 0.0 107.497 -177.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -142.16 147.54 36.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.18 1.792 . . . . 0.0 110.517 -174.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mp -127.17 150.67 49.41 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 127.839 2.456 . . . . 0.0 111.78 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -131.4 152.89 50.24 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 129.927 3.291 . . . . 0.0 104.46 162.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -125.69 135.94 52.66 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 119.015 0.825 . . . . 0.0 111.008 -168.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 105' ' ' ARG . 33.4 t0 -144.82 -176.43 5.07 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.228 2.211 . . . . 0.0 108.863 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.467 ' H ' ' CG ' ' A' ' 104' ' ' ASP . 17.5 ptt-85 -112.73 15.87 19.79 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 128.734 2.814 . . . . 0.0 111.894 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.31 -33.28 41.65 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -158.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.1 pp -78.22 -10.36 59.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.045 0.839 . . . . 0.0 112.966 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.3 -1.44 26.66 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.431 -1.761 . . . . 0.0 112.885 -169.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.7 mmt -143.41 -88.05 0.13 Allowed 'General case' 0 C--N 1.347 0.463 0 CA-C-N 120.026 1.913 . . . . 0.0 108.215 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.2 t -138.55 112.09 7.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 CA-C-N 120.25 1.386 . . . . 0.0 107.604 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.5 ttt85 -121.95 117.45 26.46 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.525 0.73 . . . . 0.0 109.723 168.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.94 141.92 47.92 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.36 159.62 33.71 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.32 0.964 . . . . 0.0 109.981 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.9 t -138.6 103.51 2.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 170.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.7 mp -124.69 175.37 7.26 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 11.5 t -64.9 166.66 8.79 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.463 0.649 . . . . 0.0 110.136 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -100.42 -4.99 27.84 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.29 1.036 . . . . 0.0 110.808 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.422 ' HG2' ' H ' ' A' ' 24' ' ' ILE . 34.7 tpt85 -131.85 -71.03 0.56 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 116.978 -1.487 . . . . 0.0 111.603 159.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.2 p -75.22 94.54 2.99 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 119.95 1.25 . . . . 0.0 109.148 -168.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -37.86 30.08 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.286 1 C-N-CA 133.965 4.906 . . . . 0.0 118.945 174.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.1 175.39 2.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.186 2.195 . . . . 0.0 111.895 174.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -71.14 -57.89 4.08 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 126.104 1.761 . . . . 0.0 111.171 -163.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.55 -112.06 0.64 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.014 1.726 . . . . 0.0 107.372 177.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.7 -104.88 0.2 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 119.051 0.841 . . . . 0.0 112.339 165.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -161.85 -177.26 5.72 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.751 0.31 . . . . 0.0 111.452 -163.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.15 140.71 43.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 126.575 1.95 . . . . 0.0 107.349 169.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -139.29 153.61 47.8 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.715 0.806 . . . . 0.0 110.768 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -64.12 119.74 10.76 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.694 0.679 . . . . 0.0 109.298 167.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -154.28 -28.74 0.12 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.253 1.021 . . . . 0.0 113.204 -177.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -95.97 -179.78 35.72 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.821 1.201 . . . . 0.0 111.428 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.64 -87.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.141 2.56 . . . . 0.0 112.085 -175.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.73 163.1 1.64 Allowed Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 127.277 2.231 . . . . 0.0 107.4 -176.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.11 -39.94 1.12 Allowed 'Cis proline' 0 C--N 1.35 0.627 0 CA-C-N 120.241 1.122 . . . . 0.0 109.817 -13.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.3 p -73.66 79.83 1.52 Allowed 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.611 1.565 . . . . 0.0 108.945 165.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -109.93 -3.05 30.15 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 126.832 2.158 . . . . 0.0 110.659 170.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 138.88 39.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 164.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -117.37 109.8 17.26 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.291 1.836 . . . . 0.0 108.303 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.577 ' CE1' ' HA ' ' A' ' 92' ' ' ASP . 50.2 m-85 -78.23 129.6 35.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 23.2 t -140.0 120.38 13.99 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.915 1.686 . . . . 0.0 108.771 -170.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 20.5 ptp -133.74 155.16 50.26 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.558 0.743 . . . . 0.0 109.854 -170.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -152.14 93.66 1.85 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.958 2.103 . . . . 0.0 107.003 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.7 p -143.3 152.94 42.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.09 -35.66 81.0 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.66 0.743 . . . . 0.0 109.421 165.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.4 75.87 0.26 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.874 1.67 . . . . 0.0 110.416 165.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 96.1 mt -144.83 46.97 1.35 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.009 2.524 . . . . 0.0 108.655 164.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -72.31 157.24 38.05 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -97.14 145.86 25.61 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.64 0.776 . . . . 0.0 109.711 164.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.65 174.96 4.03 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 160.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.46 172.29 6.85 Favored 'Trans proline' 0 C--N 1.352 0.734 0 CA-C-N 121.504 1.573 . . . . 0.0 112.061 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -38.84 -44.26 1.02 Allowed 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 127.433 2.293 . . . . 0.0 114.012 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -144.34 -78.32 0.21 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.606 1.962 . . . . 0.0 107.945 172.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -144.55 2.62 1.1 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 128.692 2.797 . . . . 0.0 111.195 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.4 pp -55.3 -24.48 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -174.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 116.901 -2.055 . . . . 0.0 110.702 176.107 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 . . . . . 0 N--CA 1.438 -1.045 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.4 pt -123.13 108.89 31.89 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.013 1.725 . . . . 0.0 107.406 -169.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.22 104.26 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.932 2.421 . . . . 0.0 109.12 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.9 mm -84.15 154.59 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -134.69 152.25 51.63 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -176.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.2 m -129.08 77.99 1.82 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.11 -38.8 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.34 1.056 . . . . 0.0 111.89 -171.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.18 -14.57 11.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.237 1.415 . . . . 0.0 113.65 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.04 10.57 4.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.984 2.114 . . . . 0.0 110.608 175.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 34.53 40.99 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.776 2.83 . . . . 0.0 113.434 -164.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -83.07 164.17 20.46 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.275 -0.89 . . . . 0.0 108.995 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.5 t -136.32 132.42 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 168.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -135.63 103.6 5.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.534 1.534 . . . . 0.0 107.129 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.5 ttm -71.05 122.02 19.29 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 120.967 -1.083 . . . . 0.0 108.81 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.9 156.32 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 173.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -88.79 164.74 15.09 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.898 -1.126 . . . . 0.0 110.199 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.401 ' HG3' ' HD3' ' A' ' 118' ' ' ARG . 39.4 ttt-85 -65.87 144.25 56.93 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.769 -0.582 . . . . 0.0 110.506 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 tt -83.89 121.81 36.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -156.99 118.0 3.67 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 169.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.2 mt -135.73 177.54 7.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.987 2.515 . . . . 0.0 108.811 -172.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.406 ' H ' ' CG ' ' A' ' 30' ' ' GLU . 1.4 p -85.62 178.7 7.29 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 164.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -60.1 -38.45 83.0 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.62 0.768 . . . . 0.0 111.083 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -18.46 59.26 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -166.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 32' ' ' ARG . 25.4 mm-40 -71.07 -45.89 62.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.399 1.08 . . . . 0.0 110.154 -169.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -63.79 21.52 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.321 2.648 . . . . 0.0 114.805 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -135.99 -10.82 2.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 166.316 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -120.77 -18.05 7.78 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 119.223 0.919 . . . . 0.0 112.824 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 pt -111.08 24.97 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 119.226 0.921 . . . . 0.0 111.27 170.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -124.87 169.47 12.02 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.832 1.253 . . . . 0.0 110.903 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -62.65 144.08 96.24 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 168.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -68.37 -12.04 33.75 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.418 2.079 . . . . 0.0 111.741 168.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -78.84 -41.08 30.96 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 118.476 -0.773 . . . . 0.0 111.065 166.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.72 -39.42 80.78 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 120.231 1.378 . . . . 0.0 111.472 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -61.21 -37.74 84.06 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.799 0.84 . . . . 0.0 113.048 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.0 ptt-85 -78.15 -49.47 13.79 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.2 -24.16 29.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 O-C-N 121.396 -0.815 . . . . 0.0 111.488 -173.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.21 -24.26 67.3 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 171.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -105.69 -37.63 6.67 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.392 1.077 . . . . 0.0 111.548 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -90.47 10.68 24.31 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.251 0.932 . . . . 0.0 112.819 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 42.36 50.74 4.67 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.701 1.6 . . . . 0.0 111.564 -177.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.564 0 CA-C-O 118.257 -1.302 . . . . 0.0 113.903 173.072 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 42.4 t0 . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 121.773 0.797 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.31 163.36 30.69 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 126.017 1.77 . . . . 0.0 111.763 168.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.7 pt -133.8 155.85 40.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 165.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -79.23 146.99 32.75 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.659 0.743 . . . . 0.0 109.489 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -110.93 110.92 21.7 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 128.613 2.765 . . . . 0.0 107.067 169.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.65 88.65 0.06 Allowed 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 165.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.6 tt -62.36 -28.13 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.591 0.71 . . . . 0.0 110.461 -170.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.91 -9.15 57.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 128.107 2.563 . . . . 0.0 113.129 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.1 p -139.5 15.29 2.55 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.754 0.821 . . . . 0.0 111.594 166.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.87 37.9 53.45 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 118.912 0.778 . . . . 0.0 112.045 176.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.0 m -132.18 146.39 51.99 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 125.971 1.708 . . . . 0.0 107.27 -171.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.3 173.52 12.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.36 0.982 . . . . 0.0 111.675 176.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -168.2 -118.15 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.689 1.995 . . . . 0.0 110.392 170.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -48.25 132.32 16.21 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.83 1.652 . . . . 0.0 114.306 -159.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -80.73 145.3 31.62 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.725 0.81 . . . . 0.0 110.068 172.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.6 m -54.6 -26.39 32.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 117.572 -1.204 . . . . 0.0 113.719 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -62.63 -21.25 65.52 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.798 1.635 . . . . 0.0 112.361 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.8 p -79.25 -10.64 59.86 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.547 0.739 . . . . 0.0 112.059 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.431 ' HZ3' ' CG ' ' A' ' 82' ' ' ASP . 5.1 tmtt? -117.96 -177.97 3.39 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.327 1.451 . . . . 0.0 110.98 -161.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -140.76 25.24 2.17 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -162.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.431 ' CG ' ' HZ3' ' A' ' 80' ' ' LYS . 37.9 m-20 -56.06 -34.92 66.38 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 120.531 -1.356 . . . . 0.0 112.431 173.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.09 77.93 3.63 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 163.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 155.84 -68.02 0.29 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.601 1.096 . . . . 0.0 111.287 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.8 t -153.5 -11.58 0.15 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.455 1.279 . . . . 0.0 114.455 -173.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.06 18.5 57.6 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.781 1.173 . . . . 0.0 115.337 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.86 136.91 96.69 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 118.221 1.01 . . . . 0.0 110.708 -177.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.95 51.34 3.81 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.904 3.069 . . . . 0.0 111.771 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.3 p -138.38 117.64 12.73 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 168.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -104.33 179.77 4.18 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.62 1.968 . . . . 0.0 107.894 -170.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -119.37 -12.96 9.31 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 118.309 -0.853 . . . . 0.0 113.209 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -154.38 -178.49 7.18 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.897 1.226 . . . . 0.0 108.222 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.4 t -133.74 153.8 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.727 1.211 . . . . 0.0 110.061 -165.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -65.81 -56.72 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.154 0.982 . . . . 0.0 109.909 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.0 m 175.63 158.88 0.24 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 127.276 2.231 . . . . 0.0 107.656 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -76.36 85.23 3.12 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 160.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -119.7 -58.18 1.92 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.647 0.779 . . . . 0.0 109.561 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.71 -1.72 24.15 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.262 1.025 . . . . 0.0 111.296 169.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.06 153.86 32.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 126.393 1.877 . . . . 0.0 108.571 -169.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -140.39 134.54 30.99 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.324 1.449 . . . . 0.0 110.273 -167.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 pp -141.96 144.95 33.98 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 124.305 1.003 . . . . 0.0 113.258 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.577 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 1.5 mpt_? -137.24 123.95 21.13 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 129.522 3.129 . . . . 0.0 107.747 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.442 ' N ' ' HG ' ' A' ' 112' ' ' CYS . 14.4 tm-20 -84.35 148.44 26.63 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.776 1.23 . . . . 0.0 111.206 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -153.99 173.32 16.15 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.21 2.604 . . . . 0.0 107.49 168.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.93 20.19 11.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.599 1.159 . . . . 0.0 112.763 173.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.97 -43.48 63.57 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -158.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pp -73.36 -7.58 52.23 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.84 3.69 45.8 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.485 1.517 . . . . 0.0 112.512 -169.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.0 mtp -142.07 -98.36 0.13 Allowed 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.091 1.445 . . . . 0.0 108.474 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.7 t -139.4 106.35 2.71 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.3 ttt-85 -110.42 113.69 26.54 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.442 ' HG ' ' N ' ' A' ' 103' ' ' GLU . 42.7 t -119.77 124.32 45.87 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.577 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 16.8 pt-20 -62.54 162.26 10.68 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.221 0.464 . . . . 0.0 110.812 -174.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.8 t -137.24 106.28 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 169.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.36 168.88 15.62 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 170.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 30.4 t -70.6 138.93 51.25 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.54 -12.93 60.03 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.191 0.996 . . . . 0.0 112.297 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.401 ' HD3' ' HG3' ' A' ' 23' ' ' ARG . 38.4 tpt85 -123.26 -73.79 0.64 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 117.088 -1.434 . . . . 0.0 112.904 167.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 19.9 p -69.71 17.58 0.05 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 -158.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 68.09 -19.69 0.14 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.911 2.484 . . . . 0.0 116.087 162.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.06 165.33 18.24 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -161.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -37.12 -62.65 0.48 Allowed 'General case' 0 C--N 1.342 0.28 0 C-N-CA 129.247 3.019 . . . . 0.0 113.846 -169.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mt 46.43 -109.12 0.21 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.225 2.21 . . . . 0.0 110.604 -172.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.78 -126.47 1.03 Allowed Glycine 0 CA--C 1.521 0.456 0 CA-C-N 119.144 0.884 . . . . 0.0 113.913 175.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -167.08 168.39 13.71 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.967 0.907 . . . . 0.0 110.415 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.0 p -105.5 142.87 17.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 123.78 0.832 . . . . 0.0 110.152 170.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -140.72 166.32 25.07 Favored 'General case' 0 C--N 1.344 0.328 0 O-C-N 124.006 0.816 . . . . 0.0 111.569 172.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.24 67.94 1.43 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.056 1.742 . . . . 0.0 112.19 -172.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -142.7 25.38 1.82 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.439 1.096 . . . . 0.0 111.52 -174.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -103.2 167.43 16.91 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.971 -1.081 . . . . 0.0 111.637 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.7 167.81 25.6 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.509 2.139 . . . . 0.0 110.564 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 52.3 ptt85 -58.23 147.36 67.08 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 160.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.21 -54.28 0.15 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.525 0 CA-C-N 120.557 1.235 . . . . 0.0 113.764 7.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.1 t -79.21 -13.46 59.68 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -161.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.65 -1.36 45.42 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 119.963 1.256 . . . . 0.0 114.424 169.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -119.44 156.11 30.79 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.084 1.442 . . . . 0.0 111.434 -169.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -128.03 98.91 5.29 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 126.089 1.755 . . . . 0.0 110.128 -169.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -75.58 92.96 2.97 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.685 2.394 . . . . 0.0 109.367 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 31.3 t -92.57 140.24 29.75 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.021 0.928 . . . . 0.0 109.963 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 9.1 ttp -144.37 146.92 32.81 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.981 0.912 . . . . 0.0 109.204 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -143.13 119.12 10.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.458 1.903 . . . . 0.0 107.756 174.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 80.3 p -172.86 -175.14 1.2 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.524 1.13 . . . . 0.0 107.963 165.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.77 -21.25 40.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.615 1.566 . . . . 0.0 114.0 163.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.27 25.76 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.09 2.156 . . . . 0.0 115.751 -164.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 95.5 mt -124.63 41.58 3.47 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.157 0.89 . . . . 0.0 112.258 -160.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -78.67 145.34 34.64 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 170.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -95.31 159.16 15.14 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.777 0.717 . . . . 0.0 109.546 167.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 14.2 pt -138.53 170.98 8.99 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 125.077 1.351 . . . . 0.0 107.663 158.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -46.47 167.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.524 3.482 . . . . 0.0 113.702 162.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -15.66 -49.01 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 129.284 3.034 . . . . 0.0 116.023 163.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -170.08 -156.63 0.14 Allowed 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 131.326 3.85 . . . . 0.0 101.255 -161.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -88.05 16.02 6.6 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 129.331 3.053 . . . . 0.0 110.133 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.2 pp -76.03 -10.69 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.121 1.768 . . . . 0.0 114.171 -162.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 CA-C-O 116.964 -2.02 . . . . 0.0 111.066 177.886 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 . . . . . 0 CA--C 1.54 0.575 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 pt -108.91 114.97 57.87 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 125.66 1.584 . . . . 0.0 111.041 -175.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.91 126.13 12.25 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.238 1.959 . . . . 0.0 109.287 164.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.9 mt -110.21 93.58 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -88.76 112.21 22.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.0 m -83.41 75.56 9.98 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 166.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.4 m -57.58 -30.14 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -170.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.21 -17.9 22.29 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.104 1.362 . . . . 0.0 113.059 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.27 15.76 5.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.811 1.644 . . . . 0.0 111.201 166.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 36.67 44.47 0.33 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.604 2.762 . . . . 0.0 112.638 -166.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.448 HH12 ' CD ' ' A' ' 19' ' ' GLU . 12.5 mtm105 -84.09 156.67 22.06 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 168.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.0 t -143.64 122.03 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -177.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.448 ' CD ' HH12 ' A' ' 17' ' ' ARG . 3.5 pm0 -130.39 114.72 15.93 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.515 1.126 . . . . 0.0 108.064 171.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.5 ttm -81.96 135.19 35.4 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 121.173 -0.954 . . . . 0.0 109.197 172.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.3 t -135.46 159.17 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 126.024 1.73 . . . . 0.0 106.611 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -69.53 166.13 19.54 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.743 -1.223 . . . . 0.0 113.559 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.95 170.62 12.33 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 163.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.55 138.52 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -168.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -156.96 92.14 1.25 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 174.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.5 mt -126.57 -178.17 4.27 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 127.487 2.315 . . . . 0.0 108.436 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.8 p -87.45 -92.64 0.1 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.232 1.013 . . . . 0.0 109.95 176.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -150.41 -62.02 0.2 Allowed 'General case' 0 C--O 1.231 0.117 0 C-N-CA 126.564 1.946 . . . . 0.0 107.947 174.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -58.53 -21.89 53.7 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -175.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 32' ' ' ARG . 18.8 mm-40 -53.2 -46.12 68.9 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.789 0.836 . . . . 0.0 110.658 173.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -68.2 40.91 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.338 2.255 . . . . 0.0 112.935 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.405 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -150.27 -44.42 0.13 Allowed 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 125.623 1.569 . . . . 0.0 109.351 159.417 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.4 -24.0 34.63 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 117.94 -1.029 . . . . 0.0 112.549 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.1 pt -105.65 21.99 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 119.936 1.244 . . . . 0.0 112.443 172.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.9 mt -108.22 166.01 11.07 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-O 122.036 0.922 . . . . 0.0 113.272 -177.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -56.15 151.01 28.18 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.942 1.297 . . . . 0.0 109.111 163.227 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.9 22.18 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.121 1 C-N-CA 125.331 4.021 . . . . 0.0 111.981 168.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.525 ' H ' ' C ' ' A' ' 36' ' ' ASP . 7.2 tt0 -133.32 -48.72 0.84 Allowed 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 126.867 2.067 . . . . 0.0 109.317 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.21 75.24 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 120.31 1.413 . . . . 0.0 111.9 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -56.18 -46.06 79.52 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 175.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -80.83 -51.06 9.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -175.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.269 2.1 t -59.52 -23.92 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.413 1.085 . . . . 0.0 110.374 -178.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.47 -25.51 68.03 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 170.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -100.68 -34.79 9.72 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.035 1.288 . . . . 0.0 111.566 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -89.0 5.79 42.63 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.892 0.877 . . . . 0.0 112.092 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.42 51.29 16.65 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.852 1.661 . . . . 0.0 110.568 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.644 0 CA-C-O 118.778 -1.012 . . . . 0.0 114.513 178.752 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.3 t0 . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.39 -172.78 52.63 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 125.463 1.506 . . . . 0.0 111.96 162.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.4 pt -138.28 166.47 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 158.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -78.48 149.16 33.24 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.259 -0.901 . . . . 0.0 110.237 173.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.17 120.26 24.26 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.636 1.974 . . . . 0.0 107.002 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.0 t -73.76 86.6 1.7 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.832 1.653 . . . . 0.0 106.924 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 tt -66.35 -30.6 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.032 0.933 . . . . 0.0 111.099 -161.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.3 m -73.61 4.88 4.4 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.863 2.065 . . . . 0.0 112.462 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.7 p -148.47 16.54 1.02 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.878 1.271 . . . . 0.0 112.048 163.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.32 9.55 24.1 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.218 0.913 . . . . 0.0 115.172 176.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.2 m -108.53 122.54 47.28 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.928 1.364 . . . . 0.0 110.13 -159.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -64.94 151.85 44.74 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.486 0.715 . . . . 0.0 111.852 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.01 -101.43 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.863 0.865 . . . . 0.0 111.632 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -62.9 130.25 43.99 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.947 0.794 . . . . 0.0 111.15 -163.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -76.73 145.09 38.87 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.1 m -54.57 -27.59 39.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.152 -0.927 . . . . 0.0 112.549 176.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.99 -19.9 65.5 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.353 1.433 . . . . 0.0 112.96 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.4 p -79.95 -12.52 59.72 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.83 0.852 . . . . 0.0 112.046 174.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.432 ' HG2' ' H ' ' A' ' 81' ' ' PHE . 9.4 tttt -123.06 -171.36 2.28 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.408 1.883 . . . . 0.0 109.054 -166.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.432 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 74.0 m-85 -145.21 -179.79 6.87 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.668 1.987 . . . . 0.0 109.548 -177.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -155.94 -71.35 0.11 Allowed 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 127.499 2.319 . . . . 0.0 107.854 -168.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.63 53.33 2.65 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.863 0.839 . . . . 0.0 111.598 -159.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.99 -78.82 0.2 Allowed Glycine 0 CA--C 1.524 0.602 0 C-N-CA 127.083 2.277 . . . . 0.0 107.869 -173.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.2 m -77.07 53.66 0.98 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.389 1.076 . . . . 0.0 110.003 173.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.82 52.75 3.95 Favored Glycine 0 N--CA 1.45 -0.42 0 O-C-N 120.201 -1.562 . . . . 0.0 110.913 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.9 p-90 -135.11 164.67 42.28 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.673 1.189 . . . . 0.0 109.453 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.37 76.31 3.16 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.883 2.389 . . . . 0.0 112.191 -173.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.3 p -135.95 154.97 50.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.021 1.728 . . . . 0.0 109.399 167.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -143.75 168.71 19.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.22 1.408 . . . . 0.0 108.268 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -115.08 -13.83 11.83 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.001 -0.999 . . . . 0.0 113.14 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -158.16 176.65 12.22 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.39 1.45 . . . . 0.0 107.992 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.9 t -121.18 149.39 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 118.523 0.601 . . . . 0.0 111.46 -158.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -51.93 -58.72 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.114 1.766 . . . . 0.0 110.268 168.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.4 m 169.39 156.45 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 130.832 3.653 . . . . 0.0 105.205 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -79.33 79.87 5.74 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.826 1.194 . . . . 0.0 108.599 173.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -125.63 -53.65 1.56 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 122.994 0.518 . . . . 0.0 110.414 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -115.01 14.37 17.13 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.746 1.218 . . . . 0.0 112.347 171.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.1 tt -119.2 153.54 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 170.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.27 128.11 48.67 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 125.973 1.709 . . . . 0.0 106.899 168.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.68 146.94 51.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.921 1.289 . . . . 0.0 110.758 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.401 ' HE ' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -138.63 152.14 47.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 128.446 2.699 . . . . 0.0 105.064 174.069 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -131.79 130.39 41.76 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.807 0.843 . . . . 0.0 109.556 -169.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -137.06 -178.49 5.22 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.07 2.548 . . . . 0.0 107.355 -175.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -103.39 9.53 37.79 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.345 1.458 . . . . 0.0 111.045 174.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.4 t -59.81 14.46 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 129.669 3.188 . . . . 0.0 119.079 -161.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 pp -118.87 -9.61 10.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.501 1.52 . . . . 0.0 111.809 168.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 122.11 -23.36 7.32 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.94 2.21 . . . . 0.0 112.091 -166.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 28.0 ttm -136.25 -74.39 0.44 Allowed 'General case' 0 C--N 1.348 0.519 0 CA-C-N 119.541 1.67 . . . . 0.0 112.352 -168.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.9 p -155.24 100.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -111.71 128.78 56.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.78 144.59 51.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -178.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.401 ' CD ' ' HE ' ' A' ' 102' ' ' ARG . 10.1 pt-20 -79.05 156.57 28.31 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 63.3 t -134.87 109.03 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 171.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.72 161.34 29.95 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.2 t -70.96 150.58 45.54 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.21 -52.14 44.76 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 172.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -57.51 8.41 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 124.965 1.306 . . . . 0.0 112.667 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.0 p -121.11 77.53 1.32 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.548 1.139 . . . . 0.0 109.742 -158.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.31 20.62 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.005 1 C-N-CA 133.612 4.765 . . . . 0.0 115.572 -174.62 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.92 -58.08 6.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.333 1.853 . . . . 0.0 114.146 -159.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -158.37 -73.66 0.09 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.2 mt 49.62 -105.27 0.16 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.403 1.881 . . . . 0.0 110.462 -170.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.23 -115.55 0.54 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.481 172.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -149.47 177.05 10.06 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.195 0.522 . . . . 0.0 111.745 -167.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.49 149.63 32.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.998 1.719 . . . . 0.0 109.029 161.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -147.0 161.47 40.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.797 1.239 . . . . 0.0 109.961 174.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -67.35 121.4 15.65 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.327 0.651 . . . . 0.0 109.767 171.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -160.91 -31.61 0.05 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -74.29 148.34 38.96 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -173.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.93 -14.35 19.21 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.323 2.015 . . . . 0.0 113.205 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 175.27 168.4 0.36 Allowed Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 131.568 3.947 . . . . 0.0 106.607 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.98 -71.77 0.02 OUTLIER 'Cis proline' 0 C--N 1.35 0.635 0 CA-C-N 121.136 1.441 . . . . 0.0 110.709 -13.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.8 t -70.28 -9.29 55.56 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.196 0.998 . . . . 0.0 113.623 -176.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.14 -14.88 41.95 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.25 1.405 . . . . 0.0 113.704 172.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -97.58 152.26 19.22 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 120.942 -1.328 . . . . 0.0 110.493 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -126.14 109.65 12.6 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 127.474 2.309 . . . . 0.0 106.335 -171.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -85.03 141.76 30.07 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.479 1.512 . . . . 0.0 107.737 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 18.5 t -146.29 144.77 30.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.883 0.873 . . . . 0.0 109.774 172.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 16.7 ptm -142.22 152.31 42.96 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.178 0.991 . . . . 0.0 110.351 -171.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -144.25 138.27 27.88 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.848 1.259 . . . . 0.0 108.371 164.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 63.5 p -179.21 175.11 0.98 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.18 1.392 . . . . 0.0 109.549 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -71.65 2.96 4.46 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.456 1.102 . . . . 0.0 113.139 160.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -81.84 -6.16 58.84 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 120.409 1.459 . . . . 0.0 112.837 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.93 113.3 21.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.125 0.97 . . . . 0.0 111.881 -170.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -141.34 156.85 45.79 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 158.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -92.24 162.68 14.2 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 163.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 18.3 pt -135.86 171.11 9.38 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.456 1.903 . . . . 0.0 106.966 159.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.56 171.82 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.392 2.062 . . . . 0.0 111.977 162.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -34.97 -38.23 0.08 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 128.843 2.857 . . . . 0.0 114.857 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -159.28 -102.83 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -115.21 8.75 15.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.534 1.134 . . . . 0.0 111.265 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.3 pp -69.41 -16.46 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -159.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 116.357 -2.357 . . . . 0.0 109.75 -172.925 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 79.3 mtp . . . . . 0 C--O 1.238 0.482 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -69.67 26.9 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.855 2.062 . . . . 0.0 114.774 -172.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -65.3 175.77 1.58 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.789 0.836 . . . . 0.0 109.532 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.503 HH11 ' HG2' ' A' ' 22' ' ' GLU . 3.5 mmt180 -122.72 153.22 39.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 166.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 pt -115.18 130.97 23.8 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.668 0.787 . . . . 0.0 109.695 -174.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.14 146.39 57.72 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 N-CA-C 108.993 -1.195 . . . . 0.0 108.993 167.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -124.97 105.75 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 166.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -98.31 101.1 12.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.9 m -67.18 74.45 0.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.478 1.111 . . . . 0.0 109.1 165.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.52 -46.89 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 124.853 1.261 . . . . 0.0 110.712 -168.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.24 -16.99 60.42 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.981 -174.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 150' ' ' ARG . 1.4 mtmp? -99.45 0.47 42.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.101 1.76 . . . . 0.0 110.549 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 39.72 59.44 1.86 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.344 2.658 . . . . 0.0 113.141 -167.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.73 165.83 16.59 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.334 0.654 . . . . 0.0 109.759 171.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -143.38 124.4 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -136.67 112.94 9.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.823 1.649 . . . . 0.0 107.023 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 46.0 ttm -79.5 146.15 32.84 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.775 -1.203 . . . . 0.0 108.855 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.4 t -137.7 157.41 33.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.503 ' HG2' HH11 ' A' ' 7' ' ' ARG . 3.3 mp0 -65.8 165.8 12.21 Favored 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 121.22 -0.925 . . . . 0.0 112.084 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -64.46 174.21 1.8 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.303 -0.873 . . . . 0.0 110.947 165.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.85 103.63 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 169.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -134.95 103.94 5.78 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 166.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -136.85 177.47 7.83 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.856 1.663 . . . . 0.0 106.676 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.5 t -111.46 164.85 12.51 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 159.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.03 -27.32 43.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.579 1.552 . . . . 0.0 111.509 -175.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.21 -26.89 65.04 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 32' ' ' ARG . 62.6 mm-40 -71.62 -43.35 66.34 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.33 1.052 . . . . 0.0 109.316 -177.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -61.87 19.61 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.391 2.677 . . . . 0.0 114.932 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.447 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -136.78 1.1 2.5 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 165.251 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -133.37 -17.28 2.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 118.201 -0.904 . . . . 0.0 113.196 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 pt -110.53 -4.73 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 119.261 0.937 . . . . 0.0 112.491 171.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 mt -78.87 172.59 13.56 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.626 1.171 . . . . 0.0 110.78 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 38' ' ' GLU . 72.6 m-20 -78.52 155.62 78.66 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.084 0.953 . . . . 0.0 110.997 175.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -68.51 16.82 0.15 Allowed 'Trans proline' 0 CA--C 1.546 1.092 1 C-N-CA 126.213 4.608 . . . . 0.0 114.039 168.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.46 ' H ' ' C ' ' A' ' 36' ' ' ASP . 7.2 tt0 -128.1 -31.8 2.33 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 127.376 2.271 . . . . 0.0 110.123 167.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.95 -38.71 83.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.123 0.874 . . . . 0.0 108.793 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -59.09 -45.82 89.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.099 0.408 . . . . 0.0 111.143 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.1 -48.9 31.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 116.718 -1.611 . . . . 0.0 107.922 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.1 t -49.5 -32.28 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 119.868 1.213 . . . . 0.0 110.384 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.46 -25.54 66.1 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 114.05 1.129 . . . . 0.0 114.05 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.78 -27.78 15.61 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.396 0.998 . . . . 0.0 111.865 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -113.35 -0.53 14.49 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -163.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.93 42.12 5.92 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.436 1.094 . . . . 0.0 110.846 -171.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.39 -58.07 0.46 Allowed Glycine 0 C--N 1.336 0.555 0 C-N-CA 125.479 1.514 . . . . 0.0 111.568 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.1 t -145.64 120.62 10.03 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.472 0.636 . . . . 0.0 110.297 -170.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -56.96 -64.19 2.8 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.214 1.406 . . . . 0.0 111.126 166.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -70.07 157.56 59.39 Favored 'Trans proline' 0 C--N 1.353 0.808 0 CA-C-N 121.595 1.605 . . . . 0.0 108.81 171.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.95 -18.45 52.19 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.651 2.234 . . . . 0.0 112.999 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -155.97 167.05 31.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.131 1.772 . . . . 0.0 107.83 170.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.2 t -139.34 7.86 2.41 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.812 0.845 . . . . 0.0 112.543 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 170.14 179.14 41.51 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -149.7 93.07 1.99 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -159.42 167.82 27.8 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.091 1.756 . . . . 0.0 107.753 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -165.24 85.98 0.39 Allowed 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 168.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.15 89.2 3.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 -161.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.6 mt -144.21 -173.84 4.13 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.094 1.357 . . . . 0.0 109.782 -168.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -154.97 170.01 22.74 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.367 2.267 . . . . 0.0 107.177 -176.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -77.55 74.85 4.11 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-O 122.911 1.339 . . . . 0.0 110.07 172.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -142.77 161.92 36.84 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 158.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.82 173.73 49.93 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.853 -172.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.8 pt -135.79 164.67 31.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.997 1.719 . . . . 0.0 108.696 170.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -72.88 148.09 44.74 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 2.8 tmt_? -141.12 112.71 7.57 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.098 0.959 . . . . 0.0 109.092 175.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.73 95.71 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.403 1.881 . . . . 0.0 109.082 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.2 tt -65.1 -16.22 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.188 0.595 . . . . 0.0 111.117 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.4 m -86.73 1.65 51.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.071 2.148 . . . . 0.0 112.741 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 22.0 p -150.23 -11.05 0.26 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 162.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.8 3.1 62.52 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 118.083 -1.398 . . . . 0.0 114.197 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.3 m -97.61 143.66 28.06 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.591 1.696 . . . . 0.0 111.281 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 11.7 p-10 -97.05 156.1 16.51 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.855 2.062 . . . . 0.0 112.128 177.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.265 0.2 OUTLIER -151.72 -95.79 0.06 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.172 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -60.25 111.07 1.4 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.993 0.917 . . . . 0.0 113.414 -159.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.41 115.92 5.06 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.643 1.577 . . . . 0.0 107.749 166.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.6 m -56.12 -10.63 0.88 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 117.915 2.561 . . . . 0.0 117.915 -162.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -62.92 -25.69 68.45 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.686 1.585 . . . . 0.0 111.827 163.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.9 p -88.51 20.85 3.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.966 2.507 . . . . 0.0 111.817 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.481 ' HG2' ' H ' ' A' ' 81' ' ' PHE . 30.2 tttt -118.51 179.55 4.09 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.878 2.071 . . . . 0.0 108.205 166.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.481 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 16.5 m-85 -113.61 165.26 12.68 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 158.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -146.88 -65.23 0.28 Allowed 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 119.007 0.821 . . . . 0.0 109.466 171.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -57.29 161.64 3.18 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.832 0.825 . . . . 0.0 110.83 166.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.63 -62.74 3.49 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 119.261 -0.744 . . . . 0.0 111.511 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t -152.35 -10.67 0.18 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 47.13 23.64 1.79 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.872 1.701 . . . . 0.0 116.576 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -63.44 156.62 69.48 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 117.707 0.753 . . . . 0.0 111.811 -168.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -79.62 47.72 2.61 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.637 2.891 . . . . 0.0 110.634 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.01 144.57 31.09 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 126.418 1.887 . . . . 0.0 107.95 -176.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -158.8 177.09 11.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.645 1.178 . . . . 0.0 109.339 -161.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -128.62 0.49 5.52 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -165.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -161.48 -177.38 5.92 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.677 1.191 . . . . 0.0 108.079 166.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.4 m -140.87 165.77 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 118.873 0.76 . . . . 0.0 112.303 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 p -60.97 -54.7 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.405 1.482 . . . . 0.0 110.603 174.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.5 t 175.58 165.57 0.34 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.406 2.682 . . . . 0.0 107.921 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -75.61 79.22 2.6 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 162.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -126.82 -51.05 1.46 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.645 0.778 . . . . 0.0 109.967 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -117.13 1.55 12.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.697 1.599 . . . . 0.0 111.168 171.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.67 149.42 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 126.497 1.919 . . . . 0.0 106.942 174.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -134.3 143.21 47.6 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.247 1.419 . . . . 0.0 108.918 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 mp -120.68 152.16 38.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.883 2.073 . . . . 0.0 112.265 170.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -129.18 126.45 39.25 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 163.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -67.92 143.05 55.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.764 0.826 . . . . 0.0 110.354 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -146.03 173.48 12.13 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 158.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.35 22.13 16.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.442 2.297 . . . . 0.0 110.739 175.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.93 23.27 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.907 2.483 . . . . 0.0 116.843 -165.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 pp -131.13 -5.72 3.88 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.407 -1.433 . . . . 0.0 112.455 162.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.32 1.01 40.99 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 117.387 -1.785 . . . . 0.0 113.089 -167.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 55.4 mtm -140.92 -90.81 0.15 Allowed 'General case' 0 C--N 1.349 0.544 0 CA-C-N 120.383 2.092 . . . . 0.0 108.306 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.2 t -142.87 111.78 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.416 ' HE ' ' CD2' ' A' ' 125' ' ' HIS . 18.9 ttt180 -130.14 88.12 2.61 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.641 1.576 . . . . 0.0 111.047 175.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 7.9 m -89.12 144.09 26.38 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -66.52 162.36 20.94 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.218 0.917 . . . . 0.0 110.182 170.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.2 t -136.88 110.11 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 174.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.4 mt -131.29 160.33 35.25 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.52 1.128 . . . . 0.0 109.64 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.8 t -81.66 118.11 22.55 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.26 -6.31 4.36 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.971 1.308 . . . . 0.0 113.876 -175.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.3 ttt-85 -115.13 -9.94 12.24 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.504 1.922 . . . . 0.0 113.645 171.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 22.5 p -164.37 81.58 0.4 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.46 1.482 . . . . 0.0 109.474 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -70.01 56.23 0.14 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.483 1.513 . . . . 0.0 113.039 -174.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -75.17 -49.5 19.26 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.709 1.204 . . . . 0.0 112.952 -166.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -159.71 -67.46 0.08 Allowed 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 122.981 0.512 . . . . 0.0 109.832 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 mt 44.98 -110.66 0.21 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.25 1.82 . . . . 0.0 110.074 -173.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.55 -123.69 0.86 Allowed Glycine 0 CA--C 1.521 0.441 0 CA-C-N 118.751 0.705 . . . . 0.0 112.636 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.416 ' CD2' ' HE ' ' A' ' 111' ' ' ARG . 42.6 p-80 -158.86 174.06 15.57 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.427 -0.455 . . . . 0.0 111.18 -173.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.4 p -122.83 141.37 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.219 1.408 . . . . 0.0 108.014 172.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -134.89 133.19 39.39 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.604 1.162 . . . . 0.0 108.808 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -65.16 107.36 1.54 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.809 0.844 . . . . 0.0 109.67 172.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -162.28 -5.18 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -161.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -110.4 179.28 20.29 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 119.959 -1.713 . . . . 0.0 112.455 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.2 146.69 41.14 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.038 2.492 . . . . 0.0 110.837 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.5 ptt-85 -59.71 153.23 53.48 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.588 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.86 -41.44 0.9 Allowed 'Cis proline' 0 C--N 1.35 0.618 0 CA-C-N 119.816 0.97 . . . . 0.0 111.573 -6.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.53 71.7 4.03 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 125.968 1.707 . . . . 0.0 109.663 176.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -103.95 5.96 47.04 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 112.372 -2.195 . . . . 0.0 111.291 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.75 157.39 27.13 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 116.661 -2.016 . . . . 0.0 107.189 166.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -132.14 94.54 3.48 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -65.72 143.77 57.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 164.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 12.5 t -142.28 135.19 28.52 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.061 1.745 . . . . 0.0 108.001 159.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -133.1 141.92 48.44 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.71 0.804 . . . . 0.0 109.379 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -140.6 87.52 2.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.859 1.264 . . . . 0.0 108.082 -163.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 80.2 p -153.2 177.15 11.15 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.505 0.722 . . . . 0.0 109.586 173.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.61 -8.19 45.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 170.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.06 -25.7 61.58 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.549 1.14 . . . . 0.0 113.141 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 64.2 mt -76.68 44.62 0.37 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.157 2.583 . . . . 0.0 115.35 -158.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -73.43 155.88 38.84 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 166.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -103.65 160.61 14.61 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.67 0.788 . . . . 0.0 109.233 168.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.9 pt -132.73 165.5 36.01 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.222 1.009 . . . . 0.0 108.713 160.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -50.49 150.74 11.14 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.931 2.421 . . . . 0.0 110.507 159.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.402 ' O ' ' HE2' ' A' ' 15' ' ' LYS . 12.1 mmt180 -40.43 -44.45 2.01 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 126.444 1.898 . . . . 0.0 112.352 -164.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -145.8 -75.3 0.21 Allowed 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.525 1.13 . . . . 0.0 110.112 167.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -146.05 8.92 1.11 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.285 3.034 . . . . 0.0 109.83 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -59.2 -14.3 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.14 -0.975 . . . . 0.0 113.298 167.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.478 0 C-N-CA 128.16 2.791 . . . . 0.0 107.074 163.336 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 72.2 mtp . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -153.15 10.44 0.45 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.084 1.754 . . . . 0.0 109.859 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -88.55 155.23 19.76 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 128.266 2.626 . . . . 0.0 112.584 -160.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.0 ptt-85 -58.57 165.23 2.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.731 1.612 . . . . 0.0 113.475 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.8 pt -111.88 91.88 16.36 Favored Pre-proline 0 N--CA 1.45 -0.461 0 C-N-CA 125.88 1.672 . . . . 0.0 106.759 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 73.6 Cg_endo -64.91 138.06 55.91 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 N-CA-C 107.413 -1.803 . . . . 0.0 107.413 168.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.9 mt -121.25 152.1 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -173.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -147.0 91.58 2.02 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.229 1.412 . . . . 0.0 107.441 -164.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.4 m -66.43 77.17 0.1 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.809 0.731 . . . . 0.0 109.53 165.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -60.68 -36.58 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.658 1.183 . . . . 0.0 111.546 -170.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.52 -11.53 53.15 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.231 1.012 . . . . 0.0 112.233 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -123.31 10.22 9.24 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.362 1.865 . . . . 0.0 110.798 174.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 27.58 52.01 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.572 3.149 . . . . 0.0 113.332 -161.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.95 169.87 17.27 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 118.846 -1.142 . . . . 0.0 111.173 167.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.52 136.72 43.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 158.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -145.01 107.36 4.37 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.46 1.904 . . . . 0.0 108.427 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 47.8 ttp -82.09 125.41 30.81 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.664 -1.273 . . . . 0.0 111.568 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.4 t -130.89 135.1 60.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -55.81 166.74 0.67 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 166.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.0 mtp-105 -66.23 163.68 17.38 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.413 177.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.413 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 3.2 tt -90.2 122.66 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 169.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -149.33 112.67 4.97 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 167.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.7 mt -136.99 178.4 7.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.052 1.741 . . . . 0.0 108.316 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.31 -177.88 2.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.465 1.906 . . . . 0.0 107.843 159.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.3 -42.88 71.44 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.812 -1.18 . . . . 0.0 109.835 164.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.27 -18.97 30.58 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 128.834 2.853 . . . . 0.0 112.441 -161.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 32' ' ' ARG . 35.7 mt-10 -86.9 -40.71 14.59 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 129.664 3.186 . . . . 0.0 110.378 -168.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -62.25 7.46 0.06 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.269 2.228 . . . . 0.0 114.784 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.433 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -128.85 -4.78 5.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.938 1.695 . . . . 0.0 113.837 177.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -132.01 -18.86 2.61 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.612 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 pt -109.16 8.97 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.096 0.862 . . . . 0.0 111.356 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -115.84 164.94 13.66 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.97 1.308 . . . . 0.0 110.219 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -58.22 149.02 60.13 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 122.932 0.493 . . . . 0.0 110.784 176.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -69.19 4.48 1.93 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.466 2.777 . . . . 0.0 112.249 164.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -93.07 -48.84 6.3 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.101 -1.0 . . . . 0.0 111.277 161.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.405 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -56.58 -44.47 81.07 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 120.274 1.397 . . . . 0.0 111.355 -172.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -58.14 -40.09 80.44 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.887 1.275 . . . . 0.0 112.432 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -80.98 -45.96 15.83 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 118.645 0.657 . . . . 0.0 109.646 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.266 2.0 t -60.28 -24.44 30.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.771 1.228 . . . . 0.0 110.534 -177.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.13 -23.13 66.38 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 169.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -99.94 -40.66 7.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.309 1.413 . . . . 0.0 111.996 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -83.85 5.82 23.79 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.15 0.58 . . . . 0.0 111.791 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.43 49.01 20.54 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.892 1.677 . . . . 0.0 109.882 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.0 -5.04 8.57 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 119.217 -0.768 . . . . 0.0 114.485 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.4 m -110.85 79.23 1.18 Allowed 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -159.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -78.87 151.7 76.67 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.339 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -70.76 118.13 5.53 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.364 2.043 . . . . 0.0 108.852 165.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.55 -32.58 7.65 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 121.868 1.712 . . . . 0.0 112.834 -172.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 7.8 t80 175.13 -62.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 128.658 2.783 . . . . 0.0 106.423 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 t -139.65 -58.03 0.57 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.397 1.479 . . . . 0.0 107.236 169.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -154.32 153.58 24.91 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 163.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -164.36 160.79 21.19 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.905 1.682 . . . . 0.0 106.795 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -143.22 167.2 22.69 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 159.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -153.34 96.72 2.08 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -176.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -88.01 168.53 12.76 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 158.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -146.71 -72.04 0.23 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 170.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -173.14 176.39 2.97 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.85 2.46 . . . . 0.0 105.855 169.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -91.89 54.67 2.48 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.381 1.073 . . . . 0.0 108.585 -159.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -128.67 162.91 26.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.335 2.654 . . . . 0.0 108.101 174.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.45 175.9 50.4 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -158.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.5 pt -141.9 -178.69 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.363 1.065 . . . . 0.0 108.624 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -98.43 162.13 13.32 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 122.307 1.051 . . . . 0.0 110.293 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.84 108.61 9.53 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 17.6 t -68.3 84.54 0.26 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 170.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.1 tt -65.31 -25.89 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 122.062 -0.399 . . . . 0.0 110.204 -168.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.3 m -66.52 -1.87 4.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.37 2.268 . . . . 0.0 113.808 173.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 19.7 p -143.47 21.34 1.86 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.263 1.025 . . . . 0.0 110.843 158.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.63 12.02 51.06 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.588 1.09 . . . . 0.0 113.98 171.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 m -111.48 150.08 30.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.639 1.976 . . . . 0.0 110.636 -158.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -89.65 156.72 18.38 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.228 1.376 . . . . 0.0 113.082 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.06 -168.8 0.14 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.826 2.45 . . . . 0.0 109.361 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.9 t80 39.31 79.66 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 128.99 2.916 . . . . 0.0 112.607 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.7 148.43 49.26 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.92 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.8 t -71.34 -9.19 57.74 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -166.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -63.88 -39.84 95.14 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.732 1.213 . . . . 0.0 112.253 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.3 t -85.95 -18.16 33.4 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.276 0.631 . . . . 0.0 111.514 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.482 ' HG2' ' H ' ' A' ' 81' ' ' PHE . 20.9 tttt -74.41 178.09 5.48 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.587 0.755 . . . . 0.0 109.815 168.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.482 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -131.32 151.72 51.25 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 105.102 -2.185 . . . . 0.0 105.102 158.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -131.93 -57.05 0.98 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.497 1.119 . . . . 0.0 110.038 -167.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.4 t -88.09 177.93 6.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.441 0.639 . . . . 0.0 109.898 163.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 55.86 -97.42 0.05 OUTLIER Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.6 1.571 . . . . 0.0 110.989 -173.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.2 m -60.24 -55.52 32.69 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.724 1.61 . . . . 0.0 110.667 177.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 43.64 44.3 6.73 Favored Glycine 0 C--N 1.343 0.932 0 C-N-CA 127.591 2.519 . . . . 0.0 113.837 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -118.62 152.61 51.47 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.239 1.415 . . . . 0.0 109.992 -169.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.08 46.88 1.85 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.779 2.986 . . . . 0.0 112.969 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.3 p -124.62 150.43 46.01 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.822 0.849 . . . . 0.0 109.501 166.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -141.43 178.56 7.35 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.034 1.334 . . . . 0.0 109.851 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -135.02 -0.62 2.75 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -172.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -159.96 177.81 10.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.452 1.101 . . . . 0.0 110.583 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.14 153.33 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 120.554 1.524 . . . . 0.0 111.544 -174.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.4 t -59.84 -63.43 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 127.976 2.51 . . . . 0.0 110.828 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.4 t -173.03 159.73 4.03 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.148 2.179 . . . . 0.0 106.326 -173.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -82.5 54.46 2.63 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.008 1.323 . . . . 0.0 108.167 173.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.554 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 15.6 p80 -102.8 -64.48 1.07 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 -159.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.554 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 16.3 t-20 -109.47 5.9 23.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.461 1.904 . . . . 0.0 112.33 173.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.1 tt -125.15 152.83 31.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 126.0 1.72 . . . . 0.0 107.22 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -132.6 135.44 45.89 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.172 0.589 . . . . 0.0 109.475 173.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.15 146.38 49.52 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.623 2.369 . . . . 0.0 111.381 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -143.0 113.04 7.11 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 127.183 2.193 . . . . 0.0 107.468 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.56 158.54 20.11 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 122.538 1.161 . . . . 0.0 111.014 -177.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -164.39 176.99 8.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.127 2.571 . . . . 0.0 109.803 -172.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.271 0.0 OUTLIER -109.27 39.02 2.16 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.465 -1.397 . . . . 0.0 111.865 170.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.7 m -73.04 18.62 0.1 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 pp -130.66 0.91 4.42 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.172 -0.955 . . . . 0.0 111.542 158.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.67 1.94 60.08 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 117.747 -1.585 . . . . 0.0 113.665 -170.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.1 mmt -136.99 -95.68 0.22 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.366 1.583 . . . . 0.0 108.626 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.0 t -137.23 113.45 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 18.8 ttt180 -120.71 151.17 39.87 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 165.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 8.6 t -157.37 123.17 4.7 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -171.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -64.77 154.21 37.58 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.349 0.522 . . . . 0.0 110.522 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 78.5 t -134.39 107.91 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mp -129.44 172.45 11.52 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 171.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 42.4 t -66.56 148.35 52.01 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.05 -33.39 73.23 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 119.138 -0.458 . . . . 0.0 110.703 171.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.413 ' HG2' ' H ' ' A' ' 24' ' ' ILE . 10.4 tpt85 -106.23 -83.51 0.52 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 117.336 -1.316 . . . . 0.0 114.016 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 20.6 p -64.49 27.74 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 119.595 3.183 . . . . 0.0 119.595 -157.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 64.28 -19.59 0.07 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 158.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.65 164.32 23.64 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -159.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -38.09 -58.5 0.95 Allowed 'General case' 0 C--N 1.346 0.415 0 C-N-CA 128.42 2.688 . . . . 0.0 113.291 -174.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.502 ' CD2' ' HG ' ' A' ' 142' ' ' SER . 0.4 OUTLIER 45.01 -108.84 0.15 Allowed 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.752 2.021 . . . . 0.0 109.065 -173.36 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.69 -124.68 0.9 Allowed Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.792 170.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.21 166.24 30.0 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 122.953 0.501 . . . . 0.0 110.932 -175.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.3 p -115.38 143.28 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 126.176 1.79 . . . . 0.0 109.457 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -144.77 159.28 43.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.819 0.848 . . . . 0.0 110.906 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -67.86 76.07 0.21 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.109 2.164 . . . . 0.0 111.588 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -157.3 20.72 0.3 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.323 1.449 . . . . 0.0 111.601 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.74 171.44 17.13 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 120.414 -1.429 . . . . 0.0 113.278 -173.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.03 152.77 68.03 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.754 2.303 . . . . 0.0 110.15 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -63.32 151.95 86.06 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 162.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.8 -41.27 1.02 Allowed 'Cis proline' 0 C--N 1.347 0.465 0 CA-C-N 120.626 1.259 . . . . 0.0 113.848 11.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.2 p -67.97 -30.11 69.32 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -169.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.18 -1.89 39.0 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.649 1.118 . . . . 0.0 113.576 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -120.26 147.81 44.5 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.552 1.176 . . . . 0.0 110.011 -168.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -123.4 110.38 15.06 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 126.923 2.089 . . . . 0.0 107.753 -169.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -86.01 137.95 32.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.659 1.984 . . . . 0.0 107.026 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 17.1 t -140.11 138.64 35.44 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 168.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -145.64 153.01 40.56 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.326 0.65 . . . . 0.0 110.558 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -149.47 127.43 11.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.734 1.614 . . . . 0.0 108.827 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.502 ' HG ' ' CD2' ' A' ' 123' ' ' LEU . 97.2 p -166.79 175.17 7.99 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.799 0.84 . . . . 0.0 109.219 166.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.06 -13.89 8.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.872 0.869 . . . . 0.0 112.824 164.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.28 -12.01 60.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.484 1.038 . . . . 0.0 112.693 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 53.5 mt -84.53 81.93 8.63 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.902 1.228 . . . . 0.0 112.144 -170.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -92.42 126.73 37.63 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 162.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -75.72 146.73 39.89 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 162.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.7 pt -144.9 165.38 22.63 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 118.817 0.735 . . . . 0.0 110.868 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -60.21 174.87 1.24 Allowed 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.041 2.494 . . . . 0.0 111.675 159.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -55.02 -25.75 32.5 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -164.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 152' ' ' GLN . 23.9 p-10 -166.14 -61.71 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 128.192 2.597 . . . . 0.0 110.757 159.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.413 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 23.8 mm-40 -153.2 -0.41 0.24 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 130.669 3.587 . . . . 0.0 109.672 -163.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -62.08 -18.53 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.021 0.928 . . . . 0.0 112.003 169.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.404 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 158.968 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.1 tpt . . . . . 0 CA--C 1.544 0.729 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -162.73 55.69 0.21 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.728 1.604 . . . . 0.0 111.285 -169.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -159.3 177.4 11.05 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.03 0.919 . . . . 0.0 112.322 -159.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -125.1 148.05 48.72 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 128.21 2.604 . . . . 0.0 104.775 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.3 pt -138.67 145.13 44.87 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.412 0.685 . . . . 0.0 111.865 -158.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.56 117.33 3.68 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.274 2.649 . . . . 0.0 110.236 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.1 mm -79.56 101.15 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 163.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -108.96 109.54 20.62 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 t -82.88 96.21 8.19 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.72 -34.67 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 120.749 1.613 . . . . 0.0 109.118 173.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.81 -20.99 0.55 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 171.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -131.25 3.06 4.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.861 1.664 . . . . 0.0 112.184 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 t30 37.26 64.1 0.65 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.892 1.677 . . . . 0.0 111.224 -158.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.8 mtp-105 -107.38 157.99 17.52 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 168.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.12 137.32 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 158.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -134.27 156.52 48.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 159.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 33.6 ttm -112.95 131.9 55.56 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 68.9 t -136.08 155.68 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.726 1.611 . . . . 0.0 106.82 -170.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -68.53 154.44 41.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.63 -1.294 . . . . 0.0 111.288 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.86 147.63 52.99 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 162.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.1 tt -60.68 122.12 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.278 0.631 . . . . 0.0 109.484 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -148.19 108.1 4.03 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 104.235 -2.505 . . . . 0.0 104.235 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.4 mt -135.69 177.9 7.47 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.944 1.298 . . . . 0.0 109.361 -173.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 90.2 p -83.45 176.01 9.39 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 159.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -62.2 -48.59 79.33 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.731 -0.606 . . . . 0.0 110.804 176.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.36 -20.71 65.61 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -169.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -58.84 -42.16 88.65 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.804 0.842 . . . . 0.0 111.229 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -61.69 10.99 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.887 2.475 . . . . 0.0 115.852 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.54 -10.22 3.19 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.736 1.215 . . . . 0.0 113.858 171.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -119.99 -17.5 8.41 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.845 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 pt -112.04 4.88 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 119.342 0.974 . . . . 0.0 112.337 168.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -110.57 163.69 13.47 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.457 1.103 . . . . 0.0 110.826 -176.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.92 136.09 79.62 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 163.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.44 -17.08 53.13 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.081 1.854 . . . . 0.0 111.431 173.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -72.58 -41.33 65.79 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 118.53 -0.748 . . . . 0.0 110.114 170.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.32 -45.64 93.59 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 119.7 1.136 . . . . 0.0 110.091 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -55.92 -47.38 77.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.764 0.825 . . . . 0.0 111.588 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -73.26 -47.89 39.37 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 117.643 -1.17 . . . . 0.0 108.051 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 37.0 t -55.43 -29.6 24.31 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 124.516 1.126 . . . . 0.0 110.297 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.09 -22.57 66.95 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.47 -33.18 16.07 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.363 1.438 . . . . 0.0 111.304 175.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -102.02 -1.06 32.56 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 124.429 1.092 . . . . 0.0 112.34 -167.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 41.18 39.97 1.04 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.559 1.544 . . . . 0.0 111.15 -168.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.89 -8.66 70.63 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-O 117.568 -1.685 . . . . 0.0 115.054 173.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 t -153.35 121.8 6.28 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 120.04 1.92 . . . . 0.0 111.223 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -51.46 -59.13 8.54 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.856 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.71 156.65 31.6 Favored 'Trans proline' 0 C--N 1.353 0.779 0 CA-C-N 121.495 1.57 . . . . 0.0 109.886 167.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.05 135.72 52.68 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.853 1.702 . . . . 0.0 109.049 168.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -151.07 171.78 16.79 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.573 1.149 . . . . 0.0 107.933 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.0 m -155.58 139.75 16.53 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.56 -177.76 12.33 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.757 0.694 . . . . 0.0 112.215 -173.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -171.29 167.13 7.01 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 126.631 1.972 . . . . 0.0 107.106 164.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -141.76 150.4 41.7 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 169.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -179.08 -178.28 0.51 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.335 2.654 . . . . 0.0 105.95 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -65.92 164.45 15.03 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.571 0.701 . . . . 0.0 110.498 167.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -153.53 157.97 40.58 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.905 1.282 . . . . 0.0 108.524 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -138.15 112.91 8.98 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 172.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.257 5.7 m-20 -103.41 36.25 2.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.719 0.808 . . . . 0.0 111.364 -173.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -113.87 103.47 11.22 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 159.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.1 -177.43 33.15 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -164.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 48.1 pt -133.91 155.29 39.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 121.578 0.704 . . . . 0.0 109.403 176.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -78.86 146.22 33.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 3.8 tmt_? -138.24 109.45 6.86 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.243 1.017 . . . . 0.0 108.45 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.19 101.34 0.4 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.504 1.522 . . . . 0.0 108.194 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.8 tt -63.14 -28.4 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.626 0.77 . . . . 0.0 110.715 -170.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.0 m -83.45 11.87 6.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.478 1.911 . . . . 0.0 112.255 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.4 p -143.39 -7.11 0.79 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.577 0.751 . . . . 0.0 111.859 158.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.31 1.85 83.54 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.369 1.461 . . . . 0.0 113.131 177.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.0 m -119.82 147.57 44.5 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.228 1.514 . . . . 0.0 112.582 -159.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 10.1 p-10 -91.33 155.89 18.18 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.757 1.623 . . . . 0.0 113.221 -173.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.255 0.2 OUTLIER -162.34 -109.63 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.037 1.735 . . . . 0.0 110.013 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -51.62 120.3 5.04 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.338 1.055 . . . . 0.0 112.587 -159.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.31 139.63 48.09 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -20.62 65.82 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.99 -13.2 59.45 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.321 -1.487 . . . . 0.0 113.057 170.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.4 p -84.38 -19.39 33.64 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.991 -1.068 . . . . 0.0 112.564 166.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.28 86.78 2.25 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.707 1.603 . . . . 0.0 107.378 -166.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -135.0 133.52 39.53 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -142.07 114.17 8.15 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 168.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.6 p -70.78 71.93 0.53 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.024 1.729 . . . . 0.0 111.348 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.31 -44.55 1.08 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.098 1.333 . . . . 0.0 111.461 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.29 -46.6 17.42 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.181 0.99 . . . . 0.0 109.551 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 53.83 15.88 5.23 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.662 2.077 . . . . 0.0 115.882 -170.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -50.5 144.64 11.95 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 125.406 1.483 . . . . 0.0 112.782 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.98 65.02 6.06 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.375 3.384 . . . . 0.0 111.827 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.1 p -129.53 142.28 50.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.906 0.883 . . . . 0.0 109.041 164.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.4 167.53 21.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.973 1.709 . . . . 0.0 108.589 -168.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -122.42 -8.69 8.59 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.435 0.694 . . . . 0.0 112.679 -169.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -156.36 179.99 8.72 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.3 m -131.31 162.61 39.0 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-N 119.579 1.081 . . . . 0.0 112.305 -171.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.2 p -55.84 -38.41 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.211 1.405 . . . . 0.0 111.037 166.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.4 m 141.78 154.03 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 1 C-N-CA 132.194 4.198 . . . . 0.0 108.555 -173.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 53.3 mp0 -71.24 59.79 0.27 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.992 1.717 . . . . 0.0 109.914 166.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -105.46 -47.88 3.82 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.763 1.225 . . . . 0.0 108.526 -175.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.96 12.52 7.81 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 125.095 1.358 . . . . 0.0 112.28 170.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.89 145.82 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 125.369 1.468 . . . . 0.0 107.677 169.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -120.07 144.82 47.38 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.174 1.79 . . . . 0.0 108.329 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mp -131.74 157.21 44.4 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.89 1.276 . . . . 0.0 110.484 167.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.42 ' HE ' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -135.27 142.92 46.01 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 130.868 3.667 . . . . 0.0 102.817 164.42 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -126.76 130.76 50.94 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.936 1.294 . . . . 0.0 109.216 -165.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 105' ' ' ARG . 18.1 t70 -144.55 -170.98 3.51 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.528 2.331 . . . . 0.0 108.419 -172.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.443 ' H ' ' CG ' ' A' ' 104' ' ' ASP . 34.1 ptt180 -115.85 6.92 14.39 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.582 2.353 . . . . 0.0 112.119 -178.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -65.98 31.64 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 130.154 3.382 . . . . 0.0 116.968 -163.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 pp -133.08 -7.13 3.05 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.509 1.524 . . . . 0.0 112.278 160.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.44 1.64 35.2 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 117.441 -1.755 . . . . 0.0 113.029 -168.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.3 mtt -141.94 -89.18 0.15 Allowed 'General case' 0 C--N 1.348 0.513 0 CA-C-N 120.322 2.061 . . . . 0.0 109.024 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.3 p -150.41 109.76 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -117.76 124.27 48.03 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.487 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.83 144.61 50.58 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.42 ' CD ' ' HE ' ' A' ' 102' ' ' ARG . 10.3 pt-20 -75.75 157.22 33.8 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 173.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.1 t -136.57 110.73 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -135.82 150.61 49.49 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 51.9 t -72.66 108.13 5.51 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.62 -30.13 67.03 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.225 1.41 . . . . 0.0 112.029 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.02 -21.07 66.37 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 118.805 -0.617 . . . . 0.0 112.422 176.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 5.6 p -121.44 -100.76 0.42 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 165.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.2 p30 156.02 30.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 128.489 2.716 . . . . 0.0 110.606 -165.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.9 166.11 10.95 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.253 1.021 . . . . 0.0 111.844 -167.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -30.35 -78.3 0.02 OUTLIER 'General case' 0 C--N 1.339 0.138 0 C-N-CA 129.585 3.154 . . . . 0.0 116.016 -159.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.2 mt 43.55 -111.55 0.2 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.588 1.555 . . . . 0.0 111.807 -170.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.37 -109.36 0.3 Allowed Glycine 0 C--N 1.336 0.532 0 CA-C-N 119.623 1.101 . . . . 0.0 113.333 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -147.01 179.83 7.33 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 112.147 -166.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.1 p -130.97 144.83 36.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.715 1.606 . . . . 0.0 108.289 159.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -136.0 161.67 35.02 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.446 1.098 . . . . 0.0 110.394 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.11 117.78 14.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.903 0.881 . . . . 0.0 109.538 172.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.57 -28.87 0.11 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.05 155.52 40.65 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.12 -13.98 21.0 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.52 2.147 . . . . 0.0 113.295 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.2 ptt-85 134.57 167.28 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.918 1 C-N-CA 133.97 4.908 . . . . 0.0 106.293 -163.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.94 -58.29 0.12 OUTLIER 'Cis proline' 0 C--N 1.351 0.681 0 CA-C-N 122.314 1.862 . . . . 0.0 111.875 -3.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.4 p -69.69 -25.07 63.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.474 1.51 . . . . 0.0 112.862 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.39 -6.64 28.99 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.961 1.267 . . . . 0.0 113.343 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -115.69 152.52 33.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 120.914 -1.345 . . . . 0.0 110.017 -169.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -122.96 106.07 10.53 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.92 2.088 . . . . 0.0 107.452 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -70.15 133.93 47.61 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 162.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 23.3 t -140.71 129.45 22.97 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 174.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -129.83 147.24 51.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.28 0.632 . . . . 0.0 110.063 -175.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -139.34 99.96 3.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.4 p -138.9 166.88 23.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 162.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.27 -13.51 60.78 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.183 170.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -81.59 0.04 40.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 114.792 1.405 . . . . 0.0 114.792 -165.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 72.4 mt -79.5 54.23 1.71 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.715 1.606 . . . . 0.0 112.116 -164.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -70.59 145.1 50.95 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -85.38 156.31 20.92 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 166.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 30.6 pt -136.91 162.96 52.82 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 158.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.49 168.45 6.61 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.559 1.506 . . . . 0.0 111.238 164.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -31.66 -36.65 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 130.583 3.553 . . . . 0.0 118.21 -169.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -176.14 -57.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.564 1.946 . . . . 0.0 107.5 169.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -157.31 66.48 0.5 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -176.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -121.74 -2.55 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.686 1.194 . . . . 0.0 111.071 161.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 0 C-N-CA 129.369 3.366 . . . . 0.0 105.699 159.685 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.504 ' HG3' ' H ' ' A' ' 5' ' ' LYS . 8.6 tpt . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.504 ' H ' ' HG3' ' A' ' 4' ' ' MET . 73.6 mmtt -69.94 61.65 0.19 Allowed 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.88 -1.137 . . . . 0.0 109.47 164.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.06 -162.18 0.32 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.455 1.902 . . . . 0.0 109.268 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 7.0 mmm180 -107.73 160.16 15.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -161.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.2 pt -126.48 109.24 23.37 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 127.08 2.152 . . . . 0.0 109.383 -174.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.55 101.41 1.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.567 2.178 . . . . 0.0 108.52 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.1 mt -76.78 151.68 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -137.93 101.73 4.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.727 1.611 . . . . 0.0 106.859 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.0 m -68.35 73.74 0.23 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.177 0.899 . . . . 0.0 108.818 159.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.32 -30.8 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 121.772 -0.58 . . . . 0.0 110.438 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.4 -27.88 1.86 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.441 2.296 . . . . 0.0 113.64 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -130.73 15.62 5.34 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.081 2.153 . . . . 0.0 110.819 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 32.59 52.24 0.28 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.805 2.842 . . . . 0.0 113.604 -165.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -86.82 167.44 14.38 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.917 -0.49 . . . . 0.0 109.771 165.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.4 t -143.28 132.81 21.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -145.65 102.19 3.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.988 1.315 . . . . 0.0 108.713 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.3 ttt -82.86 118.99 23.82 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.436 -0.79 . . . . 0.0 111.019 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.2 t -113.78 -177.77 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 128.535 2.734 . . . . 0.0 106.524 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 4.1 pm0 -112.94 160.86 17.65 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.842 1.655 . . . . 0.0 112.103 177.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -56.74 154.86 8.43 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.9 1.28 . . . . 0.0 110.996 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -72.9 124.1 29.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -176.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.418 ' OE2' ' HE3' ' A' ' 5' ' ' LYS . 20.7 tt0 -148.12 115.7 6.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 163.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.3 mt -138.36 -177.81 5.01 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 128.669 2.788 . . . . 0.0 105.984 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.9 m -167.17 -24.39 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 30' ' ' GLU . 4.4 t70 -91.73 -152.5 0.3 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.119 0.872 . . . . 0.0 109.462 -176.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.91 5.19 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.454 1.902 . . . . 0.0 114.101 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.469 ' H ' ' C ' ' A' ' 28' ' ' ASP . 36.4 mt-10 -60.43 -45.1 94.85 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 126.633 1.973 . . . . 0.0 110.58 -162.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -68.65 42.41 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.468 2.307 . . . . 0.0 113.104 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.9 -34.05 0.09 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.793 1.637 . . . . 0.0 110.634 160.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -91.08 -24.65 19.95 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.012 -0.994 . . . . 0.0 113.451 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 pt -108.43 15.53 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 120.203 1.365 . . . . 0.0 112.464 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.79 175.98 9.12 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.261 1.424 . . . . 0.0 109.837 -167.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.482 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -61.95 135.13 94.51 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 166.352 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -66.31 -12.4 35.47 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.929 1.753 . . . . 0.0 110.886 165.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -76.51 -43.05 41.08 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.367 167.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.482 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -57.38 -47.59 81.28 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 119.541 1.064 . . . . 0.0 109.841 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -48.1 -52.41 20.53 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.669 1.987 . . . . 0.0 111.603 175.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ptt-85 -76.08 -47.98 22.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.383 -0.818 . . . . 0.0 109.206 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.0 t -58.21 -27.11 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 124.91 1.284 . . . . 0.0 109.518 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.44 -13.04 36.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 171.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -112.44 -26.06 8.89 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.417 1.462 . . . . 0.0 112.061 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt -112.48 14.5 20.26 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.989 1.716 . . . . 0.0 112.043 -172.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.67 -12.96 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 130.052 3.341 . . . . 0.0 116.408 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 126.29 15.42 2.77 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.908 1.242 . . . . 0.0 113.956 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 m -149.19 130.85 14.97 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 120.298 2.049 . . . . 0.0 108.973 160.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -73.58 -55.16 3.58 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.698 1.599 . . . . 0.0 111.368 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -71.34 165.42 32.5 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 121.742 1.628 . . . . 0.0 110.798 167.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.27 -13.24 35.55 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.559 2.173 . . . . 0.0 113.032 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -77.39 68.12 3.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.843 1.257 . . . . 0.0 110.418 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.0 p -57.37 104.78 0.19 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.668 1.587 . . . . 0.0 109.317 174.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 179.79 -172.85 44.57 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -172.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -138.64 146.34 41.55 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.229 1.812 . . . . 0.0 106.511 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -64.6 -53.92 40.15 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.671 0.388 . . . . 0.0 111.629 -172.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -163.64 177.91 8.36 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.626 1.17 . . . . 0.0 108.557 173.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.98 171.2 12.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.998 2.119 . . . . 0.0 109.215 174.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -149.35 -67.2 0.22 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.052 167.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 141.25 107.69 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 130.455 3.502 . . . . 0.0 109.912 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -128.73 146.5 50.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 158.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -86.25 137.61 32.49 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 122.254 1.025 . . . . 0.0 110.935 -171.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.62 177.51 46.72 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.694 -161.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.3 pt -136.96 171.68 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.44 1.496 . . . . 0.0 108.538 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -96.56 136.04 37.63 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.994 0.518 . . . . 0.0 110.571 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 0.0 OUTLIER -102.32 120.09 39.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 163.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 35.1 t -65.79 90.7 0.13 Allowed 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 169.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.8 tt -66.57 -10.05 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.482 0.713 . . . . 0.0 111.735 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.7 t -77.94 -3.01 39.69 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.638 1.175 . . . . 0.0 111.759 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.3 p -154.68 -5.45 0.15 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 173.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.431 ' C ' ' HG1' ' A' ' 72' ' ' THR . . . 68.21 62.03 4.45 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -174.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.431 ' HG1' ' C ' ' A' ' 71' ' ' GLY . 62.9 m -154.52 137.98 15.9 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 121.035 -1.274 . . . . 0.0 108.523 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 37.1 m-20 -101.19 157.21 16.95 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.942 0.792 . . . . 0.0 110.333 -167.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.25 0.3 OUTLIER -159.72 -103.16 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.377 1.071 . . . . 0.0 112.657 -179.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -52.65 121.2 6.7 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -158.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.07 122.38 15.38 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.628 1.171 . . . . 0.0 108.754 168.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 t -66.61 -15.93 63.81 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -167.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -70.36 -16.8 63.02 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.41 1.084 . . . . 0.0 112.506 173.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.1 p -71.25 -22.64 61.95 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.366 -0.834 . . . . 0.0 111.484 167.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -98.63 -172.57 2.34 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.539 1.536 . . . . 0.0 109.839 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.73 8.14 16.07 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.659 1.183 . . . . 0.0 113.536 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -53.11 134.86 38.42 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 159.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.4 p 111.44 -36.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 1 C-N-CA 132.482 4.313 . . . . 0.0 111.29 -166.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.32 -69.27 0.39 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 -173.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.1 t -118.96 -21.21 7.81 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.722 0.809 . . . . 0.0 111.266 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.08 11.79 13.38 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.69 1.138 . . . . 0.0 114.525 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -62.82 130.84 94.18 Favored Pre-proline 0 C--O 1.237 0.439 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.63 70.03 5.84 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.895 3.063 . . . . 0.0 112.613 -165.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 72.3 p -138.01 154.18 49.34 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.019 1.728 . . . . 0.0 110.055 173.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -145.17 170.21 16.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.645 1.578 . . . . 0.0 109.08 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -128.06 -13.52 5.09 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -175.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -141.42 178.16 7.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 169.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.29 160.89 22.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.918 0.865 . . . . 0.0 111.439 -167.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 p -59.74 -40.15 81.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 125.55 1.54 . . . . 0.0 111.038 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.5 m 156.73 156.65 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.286 1 C-N-CA 131.747 4.019 . . . . 0.0 106.495 -176.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -75.61 48.79 0.47 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.72 2.008 . . . . 0.0 109.794 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -110.4 -46.93 3.34 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.406 -0.808 . . . . 0.0 109.654 -159.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.56 17.69 8.84 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 124.17 0.988 . . . . 0.0 112.118 170.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.38 135.65 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 174.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.439 ' HD2' ' H ' ' A' ' 101' ' ' LEU . 39.0 tptt -108.56 144.24 36.52 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.306 1.842 . . . . 0.0 108.991 -173.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.439 ' H ' ' HD2' ' A' ' 100' ' ' LYS . 54.9 mt -138.39 128.79 26.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 130.355 3.462 . . . . 0.0 107.468 -167.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.39 114.7 13.99 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 128.716 2.806 . . . . 0.0 104.778 163.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -101.73 142.4 33.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 124.283 0.989 . . . . 0.0 110.822 -172.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -148.34 176.68 10.07 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.605 2.362 . . . . 0.0 107.577 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.83 10.24 36.03 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 119.977 -1.702 . . . . 0.0 112.494 172.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.0 t -58.31 16.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 130.157 3.383 . . . . 0.0 119.342 -158.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 pp -128.85 -6.25 5.06 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.694 1.198 . . . . 0.0 112.136 168.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.69 -1.66 32.19 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 117.246 -1.863 . . . . 0.0 113.38 -167.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -141.29 -91.15 0.15 Allowed 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.648 2.224 . . . . 0.0 108.74 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 56.8 t -141.72 114.59 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.439 HH21 ' CE1' ' A' ' 125' ' ' HIS . 22.2 ttt180 -118.86 127.82 53.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.359 1.037 . . . . 0.0 108.512 168.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 23.7 t -127.17 146.25 50.47 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 171.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -68.64 162.3 26.27 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.995 0.816 . . . . 0.0 110.508 172.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.2 t -142.43 100.52 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 174.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mp -130.82 162.22 30.04 Favored 'General case' 0 N--CA 1.461 0.116 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.6 t -71.82 124.52 25.0 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.21 -9.01 20.02 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.396 0.678 . . . . 0.0 111.76 174.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.98 -25.5 15.36 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.54 1.936 . . . . 0.0 113.011 170.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 31.2 p -159.71 95.38 1.2 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.6 1.56 . . . . 0.0 109.514 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.9 32.51 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.004 1 C-N-CA 131.79 4.036 . . . . 0.0 113.068 178.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.91 -63.57 1.25 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -158.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.435 ' H ' HD23 ' A' ' 123' ' ' LEU . 50.7 t-80 -158.0 -64.46 0.09 Allowed 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 174.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.435 HD23 ' H ' ' A' ' 122' ' ' HIS . 2.3 mm? 54.02 -106.32 0.3 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.153 2.181 . . . . 0.0 106.464 173.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 176.62 -120.43 0.74 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.228 -0.986 . . . . 0.0 112.685 167.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.439 ' CE1' HH21 ' A' ' 111' ' ' ARG . 22.6 p-80 -159.69 173.68 15.69 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.749 -0.266 . . . . 0.0 110.761 -168.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.4 p -123.61 143.38 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.579 1.552 . . . . 0.0 107.884 171.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -138.79 151.74 47.31 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.273 1.029 . . . . 0.0 109.413 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -65.83 118.5 9.76 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 170.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -142.57 -47.06 0.33 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.068 0.947 . . . . 0.0 113.511 -168.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -104.45 -179.78 24.77 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.096 1.332 . . . . 0.0 114.566 -159.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.22 147.16 83.22 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.108 2.539 . . . . 0.0 110.186 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -77.43 159.34 77.6 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 118.731 -0.652 . . . . 0.0 109.451 -174.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.35 -49.17 0.24 Allowed 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 120.037 1.049 . . . . 0.0 111.521 0.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.3 p -77.74 76.24 4.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 123.043 1.401 . . . . 0.0 109.907 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -110.0 7.53 31.17 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 128.138 2.78 . . . . 0.0 110.249 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -78.2 138.65 38.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.712 1.756 . . . . 0.0 106.754 163.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.21 101.05 10.56 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 173.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -67.74 143.4 55.91 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 161.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 36.3 t -146.6 137.44 24.07 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.139 1.375 . . . . 0.0 108.497 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -138.43 153.99 48.87 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.759 0.824 . . . . 0.0 111.262 -177.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -156.33 114.76 3.36 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.14 2.176 . . . . 0.0 107.334 173.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.0 p -171.87 177.82 3.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.472 1.509 . . . . 0.0 108.995 174.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.31 21.45 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.113 1.765 . . . . 0.0 113.1 165.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -90.91 -15.88 29.09 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.98 1.264 . . . . 0.0 113.286 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.4 mt -83.46 88.49 6.99 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.376 0.535 . . . . 0.0 111.802 -159.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -127.87 114.32 17.05 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.427 1.091 . . . . 0.0 108.915 167.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -68.86 145.47 53.68 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 163.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.2 pt -137.8 163.4 48.42 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 125.329 1.452 . . . . 0.0 109.382 168.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.18 161.13 11.64 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.232 1.954 . . . . 0.0 111.694 166.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -34.13 -24.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 131.543 3.937 . . . . 0.0 120.273 -167.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -167.42 -82.37 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.253 1.821 . . . . 0.0 107.289 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -141.73 9.63 1.98 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.967 2.107 . . . . 0.0 110.191 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.9 pp -69.81 -16.25 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -167.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 116.783 -2.121 . . . . 0.0 112.077 170.897 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.2 tpt . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -64.76 91.25 0.09 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 159.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.3 p30 -149.99 -161.8 1.42 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.412 1.101 . . . . 0.0 111.993 -161.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -108.63 172.57 6.77 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.149 2.179 . . . . 0.0 110.534 -170.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 pt -122.72 102.57 38.39 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 124.852 1.261 . . . . 0.0 110.447 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.2 99.46 1.01 Allowed 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.375 2.05 . . . . 0.0 109.325 174.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.4 mt -79.85 88.31 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -78.26 97.31 5.5 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -69.55 72.0 0.33 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 160.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.1 t -56.26 -37.98 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 123.677 0.791 . . . . 0.0 111.506 -170.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.09 -12.17 25.07 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -125.54 7.12 7.6 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.248 1.819 . . . . 0.0 111.067 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 31.39 48.31 0.08 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 128.72 2.808 . . . . 0.0 112.81 -161.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -90.18 157.96 17.47 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 168.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.5 t -148.77 92.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 -176.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -100.48 102.96 14.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 32.9 ttm -80.05 87.41 5.44 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.669 173.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 80.8 t -84.47 174.7 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 125.853 1.661 . . . . 0.0 107.001 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -105.74 155.18 19.53 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 120.232 -1.542 . . . . 0.0 110.55 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.54 150.05 41.43 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.24 113.77 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -139.84 105.34 5.09 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 162.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.6 mt -133.12 171.89 13.39 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.492 1.517 . . . . 0.0 109.306 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.6 t -85.32 165.38 17.33 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 158.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.2 -38.8 74.22 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.138 0.881 . . . . 0.0 110.111 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.95 -25.78 65.46 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -170.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -67.56 -45.06 76.7 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.818 1.647 . . . . 0.0 109.846 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -61.2 10.93 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.058 2.143 . . . . 0.0 115.864 -174.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.75 -5.79 4.07 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 173.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -128.7 -18.96 3.79 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.639 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 pt -104.97 4.41 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.88 0.763 . . . . 0.0 111.391 166.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mt -112.36 160.46 17.68 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.85 1.26 . . . . 0.0 110.372 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.4 145.51 75.23 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.65 -4.48 12.21 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.678 2.252 . . . . 0.0 112.33 166.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -77.93 -56.43 4.5 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.725 1.21 . . . . 0.0 109.996 162.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.74 -42.48 71.66 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.571 1.078 . . . . 0.0 111.223 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -58.03 -47.2 83.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.956 1.302 . . . . 0.0 111.613 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -75.69 -38.86 58.32 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 119.458 1.026 . . . . 0.0 110.572 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 t -55.05 -28.61 21.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.943 1.297 . . . . 0.0 111.068 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.88 -20.57 63.88 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 172.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -101.3 -45.11 5.44 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 119.722 1.146 . . . . 0.0 111.807 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -89.93 12.55 17.11 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.591 1.087 . . . . 0.0 112.833 -174.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.37 36.75 1.16 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 128.082 2.553 . . . . 0.0 113.557 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.91 29.4 26.15 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-O 119.883 -0.398 . . . . 0.0 113.688 171.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.0 m -142.89 103.32 4.17 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 118.974 1.387 . . . . 0.0 109.061 166.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -72.06 169.24 17.11 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 161.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -61.79 157.08 44.66 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 121.474 1.449 . . . . 0.0 110.701 160.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.78 164.85 34.35 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.755 2.304 . . . . 0.0 112.054 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -145.82 170.56 16.31 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.556 1.542 . . . . 0.0 108.94 176.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.2 m -71.01 91.76 0.9 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.524 1.129 . . . . 0.0 110.495 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -65.96 158.61 47.44 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 161.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -154.59 -51.72 0.09 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 122.264 -0.551 . . . . 0.0 111.455 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -57.72 139.92 52.69 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 175.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -159.69 171.58 19.3 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.534 2.334 . . . . 0.0 106.533 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -148.9 -173.83 4.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 172.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.0 mp -130.98 27.21 4.9 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.113 1.765 . . . . 0.0 109.923 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.62 171.79 11.82 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.082 1.753 . . . . 0.0 109.497 174.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -74.89 36.58 0.11 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.955 2.902 . . . . 0.0 112.684 -173.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -75.64 143.24 42.34 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 121.803 0.811 . . . . 0.0 112.504 -172.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.63 151.83 24.72 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.684 1.611 . . . . 0.0 111.944 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 42.8 pt -132.85 161.94 40.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 125.171 1.388 . . . . 0.0 108.178 169.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -82.67 142.5 31.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.012 0.434 . . . . 0.0 110.144 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.8 140.33 49.01 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 124.372 1.069 . . . . 0.0 110.2 160.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.2 t -70.6 84.49 0.62 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 162.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.9 tp -59.74 -13.37 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.044 1.338 . . . . 0.0 112.218 172.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.7 t -78.47 1.89 20.78 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.635 1.574 . . . . 0.0 111.737 173.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.6 p -159.02 -9.56 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 170.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.35 64.31 2.67 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -173.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.22 135.23 30.51 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.113 2.165 . . . . 0.0 106.238 176.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -100.13 152.34 20.36 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.555 1.525 . . . . 0.0 112.222 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.283 0.0 OUTLIER -154.51 -107.97 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.387 1.075 . . . . 0.0 112.864 178.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -50.49 121.69 6.06 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.467 1.907 . . . . 0.0 113.622 -160.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -86.95 156.84 19.63 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.139 0.976 . . . . 0.0 111.402 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.1 t -56.8 -17.71 10.17 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -63.55 -26.96 68.94 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.862 1.664 . . . . 0.0 111.43 170.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.1 p -92.05 -47.14 7.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.211 1.405 . . . . 0.0 109.177 174.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.35 112.55 15.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.793 1.237 . . . . 0.0 109.725 -159.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -52.59 145.73 11.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.959 0.904 . . . . 0.0 111.165 173.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -140.93 -69.62 0.38 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.789 1.236 . . . . 0.0 110.287 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.7 m -73.16 120.51 18.88 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.53 -158.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.92 -64.95 3.3 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.6 m -120.37 78.67 1.38 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.734 1.214 . . . . 0.0 108.703 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -77.76 32.84 1.67 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 123.884 0.754 . . . . 0.0 113.895 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -59.54 152.6 55.11 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 125.14 1.376 . . . . 0.0 112.002 -172.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.91 60.09 7.61 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.297 2.665 . . . . 0.0 109.657 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.1 p -145.49 145.92 31.26 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 163.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -153.69 175.45 13.24 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.578 1.151 . . . . 0.0 109.463 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -112.1 -12.87 13.62 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.619 0.768 . . . . 0.0 112.384 -164.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -154.49 -175.86 5.61 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -173.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.75 154.35 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 124.861 1.264 . . . . 0.0 109.478 -163.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.7 p -62.17 -32.34 54.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 122.581 0.352 . . . . 0.0 110.197 164.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.1 m 153.03 165.83 0.01 OUTLIER 'General case' 0 C--O 1.234 0.238 1 C-N-CA 132.943 4.497 . . . . 0.0 106.51 -175.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -107.96 75.97 1.03 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -132.46 -28.8 1.62 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.357 1.463 . . . . 0.0 112.597 -161.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.71 16.57 11.93 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.636 1.175 . . . . 0.0 111.876 167.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.0 tt -132.22 146.18 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 125.94 1.696 . . . . 0.0 108.114 -173.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -127.92 124.47 37.45 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.815 1.246 . . . . 0.0 108.834 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 mp -118.79 139.8 51.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.032 2.133 . . . . 0.0 108.756 -173.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -131.61 116.91 18.0 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.673 1.589 . . . . 0.0 106.715 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -79.19 135.67 36.87 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.693 1.235 . . . . 0.0 112.174 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.496 ' CG ' ' H ' ' A' ' 105' ' ' ARG . 19.2 t70 -143.41 -172.03 3.62 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.351 1.86 . . . . 0.0 110.697 170.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.496 ' H ' ' CG ' ' A' ' 104' ' ' ASP . 0.2 OUTLIER -122.7 7.16 9.41 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.537 2.735 . . . . 0.0 111.838 -173.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -65.65 30.42 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 129.928 3.291 . . . . 0.0 116.905 -161.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pp -131.09 -2.52 4.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.017 1.327 . . . . 0.0 112.023 161.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.14 3.31 51.36 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 117.908 -1.496 . . . . 0.0 112.415 -168.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.5 mtp -140.69 -95.35 0.15 Allowed 'General case' 0 C--N 1.347 0.494 0 CA-C-N 120.01 1.905 . . . . 0.0 107.993 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.8 t -142.64 111.4 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -119.03 100.72 7.53 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.768 1.227 . . . . 0.0 107.966 171.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 36.1 t -100.9 128.07 47.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.62 158.96 22.98 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.968 0.804 . . . . 0.0 110.099 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 95.0 t -141.65 98.95 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.3 mp -126.84 164.26 21.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 174.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.3 m -77.47 145.29 37.15 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.403 -1.436 . . . . 0.0 110.625 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -82.14 -22.89 35.9 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.09 0.956 . . . . 0.0 111.249 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -38.22 54.33 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 117.993 -1.003 . . . . 0.0 111.092 169.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.2 p -147.58 115.72 6.54 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 173.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.53 56.28 0.06 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.411 1.485 . . . . 0.0 111.304 176.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.14 168.38 16.89 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.242 1.817 . . . . 0.0 110.682 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -44.69 -64.04 0.78 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.756 2.022 . . . . 0.0 113.264 -161.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 50.94 -114.29 0.77 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.414 1.886 . . . . 0.0 107.983 174.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.22 -119.65 0.68 Allowed Glycine 0 CA--C 1.522 0.518 0 CA-C-N 118.653 0.66 . . . . 0.0 113.271 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 54.1 p-80 -161.18 170.7 19.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.237 0.615 . . . . 0.0 110.648 -170.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.6 p -115.2 139.61 40.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.161 1.384 . . . . 0.0 108.283 172.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -132.23 150.47 52.15 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 123.593 0.558 . . . . 0.0 110.812 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -66.42 108.59 2.42 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.732 1.213 . . . . 0.0 109.206 174.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.33 -44.47 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.683 1.193 . . . . 0.0 112.257 -170.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.74 -179.65 32.51 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.222 0.915 . . . . 0.0 114.94 -159.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.55 165.25 31.35 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.219 2.613 . . . . 0.0 110.629 171.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.72 154.87 84.14 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 164.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.46 -55.52 0.14 OUTLIER 'Cis proline' 0 C--N 1.348 0.55 0 CA-C-N 120.745 1.302 . . . . 0.0 113.751 10.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 19.1 p -66.7 -31.16 71.64 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.366 1.067 . . . . 0.0 113.149 -166.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 71.81 -2.37 25.08 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.052 0.834 . . . . 0.0 114.797 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -103.38 159.09 15.87 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.3 1.05 . . . . 0.0 108.863 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.4 ttp85 -129.14 99.91 5.43 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.68 1.192 . . . . 0.0 108.856 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -62.5 132.15 51.52 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.656 1.582 . . . . 0.0 107.413 163.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 42.6 t -141.77 144.86 34.19 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.654 1.116 . . . . 0.0 109.386 173.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.5 ptp -149.76 158.19 43.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.457 0.646 . . . . 0.0 110.655 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.17 89.17 1.93 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.566 2.346 . . . . 0.0 106.096 -176.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.433 ' HB3' ' H ' ' A' ' 144' ' ' ALA . 2.8 m -147.2 162.27 39.23 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.31 1.444 . . . . 0.0 108.63 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.7 -20.31 65.62 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.355 1.062 . . . . 0.0 113.072 163.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.433 ' H ' ' HB3' ' A' ' 142' ' ' SER . . . -62.81 29.3 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 130.661 3.584 . . . . 0.0 114.881 -175.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 93.8 mt -132.81 47.41 2.51 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.283 1.833 . . . . 0.0 108.861 -168.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.6 tttt -74.43 122.45 23.01 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -66.95 131.9 46.82 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 165.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 17.2 pt -114.17 164.42 16.27 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 160.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -60.13 173.26 1.94 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 121.657 1.571 . . . . 0.0 110.038 160.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -41.77 -28.34 0.15 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -168.75 -83.53 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 170.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -146.14 26.98 1.18 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.169 1.788 . . . . 0.0 110.244 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -73.28 -12.61 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.97 1.308 . . . . 0.0 112.152 170.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.49 0 N-CA-C 106.977 -2.449 . . . . 0.0 106.977 160.483 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 95.4 mtp . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -122.15 33.86 5.34 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.291 1.436 . . . . 0.0 111.195 -177.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -74.07 -147.85 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 129.862 3.265 . . . . 0.0 111.913 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.7 mtt85 -145.53 166.03 26.9 Favored 'General case' 0 C--N 1.32 -0.689 1 C-N-CA 135.192 5.397 . . . . 0.0 105.228 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.0 pt -132.55 128.75 21.13 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.046 0.938 . . . . 0.0 110.395 -164.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.17 132.97 17.27 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.86 1.707 . . . . 0.0 110.256 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.9 mm -101.01 148.77 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 160.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.98 91.49 1.79 Allowed 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.872 1.269 . . . . 0.0 107.869 -169.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.9 m -71.37 80.22 0.76 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.579 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.39 -33.96 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.995 1.271 . . . . 0.0 111.09 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.05 -6.75 4.33 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 173.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -130.02 11.45 5.55 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.306 2.242 . . . . 0.0 110.512 170.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.3 t30 28.11 66.82 0.08 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.821 2.448 . . . . 0.0 112.248 -162.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -114.7 161.44 18.13 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.6 t -144.75 122.5 5.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -141.43 98.87 3.44 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -170.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 44.2 ttm -70.52 133.5 46.84 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.077 -1.014 . . . . 0.0 109.477 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.3 t -121.25 161.33 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 176.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -78.46 167.15 21.74 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.186 -1.571 . . . . 0.0 109.565 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.5 mtm105 -63.24 165.2 7.68 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.669 -0.644 . . . . 0.0 109.96 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.2 tp -70.28 120.61 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 167.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -152.43 118.17 5.39 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 160.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.1 mt -140.4 172.86 12.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.885 1.674 . . . . 0.0 108.442 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.486 ' H ' ' CG ' ' A' ' 30' ' ' GLU . 10.7 p -94.51 168.62 10.75 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.019 1.328 . . . . 0.0 109.67 171.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -77.66 70.05 3.99 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.791 0.805 . . . . 0.0 109.5 164.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -167.14 -26.81 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 125.286 1.435 . . . . 0.0 110.988 158.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.486 ' CG ' ' H ' ' A' ' 27' ' ' SER . 23.1 mm-40 -55.62 -45.24 77.56 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.309 0.644 . . . . 0.0 110.348 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -68.19 37.34 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.275 2.63 . . . . 0.0 112.767 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.406 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -149.56 -34.34 0.19 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.632 1.173 . . . . 0.0 111.402 161.466 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -92.24 -26.37 18.2 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.807 -1.092 . . . . 0.0 113.049 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.2 pt -100.81 23.44 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 120.186 1.357 . . . . 0.0 111.467 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.7 mt -122.25 161.49 23.19 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.443 1.097 . . . . 0.0 112.233 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.49 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -61.54 149.03 85.26 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.082 170.334 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -68.83 5.1 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.419 2.746 . . . . 0.0 112.657 167.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -102.79 -39.82 6.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.672 -1.156 . . . . 0.0 111.441 165.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.49 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -60.78 -43.68 97.75 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 121.421 1.919 . . . . 0.0 111.455 -173.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -57.66 -45.7 85.18 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.929 1.292 . . . . 0.0 111.549 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -76.33 -36.78 58.07 Favored 'General case' 0 C--O 1.221 -0.434 0 O-C-N 121.526 -0.734 . . . . 0.0 111.066 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.2 t -55.0 -27.99 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 120.701 -1.25 . . . . 0.0 111.143 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.45 -22.91 67.16 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -93.84 -41.82 9.43 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.514 1.506 . . . . 0.0 111.537 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -96.13 4.82 52.22 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.302 1.841 . . . . 0.0 112.884 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.04 15.58 1.84 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.939 1.695 . . . . 0.0 113.533 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.53 -0.24 30.82 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 117.702 -1.61 . . . . 0.0 114.805 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.0 m -150.19 116.42 5.7 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 121.622 2.711 . . . . 0.0 112.035 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -103.97 159.38 29.5 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 126.731 2.012 . . . . 0.0 107.063 169.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.36 153.84 76.51 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 121.281 1.321 . . . . 0.0 111.142 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -66.19 133.29 32.46 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.865 2.376 . . . . 0.0 110.376 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -153.28 -69.69 0.15 Allowed 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.7 m -68.67 163.83 22.95 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 158.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -128.85 171.08 19.86 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 172.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.3 ttmt -150.24 178.78 8.67 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.463 1.505 . . . . 0.0 107.258 174.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -136.74 164.58 27.93 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.884 1.674 . . . . 0.0 107.251 167.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -141.73 -40.24 0.37 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.704 1.602 . . . . 0.0 108.589 172.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -41.61 98.23 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 130.939 3.696 . . . . 0.0 111.652 158.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.1 mt -137.44 -38.99 0.59 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.521 1.528 . . . . 0.0 110.167 167.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -143.89 163.53 33.15 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 165.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -75.0 89.2 2.4 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 162.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -158.03 -178.22 7.14 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.457 1.503 . . . . 0.0 108.047 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.61 172.12 17.39 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 122.206 0.892 . . . . 0.0 114.978 166.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 14.2 pt -136.2 170.79 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.829 1.651 . . . . 0.0 109.618 176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -96.95 111.04 23.43 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.457 1.103 . . . . 0.0 109.999 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.49 113.73 14.42 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 163.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 20.7 t -65.84 85.32 0.08 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.512 1.525 . . . . 0.0 109.14 166.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.1 tt -66.33 -11.61 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.704 1.602 . . . . 0.0 111.587 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.5 m -82.28 -1.44 49.47 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.309 1.844 . . . . 0.0 113.0 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.8 p -152.17 -16.43 0.18 Allowed 'General case' 0 C--N 1.338 0.104 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 165.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.66 65.84 1.59 Allowed Glycine 0 C--N 1.337 0.616 0 N-CA-C 107.593 -2.203 . . . . 0.0 107.593 -162.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.1 m -143.21 166.63 24.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 172.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -135.53 145.89 47.51 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.57 -102.82 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.666 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -54.4 108.01 0.34 Allowed 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.487 1.115 . . . . 0.0 112.815 -159.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -68.37 135.86 52.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -10.11 57.31 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.38 0.991 . . . . 0.0 112.949 -171.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.91 -20.8 62.64 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.468 -1.395 . . . . 0.0 112.472 163.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.3 p -86.69 -20.14 28.17 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.659 1.184 . . . . 0.0 112.89 168.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -137.05 86.29 2.19 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.229 1.812 . . . . 0.0 107.471 -169.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -139.06 124.24 19.05 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -144.83 93.62 2.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -176.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.0 m -61.81 124.97 22.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.825 1.25 . . . . 0.0 111.14 -170.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.12 -60.88 4.8 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.79 -49.6 70.04 Favored 'General case' 0 CA--C 1.526 0.039 0 CA-C-N 117.941 0.87 . . . . 0.0 112.285 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 42.35 42.11 4.26 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.918 2.199 . . . . 0.0 115.657 -162.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -61.44 143.81 92.79 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 118.528 1.164 . . . . 0.0 108.874 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.14 70.44 6.69 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.02 2.48 . . . . 0.0 110.895 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.3 p -136.44 150.29 48.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.521 1.129 . . . . 0.0 110.967 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.25 166.77 22.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.901 2.08 . . . . 0.0 107.568 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -127.7 -6.9 5.66 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.393 0.677 . . . . 0.0 112.451 -170.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -151.96 -178.02 6.5 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 167.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.23 158.76 43.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 124.105 0.962 . . . . 0.0 111.825 -176.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 p -51.36 -42.44 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 127.271 2.228 . . . . 0.0 111.444 171.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.6 m 157.14 155.07 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.515 1 C-N-CA 131.959 4.104 . . . . 0.0 106.786 -176.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -74.06 75.51 1.73 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 161.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -114.8 -53.51 2.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.573 1.149 . . . . 0.0 108.991 177.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -126.82 14.33 7.45 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 173.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.5 tt -106.12 154.25 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 159.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -123.49 134.11 53.94 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 166.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 46.8 mt -117.41 148.97 41.29 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.855 2.062 . . . . 0.0 109.02 172.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.17 115.69 15.34 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 162.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.96 143.44 56.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.221 1.409 . . . . 0.0 110.034 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -147.79 -178.97 6.55 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 158.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.95 14.7 9.95 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.024 2.13 . . . . 0.0 110.377 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.8 m -62.33 -21.81 65.57 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 126.194 1.798 . . . . 0.0 115.692 -158.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 pp -77.08 -14.72 59.77 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.556 1.071 . . . . 0.0 112.231 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.86 0.6 25.73 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 117.316 -1.824 . . . . 0.0 113.012 -168.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.0 mmt -143.31 -85.18 0.15 Allowed 'General case' 0 C--N 1.349 0.553 0 CA-C-N 120.456 2.128 . . . . 0.0 107.9 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.2 t -145.19 114.69 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -129.37 103.44 6.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.305 1.442 . . . . 0.0 110.186 172.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 2.6 m -106.85 151.87 24.64 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -70.43 163.68 26.21 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.354 0.979 . . . . 0.0 110.838 171.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.3 t -137.09 107.51 5.38 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 168.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.49 164.49 18.83 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 167.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 17.0 t -65.47 156.22 33.12 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 162.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.72 -28.91 66.21 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . 0.285 0.0 OUTLIER -116.1 -52.45 2.6 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 179.451 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 15.9 p -77.51 77.68 4.03 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 121.077 1.762 . . . . 0.0 109.227 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -52.86 67.04 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 128.983 2.913 . . . . 0.0 111.071 166.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.4 -178.9 4.51 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.37 2.268 . . . . 0.0 110.264 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -43.75 -57.99 2.94 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.259 2.224 . . . . 0.0 113.366 -165.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 42.54 -112.08 0.19 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.616 1.966 . . . . 0.0 109.422 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -178.29 -125.3 0.91 Allowed Glycine 0 CA--C 1.519 0.328 0 CA-C-N 118.954 0.797 . . . . 0.0 113.767 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -158.46 174.87 14.44 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.076 0.55 . . . . 0.0 110.085 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.4 p -124.85 137.14 58.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 124.285 1.034 . . . . 0.0 108.774 171.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -135.07 147.15 49.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.193 0.597 . . . . 0.0 109.675 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -58.66 111.32 1.22 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.842 1.257 . . . . 0.0 109.442 170.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -153.94 -29.5 0.12 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -78.7 155.8 41.69 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.19 -30.02 7.34 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.141 1.894 . . . . 0.0 112.632 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 179.37 168.58 0.64 Allowed Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 128.744 2.818 . . . . 0.0 106.584 -172.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.11 -51.06 0.16 OUTLIER 'Cis proline' 0 C--N 1.349 0.589 0 CA-C-N 121.081 1.422 . . . . 0.0 111.407 -12.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.0 p -71.13 -23.43 62.08 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.686 1.595 . . . . 0.0 112.44 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.03 -8.85 21.08 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.499 1.523 . . . . 0.0 113.257 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -105.76 152.84 22.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 120.64 -1.506 . . . . 0.0 109.977 -171.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -126.96 97.74 5.07 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.53 1.932 . . . . 0.0 107.033 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -67.74 140.21 56.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 164.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 45.7 t -140.65 149.23 42.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.448 1.099 . . . . 0.0 109.192 170.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.7 ptt? -140.84 148.95 41.35 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.317 1.447 . . . . 0.0 109.337 -176.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -147.65 88.77 1.71 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.999 2.12 . . . . 0.0 107.424 -173.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 88.7 p -165.28 178.44 6.9 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 121.551 -0.718 . . . . 0.0 109.549 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.62 -18.26 63.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.121 1.368 . . . . 0.0 114.169 167.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.82 22.68 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.539 1.936 . . . . 0.0 115.445 -159.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 28.3 mt -121.23 41.03 3.43 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -158.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -75.77 101.59 5.12 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -53.92 137.28 39.38 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 167.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 14.8 pt -136.2 166.59 26.83 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.242 1.417 . . . . 0.0 108.297 167.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.89 168.1 4.74 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.646 2.231 . . . . 0.0 112.435 164.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -18.87 -49.58 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 130.206 3.402 . . . . 0.0 118.118 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -165.42 -81.01 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.218 1.407 . . . . 0.0 107.609 -167.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -144.74 16.64 1.61 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.085 1.754 . . . . 0.0 111.412 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.79 -3.92 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.259 -0.901 . . . . 0.0 112.728 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.475 0 C-N-CA 128.117 2.77 . . . . 0.0 106.554 159.88 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -149.4 69.47 1.05 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 167.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -177.57 -168.3 0.18 Allowed 'General case' 0 C--O 1.239 0.541 0 C-N-CA 127.263 2.225 . . . . 0.0 106.623 -159.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -119.13 160.23 22.5 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -164.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 pt -132.01 112.83 14.73 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.439 1.495 . . . . 0.0 108.856 -162.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.08 106.34 2.01 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.52 2.146 . . . . 0.0 109.274 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.4 mm -78.72 80.69 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 173.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -83.66 89.54 7.14 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.328 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.7 m -71.41 83.57 0.8 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 173.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 p -56.42 -36.62 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.444 1.497 . . . . 0.0 111.842 -171.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -17.86 49.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.665 1.186 . . . . 0.0 112.648 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -129.11 12.44 6.11 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.602 1.961 . . . . 0.0 110.015 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 26.48 58.31 0.07 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 129.104 2.962 . . . . 0.0 111.32 -164.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.9 mtp85 -94.63 175.14 6.78 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 118.569 -1.252 . . . . 0.0 108.881 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -149.8 120.97 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 159.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.41 111.57 22.51 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 167.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.9 ttt -77.42 105.83 8.8 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.819 1.19 . . . . 0.0 108.808 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.94 178.96 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -130.96 168.82 16.69 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 120.292 -1.505 . . . . 0.0 112.516 172.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.89 139.61 57.24 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.659 0.784 . . . . 0.0 111.545 -171.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.427 ' H ' ' HD2' ' A' ' 118' ' ' ARG . 12.9 tt -73.72 115.38 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -175.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -139.0 99.52 3.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.4 mt -133.39 177.41 7.71 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.203 1.801 . . . . 0.0 108.805 -171.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.2 t -84.4 179.77 7.35 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 158.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 30' ' ' GLU . 10.9 t70 -54.19 -36.99 64.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.846 0.748 . . . . 0.0 109.231 158.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.559 ' HA ' ' CZ ' ' A' ' 32' ' ' ARG . 18.6 m-20 -62.82 17.07 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 129.978 3.311 . . . . 0.0 117.269 -169.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 28' ' ' ASP . 48.1 mm-40 -133.04 -46.9 0.85 Allowed 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -172.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -62.36 5.69 0.1 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.601 1.96 . . . . 0.0 114.922 -175.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.559 ' CZ ' ' HA ' ' A' ' 29' ' ' ASP . 3.7 ptt180 -124.75 -10.51 7.27 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.611 1.564 . . . . 0.0 113.869 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -134.66 -11.42 2.37 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.628 0.771 . . . . 0.0 112.19 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pt -119.55 11.39 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.828 0.851 . . . . 0.0 111.283 166.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -113.49 170.78 7.99 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.479 1.111 . . . . 0.0 111.825 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.42 142.41 90.7 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.902 0.881 . . . . 0.0 110.527 172.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.34 -7.2 20.66 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.556 2.837 . . . . 0.0 112.707 170.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -82.85 -45.32 14.41 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.504 1.121 . . . . 0.0 109.671 163.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.41 -42.47 98.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 120.579 1.536 . . . . 0.0 111.461 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -57.89 -45.75 85.92 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.029 0.532 . . . . 0.0 111.196 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -69.85 -49.6 50.88 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 119.304 -0.958 . . . . 0.0 109.642 172.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 t -55.89 -29.11 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 119.544 1.065 . . . . 0.0 111.01 -170.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.3 -28.31 69.64 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 174.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -100.46 -22.6 14.96 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.581 1.082 . . . . 0.0 113.12 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.427 ' CD ' ' HG2' ' A' ' 49' ' ' GLU . 10.8 ptpt -107.35 3.72 25.63 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.963 0.905 . . . . 0.0 112.712 -177.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.51 49.48 15.96 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.74 1.616 . . . . 0.0 111.047 -172.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.35 -73.26 1.9 Allowed Glycine 0 C--N 1.335 0.495 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.2 m -74.48 107.24 6.5 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.784 -0.708 . . . . 0.0 111.412 -158.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.427 ' HG2' ' CD ' ' A' ' 45' ' ' LYS . 28.8 mt-10 -61.87 141.77 95.24 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 123.663 0.785 . . . . 0.0 111.814 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.42 163.8 30.95 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.322 2.014 . . . . 0.0 110.422 168.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.94 90.67 0.64 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.332 2.688 . . . . 0.0 112.056 -172.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -131.0 133.19 45.54 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.503 1.521 . . . . 0.0 108.1 170.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 m -75.01 51.93 0.53 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.199 2.2 . . . . 0.0 112.898 -166.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.22 69.68 0.21 Allowed Glycine 0 C--N 1.338 0.655 0 O-C-N 121.179 -0.951 . . . . 0.0 111.731 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.53 162.89 40.83 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.268 1.027 . . . . 0.0 110.366 177.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -162.84 167.33 22.94 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.111 1.764 . . . . 0.0 108.211 165.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -151.76 178.16 9.66 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 128.478 2.711 . . . . 0.0 104.548 163.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -139.39 158.76 43.6 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.626 1.103 . . . . 0.0 109.986 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.2 tt -154.46 118.36 4.67 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 129.09 2.956 . . . . 0.0 104.811 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.44 ' C ' ' H ' ' A' ' 62' ' ' ASP . 11.8 m80 -132.93 167.44 20.25 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.812 1.645 . . . . 0.0 107.586 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.33 24.6 0.18 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.05 1.74 . . . . 0.0 112.506 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 60' ' ' HIS . 22.4 t70 -144.95 135.74 24.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.326 2.25 . . . . 0.0 107.407 170.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.54 178.44 25.41 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.1 pt -135.2 167.5 25.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 125.507 1.523 . . . . 0.0 107.859 167.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -84.07 127.8 34.14 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 122.239 1.019 . . . . 0.0 110.172 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -87.31 130.97 34.4 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 158.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.9 t -75.23 100.59 4.38 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 159.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.6 tt -66.34 -18.59 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.435 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.9 t -82.11 7.62 12.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.653 0.781 . . . . 0.0 111.147 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.9 p -153.49 0.05 0.24 Allowed 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.965 -1.084 . . . . 0.0 113.87 168.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.411 ' C ' ' HG1' ' A' ' 72' ' ' THR . . . 64.82 55.24 23.49 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.411 ' HG1' ' C ' ' A' ' 71' ' ' GLY . 99.4 m -153.8 154.45 34.01 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.067 -1.255 . . . . 0.0 109.259 -173.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -85.95 152.21 23.13 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.07 0.948 . . . . 0.0 112.914 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.29 0.2 OUTLIER -146.89 -101.81 0.09 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.518 168.027 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -66.29 138.29 57.53 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.269 0.941 . . . . 0.0 111.19 -164.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -99.11 152.45 19.84 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.465 1.106 . . . . 0.0 108.63 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.66 -22.05 31.76 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.99 -29.66 57.69 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.706 1.139 . . . . 0.0 112.411 169.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 t -120.78 54.69 1.06 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.453 1.901 . . . . 0.0 109.466 168.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -140.79 162.21 35.98 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.504 -1.373 . . . . 0.0 110.073 159.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -104.23 120.27 40.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 163.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -138.15 -55.54 0.65 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.822 2.049 . . . . 0.0 108.287 -165.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 t -67.11 173.24 3.89 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.063 0.935 . . . . 0.0 110.167 159.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 52.38 -110.03 1.08 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.428 1.489 . . . . 0.0 110.966 -173.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -66.19 -37.76 86.38 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.455 1.102 . . . . 0.0 112.425 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.79 18.34 17.37 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.371 1.462 . . . . 0.0 116.33 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.86 151.09 97.43 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 117.679 0.74 . . . . 0.0 111.836 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.62 62.12 7.06 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.052 3.168 . . . . 0.0 110.968 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.6 p -135.79 155.87 49.69 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.859 0.863 . . . . 0.0 109.29 166.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -156.88 178.29 10.52 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.475 1.11 . . . . 0.0 110.762 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -117.75 -11.44 10.36 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -169.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -149.1 176.86 10.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.631 1.173 . . . . 0.0 110.895 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 m -129.25 156.54 41.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.133 0 O-C-N 121.136 -0.978 . . . . 0.0 111.371 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.1 p -60.94 -34.03 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.768 1.227 . . . . 0.0 111.166 173.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.2 m 164.6 166.4 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 131.614 3.966 . . . . 0.0 106.628 -175.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -96.4 77.2 2.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.152 1.781 . . . . 0.0 107.793 174.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.529 ' CD2' ' H ' ' A' ' 98' ' ' ASN . 5.4 p80 -133.93 -65.23 0.67 Allowed 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.64 -0.663 . . . . 0.0 111.619 -159.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.529 ' H ' ' CD2' ' A' ' 97' ' ' HIS . 0.9 OUTLIER -96.51 16.93 17.35 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.19 1.396 . . . . 0.0 108.935 167.017 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.03 140.64 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 128.315 2.646 . . . . 0.0 107.451 -174.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.418 ' HD3' ' H ' ' A' ' 101' ' ' LEU . 14.4 tppt? -129.24 151.43 49.91 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 128.226 2.61 . . . . 0.0 108.591 -173.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.418 ' H ' ' HD3' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -146.05 154.14 41.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.479 1.911 . . . . 0.0 107.875 -176.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.4 ' HG2' ' CG ' ' A' ' 113' ' ' GLU . 19.3 mmt180 -136.52 121.9 19.37 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -71.04 126.02 28.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.473 1.033 . . . . 0.0 110.274 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.439 ' CG ' ' H ' ' A' ' 105' ' ' ARG . 37.3 t0 -128.4 176.98 7.3 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.866 0.841 . . . . 0.0 109.786 158.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.439 ' H ' ' CG ' ' A' ' 104' ' ' ASP . 0.0 OUTLIER -108.31 14.24 25.02 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.229 2.212 . . . . 0.0 111.542 173.447 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 t -46.96 -40.55 14.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.408 1.883 . . . . 0.0 115.44 -159.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.6 pp -73.36 -11.25 60.42 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 115.11 -4.81 22.11 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.158 1.837 . . . . 0.0 112.957 -169.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -141.61 -85.35 0.18 Allowed 'General case' 0 C--N 1.349 0.584 0 CA-C-N 120.143 1.971 . . . . 0.0 109.753 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.2 t -144.58 111.68 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -129.56 106.56 8.83 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.678 1.591 . . . . 0.0 108.79 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 10.1 m -106.28 141.94 36.78 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.602 -1.189 . . . . 0.0 107.88 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.4 ' CG ' ' HG2' ' A' ' 102' ' ' ARG . 22.2 pt-20 -67.71 160.97 26.98 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.791 1.632 . . . . 0.0 110.691 172.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.7 t -141.64 104.04 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.19 161.26 28.11 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.731 0.812 . . . . 0.0 109.078 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 13.5 m -77.73 106.71 9.72 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.79 -25.1 10.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.259 1.424 . . . . 0.0 113.177 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.427 ' HD2' ' H ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -80.72 -37.29 30.88 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 126.596 1.958 . . . . 0.0 113.149 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 3.9 p -153.82 69.88 0.81 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -161.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.27 58.0 0.25 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 128.086 2.554 . . . . 0.0 113.693 -159.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.7 -147.55 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.738 1.615 . . . . 0.0 112.319 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -70.12 -64.89 0.8 Allowed 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.282 1.433 . . . . 0.0 109.423 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 49.84 -116.84 0.94 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.421 1.889 . . . . 0.0 107.561 -177.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.76 -119.32 0.62 Allowed Glycine 0 CA--C 1.521 0.445 0 CA-C-N 118.501 0.591 . . . . 0.0 112.578 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -158.0 177.57 11.17 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 122.453 -0.44 . . . . 0.0 111.155 -170.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.1 p -124.64 145.02 32.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 124.663 1.185 . . . . 0.0 108.884 170.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -140.05 144.67 36.99 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.584 1.554 . . . . 0.0 108.668 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.08 121.12 19.67 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.403 0.547 . . . . 0.0 109.55 173.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.39 -45.15 0.22 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.624 2.37 . . . . 0.0 111.946 -165.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -90.53 -178.34 44.01 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.404 1.002 . . . . 0.0 112.935 -170.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.93 155.22 69.22 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.829 2.353 . . . . 0.0 111.017 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.89 154.06 95.33 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.908 174.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.07 -36.64 2.45 Favored 'Cis proline' 0 C--N 1.35 0.642 0 CA-C-N 119.506 0.859 . . . . 0.0 111.429 -5.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.51 59.19 1.87 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 127.826 2.451 . . . . 0.0 111.531 -175.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -88.33 -5.79 75.34 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.869 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.29 104.37 16.39 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 119.414 1.607 . . . . 0.0 111.048 -166.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.64 94.06 5.62 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.173 1.789 . . . . 0.0 108.347 -173.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -62.33 130.37 44.98 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 160.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 22.1 t -144.02 130.23 19.71 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.3 ptp -142.8 140.95 31.54 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.445 0.698 . . . . 0.0 110.395 -173.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.91 15.5 28.83 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.991 2.116 . . . . 0.0 110.647 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.2 p -65.96 112.0 3.6 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.023 1.729 . . . . 0.0 110.53 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -54.29 -24.84 20.54 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.54 1.136 . . . . 0.0 112.993 164.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.83 2.29 3.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.317 2.247 . . . . 0.0 116.351 -170.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 90.7 mt -87.26 87.02 7.32 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.091 0.859 . . . . 0.0 109.836 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -87.01 126.44 34.74 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.349 1.06 . . . . 0.0 108.785 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -70.87 135.22 47.89 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.327 0.967 . . . . 0.0 109.453 170.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.2 pt -136.44 163.6 48.76 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.33 1.052 . . . . 0.0 109.764 171.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.21 168.73 7.23 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.592 2.195 . . . . 0.0 111.646 161.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.417 ' HA ' ' HD2' ' A' ' 150' ' ' ARG . 6.8 mmm-85 -62.75 -4.74 2.23 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 119.51 3.152 . . . . 0.0 119.51 -158.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 178.11 -62.58 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.195 1 C-N-CA 132.905 4.482 . . . . 0.0 109.552 161.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -156.73 8.26 0.2 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.973 2.909 . . . . 0.0 110.831 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.9 pp -65.54 -14.54 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.872 1.214 . . . . 0.0 112.936 170.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 159.097 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -126.65 14.78 7.57 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.805 1.242 . . . . 0.0 111.102 171.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -75.38 131.02 39.93 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.993 1.317 . . . . 0.0 111.126 162.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -39.11 163.98 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.51 1 C-N-CA 135.839 5.656 . . . . 0.0 113.046 166.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.4 pt -129.33 136.97 29.97 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.401 1.08 . . . . 0.0 111.901 -168.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.0 120.92 3.87 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.997 2.464 . . . . 0.0 110.454 170.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.83 146.99 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 159.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -126.87 154.81 43.92 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 127.267 2.227 . . . . 0.0 105.621 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.53 91.94 2.53 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 171.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.08 -43.76 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 C-N-CA 123.346 0.659 . . . . 0.0 111.664 -171.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.97 -28.88 58.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.633 0.773 . . . . 0.0 110.904 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 152' ' ' GLN . 7.0 ttmm -87.39 -1.4 57.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.27 1.428 . . . . 0.0 111.091 170.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.8 t30 38.15 65.83 0.55 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 128.915 2.886 . . . . 0.0 112.427 -171.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.43 162.34 28.3 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.69 1.996 . . . . 0.0 109.44 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.7 t -138.9 134.47 42.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 164.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -141.53 97.58 3.19 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.684 1.594 . . . . 0.0 108.311 -172.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.4 ttp -78.94 133.29 36.91 Favored 'General case' 0 C--N 1.339 0.14 0 O-C-N 121.371 -0.831 . . . . 0.0 109.852 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.7 t -137.15 161.27 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.558 1.543 . . . . 0.0 107.063 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -58.32 170.26 0.74 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 123.03 1.395 . . . . 0.0 112.54 164.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 -69.49 176.42 3.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.858 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.537 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 2.4 tt -78.45 128.24 38.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 164.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -158.13 97.17 1.5 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.7 mt -138.29 176.21 8.9 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.936 1.294 . . . . 0.0 108.646 -167.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.454 ' H ' ' CG ' ' A' ' 30' ' ' GLU . 12.8 p -88.11 -159.88 0.58 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 164.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.04 -48.69 56.93 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.888 1.222 . . . . 0.0 109.313 160.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.67 -12.53 16.68 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 126.58 1.952 . . . . 0.0 114.856 -159.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.489 ' C ' ' H ' ' A' ' 32' ' ' ARG . 12.9 mm-40 -85.0 -48.34 9.34 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 127.028 2.131 . . . . 0.0 110.316 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.0 m95 -60.61 8.94 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 128.135 2.574 . . . . 0.0 115.711 -168.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.489 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -139.06 -11.29 1.27 Allowed 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 128.928 2.891 . . . . 0.0 111.878 -164.037 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.9 -16.41 3.27 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 118.369 -0.824 . . . . 0.0 112.081 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pt -110.98 13.33 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 119.472 1.033 . . . . 0.0 111.958 172.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.01 167.94 14.02 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.006 0.923 . . . . 0.0 111.403 -171.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.2 137.8 74.19 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 123.89 0.876 . . . . 0.0 108.761 169.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -70.13 -3.69 12.76 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.398 2.732 . . . . 0.0 113.23 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -95.01 -30.04 14.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 127.233 2.213 . . . . 0.0 110.328 170.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.05 -48.46 81.66 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 120.975 1.716 . . . . 0.0 111.092 -174.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -59.07 -37.8 77.93 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.524 0.729 . . . . 0.0 111.885 -174.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -81.41 -45.81 15.53 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.869 -0.586 . . . . 0.0 109.827 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 t -58.59 -28.11 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 120.103 1.319 . . . . 0.0 110.005 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.19 -8.29 23.33 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 173.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -119.26 -27.51 5.63 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.429 1.468 . . . . 0.0 111.12 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -105.0 12.35 32.39 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.07 1.748 . . . . 0.0 112.868 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.47 7.92 1.49 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.669 2.788 . . . . 0.0 115.374 171.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.55 10.17 19.95 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 118.485 -1.175 . . . . 0.0 114.888 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.5 t -125.88 136.87 53.56 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 119.128 1.464 . . . . 0.0 107.596 158.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -89.08 172.12 7.94 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 159.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.28 164.22 31.36 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 122.698 2.265 . . . . 0.0 111.851 168.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.43 -7.91 20.54 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.222 2.615 . . . . 0.0 115.238 -167.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -53.87 -21.49 7.81 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.158 0.983 . . . . 0.0 112.841 171.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 t -128.27 17.05 6.6 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.588 1.155 . . . . 0.0 111.748 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -148.4 91.55 0.14 Allowed Glycine 0 C--N 1.341 0.817 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -174.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -140.54 -55.23 0.52 Allowed 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.61 0.764 . . . . 0.0 110.903 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -66.26 158.46 28.9 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 168.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -152.66 160.67 43.16 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 170.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -135.25 179.4 6.35 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.176 1.79 . . . . 0.0 109.19 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.4 tt -155.52 138.1 15.08 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 159.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.18 165.22 36.36 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.399 0.68 . . . . 0.0 109.273 169.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -76.57 39.38 0.21 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 129.129 2.971 . . . . 0.0 110.853 166.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -136.98 159.65 41.26 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.746 1.218 . . . . 0.0 109.561 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.67 169.78 46.23 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 125.894 1.711 . . . . 0.0 112.402 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.6 pt -128.19 173.32 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 162.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -94.56 119.04 32.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.889 1.275 . . . . 0.0 110.066 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.27 119.98 10.68 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 158.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 2.8 t -74.81 71.44 1.99 Allowed 'General case' 0 C--O 1.236 0.389 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 159.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 tt -62.9 -26.62 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.604 -162.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.6 t -77.65 3.15 14.6 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.334 1.454 . . . . 0.0 112.393 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.3 p -140.54 21.69 2.36 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.318 -0.864 . . . . 0.0 111.464 158.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.35 36.18 52.45 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.2 m -124.3 177.02 6.08 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.381 2.273 . . . . 0.0 106.907 -170.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -138.25 145.65 41.6 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.647 1.112 . . . . 0.0 109.235 -173.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.406 HD13 ' CD2' ' A' ' 75' ' ' PHE 0.305 0.2 OUTLIER -151.18 -102.2 0.06 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 178.377 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.406 ' CD2' HD13 ' A' ' 74' ' ' LEU . 38.8 m-85 -55.27 150.48 11.13 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -158.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -112.7 143.68 43.49 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.895 0.878 . . . . 0.0 110.726 -174.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.4 m -61.15 -16.63 46.54 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -56.7 -23.26 40.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 120.355 1.434 . . . . 0.0 112.18 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.1 t -112.96 -3.73 14.02 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.759 0.823 . . . . 0.0 112.384 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.424 ' C ' ' HE2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -114.8 68.21 0.7 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.958 -1.089 . . . . 0.0 108.134 176.691 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -135.78 49.12 2.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.989 0.916 . . . . 0.0 109.965 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -72.53 95.15 1.77 Allowed 'General case' 0 C--N 1.341 0.206 0 O-C-N 121.626 -0.671 . . . . 0.0 109.505 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.2 t -58.89 134.4 56.89 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.859 0.463 . . . . 0.0 110.287 -175.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.98 -67.93 3.66 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.61 -55.54 17.04 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.03 0.915 . . . . 0.0 111.527 -174.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.02 16.03 12.0 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 129.373 3.368 . . . . 0.0 115.871 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.39 150.62 8.51 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 125.261 1.424 . . . . 0.0 112.137 171.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.71 71.69 4.7 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.77 2.98 . . . . 0.0 110.384 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.4 p -133.89 152.31 51.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 164.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -131.78 176.45 8.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.816 1.246 . . . . 0.0 109.433 -170.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -124.91 -3.08 7.7 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.239 1.015 . . . . 0.0 112.587 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -151.64 -173.26 4.46 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.711 2.004 . . . . 0.0 107.693 -176.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.84 155.34 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 C-N-CA 123.783 0.833 . . . . 0.0 109.304 178.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 p -61.46 -33.34 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.382 0.611 . . . . 0.0 110.486 170.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.8 m 168.02 159.82 0.04 OUTLIER 'General case' 0 C--O 1.234 0.279 1 C-N-CA 132.559 4.343 . . . . 0.0 105.075 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -101.04 80.9 2.18 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.509 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 17.9 p80 -125.43 -67.04 0.91 Allowed 'General case' 0 C--N 1.347 0.484 0 C-N-CA 126.443 1.897 . . . . 0.0 109.345 -165.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.509 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 0.7 OUTLIER -96.9 22.08 8.79 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 122.071 0.938 . . . . 0.0 112.429 179.525 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.9 tt -126.61 147.78 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 128.628 2.771 . . . . 0.0 104.847 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -125.14 138.35 54.15 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 122.803 0.441 . . . . 0.0 110.713 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mp -144.41 130.28 19.32 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.964 1.706 . . . . 0.0 109.07 -164.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.422 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 2.3 mpt_? -131.35 111.95 12.31 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 128.364 2.665 . . . . 0.0 105.345 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -74.41 128.44 35.54 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.629 1.571 . . . . 0.0 110.845 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 105' ' ' ARG . 32.0 t0 -134.2 178.01 7.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.095 1.358 . . . . 0.0 109.156 162.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.414 ' H ' ' CG ' ' A' ' 104' ' ' ASP . 0.0 OUTLIER -113.62 18.39 17.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.995 1.718 . . . . 0.0 110.544 -178.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.18 -30.56 60.16 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -158.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.85 -12.99 60.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.827 0.739 . . . . 0.0 112.617 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.5 -2.5 23.47 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 126.343 1.925 . . . . 0.0 112.936 -169.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 76.6 mtm -143.47 -81.91 0.18 Allowed 'General case' 0 C--N 1.35 0.605 0 CA-C-N 120.484 2.142 . . . . 0.0 109.629 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 42.9 t -143.08 116.6 3.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -125.44 111.2 14.83 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 126.33 1.852 . . . . 0.0 107.845 168.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 38.3 t -129.25 125.45 36.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -170.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.422 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 24.1 pt-20 -60.38 159.16 10.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.002 0.819 . . . . 0.0 111.387 -172.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -137.39 106.62 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 171.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.7 mp -120.67 170.28 9.58 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 164.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.1 163.34 12.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 118.927 -1.109 . . . . 0.0 108.592 164.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.46 -20.04 66.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.713 168.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.537 ' HG2' ' H ' ' A' ' 24' ' ' ILE . 30.7 tpt85 -148.46 -48.16 0.15 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -176.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 31.8 p -80.74 65.41 5.87 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.686 1.584 . . . . 0.0 108.453 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.39 57.33 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.217 2.607 . . . . 0.0 112.156 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.98 -47.38 52.55 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.648 0.779 . . . . 0.0 111.941 -164.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -169.07 -69.26 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 125.595 1.558 . . . . 0.0 107.601 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.4 mt 52.13 -114.02 0.79 Allowed 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 126.907 2.083 . . . . 0.0 110.846 -171.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.01 -119.45 0.72 Allowed Glycine 0 CA--C 1.525 0.692 0 CA-C-N 119.09 0.859 . . . . 0.0 112.367 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -159.47 163.55 35.22 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 122.299 -0.53 . . . . 0.0 111.17 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.5 p -101.49 132.96 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 168.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -131.53 155.57 47.22 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.369 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.06 112.7 3.1 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.253 1.021 . . . . 0.0 109.182 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -144.16 -24.45 0.55 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -171.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.45 163.77 13.56 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 123.349 0.5 . . . . 0.0 112.22 -167.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.86 -15.89 10.42 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.831 2.354 . . . . 0.0 114.353 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.5 ptt-85 142.63 165.08 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.945 1 C-N-CA 132.069 4.148 . . . . 0.0 107.181 -159.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.11 -53.11 0.15 OUTLIER 'Cis proline' 0 C--N 1.352 0.752 0 CA-C-N 121.624 1.616 . . . . 0.0 111.269 -9.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.9 p -73.76 -23.72 59.77 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.965 1.306 . . . . 0.0 112.743 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.74 5.37 68.9 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.282 0.944 . . . . 0.0 113.832 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -125.44 162.17 25.44 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 119.647 1.723 . . . . 0.0 111.622 -167.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 ttm105 -125.23 109.53 12.95 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.642 1.577 . . . . 0.0 108.116 173.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -74.59 106.46 6.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.881 1.673 . . . . 0.0 106.977 165.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 18.2 t -121.94 135.55 54.87 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.561 1.073 . . . . 0.0 109.898 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.8 ptp -159.18 161.06 36.14 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.444 0.698 . . . . 0.0 110.754 -171.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -148.29 146.13 28.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.532 0.733 . . . . 0.0 109.426 161.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 91.0 p -171.78 -175.53 1.55 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.572 1.949 . . . . 0.0 107.208 158.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.87 -21.07 62.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.613 1.165 . . . . 0.0 113.163 165.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.53 22.03 0.06 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.735 1.614 . . . . 0.0 114.886 -169.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 88.9 mt -130.64 106.05 8.23 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.701 1.137 . . . . 0.0 110.018 -165.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -137.88 140.07 40.2 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.318 1.047 . . . . 0.0 108.788 174.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -76.95 141.38 40.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.219 0.918 . . . . 0.0 110.341 168.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.0 pt -137.01 170.53 10.54 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.077 1.751 . . . . 0.0 108.754 165.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.19 165.19 4.33 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.73 2.287 . . . . 0.0 112.783 167.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -45.05 -18.77 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 129.006 2.922 . . . . 0.0 118.341 -165.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -164.29 -78.71 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 171.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.4 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 31.8 mm-40 -149.71 42.05 0.87 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.99 2.516 . . . . 0.0 104.637 163.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.9 pp -76.39 -25.12 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 O-C-N 120.802 -1.186 . . . . 0.0 111.907 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 CA-C-O 117.306 -1.83 . . . . 0.0 110.542 175.528 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.2 tpt . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -74.9 134.71 41.56 Favored 'General case' 0 C--N 1.337 0.062 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 170.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -154.77 -173.36 4.54 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.027 1.331 . . . . 0.0 107.583 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -97.75 178.4 5.16 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.247 1.019 . . . . 0.0 109.059 162.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.448 ' CD1' HD22 ' A' ' 98' ' ' ASN . 1.3 pt -129.35 125.74 22.65 Favored Pre-proline 0 N--CA 1.452 -0.332 0 C-N-CA 125.595 1.558 . . . . 0.0 110.78 174.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.83 143.35 36.91 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.628 1.552 . . . . 0.0 110.384 164.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.8 mt -126.23 98.94 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.4 103.26 14.64 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.073 0.949 . . . . 0.0 108.546 -171.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.7 m -72.83 76.93 1.14 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.826 173.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.8 p -56.31 -39.63 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 118.709 0.686 . . . . 0.0 110.585 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.55 -12.66 10.55 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.301 1.84 . . . . 0.0 113.907 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 151' ' ' ASP . 39.4 mtmt -128.68 7.73 5.74 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.503 1.521 . . . . 0.0 111.639 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.5 t30 32.76 74.0 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.948 2.499 . . . . 0.0 112.801 -159.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.41 167.86 20.55 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.52 142.97 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 164.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -125.15 165.59 17.97 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 158.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 46.7 ttm -132.47 133.97 44.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.4 t -137.98 161.0 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 -171.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -72.87 161.97 30.06 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.774 -1.829 . . . . 0.0 112.429 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.24 142.13 58.4 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 161.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.3 tt -60.48 137.07 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.002 1.321 . . . . 0.0 109.414 -176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -150.44 114.17 5.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 103.396 -2.816 . . . . 0.0 103.396 171.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.2 mt -137.87 -159.54 0.97 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.518 1.527 . . . . 0.0 108.357 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.0 m -144.56 175.31 10.23 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.437 -1.415 . . . . 0.0 107.65 162.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.28 -41.08 60.19 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.341 1.457 . . . . 0.0 113.363 -159.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.404 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 2.1 m-20 -77.06 -18.44 58.05 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -175.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 32' ' ' ARG . 75.0 mm-40 -66.45 -47.27 73.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.965 0.802 . . . . 0.0 109.834 -176.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -62.12 15.23 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.285 2.234 . . . . 0.0 115.889 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.412 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -133.22 -9.41 2.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 170.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -122.63 -17.56 6.88 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.19 0.905 . . . . 0.0 112.619 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 pt -110.75 19.01 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 118.949 0.795 . . . . 0.0 111.483 169.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -127.27 166.58 17.5 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.271 1.028 . . . . 0.0 111.534 -173.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.452 ' CG ' HH12 ' A' ' 66' ' ' ARG . 0.9 OUTLIER -58.62 137.56 86.22 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 163.352 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -67.83 -16.48 45.95 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.334 2.022 . . . . 0.0 112.245 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -73.49 -42.47 61.8 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.753 -0.592 . . . . 0.0 109.856 170.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.51 -38.16 80.21 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.271 0.941 . . . . 0.0 111.125 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -54.92 -56.48 19.09 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.81 0.844 . . . . 0.0 110.824 172.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -63.65 -45.65 89.22 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.683 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.7 t -51.69 -37.8 20.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 125.091 1.356 . . . . 0.0 109.952 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.34 -10.84 18.28 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 176.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.62 -17.22 11.19 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.812 1.187 . . . . 0.0 113.46 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.424 ' C ' ' H ' ' A' ' 47' ' ' GLY . 12.8 ptpt -116.1 8.77 14.57 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.254 1.022 . . . . 0.0 112.028 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.37 -30.77 0.08 Allowed 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 130.241 3.416 . . . . 0.0 113.561 -164.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 45' ' ' LYS . . . -178.19 -87.89 0.07 OUTLIER Glycine 0 C--N 1.336 0.582 0 C-N-CA 126.365 1.936 . . . . 0.0 109.486 -170.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.1 t -123.72 117.65 25.45 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.307 -2.108 . . . . 0.0 105.307 164.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -55.72 132.15 72.26 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.263 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.47 119.87 5.95 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.874 2.382 . . . . 0.0 110.382 -175.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.19 -23.32 28.99 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.076 1.85 . . . . 0.0 112.376 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -161.94 -26.15 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.836 1.654 . . . . 0.0 111.064 168.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.5 t -143.0 169.86 16.78 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.981 1.313 . . . . 0.0 108.395 170.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -122.87 100.12 0.67 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.41 147.95 40.49 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.437 1.095 . . . . 0.0 108.293 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -152.76 159.33 43.11 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -141.03 157.77 44.87 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.976 1.71 . . . . 0.0 106.486 172.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -118.49 169.58 9.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.449 0.643 . . . . 0.0 110.081 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.8 mt -117.02 -171.73 2.08 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.002 1.721 . . . . 0.0 107.265 163.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -141.55 138.22 32.55 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -154.48 172.15 18.24 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.676 1.59 . . . . 0.0 108.408 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.59 107.63 3.02 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.335 1.454 . . . . 0.0 111.213 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.66 179.32 41.91 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -173.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.2 pt -122.72 170.9 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.522 0.729 . . . . 0.0 109.617 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -97.89 143.93 27.97 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.144 0.978 . . . . 0.0 109.858 -174.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.452 HH12 ' CG ' ' A' ' 36' ' ' ASP . 34.2 ttt180 -127.62 146.68 50.46 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.669 1.188 . . . . 0.0 109.139 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 10.6 t -102.04 94.42 5.76 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 175.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.2 tt -58.11 -31.07 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.82 1.248 . . . . 0.0 111.371 -174.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.1 t -75.78 5.7 5.95 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.266 1.826 . . . . 0.0 111.906 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.402 ' HB2' ' HE ' ' A' ' 118' ' ' ARG . 26.8 p -144.06 10.63 1.53 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.741 1.216 . . . . 0.0 111.57 162.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.4 11.08 45.93 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.384 1.945 . . . . 0.0 114.712 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.0 m -114.44 142.99 45.65 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.351 1.576 . . . . 0.0 110.646 -159.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 9.7 p-10 -95.53 147.93 23.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.467 1.507 . . . . 0.0 112.584 -178.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.311 0.2 OUTLIER -152.98 -98.16 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.34 1.056 . . . . 0.0 113.666 173.485 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -49.96 131.15 22.71 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -159.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -69.64 132.1 45.66 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.447 -0.783 . . . . 0.0 109.124 171.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.8 m -62.95 -20.57 65.36 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.14 -12.57 41.09 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.202 1.365 . . . . 0.0 113.264 172.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.3 p -74.32 -25.27 59.45 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.552 -0.718 . . . . 0.0 111.886 166.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -121.69 95.07 4.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.321 1.848 . . . . 0.0 109.564 -168.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -141.93 116.07 9.41 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -137.75 110.77 7.75 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 171.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.9 p -63.48 103.16 0.49 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.127 1.371 . . . . 0.0 111.295 -167.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.47 -47.63 1.43 Allowed Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.744 1.164 . . . . 0.0 111.245 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -53.99 25.16 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.401 0.68 . . . . 0.0 110.469 177.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 47.16 23.66 1.84 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.933 2.206 . . . . 0.0 115.196 -167.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -54.66 153.28 11.01 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 118.966 1.383 . . . . 0.0 112.338 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.35 71.71 2.35 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.866 3.044 . . . . 0.0 112.26 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.9 p -133.81 149.97 51.41 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 158.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -147.24 173.46 12.53 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.66 1.184 . . . . 0.0 109.095 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -113.34 -13.6 12.88 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.473 -0.775 . . . . 0.0 112.832 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -155.27 -179.05 7.71 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.222 1.409 . . . . 0.0 108.349 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.07 166.71 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.586 1.554 . . . . 0.0 111.153 -175.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.54 -50.46 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.592 0.757 . . . . 0.0 109.534 168.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.4 m 172.81 162.58 0.12 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 130.518 3.527 . . . . 0.0 106.362 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -85.45 65.88 9.41 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -111.78 -56.78 2.34 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 124.753 1.221 . . . . 0.0 108.173 -173.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.448 HD22 ' CD1' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -100.66 4.15 43.02 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 175.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.32 131.42 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -107.96 140.98 40.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.387 1.475 . . . . 0.0 107.562 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.01 155.33 49.38 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.572 1.549 . . . . 0.0 109.77 175.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.36 131.54 36.5 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 128.561 2.744 . . . . 0.0 104.138 165.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.42 150.15 45.25 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 171.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' A' ' 106' ' ' SER . 53.0 t0 -148.3 140.24 23.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 158.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 16.39 0.07 Allowed 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.644 -1.285 . . . . 0.0 112.355 172.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 104' ' ' ASP . 0.4 OUTLIER -43.51 -61.56 1.34 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 127.419 2.288 . . . . 0.0 113.149 -158.675 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pp -58.95 -14.34 8.95 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.389 1.076 . . . . 0.0 113.618 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 118.83 -4.9 14.25 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 126.651 2.072 . . . . 0.0 111.893 -172.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -141.02 -84.64 0.2 Allowed 'General case' 0 C--N 1.348 0.538 0 CA-C-N 119.645 1.723 . . . . 0.0 109.018 -174.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.2 t -147.13 108.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -173.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.426 ' HE ' ' CD2' ' A' ' 125' ' ' HIS . 44.2 ttt180 -131.17 83.31 2.1 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.478 1.511 . . . . 0.0 110.785 176.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 1.4 m -85.14 137.16 33.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.879 -0.581 . . . . 0.0 109.771 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -67.05 157.33 33.8 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.21 0.914 . . . . 0.0 111.132 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.4 t -133.82 107.13 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -129.81 154.27 47.41 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 27.8 t -69.59 137.0 51.97 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -70.43 -17.37 63.0 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.402 ' HE ' ' HB2' ' A' ' 70' ' ' CYS . 0.0 OUTLIER -104.98 -37.22 7.05 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.205 1.802 . . . . 0.0 112.781 -173.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 29.6 p -135.04 74.64 1.53 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 123.551 1.644 . . . . 0.0 108.337 171.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.82 55.93 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 1 C-N-CA 133.697 4.799 . . . . 0.0 113.462 172.334 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -112.05 -57.95 2.2 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 -159.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -138.54 -89.26 0.22 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.257 0.935 . . . . 0.0 109.678 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 mt 58.94 -120.24 1.08 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.705 2.002 . . . . 0.0 109.88 -176.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -174.96 -125.07 0.84 Allowed Glycine 0 CA--C 1.522 0.509 0 CA-C-N 118.972 0.805 . . . . 0.0 112.962 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.426 ' CD2' ' HE ' ' A' ' 111' ' ' ARG . 31.9 p-80 -161.2 179.07 8.66 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.169 0.587 . . . . 0.0 110.569 -172.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.62 143.24 41.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.767 1.227 . . . . 0.0 108.936 172.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -139.37 154.77 47.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.841 1.256 . . . . 0.0 109.219 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.84 113.76 10.23 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -164.93 -46.97 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.461 1.504 . . . . 0.0 111.48 -168.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -64.52 167.91 27.74 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.249 0.452 . . . . 0.0 112.508 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.55 177.16 7.79 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.594 2.196 . . . . 0.0 110.999 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -57.0 146.48 59.76 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 160.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.18 -52.6 0.16 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.529 0 CA-C-N 120.103 1.073 . . . . 0.0 114.641 15.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 17.5 p -77.95 -24.07 48.29 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -164.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.65 5.72 86.38 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 119.278 -0.734 . . . . 0.0 113.684 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -132.9 159.81 38.83 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.38 1.59 . . . . 0.0 111.787 -168.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.2 ttm105 -125.07 109.17 12.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.759 1.624 . . . . 0.0 106.69 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -72.04 128.45 35.74 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 160.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 17.5 t -135.73 135.88 40.36 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.786 1.234 . . . . 0.0 108.282 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 35.1 ttm -140.04 156.5 46.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 122.276 1.036 . . . . 0.0 109.824 -165.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.58 104.11 4.33 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.469 1.908 . . . . 0.0 105.921 173.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 58.1 p -153.65 157.49 39.69 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 162.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.14 -25.01 54.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.56 4.91 0.91 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.745 2.018 . . . . 0.0 115.855 -159.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 83.4 mt -90.84 87.97 6.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.084 1.354 . . . . 0.0 109.674 -159.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -93.26 133.68 36.24 Favored 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -71.43 146.33 48.72 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 159.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.6 pt -137.84 166.27 27.48 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.818 1.247 . . . . 0.0 107.977 166.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.36 173.3 0.71 Allowed 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.419 2.079 . . . . 0.0 111.696 164.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -52.66 -17.81 1.48 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 -163.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.404 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 5.0 t70 -175.66 -77.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.546 2.338 . . . . 0.0 107.199 170.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -144.4 17.67 1.7 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.353 2.261 . . . . 0.0 110.175 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -74.0 -9.74 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.205 -0.934 . . . . 0.0 112.348 173.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.513 0 N-CA-C 106.935 -2.466 . . . . 0.0 106.935 159.271 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 31.8 tpp . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -73.84 57.01 0.59 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.651 1.18 . . . . 0.0 110.802 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -151.08 -175.21 5.06 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.69 1.196 . . . . 0.0 108.344 165.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.59 169.48 0.32 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 128.73 2.812 . . . . 0.0 113.902 172.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.8 pt -123.46 128.22 25.3 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.953 1.301 . . . . 0.0 110.556 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.58 108.76 2.63 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.29 2.66 . . . . 0.0 109.747 172.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mp -86.84 155.95 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 167.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -135.45 101.53 4.84 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.896 1.279 . . . . 0.0 108.71 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.8 m -65.84 79.61 0.08 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 161.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.5 p -56.21 -41.92 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.041 0.936 . . . . 0.0 110.54 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.07 -12.03 10.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.388 1.475 . . . . 0.0 114.216 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.93 12.47 6.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.387 1.475 . . . . 0.0 110.925 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 33.57 59.15 0.52 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.105 2.562 . . . . 0.0 112.208 -167.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.8 mtp85 -106.48 169.13 8.7 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 173.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.9 t -137.6 97.94 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 168.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -98.89 81.97 2.7 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.882 1.673 . . . . 0.0 108.286 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 43.4 ttp -66.51 127.9 34.12 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.639 -0.663 . . . . 0.0 110.551 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.7 t -129.47 142.42 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.164 1.386 . . . . 0.0 108.278 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -78.99 144.1 35.06 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.399 0.619 . . . . 0.0 110.211 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 mtm105 -65.74 148.16 52.21 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.204 -160.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.91 114.87 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.286 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 168.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -145.84 102.1 3.62 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 102.626 -3.101 . . . . 0.0 102.626 170.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.7 mt -136.65 175.27 9.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.719 0.808 . . . . 0.0 109.72 -168.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.1 t -102.16 163.71 12.09 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 162.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -54.88 -30.89 59.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.04 0.936 . . . . 0.0 111.182 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.91 -27.6 60.96 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.013 2.525 . . . . 0.0 112.634 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 32' ' ' ARG . 67.3 mm-40 -85.51 -45.31 11.92 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.796 1.238 . . . . 0.0 110.68 -170.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -60.61 14.15 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.749 2.42 . . . . 0.0 115.443 -174.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.452 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -127.29 -14.35 5.39 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.143 1.377 . . . . 0.0 113.701 172.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.34 -12.75 4.47 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.43 -172.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 pt -112.82 14.62 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 118.732 0.696 . . . . 0.0 111.356 167.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -117.32 171.84 7.7 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.192 1.397 . . . . 0.0 110.415 -175.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.93 143.01 88.33 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 165.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -70.58 -10.66 28.37 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.974 2.45 . . . . 0.0 111.875 168.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -75.61 -46.62 30.63 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 125.004 1.322 . . . . 0.0 109.889 165.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.89 -41.62 87.61 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 119.859 1.209 . . . . 0.0 110.675 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -57.21 -44.21 83.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.713 1.205 . . . . 0.0 112.014 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -80.1 -41.6 25.21 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 118.79 0.723 . . . . 0.0 110.16 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.9 t -52.75 -31.78 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 126.355 1.862 . . . . 0.0 109.728 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.77 -19.6 64.16 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 173.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.98 -31.85 12.88 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.057 1.299 . . . . 0.0 111.594 173.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' A' ' 47' ' ' GLY . 15.8 ptpt -103.16 1.48 33.23 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.46 1.104 . . . . 0.0 113.371 -169.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.23 3.08 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.998 2.519 . . . . 0.0 114.712 -168.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 45' ' ' LYS . . . 148.61 -38.09 1.01 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 125.893 1.711 . . . . 0.0 113.168 174.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.5 t -150.09 127.82 11.69 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.334 1.567 . . . . 0.0 110.476 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -67.46 -60.2 6.04 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.749 1.22 . . . . 0.0 110.105 167.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -80.77 168.58 17.49 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.305 2.003 . . . . 0.0 111.355 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.48 175.99 6.3 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.659 2.24 . . . . 0.0 110.45 159.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -137.49 166.04 24.82 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.308 1.043 . . . . 0.0 109.631 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.9 m -141.35 146.21 36.38 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -172.15 56.49 0.17 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -58.67 -25.87 63.25 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -175.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.03 166.88 31.65 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.186 2.194 . . . . 0.0 106.412 168.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -149.4 -60.37 0.22 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 169.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -145.71 -167.26 2.66 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.727 2.411 . . . . 0.0 107.115 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.9 tp -145.48 42.88 1.28 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.077 0.951 . . . . 0.0 110.167 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.35 -176.82 4.08 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.446 1.099 . . . . 0.0 111.545 -176.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -106.76 101.36 10.81 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 129.074 2.95 . . . . 0.0 109.593 -172.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -142.0 153.05 43.98 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 164.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.8 153.13 11.49 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 125.444 1.497 . . . . 0.0 113.031 158.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.7 pt -130.05 154.17 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 162.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.68 126.46 32.37 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -80.36 114.27 19.15 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 158.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 19.7 t -65.11 85.07 0.05 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 162.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.9 tt -66.78 -22.92 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 122.061 -0.399 . . . . 0.0 110.487 -169.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.7 m -61.42 -8.65 4.28 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.797 1.639 . . . . 0.0 113.704 169.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 21.4 p -138.88 15.94 2.67 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.893 1.224 . . . . 0.0 111.647 160.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.99 17.11 21.27 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.293 -1.282 . . . . 0.0 113.961 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.1 m -121.23 143.07 49.34 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.14 1.47 . . . . 0.0 108.95 -164.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.9 167.93 19.99 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 176.08 -160.1 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 131.35 3.86 . . . . 0.0 109.001 172.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 0.14 107.52 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 131.548 3.939 . . . . 0.0 117.023 -165.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.12 144.58 57.0 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.454 1.502 . . . . 0.0 111.13 171.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.8 m -56.46 -30.47 62.93 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.59 -22.14 66.89 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -175.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 p -93.0 -7.37 46.02 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.729 0.695 . . . . 0.0 111.637 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.93 47.63 2.38 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.86 2.064 . . . . 0.0 108.819 -159.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -117.39 60.92 0.75 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.967 0.907 . . . . 0.0 109.666 -167.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -68.3 97.24 0.72 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.0 m -57.3 117.93 4.59 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.147 0.979 . . . . 0.0 112.039 -164.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.88 -49.86 4.29 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.354 0.978 . . . . 0.0 112.102 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.7 -43.97 91.77 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.208 1.004 . . . . 0.0 111.878 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 41.5 35.76 1.38 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 128.833 3.111 . . . . 0.0 114.662 -159.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.5 150.11 5.07 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 126.063 1.745 . . . . 0.0 110.243 175.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.96 69.91 6.1 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.564 2.842 . . . . 0.0 110.769 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.6 p -144.96 152.39 40.1 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.752 1.621 . . . . 0.0 108.821 -177.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.95 168.48 19.61 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.88 1.272 . . . . 0.0 109.085 -176.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -115.84 -9.75 11.8 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 118.811 -0.614 . . . . 0.0 112.445 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -156.64 176.02 13.28 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.846 1.259 . . . . 0.0 107.925 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.6 t -125.99 149.12 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.627 0.771 . . . . 0.0 110.907 -162.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 p -56.54 -54.65 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 126.452 1.901 . . . . 0.0 110.769 171.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.0 m 169.8 164.1 0.06 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 130.669 3.588 . . . . 0.0 107.282 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 mp0 -76.92 64.55 2.45 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.823 1.649 . . . . 0.0 109.508 173.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -115.41 -54.79 2.51 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.879 0.872 . . . . 0.0 109.284 -170.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -121.38 14.24 11.16 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.463 1.105 . . . . 0.0 111.859 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.88 150.77 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.807 1.643 . . . . 0.0 108.846 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -123.27 150.32 43.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.876 2.07 . . . . 0.0 110.771 -174.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.4 mt -145.72 137.14 24.98 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.804 2.442 . . . . 0.0 110.298 -166.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.435 ' HE ' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -139.98 117.25 11.28 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 129.102 2.961 . . . . 0.0 105.879 159.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -104.08 144.26 31.8 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.242 1.017 . . . . 0.0 110.869 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -152.62 179.44 8.61 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.946 2.499 . . . . 0.0 108.11 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.51 27.52 8.29 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.704 -1.248 . . . . 0.0 111.43 173.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.74 -38.9 67.71 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -159.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 pp -75.86 -9.41 58.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.16 6.09 37.03 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 117.579 -1.678 . . . . 0.0 112.781 -168.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 13.3 tpt -145.67 -91.23 0.1 Allowed 'General case' 0 C--N 1.349 0.567 0 CA-C-N 120.298 2.049 . . . . 0.0 109.212 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.3 t -139.37 119.68 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 172.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.433 HH21 ' CE1' ' A' ' 125' ' ' HIS . 17.5 ttt180 -121.83 128.23 51.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 165.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 43.3 t -124.49 142.55 51.24 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 168.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.435 ' CD ' ' HE ' ' A' ' 102' ' ' ARG . 17.4 pt-20 -67.61 162.68 22.98 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.886 170.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 73.2 t -136.81 108.67 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 169.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -125.29 173.09 9.05 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 168.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 39.6 t -71.29 159.59 34.32 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.448 -0.783 . . . . 0.0 108.985 171.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -81.55 -13.89 57.51 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 170.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -115.94 -58.44 2.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 173.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.2 p -94.71 62.39 2.73 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.8 51.29 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 128.362 2.665 . . . . 0.0 113.434 -168.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.38 -71.77 0.59 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.787 1.235 . . . . 0.0 113.359 -167.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -130.79 -83.93 0.53 Allowed 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.761 0.824 . . . . 0.0 109.135 -165.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mt 50.66 -108.88 0.37 Allowed 'General case' 0 C--N 1.338 0.097 0 C-N-CA 126.89 2.076 . . . . 0.0 109.989 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.23 -125.42 0.94 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.586 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.433 ' CE1' HH21 ' A' ' 111' ' ' ARG . 20.3 p-80 -162.42 178.97 8.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.387 -0.478 . . . . 0.0 110.468 -170.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.9 p -129.5 143.25 41.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 124.72 1.208 . . . . 0.0 108.89 172.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -133.79 150.79 51.45 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 124.225 0.953 . . . . 0.0 110.744 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -64.13 106.83 1.14 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.048 1.339 . . . . 0.0 109.333 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -167.57 -48.53 0.02 OUTLIER 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.082 1.353 . . . . 0.0 111.472 -169.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -65.18 172.37 21.8 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.785 0.707 . . . . 0.0 113.408 -170.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -69.83 167.84 23.38 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.253 1.969 . . . . 0.0 111.348 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -61.63 151.6 77.73 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 162.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.33 -47.67 0.3 Allowed 'Cis proline' 0 C--N 1.347 0.472 0 CA-C-N 119.944 1.016 . . . . 0.0 114.182 14.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.2 p -73.96 -26.28 60.4 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -166.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.72 5.62 79.46 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 119.184 0.902 . . . . 0.0 113.678 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -130.23 156.83 43.96 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.983 1.391 . . . . 0.0 111.275 -168.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 14.7 ttt85 -125.27 103.83 8.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.271 1.828 . . . . 0.0 108.234 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -73.89 141.19 46.06 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.105 1.362 . . . . 0.0 107.346 167.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 53.7 t -142.92 136.13 28.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.319 1.847 . . . . 0.0 107.703 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 6.8 ttt -144.71 141.54 29.37 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.744 0.818 . . . . 0.0 108.976 -174.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -148.11 93.48 2.18 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.589 1.156 . . . . 0.0 108.917 -170.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 77.3 p -163.27 -173.41 3.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 167.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.75 -21.31 27.32 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.225 1.41 . . . . 0.0 114.183 168.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.34 26.29 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.725 2.41 . . . . 0.0 115.98 -164.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 62.3 mt -121.33 38.33 4.11 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.744 1.218 . . . . 0.0 111.852 -162.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -75.47 108.99 8.64 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -64.19 140.18 58.84 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.477 -0.764 . . . . 0.0 109.207 163.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.3 pt -128.01 165.25 31.8 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 159.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -53.34 163.08 2.65 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.584 2.856 . . . . 0.0 112.976 166.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -15.76 -53.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 129.669 3.188 . . . . 0.0 114.865 173.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' A' ' 152' ' ' GLN . 4.6 p-10 -157.08 -67.68 0.1 Allowed 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 127.313 2.245 . . . . 0.0 111.283 159.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.421 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 38.4 mt-30 -144.17 1.42 1.1 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.353 1.461 . . . . 0.0 110.9 -163.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.06 -19.03 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.189 1.796 . . . . 0.0 114.56 -170.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.958 0 CA-C-O 116.951 -2.027 . . . . 0.0 109.529 -177.523 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -146.55 58.51 1.2 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.913 1.285 . . . . 0.0 107.623 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -135.61 -158.51 0.88 Allowed 'General case' 0 C--O 1.232 0.184 0 C-N-CA 125.493 1.517 . . . . 0.0 108.505 -162.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 8.6 ttt85 -117.02 162.36 17.92 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 123.982 0.913 . . . . 0.0 110.019 169.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.7 pt -136.45 146.94 57.95 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 113.89 -1.505 . . . . 0.0 112.259 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.86 134.12 10.56 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.71 2.94 . . . . 0.0 111.485 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.4 mm -114.58 100.11 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 127.053 2.141 . . . . 0.0 105.737 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -100.4 124.18 45.57 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.9 m -101.8 87.1 3.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -54.01 -39.3 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.679 0.791 . . . . 0.0 111.255 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.65 -25.58 11.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.286 2.234 . . . . 0.0 114.78 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -124.71 7.1 8.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.763 2.025 . . . . 0.0 111.348 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 33.44 63.1 0.37 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.53 2.332 . . . . 0.0 111.638 -161.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.5 mtp-105 -109.87 164.28 12.73 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.1 p -134.85 144.92 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 158.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -136.71 165.55 25.64 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 158.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.7 ttp -127.66 116.98 21.12 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -170.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.76 139.12 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.044 1.738 . . . . 0.0 107.64 -160.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 7' ' ' ARG 0.284 3.5 pm0 -89.53 148.87 23.15 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 122.234 1.016 . . . . 0.0 112.42 -169.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.429 HH11 ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -66.93 146.18 54.66 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.329 -162.503 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.13 118.81 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -167.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -137.73 101.83 4.57 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.487 1.515 . . . . 0.0 107.388 173.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.9 mt -134.15 177.83 7.44 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 127.227 2.211 . . . . 0.0 106.83 166.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.6 t -162.73 -14.84 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -176.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 30' ' ' GLU . 8.4 t70 -118.63 -146.51 0.39 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.623 1.102 . . . . 0.0 109.576 -171.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.7 5.35 0.12 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.841 1.657 . . . . 0.0 113.643 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 28' ' ' ASP . 27.8 mt-10 -62.79 -44.61 95.73 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 125.577 1.551 . . . . 0.0 110.728 -163.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -68.58 45.03 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 128.334 2.654 . . . . 0.0 112.179 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.38 -44.35 0.07 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.469 1.908 . . . . 0.0 108.878 160.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -75.22 -27.19 59.44 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.446 -0.788 . . . . 0.0 112.305 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 pt -110.83 28.18 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 119.377 0.99 . . . . 0.0 111.847 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mt -117.93 166.57 12.34 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 125.133 1.373 . . . . 0.0 111.511 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 5.2 m-20 -61.35 146.76 88.61 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 163.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -67.3 -9.71 26.15 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.471 2.114 . . . . 0.0 112.327 169.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -78.63 -51.83 9.32 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.973 1.709 . . . . 0.0 109.95 163.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.466 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -58.67 -37.93 77.08 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.45 1.477 . . . . 0.0 110.451 -176.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -52.6 -52.9 53.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.896 1.278 . . . . 0.0 111.84 173.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -77.21 -45.08 27.75 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.596 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.9 t -53.72 -31.15 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.56 1.144 . . . . 0.0 110.13 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.59 -18.31 64.77 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 174.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -102.34 -37.03 8.24 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.383 1.447 . . . . 0.0 112.43 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -97.29 2.95 51.34 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.798 1.239 . . . . 0.0 113.2 -176.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.69 13.82 0.55 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.773 2.429 . . . . 0.0 114.437 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.45 -86.39 0.14 Allowed Glycine 0 C--N 1.339 0.711 0 C-N-CA 125.645 1.593 . . . . 0.0 109.381 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.1 m -129.49 122.8 30.01 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -170.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -57.16 -61.86 6.3 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.025 0.93 . . . . 0.0 110.268 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.42 172.03 17.12 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.767 2.311 . . . . 0.0 111.149 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -63.95 170.44 8.86 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.241 1.961 . . . . 0.0 111.14 165.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -141.13 168.72 19.11 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.152 0.981 . . . . 0.0 110.071 -173.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.6 m -143.69 155.52 44.25 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.63 1.572 . . . . 0.0 107.353 -172.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.02 34.89 0.4 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.436 1.494 . . . . 0.0 114.324 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.31 -36.13 52.41 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.732 2.013 . . . . 0.0 111.5 -171.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -73.65 -39.38 64.52 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 118.198 -0.906 . . . . 0.0 112.197 -174.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -168.21 131.44 1.54 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.014 0.824 . . . . 0.0 110.42 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -155.51 83.42 1.04 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 159.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 pp -158.46 -38.71 0.06 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -168.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -160.31 177.37 10.69 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.722 1.146 . . . . 0.0 108.364 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -86.58 63.3 7.9 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 127.624 2.37 . . . . 0.0 109.687 -159.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -136.34 159.97 40.14 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 122.109 0.957 . . . . 0.0 113.088 172.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.23 154.64 25.53 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 128.558 2.98 . . . . 0.0 110.1 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.6 pt -140.07 174.7 7.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.724 1.21 . . . . 0.0 109.327 173.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -99.79 108.34 20.61 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.564 1.146 . . . . 0.0 110.285 -177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.54 122.96 20.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 158.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 40.5 t -72.16 90.39 1.21 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 158.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 17.1 tt -65.15 -21.42 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 121.984 -0.447 . . . . 0.0 111.092 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.3 t -72.66 -0.25 12.52 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.12 1.768 . . . . 0.0 111.859 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.7 p -143.82 9.5 1.54 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.427 1.012 . . . . 0.0 113.334 160.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.439 ' C ' ' HG1' ' A' ' 72' ' ' THR . . . 56.76 55.36 30.44 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.439 ' HG1' ' C ' ' A' ' 71' ' ' GLY . 49.2 m -151.95 179.08 8.77 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.75 -1.441 . . . . 0.0 108.467 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.5 141.27 48.7 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.135 1.374 . . . . 0.0 108.487 -163.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.283 0.0 OUTLIER -151.23 -89.55 0.06 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 177.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -54.29 151.65 7.17 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.263 1.025 . . . . 0.0 112.96 -170.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -126.32 150.75 48.31 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.743 1.217 . . . . 0.0 111.099 -166.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.4 t -59.94 -23.06 63.25 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.053 -1.451 . . . . 0.0 113.739 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -60.54 -19.69 57.98 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 120.953 1.706 . . . . 0.0 112.583 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . 0.253 2.2 t -119.65 -3.76 10.32 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.401 1.48 . . . . 0.0 111.035 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -96.51 94.45 7.38 Favored 'General case' 0 C--N 1.344 0.36 0 O-C-N 120.739 -1.226 . . . . 0.0 109.781 -175.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -63.22 127.33 30.78 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 163.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.441 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 1.7 t70 -147.13 -58.92 0.27 Allowed 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 127.474 2.31 . . . . 0.0 107.322 -163.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.8 m -51.89 111.78 0.67 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.519 1.527 . . . . 0.0 111.401 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.07 -43.19 0.64 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.333 1.92 . . . . 0.0 114.743 174.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.3 m -81.93 -72.0 0.46 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.041 1.336 . . . . 0.0 108.88 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 82' ' ' ASP . . . 48.46 45.24 29.21 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 126.467 1.984 . . . . 0.0 114.26 170.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.21 148.07 34.96 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 113.801 -1.199 . . . . 0.0 107.952 166.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.67 68.59 7.03 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.836 2.357 . . . . 0.0 110.574 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.6 p -139.02 150.16 45.5 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.703 1.201 . . . . 0.0 109.222 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -130.04 166.2 20.62 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.629 1.972 . . . . 0.0 107.779 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -123.57 -16.43 6.76 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.31 176.08 9.14 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.55 2.34 . . . . 0.0 106.073 175.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.9 p -145.5 155.86 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 121.681 -0.637 . . . . 0.0 110.982 -168.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 p -60.93 -36.27 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.397 1.479 . . . . 0.0 111.501 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.5 m 140.21 151.84 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 1 C-N-CA 131.794 4.038 . . . . 0.0 108.113 -169.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -75.9 52.17 0.68 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.981 1.712 . . . . 0.0 111.021 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -105.63 -49.1 3.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.274 1.029 . . . . 0.0 109.593 -167.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -125.26 22.97 7.73 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.526 1.13 . . . . 0.0 111.346 165.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.03 125.52 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 163.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.47 148.97 25.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.996 2.118 . . . . 0.0 107.142 -178.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mp -134.58 160.6 37.57 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.576 1.151 . . . . 0.0 108.752 167.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -133.57 130.12 37.97 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 131.336 3.854 . . . . 0.0 102.903 162.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -66.07 140.63 58.26 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.4 0.619 . . . . 0.0 109.592 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -142.69 171.86 13.48 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 103.808 -2.664 . . . . 0.0 103.808 158.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -130.74 18.93 5.13 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.561 2.344 . . . . 0.0 110.281 -173.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 t -54.64 -38.35 66.78 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 128.332 2.653 . . . . 0.0 113.702 -159.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.0 pp -75.69 -8.38 56.68 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.16 4.06 41.43 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.338 1.446 . . . . 0.0 112.55 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 97.2 mtp -140.14 -99.17 0.15 Allowed 'General case' 0 C--N 1.346 0.43 0 CA-C-N 119.382 1.591 . . . . 0.0 107.915 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -143.97 100.98 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.272 0 CA-C-N 120.733 1.606 . . . . 0.0 108.225 -173.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -114.54 61.36 0.67 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.071 1.348 . . . . 0.0 111.085 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 46.7 m -70.07 137.7 51.44 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -64.58 158.32 24.61 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.95 0.796 . . . . 0.0 110.591 173.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.8 t -139.22 102.21 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -132.2 160.17 36.88 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.3 m -70.97 128.24 35.31 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -72.61 -18.84 61.56 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -169.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -78.87 -38.17 38.39 Favored 'General case' 0 CA--C 1.525 0.012 0 C-N-CA 126.483 1.913 . . . . 0.0 111.794 168.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 23.9 p -146.51 89.66 1.87 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.501 1.521 . . . . 0.0 107.846 -166.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.18 55.27 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.323 2.649 . . . . 0.0 112.127 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -74.76 -77.26 0.12 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -158.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.436 ' H ' ' CD2' ' A' ' 123' ' ' LEU . 55.4 t-80 -138.14 -73.19 0.41 Allowed 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.436 ' CD2' ' H ' ' A' ' 122' ' ' HIS . 1.9 mm? 56.83 -112.74 0.71 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.808 2.043 . . . . 0.0 108.228 169.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.72 -126.95 1.27 Allowed Glycine 0 CA--C 1.526 0.72 0 CA-C-N 119.504 1.047 . . . . 0.0 113.959 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -155.59 172.91 17.48 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.349 0.659 . . . . 0.0 111.227 -174.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.1 p -114.3 144.41 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 C-N-CA 124.516 1.126 . . . . 0.0 108.024 170.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -144.89 157.9 43.99 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.191 0.996 . . . . 0.0 110.627 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.15 102.34 2.48 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.378 1.871 . . . . 0.0 109.155 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -165.74 -48.7 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.335 1.054 . . . . 0.0 111.348 -171.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -66.18 173.08 24.81 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 123.173 0.416 . . . . 0.0 112.909 -173.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.42 168.26 24.77 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.698 2.266 . . . . 0.0 111.77 -171.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -61.06 151.44 75.09 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 161.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.44 -42.23 0.84 Allowed 'Cis proline' 0 C--N 1.345 0.383 0 CA-C-N 119.999 1.035 . . . . 0.0 114.655 16.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.3 p -77.29 -30.04 54.05 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -168.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.48 13.55 82.8 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 118.77 0.714 . . . . 0.0 113.767 -174.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -128.71 154.56 46.21 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 119.172 1.486 . . . . 0.0 111.029 -171.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.3 ttm105 -120.82 106.19 11.43 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -71.99 126.98 31.14 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 160.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 23.6 t -135.82 126.85 27.84 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.607 1.094 . . . . 0.0 108.184 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -145.65 147.48 32.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.279 0.632 . . . . 0.0 109.632 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -140.89 130.36 23.88 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.2 p -168.98 174.66 6.22 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.686 1.594 . . . . 0.0 107.941 167.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.91 -9.15 8.72 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.301 1.04 . . . . 0.0 112.972 167.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.27 -20.43 63.05 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.692 1.197 . . . . 0.0 114.202 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.2 mt -83.12 74.38 10.0 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.112 0.869 . . . . 0.0 111.333 -161.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -98.3 119.16 36.49 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.045 0.938 . . . . 0.0 110.006 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.18 147.14 53.77 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.961 0.41 . . . . 0.0 110.192 164.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.7 pt -140.89 170.22 9.92 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 126.516 1.926 . . . . 0.0 108.42 162.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -54.86 177.19 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.541 3.494 . . . . 0.0 113.184 159.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.5 mmt-85 -32.39 -45.42 0.11 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.726 2.411 . . . . 0.0 115.989 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -165.42 -71.85 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.577 0.751 . . . . 0.0 108.988 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.9 9.19 0.77 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.906 1.282 . . . . 0.0 112.799 -176.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.5 pp -67.85 -30.68 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -169.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 CA-C-O 117.191 -1.894 . . . . 0.0 109.478 -175.711 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.2 mmt . . . . . 0 CA--C 1.536 0.414 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.27 31.24 0.39 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.853 0.861 . . . . 0.0 111.091 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -157.94 -174.4 4.82 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.779 1.232 . . . . 0.0 110.669 -158.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -103.74 178.08 4.66 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.213 1.805 . . . . 0.0 110.937 -162.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.418 ' HB ' HD22 ' A' ' 98' ' ' ASN . 47.2 pt -122.2 110.25 32.8 Favored Pre-proline 0 CA--C 1.536 0.435 0 O-C-N 120.715 -1.241 . . . . 0.0 110.842 -173.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.03 140.42 34.61 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.42 1.413 . . . . 0.0 109.016 171.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.406 ' HA ' ' HD1' ' A' ' 97' ' ' HIS . 46.6 mt -127.9 149.13 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 172.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -132.06 152.32 51.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -175.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.2 m -126.73 80.13 1.92 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 p -57.05 -39.2 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 123.005 0.522 . . . . 0.0 110.908 -169.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.75 2.81 3.74 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.333 1.053 . . . . 0.0 113.604 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -135.45 5.75 3.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.567 2.347 . . . . 0.0 110.274 171.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 34.09 42.6 0.06 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 128.375 2.67 . . . . 0.0 113.393 -162.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -87.09 161.99 17.82 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.315 -0.866 . . . . 0.0 108.995 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -135.96 132.19 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 167.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -133.83 107.05 7.64 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.868 1.667 . . . . 0.0 106.535 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 40.5 ttp -81.76 136.45 35.43 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.099 -1.001 . . . . 0.0 108.637 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.4 t -129.27 169.77 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.708 2.003 . . . . 0.0 106.067 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -99.95 152.82 19.73 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 120.526 -1.359 . . . . 0.0 110.37 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.402 ' CG ' ' HD3' ' A' ' 118' ' ' ARG . 25.0 ttm180 -68.18 137.2 54.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.02 1.728 . . . . 0.0 110.427 -168.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.2 tt -74.4 125.7 34.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.482 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.9 -170.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -154.37 110.67 3.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.9 mt -138.88 173.77 11.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.591 1.556 . . . . 0.0 109.256 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.63 159.02 21.66 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.042 2.137 . . . . 0.0 107.786 165.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.53 -35.09 76.75 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.562 -0.711 . . . . 0.0 112.607 -172.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.22 -28.62 65.41 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-O 121.051 0.453 . . . . 0.0 112.192 -174.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -59.72 -38.15 80.87 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.011 1.324 . . . . 0.0 110.048 -169.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -61.47 11.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.047 2.539 . . . . 0.0 116.61 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.89 -1.35 2.71 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 166.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -126.73 -20.59 4.25 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.825 -174.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 pt -109.13 -1.64 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.635 0.652 . . . . 0.0 111.704 165.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -101.72 163.72 12.11 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.306 1.042 . . . . 0.0 110.573 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.96 142.62 79.22 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.371 0.668 . . . . 0.0 109.772 168.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -65.84 -16.53 53.3 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.02 1.813 . . . . 0.0 111.453 166.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -71.57 -42.9 67.22 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 121.982 -0.449 . . . . 0.0 110.014 169.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.6 -44.47 96.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 121.225 -0.922 . . . . 0.0 109.912 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -56.8 -45.24 82.32 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.144 0.978 . . . . 0.0 112.336 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -76.44 -49.26 17.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -176.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 74.0 t -54.54 -33.41 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 125.156 1.382 . . . . 0.0 108.685 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.01 -18.95 63.88 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.44 -26.39 14.47 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.244 1.384 . . . . 0.0 112.192 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -108.86 -1.37 19.22 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 124.575 1.15 . . . . 0.0 112.779 -172.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.18 -2.4 0.05 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.18 2.592 . . . . 0.0 115.059 -169.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.55 -66.51 0.2 Allowed Glycine 0 C--N 1.339 0.744 0 CA-C-N 119.417 1.008 . . . . 0.0 111.94 174.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.8 t -144.05 141.87 30.33 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 168.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -57.58 -48.65 96.88 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.31 -1.329 . . . . 0.0 114.207 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.43 165.77 30.64 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 CA-C-N 121.823 1.687 . . . . 0.0 111.033 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.96 152.32 77.02 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.165 1.243 . . . . 0.0 110.061 173.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -74.93 46.95 0.32 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.121 1.368 . . . . 0.0 111.808 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 36.1 p -75.54 78.6 2.56 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.855 -1.153 . . . . 0.0 109.284 175.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.59 144.2 10.52 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 173.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.56 114.1 3.21 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -142.3 144.95 33.49 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 169.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -158.65 163.64 36.72 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 174.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -146.72 -111.5 0.09 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 165.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.04 -178.35 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.874 2.07 . . . . 0.0 112.918 163.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -39.43 137.11 0.84 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.624 2.37 . . . . 0.0 111.883 175.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -57.78 170.52 0.59 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 128.391 2.676 . . . . 0.0 112.721 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -132.56 168.54 18.06 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 166.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.53 168.41 28.82 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 125.116 1.341 . . . . 0.0 112.167 161.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.6 pt -135.35 164.21 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 113.587 -1.307 . . . . 0.0 108.091 163.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -78.27 122.57 25.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.634 0.73 . . . . 0.0 109.306 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.79 117.48 23.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.234 1.814 . . . . 0.0 106.377 163.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 5.2 t -71.38 69.72 0.58 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.455 1.502 . . . . 0.0 108.746 171.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.4 tt -61.46 -19.39 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 125.512 1.525 . . . . 0.0 112.754 -169.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.1 t -70.89 -1.0 10.36 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.267 1.427 . . . . 0.0 112.617 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 9.6 p -146.19 -7.57 0.54 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.494 1.043 . . . . 0.0 113.246 158.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.9 -8.28 59.45 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.207 -1.329 . . . . 0.0 113.032 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.2 m -64.34 171.79 2.9 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.483 2.713 . . . . 0.0 111.137 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.93 152.43 51.08 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.767 1.627 . . . . 0.0 107.9 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.401 HD13 ' CD2' ' A' ' 75' ' ' PHE 0.28 0.3 OUTLIER -155.34 -98.85 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 178.996 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.401 ' CD2' HD13 ' A' ' 74' ' ' LEU . 28.2 m-85 -61.51 132.42 53.34 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.489 1.041 . . . . 0.0 113.723 -158.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.46 136.6 36.97 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.52 1.128 . . . . 0.0 110.805 173.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 58.7 m -53.02 -33.6 52.48 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.448 1.099 . . . . 0.0 113.527 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.7 -17.48 63.02 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.147 0.979 . . . . 0.0 113.235 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.4 p -76.23 -23.31 54.53 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 121.705 -0.622 . . . . 0.0 112.037 172.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 87' ' ' TRP . 1.3 mtpt -86.96 -169.81 2.79 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.524 1.53 . . . . 0.0 109.806 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -133.18 32.78 3.68 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.847 0.859 . . . . 0.0 113.051 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -54.96 -21.97 13.53 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.407 1.483 . . . . 0.0 112.424 166.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.0 p -66.54 58.67 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.293 2.237 . . . . 0.0 110.802 165.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.95 -32.91 2.8 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.555 1.55 . . . . 0.0 113.615 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.3 m -131.3 -60.41 0.95 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.549 1.674 . . . . 0.0 112.449 -167.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.08 7.29 87.25 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 115.586 0.994 . . . . 0.0 115.586 177.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.412 ' O ' ' HE3' ' A' ' 80' ' ' LYS . 2.8 t90 -67.01 144.9 98.76 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 118.44 1.12 . . . . 0.0 109.147 173.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.48 64.32 6.45 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.207 3.271 . . . . 0.0 112.393 -173.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 61.5 p -133.52 141.64 47.84 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.052 1.741 . . . . 0.0 108.983 173.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.83 168.22 19.14 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.82 1.648 . . . . 0.0 109.208 -175.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -129.4 -9.14 4.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -146.23 175.42 10.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 169.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.81 155.7 27.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 122.232 1.015 . . . . 0.0 111.682 -167.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.76 -36.44 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.898 1.679 . . . . 0.0 111.634 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.2 m 151.04 160.08 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 131.295 3.838 . . . . 0.0 108.642 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -77.26 66.54 3.05 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.151 0.98 . . . . 0.0 108.591 168.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.406 ' HD1' ' HA ' ' A' ' 10' ' ' ILE . 18.6 p80 -109.17 -54.05 2.58 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.163 0.585 . . . . 0.0 110.114 -173.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.418 HD22 ' HB ' ' A' ' 8' ' ' ILE . 1.0 OUTLIER -133.75 23.49 3.96 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 174.336 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.52 138.31 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 125.813 1.645 . . . . 0.0 106.708 172.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -105.35 137.22 43.49 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 127.251 2.22 . . . . 0.0 109.061 -174.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mp -136.71 153.42 50.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.197 1.799 . . . . 0.0 111.101 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -143.88 129.56 19.23 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 131.43 3.892 . . . . 0.0 104.332 164.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -62.18 145.44 53.46 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.559 1.144 . . . . 0.0 110.421 166.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -150.34 175.7 11.58 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 158.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.08 20.22 13.87 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.026 1.33 . . . . 0.0 110.917 175.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.9 m -64.68 26.89 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 129.803 3.241 . . . . 0.0 116.654 -169.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 pp -130.85 -7.29 3.99 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.086 1.354 . . . . 0.0 112.086 162.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.45 -1.73 32.66 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 117.08 -1.955 . . . . 0.0 113.09 -168.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.8 mtm -141.29 -87.59 0.17 Allowed 'General case' 0 C--N 1.35 0.599 0 CA-C-N 120.733 2.266 . . . . 0.0 109.442 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 49.1 t -145.92 113.78 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -123.63 94.36 4.22 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.001 1.72 . . . . 0.0 108.566 174.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 14.6 t -105.91 129.27 54.09 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -174.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -64.44 160.08 19.99 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.114 0.87 . . . . 0.0 112.119 -174.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.5 t -138.73 105.93 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -126.93 173.79 9.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.051 0.94 . . . . 0.0 108.607 170.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.5 t -70.18 149.02 47.96 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.165 -0.959 . . . . 0.0 109.161 165.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.07 -16.48 63.7 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.402 ' HD3' ' CG ' ' A' ' 23' ' ' ARG . 28.2 tpt85 -117.72 -70.07 0.81 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-O 118.27 -0.871 . . . . 0.0 113.243 170.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 17.0 p -68.13 18.72 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 118.664 2.838 . . . . 0.0 118.664 -158.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 61.79 -11.44 0.07 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.955 2.502 . . . . 0.0 116.464 166.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.48 150.12 40.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.924 0.89 . . . . 0.0 112.388 -163.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -33.39 -59.84 0.37 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 128.734 2.814 . . . . 0.0 113.224 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 45.52 -106.01 0.11 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.875 2.07 . . . . 0.0 109.365 -173.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.29 -119.56 0.69 Allowed Glycine 0 CA--C 1.522 0.491 0 CA-C-N 118.081 0.4 . . . . 0.0 112.209 171.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -163.84 172.27 14.29 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.166 0.586 . . . . 0.0 110.412 -172.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.413 HG23 ' HE2' ' A' ' 136' ' ' LYS . 3.5 p -115.45 139.54 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.423 1.489 . . . . 0.0 108.828 171.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -131.29 148.93 52.73 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.214 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.79 82.66 1.63 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.076 1.751 . . . . 0.0 109.991 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -156.51 -0.91 0.13 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.678 1.191 . . . . 0.0 112.682 -166.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.66 179.24 34.28 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 120.382 -1.449 . . . . 0.0 113.116 -169.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.44 158.84 53.14 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.707 2.272 . . . . 0.0 110.731 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 45.9 mtp85 -64.56 154.75 83.64 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 164.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.02 -41.49 0.96 Allowed 'Cis proline' 0 C--N 1.348 0.532 0 CA-C-N 119.922 1.008 . . . . 0.0 113.787 8.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.6 p -69.32 -30.08 68.06 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -168.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.94 3.88 75.71 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.817 0.722 . . . . 0.0 113.455 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.413 ' HE2' HG23 ' A' ' 126' ' ' VAL . 13.2 ptmt -123.27 152.66 41.14 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.458 1.629 . . . . 0.0 111.222 -166.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 27.3 ttm105 -125.56 99.07 5.85 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.968 1.707 . . . . 0.0 106.751 -177.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -70.06 139.17 52.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 163.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 35.1 t -143.66 140.49 30.11 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.5 1.12 . . . . 0.0 108.322 174.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -148.36 157.83 43.72 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.689 0.395 . . . . 0.0 111.312 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -155.96 126.45 6.75 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.599 1.56 . . . . 0.0 108.607 170.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 91.6 p -171.29 -179.8 2.75 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.214 1.406 . . . . 0.0 109.044 163.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.48 -17.17 43.31 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 165.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.79 8.93 0.76 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 120.694 1.588 . . . . 0.0 114.093 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.0 mt -115.6 69.47 0.73 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.63 1.172 . . . . 0.0 110.189 -164.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -97.52 129.69 44.66 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -75.55 145.62 41.11 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.575 0.625 . . . . 0.0 109.55 167.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 28.1 pt -138.13 168.06 17.6 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 126.256 1.823 . . . . 0.0 108.294 167.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -54.07 160.84 5.65 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.657 2.905 . . . . 0.0 112.124 163.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -47.69 -26.27 1.48 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -165.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' A' ' 152' ' ' GLN . 25.4 p-10 -161.45 -70.33 0.06 Allowed 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 128.728 2.811 . . . . 0.0 108.998 159.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.435 ' H ' ' CG ' ' A' ' 151' ' ' ASP . 44.9 mt-30 -148.97 7.58 0.72 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.881 2.472 . . . . 0.0 110.126 -173.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.7 pp -56.77 -24.47 19.72 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 C-N-CA 124.877 1.271 . . . . 0.0 113.938 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 CA-C-O 116.969 -2.017 . . . . 0.0 109.271 174.998 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -120.49 155.68 33.07 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 106.322 -1.732 . . . . 0.0 106.322 164.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -152.77 178.19 9.9 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.856 1.262 . . . . 0.0 109.081 -161.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -102.8 164.68 11.49 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 158.651 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.7 pt -128.9 117.64 19.39 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 125.831 1.652 . . . . 0.0 108.918 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.99 136.11 22.15 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.488 1.458 . . . . 0.0 108.403 166.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.1 mt -117.93 111.58 34.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -113.52 97.28 6.35 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.149 1.38 . . . . 0.0 108.488 -176.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -68.98 83.39 0.32 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.559 0.744 . . . . 0.0 109.234 170.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.4 p -55.07 -39.12 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 118.41 0.55 . . . . 0.0 111.159 -173.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -14.53 20.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.844 1.258 . . . . 0.0 113.98 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -126.64 2.87 6.81 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 126.318 1.847 . . . . 0.0 111.059 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 36.08 44.11 0.24 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.406 1.882 . . . . 0.0 111.665 -159.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.69 160.4 30.82 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 117.676 -1.609 . . . . 0.0 108.654 168.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.5 t -140.85 128.41 22.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 103.96 -2.607 . . . . 0.0 103.96 162.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -142.67 119.69 11.35 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.441 1.496 . . . . 0.0 107.62 169.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 28.9 ttp -83.58 142.98 30.45 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 172.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.5 t -140.94 177.23 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 129.42 3.088 . . . . 0.0 103.19 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 15.7 pt-20 -108.17 169.4 8.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 120.373 1.442 . . . . 0.0 114.052 174.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.406 HH21 ' CG ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -60.97 171.24 1.28 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.636 0.774 . . . . 0.0 110.038 176.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.32 131.63 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.553 1.141 . . . . 0.0 111.416 -169.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -157.15 99.97 1.83 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.829 0.851 . . . . 0.0 109.357 173.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.6 mt -143.9 169.48 17.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.428 2.291 . . . . 0.0 108.612 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.512 ' H ' ' CG ' ' A' ' 30' ' ' GLU . 0.7 OUTLIER -90.35 164.23 14.41 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 127.098 2.159 . . . . 0.0 109.878 176.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.22 57.9 1.52 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.382 1.087 . . . . 0.0 110.055 160.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.06 -12.06 0.22 Allowed 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 124.694 1.198 . . . . 0.0 111.869 158.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.512 ' CG ' ' H ' ' A' ' 27' ' ' SER . 45.0 mm-40 -81.92 -49.09 10.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.545 -0.722 . . . . 0.0 109.976 -170.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.441 ' CE3' ' CD1' ' A' ' 35' ' ' LEU . 62.5 m95 -60.72 9.37 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.45 1.9 . . . . 0.0 114.9 -175.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.481 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -130.68 -0.66 4.33 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.441 1.497 . . . . 0.0 114.879 177.286 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.97 -23.11 2.01 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.592 173.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 pt -103.33 16.96 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 119.306 0.957 . . . . 0.0 110.517 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.441 ' CD1' ' CE3' ' A' ' 31' ' ' TRP . 3.4 mt -139.67 160.16 40.5 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.078 0.951 . . . . 0.0 112.138 -174.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 2.4 m-20 -59.36 148.52 72.68 Favored Pre-proline 0 C--O 1.238 0.489 0 C-N-CA 124.353 1.061 . . . . 0.0 110.159 172.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -63.08 -18.37 64.79 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.749 1.633 . . . . 0.0 111.328 165.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -72.21 -50.68 25.67 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 119.323 -0.37 . . . . 0.0 110.119 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.445 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -58.14 -44.17 87.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 119.068 0.849 . . . . 0.0 110.509 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -53.95 -51.84 62.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.034 1.334 . . . . 0.0 111.911 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.1 ptt180 -68.72 -51.11 45.01 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.376 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.7 t -61.15 -28.63 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 118.805 -0.617 . . . . 0.0 109.664 -170.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.5 -17.64 64.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -107.41 -32.37 7.77 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.435 1.016 . . . . 0.0 112.346 174.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.429 ' HD3' ' H ' ' A' ' 49' ' ' GLU . 17.0 ptpt -103.74 0.35 30.38 Favored 'General case' 0 C--N 1.343 0.292 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -174.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.29 45.57 7.28 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.031 1.332 . . . . 0.0 111.819 -170.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.87 -69.22 0.27 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 168.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.5 t -141.75 117.59 10.48 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -175.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.429 ' H ' ' HD3' ' A' ' 45' ' ' LYS . 35.1 mt-10 -55.76 -57.49 21.17 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.929 170.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -83.95 160.58 13.83 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.919 1.746 . . . . 0.0 110.906 -172.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.75 66.23 5.8 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.504 2.803 . . . . 0.0 110.617 172.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -140.69 165.14 28.31 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.116 1.366 . . . . 0.0 108.787 170.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.3 p -126.47 160.9 29.23 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.726 1.21 . . . . 0.0 110.257 -173.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -169.52 113.83 0.53 Allowed Glycine 0 C--N 1.335 0.477 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.33 167.18 22.65 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -137.07 123.39 20.65 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -167.44 175.13 7.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 128.327 2.651 . . . . 0.0 106.107 167.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -136.72 -89.78 0.27 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 171.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.5 pp -143.3 126.28 16.3 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.895 1.278 . . . . 0.0 108.213 163.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.91 161.52 42.54 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.991 0.916 . . . . 0.0 112.264 177.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -138.7 87.73 2.24 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 158.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -150.34 -179.94 7.61 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 166.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.75 -171.72 39.78 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 124.115 0.864 . . . . 0.0 112.644 171.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.2 pt -140.49 179.04 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 158.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -89.1 147.65 24.11 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.061 -1.024 . . . . 0.0 110.726 169.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -120.39 141.99 49.6 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.978 0.894 . . . . 0.0 111.207 158.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 25.5 t -92.6 93.96 8.79 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 113.48 -1.691 . . . . 0.0 107.214 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.2 tt -63.32 -29.81 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 123.861 0.864 . . . . 0.0 111.322 -164.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.9 m -77.44 0.53 22.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.118 1.767 . . . . 0.0 112.503 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 6.6 p -132.0 -10.41 3.4 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.242 1.017 . . . . 0.0 112.92 163.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.7 6.13 84.49 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.002 1.286 . . . . 0.0 112.71 -172.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.2 m -106.17 132.1 52.63 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 118.442 1.121 . . . . 0.0 109.887 -164.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -75.92 165.23 25.29 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.325 1.85 . . . . 0.0 112.967 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 177.23 -171.96 0.1 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 129.048 2.939 . . . . 0.0 108.775 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 27.3 95.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 129.964 3.305 . . . . 0.0 116.109 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.55 150.43 43.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.328 1.051 . . . . 0.0 111.692 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.6 m -62.19 -24.14 67.04 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -174.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.18 -16.99 63.75 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.3 t -98.64 -9.68 24.38 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.7 -0.625 . . . . 0.0 111.293 169.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.517 ' HE2' ' H ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -84.48 179.1 7.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.12 1.368 . . . . 0.0 108.682 172.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.517 ' H ' ' HE2' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -141.24 -173.57 3.78 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.013 1.725 . . . . 0.0 107.618 174.537 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -158.82 -86.97 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -158.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.6 t -58.39 129.96 44.51 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 166.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.48 -87.68 0.52 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.8 m -81.96 50.06 1.49 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.405 1.097 . . . . 0.0 111.408 -175.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.37 32.23 3.65 Favored Glycine 0 CA--C 1.524 0.649 0 O-C-N 120.025 -1.672 . . . . 0.0 112.07 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -122.33 166.68 16.31 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.764 2.026 . . . . 0.0 108.557 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.32 71.44 6.76 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.559 2.173 . . . . 0.0 113.752 -160.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.6 p -136.86 162.09 34.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.827 1.251 . . . . 0.0 111.236 166.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -145.19 178.45 8.06 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.922 2.489 . . . . 0.0 109.471 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -128.61 -4.64 5.29 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -157.78 178.81 9.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.119 2.167 . . . . 0.0 108.146 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.0 t -134.14 151.09 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 119.182 0.901 . . . . 0.0 110.846 -168.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 p -55.01 -47.4 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.349 1.86 . . . . 0.0 111.546 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.3 m 165.22 170.24 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 131.069 3.748 . . . . 0.0 106.593 -174.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -90.4 97.15 11.01 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 159.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.433 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 11.0 p80 -131.08 -60.36 0.96 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.292 0.637 . . . . 0.0 110.804 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.433 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 30.2 m120 -115.47 18.74 15.83 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.087 1.355 . . . . 0.0 111.388 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.3 tt -130.64 163.93 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.117 2.567 . . . . 0.0 106.98 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.415 ' HD3' ' N ' ' A' ' 101' ' ' LEU . 2.7 tmtm? -135.96 128.79 31.1 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.137 0.975 . . . . 0.0 109.028 174.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.415 ' N ' ' HD3' ' A' ' 100' ' ' LYS . 1.7 mp -114.15 143.95 43.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.792 2.837 . . . . 0.0 111.256 176.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.27 113.85 8.25 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.102 1.761 . . . . 0.0 109.107 168.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -81.31 125.22 30.08 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.423 0.689 . . . . 0.0 111.498 -176.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 105' ' ' ARG . 38.7 t0 -130.62 -175.99 3.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.501 1.921 . . . . 0.0 108.753 172.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.436 ' H ' ' CG ' ' A' ' 104' ' ' ASP . 0.0 OUTLIER -111.95 19.62 17.72 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.518 1.527 . . . . 0.0 111.477 177.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.45 20.73 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 129.102 2.961 . . . . 0.0 118.155 -165.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.6 pp -132.06 -2.17 3.63 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.821 -1.174 . . . . 0.0 112.253 167.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.4 8.68 56.11 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 117.871 -1.516 . . . . 0.0 112.851 -168.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 16.1 tpt -142.23 -92.13 0.13 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 119.867 1.834 . . . . 0.0 108.507 174.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 81.5 t -143.01 114.77 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.401 ' HE ' ' CD2' ' A' ' 125' ' ' HIS . 14.1 ttt180 -119.09 113.8 21.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.646 1.178 . . . . 0.0 108.183 169.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.443 ' HB3' ' CG1' ' A' ' 126' ' ' VAL . 31.5 t -106.15 122.33 45.97 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.03 151.03 44.06 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 172.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 75.6 t -136.46 111.49 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 C-N-CA 125.016 1.326 . . . . 0.0 107.572 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 mp -127.8 164.97 21.02 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.28 1.032 . . . . 0.0 109.195 175.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 18.1 t -71.88 154.2 41.39 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.445 -0.785 . . . . 0.0 109.3 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -82.96 -20.96 34.21 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 122.055 -0.403 . . . . 0.0 112.05 172.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.22 -42.79 3.46 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.639 1.176 . . . . 0.0 112.496 -162.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 27.9 p -123.54 81.08 1.86 Allowed 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 167.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.406 ' CG ' HH21 ' A' ' 23' ' ' ARG . 0.4 OUTLIER -60.49 40.77 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.014 1 C-N-CA 132.533 4.333 . . . . 0.0 114.888 -163.909 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.21 -174.44 3.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.154 2.582 . . . . 0.0 112.434 -170.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -30.4 -70.11 0.06 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 130.012 3.325 . . . . 0.0 114.716 -164.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 mt 42.16 -111.13 0.15 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.277 2.231 . . . . 0.0 109.984 -170.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.59 -114.26 0.46 Allowed Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 118.884 0.765 . . . . 0.0 112.623 171.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.401 ' CD2' ' HE ' ' A' ' 111' ' ' ARG . 56.4 p-80 -164.76 179.08 6.77 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.826 0.45 . . . . 0.0 110.298 -170.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' A' ' 112' ' ' CYS . 2.7 p -124.49 144.93 32.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 124.795 1.238 . . . . 0.0 108.463 167.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -131.48 147.23 52.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 124.109 0.881 . . . . 0.0 109.566 175.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -65.89 115.35 5.89 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.01 -34.36 0.15 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -171.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -83.91 172.32 49.7 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -174.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.7 -84.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.685 2.256 . . . . 0.0 110.353 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.62 169.53 9.88 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 129.062 2.945 . . . . 0.0 104.887 176.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.3 -54.49 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.629 0 CA-C-N 121.572 1.597 . . . . 0.0 111.93 -2.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.8 p -69.35 -25.61 64.28 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.37 0.668 . . . . 0.0 112.442 -174.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 68.22 10.77 60.28 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.895 0.76 . . . . 0.0 113.453 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -130.29 158.57 39.42 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 119.281 1.54 . . . . 0.0 111.561 -169.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.83 103.36 7.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.941 1.696 . . . . 0.0 108.499 -175.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -73.15 135.28 44.65 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 168.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 27.0 t -142.19 133.58 26.47 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.707 1.203 . . . . 0.0 108.5 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 6.9 ptm -133.16 156.25 47.81 Favored 'General case' 0 CA--C 1.528 0.098 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -137.4 97.82 3.56 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.5 m -157.74 158.38 35.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 173.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -77.22 -30.19 54.49 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.07 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.46 54.17 0.57 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.863 2.065 . . . . 0.0 113.183 -170.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.8 mt -120.0 63.59 0.83 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.014 0.926 . . . . 0.0 108.73 -176.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -79.63 101.84 8.57 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -57.8 133.8 55.72 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 165.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.3 pt -136.99 165.72 32.72 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.567 1.147 . . . . 0.0 108.888 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.32 170.94 2.71 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.484 2.123 . . . . 0.0 111.38 162.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -50.09 -11.51 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 128.814 2.846 . . . . 0.0 118.185 -166.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.4 t0 177.31 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 128.675 2.79 . . . . 0.0 107.296 159.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.32 11.89 0.63 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.962 2.105 . . . . 0.0 112.0 -174.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -71.71 -11.58 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 O-C-N 121.186 -0.946 . . . . 0.0 112.328 173.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.543 0 C-N-CA 127.888 2.661 . . . . 0.0 106.532 159.199 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.9 ttp . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 119.07 -0.49 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -133.51 109.02 8.98 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 176.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.87 173.73 11.24 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -159.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -137.22 160.91 37.64 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.024 2.13 . . . . 0.0 105.571 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.8 pt -136.24 137.28 24.17 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.147 0.979 . . . . 0.0 111.431 -171.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.12 114.31 3.88 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.51 2.14 . . . . 0.0 110.342 170.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.5 mm -87.64 132.29 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 159.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -132.28 96.09 3.8 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 -175.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 m -68.56 61.26 0.09 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 167.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.8 t -52.21 -36.67 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 120.863 -1.148 . . . . 0.0 109.486 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.54 -18.52 65.06 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.83 -174.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -108.53 1.98 21.87 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 129.812 3.245 . . . . 0.0 111.581 169.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.0 t30 37.7 61.57 1.0 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.046 2.538 . . . . 0.0 113.164 -158.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.98 169.11 11.49 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.765 1.226 . . . . 0.0 108.949 169.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -148.39 124.35 2.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 126.401 1.88 . . . . 0.0 106.305 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -144.19 95.15 2.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.032 1.333 . . . . 0.0 107.948 -173.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 12.1 ttt -69.63 137.62 52.39 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.513 -1.367 . . . . 0.0 109.968 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.9 t -135.08 160.02 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.049 1.34 . . . . 0.0 107.385 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -68.22 155.76 39.02 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.045 -1.659 . . . . 0.0 110.961 170.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.532 HH12 ' CD ' ' A' ' 25' ' ' GLU . 41.6 ptt85 -74.93 154.11 38.3 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 121.749 -0.594 . . . . 0.0 109.421 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.61 134.53 25.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.532 ' CD ' HH12 ' A' ' 23' ' ' ARG . 0.3 OUTLIER -162.52 123.56 2.54 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 102.008 -3.33 . . . . 0.0 102.008 159.029 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.1 mt -140.49 -178.96 5.75 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.963 1.705 . . . . 0.0 106.821 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.1 t -161.58 -10.94 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -118.94 -144.22 0.37 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.58 1.082 . . . . 0.0 110.211 -172.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.24 3.02 0.69 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.603 1.161 . . . . 0.0 113.281 175.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -59.47 -46.5 88.6 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 125.994 1.718 . . . . 0.0 110.974 -163.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -69.29 45.64 0.06 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.32 2.248 . . . . 0.0 112.344 174.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.67 -36.25 0.05 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.084 2.154 . . . . 0.0 109.915 159.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -84.68 -25.85 28.16 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.109 -0.948 . . . . 0.0 112.309 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 pt -109.67 18.69 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 119.773 1.17 . . . . 0.0 112.176 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.51 174.91 10.74 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.478 1.111 . . . . 0.0 110.875 -169.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.91 141.78 96.96 Favored Pre-proline 0 C--O 1.237 0.417 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 169.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -68.57 -14.53 39.81 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.744 2.296 . . . . 0.0 111.589 171.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -79.14 -44.04 22.79 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 122.999 0.52 . . . . 0.0 109.97 168.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.98 -39.7 90.62 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.58 1.082 . . . . 0.0 110.64 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -46.9 -58.29 4.09 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.953 2.101 . . . . 0.0 111.175 171.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -72.73 -42.06 64.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.883 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.5 t -52.56 -35.36 20.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 124.595 1.158 . . . . 0.0 110.405 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.71 -8.78 11.29 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -116.23 -38.68 3.53 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.376 0.989 . . . . 0.0 111.936 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -87.15 9.43 20.02 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.304 0.956 . . . . 0.0 113.151 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.58 -36.62 0.23 Allowed 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 129.143 2.977 . . . . 0.0 113.636 -167.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 177.63 -73.4 0.07 OUTLIER Glycine 0 C--N 1.335 0.511 0 C-N-CA 127.023 2.249 . . . . 0.0 108.861 -166.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.7 p -132.9 127.89 35.35 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -47.04 -57.52 9.06 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.488 170.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.41 166.35 20.19 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.249 1.966 . . . . 0.0 110.962 166.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -74.64 58.01 4.5 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.806 3.004 . . . . 0.0 111.001 169.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -75.26 88.61 2.53 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.187 -0.946 . . . . 0.0 109.436 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.3 m -68.26 73.46 0.21 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.801 1.241 . . . . 0.0 109.935 171.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.98 72.26 0.71 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.437 1.494 . . . . 0.0 110.929 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -73.97 65.09 1.06 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.121 1.368 . . . . 0.0 110.953 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -70.14 78.16 0.51 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.344 1.457 . . . . 0.0 109.069 174.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -89.18 2.62 53.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.621 1.569 . . . . 0.0 114.292 -165.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -73.55 148.67 42.79 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.917 0.78 . . . . 0.0 110.669 -174.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.6 mt -149.67 96.58 2.5 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 127.359 2.264 . . . . 0.0 105.163 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -126.92 -74.56 0.59 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.105 0.962 . . . . 0.0 109.641 -166.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -78.03 -178.28 5.47 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.334 1.854 . . . . 0.0 109.606 164.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -69.76 167.95 16.05 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.874 -0.516 . . . . 0.0 111.8 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.39 162.83 12.82 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.875 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.5 pt -143.51 175.21 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 126.274 1.829 . . . . 0.0 109.131 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -93.35 122.51 35.84 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.295 0.569 . . . . 0.0 111.934 173.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.91 115.05 21.61 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 158.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.8 t -70.55 94.53 0.99 Allowed 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 166.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 tt -58.85 -33.0 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.599 1.16 . . . . 0.0 111.155 -165.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.4 t -82.48 5.14 21.62 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.949 1.3 . . . . 0.0 111.891 -169.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.72 18.63 1.83 Allowed 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.43 -0.794 . . . . 0.0 111.557 158.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.7 25.83 56.41 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 123.343 0.497 . . . . 0.0 112.744 174.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.4 m -120.55 124.54 45.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.863 1.265 . . . . 0.0 108.021 -164.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -64.63 145.27 56.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.408 1.083 . . . . 0.0 111.448 170.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.455 HD22 ' H ' ' A' ' 75' ' ' PHE 0.281 0.0 OUTLIER -148.88 -107.42 0.08 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.953 160.657 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.455 ' H ' HD22 ' A' ' 74' ' ' LEU . 19.4 m-85 -54.38 127.15 26.16 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.307 1.443 . . . . 0.0 112.416 -159.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -89.47 150.54 22.43 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.223 1.009 . . . . 0.0 109.494 -176.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.1 m -59.47 -26.83 65.57 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.088 172.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -70.1 -17.78 63.23 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.914 1.234 . . . . 0.0 112.449 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.8 p -96.44 -22.86 16.88 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.809 1.244 . . . . 0.0 112.196 170.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.472 ' HE2' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -125.56 79.09 1.79 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.566 1.946 . . . . 0.0 107.653 -170.482 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -127.43 118.64 24.45 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -135.68 163.65 29.67 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 104.71 -2.329 . . . . 0.0 104.71 159.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.6 t -136.48 135.89 38.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.385 0.993 . . . . 0.0 109.785 -164.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.99 -53.28 1.36 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -164.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.92 -68.96 0.28 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.26 1.424 . . . . 0.0 110.021 168.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 53.7 12.31 2.43 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 126.177 1.846 . . . . 0.0 116.225 -170.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -51.19 155.04 2.44 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 127.021 2.128 . . . . 0.0 112.307 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -73.55 68.09 4.49 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.864 3.042 . . . . 0.0 111.532 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.2 p -131.04 143.76 50.94 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.238 1.415 . . . . 0.0 108.508 167.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.92 160.22 38.97 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.659 1.584 . . . . 0.0 108.035 -171.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -123.27 7.04 9.08 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.453 -171.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -159.61 176.65 11.77 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 159.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -100.64 157.91 4.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 119.1 0.864 . . . . 0.0 110.268 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.3 p -66.25 -45.63 89.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 169.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.6 m -179.81 161.46 0.98 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 129.73 3.212 . . . . 0.0 106.714 167.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -76.74 56.99 1.22 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.03 1.732 . . . . 0.0 110.085 175.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.426 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 9.9 p80 -111.56 -61.51 1.69 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.629 0.772 . . . . 0.0 109.251 -168.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.426 ' H ' ' CG ' ' A' ' 97' ' ' HIS 0.25 0.8 OUTLIER -113.09 21.23 15.57 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 175.48 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.8 tt -111.74 153.21 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 167.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -122.22 145.26 48.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.482 1.113 . . . . 0.0 108.815 169.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.5 mt -149.52 133.34 16.96 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 128.87 2.868 . . . . 0.0 108.602 -159.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.56 101.9 4.47 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 129.105 2.962 . . . . 0.0 108.503 168.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -73.8 143.8 45.84 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.604 0.762 . . . . 0.0 111.899 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -154.94 178.0 10.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 129.407 3.083 . . . . 0.0 107.989 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.13 25.12 9.84 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 120.366 -1.459 . . . . 0.0 113.135 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.45 19.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -166.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.14 2.03 2.76 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.985 -1.072 . . . . 0.0 112.449 165.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.05 -3.55 51.9 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.061 -1.41 . . . . 0.0 113.042 -169.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -139.11 -98.32 0.17 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.416 1.608 . . . . 0.0 109.175 -174.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.6 m -135.12 110.28 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.412 ' HE ' ' CD2' ' A' ' 125' ' ' HIS . 4.8 ttt180 -106.33 142.06 36.63 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 161.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.479 ' HB3' ' CG1' ' A' ' 126' ' ' VAL . 20.8 t -137.39 138.99 40.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 166.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -61.25 153.43 26.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 169.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.3 t -134.09 107.98 10.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -125.43 165.37 18.55 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 172.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 26.8 t -73.92 146.64 43.83 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 168.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.78 -45.46 86.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.745 -0.645 . . . . 0.0 109.337 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.3 tpt85 -84.41 -77.64 0.26 Allowed 'General case' 0 C--N 1.35 0.589 0 CA-C-O 116.257 -1.83 . . . . 0.0 111.775 162.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.6 p -78.34 75.32 4.87 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.859 1.209 . . . . 0.0 110.746 -158.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -59.76 77.22 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.509 1.924 . . . . 0.0 112.536 171.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.26 -155.62 0.45 Allowed 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 112.861 -1.972 . . . . 0.0 109.748 161.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -70.11 -60.6 2.19 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 125.525 1.53 . . . . 0.0 111.296 -168.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 50.24 -113.11 0.64 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.503 1.921 . . . . 0.0 108.511 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 174.11 -128.4 1.46 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 119.815 -1.183 . . . . 0.0 113.664 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.412 ' CD2' ' HE ' ' A' ' 111' ' ' ARG . 38.2 p-80 -157.78 175.65 13.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.01 0.524 . . . . 0.0 110.044 -174.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.479 ' CG1' ' HB3' ' A' ' 112' ' ' CYS . 3.0 p -122.06 143.86 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.288 1.435 . . . . 0.0 108.776 172.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -142.1 164.95 28.78 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.619 1.168 . . . . 0.0 111.516 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -72.06 102.93 3.11 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.468 1.907 . . . . 0.0 109.452 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -162.75 -50.8 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.709 2.004 . . . . 0.0 110.21 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -63.85 157.77 41.85 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 123.311 0.382 . . . . 0.0 112.29 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.12 177.64 8.5 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.651 2.234 . . . . 0.0 112.684 -169.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -50.19 145.62 9.63 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.792 159.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -84.55 -25.36 9.03 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 CA-C-N 119.462 0.844 . . . . 0.0 113.253 18.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.261 0.9 OUTLIER -107.46 -14.01 14.95 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.463 0.705 . . . . 0.0 112.18 -159.182 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.23 16.66 79.31 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 121.465 -0.772 . . . . 0.0 114.974 159.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -146.98 159.37 43.64 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 118.579 1.189 . . . . 0.0 110.486 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 ttm105 -119.56 108.88 15.04 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 126.052 1.741 . . . . 0.0 107.18 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -73.77 138.72 44.74 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 163.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 19.3 t -141.29 133.47 27.91 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.081 0.855 . . . . 0.0 108.74 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -130.18 105.11 7.71 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 122.15 0.976 . . . . 0.0 109.336 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -83.82 68.17 9.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 169.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 p -113.91 142.59 45.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.284 1.433 . . . . 0.0 110.463 -176.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.59 91.44 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.036 0.934 . . . . 0.0 111.907 170.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.73 16.74 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.44 2.696 . . . . 0.0 116.649 -160.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 87.9 mt -92.61 75.68 5.05 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.419 1.088 . . . . 0.0 111.275 -162.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -86.14 110.94 19.9 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -62.83 144.41 56.61 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 164.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 4.9 pt -142.79 169.6 10.45 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 126.179 1.792 . . . . 0.0 108.111 171.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -56.96 177.2 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.903 2.402 . . . . 0.0 111.142 159.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -50.93 8.56 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 119.867 3.284 . . . . 0.0 119.867 -172.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.7 t70 145.08 -72.85 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.159 1 C-N-CA 133.549 4.739 . . . . 0.0 107.308 163.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -154.69 43.02 0.49 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.172 2.589 . . . . 0.0 107.083 -176.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.3 pt -77.19 -19.73 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.076 -1.015 . . . . 0.0 110.562 161.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 1 C-N-CA 130.849 4.071 . . . . 0.0 105.832 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 59.7 ttm . . . . . 0 CA--C 1.528 0.129 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.9 mttp -155.69 144.59 20.56 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.871 0.869 . . . . 0.0 108.909 168.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.77 32.58 0.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 129.937 3.295 . . . . 0.0 111.337 -172.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 4.2 mtt180 -143.5 -172.42 3.71 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 126.405 1.882 . . . . 0.0 109.225 -171.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 pt -138.93 140.56 27.35 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.801 2.04 . . . . 0.0 109.665 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -80.78 143.0 14.47 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.062 2.508 . . . . 0.0 111.015 174.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.2 mm -135.86 122.02 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 125.816 1.647 . . . . 0.0 107.254 -168.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -132.47 98.51 4.39 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.905 0.775 . . . . 0.0 110.299 -165.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.5 m -69.73 74.84 0.43 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.827 0.851 . . . . 0.0 109.602 170.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.86 -39.24 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.686 1.194 . . . . 0.0 112.074 -174.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.67 -15.64 8.33 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.162 2.185 . . . . 0.0 113.724 175.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -133.1 15.58 4.19 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.738 2.415 . . . . 0.0 110.12 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 24.38 45.58 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 131.133 3.773 . . . . 0.0 114.375 -163.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.2 mtp-105 -90.95 171.63 9.15 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.003 175.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.0 p -140.34 154.4 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 158.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -144.35 170.99 14.96 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 127.984 2.514 . . . . 0.0 106.903 158.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 43.6 ttm -127.46 92.3 3.47 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.757 0.823 . . . . 0.0 109.499 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.6 t -77.16 155.94 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -79.13 174.24 11.77 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.06 -1.025 . . . . 0.0 112.476 175.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -77.86 163.24 26.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.533 0.733 . . . . 0.0 110.413 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.288 2.8 tp -89.15 69.12 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 123.324 1.535 . . . . 0.0 111.784 -169.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.9 89.87 3.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.018 1.727 . . . . 0.0 106.532 -173.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.8 mt -130.33 -176.21 3.88 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.107 2.163 . . . . 0.0 109.952 -175.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.0 t -112.91 162.66 15.58 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.741 1.617 . . . . 0.0 107.885 163.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -52.28 -36.89 54.06 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.14 0.882 . . . . 0.0 111.514 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -46.87 -34.63 5.57 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 129.25 3.02 . . . . 0.0 111.714 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -81.92 -46.88 13.45 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.193 1.797 . . . . 0.0 111.212 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -64.01 40.5 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 129.844 3.258 . . . . 0.0 113.503 -174.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -169.29 -18.68 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.166 2.187 . . . . 0.0 113.24 -170.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -127.24 -13.69 5.53 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.31 -0.852 . . . . 0.0 112.807 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pt -109.31 3.95 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 119.061 0.846 . . . . 0.0 111.906 170.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.3 mt -97.74 170.67 8.83 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.423 1.489 . . . . 0.0 111.014 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.18 144.73 90.95 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 159.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -63.64 -15.01 46.17 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.889 1.726 . . . . 0.0 111.761 166.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -70.94 -41.9 70.53 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 122.523 0.329 . . . . 0.0 110.587 170.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.55 -40.51 97.06 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.29 0.566 . . . . 0.0 109.914 -172.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -53.48 -52.61 59.0 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.576 1.15 . . . . 0.0 112.057 172.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -76.92 -47.07 22.07 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -172.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 p -62.52 -24.39 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.23 -9.51 32.97 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 115.157 1.539 . . . . 0.0 115.157 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.78 -41.28 2.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.881 1.219 . . . . 0.0 110.849 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.424 ' HB3' ' HE2' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -89.08 3.44 51.77 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.623 1.169 . . . . 0.0 113.317 176.346 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.33 2.44 0.09 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.16 2.584 . . . . 0.0 115.663 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.88 -71.4 0.02 OUTLIER Glycine 0 C--N 1.344 1.022 0 N-CA-C 118.242 2.057 . . . . 0.0 118.242 -163.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 t -158.12 156.53 31.11 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -73.76 162.62 73.31 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 158.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -70.53 152.66 65.46 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.012 1.808 . . . . 0.0 111.241 177.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.0 168.26 25.22 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.913 2.409 . . . . 0.0 110.889 172.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -139.99 172.14 13.19 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.618 1.567 . . . . 0.0 108.418 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.0 p -63.51 107.61 1.17 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.819 1.248 . . . . 0.0 109.28 175.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -171.08 -165.71 28.82 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 108.219 -1.952 . . . . 0.0 108.219 -177.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -138.09 160.29 39.77 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 117.706 0.753 . . . . 0.0 110.023 174.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -154.53 149.33 26.6 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 127.034 2.133 . . . . 0.0 105.791 168.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -154.84 171.72 19.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 158.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -144.83 -160.14 1.09 Allowed 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 163.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.29 39.1 0.66 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.523 1.129 . . . . 0.0 110.556 170.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.18 162.28 16.73 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.154 0.582 . . . . 0.0 112.17 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -149.32 62.56 1.03 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.62 1.968 . . . . 0.0 106.139 170.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -153.23 169.02 24.05 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.111 2.164 . . . . 0.0 106.187 -175.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.96 169.5 14.76 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.909 1.242 . . . . 0.0 112.63 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 35.0 pt -138.49 172.41 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.794 1.638 . . . . 0.0 110.427 -172.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -86.6 137.51 32.43 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.893 0.477 . . . . 0.0 111.207 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.51 121.06 44.17 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.671 1.188 . . . . 0.0 109.765 164.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 16.9 t -70.16 87.64 0.59 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.309 174.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 tt -52.89 -26.28 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -171.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.0 t -75.5 -0.86 21.7 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.838 0.855 . . . . 0.0 111.684 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.3 p -149.37 20.29 0.95 Allowed 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.69 -1.256 . . . . 0.0 111.926 161.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.1 -4.93 0.45 Allowed Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.565 1.555 . . . . 0.0 116.021 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.421 HG21 HD21 ' A' ' 98' ' ' ASN . 97.3 m -71.03 142.9 50.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.778 1.631 . . . . 0.0 109.577 -171.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -89.87 135.4 33.65 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.687 0.795 . . . . 0.0 111.739 165.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.326 0.0 OUTLIER -137.26 -92.91 0.23 Allowed 'General case' 0 C--N 1.344 0.336 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 178.17 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -61.59 118.01 6.51 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.554 0.615 . . . . 0.0 110.851 -165.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.5 152.41 44.03 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 168.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.3 m -55.94 -25.8 45.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.217 -1.373 . . . . 0.0 113.565 175.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.59 -25.17 64.38 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 121.426 1.921 . . . . 0.0 111.282 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.3 p -95.87 18.52 13.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.081 1.353 . . . . 0.0 112.129 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -151.27 35.57 0.58 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.82 1.248 . . . . 0.0 111.492 161.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -84.35 57.42 4.26 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.621 0.724 . . . . 0.0 111.421 -164.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -98.75 110.24 22.87 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.169 0.587 . . . . 0.0 109.988 -172.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.6 m -50.04 102.14 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.371 1.868 . . . . 0.0 112.951 -169.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.72 -49.69 3.95 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.6 1.095 . . . . 0.0 112.305 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.9 m -59.52 -45.88 90.46 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.246 1.018 . . . . 0.0 110.967 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 49.58 26.43 7.52 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 128.034 2.73 . . . . 0.0 115.12 171.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -56.81 147.52 52.65 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.237 1.015 . . . . 0.0 111.139 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -78.97 57.62 6.54 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.163 3.242 . . . . 0.0 110.126 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.1 p -160.6 121.28 2.9 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -172.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.88 -160.78 1.1 Allowed 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 124.455 1.102 . . . . 0.0 109.082 -172.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -115.75 4.8 14.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 118.429 0.559 . . . . 0.0 112.074 -161.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -155.35 -179.18 7.84 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.144 0.578 . . . . 0.0 110.359 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 m -137.02 167.17 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 127.287 2.235 . . . . 0.0 110.114 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.5 p -58.48 -51.1 75.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.52 1.128 . . . . 0.0 111.926 -178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.4 m 159.74 151.37 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 129.216 3.006 . . . . 0.0 108.038 -169.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -74.29 79.68 1.84 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.888 0.475 . . . . 0.0 109.842 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -118.92 -56.23 2.12 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.81 0.844 . . . . 0.0 110.919 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.421 HD21 HG21 ' A' ' 72' ' ' THR . 27.9 t-20 -128.28 33.07 4.77 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.14 0.976 . . . . 0.0 111.352 170.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.7 tt -118.78 144.29 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 163.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.426 ' HD3' ' H ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -127.81 141.07 51.67 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.889 1.276 . . . . 0.0 107.698 171.418 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.426 ' H ' ' HD3' ' A' ' 100' ' ' LYS . 1.8 mp -127.85 140.8 51.8 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.452 1.901 . . . . 0.0 107.629 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -120.86 125.68 48.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 171.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -106.9 126.94 52.96 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.237 0.615 . . . . 0.0 110.769 -167.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -132.45 178.59 6.71 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.714 2.006 . . . . 0.0 109.912 176.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -106.63 11.35 30.53 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.423 1.889 . . . . 0.0 112.992 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 m -46.9 -43.44 18.86 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.616 1.566 . . . . 0.0 115.182 -159.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 pp -68.5 -12.2 60.89 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.49 4.95 30.23 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 117.615 -1.659 . . . . 0.0 112.757 -169.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.2 ttp -147.88 -86.94 0.09 Allowed 'General case' 0 C--N 1.348 0.511 0 CA-C-N 120.258 2.029 . . . . 0.0 109.172 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.8 p -148.61 114.32 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -120.56 112.1 18.5 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.221 1.808 . . . . 0.0 107.822 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.01 134.79 54.89 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.41 165.67 23.29 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.495 1.043 . . . . 0.0 110.661 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.62 108.41 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mp -131.17 167.47 19.1 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 167.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.1 t -66.53 149.2 50.8 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.6 -17.4 59.21 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 44.8 tpt85 -111.74 -58.48 2.12 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 118.627 -0.701 . . . . 0.0 111.74 170.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.8 p -84.98 77.13 10.18 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.54 74.99 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.599 1.16 . . . . 0.0 110.01 172.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -97.61 -73.6 0.6 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.909 1.284 . . . . 0.0 112.323 -165.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.68 -80.95 0.17 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.54 1.136 . . . . 0.0 109.674 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt 45.56 -110.88 0.25 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.775 1.63 . . . . 0.0 111.15 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.95 -111.79 0.39 Allowed Glycine 0 C--N 1.332 0.318 0 CA-C-N 118.88 0.764 . . . . 0.0 112.843 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -164.02 -176.45 4.53 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -166.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.88 147.53 29.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 127.163 2.185 . . . . 0.0 108.632 169.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -137.91 143.41 40.81 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.98 0.912 . . . . 0.0 108.63 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.95 111.81 9.46 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -167.82 -45.35 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.977 2.111 . . . . 0.0 110.776 -160.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.31 178.38 38.13 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.391 0.996 . . . . 0.0 113.606 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.76 162.0 42.35 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.664 2.243 . . . . 0.0 111.883 -175.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -60.72 154.37 57.79 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 163.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.66 -42.9 0.71 Allowed 'Cis proline' 0 C--N 1.346 0.432 0 CA-C-N 120.812 1.326 . . . . 0.0 113.693 12.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.2 p -70.88 -30.59 67.0 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.41 10.2 84.5 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.302 -0.721 . . . . 0.0 112.682 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.85 164.01 28.22 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.906 1.353 . . . . 0.0 112.81 -166.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.86 106.89 7.98 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.858 1.663 . . . . 0.0 107.963 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -73.05 148.12 44.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.264 1.826 . . . . 0.0 107.235 167.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 49.7 t -156.16 115.79 3.57 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.399 1.479 . . . . 0.0 108.854 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.94 138.3 33.72 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 123.903 0.881 . . . . 0.0 109.771 -175.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -142.51 126.71 17.51 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.445 1.098 . . . . 0.0 109.416 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 85.2 p -162.7 176.63 10.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 167.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -53.6 -31.43 46.9 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.599 1.559 . . . . 0.0 112.065 163.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -87.62 47.8 1.55 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.237 1.415 . . . . 0.0 112.058 -175.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 88.1 mt -131.3 61.3 1.64 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.794 1.238 . . . . 0.0 108.31 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -88.56 127.09 35.54 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -68.59 144.87 54.38 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 169.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.3 pt -137.44 168.24 17.37 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 126.304 1.842 . . . . 0.0 108.765 171.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -57.87 174.07 0.71 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.78 1.653 . . . . 0.0 110.806 158.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 11.9 mtp85 -46.8 -33.71 4.67 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.126 1.771 . . . . 0.0 113.778 -172.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -151.8 -65.08 0.18 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.583 1.953 . . . . 0.0 108.156 158.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -151.85 1.97 0.37 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 129.546 3.138 . . . . 0.0 110.668 -171.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.7 pp -55.15 -29.94 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 119.665 1.12 . . . . 0.0 113.862 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 116.824 -2.098 . . . . 0.0 109.457 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.9 ptp . . . . . 0 C--O 1.239 0.531 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 7' ' ' ARG . 75.7 mmtt -58.51 164.87 2.39 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.27 1.028 . . . . 0.0 109.829 177.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -77.25 21.38 0.25 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 123.192 1.472 . . . . 0.0 114.379 -177.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.405 ' H ' ' C ' ' A' ' 5' ' ' LYS . 3.8 mtm180 -142.63 154.53 44.46 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 128.857 2.863 . . . . 0.0 106.724 -170.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 pt -131.38 107.69 14.67 Favored Pre-proline 0 C--N 1.324 -0.5 0 C-N-CA 125.813 1.645 . . . . 0.0 108.393 -165.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.85 103.57 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.415 2.743 . . . . 0.0 109.483 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.6 mt -85.28 97.65 5.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -75.47 95.67 3.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.5 m -67.86 67.71 0.1 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.637 0.775 . . . . 0.0 108.92 159.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.11 -34.95 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.584 -0.697 . . . . 0.0 110.822 -170.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.38 -11.72 17.25 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.685 1.194 . . . . 0.0 114.088 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.503 ' HE3' ' HB3' ' A' ' 151' ' ' ASP . 35.9 ttmt -123.32 12.81 9.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.184 1.394 . . . . 0.0 110.66 172.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 30.9 68.21 0.11 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 129.915 3.286 . . . . 0.0 113.157 -164.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 mtp85 -131.5 165.36 23.74 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 172.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.9 t -144.1 98.58 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -92.84 103.47 15.81 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.5 ttt -77.88 89.08 4.08 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.656 0.662 . . . . 0.0 109.665 171.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.06 168.31 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 176.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -92.16 161.66 14.65 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.532 -1.355 . . . . 0.0 108.884 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -60.27 151.78 26.63 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.49 -0.756 . . . . 0.0 110.141 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.529 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 2.9 tp -65.87 130.4 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 172.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -153.95 120.03 5.37 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 129.109 2.964 . . . . 0.0 103.134 165.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.1 mt -143.89 175.29 10.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.542 1.537 . . . . 0.0 109.054 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.468 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 45.8 m -93.68 157.18 16.3 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 161.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.79 -36.24 64.69 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.137 0.975 . . . . 0.0 112.206 -174.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.35 -18.32 63.78 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -178.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' A' ' 27' ' ' SER . 11.3 mm-40 -70.2 -43.75 70.09 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.609 1.164 . . . . 0.0 109.748 -177.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -60.19 10.54 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.118 2.567 . . . . 0.0 115.542 -173.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -130.77 -9.89 3.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 172.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.82 -13.88 5.74 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 118.31 -0.853 . . . . 0.0 113.05 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.3 pt -113.44 -2.67 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.168 0.895 . . . . 0.0 112.45 171.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.23 173.34 7.98 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.074 0.949 . . . . 0.0 111.29 -171.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.47 133.83 70.64 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 162.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.72 -21.1 45.54 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.382 2.055 . . . . 0.0 112.731 -172.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -74.76 -31.29 61.75 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.986 171.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.18 -41.89 84.87 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 120.063 1.301 . . . . 0.0 110.54 -174.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -57.13 -48.4 78.74 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.071 0.948 . . . . 0.0 111.272 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -69.8 -46.5 65.58 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.665 0.666 . . . . 0.0 110.917 175.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.261 6.3 t -58.88 -23.64 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 125.593 1.557 . . . . 0.0 111.364 -177.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.54 70.76 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 168.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.38 -36.46 13.8 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.906 1.23 . . . . 0.0 111.782 177.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -94.75 6.0 50.23 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.473 0.709 . . . . 0.0 112.876 -174.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.11 19.32 0.19 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.258 2.223 . . . . 0.0 113.857 -172.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.65 -18.22 22.6 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.397 1.475 . . . . 0.0 114.652 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.6 m -163.99 115.61 1.35 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.708 2.254 . . . . 0.0 109.104 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -55.62 147.83 38.3 Favored Pre-proline 0 N--CA 1.47 0.534 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.806 168.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.2 121.38 8.67 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.207 1.938 . . . . 0.0 109.36 170.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -70.53 158.09 56.97 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.061 1.841 . . . . 0.0 110.499 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -146.62 -59.26 0.29 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.068 0.547 . . . . 0.0 109.756 176.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.6 p -118.09 67.84 0.76 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.007 0.923 . . . . 0.0 110.016 -172.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 155.37 171.97 22.5 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -151.0 157.79 43.32 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.115 1.366 . . . . 0.0 107.584 171.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -147.98 -179.26 6.78 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.796 2.038 . . . . 0.0 107.283 166.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -165.97 165.93 17.72 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.986 1.714 . . . . 0.0 108.397 160.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -126.56 168.49 14.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.294 1.438 . . . . 0.0 108.553 168.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.8 tt -156.08 114.11 3.34 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 170.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.27 168.85 19.44 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.473 1.909 . . . . 0.0 107.733 168.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -126.37 23.03 7.01 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 128.218 2.607 . . . . 0.0 111.242 -177.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -122.21 164.71 17.36 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.99 2.116 . . . . 0.0 110.077 -165.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.94 -175.57 36.85 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.024 1.297 . . . . 0.0 113.099 174.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.6 pt -125.91 160.24 33.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 165.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -72.96 155.54 39.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 122.424 1.107 . . . . 0.0 109.498 171.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -129.89 109.95 11.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 127.491 2.316 . . . . 0.0 106.228 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.1 t -75.76 73.85 2.72 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.193 1.397 . . . . 0.0 107.983 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.7 tt -58.57 -16.8 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 127.114 2.166 . . . . 0.0 113.002 -170.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.3 t -74.91 -0.51 18.83 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.432 1.493 . . . . 0.0 112.231 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.8 p -152.41 -13.66 0.17 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 158.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.99 10.99 57.03 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 119.805 1.184 . . . . 0.0 113.34 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -63.14 163.23 10.44 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.601 1.16 . . . . 0.0 108.936 160.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -129.2 153.65 47.53 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 169.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -169.33 -163.23 0.39 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.913 1.685 . . . . 0.0 109.426 -173.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 20.54 91.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 130.675 3.59 . . . . 0.0 114.632 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -57.61 137.27 56.56 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.0 1.32 . . . . 0.0 110.286 173.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.8 m -59.52 -21.34 60.05 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -169.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.92 -20.95 64.34 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.647 1.112 . . . . 0.0 112.448 173.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.6 p -75.72 -12.42 60.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.263 1.025 . . . . 0.0 112.549 172.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -133.67 85.34 2.2 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 125.146 1.379 . . . . 0.0 110.219 -165.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -142.8 45.31 1.59 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.639 -0.663 . . . . 0.0 112.454 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.8 98.04 0.06 Allowed 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.8 m -76.3 113.01 13.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.212 0.605 . . . . 0.0 110.57 -158.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.19 -60.61 0.49 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -175.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.25 -53.92 50.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.383 1.073 . . . . 0.0 111.306 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 37.35 35.43 0.18 Allowed Glycine 0 C--N 1.337 0.635 0 C-N-CA 130.632 3.968 . . . . 0.0 114.395 -167.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.9 158.07 13.74 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.728 0.811 . . . . 0.0 110.506 167.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.35 78.45 1.21 Allowed 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.531 2.821 . . . . 0.0 111.102 177.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.1 p -139.95 157.31 45.89 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.487 165.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -136.26 169.84 17.0 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.104 1.762 . . . . 0.0 108.55 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -122.4 -6.71 8.73 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.336 1.054 . . . . 0.0 112.274 174.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -152.25 -179.45 7.55 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.166 1.386 . . . . 0.0 107.676 173.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 m -119.25 164.9 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.853 1.661 . . . . 0.0 111.027 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.4 p -61.81 -49.83 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.466 1.106 . . . . 0.0 109.492 160.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.0 m 168.95 159.94 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 130.515 3.526 . . . . 0.0 107.912 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -70.02 81.97 0.49 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.134 1.373 . . . . 0.0 108.812 162.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -128.08 -60.44 1.14 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.611 0.764 . . . . 0.0 110.99 -175.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.23 26.52 10.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.628 1.171 . . . . 0.0 110.599 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.0 tt -132.74 158.15 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.794 1.638 . . . . 0.0 108.677 -171.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.438 ' HE3' ' OE2' ' A' ' 113' ' ' GLU . 2.9 tmtm? -135.18 119.52 17.87 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.327 1.451 . . . . 0.0 108.323 -171.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.5 mp -136.45 137.37 40.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.89 1.276 . . . . 0.0 111.919 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.436 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 1.9 mpt_? -125.48 119.49 28.37 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.104 2.562 . . . . 0.0 108.666 168.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.07 143.71 41.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.945 0.898 . . . . 0.0 110.64 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -145.9 -178.21 5.99 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.953 2.101 . . . . 0.0 106.915 167.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.44 11.73 18.53 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.173 1.789 . . . . 0.0 110.985 177.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.8 t -55.37 -3.96 0.08 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.836 3.255 . . . . 0.0 118.322 -158.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 pp -101.82 -10.37 19.96 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.68 1.127 . . . . 0.0 111.977 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.41 8.8 34.81 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 117.554 -1.692 . . . . 0.0 113.197 -165.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 43.9 tpp -148.92 -85.96 0.09 Allowed 'General case' 0 C--N 1.349 0.581 0 CA-C-N 120.481 2.141 . . . . 0.0 109.641 176.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.7 t -143.43 115.54 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 176.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -128.7 114.02 16.11 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 124.939 1.296 . . . . 0.0 108.571 171.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 22.7 t -121.87 136.17 54.92 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.387 1.075 . . . . 0.0 108.378 -175.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.438 ' OE2' ' HE3' ' A' ' 100' ' ' LYS . 25.6 pt-20 -65.37 159.79 23.31 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.735 1.152 . . . . 0.0 111.098 175.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 90.0 t -142.14 111.68 2.63 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 C-N-CA 124.961 1.304 . . . . 0.0 107.835 172.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.97 165.72 17.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.776 1.23 . . . . 0.0 108.273 170.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 35.2 t -69.64 162.65 27.23 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 164.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -86.54 -2.92 58.88 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.529 ' HG2' ' H ' ' A' ' 24' ' ' ILE . 28.2 tpt85 -142.64 -52.39 0.39 Allowed 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.322 0.965 . . . . 0.0 112.83 171.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 22.6 p -84.01 65.79 8.87 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 120.181 1.355 . . . . 0.0 108.248 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.61 53.94 0.08 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.598 2.759 . . . . 0.0 112.535 -170.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.43 -178.39 4.6 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.745 1.618 . . . . 0.0 110.802 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -39.38 -60.68 0.89 Allowed 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 128.218 2.607 . . . . 0.0 112.587 -173.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 48.53 -118.31 1.02 Allowed 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.807 1.643 . . . . 0.0 107.559 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.54 -110.11 0.29 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-N 118.124 0.42 . . . . 0.0 112.189 168.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.33 176.99 8.61 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.575 -0.368 . . . . 0.0 111.806 -165.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.411 HG23 ' HE2' ' A' ' 136' ' ' LYS . 3.1 p -127.56 138.58 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 124.826 1.251 . . . . 0.0 109.341 168.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -138.29 161.11 37.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.386 1.074 . . . . 0.0 110.95 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -66.93 112.58 4.39 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.675 1.59 . . . . 0.0 110.527 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -156.1 -28.2 0.1 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -78.12 154.15 40.6 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -173.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.21 -32.88 6.27 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 121.984 1.789 . . . . 0.0 112.15 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 164.07 166.0 0.06 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 131.511 3.925 . . . . 0.0 106.026 -170.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.12 -45.03 0.45 Allowed 'Cis proline' 0 C--N 1.349 0.57 0 CA-C-N 121.245 1.48 . . . . 0.0 112.005 -9.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.0 p -73.59 -22.18 60.12 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.863 1.265 . . . . 0.0 113.215 -172.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.54 -1.67 56.49 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.358 0.98 . . . . 0.0 113.356 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.411 ' HE2' HG23 ' A' ' 126' ' ' VAL . 12.7 ptmt -124.25 158.34 32.73 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 120.811 -1.405 . . . . 0.0 111.522 -162.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -125.98 108.8 11.75 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.824 2.05 . . . . 0.0 107.42 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -80.74 120.79 25.09 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 168.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 42.6 t -133.2 122.57 24.18 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.318 1.447 . . . . 0.0 107.794 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.7 ptp -141.94 161.87 36.88 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.309 1.044 . . . . 0.0 109.675 -176.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.99 132.68 16.87 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 126.816 2.047 . . . . 0.0 106.238 175.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 77.0 p -174.15 176.76 2.45 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.747 1.219 . . . . 0.0 108.604 165.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.95 -14.09 51.12 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.002 0.921 . . . . 0.0 112.972 162.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -75.84 6.71 4.68 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.005 1.275 . . . . 0.0 113.818 -171.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.1 mt -109.31 85.4 2.09 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.471 1.032 . . . . 0.0 110.407 -163.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -112.75 167.13 10.74 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.804 0.842 . . . . 0.0 109.11 171.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -112.86 159.44 19.03 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.352 1.461 . . . . 0.0 108.44 168.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.0 pt -141.15 169.46 11.41 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 126.825 2.05 . . . . 0.0 107.595 163.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -58.26 174.07 0.82 Allowed 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.433 2.088 . . . . 0.0 111.588 160.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -47.02 -25.52 0.83 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.34 2.256 . . . . 0.0 116.744 -164.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.503 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -176.66 -60.03 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.965 1.706 . . . . 0.0 108.258 167.389 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -151.74 19.7 0.7 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.909 2.084 . . . . 0.0 110.266 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.26 -14.07 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 120.639 -1.288 . . . . 0.0 111.669 174.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.913 0 C-N-CA 128.006 2.717 . . . . 0.0 106.444 160.472 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.7 mtm . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -161.03 32.75 0.14 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.095 1.358 . . . . 0.0 110.634 -166.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -150.8 -165.99 2.42 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.698 1.199 . . . . 0.0 113.275 -157.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.6 mtt85 -120.11 177.32 5.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 130.432 3.493 . . . . 0.0 108.452 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.42 152.06 77.3 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 119.574 1.079 . . . . 0.0 111.68 170.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.35 124.6 5.96 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.256 1.97 . . . . 0.0 109.734 164.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.4 mm -88.6 147.42 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 159.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -146.3 91.95 2.12 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -171.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 m -71.04 86.59 0.73 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 118.899 -1.12 . . . . 0.0 110.09 172.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.53 -34.78 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 124.002 0.921 . . . . 0.0 110.834 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.44 -15.22 2.46 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.826 2.05 . . . . 0.0 113.769 173.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -131.19 7.8 4.65 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.975 2.11 . . . . 0.0 111.084 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 27.6 66.9 0.08 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 128.258 2.623 . . . . 0.0 111.678 -158.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -112.45 162.07 16.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.927 1.691 . . . . 0.0 108.06 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.2 t -143.48 123.16 8.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -139.59 98.79 3.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.534 1.934 . . . . 0.0 107.265 -174.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.5 ttp -68.72 139.0 55.35 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.636 -1.29 . . . . 0.0 109.817 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 t -135.98 135.18 50.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -62.93 167.77 4.48 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 120.946 -1.096 . . . . 0.0 111.208 165.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 mtm105 -78.01 -166.67 0.84 Allowed 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.448 -0.783 . . . . 0.0 113.031 -169.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.529 ' N ' ' HE ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -86.1 112.88 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 -178.232 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -142.43 98.41 3.3 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 -177.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.9 mt -136.19 172.76 12.53 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 126.652 1.981 . . . . 0.0 109.885 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.96 166.57 21.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.97 2.108 . . . . 0.0 107.936 160.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -62.99 -54.59 35.97 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.493 -0.754 . . . . 0.0 112.196 -175.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.45 -19.01 65.28 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -171.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -56.57 -40.7 75.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.041 0.936 . . . . 0.0 109.575 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -59.3 6.82 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.412 2.285 . . . . 0.0 116.599 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.06 -8.88 3.03 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 120.756 -1.215 . . . . 0.0 114.184 173.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -117.87 -22.45 7.93 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.423 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pt -105.32 -9.5 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.456 1.025 . . . . 0.0 112.338 169.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.55 175.28 6.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.685 0.794 . . . . 0.0 111.135 -170.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.32 140.77 94.53 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 164.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.3 -12.25 27.41 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.337 2.691 . . . . 0.0 112.523 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -81.95 -38.97 24.39 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 126.76 2.024 . . . . 0.0 110.059 167.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.26 -44.5 96.4 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 119.776 1.171 . . . . 0.0 110.323 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -46.55 -57.23 4.94 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.202 1.401 . . . . 0.0 110.703 174.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.453 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 20.0 ptp180 -73.63 -49.52 25.61 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 118.084 -0.96 . . . . 0.0 108.784 -174.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.8 t -53.04 -32.85 18.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 119.08 0.854 . . . . 0.0 110.064 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.61 -28.4 68.49 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.81 -23.98 19.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.438 1.017 . . . . 0.0 112.128 175.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 41' ' ' ARG . 19.0 ptpt -111.26 -1.7 15.99 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -168.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 40.35 43.55 1.48 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.068 1.347 . . . . 0.0 111.002 -167.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.411 ' C ' ' HG1' ' A' ' 48' ' ' THR . . . 103.8 -26.27 23.83 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 125.781 1.658 . . . . 0.0 114.858 167.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.411 ' HG1' ' C ' ' A' ' 47' ' ' GLY . 2.7 m -157.85 121.36 4.03 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 120.999 2.399 . . . . 0.0 110.204 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.415 ' CD ' ' HE2' ' A' ' 45' ' ' LYS . 18.3 mt-10 -57.03 -62.69 4.69 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.25 1.42 . . . . 0.0 112.13 172.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.43 166.65 29.17 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 121.687 1.591 . . . . 0.0 110.531 166.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -65.38 154.22 74.64 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.453 1.435 . . . . 0.0 110.031 168.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -72.95 168.16 19.56 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.495 0.664 . . . . 0.0 109.996 171.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.3 m -165.01 -51.74 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.529 1.532 . . . . 0.0 106.964 171.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.2 172.83 43.8 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 164.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -141.1 177.09 8.31 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.137 1.775 . . . . 0.0 108.654 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -66.6 153.2 43.68 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.399 0.619 . . . . 0.0 110.486 167.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -85.51 158.56 20.13 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.209 1.403 . . . . 0.0 109.122 164.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.12 135.86 56.37 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.929 1.692 . . . . 0.0 108.745 168.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.47 ' CD2' ' H ' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -133.83 -171.69 2.79 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.719 1.208 . . . . 0.0 109.72 -166.306 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.47 ' H ' ' CD2' ' A' ' 59' ' ' LEU . 2.9 m-70 -72.47 66.92 0.71 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 160.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -77.67 59.63 2.03 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.952 1.701 . . . . 0.0 109.977 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -126.94 117.13 21.91 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.614 1.966 . . . . 0.0 107.616 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 161.32 -167.43 36.21 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -164.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.2 pt -130.76 162.55 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.317 1.047 . . . . 0.0 110.25 174.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -79.91 155.25 27.83 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.726 0.811 . . . . 0.0 111.243 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -139.93 152.81 46.67 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.534 1.134 . . . . 0.0 110.197 176.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.9 t -103.3 93.01 4.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.478 1.511 . . . . 0.0 107.817 169.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.401 HG23 ' HA ' ' A' ' 144' ' ' ALA . 4.0 tt -61.09 -33.91 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 125.426 1.49 . . . . 0.0 111.733 -175.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.0 t -75.77 5.95 5.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.595 1.158 . . . . 0.0 111.613 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.1 p -140.96 15.48 2.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.795 0.838 . . . . 0.0 110.811 158.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.65 11.29 35.05 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.009 1.766 . . . . 0.0 115.271 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.0 m -118.85 137.91 53.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.745 1.773 . . . . 0.0 110.849 -159.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -79.62 164.17 24.01 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.516 1.527 . . . . 0.0 113.481 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.268 0.2 OUTLIER -161.28 -101.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.983 0.913 . . . . 0.0 112.402 174.46 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -61.89 129.32 40.4 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -158.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -74.07 134.19 42.93 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 170.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.7 m -62.51 -18.12 61.24 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.153 0.981 . . . . 0.0 113.439 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -30.68 66.25 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.012 1.278 . . . . 0.0 111.635 172.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.7 p -69.53 -17.13 63.55 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.229 1.012 . . . . 0.0 112.694 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -102.17 -163.73 1.03 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.701 1.6 . . . . 0.0 109.723 -164.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.47 21.66 4.34 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.566 0.951 . . . . 0.0 113.566 -175.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -53.87 118.31 3.87 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.756 1.222 . . . . 0.0 109.015 164.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 m 111.0 -23.5 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 131.621 3.968 . . . . 0.0 110.585 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -99.16 -52.01 1.29 Allowed Glycine 0 C--N 1.34 0.786 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 176.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.4 t -155.43 -6.72 0.13 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 168.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.99 17.69 52.29 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 119.794 1.179 . . . . 0.0 115.351 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -63.15 150.49 88.68 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 118.022 0.911 . . . . 0.0 110.864 176.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -77.89 51.01 3.45 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.747 2.964 . . . . 0.0 111.489 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.4 p -129.74 146.39 51.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.676 0.791 . . . . 0.0 109.785 168.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.72 166.05 25.79 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.004 1.722 . . . . 0.0 108.568 -170.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -116.63 -9.27 11.36 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -172.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -149.65 -174.03 4.57 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 168.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 m -130.79 165.48 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 124.511 1.124 . . . . 0.0 111.475 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.3 p -52.7 -44.95 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.452 1.501 . . . . 0.0 110.877 168.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.4 m 157.14 158.33 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 130.258 3.423 . . . . 0.0 108.76 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -72.8 72.78 1.09 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 164.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.403 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 3.6 p80 -121.41 -56.19 1.9 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.379 1.072 . . . . 0.0 109.191 -174.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.403 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 49.7 t30 -118.01 13.41 13.91 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.363 1.865 . . . . 0.0 110.644 170.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.31 142.3 44.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 O-C-N 119.962 -1.711 . . . . 0.0 107.236 171.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -122.53 145.97 47.84 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.085 1.754 . . . . 0.0 107.963 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mp -128.12 157.37 40.94 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 125.092 1.357 . . . . 0.0 111.771 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.49 133.53 27.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 127.934 2.493 . . . . 0.0 106.094 167.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.491 ' CD ' HH21 ' A' ' 105' ' ' ARG . 6.8 tm-20 -76.94 144.49 38.8 Favored 'General case' 0 N--CA 1.459 0.021 0 C-N-CA 123.245 0.618 . . . . 0.0 110.878 177.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -150.9 177.73 9.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.044 2.138 . . . . 0.0 105.409 158.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.491 HH21 ' CD ' ' A' ' 103' ' ' GLU . 1.1 ptp180 -120.36 27.98 8.28 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.667 1.987 . . . . 0.0 111.072 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.03 21.3 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.961 2.905 . . . . 0.0 116.372 -168.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.64 0.57 3.29 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.539 1.136 . . . . 0.0 112.435 166.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.35 -0.13 55.79 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 117.696 -1.613 . . . . 0.0 112.842 -170.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -139.11 -88.97 0.21 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 119.854 1.827 . . . . 0.0 108.495 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 64.5 t -145.2 107.2 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -176.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -113.56 88.62 2.88 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.892 1.277 . . . . 0.0 108.757 167.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 53.5 m -86.06 133.32 33.9 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.05 159.58 30.55 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.311 0.96 . . . . 0.0 111.285 174.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.7 t -141.65 102.79 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 126.385 1.874 . . . . 0.0 107.163 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -133.09 159.66 39.45 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.551 0.614 . . . . 0.0 111.248 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 43.1 t -79.27 115.32 18.85 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.532 0.733 . . . . 0.0 111.021 -173.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.51 -24.83 65.61 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.671 1.188 . . . . 0.0 113.463 -171.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.529 ' HE ' ' N ' ' A' ' 24' ' ' ILE . 8.3 tpt180 -59.2 -26.97 65.29 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.73 1.15 . . . . 0.0 112.749 175.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 2.8 p -137.71 -94.73 0.2 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -174.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 176.42 16.45 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.99 2.516 . . . . 0.0 112.238 -174.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.83 148.36 44.55 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -158.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -41.18 -65.65 0.41 Allowed 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 128.985 2.914 . . . . 0.0 113.99 -159.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 52.66 -108.1 0.38 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.868 1.667 . . . . 0.0 108.916 176.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.06 -115.51 0.5 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.145 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -160.21 177.15 10.95 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 122.762 -0.257 . . . . 0.0 110.792 -168.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.409 HG22 ' HE2' ' A' ' 136' ' ' LYS . 5.0 p -125.68 137.35 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.265 1.426 . . . . 0.0 108.888 173.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -132.25 159.11 40.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.098 0.959 . . . . 0.0 112.133 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -72.78 84.36 1.2 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.917 2.487 . . . . 0.0 110.942 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -160.04 7.22 0.09 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.355 1.062 . . . . 0.0 112.818 -172.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -97.71 170.36 25.28 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 119.872 -1.768 . . . . 0.0 112.755 -173.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.04 165.09 33.71 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.631 2.221 . . . . 0.0 110.146 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -62.45 151.92 81.57 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 162.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.05 -44.74 0.51 Allowed 'Cis proline' 0 C--N 1.347 0.452 0 CA-C-N 119.992 1.033 . . . . 0.0 113.806 8.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 26.9 p -72.8 -25.72 61.25 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -165.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.58 3.5 62.9 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.094 0.854 . . . . 0.0 113.552 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.409 ' HE2' HG22 ' A' ' 126' ' ' VAL . 9.7 ptmt -128.97 156.76 43.26 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.327 1.563 . . . . 0.0 111.877 -165.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.7 ttm105 -125.11 101.13 6.88 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.675 1.99 . . . . 0.0 107.399 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -67.26 135.48 53.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 162.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 20.9 t -143.81 141.34 30.33 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.704 1.138 . . . . 0.0 108.609 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -141.09 158.61 43.68 Favored 'General case' 0 C--O 1.231 0.079 0 C-N-CA 123.09 0.556 . . . . 0.0 111.494 -173.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -151.17 125.56 9.45 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.95 1.7 . . . . 0.0 108.093 161.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.8 t -149.5 148.97 30.03 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 158.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.24 -19.93 63.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.571 166.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.401 ' HA ' HG23 ' A' ' 68' ' ' ILE . . . -65.78 -12.26 52.62 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.755 1.222 . . . . 0.0 113.436 172.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 89.5 mt -75.45 106.09 6.82 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.946 1.248 . . . . 0.0 109.992 -176.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -109.82 167.62 10.02 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.31 1.444 . . . . 0.0 107.923 170.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -124.39 147.12 48.45 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 23.6 pt -138.77 166.66 23.53 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.287 1.435 . . . . 0.0 107.85 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -54.82 170.24 0.67 Allowed 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.497 2.132 . . . . 0.0 111.652 167.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -52.92 -27.15 17.4 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -171.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -165.05 -83.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 158.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -123.55 12.25 9.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.489 1.116 . . . . 0.0 110.597 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.12 -24.57 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -169.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 CA-C-O 116.939 -2.034 . . . . 0.0 109.597 179.299 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 7' ' ' ARG . 98.7 mttt -142.52 153.46 43.63 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.033 1.333 . . . . 0.0 109.057 174.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.03 25.99 0.21 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 128.48 2.712 . . . . 0.0 112.344 -177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 5' ' ' LYS . 23.5 mtt180 -142.26 157.87 44.35 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 127.588 2.355 . . . . 0.0 109.3 -172.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.0 pt -116.14 113.45 41.51 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 126.882 2.073 . . . . 0.0 106.829 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.66 101.0 1.11 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.03 1.82 . . . . 0.0 107.652 168.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.18 147.01 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 170.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -141.75 160.98 39.07 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.302 1.841 . . . . 0.0 107.228 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.5 t -136.63 113.64 10.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 160.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.8 p -56.91 -45.34 83.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 119.148 0.885 . . . . 0.0 110.046 170.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.37 -31.02 61.43 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.36 1.864 . . . . 0.0 113.057 -174.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -118.75 0.41 11.44 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.059 1.344 . . . . 0.0 112.181 -175.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 41.43 41.12 1.46 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.648 1.579 . . . . 0.0 112.41 -159.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -74.46 150.92 39.7 Favored 'General case' 0 C--N 1.345 0.39 0 O-C-N 121.15 -0.969 . . . . 0.0 109.138 174.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.2 t -142.37 137.84 29.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 159.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -155.49 110.15 2.93 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.052 1.741 . . . . 0.0 109.61 173.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.2 ttt -79.79 129.34 34.4 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 120.34 -1.475 . . . . 0.0 110.192 174.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.0 t -122.8 155.24 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -79.58 162.55 25.26 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.401 -0.812 . . . . 0.0 110.61 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -75.28 160.6 30.16 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.582 -0.699 . . . . 0.0 110.688 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.422 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 7.6 tt -90.92 67.97 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 122.745 1.259 . . . . 0.0 112.133 -161.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -101.38 47.22 0.91 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.393 -169.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.5 mt -78.61 172.72 13.29 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.785 1.278 . . . . 0.0 110.984 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.23 153.57 28.45 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 127.205 2.202 . . . . 0.0 107.011 161.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -59.37 -39.05 82.06 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.216 1.371 . . . . 0.0 111.877 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.61 -22.73 62.24 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -174.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.79 -38.84 83.88 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.481 1.112 . . . . 0.0 109.563 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.6 m95 -62.85 8.3 0.06 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.731 2.412 . . . . 0.0 115.994 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.22 -2.05 3.98 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -129.7 -19.73 3.3 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.456 -0.783 . . . . 0.0 112.617 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 pt -107.31 1.78 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 119.033 0.833 . . . . 0.0 111.645 167.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -108.55 167.19 10.23 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.17 0.988 . . . . 0.0 110.894 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.39 140.04 79.77 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 166.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.17 -18.16 55.74 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.018 1.812 . . . . 0.0 111.49 168.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -70.37 -44.14 68.7 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 118.83 -0.605 . . . . 0.0 109.713 170.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.48 -43.82 93.18 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.18 0.9 . . . . 0.0 110.049 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -59.81 -45.22 93.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.84 0.856 . . . . 0.0 112.007 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -70.19 -48.38 57.44 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 119.095 0.862 . . . . 0.0 108.788 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.1 t -53.92 -32.58 22.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 124.871 1.269 . . . . 0.0 110.065 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.67 -26.35 67.97 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 175.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.5 ptt-85 -88.8 -27.62 20.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.752 1.16 . . . . 0.0 111.912 174.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -110.93 2.64 18.24 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -168.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.04 36.29 1.93 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.479 1.511 . . . . 0.0 111.621 -171.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.27 -31.87 8.17 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-O 117.967 -1.463 . . . . 0.0 113.411 174.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.7 t -153.4 118.27 5.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 119.443 1.621 . . . . 0.0 111.192 -175.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -55.31 -57.55 19.77 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.641 1.176 . . . . 0.0 112.023 167.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.39 138.88 36.8 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 CA-C-N 121.399 1.535 . . . . 0.0 108.981 169.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.32 -14.38 22.89 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.74 2.293 . . . . 0.0 112.956 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -65.65 123.74 20.51 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.228 1.011 . . . . 0.0 109.08 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.1 t -145.75 -176.57 5.18 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.866 1.266 . . . . 0.0 108.779 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.82 77.37 1.37 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 -167.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.19 171.92 13.86 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.164 1.385 . . . . 0.0 108.123 -177.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -137.64 167.01 22.53 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.205 2.202 . . . . 0.0 106.424 170.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -134.05 17.04 3.81 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.978 0.894 . . . . 0.0 110.655 174.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -145.46 151.93 38.98 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 128.79 2.836 . . . . 0.0 107.631 -158.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.9 tp -154.14 20.86 0.5 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.588 0.755 . . . . 0.0 111.094 -174.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -147.16 145.11 29.42 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.64 35.65 0.15 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 128.214 2.606 . . . . 0.0 112.356 -170.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -137.96 176.57 8.58 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.718 0.807 . . . . 0.0 111.807 -173.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.19 178.31 38.59 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -159.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 37.6 pt -136.82 160.63 36.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.427 0.691 . . . . 0.0 109.555 173.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.71 158.28 28.36 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.132 0.967 . . . . 0.0 110.693 178.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 5.2 ttt180 -143.51 134.18 25.08 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.481 1.512 . . . . 0.0 110.057 -170.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.7 t -87.03 92.71 9.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 174.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.7 tt -62.01 -25.61 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 O-C-N 122.265 -0.272 . . . . 0.0 110.994 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 57.8 m -70.12 -0.35 7.59 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.267 1.827 . . . . 0.0 113.589 176.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 25.0 p -139.56 15.2 2.54 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.918 0.887 . . . . 0.0 110.606 158.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.11 9.43 5.77 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 118.031 -1.427 . . . . 0.0 114.201 -177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.1 m -110.29 141.57 43.1 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.308 1.554 . . . . 0.0 108.851 -164.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 7.8 p-10 -65.82 163.84 15.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.51 1.124 . . . . 0.0 113.679 176.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.309 0.2 OUTLIER -154.29 -110.01 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.604 165.214 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -52.83 115.65 1.93 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.319 1.448 . . . . 0.0 112.617 -162.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -65.96 151.16 47.41 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 170.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.37 -16.67 64.26 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 176.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -63.61 -13.4 41.73 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.787 1.631 . . . . 0.0 111.828 163.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.425 ' HA ' ' CD2' ' A' ' 90' ' ' PHE . 67.5 p -119.58 12.4 12.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.813 2.445 . . . . 0.0 111.703 172.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -156.16 91.97 1.31 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.021 0.929 . . . . 0.0 110.396 178.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -141.68 147.69 37.88 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.988 1.715 . . . . 0.0 106.456 166.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -149.96 136.93 19.47 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 166.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.2 p -55.47 98.39 0.02 OUTLIER 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.805 2.042 . . . . 0.0 112.96 -158.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.9 11.95 26.75 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.832 1.206 . . . . 0.0 113.7 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.3 m -136.02 -34.45 0.8 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.218 1.007 . . . . 0.0 110.507 -159.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.7 25.82 59.25 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.428 -1.206 . . . . 0.0 114.659 172.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -59.5 140.65 88.6 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 119.223 1.511 . . . . 0.0 109.677 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -78.82 67.8 8.38 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.154 2.569 . . . . 0.0 113.301 -167.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.2 p -145.61 145.48 30.98 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.485 162.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' A' ' 79' ' ' THR . 4.7 t80 -141.94 -156.56 0.69 Allowed 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.464 0.706 . . . . 0.0 110.195 171.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -133.14 4.33 3.75 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.036 0.835 . . . . 0.0 112.184 -172.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.577 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 1.1 t0 -151.38 -176.95 5.79 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.22 158.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.8 m -134.26 164.1 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 126.594 1.958 . . . . 0.0 109.23 173.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -73.1 -17.71 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -167.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.3 m 160.43 171.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 131.121 3.768 . . . . 0.0 108.253 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -91.65 100.67 13.35 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 158.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.564 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 10.6 p80 -141.84 -60.83 0.46 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.334 0.654 . . . . 0.0 109.92 -171.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.564 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 63.1 t30 -114.37 10.72 17.12 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.468 2.307 . . . . 0.0 110.005 171.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.57 150.22 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 127.5 2.32 . . . . 0.0 107.497 -177.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -142.16 147.54 36.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.18 1.792 . . . . 0.0 110.517 -174.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.8 mp -127.17 150.67 49.41 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 127.839 2.456 . . . . 0.0 111.78 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -131.4 152.89 50.24 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 129.927 3.291 . . . . 0.0 104.46 162.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -125.69 135.94 52.66 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 119.015 0.825 . . . . 0.0 111.008 -168.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 105' ' ' ARG . 33.4 t0 -144.82 -176.43 5.07 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.228 2.211 . . . . 0.0 108.863 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.467 ' H ' ' CG ' ' A' ' 104' ' ' ASP . 17.5 ptt-85 -112.73 15.87 19.79 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 128.734 2.814 . . . . 0.0 111.894 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.31 -33.28 41.65 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -158.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.1 pp -78.22 -10.36 59.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.045 0.839 . . . . 0.0 112.966 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.3 -1.44 26.66 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.431 -1.761 . . . . 0.0 112.885 -169.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.7 mmt -143.41 -88.05 0.13 Allowed 'General case' 0 C--N 1.347 0.463 0 CA-C-N 120.026 1.913 . . . . 0.0 108.215 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.2 t -138.55 112.09 7.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 CA-C-N 120.25 1.386 . . . . 0.0 107.604 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.5 ttt85 -121.95 117.45 26.46 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.525 0.73 . . . . 0.0 109.723 168.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.94 141.92 47.92 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.36 159.62 33.71 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.32 0.964 . . . . 0.0 109.981 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.9 t -138.6 103.51 2.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 170.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.7 mp -124.69 175.37 7.26 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 11.5 t -64.9 166.66 8.79 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.463 0.649 . . . . 0.0 110.136 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -100.42 -4.99 27.84 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.29 1.036 . . . . 0.0 110.808 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.422 ' HG2' ' H ' ' A' ' 24' ' ' ILE . 34.7 tpt85 -131.85 -71.03 0.56 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 116.978 -1.487 . . . . 0.0 111.603 159.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.2 p -75.22 94.54 2.99 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 119.95 1.25 . . . . 0.0 109.148 -168.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -37.86 30.08 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.286 1 C-N-CA 133.965 4.906 . . . . 0.0 118.945 174.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.1 175.39 2.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.186 2.195 . . . . 0.0 111.895 174.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -71.14 -57.89 4.08 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 126.104 1.761 . . . . 0.0 111.171 -163.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.55 -112.06 0.64 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.014 1.726 . . . . 0.0 107.372 177.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.7 -104.88 0.2 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 119.051 0.841 . . . . 0.0 112.339 165.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -161.85 -177.26 5.72 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.751 0.31 . . . . 0.0 111.452 -163.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.15 140.71 43.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 126.575 1.95 . . . . 0.0 107.349 169.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -139.29 153.61 47.8 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.715 0.806 . . . . 0.0 110.768 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -64.12 119.74 10.76 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.694 0.679 . . . . 0.0 109.298 167.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -154.28 -28.74 0.12 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.253 1.021 . . . . 0.0 113.204 -177.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -95.97 -179.78 35.72 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.821 1.201 . . . . 0.0 111.428 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.64 -87.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.141 2.56 . . . . 0.0 112.085 -175.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.73 163.1 1.64 Allowed Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 127.277 2.231 . . . . 0.0 107.4 -176.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.11 -39.94 1.12 Allowed 'Cis proline' 0 C--N 1.35 0.627 0 CA-C-N 120.241 1.122 . . . . 0.0 109.817 -13.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.3 p -73.66 79.83 1.52 Allowed 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.611 1.565 . . . . 0.0 108.945 165.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -109.93 -3.05 30.15 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 126.832 2.158 . . . . 0.0 110.659 170.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 138.88 39.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 164.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -117.37 109.8 17.26 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.291 1.836 . . . . 0.0 108.303 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.577 ' CE1' ' HA ' ' A' ' 92' ' ' ASP . 50.2 m-85 -78.23 129.6 35.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 23.2 t -140.0 120.38 13.99 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.915 1.686 . . . . 0.0 108.771 -170.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 20.5 ptp -133.74 155.16 50.26 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.558 0.743 . . . . 0.0 109.854 -170.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -152.14 93.66 1.85 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.958 2.103 . . . . 0.0 107.003 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.7 p -143.3 152.94 42.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.09 -35.66 81.0 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.66 0.743 . . . . 0.0 109.421 165.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.4 75.87 0.26 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.874 1.67 . . . . 0.0 110.416 165.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 96.1 mt -144.83 46.97 1.35 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.009 2.524 . . . . 0.0 108.655 164.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -72.31 157.24 38.05 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -97.14 145.86 25.61 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.64 0.776 . . . . 0.0 109.711 164.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.65 174.96 4.03 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 160.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.46 172.29 6.85 Favored 'Trans proline' 0 C--N 1.352 0.734 0 CA-C-N 121.504 1.573 . . . . 0.0 112.061 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -38.84 -44.26 1.02 Allowed 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 127.433 2.293 . . . . 0.0 114.012 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -144.34 -78.32 0.21 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.606 1.962 . . . . 0.0 107.945 172.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -144.55 2.62 1.1 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 128.692 2.797 . . . . 0.0 111.195 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.4 pp -55.3 -24.48 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -174.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 116.901 -2.055 . . . . 0.0 110.702 176.107 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 60.3 mtt . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -88.78 124.41 34.12 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 170.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 52.8 p30 -145.0 -157.73 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.264 1.426 . . . . 0.0 110.927 -159.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -133.04 159.35 40.32 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 127.511 2.324 . . . . 0.0 107.272 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.4 pt -123.13 108.89 31.89 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.013 1.725 . . . . 0.0 107.406 -169.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.22 104.26 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.932 2.421 . . . . 0.0 109.12 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.9 mm -84.15 154.59 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -134.69 152.25 51.63 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -176.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.2 m -129.08 77.99 1.82 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.11 -38.8 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.34 1.056 . . . . 0.0 111.89 -171.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.18 -14.57 11.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.237 1.415 . . . . 0.0 113.65 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.04 10.57 4.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.984 2.114 . . . . 0.0 110.608 175.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 34.53 40.99 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.776 2.83 . . . . 0.0 113.434 -164.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -83.07 164.17 20.46 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.275 -0.89 . . . . 0.0 108.995 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.5 t -136.32 132.42 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 168.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -135.63 103.6 5.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.534 1.534 . . . . 0.0 107.129 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.5 ttm -71.05 122.02 19.29 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 120.967 -1.083 . . . . 0.0 108.81 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.9 156.32 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 173.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -88.79 164.74 15.09 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.898 -1.126 . . . . 0.0 110.199 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.401 ' HG3' ' HD3' ' A' ' 118' ' ' ARG . 39.4 ttt-85 -65.87 144.25 56.93 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.769 -0.582 . . . . 0.0 110.506 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 tt -83.89 121.81 36.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -156.99 118.0 3.67 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 169.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.2 mt -135.73 177.54 7.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.987 2.515 . . . . 0.0 108.811 -172.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.406 ' H ' ' CG ' ' A' ' 30' ' ' GLU . 1.4 p -85.62 178.7 7.29 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 164.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -60.1 -38.45 83.0 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.62 0.768 . . . . 0.0 111.083 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -18.46 59.26 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -166.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 32' ' ' ARG . 25.4 mm-40 -71.07 -45.89 62.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.399 1.08 . . . . 0.0 110.154 -169.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -63.79 21.52 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.321 2.648 . . . . 0.0 114.805 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -135.99 -10.82 2.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 166.316 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -120.77 -18.05 7.78 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 119.223 0.919 . . . . 0.0 112.824 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 pt -111.08 24.97 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 119.226 0.921 . . . . 0.0 111.27 170.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -124.87 169.47 12.02 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.832 1.253 . . . . 0.0 110.903 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -62.65 144.08 96.24 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 168.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -68.37 -12.04 33.75 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.418 2.079 . . . . 0.0 111.741 168.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -78.84 -41.08 30.96 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 118.476 -0.773 . . . . 0.0 111.065 166.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.72 -39.42 80.78 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 120.231 1.378 . . . . 0.0 111.472 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -61.21 -37.74 84.06 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.799 0.84 . . . . 0.0 113.048 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.0 ptt-85 -78.15 -49.47 13.79 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.2 -24.16 29.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 O-C-N 121.396 -0.815 . . . . 0.0 111.488 -173.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.21 -24.26 67.3 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 171.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -105.69 -37.63 6.67 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.392 1.077 . . . . 0.0 111.548 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -90.47 10.68 24.31 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.251 0.932 . . . . 0.0 112.819 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 42.36 50.74 4.67 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.701 1.6 . . . . 0.0 111.564 -177.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.08 -6.89 58.29 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-O 118.257 -1.302 . . . . 0.0 113.903 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 p -140.83 106.3 5.07 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.19 1.495 . . . . 0.0 111.211 -160.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -63.59 -49.84 75.41 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-O 117.594 -1.193 . . . . 0.0 112.974 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.61 155.93 49.59 Favored 'Trans proline' 0 C--N 1.353 0.802 0 CA-C-N 121.258 1.485 . . . . 0.0 111.456 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.75 -1.32 10.99 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.658 2.905 . . . . 0.0 113.848 -178.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.94 160.36 40.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.783 1.633 . . . . 0.0 107.859 176.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.4 p -63.79 113.13 3.21 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.169 0.988 . . . . 0.0 110.022 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.27 173.2 6.78 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 160.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.57 160.95 29.18 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -147.96 166.97 26.1 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.555 1.542 . . . . 0.0 107.293 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.47 146.36 25.86 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.467 1.507 . . . . 0.0 107.465 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -139.83 171.03 14.8 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.326 0.584 . . . . 0.0 112.031 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.5 mt -135.72 2.72 2.93 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.822 2.449 . . . . 0.0 111.161 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -133.47 106.06 7.26 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.153 1.381 . . . . 0.0 108.386 -175.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -70.25 39.83 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.279 2.232 . . . . 0.0 112.836 -177.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -87.78 168.68 12.73 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.76 1.224 . . . . 0.0 111.001 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.31 163.36 30.69 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 126.017 1.77 . . . . 0.0 111.763 168.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.7 pt -133.8 155.85 40.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 165.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -79.23 146.99 32.75 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.659 0.743 . . . . 0.0 109.489 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -110.93 110.92 21.7 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 128.613 2.765 . . . . 0.0 107.067 169.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.65 88.65 0.06 Allowed 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 165.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.6 tt -62.36 -28.13 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.591 0.71 . . . . 0.0 110.461 -170.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.91 -9.15 57.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 128.107 2.563 . . . . 0.0 113.129 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.1 p -139.5 15.29 2.55 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.754 0.821 . . . . 0.0 111.594 166.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.87 37.9 53.45 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 118.912 0.778 . . . . 0.0 112.045 176.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.0 m -132.18 146.39 51.99 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 125.971 1.708 . . . . 0.0 107.27 -171.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.3 173.52 12.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.36 0.982 . . . . 0.0 111.675 176.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -168.2 -118.15 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.689 1.995 . . . . 0.0 110.392 170.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -48.25 132.32 16.21 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.83 1.652 . . . . 0.0 114.306 -159.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -80.73 145.3 31.62 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.725 0.81 . . . . 0.0 110.068 172.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.6 m -54.6 -26.39 32.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 117.572 -1.204 . . . . 0.0 113.719 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -62.63 -21.25 65.52 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.798 1.635 . . . . 0.0 112.361 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.8 p -79.25 -10.64 59.86 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.547 0.739 . . . . 0.0 112.059 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.431 ' HZ3' ' CG ' ' A' ' 82' ' ' ASP . 5.1 tmtt? -117.96 -177.97 3.39 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.327 1.451 . . . . 0.0 110.98 -161.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -140.76 25.24 2.17 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -162.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.431 ' CG ' ' HZ3' ' A' ' 80' ' ' LYS . 37.9 m-20 -56.06 -34.92 66.38 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 120.531 -1.356 . . . . 0.0 112.431 173.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.09 77.93 3.63 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 163.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 155.84 -68.02 0.29 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.601 1.096 . . . . 0.0 111.287 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.8 t -153.5 -11.58 0.15 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.455 1.279 . . . . 0.0 114.455 -173.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.06 18.5 57.6 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.781 1.173 . . . . 0.0 115.337 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.86 136.91 96.69 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 118.221 1.01 . . . . 0.0 110.708 -177.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.95 51.34 3.81 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.904 3.069 . . . . 0.0 111.771 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.3 p -138.38 117.64 12.73 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 168.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -104.33 179.77 4.18 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.62 1.968 . . . . 0.0 107.894 -170.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -119.37 -12.96 9.31 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 118.309 -0.853 . . . . 0.0 113.209 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -154.38 -178.49 7.18 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.897 1.226 . . . . 0.0 108.222 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.4 t -133.74 153.8 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.727 1.211 . . . . 0.0 110.061 -165.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -65.81 -56.72 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.154 0.982 . . . . 0.0 109.909 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.0 m 175.63 158.88 0.24 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 127.276 2.231 . . . . 0.0 107.656 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -76.36 85.23 3.12 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 160.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -119.7 -58.18 1.92 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.647 0.779 . . . . 0.0 109.561 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.71 -1.72 24.15 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.262 1.025 . . . . 0.0 111.296 169.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.06 153.86 32.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 126.393 1.877 . . . . 0.0 108.571 -169.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -140.39 134.54 30.99 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.324 1.449 . . . . 0.0 110.273 -167.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 pp -141.96 144.95 33.98 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 124.305 1.003 . . . . 0.0 113.258 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.577 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 1.5 mpt_? -137.24 123.95 21.13 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 129.522 3.129 . . . . 0.0 107.747 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.442 ' N ' ' HG ' ' A' ' 112' ' ' CYS . 14.4 tm-20 -84.35 148.44 26.63 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.776 1.23 . . . . 0.0 111.206 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -153.99 173.32 16.15 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.21 2.604 . . . . 0.0 107.49 168.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.93 20.19 11.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.599 1.159 . . . . 0.0 112.763 173.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.97 -43.48 63.57 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -158.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pp -73.36 -7.58 52.23 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.84 3.69 45.8 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.485 1.517 . . . . 0.0 112.512 -169.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.0 mtp -142.07 -98.36 0.13 Allowed 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.091 1.445 . . . . 0.0 108.474 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.7 t -139.4 106.35 2.71 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.3 ttt-85 -110.42 113.69 26.54 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.442 ' HG ' ' N ' ' A' ' 103' ' ' GLU . 42.7 t -119.77 124.32 45.87 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.577 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 16.8 pt-20 -62.54 162.26 10.68 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.221 0.464 . . . . 0.0 110.812 -174.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.8 t -137.24 106.28 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 169.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.36 168.88 15.62 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 170.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 30.4 t -70.6 138.93 51.25 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.54 -12.93 60.03 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.191 0.996 . . . . 0.0 112.297 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.401 ' HD3' ' HG3' ' A' ' 23' ' ' ARG . 38.4 tpt85 -123.26 -73.79 0.64 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 117.088 -1.434 . . . . 0.0 112.904 167.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 19.9 p -69.71 17.58 0.05 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 -158.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 68.09 -19.69 0.14 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.911 2.484 . . . . 0.0 116.087 162.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.06 165.33 18.24 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -161.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -37.12 -62.65 0.48 Allowed 'General case' 0 C--N 1.342 0.28 0 C-N-CA 129.247 3.019 . . . . 0.0 113.846 -169.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mt 46.43 -109.12 0.21 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.225 2.21 . . . . 0.0 110.604 -172.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.78 -126.47 1.03 Allowed Glycine 0 CA--C 1.521 0.456 0 CA-C-N 119.144 0.884 . . . . 0.0 113.913 175.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -167.08 168.39 13.71 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.967 0.907 . . . . 0.0 110.415 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.0 p -105.5 142.87 17.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 123.78 0.832 . . . . 0.0 110.152 170.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -140.72 166.32 25.07 Favored 'General case' 0 C--N 1.344 0.328 0 O-C-N 124.006 0.816 . . . . 0.0 111.569 172.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.24 67.94 1.43 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.056 1.742 . . . . 0.0 112.19 -172.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -142.7 25.38 1.82 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.439 1.096 . . . . 0.0 111.52 -174.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -103.2 167.43 16.91 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.971 -1.081 . . . . 0.0 111.637 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.7 167.81 25.6 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.509 2.139 . . . . 0.0 110.564 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 52.3 ptt85 -58.23 147.36 67.08 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 160.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.21 -54.28 0.15 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.525 0 CA-C-N 120.557 1.235 . . . . 0.0 113.764 7.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.1 t -79.21 -13.46 59.68 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -161.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.65 -1.36 45.42 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 119.963 1.256 . . . . 0.0 114.424 169.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -119.44 156.11 30.79 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.084 1.442 . . . . 0.0 111.434 -169.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -128.03 98.91 5.29 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 126.089 1.755 . . . . 0.0 110.128 -169.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -75.58 92.96 2.97 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.685 2.394 . . . . 0.0 109.367 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 31.3 t -92.57 140.24 29.75 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.021 0.928 . . . . 0.0 109.963 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 9.1 ttp -144.37 146.92 32.81 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.981 0.912 . . . . 0.0 109.204 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -143.13 119.12 10.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.458 1.903 . . . . 0.0 107.756 174.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 80.3 p -172.86 -175.14 1.2 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.524 1.13 . . . . 0.0 107.963 165.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.77 -21.25 40.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.615 1.566 . . . . 0.0 114.0 163.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.27 25.76 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.09 2.156 . . . . 0.0 115.751 -164.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 95.5 mt -124.63 41.58 3.47 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.157 0.89 . . . . 0.0 112.258 -160.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -78.67 145.34 34.64 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 170.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -95.31 159.16 15.14 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.777 0.717 . . . . 0.0 109.546 167.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 14.2 pt -138.53 170.98 8.99 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 125.077 1.351 . . . . 0.0 107.663 158.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -46.47 167.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.524 3.482 . . . . 0.0 113.702 162.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -15.66 -49.01 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 129.284 3.034 . . . . 0.0 116.023 163.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -170.08 -156.63 0.14 Allowed 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 131.326 3.85 . . . . 0.0 101.255 -161.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -88.05 16.02 6.6 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 129.331 3.053 . . . . 0.0 110.133 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.2 pp -76.03 -10.69 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.121 1.768 . . . . 0.0 114.171 -162.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 CA-C-O 116.964 -2.02 . . . . 0.0 111.066 177.886 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.411 ' C ' ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 121.474 0.654 . . . . 0.0 111.326 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -69.56 43.53 0.05 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.808 1.643 . . . . 0.0 110.334 163.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 4' ' ' MET . 3.2 p30 -80.24 -169.79 2.23 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 127.322 2.249 . . . . 0.0 110.085 -178.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -138.33 154.13 48.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.825 2.45 . . . . 0.0 106.649 -169.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 pt -108.91 114.97 57.87 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 125.66 1.584 . . . . 0.0 111.041 -175.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.91 126.13 12.25 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.238 1.959 . . . . 0.0 109.287 164.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.9 mt -110.21 93.58 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -88.76 112.21 22.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.0 m -83.41 75.56 9.98 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 166.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.4 m -57.58 -30.14 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -170.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.21 -17.9 22.29 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.104 1.362 . . . . 0.0 113.059 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.27 15.76 5.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.811 1.644 . . . . 0.0 111.201 166.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 36.67 44.47 0.33 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.604 2.762 . . . . 0.0 112.638 -166.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.448 HH12 ' CD ' ' A' ' 19' ' ' GLU . 12.5 mtm105 -84.09 156.67 22.06 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 168.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.0 t -143.64 122.03 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -177.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.448 ' CD ' HH12 ' A' ' 17' ' ' ARG . 3.5 pm0 -130.39 114.72 15.93 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.515 1.126 . . . . 0.0 108.064 171.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.5 ttm -81.96 135.19 35.4 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 121.173 -0.954 . . . . 0.0 109.197 172.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.3 t -135.46 159.17 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 126.024 1.73 . . . . 0.0 106.611 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -69.53 166.13 19.54 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.743 -1.223 . . . . 0.0 113.559 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.95 170.62 12.33 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 163.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.55 138.52 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -168.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -156.96 92.14 1.25 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 174.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.5 mt -126.57 -178.17 4.27 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 127.487 2.315 . . . . 0.0 108.436 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.8 p -87.45 -92.64 0.1 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.232 1.013 . . . . 0.0 109.95 176.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -150.41 -62.02 0.2 Allowed 'General case' 0 C--O 1.231 0.117 0 C-N-CA 126.564 1.946 . . . . 0.0 107.947 174.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -58.53 -21.89 53.7 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -175.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 32' ' ' ARG . 18.8 mm-40 -53.2 -46.12 68.9 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.789 0.836 . . . . 0.0 110.658 173.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -68.2 40.91 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.338 2.255 . . . . 0.0 112.935 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.405 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -150.27 -44.42 0.13 Allowed 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 125.623 1.569 . . . . 0.0 109.351 159.417 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.4 -24.0 34.63 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 117.94 -1.029 . . . . 0.0 112.549 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.1 pt -105.65 21.99 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 119.936 1.244 . . . . 0.0 112.443 172.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.9 mt -108.22 166.01 11.07 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-O 122.036 0.922 . . . . 0.0 113.272 -177.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -56.15 151.01 28.18 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.942 1.297 . . . . 0.0 109.111 163.227 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.9 22.18 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.121 1 C-N-CA 125.331 4.021 . . . . 0.0 111.981 168.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.525 ' H ' ' C ' ' A' ' 36' ' ' ASP . 7.2 tt0 -133.32 -48.72 0.84 Allowed 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 126.867 2.067 . . . . 0.0 109.317 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.21 75.24 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 120.31 1.413 . . . . 0.0 111.9 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -56.18 -46.06 79.52 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 175.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -80.83 -51.06 9.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -175.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.269 2.1 t -59.52 -23.92 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.413 1.085 . . . . 0.0 110.374 -178.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.47 -25.51 68.03 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 170.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -100.68 -34.79 9.72 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.035 1.288 . . . . 0.0 111.566 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -89.0 5.79 42.63 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.892 0.877 . . . . 0.0 112.092 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.42 51.29 16.65 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.852 1.661 . . . . 0.0 110.568 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.75 -1.54 15.32 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-O 118.778 -1.012 . . . . 0.0 114.513 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.1 m -119.5 86.96 2.65 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 118.467 1.133 . . . . 0.0 108.606 -159.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -78.13 155.61 79.68 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.899 -173.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.81 154.35 73.29 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 121.989 1.793 . . . . 0.0 110.802 174.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.31 151.7 48.88 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.648 2.232 . . . . 0.0 111.879 -174.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -144.66 171.94 13.69 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.89 2.076 . . . . 0.0 107.26 170.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.3 t -77.16 172.83 12.61 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 164.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.55 85.37 0.79 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -173.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.09 169.5 17.5 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.285 1.034 . . . . 0.0 109.815 -177.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -131.31 178.46 6.69 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.805 1.642 . . . . 0.0 109.327 -175.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -136.12 -68.36 0.5 Allowed 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -81.36 160.22 24.17 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.254 1.822 . . . . 0.0 109.185 158.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' A' ' 60' ' ' HIS . 6.2 tp -149.52 -176.75 5.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.889 1.676 . . . . 0.0 108.603 170.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.42 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 18.2 m-70 -67.83 120.53 14.3 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.293 -0.879 . . . . 0.0 108.742 165.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -71.09 110.41 5.75 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 163.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -159.71 178.71 9.54 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.098 1.759 . . . . 0.0 106.83 -173.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.39 -172.78 52.63 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 125.463 1.506 . . . . 0.0 111.96 162.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 36.4 pt -138.28 166.47 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 158.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -78.48 149.16 33.24 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.259 -0.901 . . . . 0.0 110.237 173.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.17 120.26 24.26 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.636 1.974 . . . . 0.0 107.002 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.0 t -73.76 86.6 1.7 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.832 1.653 . . . . 0.0 106.924 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 tt -66.35 -30.6 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.032 0.933 . . . . 0.0 111.099 -161.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.3 m -73.61 4.88 4.4 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.863 2.065 . . . . 0.0 112.462 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.7 p -148.47 16.54 1.02 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.878 1.271 . . . . 0.0 112.048 163.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.32 9.55 24.1 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.218 0.913 . . . . 0.0 115.172 176.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.2 m -108.53 122.54 47.28 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.928 1.364 . . . . 0.0 110.13 -159.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -64.94 151.85 44.74 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.486 0.715 . . . . 0.0 111.852 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.01 -101.43 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.863 0.865 . . . . 0.0 111.632 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -62.9 130.25 43.99 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.947 0.794 . . . . 0.0 111.15 -163.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -76.73 145.09 38.87 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.1 m -54.57 -27.59 39.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.152 -0.927 . . . . 0.0 112.549 176.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.99 -19.9 65.5 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.353 1.433 . . . . 0.0 112.96 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.4 p -79.95 -12.52 59.72 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.83 0.852 . . . . 0.0 112.046 174.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.432 ' HG2' ' H ' ' A' ' 81' ' ' PHE . 9.4 tttt -123.06 -171.36 2.28 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.408 1.883 . . . . 0.0 109.054 -166.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.432 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 74.0 m-85 -145.21 -179.79 6.87 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.668 1.987 . . . . 0.0 109.548 -177.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -155.94 -71.35 0.11 Allowed 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 127.499 2.319 . . . . 0.0 107.854 -168.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.63 53.33 2.65 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.863 0.839 . . . . 0.0 111.598 -159.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.99 -78.82 0.2 Allowed Glycine 0 CA--C 1.524 0.602 0 C-N-CA 127.083 2.277 . . . . 0.0 107.869 -173.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.2 m -77.07 53.66 0.98 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.389 1.076 . . . . 0.0 110.003 173.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.82 52.75 3.95 Favored Glycine 0 N--CA 1.45 -0.42 0 O-C-N 120.201 -1.562 . . . . 0.0 110.913 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.9 p-90 -135.11 164.67 42.28 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.673 1.189 . . . . 0.0 109.453 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.37 76.31 3.16 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.883 2.389 . . . . 0.0 112.191 -173.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.3 p -135.95 154.97 50.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.021 1.728 . . . . 0.0 109.399 167.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -143.75 168.71 19.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.22 1.408 . . . . 0.0 108.268 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -115.08 -13.83 11.83 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.001 -0.999 . . . . 0.0 113.14 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -158.16 176.65 12.22 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.39 1.45 . . . . 0.0 107.992 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.9 t -121.18 149.39 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 118.523 0.601 . . . . 0.0 111.46 -158.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -51.93 -58.72 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.114 1.766 . . . . 0.0 110.268 168.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.4 m 169.39 156.45 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 130.832 3.653 . . . . 0.0 105.205 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -79.33 79.87 5.74 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.826 1.194 . . . . 0.0 108.599 173.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -125.63 -53.65 1.56 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 122.994 0.518 . . . . 0.0 110.414 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -115.01 14.37 17.13 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.746 1.218 . . . . 0.0 112.347 171.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.1 tt -119.2 153.54 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 170.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.27 128.11 48.67 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 125.973 1.709 . . . . 0.0 106.899 168.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.68 146.94 51.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.921 1.289 . . . . 0.0 110.758 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.401 ' HE ' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -138.63 152.14 47.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 128.446 2.699 . . . . 0.0 105.064 174.069 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -131.79 130.39 41.76 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.807 0.843 . . . . 0.0 109.556 -169.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -137.06 -178.49 5.22 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.07 2.548 . . . . 0.0 107.355 -175.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -103.39 9.53 37.79 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.345 1.458 . . . . 0.0 111.045 174.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.4 t -59.81 14.46 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 129.669 3.188 . . . . 0.0 119.079 -161.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 pp -118.87 -9.61 10.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.501 1.52 . . . . 0.0 111.809 168.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 122.11 -23.36 7.32 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.94 2.21 . . . . 0.0 112.091 -166.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 28.0 ttm -136.25 -74.39 0.44 Allowed 'General case' 0 C--N 1.348 0.519 0 CA-C-N 119.541 1.67 . . . . 0.0 112.352 -168.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.9 p -155.24 100.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -111.71 128.78 56.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.78 144.59 51.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -178.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.401 ' CD ' ' HE ' ' A' ' 102' ' ' ARG . 10.1 pt-20 -79.05 156.57 28.31 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 63.3 t -134.87 109.03 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 171.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.72 161.34 29.95 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.2 t -70.96 150.58 45.54 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.21 -52.14 44.76 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 172.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -57.51 8.41 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 124.965 1.306 . . . . 0.0 112.667 177.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.0 p -121.11 77.53 1.32 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.548 1.139 . . . . 0.0 109.742 -158.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.31 20.62 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.005 1 C-N-CA 133.612 4.765 . . . . 0.0 115.572 -174.62 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.92 -58.08 6.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.333 1.853 . . . . 0.0 114.146 -159.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -158.37 -73.66 0.09 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.2 mt 49.62 -105.27 0.16 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.403 1.881 . . . . 0.0 110.462 -170.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.23 -115.55 0.54 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.481 172.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -149.47 177.05 10.06 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.195 0.522 . . . . 0.0 111.745 -167.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.49 149.63 32.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.998 1.719 . . . . 0.0 109.029 161.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -147.0 161.47 40.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.797 1.239 . . . . 0.0 109.961 174.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -67.35 121.4 15.65 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.327 0.651 . . . . 0.0 109.767 171.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -160.91 -31.61 0.05 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -74.29 148.34 38.96 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -173.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.93 -14.35 19.21 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.323 2.015 . . . . 0.0 113.205 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 175.27 168.4 0.36 Allowed Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 131.568 3.947 . . . . 0.0 106.607 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.98 -71.77 0.02 OUTLIER 'Cis proline' 0 C--N 1.35 0.635 0 CA-C-N 121.136 1.441 . . . . 0.0 110.709 -13.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.8 t -70.28 -9.29 55.56 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.196 0.998 . . . . 0.0 113.623 -176.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.14 -14.88 41.95 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.25 1.405 . . . . 0.0 113.704 172.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -97.58 152.26 19.22 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 120.942 -1.328 . . . . 0.0 110.493 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -126.14 109.65 12.6 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 127.474 2.309 . . . . 0.0 106.335 -171.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -85.03 141.76 30.07 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.479 1.512 . . . . 0.0 107.737 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 18.5 t -146.29 144.77 30.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.883 0.873 . . . . 0.0 109.774 172.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 16.7 ptm -142.22 152.31 42.96 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.178 0.991 . . . . 0.0 110.351 -171.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -144.25 138.27 27.88 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.848 1.259 . . . . 0.0 108.371 164.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 63.5 p -179.21 175.11 0.98 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.18 1.392 . . . . 0.0 109.549 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -71.65 2.96 4.46 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.456 1.102 . . . . 0.0 113.139 160.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -81.84 -6.16 58.84 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 120.409 1.459 . . . . 0.0 112.837 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.93 113.3 21.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.125 0.97 . . . . 0.0 111.881 -170.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -141.34 156.85 45.79 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 158.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -92.24 162.68 14.2 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 163.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 18.3 pt -135.86 171.11 9.38 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.456 1.903 . . . . 0.0 106.966 159.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.56 171.82 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.392 2.062 . . . . 0.0 111.977 162.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -34.97 -38.23 0.08 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 128.843 2.857 . . . . 0.0 114.857 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -159.28 -102.83 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -115.21 8.75 15.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.534 1.134 . . . . 0.0 111.265 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.3 pp -69.41 -16.46 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -159.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 116.357 -2.357 . . . . 0.0 109.75 -172.925 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.522 ' HD3' ' HA ' ' A' ' 22' ' ' GLU . 3.5 mmt180 . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 pt -115.18 130.97 23.8 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.668 0.787 . . . . 0.0 109.695 -174.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.14 146.39 57.72 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 N-CA-C 108.993 -1.195 . . . . 0.0 108.993 167.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -124.97 105.75 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 166.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -98.31 101.1 12.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.9 m -67.18 74.45 0.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.478 1.111 . . . . 0.0 109.1 165.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.52 -46.89 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 124.853 1.261 . . . . 0.0 110.712 -168.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.24 -16.99 60.42 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.981 -174.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.458 ' HZ1' ' CG ' ' A' ' 76' ' ' ASP . 1.4 mtmp? -99.45 0.47 42.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.101 1.76 . . . . 0.0 110.549 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 39.72 59.44 1.86 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.344 2.658 . . . . 0.0 113.141 -167.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.73 165.83 16.59 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.334 0.654 . . . . 0.0 109.759 171.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -143.38 124.4 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -136.67 112.94 9.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.823 1.649 . . . . 0.0 107.023 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 46.0 ttm -79.5 146.15 32.84 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.775 -1.203 . . . . 0.0 108.855 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.4 t -137.7 157.41 33.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.522 ' HA ' ' HD3' ' A' ' 7' ' ' ARG . 3.3 mp0 -65.8 165.8 12.21 Favored 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 121.22 -0.925 . . . . 0.0 112.084 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.456 ' HG3' HH11 ' A' ' 23' ' ' ARG . 2.4 mmt85 -64.46 174.21 1.8 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.303 -0.873 . . . . 0.0 110.947 165.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.418 ' H ' ' HG3' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -72.85 103.63 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 169.67 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -134.95 103.94 5.78 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 166.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -136.85 177.47 7.83 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.856 1.663 . . . . 0.0 106.676 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.5 t -111.46 164.85 12.51 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 159.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.03 -27.32 43.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.579 1.552 . . . . 0.0 111.509 -175.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.21 -26.89 65.04 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -71.62 -43.35 66.34 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.33 1.052 . . . . 0.0 109.316 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -61.87 19.61 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.391 2.677 . . . . 0.0 114.932 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.78 1.1 2.5 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 165.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -133.37 -17.28 2.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 118.201 -0.904 . . . . 0.0 113.196 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 pt -110.53 -4.73 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 119.261 0.937 . . . . 0.0 112.491 171.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.511 HD22 ' CB ' ' A' ' 39' ' ' ALA . 2.5 mt -78.87 172.59 13.56 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.626 1.171 . . . . 0.0 110.78 174.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -78.52 155.62 78.66 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.084 0.953 . . . . 0.0 110.997 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -68.51 16.82 0.15 Allowed 'Trans proline' 0 CA--C 1.546 1.092 1 C-N-CA 126.213 4.608 . . . . 0.0 114.039 168.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -128.1 -31.8 2.33 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 127.376 2.271 . . . . 0.0 110.123 167.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.511 ' CB ' HD22 ' A' ' 35' ' ' LEU . . . -67.95 -38.71 83.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.123 0.874 . . . . 0.0 108.793 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -59.09 -45.82 89.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.099 0.408 . . . . 0.0 111.143 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.1 -48.9 31.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 116.718 -1.611 . . . . 0.0 107.922 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.1 t -49.5 -32.28 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 119.868 1.213 . . . . 0.0 110.384 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.46 -25.54 66.1 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 114.05 1.129 . . . . 0.0 114.05 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.78 -27.78 15.61 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.396 0.998 . . . . 0.0 111.865 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -113.35 -0.53 14.49 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -163.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.93 42.12 5.92 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.436 1.094 . . . . 0.0 110.846 -171.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.555 0 C-N-CA 125.479 1.514 . . . . 0.0 111.568 172.997 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 p30 . . . . . 0 N--CA 1.424 -1.768 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.82 173.73 49.93 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.853 -172.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.656 HG22 ' HA ' ' A' ' 76' ' ' ASP . 40.8 pt -135.79 164.67 31.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.997 1.719 . . . . 0.0 108.696 170.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -72.88 148.09 44.74 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 2.8 tmt_? -141.12 112.71 7.57 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.098 0.959 . . . . 0.0 109.092 175.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.73 95.71 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.403 1.881 . . . . 0.0 109.082 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.2 tt -65.1 -16.22 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.188 0.595 . . . . 0.0 111.117 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.4 m -86.73 1.65 51.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.071 2.148 . . . . 0.0 112.741 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 22.0 p -150.23 -11.05 0.26 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 162.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.8 3.1 62.52 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 118.083 -1.398 . . . . 0.0 114.197 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.3 m -97.61 143.66 28.06 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.591 1.696 . . . . 0.0 111.281 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 11.7 p-10 -97.05 156.1 16.51 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.855 2.062 . . . . 0.0 112.128 177.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.265 0.2 OUTLIER -151.72 -95.79 0.06 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.172 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -60.25 111.07 1.4 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.993 0.917 . . . . 0.0 113.414 -159.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.656 ' HA ' HG22 ' A' ' 64' ' ' ILE . 1.7 m-20 -63.41 115.92 5.06 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.643 1.577 . . . . 0.0 107.749 166.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.6 m -56.12 -10.63 0.88 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 117.915 2.561 . . . . 0.0 117.915 -162.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -62.92 -25.69 68.45 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.686 1.585 . . . . 0.0 111.827 163.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.9 p -88.51 20.85 3.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.966 2.507 . . . . 0.0 111.817 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -118.51 179.55 4.09 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.878 2.071 . . . . 0.0 108.205 166.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -113.61 165.26 12.68 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 158.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -146.88 -65.23 0.28 Allowed 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 119.007 0.821 . . . . 0.0 109.466 171.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -57.29 161.64 3.18 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.832 0.825 . . . . 0.0 110.83 166.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.63 -62.74 3.49 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 119.261 -0.744 . . . . 0.0 111.511 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t -152.35 -10.67 0.18 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 47.13 23.64 1.79 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.872 1.701 . . . . 0.0 116.576 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -63.44 156.62 69.48 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 117.707 0.753 . . . . 0.0 111.811 -168.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -79.62 47.72 2.61 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.637 2.891 . . . . 0.0 110.634 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.01 144.57 31.09 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 126.418 1.887 . . . . 0.0 107.95 -176.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -158.8 177.09 11.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.645 1.178 . . . . 0.0 109.339 -161.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -128.62 0.49 5.52 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -165.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -161.48 -177.38 5.92 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.677 1.191 . . . . 0.0 108.079 166.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.4 m -140.87 165.77 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 118.873 0.76 . . . . 0.0 112.303 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 p -60.97 -54.7 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.405 1.482 . . . . 0.0 110.603 174.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.5 t 175.58 165.57 0.34 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.406 2.682 . . . . 0.0 107.921 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -75.61 79.22 2.6 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 162.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -126.82 -51.05 1.46 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.645 0.778 . . . . 0.0 109.967 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -117.13 1.55 12.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.697 1.599 . . . . 0.0 111.168 171.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.67 149.42 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 126.497 1.919 . . . . 0.0 106.942 174.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 101' ' ' LEU . 4.4 tmtm? -134.3 143.21 47.6 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.247 1.419 . . . . 0.0 108.918 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.46 ' N ' ' HD3' ' A' ' 100' ' ' LYS . 1.9 mp -120.68 152.16 38.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.883 2.073 . . . . 0.0 112.265 170.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.507 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -129.18 126.45 39.25 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 163.367 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -67.92 143.05 55.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.764 0.826 . . . . 0.0 110.354 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -146.03 173.48 12.13 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 158.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.35 22.13 16.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.442 2.297 . . . . 0.0 110.739 175.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.93 23.27 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.907 2.483 . . . . 0.0 116.843 -165.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 pp -131.13 -5.72 3.88 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.407 -1.433 . . . . 0.0 112.455 162.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.32 1.01 40.99 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 117.387 -1.785 . . . . 0.0 113.089 -167.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 55.4 mtm -140.92 -90.81 0.15 Allowed 'General case' 0 C--N 1.349 0.544 0 CA-C-N 120.383 2.092 . . . . 0.0 108.306 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.2 t -142.87 111.78 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.42 ' HE ' ' CD2' ' A' ' 125' ' ' HIS . 18.9 ttt180 -130.14 88.12 2.61 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.641 1.576 . . . . 0.0 111.047 175.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 7.9 m -89.12 144.09 26.38 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.507 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 22.0 pt-20 -66.52 162.36 20.94 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.218 0.917 . . . . 0.0 110.182 170.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.2 t -136.88 110.11 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 174.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.4 mt -131.29 160.33 35.25 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.52 1.128 . . . . 0.0 109.64 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.8 t -81.66 118.11 22.55 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.26 -6.31 4.36 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.971 1.308 . . . . 0.0 113.876 -175.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.418 ' HG3' ' H ' ' A' ' 24' ' ' ILE . 26.3 ttt-85 -115.13 -9.94 12.24 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.504 1.922 . . . . 0.0 113.645 171.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 22.5 p -164.37 81.58 0.4 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.46 1.482 . . . . 0.0 109.474 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -70.01 56.23 0.14 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.483 1.513 . . . . 0.0 113.039 -174.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -75.17 -49.5 19.26 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.709 1.204 . . . . 0.0 112.952 -166.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -159.71 -67.46 0.08 Allowed 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 122.981 0.512 . . . . 0.0 109.832 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 mt 44.98 -110.66 0.21 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.25 1.82 . . . . 0.0 110.074 -173.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.55 -123.69 0.86 Allowed Glycine 0 CA--C 1.521 0.441 0 CA-C-N 118.751 0.705 . . . . 0.0 112.636 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.42 ' CD2' ' HE ' ' A' ' 111' ' ' ARG . 42.6 p-80 -158.86 174.06 15.57 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.427 -0.455 . . . . 0.0 111.18 -173.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.4 p -122.83 141.37 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.219 1.408 . . . . 0.0 108.014 172.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -134.89 133.19 39.39 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.604 1.162 . . . . 0.0 108.808 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -65.16 107.36 1.54 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.809 0.844 . . . . 0.0 109.67 172.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -162.28 -5.18 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -161.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -110.4 179.28 20.29 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 119.959 -1.713 . . . . 0.0 112.455 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.2 146.69 41.14 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.038 2.492 . . . . 0.0 110.837 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.5 ptt-85 -59.71 153.23 53.48 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.588 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.86 -41.44 0.9 Allowed 'Cis proline' 0 C--N 1.35 0.618 0 CA-C-N 119.816 0.97 . . . . 0.0 111.573 -6.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.53 71.7 4.03 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 125.968 1.707 . . . . 0.0 109.663 176.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -103.95 5.96 47.04 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 112.372 -2.195 . . . . 0.0 111.291 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.75 157.39 27.13 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 116.661 -2.016 . . . . 0.0 107.189 166.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -132.14 94.54 3.48 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -65.72 143.77 57.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 164.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 12.5 t -142.28 135.19 28.52 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.061 1.745 . . . . 0.0 108.001 159.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -133.1 141.92 48.44 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.71 0.804 . . . . 0.0 109.379 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -140.6 87.52 2.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.859 1.264 . . . . 0.0 108.082 -163.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 80.2 p -153.2 177.15 11.15 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.505 0.722 . . . . 0.0 109.586 173.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.61 -8.19 45.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 170.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.06 -25.7 61.58 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.549 1.14 . . . . 0.0 113.141 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 64.2 mt -76.68 44.62 0.37 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.157 2.583 . . . . 0.0 115.35 -158.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -73.43 155.88 38.84 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 166.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -103.65 160.61 14.61 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.67 0.788 . . . . 0.0 109.233 168.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.9 pt -132.73 165.5 36.01 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.222 1.009 . . . . 0.0 108.713 160.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -50.49 150.74 11.14 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.931 2.421 . . . . 0.0 110.507 159.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.594 ' HD3' HG23 ' A' ' 64' ' ' ILE . 12.1 mmt180 -40.43 -44.45 2.01 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 126.444 1.898 . . . . 0.0 112.352 -164.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -145.8 -75.3 0.21 Allowed 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.525 1.13 . . . . 0.0 110.112 167.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -146.05 8.92 1.11 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.285 3.034 . . . . 0.0 109.83 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -59.2 -14.3 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.14 -0.975 . . . . 0.0 113.298 167.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.478 0 C-N-CA 128.16 2.791 . . . . 0.0 107.074 163.336 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.423 ' HB3' ' HA ' ' A' ' 22' ' ' GLU . 12.0 ptt-85 . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.8 pt -111.88 91.88 16.36 Favored Pre-proline 0 N--CA 1.45 -0.461 0 C-N-CA 125.88 1.672 . . . . 0.0 106.759 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 73.6 Cg_endo -64.91 138.06 55.91 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 N-CA-C 107.413 -1.803 . . . . 0.0 107.413 168.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.9 mt -121.25 152.1 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -173.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -147.0 91.58 2.02 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.229 1.412 . . . . 0.0 107.441 -164.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.4 m -66.43 77.17 0.1 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.809 0.731 . . . . 0.0 109.53 165.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -60.68 -36.58 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.658 1.183 . . . . 0.0 111.546 -170.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.52 -11.53 53.15 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.231 1.012 . . . . 0.0 112.233 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -123.31 10.22 9.24 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.362 1.865 . . . . 0.0 110.798 174.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 27.58 52.01 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.572 3.149 . . . . 0.0 113.332 -161.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.95 169.87 17.27 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 118.846 -1.142 . . . . 0.0 111.173 167.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.52 136.72 43.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 158.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -145.01 107.36 4.37 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.46 1.904 . . . . 0.0 108.427 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.431 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 47.8 ttp -82.09 125.41 30.81 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.664 -1.273 . . . . 0.0 111.568 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.4 t -130.89 135.1 60.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 7' ' ' ARG . 7.8 mm-40 -55.81 166.74 0.67 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 166.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.0 mtp-105 -66.23 163.68 17.38 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.413 177.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.446 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 3.2 tt -90.2 122.66 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 169.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -149.33 112.67 4.97 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 167.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.7 mt -136.99 178.4 7.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.052 1.741 . . . . 0.0 108.316 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.31 -177.88 2.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.465 1.906 . . . . 0.0 107.843 159.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.3 -42.88 71.44 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.812 -1.18 . . . . 0.0 109.835 164.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.27 -18.97 30.58 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 128.834 2.853 . . . . 0.0 112.441 -161.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -86.9 -40.71 14.59 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 129.664 3.186 . . . . 0.0 110.378 -168.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -62.25 7.46 0.06 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.269 2.228 . . . . 0.0 114.784 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.85 -4.78 5.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.938 1.695 . . . . 0.0 113.837 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -132.01 -18.86 2.61 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.612 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 pt -109.16 8.97 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.096 0.862 . . . . 0.0 111.356 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -115.84 164.94 13.66 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.97 1.308 . . . . 0.0 110.219 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.421 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -58.22 149.02 60.13 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 122.932 0.493 . . . . 0.0 110.784 176.821 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -69.19 4.48 1.93 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.466 2.777 . . . . 0.0 112.249 164.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -93.07 -48.84 6.3 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.101 -1.0 . . . . 0.0 111.277 161.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.421 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -56.58 -44.47 81.07 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 120.274 1.397 . . . . 0.0 111.355 -172.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -58.14 -40.09 80.44 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.887 1.275 . . . . 0.0 112.432 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -80.98 -45.96 15.83 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 118.645 0.657 . . . . 0.0 109.646 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.635 HG13 ' HA2' ' A' ' 47' ' ' GLY 0.266 2.0 t -60.28 -24.44 30.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.771 1.228 . . . . 0.0 110.534 -177.7 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.13 -23.13 66.38 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 169.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -99.94 -40.66 7.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.309 1.413 . . . . 0.0 111.996 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -83.85 5.82 23.79 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.15 0.58 . . . . 0.0 111.791 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.43 49.01 20.54 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.892 1.677 . . . . 0.0 109.882 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.635 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . . . . . . 0 C--N 1.338 0.663 0 CA-C-O 119.217 -0.768 . . . . 0.0 114.485 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.7 t0 . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.45 175.9 50.4 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -158.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.5 pt -141.9 -178.69 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.363 1.065 . . . . 0.0 108.624 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -98.43 162.13 13.32 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 122.307 1.051 . . . . 0.0 110.293 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.84 108.61 9.53 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 17.6 t -68.3 84.54 0.26 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 170.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 39' ' ' ALA . 14.1 tt -65.31 -25.89 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 122.062 -0.399 . . . . 0.0 110.204 -168.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.3 m -66.52 -1.87 4.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.37 2.268 . . . . 0.0 113.808 173.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 19.7 p -143.47 21.34 1.86 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.263 1.025 . . . . 0.0 110.843 158.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.63 12.02 51.06 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.588 1.09 . . . . 0.0 113.98 171.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 m -111.48 150.08 30.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.639 1.976 . . . . 0.0 110.636 -158.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -89.65 156.72 18.38 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.228 1.376 . . . . 0.0 113.082 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.06 -168.8 0.14 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.826 2.45 . . . . 0.0 109.361 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.9 t80 39.31 79.66 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 128.99 2.916 . . . . 0.0 112.607 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.7 148.43 49.26 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.92 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.8 t -71.34 -9.19 57.74 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -166.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -63.88 -39.84 95.14 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.732 1.213 . . . . 0.0 112.253 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.3 t -85.95 -18.16 33.4 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.276 0.631 . . . . 0.0 111.514 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -74.41 178.09 5.48 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.587 0.755 . . . . 0.0 109.815 168.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.32 151.72 51.25 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 105.102 -2.185 . . . . 0.0 105.102 158.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -131.93 -57.05 0.98 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.497 1.119 . . . . 0.0 110.038 -167.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.4 t -88.09 177.93 6.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.441 0.639 . . . . 0.0 109.898 163.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 55.86 -97.42 0.05 OUTLIER Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.6 1.571 . . . . 0.0 110.989 -173.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.2 m -60.24 -55.52 32.69 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.724 1.61 . . . . 0.0 110.667 177.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 43.64 44.3 6.73 Favored Glycine 0 C--N 1.343 0.932 0 C-N-CA 127.591 2.519 . . . . 0.0 113.837 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -118.62 152.61 51.47 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.239 1.415 . . . . 0.0 109.992 -169.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.08 46.88 1.85 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.779 2.986 . . . . 0.0 112.969 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.3 p -124.62 150.43 46.01 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.822 0.849 . . . . 0.0 109.501 166.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -141.43 178.56 7.35 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.034 1.334 . . . . 0.0 109.851 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -135.02 -0.62 2.75 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -172.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -159.96 177.81 10.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.452 1.101 . . . . 0.0 110.583 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.14 153.33 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 120.554 1.524 . . . . 0.0 111.544 -174.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.4 t -59.84 -63.43 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 127.976 2.51 . . . . 0.0 110.828 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.4 t -173.03 159.73 4.03 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.148 2.179 . . . . 0.0 106.326 -173.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -82.5 54.46 2.63 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.008 1.323 . . . . 0.0 108.167 173.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.469 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 15.6 p80 -102.8 -64.48 1.07 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 -159.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.469 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 16.3 t-20 -109.47 5.9 23.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.461 1.904 . . . . 0.0 112.33 173.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.1 tt -125.15 152.83 31.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 126.0 1.72 . . . . 0.0 107.22 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.471 ' HD3' ' H ' ' A' ' 101' ' ' LEU . 2.2 tmtt? -132.6 135.44 45.89 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.172 0.589 . . . . 0.0 109.475 173.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.471 ' H ' ' HD3' ' A' ' 100' ' ' LYS . 3.6 mp -125.15 146.38 49.52 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.623 2.369 . . . . 0.0 111.381 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -143.0 113.04 7.11 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 127.183 2.193 . . . . 0.0 107.468 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.56 158.54 20.11 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 122.538 1.161 . . . . 0.0 111.014 -177.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -164.39 176.99 8.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.127 2.571 . . . . 0.0 109.803 -172.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.271 0.0 OUTLIER -109.27 39.02 2.16 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.465 -1.397 . . . . 0.0 111.865 170.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.7 m -73.04 18.62 0.1 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 pp -130.66 0.91 4.42 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.172 -0.955 . . . . 0.0 111.542 158.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.67 1.94 60.08 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 117.747 -1.585 . . . . 0.0 113.665 -170.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.1 mmt -136.99 -95.68 0.22 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.366 1.583 . . . . 0.0 108.626 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.0 t -137.23 113.45 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 18.8 ttt180 -120.71 151.17 39.87 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 165.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.685 ' HB3' HG13 ' A' ' 126' ' ' VAL . 8.6 t -157.37 123.17 4.7 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -171.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -64.77 154.21 37.58 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.349 0.522 . . . . 0.0 110.522 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 78.5 t -134.39 107.91 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mp -129.44 172.45 11.52 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 171.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 42.4 t -66.56 148.35 52.01 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.05 -33.39 73.23 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 119.138 -0.458 . . . . 0.0 110.703 171.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.446 ' HG2' ' H ' ' A' ' 24' ' ' ILE . 10.4 tpt85 -106.23 -83.51 0.52 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 117.336 -1.316 . . . . 0.0 114.016 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 20.6 p -64.49 27.74 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 119.595 3.183 . . . . 0.0 119.595 -157.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 64.28 -19.59 0.07 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 158.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.65 164.32 23.64 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -159.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -38.09 -58.5 0.95 Allowed 'General case' 0 C--N 1.346 0.415 0 C-N-CA 128.42 2.688 . . . . 0.0 113.291 -174.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 45.01 -108.84 0.15 Allowed 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.752 2.021 . . . . 0.0 109.065 -173.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.69 -124.68 0.9 Allowed Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.792 170.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.21 166.24 30.0 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 122.953 0.501 . . . . 0.0 110.932 -175.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.685 HG13 ' HB3' ' A' ' 112' ' ' CYS . 2.3 p -115.38 143.28 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 126.176 1.79 . . . . 0.0 109.457 173.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -144.77 159.28 43.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.819 0.848 . . . . 0.0 110.906 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -67.86 76.07 0.21 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.109 2.164 . . . . 0.0 111.588 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -157.3 20.72 0.3 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.323 1.449 . . . . 0.0 111.601 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.74 171.44 17.13 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 120.414 -1.429 . . . . 0.0 113.278 -173.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.03 152.77 68.03 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.754 2.303 . . . . 0.0 110.15 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -63.32 151.95 86.06 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 162.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.8 -41.27 1.02 Allowed 'Cis proline' 0 C--N 1.347 0.465 0 CA-C-N 120.626 1.259 . . . . 0.0 113.848 11.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.2 p -67.97 -30.11 69.32 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -169.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.18 -1.89 39.0 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.649 1.118 . . . . 0.0 113.576 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -120.26 147.81 44.5 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.552 1.176 . . . . 0.0 110.011 -168.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -123.4 110.38 15.06 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 126.923 2.089 . . . . 0.0 107.753 -169.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -86.01 137.95 32.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.659 1.984 . . . . 0.0 107.026 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 17.1 t -140.11 138.64 35.44 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 168.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -145.64 153.01 40.56 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.326 0.65 . . . . 0.0 110.558 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -149.47 127.43 11.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.734 1.614 . . . . 0.0 108.827 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 97.2 p -166.79 175.17 7.99 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.799 0.84 . . . . 0.0 109.219 166.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.424 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -59.06 -13.89 8.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.872 0.869 . . . . 0.0 112.824 164.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.28 -12.01 60.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.484 1.038 . . . . 0.0 112.693 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 53.5 mt -84.53 81.93 8.63 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.902 1.228 . . . . 0.0 112.144 -170.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -92.42 126.73 37.63 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 162.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -75.72 146.73 39.89 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 162.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.7 pt -144.9 165.38 22.63 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 118.817 0.735 . . . . 0.0 110.868 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -60.21 174.87 1.24 Allowed 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.041 2.494 . . . . 0.0 111.675 159.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -55.02 -25.75 32.5 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -164.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -166.14 -61.71 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 128.192 2.597 . . . . 0.0 110.757 159.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -153.2 -0.41 0.24 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 130.669 3.587 . . . . 0.0 109.672 -163.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -62.08 -18.53 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.021 0.928 . . . . 0.0 112.003 169.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.404 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 158.968 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.3 pt -138.67 145.13 44.87 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.412 0.685 . . . . 0.0 111.865 -158.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.56 117.33 3.68 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.274 2.649 . . . . 0.0 110.236 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.1 mm -79.56 101.15 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 163.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -108.96 109.54 20.62 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 t -82.88 96.21 8.19 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.72 -34.67 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 120.749 1.613 . . . . 0.0 109.118 173.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.81 -20.99 0.55 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 171.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -131.25 3.06 4.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.861 1.664 . . . . 0.0 112.184 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 t30 37.26 64.1 0.65 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.892 1.677 . . . . 0.0 111.224 -158.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.8 mtp-105 -107.38 157.99 17.52 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 168.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.12 137.32 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 158.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -134.27 156.52 48.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 159.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 33.6 ttm -112.95 131.9 55.56 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 68.9 t -136.08 155.68 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.726 1.611 . . . . 0.0 106.82 -170.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -68.53 154.44 41.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.63 -1.294 . . . . 0.0 111.288 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.429 ' HA ' ' HD3' ' A' ' 118' ' ' ARG . 0.8 OUTLIER -66.86 147.63 52.99 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 162.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.481 ' H ' ' HD2' ' A' ' 118' ' ' ARG . 8.1 tt -60.68 122.12 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.278 0.631 . . . . 0.0 109.484 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -148.19 108.1 4.03 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 104.235 -2.505 . . . . 0.0 104.235 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.4 mt -135.69 177.9 7.47 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.944 1.298 . . . . 0.0 109.361 -173.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 90.2 p -83.45 176.01 9.39 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 159.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -62.2 -48.59 79.33 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.731 -0.606 . . . . 0.0 110.804 176.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.36 -20.71 65.61 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -169.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -58.84 -42.16 88.65 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.804 0.842 . . . . 0.0 111.229 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -61.69 10.99 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.887 2.475 . . . . 0.0 115.852 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.54 -10.22 3.19 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.736 1.215 . . . . 0.0 113.858 171.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -119.99 -17.5 8.41 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.845 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 pt -112.04 4.88 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 119.342 0.974 . . . . 0.0 112.337 168.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -110.57 163.69 13.47 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.457 1.103 . . . . 0.0 110.826 -176.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.92 136.09 79.62 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 163.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.44 -17.08 53.13 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.081 1.854 . . . . 0.0 111.431 173.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -72.58 -41.33 65.79 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 118.53 -0.748 . . . . 0.0 110.114 170.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.32 -45.64 93.59 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 119.7 1.136 . . . . 0.0 110.091 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -55.92 -47.38 77.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.764 0.825 . . . . 0.0 111.588 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -73.26 -47.89 39.37 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 117.643 -1.17 . . . . 0.0 108.051 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.427 HG13 ' HA2' ' A' ' 47' ' ' GLY . 37.0 t -55.43 -29.6 24.31 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 124.516 1.126 . . . . 0.0 110.297 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.09 -22.57 66.95 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.47 -33.18 16.07 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.363 1.438 . . . . 0.0 111.304 175.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -102.02 -1.06 32.56 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 124.429 1.092 . . . . 0.0 112.34 -167.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 41.18 39.97 1.04 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.559 1.544 . . . . 0.0 111.15 -168.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.427 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . . . . . . 0 C--N 1.335 0.499 0 CA-C-O 117.568 -1.685 . . . . 0.0 115.054 173.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 t70 . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.1 -177.43 33.15 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -164.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.566 HG22 ' HA ' ' A' ' 76' ' ' ASP . 48.1 pt -133.91 155.29 39.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 121.578 0.704 . . . . 0.0 109.403 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -78.86 146.22 33.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 3.8 tmt_? -138.24 109.45 6.86 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.243 1.017 . . . . 0.0 108.45 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.19 101.34 0.4 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.504 1.522 . . . . 0.0 108.194 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 144' ' ' ALA . 4.8 tt -63.14 -28.4 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.626 0.77 . . . . 0.0 110.715 -170.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.0 m -83.45 11.87 6.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.478 1.911 . . . . 0.0 112.255 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.4 p -143.39 -7.11 0.79 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.577 0.751 . . . . 0.0 111.859 158.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.31 1.85 83.54 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.369 1.461 . . . . 0.0 113.131 177.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.0 m -119.82 147.57 44.5 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.228 1.514 . . . . 0.0 112.582 -159.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 10.1 p-10 -91.33 155.89 18.18 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.757 1.623 . . . . 0.0 113.221 -173.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.255 0.2 OUTLIER -162.34 -109.63 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.037 1.735 . . . . 0.0 110.013 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -51.62 120.3 5.04 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.338 1.055 . . . . 0.0 112.587 -159.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.566 ' HA ' HG22 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -72.31 139.63 48.09 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.135 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -20.62 65.82 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.99 -13.2 59.45 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.321 -1.487 . . . . 0.0 113.057 170.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.4 p -84.38 -19.39 33.64 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.991 -1.068 . . . . 0.0 112.564 166.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.28 86.78 2.25 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.707 1.603 . . . . 0.0 107.378 -166.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -135.0 133.52 39.53 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -142.07 114.17 8.15 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 168.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.6 p -70.78 71.93 0.53 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.024 1.729 . . . . 0.0 111.348 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.31 -44.55 1.08 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.098 1.333 . . . . 0.0 111.461 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.29 -46.6 17.42 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.181 0.99 . . . . 0.0 109.551 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 53.83 15.88 5.23 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.662 2.077 . . . . 0.0 115.882 -170.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -50.5 144.64 11.95 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 125.406 1.483 . . . . 0.0 112.782 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.98 65.02 6.06 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.375 3.384 . . . . 0.0 111.827 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.1 p -129.53 142.28 50.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.906 0.883 . . . . 0.0 109.041 164.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.4 167.53 21.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.973 1.709 . . . . 0.0 108.589 -168.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -122.42 -8.69 8.59 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.435 0.694 . . . . 0.0 112.679 -169.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -156.36 179.99 8.72 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.3 m -131.31 162.61 39.0 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-N 119.579 1.081 . . . . 0.0 112.305 -171.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.2 p -55.84 -38.41 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.211 1.405 . . . . 0.0 111.037 166.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.4 m 141.78 154.03 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 1 C-N-CA 132.194 4.198 . . . . 0.0 108.555 -173.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 53.3 mp0 -71.24 59.79 0.27 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.992 1.717 . . . . 0.0 109.914 166.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -105.46 -47.88 3.82 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.763 1.225 . . . . 0.0 108.526 -175.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.96 12.52 7.81 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 125.095 1.358 . . . . 0.0 112.28 170.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.89 145.82 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 125.369 1.468 . . . . 0.0 107.677 169.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -120.07 144.82 47.38 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.174 1.79 . . . . 0.0 108.329 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mp -131.74 157.21 44.4 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.89 1.276 . . . . 0.0 110.484 167.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.44 ' HE ' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -135.27 142.92 46.01 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 130.868 3.667 . . . . 0.0 102.817 164.42 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -126.76 130.76 50.94 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.936 1.294 . . . . 0.0 109.216 -165.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -144.55 -170.98 3.51 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.528 2.331 . . . . 0.0 108.419 -172.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -115.85 6.92 14.39 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.582 2.353 . . . . 0.0 112.119 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -65.98 31.64 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 130.154 3.382 . . . . 0.0 116.968 -163.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 pp -133.08 -7.13 3.05 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.509 1.524 . . . . 0.0 112.278 160.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.44 1.64 35.2 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 117.441 -1.755 . . . . 0.0 113.029 -168.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.3 mtt -141.94 -89.18 0.15 Allowed 'General case' 0 C--N 1.348 0.513 0 CA-C-N 120.322 2.061 . . . . 0.0 109.024 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.3 p -150.41 109.76 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -117.76 124.27 48.03 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.487 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.83 144.61 50.58 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.44 ' CD ' ' HE ' ' A' ' 102' ' ' ARG . 10.3 pt-20 -75.75 157.22 33.8 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 173.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.1 t -136.57 110.73 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -135.82 150.61 49.49 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 51.9 t -72.66 108.13 5.51 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.62 -30.13 67.03 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.225 1.41 . . . . 0.0 112.029 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.481 ' HD2' ' H ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -66.02 -21.07 66.37 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 118.805 -0.617 . . . . 0.0 112.422 176.025 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 5.6 p -121.44 -100.76 0.42 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 165.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.2 p30 156.02 30.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 128.489 2.716 . . . . 0.0 110.606 -165.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.9 166.11 10.95 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.253 1.021 . . . . 0.0 111.844 -167.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -30.35 -78.3 0.02 OUTLIER 'General case' 0 C--N 1.339 0.138 0 C-N-CA 129.585 3.154 . . . . 0.0 116.016 -159.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.2 mt 43.55 -111.55 0.2 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.588 1.555 . . . . 0.0 111.807 -170.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.37 -109.36 0.3 Allowed Glycine 0 C--N 1.336 0.532 0 CA-C-N 119.623 1.101 . . . . 0.0 113.333 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -147.01 179.83 7.33 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 112.147 -166.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.422 HG21 ' HE2' ' A' ' 136' ' ' LYS . 2.1 p -130.97 144.83 36.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.715 1.606 . . . . 0.0 108.289 159.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -136.0 161.67 35.02 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.446 1.098 . . . . 0.0 110.394 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.11 117.78 14.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.903 0.881 . . . . 0.0 109.538 172.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.57 -28.87 0.11 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.05 155.52 40.65 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.12 -13.98 21.0 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.52 2.147 . . . . 0.0 113.295 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.2 ptt-85 134.57 167.28 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.918 1 C-N-CA 133.97 4.908 . . . . 0.0 106.293 -163.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.94 -58.29 0.12 OUTLIER 'Cis proline' 0 C--N 1.351 0.681 0 CA-C-N 122.314 1.862 . . . . 0.0 111.875 -3.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.4 p -69.69 -25.07 63.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.474 1.51 . . . . 0.0 112.862 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.39 -6.64 28.99 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.961 1.267 . . . . 0.0 113.343 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.422 ' HE2' HG21 ' A' ' 126' ' ' VAL . 13.7 ptmt -115.69 152.52 33.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 120.914 -1.345 . . . . 0.0 110.017 -169.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -122.96 106.07 10.53 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.92 2.088 . . . . 0.0 107.452 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -70.15 133.93 47.61 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 162.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 23.3 t -140.71 129.45 22.97 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 174.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -129.83 147.24 51.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.28 0.632 . . . . 0.0 110.063 -175.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -139.34 99.96 3.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.4 p -138.9 166.88 23.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 162.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.27 -13.51 60.78 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.183 170.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.672 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -81.59 0.04 40.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 114.792 1.405 . . . . 0.0 114.792 -165.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 72.4 mt -79.5 54.23 1.71 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.715 1.606 . . . . 0.0 112.116 -164.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -70.59 145.1 50.95 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -85.38 156.31 20.92 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 166.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 30.6 pt -136.91 162.96 52.82 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 158.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.49 168.45 6.61 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.559 1.506 . . . . 0.0 111.238 164.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -31.66 -36.65 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 130.583 3.553 . . . . 0.0 118.21 -169.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -176.14 -57.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.564 1.946 . . . . 0.0 107.5 169.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -157.31 66.48 0.5 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -176.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -121.74 -2.55 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.686 1.194 . . . . 0.0 111.071 161.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 0 C-N-CA 129.369 3.366 . . . . 0.0 105.699 159.685 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 7.0 mmm180 . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.2 pt -126.48 109.24 23.37 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 127.08 2.152 . . . . 0.0 109.383 -174.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.55 101.41 1.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.567 2.178 . . . . 0.0 108.52 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.1 mt -76.78 151.68 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -137.93 101.73 4.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.727 1.611 . . . . 0.0 106.859 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.0 m -68.35 73.74 0.23 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.177 0.899 . . . . 0.0 108.818 159.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.32 -30.8 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 121.772 -0.58 . . . . 0.0 110.438 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.4 -27.88 1.86 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.441 2.296 . . . . 0.0 113.64 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -130.73 15.62 5.34 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.081 2.153 . . . . 0.0 110.819 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 32.59 52.24 0.28 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.805 2.842 . . . . 0.0 113.604 -165.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -86.82 167.44 14.38 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.917 -0.49 . . . . 0.0 109.771 165.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.4 t -143.28 132.81 21.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -145.65 102.19 3.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.988 1.315 . . . . 0.0 108.713 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.3 ttt -82.86 118.99 23.82 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.436 -0.79 . . . . 0.0 111.019 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.2 t -113.78 -177.77 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 128.535 2.734 . . . . 0.0 106.524 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 4.1 pm0 -112.94 160.86 17.65 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.842 1.655 . . . . 0.0 112.103 177.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -56.74 154.86 8.43 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.9 1.28 . . . . 0.0 110.996 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -72.9 124.1 29.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -176.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -148.12 115.7 6.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 163.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.432 HD11 HD11 ' A' ' 34' ' ' ILE . 38.3 mt -138.36 -177.81 5.01 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 128.669 2.788 . . . . 0.0 105.984 170.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.9 m -167.17 -24.39 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.431 ' C ' ' H ' ' A' ' 30' ' ' GLU . 4.4 t70 -91.73 -152.5 0.3 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.119 0.872 . . . . 0.0 109.462 -176.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.91 5.19 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.454 1.902 . . . . 0.0 114.101 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' A' ' 28' ' ' ASP . 36.4 mt-10 -60.43 -45.1 94.85 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 126.633 1.973 . . . . 0.0 110.58 -162.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -68.65 42.41 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.468 2.307 . . . . 0.0 113.104 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.9 -34.05 0.09 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.793 1.637 . . . . 0.0 110.634 160.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -91.08 -24.65 19.95 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.012 -0.994 . . . . 0.0 113.451 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.432 HD11 HD11 ' A' ' 26' ' ' LEU . 1.6 pt -108.43 15.53 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 120.203 1.365 . . . . 0.0 112.464 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.79 175.98 9.12 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.261 1.424 . . . . 0.0 109.837 -167.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.591 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -61.95 135.13 94.51 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 166.352 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -66.31 -12.4 35.47 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.929 1.753 . . . . 0.0 110.886 165.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -76.51 -43.05 41.08 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.367 167.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.591 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -57.38 -47.59 81.28 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 119.541 1.064 . . . . 0.0 109.841 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -48.1 -52.41 20.53 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.669 1.987 . . . . 0.0 111.603 175.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ptt-85 -76.08 -47.98 22.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.383 -0.818 . . . . 0.0 109.206 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.582 HG12 ' HB1' ' A' ' 143' ' ' ALA . 25.0 t -58.21 -27.11 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 124.91 1.284 . . . . 0.0 109.518 -176.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.44 -13.04 36.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 171.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -112.44 -26.06 8.89 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.417 1.462 . . . . 0.0 112.061 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt -112.48 14.5 20.26 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.989 1.716 . . . . 0.0 112.043 -172.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.67 -12.96 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 130.052 3.341 . . . . 0.0 116.408 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.54 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . . . . . . 0 CA--C 1.525 0.684 0 C-N-CA 124.908 1.242 . . . . 0.0 113.956 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 122.254 1.025 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.62 177.51 46.72 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.694 -161.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.434 HG22 ' HA ' ' A' ' 76' ' ' ASP . 46.3 pt -136.96 171.68 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.44 1.496 . . . . 0.0 108.538 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -96.56 136.04 37.63 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.994 0.518 . . . . 0.0 110.571 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 0.0 OUTLIER -102.32 120.09 39.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 163.876 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 35.1 t -65.79 90.7 0.13 Allowed 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 169.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.8 tt -66.57 -10.05 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.482 0.713 . . . . 0.0 111.735 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.7 t -77.94 -3.01 39.69 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.638 1.175 . . . . 0.0 111.759 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.3 p -154.68 -5.45 0.15 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 173.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.21 62.03 4.45 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -174.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.9 m -154.52 137.98 15.9 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 121.035 -1.274 . . . . 0.0 108.523 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 37.1 m-20 -101.19 157.21 16.95 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.942 0.792 . . . . 0.0 110.333 -167.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.25 0.3 OUTLIER -159.72 -103.16 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.377 1.071 . . . . 0.0 112.657 -179.516 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -52.65 121.2 6.7 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -158.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.434 ' HA ' HG22 ' A' ' 64' ' ' ILE . 5.5 m-20 -62.07 122.38 15.38 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.628 1.171 . . . . 0.0 108.754 168.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 t -66.61 -15.93 63.81 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -167.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -70.36 -16.8 63.02 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.41 1.084 . . . . 0.0 112.506 173.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.1 p -71.25 -22.64 61.95 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.366 -0.834 . . . . 0.0 111.484 167.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -98.63 -172.57 2.34 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.539 1.536 . . . . 0.0 109.839 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.73 8.14 16.07 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.659 1.183 . . . . 0.0 113.536 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -53.11 134.86 38.42 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 159.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.4 p 111.44 -36.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 1 C-N-CA 132.482 4.313 . . . . 0.0 111.29 -166.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.32 -69.27 0.39 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 -173.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.1 t -118.96 -21.21 7.81 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.722 0.809 . . . . 0.0 111.266 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.08 11.79 13.38 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.69 1.138 . . . . 0.0 114.525 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -62.82 130.84 94.18 Favored Pre-proline 0 C--O 1.237 0.439 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.63 70.03 5.84 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.895 3.063 . . . . 0.0 112.613 -165.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 72.3 p -138.01 154.18 49.34 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.019 1.728 . . . . 0.0 110.055 173.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -145.17 170.21 16.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.645 1.578 . . . . 0.0 109.08 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -128.06 -13.52 5.09 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -175.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -141.42 178.16 7.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 169.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.29 160.89 22.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.918 0.865 . . . . 0.0 111.439 -167.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 p -59.74 -40.15 81.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 125.55 1.54 . . . . 0.0 111.038 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.5 m 156.73 156.65 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.286 1 C-N-CA 131.747 4.019 . . . . 0.0 106.495 -176.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -75.61 48.79 0.47 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.72 2.008 . . . . 0.0 109.794 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.416 ' C ' HD22 ' A' ' 98' ' ' ASN . 8.1 p80 -110.4 -46.93 3.34 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.406 -0.808 . . . . 0.0 109.654 -159.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.416 HD22 ' C ' ' A' ' 97' ' ' HIS . 0.9 OUTLIER -124.56 17.69 8.84 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 124.17 0.988 . . . . 0.0 112.118 170.596 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.38 135.65 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 174.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.57 ' HD2' ' H ' ' A' ' 101' ' ' LEU . 39.0 tptt -108.56 144.24 36.52 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.306 1.842 . . . . 0.0 108.991 -173.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.57 ' H ' ' HD2' ' A' ' 100' ' ' LYS . 54.9 mt -138.39 128.79 26.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 130.355 3.462 . . . . 0.0 107.468 -167.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.449 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -133.39 114.7 13.99 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 128.716 2.806 . . . . 0.0 104.778 163.254 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -101.73 142.4 33.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 124.283 0.989 . . . . 0.0 110.822 -172.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -148.34 176.68 10.07 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.605 2.362 . . . . 0.0 107.577 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.83 10.24 36.03 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 119.977 -1.702 . . . . 0.0 112.494 172.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.0 t -58.31 16.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 130.157 3.383 . . . . 0.0 119.342 -158.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 pp -128.85 -6.25 5.06 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.694 1.198 . . . . 0.0 112.136 168.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.69 -1.66 32.19 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 117.246 -1.863 . . . . 0.0 113.38 -167.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -141.29 -91.15 0.15 Allowed 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.648 2.224 . . . . 0.0 108.74 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 56.8 t -141.72 114.59 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.435 HH21 ' CE1' ' A' ' 125' ' ' HIS . 22.2 ttt180 -118.86 127.82 53.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.359 1.037 . . . . 0.0 108.512 168.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 23.7 t -127.17 146.25 50.47 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 171.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 16.2 pt-20 -68.64 162.3 26.27 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.995 0.816 . . . . 0.0 110.508 172.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.2 t -142.43 100.52 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 174.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mp -130.82 162.22 30.04 Favored 'General case' 0 N--CA 1.461 0.116 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.45 ' HB3' ' H ' ' A' ' 119' ' ' CYS . 1.6 t -71.82 124.52 25.0 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.21 -9.01 20.02 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.396 0.678 . . . . 0.0 111.76 174.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.98 -25.5 15.36 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.54 1.936 . . . . 0.0 113.011 170.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.45 ' H ' ' HB3' ' A' ' 116' ' ' CYS . 31.2 p -159.71 95.38 1.2 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.6 1.56 . . . . 0.0 109.514 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.9 32.51 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.004 1 C-N-CA 131.79 4.036 . . . . 0.0 113.068 178.285 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.91 -63.57 1.25 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -158.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.401 ' H ' HD23 ' A' ' 123' ' ' LEU . 50.7 t-80 -158.0 -64.46 0.09 Allowed 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 174.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.401 HD23 ' H ' ' A' ' 122' ' ' HIS . 2.3 mm? 54.02 -106.32 0.3 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.153 2.181 . . . . 0.0 106.464 173.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 176.62 -120.43 0.74 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.228 -0.986 . . . . 0.0 112.685 167.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.435 ' CE1' HH21 ' A' ' 111' ' ' ARG . 22.6 p-80 -159.69 173.68 15.69 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.749 -0.266 . . . . 0.0 110.761 -168.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.4 p -123.61 143.38 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.579 1.552 . . . . 0.0 107.884 171.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -138.79 151.74 47.31 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.273 1.029 . . . . 0.0 109.413 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -65.83 118.5 9.76 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 170.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -142.57 -47.06 0.33 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.068 0.947 . . . . 0.0 113.511 -168.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -104.45 -179.78 24.77 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.096 1.332 . . . . 0.0 114.566 -159.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.22 147.16 83.22 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.108 2.539 . . . . 0.0 110.186 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -77.43 159.34 77.6 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 118.731 -0.652 . . . . 0.0 109.451 -174.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.35 -49.17 0.24 Allowed 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 120.037 1.049 . . . . 0.0 111.521 0.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.3 p -77.74 76.24 4.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 123.043 1.401 . . . . 0.0 109.907 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -110.0 7.53 31.17 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 128.138 2.78 . . . . 0.0 110.249 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -78.2 138.65 38.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.712 1.756 . . . . 0.0 106.754 163.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.21 101.05 10.56 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 173.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -67.74 143.4 55.91 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 161.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 36.3 t -146.6 137.44 24.07 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.139 1.375 . . . . 0.0 108.497 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -138.43 153.99 48.87 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.759 0.824 . . . . 0.0 111.262 -177.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -156.33 114.76 3.36 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.14 2.176 . . . . 0.0 107.334 173.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.0 p -171.87 177.82 3.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.472 1.509 . . . . 0.0 108.995 174.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.582 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -66.31 21.45 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.113 1.765 . . . . 0.0 113.1 165.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -90.91 -15.88 29.09 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.98 1.264 . . . . 0.0 113.286 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.4 mt -83.46 88.49 6.99 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.376 0.535 . . . . 0.0 111.802 -159.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -127.87 114.32 17.05 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.427 1.091 . . . . 0.0 108.915 167.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -68.86 145.47 53.68 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 163.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.2 pt -137.8 163.4 48.42 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 125.329 1.452 . . . . 0.0 109.382 168.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.18 161.13 11.64 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.232 1.954 . . . . 0.0 111.694 166.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -34.13 -24.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 131.543 3.937 . . . . 0.0 120.273 -167.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -167.42 -82.37 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.253 1.821 . . . . 0.0 107.289 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -141.73 9.63 1.98 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.967 2.107 . . . . 0.0 110.191 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.9 pp -69.81 -16.25 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -167.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 116.783 -2.121 . . . . 0.0 112.077 170.897 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 121.413 0.625 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.451 HD13 ' HD3' ' A' ' 118' ' ' ARG . 1.3 pt -122.72 102.57 38.39 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 124.852 1.261 . . . . 0.0 110.447 -173.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.2 99.46 1.01 Allowed 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.375 2.05 . . . . 0.0 109.325 174.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.4 mt -79.85 88.31 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -78.26 97.31 5.5 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -69.55 72.0 0.33 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 160.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.1 t -56.26 -37.98 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 123.677 0.791 . . . . 0.0 111.506 -170.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.09 -12.17 25.07 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -125.54 7.12 7.6 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.248 1.819 . . . . 0.0 111.067 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 31.39 48.31 0.08 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 128.72 2.808 . . . . 0.0 112.81 -161.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -90.18 157.96 17.47 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 168.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.5 t -148.77 92.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 -176.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -100.48 102.96 14.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 32.9 ttm -80.05 87.41 5.44 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.669 173.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 80.8 t -84.47 174.7 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 125.853 1.661 . . . . 0.0 107.001 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -105.74 155.18 19.53 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 120.232 -1.542 . . . . 0.0 110.55 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.54 150.05 41.43 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.24 113.77 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -139.84 105.34 5.09 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 162.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.6 mt -133.12 171.89 13.39 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.492 1.517 . . . . 0.0 109.306 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.6 t -85.32 165.38 17.33 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 158.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.2 -38.8 74.22 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.138 0.881 . . . . 0.0 110.111 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.407 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -59.95 -25.78 65.46 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -170.43 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -67.56 -45.06 76.7 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.818 1.647 . . . . 0.0 109.846 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -61.2 10.93 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.058 2.143 . . . . 0.0 115.864 -174.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.407 ' NE ' ' HA ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -130.75 -5.79 4.07 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 173.013 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -128.7 -18.96 3.79 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.639 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 pt -104.97 4.41 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.88 0.763 . . . . 0.0 111.391 166.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mt -112.36 160.46 17.68 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.85 1.26 . . . . 0.0 110.372 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.4 145.51 75.23 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.65 -4.48 12.21 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.678 2.252 . . . . 0.0 112.33 166.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -77.93 -56.43 4.5 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.725 1.21 . . . . 0.0 109.996 162.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.74 -42.48 71.66 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.571 1.078 . . . . 0.0 111.223 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -58.03 -47.2 83.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.956 1.302 . . . . 0.0 111.613 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -75.69 -38.86 58.32 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 119.458 1.026 . . . . 0.0 110.572 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 t -55.05 -28.61 21.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.943 1.297 . . . . 0.0 111.068 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.88 -20.57 63.88 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 172.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -101.3 -45.11 5.44 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 119.722 1.146 . . . . 0.0 111.807 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -89.93 12.55 17.11 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.591 1.087 . . . . 0.0 112.833 -174.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.37 36.75 1.16 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 128.082 2.553 . . . . 0.0 113.557 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.697 0 CA-C-O 119.883 -0.398 . . . . 0.0 113.688 171.128 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.6 t70 . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 121.803 0.811 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.63 151.83 24.72 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.684 1.611 . . . . 0.0 111.944 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.533 HG22 ' HA ' ' A' ' 76' ' ' ASP . 42.8 pt -132.85 161.94 40.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 125.171 1.388 . . . . 0.0 108.178 169.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -82.67 142.5 31.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.012 0.434 . . . . 0.0 110.144 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 0.0 OUTLIER -114.8 140.33 49.01 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 124.372 1.069 . . . . 0.0 110.2 160.274 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.2 t -70.6 84.49 0.62 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 162.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.9 tp -59.74 -13.37 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.044 1.338 . . . . 0.0 112.218 172.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.7 t -78.47 1.89 20.78 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.635 1.574 . . . . 0.0 111.737 173.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.6 p -159.02 -9.56 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 170.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.35 64.31 2.67 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -173.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.22 135.23 30.51 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.113 2.165 . . . . 0.0 106.238 176.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 5.7 p-10 -100.13 152.34 20.36 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.555 1.525 . . . . 0.0 112.222 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.419 HD23 ' H ' ' A' ' 75' ' ' PHE 0.283 0.0 OUTLIER -154.51 -107.97 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.387 1.075 . . . . 0.0 112.864 178.409 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.489 ' CE1' HG13 ' A' ' 93' ' ' VAL . 73.6 m-85 -50.49 121.69 6.06 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.467 1.907 . . . . 0.0 113.622 -160.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.533 ' HA ' HG22 ' A' ' 64' ' ' ILE . 18.2 t70 -86.95 156.84 19.63 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.139 0.976 . . . . 0.0 111.402 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.1 t -56.8 -17.71 10.17 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -63.55 -26.96 68.94 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.862 1.664 . . . . 0.0 111.43 170.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.1 p -92.05 -47.14 7.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.211 1.405 . . . . 0.0 109.177 174.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.35 112.55 15.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.793 1.237 . . . . 0.0 109.725 -159.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -52.59 145.73 11.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.959 0.904 . . . . 0.0 111.165 173.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -140.93 -69.62 0.38 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.789 1.236 . . . . 0.0 110.287 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.7 m -73.16 120.51 18.88 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.53 -158.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.92 -64.95 3.3 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.6 m -120.37 78.67 1.38 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.734 1.214 . . . . 0.0 108.703 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -77.76 32.84 1.67 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 123.884 0.754 . . . . 0.0 113.895 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -59.54 152.6 55.11 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 125.14 1.376 . . . . 0.0 112.002 -172.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.91 60.09 7.61 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.297 2.665 . . . . 0.0 109.657 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.1 p -145.49 145.92 31.26 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 163.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -153.69 175.45 13.24 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.578 1.151 . . . . 0.0 109.463 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -112.1 -12.87 13.62 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.619 0.768 . . . . 0.0 112.384 -164.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -154.49 -175.86 5.61 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -173.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.489 HG13 ' CE1' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -136.75 154.35 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 124.861 1.264 . . . . 0.0 109.478 -163.212 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.7 p -62.17 -32.34 54.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 122.581 0.352 . . . . 0.0 110.197 164.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.1 m 153.03 165.83 0.01 OUTLIER 'General case' 0 C--O 1.234 0.238 1 C-N-CA 132.943 4.497 . . . . 0.0 106.51 -175.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.423 ' HA ' ' CG2' ' A' ' 99' ' ' ILE . 99.3 mt-10 -107.96 75.97 1.03 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -132.46 -28.8 1.62 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.357 1.463 . . . . 0.0 112.597 -161.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.71 16.57 11.93 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.636 1.175 . . . . 0.0 111.876 167.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.613 HD11 HG13 ' A' ' 114' ' ' VAL . 12.0 tt -132.22 146.18 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 125.94 1.696 . . . . 0.0 108.114 -173.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -127.92 124.47 37.45 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.815 1.246 . . . . 0.0 108.834 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 mp -118.79 139.8 51.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.032 2.133 . . . . 0.0 108.756 -173.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -131.61 116.91 18.0 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.673 1.589 . . . . 0.0 106.715 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -79.19 135.67 36.87 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.693 1.235 . . . . 0.0 112.174 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 105' ' ' ARG . 19.2 t70 -143.41 -172.03 3.62 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.351 1.86 . . . . 0.0 110.697 170.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.454 ' H ' ' CG ' ' A' ' 104' ' ' ASP . 0.2 OUTLIER -122.7 7.16 9.41 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.537 2.735 . . . . 0.0 111.838 -173.439 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -65.65 30.42 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 129.928 3.291 . . . . 0.0 116.905 -161.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pp -131.09 -2.52 4.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.017 1.327 . . . . 0.0 112.023 161.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.14 3.31 51.36 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 117.908 -1.496 . . . . 0.0 112.415 -168.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.5 mtp -140.69 -95.35 0.15 Allowed 'General case' 0 C--N 1.347 0.494 0 CA-C-N 120.01 1.905 . . . . 0.0 107.993 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.8 t -142.64 111.4 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -119.03 100.72 7.53 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.768 1.227 . . . . 0.0 107.966 171.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 36.1 t -100.9 128.07 47.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.62 158.96 22.98 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.968 0.804 . . . . 0.0 110.099 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.613 HG13 HD11 ' A' ' 99' ' ' ILE . 95.0 t -141.65 98.95 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -176.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.3 mp -126.84 164.26 21.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 174.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.3 m -77.47 145.29 37.15 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.403 -1.436 . . . . 0.0 110.625 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -82.14 -22.89 35.9 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.09 0.956 . . . . 0.0 111.249 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.451 ' HD3' HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -76.8 -38.22 54.33 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 117.993 -1.003 . . . . 0.0 111.092 169.604 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.2 p -147.58 115.72 6.54 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 173.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.53 56.28 0.06 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.411 1.485 . . . . 0.0 111.304 176.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.14 168.38 16.89 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.242 1.817 . . . . 0.0 110.682 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -44.69 -64.04 0.78 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.756 2.022 . . . . 0.0 113.264 -161.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 50.94 -114.29 0.77 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.414 1.886 . . . . 0.0 107.983 174.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.22 -119.65 0.68 Allowed Glycine 0 CA--C 1.522 0.518 0 CA-C-N 118.653 0.66 . . . . 0.0 113.271 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 54.1 p-80 -161.18 170.7 19.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.237 0.615 . . . . 0.0 110.648 -170.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.586 HG21 ' HE2' ' A' ' 136' ' ' LYS . 3.6 p -115.2 139.61 40.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.161 1.384 . . . . 0.0 108.283 172.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -132.23 150.47 52.15 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 123.593 0.558 . . . . 0.0 110.812 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -66.42 108.59 2.42 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.732 1.213 . . . . 0.0 109.206 174.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.33 -44.47 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.683 1.193 . . . . 0.0 112.257 -170.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.74 -179.65 32.51 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.222 0.915 . . . . 0.0 114.94 -159.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.55 165.25 31.35 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.219 2.613 . . . . 0.0 110.629 171.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.72 154.87 84.14 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 164.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.46 -55.52 0.14 OUTLIER 'Cis proline' 0 C--N 1.348 0.55 0 CA-C-N 120.745 1.302 . . . . 0.0 113.751 10.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 19.1 p -66.7 -31.16 71.64 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.366 1.067 . . . . 0.0 113.149 -166.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 71.81 -2.37 25.08 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.052 0.834 . . . . 0.0 114.797 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.586 ' HE2' HG21 ' A' ' 126' ' ' VAL . 14.6 ptmt -103.38 159.09 15.87 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.3 1.05 . . . . 0.0 108.863 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.4 ttp85 -129.14 99.91 5.43 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.68 1.192 . . . . 0.0 108.856 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -62.5 132.15 51.52 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.656 1.582 . . . . 0.0 107.413 163.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 42.6 t -141.77 144.86 34.19 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.654 1.116 . . . . 0.0 109.386 173.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.5 ptp -149.76 158.19 43.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.457 0.646 . . . . 0.0 110.655 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.17 89.17 1.93 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.566 2.346 . . . . 0.0 106.096 -176.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.523 ' HB3' ' H ' ' A' ' 144' ' ' ALA . 2.8 m -147.2 162.27 39.23 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.31 1.444 . . . . 0.0 108.63 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.7 -20.31 65.62 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.355 1.062 . . . . 0.0 113.072 163.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.523 ' H ' ' HB3' ' A' ' 142' ' ' SER . . . -62.81 29.3 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 130.661 3.584 . . . . 0.0 114.881 -175.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 93.8 mt -132.81 47.41 2.51 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.283 1.833 . . . . 0.0 108.861 -168.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.6 tttt -74.43 122.45 23.01 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -66.95 131.9 46.82 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 165.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 17.2 pt -114.17 164.42 16.27 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 160.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -60.13 173.26 1.94 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 121.657 1.571 . . . . 0.0 110.038 160.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -41.77 -28.34 0.15 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -168.75 -83.53 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 170.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -146.14 26.98 1.18 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.169 1.788 . . . . 0.0 110.244 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -73.28 -12.61 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.97 1.308 . . . . 0.0 112.152 170.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.49 0 N-CA-C 106.977 -2.449 . . . . 0.0 106.977 160.483 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.7 mtt85 . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.0 pt -132.55 128.75 21.13 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.046 0.938 . . . . 0.0 110.395 -164.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.17 132.97 17.27 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.86 1.707 . . . . 0.0 110.256 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.9 mm -101.01 148.77 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 160.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.98 91.49 1.79 Allowed 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.872 1.269 . . . . 0.0 107.869 -169.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.9 m -71.37 80.22 0.76 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.579 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.39 -33.96 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.995 1.271 . . . . 0.0 111.09 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.05 -6.75 4.33 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 173.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -130.02 11.45 5.55 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.306 2.242 . . . . 0.0 110.512 170.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.3 t30 28.11 66.82 0.08 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.821 2.448 . . . . 0.0 112.248 -162.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -114.7 161.44 18.13 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.6 t -144.75 122.5 5.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -141.43 98.87 3.44 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -170.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 44.2 ttm -70.52 133.5 46.84 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.077 -1.014 . . . . 0.0 109.477 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.3 t -121.25 161.33 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 176.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -78.46 167.15 21.74 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.186 -1.571 . . . . 0.0 109.565 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.5 mtm105 -63.24 165.2 7.68 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.669 -0.644 . . . . 0.0 109.96 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.45 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 6.2 tp -70.28 120.61 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 167.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -152.43 118.17 5.39 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 160.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.1 mt -140.4 172.86 12.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.885 1.674 . . . . 0.0 108.442 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.453 ' H ' ' HG2' ' A' ' 30' ' ' GLU . 10.7 p -94.51 168.62 10.75 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.019 1.328 . . . . 0.0 109.67 171.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -77.66 70.05 3.99 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.791 0.805 . . . . 0.0 109.5 164.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -167.14 -26.81 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 125.286 1.435 . . . . 0.0 110.988 158.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.453 ' HG2' ' H ' ' A' ' 27' ' ' SER . 23.1 mm-40 -55.62 -45.24 77.56 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.309 0.644 . . . . 0.0 110.348 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -68.19 37.34 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.275 2.63 . . . . 0.0 112.767 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.56 -34.34 0.19 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.632 1.173 . . . . 0.0 111.402 161.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -92.24 -26.37 18.2 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.807 -1.092 . . . . 0.0 113.049 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.2 pt -100.81 23.44 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 120.186 1.357 . . . . 0.0 111.467 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.7 mt -122.25 161.49 23.19 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.443 1.097 . . . . 0.0 112.233 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.514 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -61.54 149.03 85.26 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.082 170.334 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -68.83 5.1 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.419 2.746 . . . . 0.0 112.657 167.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -102.79 -39.82 6.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.672 -1.156 . . . . 0.0 111.441 165.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.514 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -60.78 -43.68 97.75 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 121.421 1.919 . . . . 0.0 111.455 -173.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -57.66 -45.7 85.18 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.929 1.292 . . . . 0.0 111.549 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -76.33 -36.78 58.07 Favored 'General case' 0 C--O 1.221 -0.434 0 O-C-N 121.526 -0.734 . . . . 0.0 111.066 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.635 ' CG1' ' HB1' ' A' ' 143' ' ' ALA . 25.2 t -55.0 -27.99 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 120.701 -1.25 . . . . 0.0 111.143 175.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.45 -22.91 67.16 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -93.84 -41.82 9.43 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.514 1.506 . . . . 0.0 111.537 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -96.13 4.82 52.22 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.302 1.841 . . . . 0.0 112.884 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.04 15.58 1.84 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.939 1.695 . . . . 0.0 113.533 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.792 0 CA-C-O 117.702 -1.61 . . . . 0.0 114.805 -179.779 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.61 172.12 17.39 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 122.206 0.892 . . . . 0.0 114.978 166.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.514 HG22 ' HA ' ' A' ' 76' ' ' ASP . 14.2 pt -136.2 170.79 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.829 1.651 . . . . 0.0 109.618 176.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -96.95 111.04 23.43 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.457 1.103 . . . . 0.0 109.999 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.49 113.73 14.42 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 163.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 20.7 t -65.84 85.32 0.08 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.512 1.525 . . . . 0.0 109.14 166.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.1 tt -66.33 -11.61 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.704 1.602 . . . . 0.0 111.587 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.5 m -82.28 -1.44 49.47 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.309 1.844 . . . . 0.0 113.0 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.8 p -152.17 -16.43 0.18 Allowed 'General case' 0 C--N 1.338 0.104 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 165.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.66 65.84 1.59 Allowed Glycine 0 C--N 1.337 0.616 0 N-CA-C 107.593 -2.203 . . . . 0.0 107.593 -162.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.1 m -143.21 166.63 24.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 172.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -135.53 145.89 47.51 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.57 -102.82 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.666 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -54.4 108.01 0.34 Allowed 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.487 1.115 . . . . 0.0 112.815 -159.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.514 ' HA ' HG22 ' A' ' 64' ' ' ILE . 1.6 m-20 -68.37 135.86 52.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -10.11 57.31 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.38 0.991 . . . . 0.0 112.949 -171.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.91 -20.8 62.64 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.468 -1.395 . . . . 0.0 112.472 163.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.3 p -86.69 -20.14 28.17 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.659 1.184 . . . . 0.0 112.89 168.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -137.05 86.29 2.19 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.229 1.812 . . . . 0.0 107.471 -169.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -139.06 124.24 19.05 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -144.83 93.62 2.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -176.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.0 m -61.81 124.97 22.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.825 1.25 . . . . 0.0 111.14 -170.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.12 -60.88 4.8 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.79 -49.6 70.04 Favored 'General case' 0 CA--C 1.526 0.039 0 CA-C-N 117.941 0.87 . . . . 0.0 112.285 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 42.35 42.11 4.26 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.918 2.199 . . . . 0.0 115.657 -162.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -61.44 143.81 92.79 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 118.528 1.164 . . . . 0.0 108.874 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.14 70.44 6.69 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.02 2.48 . . . . 0.0 110.895 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.3 p -136.44 150.29 48.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.521 1.129 . . . . 0.0 110.967 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.25 166.77 22.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.901 2.08 . . . . 0.0 107.568 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -127.7 -6.9 5.66 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.393 0.677 . . . . 0.0 112.451 -170.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -151.96 -178.02 6.5 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 167.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.23 158.76 43.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 124.105 0.962 . . . . 0.0 111.825 -176.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 p -51.36 -42.44 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 127.271 2.228 . . . . 0.0 111.444 171.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.6 m 157.14 155.07 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.515 1 C-N-CA 131.959 4.104 . . . . 0.0 106.786 -176.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -74.06 75.51 1.73 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 161.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -114.8 -53.51 2.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.573 1.149 . . . . 0.0 108.991 177.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.82 14.33 7.45 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 173.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.5 tt -106.12 154.25 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 159.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -123.49 134.11 53.94 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 166.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 46.8 mt -117.41 148.97 41.29 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.855 2.062 . . . . 0.0 109.02 172.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.473 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 0.2 OUTLIER -133.17 115.69 15.34 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 162.422 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.96 143.44 56.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.221 1.409 . . . . 0.0 110.034 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -147.79 -178.97 6.55 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 158.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.95 14.7 9.95 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.024 2.13 . . . . 0.0 110.377 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.8 m -62.33 -21.81 65.57 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 126.194 1.798 . . . . 0.0 115.692 -158.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 pp -77.08 -14.72 59.77 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.556 1.071 . . . . 0.0 112.231 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.86 0.6 25.73 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 117.316 -1.824 . . . . 0.0 113.012 -168.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.0 mmt -143.31 -85.18 0.15 Allowed 'General case' 0 C--N 1.349 0.553 0 CA-C-N 120.456 2.128 . . . . 0.0 107.9 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.2 t -145.19 114.69 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -129.37 103.44 6.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.305 1.442 . . . . 0.0 110.186 172.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.4 ' HB2' ' CG1' ' A' ' 126' ' ' VAL . 2.6 m -106.85 151.87 24.64 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 23.9 pt-20 -70.43 163.68 26.21 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.354 0.979 . . . . 0.0 110.838 171.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.3 t -137.09 107.51 5.38 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 168.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.49 164.49 18.83 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 167.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 17.0 t -65.47 156.22 33.12 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 162.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.72 -28.91 66.21 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.45 ' HG2' ' H ' ' A' ' 24' ' ' ILE 0.285 0.0 OUTLIER -116.1 -52.45 2.6 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 179.451 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 15.9 p -77.51 77.68 4.03 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 121.077 1.762 . . . . 0.0 109.227 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -52.86 67.04 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 128.983 2.913 . . . . 0.0 111.071 166.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.4 -178.9 4.51 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.37 2.268 . . . . 0.0 110.264 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -43.75 -57.99 2.94 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.259 2.224 . . . . 0.0 113.366 -165.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 42.54 -112.08 0.19 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.616 1.966 . . . . 0.0 109.422 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -178.29 -125.3 0.91 Allowed Glycine 0 CA--C 1.519 0.328 0 CA-C-N 118.954 0.797 . . . . 0.0 113.767 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -158.46 174.87 14.44 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.076 0.55 . . . . 0.0 110.085 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.582 HG21 ' HE2' ' A' ' 136' ' ' LYS . 2.4 p -124.85 137.14 58.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 124.285 1.034 . . . . 0.0 108.774 171.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -135.07 147.15 49.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.193 0.597 . . . . 0.0 109.675 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -58.66 111.32 1.22 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.842 1.257 . . . . 0.0 109.442 170.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -153.94 -29.5 0.12 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -78.7 155.8 41.69 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.19 -30.02 7.34 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.141 1.894 . . . . 0.0 112.632 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 179.37 168.58 0.64 Allowed Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 128.744 2.818 . . . . 0.0 106.584 -172.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.11 -51.06 0.16 OUTLIER 'Cis proline' 0 C--N 1.349 0.589 0 CA-C-N 121.081 1.422 . . . . 0.0 111.407 -12.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.0 p -71.13 -23.43 62.08 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.686 1.595 . . . . 0.0 112.44 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.03 -8.85 21.08 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.499 1.523 . . . . 0.0 113.257 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.582 ' HE2' HG21 ' A' ' 126' ' ' VAL . 12.2 ptmt -105.76 152.84 22.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 120.64 -1.506 . . . . 0.0 109.977 -171.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -126.96 97.74 5.07 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.53 1.932 . . . . 0.0 107.033 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -67.74 140.21 56.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 164.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 45.7 t -140.65 149.23 42.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.448 1.099 . . . . 0.0 109.192 170.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.7 ptt? -140.84 148.95 41.35 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.317 1.447 . . . . 0.0 109.337 -176.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -147.65 88.77 1.71 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.999 2.12 . . . . 0.0 107.424 -173.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 88.7 p -165.28 178.44 6.9 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 121.551 -0.718 . . . . 0.0 109.549 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.635 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -63.62 -18.26 63.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.121 1.368 . . . . 0.0 114.169 167.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.82 22.68 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.539 1.936 . . . . 0.0 115.445 -159.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 28.3 mt -121.23 41.03 3.43 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -158.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -75.77 101.59 5.12 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -53.92 137.28 39.38 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 167.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 14.8 pt -136.2 166.59 26.83 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.242 1.417 . . . . 0.0 108.297 167.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.89 168.1 4.74 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.646 2.231 . . . . 0.0 112.435 164.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -18.87 -49.58 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 130.206 3.402 . . . . 0.0 118.118 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -165.42 -81.01 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.218 1.407 . . . . 0.0 107.609 -167.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -144.74 16.64 1.61 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.085 1.754 . . . . 0.0 111.412 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.79 -3.92 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.259 -0.901 . . . . 0.0 112.728 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.475 0 C-N-CA 128.117 2.77 . . . . 0.0 106.554 159.88 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 24.2 mtt180 . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.559 HD13 ' HD3' ' A' ' 118' ' ' ARG . 2.7 pt -132.01 112.83 14.73 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.439 1.495 . . . . 0.0 108.856 -162.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.08 106.34 2.01 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.52 2.146 . . . . 0.0 109.274 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.553 HD11 HD12 ' A' ' 8' ' ' ILE . 23.4 mm -78.72 80.69 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 173.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -83.66 89.54 7.14 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.328 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.7 m -71.41 83.57 0.8 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 173.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 p -56.42 -36.62 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.444 1.497 . . . . 0.0 111.842 -171.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -17.86 49.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.665 1.186 . . . . 0.0 112.648 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -129.11 12.44 6.11 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.602 1.961 . . . . 0.0 110.015 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 26.48 58.31 0.07 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 129.104 2.962 . . . . 0.0 111.32 -164.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.9 mtp85 -94.63 175.14 6.78 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 118.569 -1.252 . . . . 0.0 108.881 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -149.8 120.97 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 159.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.41 111.57 22.51 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 167.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.9 ttt -77.42 105.83 8.8 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.819 1.19 . . . . 0.0 108.808 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.94 178.96 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 16.1 pt-20 -130.96 168.82 16.69 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 120.292 -1.505 . . . . 0.0 112.516 172.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.89 139.61 57.24 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.659 0.784 . . . . 0.0 111.545 -171.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.476 ' H ' ' HD2' ' A' ' 118' ' ' ARG . 12.9 tt -73.72 115.38 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -175.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -139.0 99.52 3.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.4 mt -133.39 177.41 7.71 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.203 1.801 . . . . 0.0 108.805 -171.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.2 t -84.4 179.77 7.35 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 158.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -54.19 -36.99 64.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.846 0.748 . . . . 0.0 109.231 158.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 32' ' ' ARG . 18.6 m-20 -62.82 17.07 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 129.978 3.311 . . . . 0.0 117.269 -169.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -133.04 -46.9 0.85 Allowed 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -172.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -62.36 5.69 0.1 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.601 1.96 . . . . 0.0 114.922 -175.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 29' ' ' ASP . 3.7 ptt180 -124.75 -10.51 7.27 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.611 1.564 . . . . 0.0 113.869 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -134.66 -11.42 2.37 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.628 0.771 . . . . 0.0 112.19 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pt -119.55 11.39 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.828 0.851 . . . . 0.0 111.283 166.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -113.49 170.78 7.99 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.479 1.111 . . . . 0.0 111.825 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.42 142.41 90.7 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.902 0.881 . . . . 0.0 110.527 172.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.34 -7.2 20.66 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.556 2.837 . . . . 0.0 112.707 170.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -82.85 -45.32 14.41 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.504 1.121 . . . . 0.0 109.671 163.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.41 -42.47 98.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 120.579 1.536 . . . . 0.0 111.461 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -57.89 -45.75 85.92 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.029 0.532 . . . . 0.0 111.196 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -69.85 -49.6 50.88 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 119.304 -0.958 . . . . 0.0 109.642 172.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.471 HG22 ' HA2' ' A' ' 47' ' ' GLY . 5.7 t -55.89 -29.11 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 119.544 1.065 . . . . 0.0 111.01 -170.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.3 -28.31 69.64 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 174.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -100.46 -22.6 14.96 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.581 1.082 . . . . 0.0 113.12 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -107.35 3.72 25.63 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.963 0.905 . . . . 0.0 112.712 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.51 49.48 15.96 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.74 1.616 . . . . 0.0 111.047 -172.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 42' ' ' VAL . . . . . . . . 0 C--N 1.335 0.495 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.4 t70 . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.54 178.44 25.41 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.415 HD12 ' HB2' ' A' ' 73' ' ' ASP . 21.1 pt -135.2 167.5 25.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 125.507 1.523 . . . . 0.0 107.859 167.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -84.07 127.8 34.14 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 122.239 1.019 . . . . 0.0 110.172 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -87.31 130.97 34.4 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 158.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.9 t -75.23 100.59 4.38 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 159.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 144' ' ' ALA . 3.6 tt -66.34 -18.59 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.435 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.9 t -82.11 7.62 12.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.653 0.781 . . . . 0.0 111.147 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.9 p -153.49 0.05 0.24 Allowed 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.965 -1.084 . . . . 0.0 113.87 168.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.82 55.24 23.49 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.4 m -153.8 154.45 34.01 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.067 -1.255 . . . . 0.0 109.259 -173.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.415 ' HB2' HD12 ' A' ' 64' ' ' ILE . 15.6 p-10 -85.95 152.21 23.13 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.07 0.948 . . . . 0.0 112.914 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.29 0.2 OUTLIER -146.89 -101.81 0.09 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.518 168.027 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -66.29 138.29 57.53 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.269 0.941 . . . . 0.0 111.19 -164.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -99.11 152.45 19.84 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.465 1.106 . . . . 0.0 108.63 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.66 -22.05 31.76 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.99 -29.66 57.69 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.706 1.139 . . . . 0.0 112.411 169.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 t -120.78 54.69 1.06 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.453 1.901 . . . . 0.0 109.466 168.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -140.79 162.21 35.98 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.504 -1.373 . . . . 0.0 110.073 159.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -104.23 120.27 40.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 163.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -138.15 -55.54 0.65 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.822 2.049 . . . . 0.0 108.287 -165.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 t -67.11 173.24 3.89 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.063 0.935 . . . . 0.0 110.167 159.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 52.38 -110.03 1.08 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.428 1.489 . . . . 0.0 110.966 -173.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -66.19 -37.76 86.38 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.455 1.102 . . . . 0.0 112.425 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.79 18.34 17.37 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.371 1.462 . . . . 0.0 116.33 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.86 151.09 97.43 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 117.679 0.74 . . . . 0.0 111.836 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.62 62.12 7.06 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.052 3.168 . . . . 0.0 110.968 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.6 p -135.79 155.87 49.69 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.859 0.863 . . . . 0.0 109.29 166.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -156.88 178.29 10.52 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.475 1.11 . . . . 0.0 110.762 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -117.75 -11.44 10.36 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -169.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -149.1 176.86 10.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.631 1.173 . . . . 0.0 110.895 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 m -129.25 156.54 41.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.133 0 O-C-N 121.136 -0.978 . . . . 0.0 111.371 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.1 p -60.94 -34.03 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.768 1.227 . . . . 0.0 111.166 173.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.2 m 164.6 166.4 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 131.614 3.966 . . . . 0.0 106.628 -175.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -96.4 77.2 2.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.152 1.781 . . . . 0.0 107.793 174.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.504 ' CD2' ' H ' ' A' ' 98' ' ' ASN . 5.4 p80 -133.93 -65.23 0.67 Allowed 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.64 -0.663 . . . . 0.0 111.619 -159.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.504 ' H ' ' CD2' ' A' ' 97' ' ' HIS . 0.9 OUTLIER -96.51 16.93 17.35 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.19 1.396 . . . . 0.0 108.935 167.017 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.03 140.64 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 128.315 2.646 . . . . 0.0 107.451 -174.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.417 ' HD3' ' H ' ' A' ' 101' ' ' LEU . 14.4 tppt? -129.24 151.43 49.91 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 128.226 2.61 . . . . 0.0 108.591 -173.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.417 ' H ' ' HD3' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -146.05 154.14 41.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.479 1.911 . . . . 0.0 107.875 -176.729 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.511 ' HG2' ' CG ' ' A' ' 113' ' ' GLU . 19.3 mmt180 -136.52 121.9 19.37 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -71.04 126.02 28.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.473 1.033 . . . . 0.0 110.274 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -128.4 176.98 7.3 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.866 0.841 . . . . 0.0 109.786 158.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.31 14.24 25.02 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.229 2.212 . . . . 0.0 111.542 173.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 t -46.96 -40.55 14.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.408 1.883 . . . . 0.0 115.44 -159.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.6 pp -73.36 -11.25 60.42 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 115.11 -4.81 22.11 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.158 1.837 . . . . 0.0 112.957 -169.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -141.61 -85.35 0.18 Allowed 'General case' 0 C--N 1.349 0.584 0 CA-C-N 120.143 1.971 . . . . 0.0 109.753 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.2 t -144.58 111.68 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -129.56 106.56 8.83 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.678 1.591 . . . . 0.0 108.79 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 10.1 m -106.28 141.94 36.78 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.602 -1.189 . . . . 0.0 107.88 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.511 ' CG ' ' HG2' ' A' ' 102' ' ' ARG . 22.2 pt-20 -67.71 160.97 26.98 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.791 1.632 . . . . 0.0 110.691 172.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.7 t -141.64 104.04 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.19 161.26 28.11 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.731 0.812 . . . . 0.0 109.078 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 13.5 m -77.73 106.71 9.72 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.79 -25.1 10.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.259 1.424 . . . . 0.0 113.177 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.559 ' HD3' HD13 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -80.72 -37.29 30.88 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 126.596 1.958 . . . . 0.0 113.149 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 3.9 p -153.82 69.88 0.81 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -161.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.27 58.0 0.25 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 128.086 2.554 . . . . 0.0 113.693 -159.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.7 -147.55 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.738 1.615 . . . . 0.0 112.319 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -70.12 -64.89 0.8 Allowed 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.282 1.433 . . . . 0.0 109.423 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 49.84 -116.84 0.94 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.421 1.889 . . . . 0.0 107.561 -177.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.76 -119.32 0.62 Allowed Glycine 0 CA--C 1.521 0.445 0 CA-C-N 118.501 0.591 . . . . 0.0 112.578 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -158.0 177.57 11.17 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 122.453 -0.44 . . . . 0.0 111.155 -170.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.1 p -124.64 145.02 32.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 124.663 1.185 . . . . 0.0 108.884 170.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -140.05 144.67 36.99 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.584 1.554 . . . . 0.0 108.668 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.08 121.12 19.67 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.403 0.547 . . . . 0.0 109.55 173.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.39 -45.15 0.22 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.624 2.37 . . . . 0.0 111.946 -165.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -90.53 -178.34 44.01 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.404 1.002 . . . . 0.0 112.935 -170.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.93 155.22 69.22 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.829 2.353 . . . . 0.0 111.017 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.48 ' HD2' ' H ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -68.89 154.06 95.33 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.908 174.639 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.07 -36.64 2.45 Favored 'Cis proline' 0 C--N 1.35 0.642 0 CA-C-N 119.506 0.859 . . . . 0.0 111.429 -5.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.51 59.19 1.87 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 127.826 2.451 . . . . 0.0 111.531 -175.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -88.33 -5.79 75.34 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.869 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -98.29 104.37 16.39 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 119.414 1.607 . . . . 0.0 111.048 -166.752 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.64 94.06 5.62 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.173 1.789 . . . . 0.0 108.347 -173.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -62.33 130.37 44.98 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 160.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 22.1 t -144.02 130.23 19.71 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.3 ptp -142.8 140.95 31.54 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.445 0.698 . . . . 0.0 110.395 -173.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.91 15.5 28.83 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.991 2.116 . . . . 0.0 110.647 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.2 p -65.96 112.0 3.6 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.023 1.729 . . . . 0.0 110.53 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -54.29 -24.84 20.54 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.54 1.136 . . . . 0.0 112.993 164.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -69.83 2.29 3.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.317 2.247 . . . . 0.0 116.351 -170.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 90.7 mt -87.26 87.02 7.32 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.091 0.859 . . . . 0.0 109.836 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -87.01 126.44 34.74 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.349 1.06 . . . . 0.0 108.785 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -70.87 135.22 47.89 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.327 0.967 . . . . 0.0 109.453 170.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.2 pt -136.44 163.6 48.76 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.33 1.052 . . . . 0.0 109.764 171.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.21 168.73 7.23 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.592 2.195 . . . . 0.0 111.646 161.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.414 ' HA ' ' HD2' ' A' ' 150' ' ' ARG . 6.8 mmm-85 -62.75 -4.74 2.23 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 119.51 3.152 . . . . 0.0 119.51 -158.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 178.11 -62.58 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.195 1 C-N-CA 132.905 4.482 . . . . 0.0 109.552 161.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -156.73 8.26 0.2 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.973 2.909 . . . . 0.0 110.831 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.9 pp -65.54 -14.54 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.872 1.214 . . . . 0.0 112.936 170.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 159.097 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.4 pt -129.33 136.97 29.97 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.401 1.08 . . . . 0.0 111.901 -168.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.0 120.92 3.87 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.997 2.464 . . . . 0.0 110.454 170.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.83 146.99 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 159.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -126.87 154.81 43.92 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 127.267 2.227 . . . . 0.0 105.621 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.53 91.94 2.53 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 171.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.08 -43.76 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 C-N-CA 123.346 0.659 . . . . 0.0 111.664 -171.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.97 -28.88 58.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.633 0.773 . . . . 0.0 110.904 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 152' ' ' GLN . 7.0 ttmm -87.39 -1.4 57.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.27 1.428 . . . . 0.0 111.091 170.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.8 t30 38.15 65.83 0.55 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 128.915 2.886 . . . . 0.0 112.427 -171.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.43 162.34 28.3 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.69 1.996 . . . . 0.0 109.44 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.7 t -138.9 134.47 42.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 164.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -141.53 97.58 3.19 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.684 1.594 . . . . 0.0 108.311 -172.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.4 ttp -78.94 133.29 36.91 Favored 'General case' 0 C--N 1.339 0.14 0 O-C-N 121.371 -0.831 . . . . 0.0 109.852 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.7 t -137.15 161.27 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.558 1.543 . . . . 0.0 107.063 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -58.32 170.26 0.74 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 123.03 1.395 . . . . 0.0 112.54 164.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 -69.49 176.42 3.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.858 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.56 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 2.4 tt -78.45 128.24 38.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 164.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -158.13 97.17 1.5 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.7 mt -138.29 176.21 8.9 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.936 1.294 . . . . 0.0 108.646 -167.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.8 p -88.11 -159.88 0.58 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 164.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.04 -48.69 56.93 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.888 1.222 . . . . 0.0 109.313 160.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.67 -12.53 16.68 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 126.58 1.952 . . . . 0.0 114.856 -159.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.41 ' C ' ' H ' ' A' ' 32' ' ' ARG . 12.9 mm-40 -85.0 -48.34 9.34 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 127.028 2.131 . . . . 0.0 110.316 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.437 ' CH2' HD13 ' A' ' 24' ' ' ILE . 61.0 m95 -60.61 8.94 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 128.135 2.574 . . . . 0.0 115.711 -168.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -139.06 -11.29 1.27 Allowed 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 128.928 2.891 . . . . 0.0 111.878 -164.037 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.9 -16.41 3.27 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 118.369 -0.824 . . . . 0.0 112.081 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pt -110.98 13.33 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 119.472 1.033 . . . . 0.0 111.958 172.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.01 167.94 14.02 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.006 0.923 . . . . 0.0 111.403 -171.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.2 137.8 74.19 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 123.89 0.876 . . . . 0.0 108.761 169.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -70.13 -3.69 12.76 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.398 2.732 . . . . 0.0 113.23 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -95.01 -30.04 14.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 127.233 2.213 . . . . 0.0 110.328 170.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.05 -48.46 81.66 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 120.975 1.716 . . . . 0.0 111.092 -174.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -59.07 -37.8 77.93 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.524 0.729 . . . . 0.0 111.885 -174.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -81.41 -45.81 15.53 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.869 -0.586 . . . . 0.0 109.827 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.581 HG12 ' HB1' ' A' ' 143' ' ' ALA . 2.8 t -58.59 -28.11 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 120.103 1.319 . . . . 0.0 110.005 -177.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.19 -8.29 23.33 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 173.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -119.26 -27.51 5.63 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.429 1.468 . . . . 0.0 111.12 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -105.0 12.35 32.39 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.07 1.748 . . . . 0.0 112.868 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.47 7.92 1.49 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.669 2.788 . . . . 0.0 115.374 171.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.496 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . . . . . . 0 CA--C 1.526 0.74 0 CA-C-O 118.485 -1.175 . . . . 0.0 114.888 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 t0 . . . . . 0 C--O 1.234 0.28 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.67 169.78 46.23 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 125.894 1.711 . . . . 0.0 112.402 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.6 pt -128.19 173.32 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 162.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -94.56 119.04 32.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.889 1.275 . . . . 0.0 110.066 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.27 119.98 10.68 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 158.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 2.8 t -74.81 71.44 1.99 Allowed 'General case' 0 C--O 1.236 0.389 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 159.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 tt -62.9 -26.62 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.604 -162.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.6 t -77.65 3.15 14.6 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.334 1.454 . . . . 0.0 112.393 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.3 p -140.54 21.69 2.36 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.318 -0.864 . . . . 0.0 111.464 158.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.35 36.18 52.45 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.2 m -124.3 177.02 6.08 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.381 2.273 . . . . 0.0 106.907 -170.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -138.25 145.65 41.6 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.647 1.112 . . . . 0.0 109.235 -173.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.43 HD13 ' CD2' ' A' ' 75' ' ' PHE 0.305 0.2 OUTLIER -151.18 -102.2 0.06 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 178.377 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.43 ' CD2' HD13 ' A' ' 74' ' ' LEU . 38.8 m-85 -55.27 150.48 11.13 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -158.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -112.7 143.68 43.49 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.895 0.878 . . . . 0.0 110.726 -174.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.4 m -61.15 -16.63 46.54 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -56.7 -23.26 40.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 120.355 1.434 . . . . 0.0 112.18 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 91' ' ' TYR . 7.1 t -112.96 -3.73 14.02 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.759 0.823 . . . . 0.0 112.384 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.418 ' HE2' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -114.8 68.21 0.7 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.958 -1.089 . . . . 0.0 108.134 176.691 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -135.78 49.12 2.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.989 0.916 . . . . 0.0 109.965 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -72.53 95.15 1.77 Allowed 'General case' 0 C--N 1.341 0.206 0 O-C-N 121.626 -0.671 . . . . 0.0 109.505 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.2 t -58.89 134.4 56.89 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.859 0.463 . . . . 0.0 110.287 -175.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.98 -67.93 3.66 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.61 -55.54 17.04 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.03 0.915 . . . . 0.0 111.527 -174.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.02 16.03 12.0 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 129.373 3.368 . . . . 0.0 115.871 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.39 150.62 8.51 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 125.261 1.424 . . . . 0.0 112.137 171.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.71 71.69 4.7 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.77 2.98 . . . . 0.0 110.384 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.4 p -133.89 152.31 51.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 164.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -131.78 176.45 8.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.816 1.246 . . . . 0.0 109.433 -170.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 79' ' ' THR . 7.5 p90 -124.91 -3.08 7.7 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.239 1.015 . . . . 0.0 112.587 176.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -151.64 -173.26 4.46 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.711 2.004 . . . . 0.0 107.693 -176.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.84 155.34 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 C-N-CA 123.783 0.833 . . . . 0.0 109.304 178.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 p -61.46 -33.34 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.382 0.611 . . . . 0.0 110.486 170.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.8 m 168.02 159.82 0.04 OUTLIER 'General case' 0 C--O 1.234 0.279 1 C-N-CA 132.559 4.343 . . . . 0.0 105.075 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -101.04 80.9 2.18 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.411 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 17.9 p80 -125.43 -67.04 0.91 Allowed 'General case' 0 C--N 1.347 0.484 0 C-N-CA 126.443 1.897 . . . . 0.0 109.345 -165.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.411 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 0.7 OUTLIER -96.9 22.08 8.79 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 122.071 0.938 . . . . 0.0 112.429 179.525 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.9 tt -126.61 147.78 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 128.628 2.771 . . . . 0.0 104.847 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -125.14 138.35 54.15 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 122.803 0.441 . . . . 0.0 110.713 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mp -144.41 130.28 19.32 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.964 1.706 . . . . 0.0 109.07 -164.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.494 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 2.3 mpt_? -131.35 111.95 12.31 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 128.364 2.665 . . . . 0.0 105.345 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -74.41 128.44 35.54 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.629 1.571 . . . . 0.0 110.845 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 105' ' ' ARG . 32.0 t0 -134.2 178.01 7.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.095 1.358 . . . . 0.0 109.156 162.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.407 ' CZ ' ' HA ' ' A' ' 104' ' ' ASP . 0.0 OUTLIER -113.62 18.39 17.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.995 1.718 . . . . 0.0 110.544 -178.548 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.18 -30.56 60.16 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -158.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.85 -12.99 60.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.827 0.739 . . . . 0.0 112.617 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.5 -2.5 23.47 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 126.343 1.925 . . . . 0.0 112.936 -169.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 76.6 mtm -143.47 -81.91 0.18 Allowed 'General case' 0 C--N 1.35 0.605 0 CA-C-N 120.484 2.142 . . . . 0.0 109.629 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 42.9 t -143.08 116.6 3.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -125.44 111.2 14.83 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 126.33 1.852 . . . . 0.0 107.845 168.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.416 ' HB3' HG13 ' A' ' 126' ' ' VAL . 38.3 t -129.25 125.45 36.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -170.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.494 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 24.1 pt-20 -60.38 159.16 10.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.002 0.819 . . . . 0.0 111.387 -172.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -137.39 106.62 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 171.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.7 mp -120.67 170.28 9.58 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 164.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.1 163.34 12.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 118.927 -1.109 . . . . 0.0 108.592 164.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.46 -20.04 66.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.713 168.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.56 ' HG2' ' H ' ' A' ' 24' ' ' ILE . 30.7 tpt85 -148.46 -48.16 0.15 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -176.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 31.8 p -80.74 65.41 5.87 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.686 1.584 . . . . 0.0 108.453 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.39 57.33 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.217 2.607 . . . . 0.0 112.156 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.98 -47.38 52.55 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.648 0.779 . . . . 0.0 111.941 -164.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -169.07 -69.26 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 125.595 1.558 . . . . 0.0 107.601 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.4 mt 52.13 -114.02 0.79 Allowed 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 126.907 2.083 . . . . 0.0 110.846 -171.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.01 -119.45 0.72 Allowed Glycine 0 CA--C 1.525 0.692 0 CA-C-N 119.09 0.859 . . . . 0.0 112.367 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -159.47 163.55 35.22 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 122.299 -0.53 . . . . 0.0 111.17 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.561 HG21 ' HE2' ' A' ' 136' ' ' LYS . 5.5 p -101.49 132.96 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 168.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -131.53 155.57 47.22 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.369 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.06 112.7 3.1 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.253 1.021 . . . . 0.0 109.182 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -144.16 -24.45 0.55 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -171.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.45 163.77 13.56 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 123.349 0.5 . . . . 0.0 112.22 -167.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.86 -15.89 10.42 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.831 2.354 . . . . 0.0 114.353 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.5 ptt-85 142.63 165.08 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.945 1 C-N-CA 132.069 4.148 . . . . 0.0 107.181 -159.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.11 -53.11 0.15 OUTLIER 'Cis proline' 0 C--N 1.352 0.752 0 CA-C-N 121.624 1.616 . . . . 0.0 111.269 -9.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.9 p -73.76 -23.72 59.77 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.965 1.306 . . . . 0.0 112.743 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.74 5.37 68.9 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.282 0.944 . . . . 0.0 113.832 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.561 ' HE2' HG21 ' A' ' 126' ' ' VAL . 11.8 ptmt -125.44 162.17 25.44 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 119.647 1.723 . . . . 0.0 111.622 -167.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 ttm105 -125.23 109.53 12.95 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.642 1.577 . . . . 0.0 108.116 173.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -74.59 106.46 6.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.881 1.673 . . . . 0.0 106.977 165.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 18.2 t -121.94 135.55 54.87 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.561 1.073 . . . . 0.0 109.898 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.8 ptp -159.18 161.06 36.14 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.444 0.698 . . . . 0.0 110.754 -171.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -148.29 146.13 28.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.532 0.733 . . . . 0.0 109.426 161.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 91.0 p -171.78 -175.53 1.55 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.572 1.949 . . . . 0.0 107.208 158.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.581 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -60.87 -21.07 62.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.613 1.165 . . . . 0.0 113.163 165.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.53 22.03 0.06 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.735 1.614 . . . . 0.0 114.886 -169.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 88.9 mt -130.64 106.05 8.23 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.701 1.137 . . . . 0.0 110.018 -165.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -137.88 140.07 40.2 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.318 1.047 . . . . 0.0 108.788 174.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -76.95 141.38 40.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.219 0.918 . . . . 0.0 110.341 168.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.0 pt -137.01 170.53 10.54 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.077 1.751 . . . . 0.0 108.754 165.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.19 165.19 4.33 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.73 2.287 . . . . 0.0 112.783 167.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -45.05 -18.77 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 129.006 2.922 . . . . 0.0 118.341 -165.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -164.29 -78.71 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 171.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.418 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 31.8 mm-40 -149.71 42.05 0.87 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.99 2.516 . . . . 0.0 104.637 163.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.9 pp -76.39 -25.12 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 O-C-N 120.802 -1.186 . . . . 0.0 111.907 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 CA-C-O 117.306 -1.83 . . . . 0.0 110.542 175.528 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 . . . . . 0 N--CA 1.447 -0.604 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.419 HD13 ' CG ' ' A' ' 118' ' ' ARG . 1.3 pt -129.35 125.74 22.65 Favored Pre-proline 0 N--CA 1.452 -0.332 0 C-N-CA 125.595 1.558 . . . . 0.0 110.78 174.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.83 143.35 36.91 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.628 1.552 . . . . 0.0 110.384 164.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.8 mt -126.23 98.94 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.4 103.26 14.64 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.073 0.949 . . . . 0.0 108.546 -171.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.406 ' OG ' ' OD2' ' A' ' 151' ' ' ASP . 72.7 m -72.83 76.93 1.14 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.826 173.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.8 p -56.31 -39.63 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 118.709 0.686 . . . . 0.0 110.585 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.55 -12.66 10.55 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.301 1.84 . . . . 0.0 113.907 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' A' ' 151' ' ' ASP . 39.4 mtmt -128.68 7.73 5.74 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.503 1.521 . . . . 0.0 111.639 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.5 t30 32.76 74.0 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.948 2.499 . . . . 0.0 112.801 -159.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.41 167.86 20.55 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.52 142.97 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 164.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -125.15 165.59 17.97 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 158.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 46.7 ttm -132.47 133.97 44.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.4 t -137.98 161.0 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 -171.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -72.87 161.97 30.06 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.774 -1.829 . . . . 0.0 112.429 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.24 142.13 58.4 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 161.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.3 tt -60.48 137.07 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.002 1.321 . . . . 0.0 109.414 -176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -150.44 114.17 5.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 103.396 -2.816 . . . . 0.0 103.396 171.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.2 mt -137.87 -159.54 0.97 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.518 1.527 . . . . 0.0 108.357 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.0 m -144.56 175.31 10.23 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.437 -1.415 . . . . 0.0 107.65 162.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.28 -41.08 60.19 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.341 1.457 . . . . 0.0 113.363 -159.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.419 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 2.1 m-20 -77.06 -18.44 58.05 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -175.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -66.45 -47.27 73.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.965 0.802 . . . . 0.0 109.834 -176.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -62.12 15.23 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.285 2.234 . . . . 0.0 115.889 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.419 ' NE ' ' HA ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -133.22 -9.41 2.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 170.456 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -122.63 -17.56 6.88 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.19 0.905 . . . . 0.0 112.619 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 pt -110.75 19.01 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 118.949 0.795 . . . . 0.0 111.483 169.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -127.27 166.58 17.5 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.271 1.028 . . . . 0.0 111.534 -173.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.412 ' CG ' HH12 ' A' ' 66' ' ' ARG . 0.9 OUTLIER -58.62 137.56 86.22 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 163.352 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -67.83 -16.48 45.95 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.334 2.022 . . . . 0.0 112.245 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 3.7 tt0 -73.49 -42.47 61.8 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.753 -0.592 . . . . 0.0 109.856 170.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.51 -38.16 80.21 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.271 0.941 . . . . 0.0 111.125 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -54.92 -56.48 19.09 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.81 0.844 . . . . 0.0 110.824 172.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.41 ' HG2' ' HA ' ' A' ' 38' ' ' GLU . 27.6 ptt180 -63.65 -45.65 89.22 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.683 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.7 t -51.69 -37.8 20.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 125.091 1.356 . . . . 0.0 109.952 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.34 -10.84 18.28 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 176.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.62 -17.22 11.19 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.812 1.187 . . . . 0.0 113.46 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -116.1 8.77 14.57 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.254 1.022 . . . . 0.0 112.028 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.37 -30.77 0.08 Allowed 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 130.241 3.416 . . . . 0.0 113.561 -164.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.582 0 C-N-CA 126.365 1.936 . . . . 0.0 109.486 -170.527 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 CA--C 1.532 0.261 0 CA-C-O 121.606 0.717 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.66 179.32 41.91 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -173.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.2 pt -122.72 170.9 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.522 0.729 . . . . 0.0 109.617 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -97.89 143.93 27.97 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.144 0.978 . . . . 0.0 109.858 -174.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 34.2 ttt180 -127.62 146.68 50.46 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.669 1.188 . . . . 0.0 109.139 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 10.6 t -102.04 94.42 5.76 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 175.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.488 HG22 ' HA ' ' A' ' 144' ' ' ALA . 5.2 tt -58.11 -31.07 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.82 1.248 . . . . 0.0 111.371 -174.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.1 t -75.78 5.7 5.95 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.266 1.826 . . . . 0.0 111.906 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.8 p -144.06 10.63 1.53 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.741 1.216 . . . . 0.0 111.57 162.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.4 11.08 45.93 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.384 1.945 . . . . 0.0 114.712 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.0 m -114.44 142.99 45.65 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.351 1.576 . . . . 0.0 110.646 -159.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.459 ' C ' HD23 ' A' ' 74' ' ' LEU . 9.7 p-10 -95.53 147.93 23.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.467 1.507 . . . . 0.0 112.584 -178.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.482 HD22 ' HB3' ' A' ' 98' ' ' ASN 0.311 0.2 OUTLIER -152.98 -98.16 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.34 1.056 . . . . 0.0 113.666 173.485 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -49.96 131.15 22.71 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -159.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -69.64 132.1 45.66 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.447 -0.783 . . . . 0.0 109.124 171.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.8 m -62.95 -20.57 65.36 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.14 -12.57 41.09 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.202 1.365 . . . . 0.0 113.264 172.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.3 p -74.32 -25.27 59.45 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.552 -0.718 . . . . 0.0 111.886 166.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -121.69 95.07 4.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.321 1.848 . . . . 0.0 109.564 -168.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -141.93 116.07 9.41 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -137.75 110.77 7.75 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 171.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.9 p -63.48 103.16 0.49 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.127 1.371 . . . . 0.0 111.295 -167.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.47 -47.63 1.43 Allowed Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.744 1.164 . . . . 0.0 111.245 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -53.99 25.16 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.401 0.68 . . . . 0.0 110.469 177.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 47.16 23.66 1.84 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.933 2.206 . . . . 0.0 115.196 -167.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -54.66 153.28 11.01 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 118.966 1.383 . . . . 0.0 112.338 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.35 71.71 2.35 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.866 3.044 . . . . 0.0 112.26 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.9 p -133.81 149.97 51.41 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 158.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -147.24 173.46 12.53 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.66 1.184 . . . . 0.0 109.095 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -113.34 -13.6 12.88 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.473 -0.775 . . . . 0.0 112.832 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -155.27 -179.05 7.71 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.222 1.409 . . . . 0.0 108.349 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.07 166.71 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.586 1.554 . . . . 0.0 111.153 -175.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.54 -50.46 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.592 0.757 . . . . 0.0 109.534 168.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.4 m 172.81 162.58 0.12 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 130.518 3.527 . . . . 0.0 106.362 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -85.45 65.88 9.41 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -111.78 -56.78 2.34 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 124.753 1.221 . . . . 0.0 108.173 -173.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.482 ' HB3' HD22 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -100.66 4.15 43.02 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 175.66 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.32 131.42 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -107.96 140.98 40.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.387 1.475 . . . . 0.0 107.562 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.01 155.33 49.38 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.572 1.549 . . . . 0.0 109.77 175.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.36 131.54 36.5 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 128.561 2.744 . . . . 0.0 104.138 165.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.42 150.15 45.25 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 171.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.408 ' OD2' ' OG ' ' A' ' 106' ' ' SER . 53.0 t0 -148.3 140.24 23.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 158.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 16.39 0.07 Allowed 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.644 -1.285 . . . . 0.0 112.355 172.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.408 ' OG ' ' OD2' ' A' ' 104' ' ' ASP . 0.4 OUTLIER -43.51 -61.56 1.34 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 127.419 2.288 . . . . 0.0 113.149 -158.675 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pp -58.95 -14.34 8.95 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.389 1.076 . . . . 0.0 113.618 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 118.83 -4.9 14.25 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 126.651 2.072 . . . . 0.0 111.893 -172.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -141.02 -84.64 0.2 Allowed 'General case' 0 C--N 1.348 0.538 0 CA-C-N 119.645 1.723 . . . . 0.0 109.018 -174.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.2 t -147.13 108.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -173.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.412 ' HE ' ' CD2' ' A' ' 125' ' ' HIS . 44.2 ttt180 -131.17 83.31 2.1 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.478 1.511 . . . . 0.0 110.785 176.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 1.4 m -85.14 137.16 33.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.879 -0.581 . . . . 0.0 109.771 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -67.05 157.33 33.8 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.21 0.914 . . . . 0.0 111.132 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.4 t -133.82 107.13 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -129.81 154.27 47.41 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 27.8 t -69.59 137.0 51.97 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -70.43 -17.37 63.0 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.419 ' CG ' HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -104.98 -37.22 7.05 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.205 1.802 . . . . 0.0 112.781 -173.759 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 29.6 p -135.04 74.64 1.53 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 123.551 1.644 . . . . 0.0 108.337 171.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.82 55.93 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 1 C-N-CA 133.697 4.799 . . . . 0.0 113.462 172.334 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -112.05 -57.95 2.2 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 -159.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -138.54 -89.26 0.22 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.257 0.935 . . . . 0.0 109.678 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.422 ' HA ' ' HG3' ' A' ' 140' ' ' MET . 3.8 mt 58.94 -120.24 1.08 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.705 2.002 . . . . 0.0 109.88 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -174.96 -125.07 0.84 Allowed Glycine 0 CA--C 1.522 0.509 0 CA-C-N 118.972 0.805 . . . . 0.0 112.962 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.412 ' CD2' ' HE ' ' A' ' 111' ' ' ARG . 31.9 p-80 -161.2 179.07 8.66 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.169 0.587 . . . . 0.0 110.569 -172.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.582 HG21 ' HE2' ' A' ' 136' ' ' LYS . 2.8 p -129.62 143.24 41.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.767 1.227 . . . . 0.0 108.936 172.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -139.37 154.77 47.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.841 1.256 . . . . 0.0 109.219 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.84 113.76 10.23 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -164.93 -46.97 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.461 1.504 . . . . 0.0 111.48 -168.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -64.52 167.91 27.74 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.249 0.452 . . . . 0.0 112.508 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.55 177.16 7.79 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.594 2.196 . . . . 0.0 110.999 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -57.0 146.48 59.76 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 160.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.18 -52.6 0.16 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.529 0 CA-C-N 120.103 1.073 . . . . 0.0 114.641 15.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 17.5 p -77.95 -24.07 48.29 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -164.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.65 5.72 86.38 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 119.278 -0.734 . . . . 0.0 113.684 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.582 ' HE2' HG21 ' A' ' 126' ' ' VAL . 8.6 ptmt -132.9 159.81 38.83 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.38 1.59 . . . . 0.0 111.787 -168.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.2 ttm105 -125.07 109.17 12.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.759 1.624 . . . . 0.0 106.69 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -72.04 128.45 35.74 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 160.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 17.5 t -135.73 135.88 40.36 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.786 1.234 . . . . 0.0 108.282 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.422 ' HG3' ' HA ' ' A' ' 123' ' ' LEU . 35.1 ttm -140.04 156.5 46.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 122.276 1.036 . . . . 0.0 109.824 -165.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.58 104.11 4.33 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.469 1.908 . . . . 0.0 105.921 173.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 58.1 p -153.65 157.49 39.69 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 162.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.14 -25.01 54.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.488 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -67.56 4.91 0.91 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.745 2.018 . . . . 0.0 115.855 -159.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 83.4 mt -90.84 87.97 6.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.084 1.354 . . . . 0.0 109.674 -159.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -93.26 133.68 36.24 Favored 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -71.43 146.33 48.72 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 159.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.6 pt -137.84 166.27 27.48 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.818 1.247 . . . . 0.0 107.977 166.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.36 173.3 0.71 Allowed 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.419 2.079 . . . . 0.0 111.696 164.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -52.66 -17.81 1.48 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 -163.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.416 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 5.0 t70 -175.66 -77.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.546 2.338 . . . . 0.0 107.199 170.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -144.4 17.67 1.7 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.353 2.261 . . . . 0.0 110.175 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -74.0 -9.74 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.205 -0.934 . . . . 0.0 112.348 173.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.513 0 N-CA-C 106.935 -2.466 . . . . 0.0 106.935 159.271 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.8 pt -123.46 128.22 25.3 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.953 1.301 . . . . 0.0 110.556 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.58 108.76 2.63 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.29 2.66 . . . . 0.0 109.747 172.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.473 ' HA ' ' HD1' ' A' ' 97' ' ' HIS . 2.5 mp -86.84 155.95 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 167.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -135.45 101.53 4.84 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.896 1.279 . . . . 0.0 108.71 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.8 m -65.84 79.61 0.08 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 161.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.5 p -56.21 -41.92 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.041 0.936 . . . . 0.0 110.54 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.07 -12.03 10.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.388 1.475 . . . . 0.0 114.216 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.93 12.47 6.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.387 1.475 . . . . 0.0 110.925 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 33.57 59.15 0.52 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.105 2.562 . . . . 0.0 112.208 -167.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.8 mtp85 -106.48 169.13 8.7 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 173.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.9 t -137.6 97.94 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 168.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -98.89 81.97 2.7 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.882 1.673 . . . . 0.0 108.286 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 43.4 ttp -66.51 127.9 34.12 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.639 -0.663 . . . . 0.0 110.551 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.7 t -129.47 142.42 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.164 1.386 . . . . 0.0 108.278 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -78.99 144.1 35.06 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.399 0.619 . . . . 0.0 110.211 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 mtm105 -65.74 148.16 52.21 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.204 -160.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.91 114.87 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.286 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 168.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -145.84 102.1 3.62 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 102.626 -3.101 . . . . 0.0 102.626 170.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.7 mt -136.65 175.27 9.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.719 0.808 . . . . 0.0 109.72 -168.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.1 t -102.16 163.71 12.09 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 162.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -54.88 -30.89 59.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.04 0.936 . . . . 0.0 111.182 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.91 -27.6 60.96 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.013 2.525 . . . . 0.0 112.634 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -85.51 -45.31 11.92 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.796 1.238 . . . . 0.0 110.68 -170.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -60.61 14.15 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.749 2.42 . . . . 0.0 115.443 -174.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.29 -14.35 5.39 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.143 1.377 . . . . 0.0 113.701 172.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.34 -12.75 4.47 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.43 -172.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 pt -112.82 14.62 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 118.732 0.696 . . . . 0.0 111.356 167.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -117.32 171.84 7.7 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.192 1.397 . . . . 0.0 110.415 -175.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.93 143.01 88.33 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 165.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -70.58 -10.66 28.37 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.974 2.45 . . . . 0.0 111.875 168.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -75.61 -46.62 30.63 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 125.004 1.322 . . . . 0.0 109.889 165.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.89 -41.62 87.61 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 119.859 1.209 . . . . 0.0 110.675 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -57.21 -44.21 83.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.713 1.205 . . . . 0.0 112.014 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -80.1 -41.6 25.21 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 118.79 0.723 . . . . 0.0 110.16 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.54 HG12 ' HB1' ' A' ' 143' ' ' ALA . 23.9 t -52.75 -31.78 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 126.355 1.862 . . . . 0.0 109.728 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.77 -19.6 64.16 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 173.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.98 -31.85 12.88 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.057 1.299 . . . . 0.0 111.594 173.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -103.16 1.48 33.23 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.46 1.104 . . . . 0.0 113.371 -169.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.23 3.08 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.998 2.519 . . . . 0.0 114.712 -168.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.416 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . . . . . . 0 C--N 1.338 0.673 0 C-N-CA 125.893 1.711 . . . . 0.0 113.168 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.8 t0 . . . . . 0 C--O 1.235 0.309 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.8 153.13 11.49 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 125.444 1.497 . . . . 0.0 113.031 158.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.7 pt -130.05 154.17 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 162.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.68 126.46 32.37 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -80.36 114.27 19.15 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 158.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 19.7 t -65.11 85.07 0.05 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 162.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.9 tt -66.78 -22.92 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 122.061 -0.399 . . . . 0.0 110.487 -169.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 143' ' ' ALA . 64.7 m -61.42 -8.65 4.28 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.797 1.639 . . . . 0.0 113.704 169.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 21.4 p -138.88 15.94 2.67 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.893 1.224 . . . . 0.0 111.647 160.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.99 17.11 21.27 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.293 -1.282 . . . . 0.0 113.961 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.1 m -121.23 143.07 49.34 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.14 1.47 . . . . 0.0 108.95 -164.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.9 167.93 19.99 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.453 HD13 ' CD2' ' A' ' 75' ' ' PHE . 0.3 OUTLIER 176.08 -160.1 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 131.35 3.86 . . . . 0.0 109.001 172.72 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.453 ' CD2' HD13 ' A' ' 74' ' ' LEU . 5.0 m-85 0.14 107.52 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 131.548 3.939 . . . . 0.0 117.023 -165.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.12 144.58 57.0 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.454 1.502 . . . . 0.0 111.13 171.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.8 m -56.46 -30.47 62.93 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.59 -22.14 66.89 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -175.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 p -93.0 -7.37 46.02 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.729 0.695 . . . . 0.0 111.637 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.93 47.63 2.38 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.86 2.064 . . . . 0.0 108.819 -159.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -117.39 60.92 0.75 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.967 0.907 . . . . 0.0 109.666 -167.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -68.3 97.24 0.72 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.0 m -57.3 117.93 4.59 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.147 0.979 . . . . 0.0 112.039 -164.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.88 -49.86 4.29 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.354 0.978 . . . . 0.0 112.102 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.7 -43.97 91.77 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.208 1.004 . . . . 0.0 111.878 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 41.5 35.76 1.38 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 128.833 3.111 . . . . 0.0 114.662 -159.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.5 150.11 5.07 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 126.063 1.745 . . . . 0.0 110.243 175.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.96 69.91 6.1 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.564 2.842 . . . . 0.0 110.769 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.6 p -144.96 152.39 40.1 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.752 1.621 . . . . 0.0 108.821 -177.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.95 168.48 19.61 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.88 1.272 . . . . 0.0 109.085 -176.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -115.84 -9.75 11.8 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 118.811 -0.614 . . . . 0.0 112.445 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -156.64 176.02 13.28 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.846 1.259 . . . . 0.0 107.925 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.6 t -125.99 149.12 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.627 0.771 . . . . 0.0 110.907 -162.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 p -56.54 -54.65 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 126.452 1.901 . . . . 0.0 110.769 171.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.0 m 169.8 164.1 0.06 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 130.669 3.588 . . . . 0.0 107.282 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 mp0 -76.92 64.55 2.45 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.823 1.649 . . . . 0.0 109.508 173.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.473 ' HD1' ' HA ' ' A' ' 10' ' ' ILE . 18.5 p80 -115.41 -54.79 2.51 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.879 0.872 . . . . 0.0 109.284 -170.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -121.38 14.24 11.16 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.463 1.105 . . . . 0.0 111.859 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.88 150.77 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.807 1.643 . . . . 0.0 108.846 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -123.27 150.32 43.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.876 2.07 . . . . 0.0 110.771 -174.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.4 mt -145.72 137.14 24.98 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.804 2.442 . . . . 0.0 110.298 -166.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.98 117.25 11.28 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 129.102 2.961 . . . . 0.0 105.879 159.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -104.08 144.26 31.8 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.242 1.017 . . . . 0.0 110.869 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -152.62 179.44 8.61 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.946 2.499 . . . . 0.0 108.11 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.51 27.52 8.29 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.704 -1.248 . . . . 0.0 111.43 173.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.74 -38.9 67.71 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -159.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 pp -75.86 -9.41 58.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.16 6.09 37.03 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 117.579 -1.678 . . . . 0.0 112.781 -168.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 13.3 tpt -145.67 -91.23 0.1 Allowed 'General case' 0 C--N 1.349 0.567 0 CA-C-N 120.298 2.049 . . . . 0.0 109.212 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.3 t -139.37 119.68 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 172.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.424 HH21 ' CE1' ' A' ' 125' ' ' HIS . 17.5 ttt180 -121.83 128.23 51.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 165.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 43.3 t -124.49 142.55 51.24 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 168.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -67.61 162.68 22.98 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.886 170.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 73.2 t -136.81 108.67 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 169.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -125.29 173.09 9.05 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 168.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 39.6 t -71.29 159.59 34.32 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.448 -0.783 . . . . 0.0 108.985 171.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -81.55 -13.89 57.51 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 170.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -115.94 -58.44 2.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 173.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.2 p -94.71 62.39 2.73 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.8 51.29 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 128.362 2.665 . . . . 0.0 113.434 -168.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.38 -71.77 0.59 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.787 1.235 . . . . 0.0 113.359 -167.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -130.79 -83.93 0.53 Allowed 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.761 0.824 . . . . 0.0 109.135 -165.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mt 50.66 -108.88 0.37 Allowed 'General case' 0 C--N 1.338 0.097 0 C-N-CA 126.89 2.076 . . . . 0.0 109.989 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.23 -125.42 0.94 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.586 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.424 ' CE1' HH21 ' A' ' 111' ' ' ARG . 20.3 p-80 -162.42 178.97 8.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.387 -0.478 . . . . 0.0 110.468 -170.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.571 HG21 ' HE2' ' A' ' 136' ' ' LYS . 2.9 p -129.5 143.25 41.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 124.72 1.208 . . . . 0.0 108.89 172.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -133.79 150.79 51.45 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 124.225 0.953 . . . . 0.0 110.744 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -64.13 106.83 1.14 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.048 1.339 . . . . 0.0 109.333 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -167.57 -48.53 0.02 OUTLIER 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.082 1.353 . . . . 0.0 111.472 -169.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -65.18 172.37 21.8 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.785 0.707 . . . . 0.0 113.408 -170.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -69.83 167.84 23.38 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.253 1.969 . . . . 0.0 111.348 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -61.63 151.6 77.73 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 162.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.33 -47.67 0.3 Allowed 'Cis proline' 0 C--N 1.347 0.472 0 CA-C-N 119.944 1.016 . . . . 0.0 114.182 14.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.2 p -73.96 -26.28 60.4 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -166.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.72 5.62 79.46 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 119.184 0.902 . . . . 0.0 113.678 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.571 ' HE2' HG21 ' A' ' 126' ' ' VAL . 10.3 ptmt -130.23 156.83 43.96 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.983 1.391 . . . . 0.0 111.275 -168.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 14.7 ttt85 -125.27 103.83 8.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.271 1.828 . . . . 0.0 108.234 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -73.89 141.19 46.06 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.105 1.362 . . . . 0.0 107.346 167.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 53.7 t -142.92 136.13 28.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.319 1.847 . . . . 0.0 107.703 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 6.8 ttt -144.71 141.54 29.37 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.744 0.818 . . . . 0.0 108.976 -174.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -148.11 93.48 2.18 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.589 1.156 . . . . 0.0 108.917 -170.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 77.3 p -163.27 -173.41 3.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 167.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.54 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -56.75 -21.31 27.32 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.225 1.41 . . . . 0.0 114.183 168.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.34 26.29 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.725 2.41 . . . . 0.0 115.98 -164.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 62.3 mt -121.33 38.33 4.11 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.744 1.218 . . . . 0.0 111.852 -162.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -75.47 108.99 8.64 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -64.19 140.18 58.84 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.477 -0.764 . . . . 0.0 109.207 163.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.3 pt -128.01 165.25 31.8 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 159.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -53.34 163.08 2.65 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.584 2.856 . . . . 0.0 112.976 166.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -15.76 -53.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 129.669 3.188 . . . . 0.0 114.865 173.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -157.08 -67.68 0.1 Allowed 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 127.313 2.245 . . . . 0.0 111.283 159.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -144.17 1.42 1.1 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.353 1.461 . . . . 0.0 110.9 -163.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.06 -19.03 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.189 1.796 . . . . 0.0 114.56 -170.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.958 0 CA-C-O 116.951 -2.027 . . . . 0.0 109.529 -177.523 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 8.6 ttt85 . . . . . 0 CA--C 1.508 -0.659 0 CA-C-O 121.291 0.567 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.509 HD11 ' HD3' ' A' ' 118' ' ' ARG . 7.7 pt -136.45 146.94 57.95 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 113.89 -1.505 . . . . 0.0 112.259 -177.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.86 134.12 10.56 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.71 2.94 . . . . 0.0 111.485 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.4 mm -114.58 100.11 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 127.053 2.141 . . . . 0.0 105.737 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -100.4 124.18 45.57 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.9 m -101.8 87.1 3.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -54.01 -39.3 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.679 0.791 . . . . 0.0 111.255 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.645 ' HB1' ' HD2' ' A' ' 150' ' ' ARG . . . -52.65 -25.58 11.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.286 2.234 . . . . 0.0 114.78 178.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -124.71 7.1 8.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.763 2.025 . . . . 0.0 111.348 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 33.44 63.1 0.37 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.53 2.332 . . . . 0.0 111.638 -161.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.5 mtp-105 -109.87 164.28 12.73 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.1 p -134.85 144.92 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 158.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -136.71 165.55 25.64 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 158.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.7 ttp -127.66 116.98 21.12 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -170.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.76 139.12 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.044 1.738 . . . . 0.0 107.64 -160.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 7' ' ' ARG 0.284 3.5 pm0 -89.53 148.87 23.15 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 122.234 1.016 . . . . 0.0 112.42 -169.873 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.484 HH11 ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -66.93 146.18 54.66 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.329 -162.503 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.13 118.81 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -167.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -137.73 101.83 4.57 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.487 1.515 . . . . 0.0 107.388 173.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.437 HD11 HD11 ' A' ' 34' ' ' ILE . 40.9 mt -134.15 177.83 7.44 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 127.227 2.211 . . . . 0.0 106.83 166.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.6 t -162.73 -14.84 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -176.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 30' ' ' GLU . 8.4 t70 -118.63 -146.51 0.39 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.623 1.102 . . . . 0.0 109.576 -171.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.7 5.35 0.12 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.841 1.657 . . . . 0.0 113.643 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 28' ' ' ASP . 27.8 mt-10 -62.79 -44.61 95.73 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 125.577 1.551 . . . . 0.0 110.728 -163.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -68.58 45.03 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 128.334 2.654 . . . . 0.0 112.179 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.38 -44.35 0.07 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.469 1.908 . . . . 0.0 108.878 160.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -75.22 -27.19 59.44 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.446 -0.788 . . . . 0.0 112.305 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.437 HD11 HD11 ' A' ' 26' ' ' LEU . 4.6 pt -110.83 28.18 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 119.377 0.99 . . . . 0.0 111.847 176.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mt -117.93 166.57 12.34 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 125.133 1.373 . . . . 0.0 111.511 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.506 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 5.2 m-20 -61.35 146.76 88.61 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 163.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -67.3 -9.71 26.15 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.471 2.114 . . . . 0.0 112.327 169.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -78.63 -51.83 9.32 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.973 1.709 . . . . 0.0 109.95 163.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.506 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -58.67 -37.93 77.08 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.45 1.477 . . . . 0.0 110.451 -176.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -52.6 -52.9 53.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.896 1.278 . . . . 0.0 111.84 173.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.402 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 19.4 ptp180 -77.21 -45.08 27.75 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.596 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.855 HG12 ' HB1' ' A' ' 143' ' ' ALA . 54.9 t -53.72 -31.15 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.56 1.144 . . . . 0.0 110.13 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.59 -18.31 64.77 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 174.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -102.34 -37.03 8.24 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.383 1.447 . . . . 0.0 112.43 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 41' ' ' ARG . 18.0 ptpt -97.29 2.95 51.34 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.798 1.239 . . . . 0.0 113.2 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.69 13.82 0.55 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.773 2.429 . . . . 0.0 114.437 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.711 0 C-N-CA 125.645 1.593 . . . . 0.0 109.381 177.492 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.8 t0 . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 122.109 0.957 . . . . 0.0 113.088 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.23 154.64 25.53 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 128.558 2.98 . . . . 0.0 110.1 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.6 pt -140.07 174.7 7.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.724 1.21 . . . . 0.0 109.327 173.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -99.79 108.34 20.61 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.564 1.146 . . . . 0.0 110.285 -177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.54 122.96 20.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 158.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.496 ' HB2' HD11 ' A' ' 74' ' ' LEU . 40.5 t -72.16 90.39 1.21 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 158.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.701 HD12 ' HD2' ' A' ' 146' ' ' LYS . 17.1 tt -65.15 -21.42 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 121.984 -0.447 . . . . 0.0 111.092 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.3 t -72.66 -0.25 12.52 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.12 1.768 . . . . 0.0 111.859 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.7 p -143.82 9.5 1.54 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.427 1.012 . . . . 0.0 113.334 160.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.76 55.36 30.44 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 -176.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 73' ' ' ASP . 49.2 m -151.95 179.08 8.77 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.75 -1.441 . . . . 0.0 108.467 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.44 ' C ' HD13 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -132.5 141.27 48.7 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.135 1.374 . . . . 0.0 108.487 -163.598 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 67' ' ' CYS 0.283 0.0 OUTLIER -151.23 -89.55 0.06 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 177.8 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -54.29 151.65 7.17 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.263 1.025 . . . . 0.0 112.96 -170.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.431 ' OD2' ' HB2' ' A' ' 14' ' ' ALA . 12.0 t70 -126.32 150.75 48.31 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.743 1.217 . . . . 0.0 111.099 -166.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.4 t -59.94 -23.06 63.25 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.053 -1.451 . . . . 0.0 113.739 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -60.54 -19.69 57.98 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 120.953 1.706 . . . . 0.0 112.583 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.422 ' HA ' ' CE2' ' A' ' 91' ' ' TYR 0.253 2.2 t -119.65 -3.76 10.32 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.401 1.48 . . . . 0.0 111.035 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -96.51 94.45 7.38 Favored 'General case' 0 C--N 1.344 0.36 0 O-C-N 120.739 -1.226 . . . . 0.0 109.781 -175.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -63.22 127.33 30.78 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 163.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.547 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 1.7 t70 -147.13 -58.92 0.27 Allowed 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 127.474 2.31 . . . . 0.0 107.322 -163.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.8 m -51.89 111.78 0.67 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.519 1.527 . . . . 0.0 111.401 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.07 -43.19 0.64 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.333 1.92 . . . . 0.0 114.743 174.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.3 m -81.93 -72.0 0.46 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.041 1.336 . . . . 0.0 108.88 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 82' ' ' ASP . . . 48.46 45.24 29.21 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 126.467 1.984 . . . . 0.0 114.26 170.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.21 148.07 34.96 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 113.801 -1.199 . . . . 0.0 107.952 166.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.67 68.59 7.03 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.836 2.357 . . . . 0.0 110.574 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.6 p -139.02 150.16 45.5 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.703 1.201 . . . . 0.0 109.222 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -130.04 166.2 20.62 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.629 1.972 . . . . 0.0 107.779 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.422 ' CE2' ' HA ' ' A' ' 79' ' ' THR . 41.7 p90 -123.57 -16.43 6.76 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.31 176.08 9.14 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.55 2.34 . . . . 0.0 106.073 175.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.9 p -145.5 155.86 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 121.681 -0.637 . . . . 0.0 110.982 -168.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 p -60.93 -36.27 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.397 1.479 . . . . 0.0 111.501 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.5 m 140.21 151.84 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 1 C-N-CA 131.794 4.038 . . . . 0.0 108.113 -169.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -75.9 52.17 0.68 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.981 1.712 . . . . 0.0 111.021 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -105.63 -49.1 3.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.274 1.029 . . . . 0.0 109.593 -167.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.505 ' HA ' ' HB3' ' A' ' 117' ' ' ALA . 38.5 t-20 -125.26 22.97 7.73 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.526 1.13 . . . . 0.0 111.346 165.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.03 125.52 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 163.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.47 148.97 25.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.996 2.118 . . . . 0.0 107.142 -178.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mp -134.58 160.6 37.57 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.576 1.151 . . . . 0.0 108.752 167.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.447 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 6.1 mpt_? -133.57 130.12 37.97 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 131.336 3.854 . . . . 0.0 102.903 162.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -66.07 140.63 58.26 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.4 0.619 . . . . 0.0 109.592 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -142.69 171.86 13.48 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 103.808 -2.664 . . . . 0.0 103.808 158.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -130.74 18.93 5.13 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.561 2.344 . . . . 0.0 110.281 -173.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 t -54.64 -38.35 66.78 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 128.332 2.653 . . . . 0.0 113.702 -159.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.0 pp -75.69 -8.38 56.68 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.16 4.06 41.43 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.338 1.446 . . . . 0.0 112.55 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 97.2 mtp -140.14 -99.17 0.15 Allowed 'General case' 0 C--N 1.346 0.43 0 CA-C-N 119.382 1.591 . . . . 0.0 107.915 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -143.97 100.98 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.272 0 CA-C-N 120.733 1.606 . . . . 0.0 108.225 -173.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -114.54 61.36 0.67 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.071 1.348 . . . . 0.0 111.085 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 46.7 m -70.07 137.7 51.44 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.447 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 18.8 pt-20 -64.58 158.32 24.61 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.95 0.796 . . . . 0.0 110.591 173.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.8 t -139.22 102.21 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -132.2 160.17 36.88 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.3 m -70.97 128.24 35.31 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.505 ' HB3' ' HA ' ' A' ' 98' ' ' ASN . . . -72.61 -18.84 61.56 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -169.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.509 ' HD3' HD11 ' A' ' 8' ' ' ILE . 1.8 tpt180 -78.87 -38.17 38.39 Favored 'General case' 0 CA--C 1.525 0.012 0 C-N-CA 126.483 1.913 . . . . 0.0 111.794 168.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 23.9 p -146.51 89.66 1.87 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.501 1.521 . . . . 0.0 107.846 -166.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.18 55.27 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.323 2.649 . . . . 0.0 112.127 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -74.76 -77.26 0.12 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -158.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.416 ' H ' ' CD2' ' A' ' 123' ' ' LEU . 55.4 t-80 -138.14 -73.19 0.41 Allowed 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.416 ' CD2' ' H ' ' A' ' 122' ' ' HIS . 1.9 mm? 56.83 -112.74 0.71 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.808 2.043 . . . . 0.0 108.228 169.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.72 -126.95 1.27 Allowed Glycine 0 CA--C 1.526 0.72 0 CA-C-N 119.504 1.047 . . . . 0.0 113.959 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -155.59 172.91 17.48 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.349 0.659 . . . . 0.0 111.227 -174.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.451 HG21 ' HE2' ' A' ' 136' ' ' LYS . 5.1 p -114.3 144.41 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 C-N-CA 124.516 1.126 . . . . 0.0 108.024 170.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -144.89 157.9 43.99 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.191 0.996 . . . . 0.0 110.627 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.15 102.34 2.48 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.378 1.871 . . . . 0.0 109.155 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -165.74 -48.7 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.335 1.054 . . . . 0.0 111.348 -171.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -66.18 173.08 24.81 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 123.173 0.416 . . . . 0.0 112.909 -173.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.42 168.26 24.77 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.698 2.266 . . . . 0.0 111.77 -171.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -61.06 151.44 75.09 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 161.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.44 -42.23 0.84 Allowed 'Cis proline' 0 C--N 1.345 0.383 0 CA-C-N 119.999 1.035 . . . . 0.0 114.655 16.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.3 p -77.29 -30.04 54.05 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -168.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.48 13.55 82.8 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 118.77 0.714 . . . . 0.0 113.767 -174.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.451 ' HE2' HG21 ' A' ' 126' ' ' VAL . 11.4 ptmt -128.71 154.56 46.21 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 119.172 1.486 . . . . 0.0 111.029 -171.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.3 ttm105 -120.82 106.19 11.43 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -71.99 126.98 31.14 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 160.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 23.6 t -135.82 126.85 27.84 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.607 1.094 . . . . 0.0 108.184 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -145.65 147.48 32.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.279 0.632 . . . . 0.0 109.632 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -140.89 130.36 23.88 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.2 p -168.98 174.66 6.22 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.686 1.594 . . . . 0.0 107.941 167.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.855 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -62.91 -9.15 8.72 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.301 1.04 . . . . 0.0 112.972 167.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.27 -20.43 63.05 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.692 1.197 . . . . 0.0 114.202 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.2 mt -83.12 74.38 10.0 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.112 0.869 . . . . 0.0 111.333 -161.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.701 ' HD2' HD12 ' A' ' 68' ' ' ILE . 66.8 tttt -98.3 119.16 36.49 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.045 0.938 . . . . 0.0 110.006 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.18 147.14 53.77 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.961 0.41 . . . . 0.0 110.192 164.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.7 pt -140.89 170.22 9.92 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 126.516 1.926 . . . . 0.0 108.42 162.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -54.86 177.19 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.541 3.494 . . . . 0.0 113.184 159.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.645 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 5.5 mmt-85 -32.39 -45.42 0.11 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.726 2.411 . . . . 0.0 115.989 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -165.42 -71.85 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.577 0.751 . . . . 0.0 108.988 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.9 9.19 0.77 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.906 1.282 . . . . 0.0 112.799 -176.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.5 pp -67.85 -30.68 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -169.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 CA-C-O 117.191 -1.894 . . . . 0.0 109.478 -175.711 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 119.846 -0.121 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.483 ' HB ' HD21 ' A' ' 98' ' ' ASN . 47.2 pt -122.2 110.25 32.8 Favored Pre-proline 0 CA--C 1.536 0.435 0 O-C-N 120.715 -1.241 . . . . 0.0 110.842 -173.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.03 140.42 34.61 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.42 1.413 . . . . 0.0 109.016 171.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.6 mt -127.9 149.13 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -132.06 152.32 51.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -175.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.2 m -126.73 80.13 1.92 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 p -57.05 -39.2 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 123.005 0.522 . . . . 0.0 110.908 -169.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.75 2.81 3.74 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.333 1.053 . . . . 0.0 113.604 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -135.45 5.75 3.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.567 2.347 . . . . 0.0 110.274 171.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 34.09 42.6 0.06 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 128.375 2.67 . . . . 0.0 113.393 -162.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -87.09 161.99 17.82 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.315 -0.866 . . . . 0.0 108.995 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -135.96 132.19 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 167.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -133.83 107.05 7.64 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.868 1.667 . . . . 0.0 106.535 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 40.5 ttp -81.76 136.45 35.43 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.099 -1.001 . . . . 0.0 108.637 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.4 t -129.27 169.77 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.708 2.003 . . . . 0.0 106.067 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -99.95 152.82 19.73 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 120.526 -1.359 . . . . 0.0 110.37 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.426 ' CG ' ' HD3' ' A' ' 118' ' ' ARG . 25.0 ttm180 -68.18 137.2 54.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.02 1.728 . . . . 0.0 110.427 -168.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.2 tt -74.4 125.7 34.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.482 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.9 -170.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -154.37 110.67 3.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.9 mt -138.88 173.77 11.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.591 1.556 . . . . 0.0 109.256 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.63 159.02 21.66 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.042 2.137 . . . . 0.0 107.786 165.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.53 -35.09 76.75 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.562 -0.711 . . . . 0.0 112.607 -172.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.22 -28.62 65.41 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-O 121.051 0.453 . . . . 0.0 112.192 -174.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -59.72 -38.15 80.87 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.011 1.324 . . . . 0.0 110.048 -169.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -61.47 11.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.047 2.539 . . . . 0.0 116.61 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.89 -1.35 2.71 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 166.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -126.73 -20.59 4.25 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.825 -174.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 pt -109.13 -1.64 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.635 0.652 . . . . 0.0 111.704 165.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -101.72 163.72 12.11 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.306 1.042 . . . . 0.0 110.573 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.96 142.62 79.22 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.371 0.668 . . . . 0.0 109.772 168.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -65.84 -16.53 53.3 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.02 1.813 . . . . 0.0 111.453 166.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -71.57 -42.9 67.22 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 121.982 -0.449 . . . . 0.0 110.014 169.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.6 -44.47 96.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 121.225 -0.922 . . . . 0.0 109.912 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -56.8 -45.24 82.32 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.144 0.978 . . . . 0.0 112.336 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -76.44 -49.26 17.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -176.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.734 HG13 ' HA2' ' A' ' 47' ' ' GLY . 74.0 t -54.54 -33.41 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 125.156 1.382 . . . . 0.0 108.685 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.01 -18.95 63.88 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.44 -26.39 14.47 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.244 1.384 . . . . 0.0 112.192 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -108.86 -1.37 19.22 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 124.575 1.15 . . . . 0.0 112.779 -172.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.18 -2.4 0.05 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.18 2.592 . . . . 0.0 115.059 -169.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.734 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . . . . . . 0 C--N 1.339 0.744 0 CA-C-N 119.417 1.008 . . . . 0.0 111.94 174.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.5 t0 . . . . . 0 C--O 1.238 0.469 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.521 ' H ' ' HG2' ' A' ' 150' ' ' ARG . . . 100.53 168.41 28.82 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 125.116 1.341 . . . . 0.0 112.167 161.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 76' ' ' ASP . 38.6 pt -135.35 164.21 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 113.587 -1.307 . . . . 0.0 108.091 163.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -78.27 122.57 25.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.634 0.73 . . . . 0.0 109.306 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.79 117.48 23.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.234 1.814 . . . . 0.0 106.377 163.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 5.2 t -71.38 69.72 0.58 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.455 1.502 . . . . 0.0 108.746 171.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.4 tt -61.46 -19.39 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 125.512 1.525 . . . . 0.0 112.754 -169.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.1 t -70.89 -1.0 10.36 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.267 1.427 . . . . 0.0 112.617 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 9.6 p -146.19 -7.57 0.54 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.494 1.043 . . . . 0.0 113.246 158.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.9 -8.28 59.45 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.207 -1.329 . . . . 0.0 113.032 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.2 m -64.34 171.79 2.9 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.483 2.713 . . . . 0.0 111.137 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.93 152.43 51.08 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.767 1.627 . . . . 0.0 107.9 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.411 HD13 ' CD2' ' A' ' 75' ' ' PHE 0.28 0.3 OUTLIER -155.34 -98.85 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 178.996 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.411 ' CD2' HD13 ' A' ' 74' ' ' LEU . 28.2 m-85 -61.51 132.42 53.34 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.489 1.041 . . . . 0.0 113.723 -158.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.506 ' HA ' HG22 ' A' ' 64' ' ' ILE . 4.4 m-20 -79.46 136.6 36.97 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.52 1.128 . . . . 0.0 110.805 173.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 58.7 m -53.02 -33.6 52.48 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.448 1.099 . . . . 0.0 113.527 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.7 -17.48 63.02 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.147 0.979 . . . . 0.0 113.235 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.4 p -76.23 -23.31 54.53 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 121.705 -0.622 . . . . 0.0 112.037 172.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HE3' ' O ' ' A' ' 87' ' ' TRP . 1.3 mtpt -86.96 -169.81 2.79 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.524 1.53 . . . . 0.0 109.806 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -133.18 32.78 3.68 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.847 0.859 . . . . 0.0 113.051 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -54.96 -21.97 13.53 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.407 1.483 . . . . 0.0 112.424 166.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.0 p -66.54 58.67 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.293 2.237 . . . . 0.0 110.802 165.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.95 -32.91 2.8 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.555 1.55 . . . . 0.0 113.615 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.3 m -131.3 -60.41 0.95 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.549 1.674 . . . . 0.0 112.449 -167.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.08 7.29 87.25 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 115.586 0.994 . . . . 0.0 115.586 177.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.417 ' O ' ' HE3' ' A' ' 80' ' ' LYS . 2.8 t90 -67.01 144.9 98.76 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 118.44 1.12 . . . . 0.0 109.147 173.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.48 64.32 6.45 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.207 3.271 . . . . 0.0 112.393 -173.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 61.5 p -133.52 141.64 47.84 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.052 1.741 . . . . 0.0 108.983 173.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.83 168.22 19.14 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.82 1.648 . . . . 0.0 109.208 -175.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -129.4 -9.14 4.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -146.23 175.42 10.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 169.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.81 155.7 27.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 122.232 1.015 . . . . 0.0 111.682 -167.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.76 -36.44 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.898 1.679 . . . . 0.0 111.634 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.2 m 151.04 160.08 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 131.295 3.838 . . . . 0.0 108.642 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -77.26 66.54 3.05 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.151 0.98 . . . . 0.0 108.591 168.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -109.17 -54.05 2.58 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.163 0.585 . . . . 0.0 110.114 -173.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.483 HD21 ' HB ' ' A' ' 8' ' ' ILE . 1.0 OUTLIER -133.75 23.49 3.96 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 174.336 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.52 138.31 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 125.813 1.645 . . . . 0.0 106.708 172.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -105.35 137.22 43.49 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 127.251 2.22 . . . . 0.0 109.061 -174.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mp -136.71 153.42 50.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.197 1.799 . . . . 0.0 111.101 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.465 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 0.9 OUTLIER -143.88 129.56 19.23 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 131.43 3.892 . . . . 0.0 104.332 164.093 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -62.18 145.44 53.46 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.559 1.144 . . . . 0.0 110.421 166.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -150.34 175.7 11.58 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 158.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.08 20.22 13.87 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.026 1.33 . . . . 0.0 110.917 175.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.9 m -64.68 26.89 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 129.803 3.241 . . . . 0.0 116.654 -169.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 pp -130.85 -7.29 3.99 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.086 1.354 . . . . 0.0 112.086 162.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.45 -1.73 32.66 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 117.08 -1.955 . . . . 0.0 113.09 -168.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.8 mtm -141.29 -87.59 0.17 Allowed 'General case' 0 C--N 1.35 0.599 0 CA-C-N 120.733 2.266 . . . . 0.0 109.442 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 49.1 t -145.92 113.78 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -123.63 94.36 4.22 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.001 1.72 . . . . 0.0 108.566 174.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 14.6 t -105.91 129.27 54.09 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -174.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.465 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 17.8 pt-20 -64.44 160.08 19.99 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.114 0.87 . . . . 0.0 112.119 -174.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.5 t -138.73 105.93 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -126.93 173.79 9.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.051 0.94 . . . . 0.0 108.607 170.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.5 t -70.18 149.02 47.96 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.165 -0.959 . . . . 0.0 109.161 165.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.07 -16.48 63.7 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.426 ' HD3' ' CG ' ' A' ' 23' ' ' ARG . 28.2 tpt85 -117.72 -70.07 0.81 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-O 118.27 -0.871 . . . . 0.0 113.243 170.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 17.0 p -68.13 18.72 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 118.664 2.838 . . . . 0.0 118.664 -158.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 61.79 -11.44 0.07 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.955 2.502 . . . . 0.0 116.464 166.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.48 150.12 40.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.924 0.89 . . . . 0.0 112.388 -163.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -33.39 -59.84 0.37 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 128.734 2.814 . . . . 0.0 113.224 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 45.52 -106.01 0.11 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.875 2.07 . . . . 0.0 109.365 -173.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.29 -119.56 0.69 Allowed Glycine 0 CA--C 1.522 0.491 0 CA-C-N 118.081 0.4 . . . . 0.0 112.209 171.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -163.84 172.27 14.29 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.166 0.586 . . . . 0.0 110.412 -172.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.645 HG21 ' HE2' ' A' ' 136' ' ' LYS . 3.5 p -115.45 139.54 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.423 1.489 . . . . 0.0 108.828 171.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -131.29 148.93 52.73 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.214 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.79 82.66 1.63 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.076 1.751 . . . . 0.0 109.991 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -156.51 -0.91 0.13 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.678 1.191 . . . . 0.0 112.682 -166.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.66 179.24 34.28 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 120.382 -1.449 . . . . 0.0 113.116 -169.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.44 158.84 53.14 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.707 2.272 . . . . 0.0 110.731 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 45.9 mtp85 -64.56 154.75 83.64 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 164.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.02 -41.49 0.96 Allowed 'Cis proline' 0 C--N 1.348 0.532 0 CA-C-N 119.922 1.008 . . . . 0.0 113.787 8.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.6 p -69.32 -30.08 68.06 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -168.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.94 3.88 75.71 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.817 0.722 . . . . 0.0 113.455 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.645 ' HE2' HG21 ' A' ' 126' ' ' VAL . 13.2 ptmt -123.27 152.66 41.14 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.458 1.629 . . . . 0.0 111.222 -166.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 27.3 ttm105 -125.56 99.07 5.85 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.968 1.707 . . . . 0.0 106.751 -177.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -70.06 139.17 52.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 163.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 35.1 t -143.66 140.49 30.11 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.5 1.12 . . . . 0.0 108.322 174.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -148.36 157.83 43.72 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.689 0.395 . . . . 0.0 111.312 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -155.96 126.45 6.75 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.599 1.56 . . . . 0.0 108.607 170.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 91.6 p -171.29 -179.8 2.75 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.214 1.406 . . . . 0.0 109.044 163.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.51 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -60.48 -17.17 43.31 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 165.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.79 8.93 0.76 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 120.694 1.588 . . . . 0.0 114.093 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.0 mt -115.6 69.47 0.73 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.63 1.172 . . . . 0.0 110.189 -164.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -97.52 129.69 44.66 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -75.55 145.62 41.11 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.575 0.625 . . . . 0.0 109.55 167.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 28.1 pt -138.13 168.06 17.6 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 126.256 1.823 . . . . 0.0 108.294 167.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -54.07 160.84 5.65 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.657 2.905 . . . . 0.0 112.124 163.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.521 ' HG2' ' H ' ' A' ' 63' ' ' GLY . 1.6 mmt180 -47.69 -26.27 1.48 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -165.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -161.45 -70.33 0.06 Allowed 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 128.728 2.811 . . . . 0.0 108.998 159.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -148.97 7.58 0.72 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.881 2.472 . . . . 0.0 110.126 -173.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.7 pp -56.77 -24.47 19.72 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 C-N-CA 124.877 1.271 . . . . 0.0 113.938 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 CA-C-O 116.969 -2.017 . . . . 0.0 109.271 174.998 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.581 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.7 pt -128.9 117.64 19.39 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 125.831 1.652 . . . . 0.0 108.918 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.99 136.11 22.15 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.488 1.458 . . . . 0.0 108.403 166.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.1 mt -117.93 111.58 34.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -113.52 97.28 6.35 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.149 1.38 . . . . 0.0 108.488 -176.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -68.98 83.39 0.32 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.559 0.744 . . . . 0.0 109.234 170.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.4 p -55.07 -39.12 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 118.41 0.55 . . . . 0.0 111.159 -173.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -14.53 20.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.844 1.258 . . . . 0.0 113.98 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -126.64 2.87 6.81 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 126.318 1.847 . . . . 0.0 111.059 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 36.08 44.11 0.24 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.406 1.882 . . . . 0.0 111.665 -159.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.69 160.4 30.82 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 117.676 -1.609 . . . . 0.0 108.654 168.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.5 t -140.85 128.41 22.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 103.96 -2.607 . . . . 0.0 103.96 162.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -142.67 119.69 11.35 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.441 1.496 . . . . 0.0 107.62 169.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 28.9 ttp -83.58 142.98 30.45 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 172.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.5 t -140.94 177.23 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 129.42 3.088 . . . . 0.0 103.19 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 15.7 pt-20 -108.17 169.4 8.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 120.373 1.442 . . . . 0.0 114.052 174.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.97 171.24 1.28 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.636 0.774 . . . . 0.0 110.038 176.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.32 131.63 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.553 1.141 . . . . 0.0 111.416 -169.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -157.15 99.97 1.83 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.829 0.851 . . . . 0.0 109.357 173.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.6 mt -143.9 169.48 17.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.428 2.291 . . . . 0.0 108.612 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.503 ' H ' ' CG ' ' A' ' 30' ' ' GLU . 0.7 OUTLIER -90.35 164.23 14.41 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 127.098 2.159 . . . . 0.0 109.878 176.527 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.22 57.9 1.52 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.382 1.087 . . . . 0.0 110.055 160.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.06 -12.06 0.22 Allowed 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 124.694 1.198 . . . . 0.0 111.869 158.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.503 ' CG ' ' H ' ' A' ' 27' ' ' SER . 45.0 mm-40 -81.92 -49.09 10.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.545 -0.722 . . . . 0.0 109.976 -170.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.441 ' CE3' ' CD1' ' A' ' 35' ' ' LEU . 62.5 m95 -60.72 9.37 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.45 1.9 . . . . 0.0 114.9 -175.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.68 -0.66 4.33 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.441 1.497 . . . . 0.0 114.879 177.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.97 -23.11 2.01 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.592 173.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 pt -103.33 16.96 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 119.306 0.957 . . . . 0.0 110.517 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.461 HD22 ' CB ' ' A' ' 39' ' ' ALA . 3.4 mt -139.67 160.16 40.5 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.078 0.951 . . . . 0.0 112.138 -174.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.479 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 2.4 m-20 -59.36 148.52 72.68 Favored Pre-proline 0 C--O 1.238 0.489 0 C-N-CA 124.353 1.061 . . . . 0.0 110.159 172.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -63.08 -18.37 64.79 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.749 1.633 . . . . 0.0 111.328 165.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -72.21 -50.68 25.67 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 119.323 -0.37 . . . . 0.0 110.119 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.479 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -58.14 -44.17 87.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 119.068 0.849 . . . . 0.0 110.509 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -53.95 -51.84 62.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.034 1.334 . . . . 0.0 111.911 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.411 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 41.1 ptt180 -68.72 -51.11 45.01 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.376 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.7 t -61.15 -28.63 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 118.805 -0.617 . . . . 0.0 109.664 -170.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.5 -17.64 64.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -107.41 -32.37 7.77 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.435 1.016 . . . . 0.0 112.346 174.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 41' ' ' ARG . 17.0 ptpt -103.74 0.35 30.38 Favored 'General case' 0 C--N 1.343 0.292 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -174.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.29 45.57 7.28 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.031 1.332 . . . . 0.0 111.819 -170.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 168.666 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 C--O 1.236 0.379 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.75 -171.72 39.78 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 124.115 0.864 . . . . 0.0 112.644 171.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.2 pt -140.49 179.04 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 158.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -89.1 147.65 24.11 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.061 -1.024 . . . . 0.0 110.726 169.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -120.39 141.99 49.6 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.978 0.894 . . . . 0.0 111.207 158.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 25.5 t -92.6 93.96 8.79 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 113.48 -1.691 . . . . 0.0 107.214 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.458 HG22 ' HA ' ' A' ' 144' ' ' ALA . 4.2 tt -63.32 -29.81 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 123.861 0.864 . . . . 0.0 111.322 -164.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.9 m -77.44 0.53 22.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.118 1.767 . . . . 0.0 112.503 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 6.6 p -132.0 -10.41 3.4 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.242 1.017 . . . . 0.0 112.92 163.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.7 6.13 84.49 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.002 1.286 . . . . 0.0 112.71 -172.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.2 m -106.17 132.1 52.63 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 118.442 1.121 . . . . 0.0 109.887 -164.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -75.92 165.23 25.29 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.325 1.85 . . . . 0.0 112.967 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 177.23 -171.96 0.1 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 129.048 2.939 . . . . 0.0 108.775 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 27.3 95.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 129.964 3.305 . . . . 0.0 116.109 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.55 150.43 43.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.328 1.051 . . . . 0.0 111.692 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.6 m -62.19 -24.14 67.04 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -174.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.18 -16.99 63.75 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.3 t -98.64 -9.68 24.38 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.7 -0.625 . . . . 0.0 111.293 169.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.691 ' HE2' ' H ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -84.48 179.1 7.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.12 1.368 . . . . 0.0 108.682 172.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.691 ' H ' ' HE2' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -141.24 -173.57 3.78 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.013 1.725 . . . . 0.0 107.618 174.537 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -158.82 -86.97 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -158.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.6 t -58.39 129.96 44.51 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 166.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.48 -87.68 0.52 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.8 m -81.96 50.06 1.49 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.405 1.097 . . . . 0.0 111.408 -175.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.37 32.23 3.65 Favored Glycine 0 CA--C 1.524 0.649 0 O-C-N 120.025 -1.672 . . . . 0.0 112.07 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -122.33 166.68 16.31 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.764 2.026 . . . . 0.0 108.557 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.32 71.44 6.76 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.559 2.173 . . . . 0.0 113.752 -160.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.6 p -136.86 162.09 34.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.827 1.251 . . . . 0.0 111.236 166.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -145.19 178.45 8.06 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.922 2.489 . . . . 0.0 109.471 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -128.61 -4.64 5.29 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -157.78 178.81 9.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.119 2.167 . . . . 0.0 108.146 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.0 t -134.14 151.09 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 119.182 0.901 . . . . 0.0 110.846 -168.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 p -55.01 -47.4 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.349 1.86 . . . . 0.0 111.546 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.3 m 165.22 170.24 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 131.069 3.748 . . . . 0.0 106.593 -174.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -90.4 97.15 11.01 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 159.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -131.08 -60.36 0.96 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.292 0.637 . . . . 0.0 110.804 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -115.47 18.74 15.83 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.087 1.355 . . . . 0.0 111.388 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.3 tt -130.64 163.93 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.117 2.567 . . . . 0.0 106.98 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.485 ' HD3' ' N ' ' A' ' 101' ' ' LEU . 2.7 tmtm? -135.96 128.79 31.1 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.137 0.975 . . . . 0.0 109.028 174.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.485 ' N ' ' HD3' ' A' ' 100' ' ' LYS . 1.7 mp -114.15 143.95 43.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.792 2.837 . . . . 0.0 111.256 176.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.27 113.85 8.25 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.102 1.761 . . . . 0.0 109.107 168.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -81.31 125.22 30.08 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.423 0.689 . . . . 0.0 111.498 -176.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -130.62 -175.99 3.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.501 1.921 . . . . 0.0 108.753 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.95 19.62 17.72 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.518 1.527 . . . . 0.0 111.477 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.45 20.73 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 129.102 2.961 . . . . 0.0 118.155 -165.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.6 pp -132.06 -2.17 3.63 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.821 -1.174 . . . . 0.0 112.253 167.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.4 8.68 56.11 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 117.871 -1.516 . . . . 0.0 112.851 -168.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 16.1 tpt -142.23 -92.13 0.13 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 119.867 1.834 . . . . 0.0 108.507 174.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 81.5 t -143.01 114.77 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -119.09 113.8 21.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.646 1.178 . . . . 0.0 108.183 169.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.452 ' HB3' ' CG1' ' A' ' 126' ' ' VAL . 31.5 t -106.15 122.33 45.97 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.03 151.03 44.06 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 172.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 75.6 t -136.46 111.49 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 C-N-CA 125.016 1.326 . . . . 0.0 107.572 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 mp -127.8 164.97 21.02 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.28 1.032 . . . . 0.0 109.195 175.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 18.1 t -71.88 154.2 41.39 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.445 -0.785 . . . . 0.0 109.3 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -82.96 -20.96 34.21 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 122.055 -0.403 . . . . 0.0 112.05 172.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.22 -42.79 3.46 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.639 1.176 . . . . 0.0 112.496 -162.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 27.9 p -123.54 81.08 1.86 Allowed 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 167.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.49 40.77 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.014 1 C-N-CA 132.533 4.333 . . . . 0.0 114.888 -163.909 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.21 -174.44 3.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.154 2.582 . . . . 0.0 112.434 -170.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -30.4 -70.11 0.06 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 130.012 3.325 . . . . 0.0 114.716 -164.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 mt 42.16 -111.13 0.15 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.277 2.231 . . . . 0.0 109.984 -170.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.59 -114.26 0.46 Allowed Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 118.884 0.765 . . . . 0.0 112.623 171.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -164.76 179.08 6.77 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.826 0.45 . . . . 0.0 110.298 -170.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.547 HG21 ' HE2' ' A' ' 136' ' ' LYS . 2.7 p -124.49 144.93 32.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 124.795 1.238 . . . . 0.0 108.463 167.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -131.48 147.23 52.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 124.109 0.881 . . . . 0.0 109.566 175.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -65.89 115.35 5.89 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.01 -34.36 0.15 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -171.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -83.91 172.32 49.7 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -174.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.7 -84.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.685 2.256 . . . . 0.0 110.353 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.62 169.53 9.88 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 129.062 2.945 . . . . 0.0 104.887 176.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.3 -54.49 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.629 0 CA-C-N 121.572 1.597 . . . . 0.0 111.93 -2.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.8 p -69.35 -25.61 64.28 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.37 0.668 . . . . 0.0 112.442 -174.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 68.22 10.77 60.28 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.895 0.76 . . . . 0.0 113.453 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.547 ' HE2' HG21 ' A' ' 126' ' ' VAL . 14.7 ptmt -130.29 158.57 39.42 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 119.281 1.54 . . . . 0.0 111.561 -169.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.83 103.36 7.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.941 1.696 . . . . 0.0 108.499 -175.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -73.15 135.28 44.65 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 168.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 27.0 t -142.19 133.58 26.47 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.707 1.203 . . . . 0.0 108.5 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 6.9 ptm -133.16 156.25 47.81 Favored 'General case' 0 CA--C 1.528 0.098 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -137.4 97.82 3.56 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.5 m -157.74 158.38 35.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 173.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -77.22 -30.19 54.49 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.07 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -74.46 54.17 0.57 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.863 2.065 . . . . 0.0 113.183 -170.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.8 mt -120.0 63.59 0.83 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.014 0.926 . . . . 0.0 108.73 -176.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -79.63 101.84 8.57 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -57.8 133.8 55.72 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 165.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.3 pt -136.99 165.72 32.72 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.567 1.147 . . . . 0.0 108.888 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.32 170.94 2.71 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.484 2.123 . . . . 0.0 111.38 162.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -50.09 -11.51 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 128.814 2.846 . . . . 0.0 118.185 -166.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.4 t0 177.31 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 128.675 2.79 . . . . 0.0 107.296 159.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.32 11.89 0.63 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.962 2.105 . . . . 0.0 112.0 -174.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -71.71 -11.58 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 O-C-N 121.186 -0.946 . . . . 0.0 112.328 173.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.543 0 C-N-CA 127.888 2.661 . . . . 0.0 106.532 159.199 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 . . . . . 0 CA--C 1.538 0.491 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.8 pt -136.24 137.28 24.17 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.147 0.979 . . . . 0.0 111.431 -171.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.12 114.31 3.88 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.51 2.14 . . . . 0.0 110.342 170.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.446 HD12 HG23 ' A' ' 72' ' ' THR . 5.5 mm -87.64 132.29 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 159.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -132.28 96.09 3.8 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 -175.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 m -68.56 61.26 0.09 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 167.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.8 t -52.21 -36.67 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 120.863 -1.148 . . . . 0.0 109.486 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.54 -18.52 65.06 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.83 -174.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -108.53 1.98 21.87 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 129.812 3.245 . . . . 0.0 111.581 169.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.0 t30 37.7 61.57 1.0 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.046 2.538 . . . . 0.0 113.164 -158.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.98 169.11 11.49 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.765 1.226 . . . . 0.0 108.949 169.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -148.39 124.35 2.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 126.401 1.88 . . . . 0.0 106.305 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -144.19 95.15 2.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.032 1.333 . . . . 0.0 107.948 -173.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 12.1 ttt -69.63 137.62 52.39 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.513 -1.367 . . . . 0.0 109.968 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.9 t -135.08 160.02 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.049 1.34 . . . . 0.0 107.385 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -68.22 155.76 39.02 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.045 -1.659 . . . . 0.0 110.961 170.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.548 HH12 ' CD ' ' A' ' 25' ' ' GLU . 41.6 ptt85 -74.93 154.11 38.3 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 121.749 -0.594 . . . . 0.0 109.421 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.61 134.53 25.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.548 ' CD ' HH12 ' A' ' 23' ' ' ARG . 0.3 OUTLIER -162.52 123.56 2.54 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 102.008 -3.33 . . . . 0.0 102.008 159.029 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.1 mt -140.49 -178.96 5.75 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.963 1.705 . . . . 0.0 106.821 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.1 t -161.58 -10.94 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -118.94 -144.22 0.37 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.58 1.082 . . . . 0.0 110.211 -172.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.24 3.02 0.69 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.603 1.161 . . . . 0.0 113.281 175.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -59.47 -46.5 88.6 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 125.994 1.718 . . . . 0.0 110.974 -163.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.414 ' CE3' HD13 ' A' ' 35' ' ' LEU . 93.2 m95 -69.29 45.64 0.06 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.32 2.248 . . . . 0.0 112.344 174.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.67 -36.25 0.05 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.084 2.154 . . . . 0.0 109.915 159.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -84.68 -25.85 28.16 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.109 -0.948 . . . . 0.0 112.309 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 pt -109.67 18.69 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 119.773 1.17 . . . . 0.0 112.176 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.414 HD13 ' CE3' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -145.51 174.91 10.74 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.478 1.111 . . . . 0.0 110.875 -169.726 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.91 141.78 96.96 Favored Pre-proline 0 C--O 1.237 0.417 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 169.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -68.57 -14.53 39.81 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.744 2.296 . . . . 0.0 111.589 171.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -79.14 -44.04 22.79 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 122.999 0.52 . . . . 0.0 109.97 168.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.98 -39.7 90.62 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.58 1.082 . . . . 0.0 110.64 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -46.9 -58.29 4.09 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.953 2.101 . . . . 0.0 111.175 171.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 8.3 ptp85 -72.73 -42.06 64.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.883 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.469 HG13 ' HA2' ' A' ' 47' ' ' GLY . 44.5 t -52.56 -35.36 20.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 124.595 1.158 . . . . 0.0 110.405 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.71 -8.78 11.29 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -116.23 -38.68 3.53 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.376 0.989 . . . . 0.0 111.936 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 41' ' ' ARG . 19.3 ptpt -87.15 9.43 20.02 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.304 0.956 . . . . 0.0 113.151 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.58 -36.62 0.23 Allowed 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 129.143 2.977 . . . . 0.0 113.636 -167.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.469 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . . . . . . 0 C--N 1.335 0.511 0 C-N-CA 127.023 2.249 . . . . 0.0 108.861 -166.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 p30 . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 120.912 0.386 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.39 162.83 12.82 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.875 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.423 HG22 ' HA ' ' A' ' 76' ' ' ASP . 38.5 pt -143.51 175.21 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 126.274 1.829 . . . . 0.0 109.131 -179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -93.35 122.51 35.84 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.295 0.569 . . . . 0.0 111.934 173.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.91 115.05 21.61 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 158.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.8 t -70.55 94.53 0.99 Allowed 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 166.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.455 HG22 ' HA ' ' A' ' 144' ' ' ALA . 2.0 tt -58.85 -33.0 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.599 1.16 . . . . 0.0 111.155 -165.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.4 t -82.48 5.14 21.62 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.949 1.3 . . . . 0.0 111.891 -169.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.72 18.63 1.83 Allowed 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.43 -0.794 . . . . 0.0 111.557 158.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.7 25.83 56.41 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 123.343 0.497 . . . . 0.0 112.744 174.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.446 HG23 HD12 ' A' ' 10' ' ' ILE . 28.4 m -120.55 124.54 45.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.863 1.265 . . . . 0.0 108.021 -164.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -64.63 145.27 56.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.408 1.083 . . . . 0.0 111.448 170.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.466 HD23 ' H ' ' A' ' 75' ' ' PHE 0.281 0.0 OUTLIER -148.88 -107.42 0.08 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.953 160.657 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.466 ' H ' HD23 ' A' ' 74' ' ' LEU . 19.4 m-85 -54.38 127.15 26.16 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.307 1.443 . . . . 0.0 112.416 -159.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.423 ' HA ' HG22 ' A' ' 64' ' ' ILE . 8.8 t70 -89.47 150.54 22.43 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.223 1.009 . . . . 0.0 109.494 -176.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.1 m -59.47 -26.83 65.57 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.088 172.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -70.1 -17.78 63.23 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.914 1.234 . . . . 0.0 112.449 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.8 p -96.44 -22.86 16.88 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.809 1.244 . . . . 0.0 112.196 170.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.477 ' HE2' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -125.56 79.09 1.79 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.566 1.946 . . . . 0.0 107.653 -170.482 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -127.43 118.64 24.45 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -135.68 163.65 29.67 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 104.71 -2.329 . . . . 0.0 104.71 159.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.6 t -136.48 135.89 38.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.385 0.993 . . . . 0.0 109.785 -164.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.99 -53.28 1.36 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -164.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.92 -68.96 0.28 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.26 1.424 . . . . 0.0 110.021 168.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 53.7 12.31 2.43 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 126.177 1.846 . . . . 0.0 116.225 -170.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -51.19 155.04 2.44 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 127.021 2.128 . . . . 0.0 112.307 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -73.55 68.09 4.49 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.864 3.042 . . . . 0.0 111.532 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.2 p -131.04 143.76 50.94 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.238 1.415 . . . . 0.0 108.508 167.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.92 160.22 38.97 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.659 1.584 . . . . 0.0 108.035 -171.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -123.27 7.04 9.08 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.453 -171.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -159.61 176.65 11.77 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 159.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -100.64 157.91 4.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 119.1 0.864 . . . . 0.0 110.268 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.3 p -66.25 -45.63 89.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 169.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.6 m -179.81 161.46 0.98 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 129.73 3.212 . . . . 0.0 106.714 167.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -76.74 56.99 1.22 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.03 1.732 . . . . 0.0 110.085 175.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -111.56 -61.51 1.69 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.629 0.772 . . . . 0.0 109.251 -168.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . 0.25 0.7 OUTLIER -113.09 21.23 15.57 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 175.48 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.8 tt -111.74 153.21 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 167.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -122.22 145.26 48.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.482 1.113 . . . . 0.0 108.815 169.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.5 mt -149.52 133.34 16.96 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 128.87 2.868 . . . . 0.0 108.602 -159.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.56 101.9 4.47 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 129.105 2.962 . . . . 0.0 108.503 168.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -73.8 143.8 45.84 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.604 0.762 . . . . 0.0 111.899 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -154.94 178.0 10.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 129.407 3.083 . . . . 0.0 107.989 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.456 ' HD2' ' H ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -103.13 25.12 9.84 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 120.366 -1.459 . . . . 0.0 113.135 178.05 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.45 19.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -166.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.14 2.03 2.76 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.985 -1.072 . . . . 0.0 112.449 165.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.05 -3.55 51.9 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.061 -1.41 . . . . 0.0 113.042 -169.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -139.11 -98.32 0.17 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.416 1.608 . . . . 0.0 109.175 -174.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.6 m -135.12 110.28 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.41 ' HE ' ' CD2' ' A' ' 125' ' ' HIS . 4.8 ttt180 -106.33 142.06 36.63 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 161.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.508 ' HB3' ' CG1' ' A' ' 126' ' ' VAL . 20.8 t -137.39 138.99 40.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 166.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -61.25 153.43 26.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 169.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.3 t -134.09 107.98 10.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -125.43 165.37 18.55 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 172.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 26.8 t -73.92 146.64 43.83 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 168.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.78 -45.46 86.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.745 -0.645 . . . . 0.0 109.337 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.3 tpt85 -84.41 -77.64 0.26 Allowed 'General case' 0 C--N 1.35 0.589 0 CA-C-O 116.257 -1.83 . . . . 0.0 111.775 162.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.6 p -78.34 75.32 4.87 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.859 1.209 . . . . 0.0 110.746 -158.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -59.76 77.22 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.509 1.924 . . . . 0.0 112.536 171.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.26 -155.62 0.45 Allowed 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 112.861 -1.972 . . . . 0.0 109.748 161.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -70.11 -60.6 2.19 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 125.525 1.53 . . . . 0.0 111.296 -168.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 50.24 -113.11 0.64 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.503 1.921 . . . . 0.0 108.511 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 174.11 -128.4 1.46 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 119.815 -1.183 . . . . 0.0 113.664 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.41 ' CD2' ' HE ' ' A' ' 111' ' ' ARG . 38.2 p-80 -157.78 175.65 13.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.01 0.524 . . . . 0.0 110.044 -174.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.508 ' CG1' ' HB3' ' A' ' 112' ' ' CYS . 3.0 p -122.06 143.86 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.288 1.435 . . . . 0.0 108.776 172.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -142.1 164.95 28.78 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.619 1.168 . . . . 0.0 111.516 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -72.06 102.93 3.11 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.468 1.907 . . . . 0.0 109.452 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -162.75 -50.8 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.709 2.004 . . . . 0.0 110.21 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -63.85 157.77 41.85 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 123.311 0.382 . . . . 0.0 112.29 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.12 177.64 8.5 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.651 2.234 . . . . 0.0 112.684 -169.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -50.19 145.62 9.63 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.792 159.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -84.55 -25.36 9.03 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 CA-C-N 119.462 0.844 . . . . 0.0 113.253 18.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.261 0.9 OUTLIER -107.46 -14.01 14.95 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.463 0.705 . . . . 0.0 112.18 -159.182 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.23 16.66 79.31 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 121.465 -0.772 . . . . 0.0 114.974 159.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -146.98 159.37 43.64 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 118.579 1.189 . . . . 0.0 110.486 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 ttm105 -119.56 108.88 15.04 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 126.052 1.741 . . . . 0.0 107.18 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -73.77 138.72 44.74 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 163.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 19.3 t -141.29 133.47 27.91 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.081 0.855 . . . . 0.0 108.74 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -130.18 105.11 7.71 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 122.15 0.976 . . . . 0.0 109.336 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -83.82 68.17 9.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 169.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 p -113.91 142.59 45.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.284 1.433 . . . . 0.0 110.463 -176.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.59 91.44 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.036 0.934 . . . . 0.0 111.907 170.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.455 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -66.73 16.74 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.44 2.696 . . . . 0.0 116.649 -160.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 87.9 mt -92.61 75.68 5.05 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.419 1.088 . . . . 0.0 111.275 -162.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -86.14 110.94 19.9 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -62.83 144.41 56.61 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 164.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 4.9 pt -142.79 169.6 10.45 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 126.179 1.792 . . . . 0.0 108.111 171.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -56.96 177.2 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.903 2.402 . . . . 0.0 111.142 159.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -50.93 8.56 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 119.867 3.284 . . . . 0.0 119.867 -172.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.7 t70 145.08 -72.85 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.159 1 C-N-CA 133.549 4.739 . . . . 0.0 107.308 163.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -154.69 43.02 0.49 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.172 2.589 . . . . 0.0 107.083 -176.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.3 pt -77.19 -19.73 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.076 -1.015 . . . . 0.0 110.562 161.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 1 C-N-CA 130.849 4.071 . . . . 0.0 105.832 171.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 4.2 mtt180 . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 pt -138.93 140.56 27.35 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.801 2.04 . . . . 0.0 109.665 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.471 ' O ' HD13 ' A' ' 10' ' ' ILE . 90.1 Cg_endo -80.78 143.0 14.47 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.062 2.508 . . . . 0.0 111.015 174.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.808 HD12 HG23 ' A' ' 72' ' ' THR . 17.2 mm -135.86 122.02 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 125.816 1.647 . . . . 0.0 107.254 -168.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -132.47 98.51 4.39 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.905 0.775 . . . . 0.0 110.299 -165.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.5 m -69.73 74.84 0.43 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.827 0.851 . . . . 0.0 109.602 170.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.86 -39.24 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.686 1.194 . . . . 0.0 112.074 -174.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.67 -15.64 8.33 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.162 2.185 . . . . 0.0 113.724 175.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.412 ' HE3' ' CD ' ' A' ' 17' ' ' ARG . 4.7 ttpt -133.1 15.58 4.19 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.738 2.415 . . . . 0.0 110.12 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 24.38 45.58 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 131.133 3.773 . . . . 0.0 114.375 -163.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.412 ' CD ' ' HE3' ' A' ' 15' ' ' LYS . 19.2 mtp-105 -90.95 171.63 9.15 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.003 175.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.0 p -140.34 154.4 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 158.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -144.35 170.99 14.96 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 127.984 2.514 . . . . 0.0 106.903 158.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 43.6 ttm -127.46 92.3 3.47 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.757 0.823 . . . . 0.0 109.499 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.6 t -77.16 155.94 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -79.13 174.24 11.77 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.06 -1.025 . . . . 0.0 112.476 175.925 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -77.86 163.24 26.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.533 0.733 . . . . 0.0 110.413 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.288 2.8 tp -89.15 69.12 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 123.324 1.535 . . . . 0.0 111.784 -169.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.9 89.87 3.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.018 1.727 . . . . 0.0 106.532 -173.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.8 mt -130.33 -176.21 3.88 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.107 2.163 . . . . 0.0 109.952 -175.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.0 t -112.91 162.66 15.58 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.741 1.617 . . . . 0.0 107.885 163.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -52.28 -36.89 54.06 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.14 0.882 . . . . 0.0 111.514 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -46.87 -34.63 5.57 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 129.25 3.02 . . . . 0.0 111.714 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -81.92 -46.88 13.45 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.193 1.797 . . . . 0.0 111.212 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.418 ' C ' HD12 ' A' ' 35' ' ' LEU . 91.3 m95 -64.01 40.5 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 129.844 3.258 . . . . 0.0 113.503 -174.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -169.29 -18.68 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.166 2.187 . . . . 0.0 113.24 -170.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -127.24 -13.69 5.53 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.31 -0.852 . . . . 0.0 112.807 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pt -109.31 3.95 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 119.061 0.846 . . . . 0.0 111.906 170.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.418 HD12 ' C ' ' A' ' 31' ' ' TRP . 12.3 mt -97.74 170.67 8.83 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.423 1.489 . . . . 0.0 111.014 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.18 144.73 90.95 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 159.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -63.64 -15.01 46.17 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.889 1.726 . . . . 0.0 111.761 166.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -70.94 -41.9 70.53 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 122.523 0.329 . . . . 0.0 110.587 170.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.441 ' HB2' HG12 ' A' ' 68' ' ' ILE . . . -62.55 -40.51 97.06 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.29 0.566 . . . . 0.0 109.914 -172.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -53.48 -52.61 59.0 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.576 1.15 . . . . 0.0 112.057 172.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 42' ' ' VAL . 3.8 ptp180 -76.92 -47.07 22.07 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -172.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' A' ' 39' ' ' ALA . 4.1 p -62.52 -24.39 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -174.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.23 -9.51 32.97 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 115.157 1.539 . . . . 0.0 115.157 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.78 -41.28 2.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.881 1.219 . . . . 0.0 110.849 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.413 ' H ' ' HG2' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -89.08 3.44 51.77 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.623 1.169 . . . . 0.0 113.317 176.346 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.33 2.44 0.09 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.16 2.584 . . . . 0.0 115.663 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 1.022 0 N-CA-C 118.242 2.057 . . . . 0.0 118.242 -163.721 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.3 t0 . . . . . 0 CA--C 1.537 0.475 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.96 169.5 14.76 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.909 1.242 . . . . 0.0 112.63 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.474 HG22 ' HA ' ' A' ' 76' ' ' ASP . 35.0 pt -138.49 172.41 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.794 1.638 . . . . 0.0 110.427 -172.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -86.6 137.51 32.43 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.893 0.477 . . . . 0.0 111.207 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.51 121.06 44.17 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.671 1.188 . . . . 0.0 109.765 164.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.424 ' HB2' HD11 ' A' ' 74' ' ' LEU . 16.9 t -70.16 87.64 0.59 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.309 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.463 HG22 ' HA ' ' A' ' 144' ' ' ALA . 2.6 tt -52.89 -26.28 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -171.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.0 t -75.5 -0.86 21.7 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.838 0.855 . . . . 0.0 111.684 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.3 p -149.37 20.29 0.95 Allowed 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.69 -1.256 . . . . 0.0 111.926 161.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.1 -4.93 0.45 Allowed Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.565 1.555 . . . . 0.0 116.021 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.808 HG23 HD12 ' A' ' 10' ' ' ILE . 97.3 m -71.03 142.9 50.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.778 1.631 . . . . 0.0 109.577 -171.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -89.87 135.4 33.65 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.687 0.795 . . . . 0.0 111.739 165.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' A' ' 67' ' ' CYS 0.326 0.0 OUTLIER -137.26 -92.91 0.23 Allowed 'General case' 0 C--N 1.344 0.336 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 178.17 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -61.59 118.01 6.51 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.554 0.615 . . . . 0.0 110.851 -165.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.474 ' HA ' HG22 ' A' ' 64' ' ' ILE . 22.2 t70 -70.5 152.41 44.03 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 168.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.3 m -55.94 -25.8 45.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.217 -1.373 . . . . 0.0 113.565 175.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.59 -25.17 64.38 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 121.426 1.921 . . . . 0.0 111.282 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.3 p -95.87 18.52 13.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.081 1.353 . . . . 0.0 112.129 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -151.27 35.57 0.58 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.82 1.248 . . . . 0.0 111.492 161.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -84.35 57.42 4.26 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.621 0.724 . . . . 0.0 111.421 -164.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -98.75 110.24 22.87 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.169 0.587 . . . . 0.0 109.988 -172.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.6 m -50.04 102.14 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.371 1.868 . . . . 0.0 112.951 -169.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.72 -49.69 3.95 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.6 1.095 . . . . 0.0 112.305 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.9 m -59.52 -45.88 90.46 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.246 1.018 . . . . 0.0 110.967 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 49.58 26.43 7.52 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 128.034 2.73 . . . . 0.0 115.12 171.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -56.81 147.52 52.65 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.237 1.015 . . . . 0.0 111.139 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -78.97 57.62 6.54 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.163 3.242 . . . . 0.0 110.126 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.1 p -160.6 121.28 2.9 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -172.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.88 -160.78 1.1 Allowed 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 124.455 1.102 . . . . 0.0 109.082 -172.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -115.75 4.8 14.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 118.429 0.559 . . . . 0.0 112.074 -161.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -155.35 -179.18 7.84 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.144 0.578 . . . . 0.0 110.359 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 m -137.02 167.17 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 127.287 2.235 . . . . 0.0 110.114 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.5 p -58.48 -51.1 75.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.52 1.128 . . . . 0.0 111.926 -178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.4 m 159.74 151.37 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 129.216 3.006 . . . . 0.0 108.038 -169.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -74.29 79.68 1.84 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.888 0.475 . . . . 0.0 109.842 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -118.92 -56.23 2.12 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.81 0.844 . . . . 0.0 110.919 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.51 HD22 HG21 ' A' ' 72' ' ' THR . 27.9 t-20 -128.28 33.07 4.77 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.14 0.976 . . . . 0.0 111.352 170.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.7 tt -118.78 144.29 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 163.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.423 ' HD3' ' H ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -127.81 141.07 51.67 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.889 1.276 . . . . 0.0 107.698 171.418 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.423 ' H ' ' HD3' ' A' ' 100' ' ' LYS . 1.8 mp -127.85 140.8 51.8 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.452 1.901 . . . . 0.0 107.629 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.516 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 5.6 mpt_? -120.86 125.68 48.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 171.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -106.9 126.94 52.96 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.237 0.615 . . . . 0.0 110.769 -167.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -132.45 178.59 6.71 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.714 2.006 . . . . 0.0 109.912 176.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -106.63 11.35 30.53 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.423 1.889 . . . . 0.0 112.992 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 m -46.9 -43.44 18.86 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.616 1.566 . . . . 0.0 115.182 -159.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 pp -68.5 -12.2 60.89 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.49 4.95 30.23 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 117.615 -1.659 . . . . 0.0 112.757 -169.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.2 ttp -147.88 -86.94 0.09 Allowed 'General case' 0 C--N 1.348 0.511 0 CA-C-N 120.258 2.029 . . . . 0.0 109.172 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.8 p -148.61 114.32 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -120.56 112.1 18.5 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.221 1.808 . . . . 0.0 107.822 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.01 134.79 54.89 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.516 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 9.1 pt-20 -71.41 165.67 23.29 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.495 1.043 . . . . 0.0 110.661 174.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.62 108.41 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mp -131.17 167.47 19.1 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 167.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.1 t -66.53 149.2 50.8 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 98' ' ' ASN . . . -76.6 -17.4 59.21 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 44.8 tpt85 -111.74 -58.48 2.12 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 118.627 -0.701 . . . . 0.0 111.74 170.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.8 p -84.98 77.13 10.18 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.54 74.99 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.599 1.16 . . . . 0.0 110.01 172.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -97.61 -73.6 0.6 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.909 1.284 . . . . 0.0 112.323 -165.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.68 -80.95 0.17 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.54 1.136 . . . . 0.0 109.674 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt 45.56 -110.88 0.25 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.775 1.63 . . . . 0.0 111.15 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.95 -111.79 0.39 Allowed Glycine 0 C--N 1.332 0.318 0 CA-C-N 118.88 0.764 . . . . 0.0 112.843 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -164.02 -176.45 4.53 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -166.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.88 147.53 29.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 127.163 2.185 . . . . 0.0 108.632 169.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -137.91 143.41 40.81 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.98 0.912 . . . . 0.0 108.63 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.95 111.81 9.46 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -167.82 -45.35 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.977 2.111 . . . . 0.0 110.776 -160.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.31 178.38 38.13 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.391 0.996 . . . . 0.0 113.606 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.76 162.0 42.35 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.664 2.243 . . . . 0.0 111.883 -175.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -60.72 154.37 57.79 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 163.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.66 -42.9 0.71 Allowed 'Cis proline' 0 C--N 1.346 0.432 0 CA-C-N 120.812 1.326 . . . . 0.0 113.693 12.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.2 p -70.88 -30.59 67.0 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.41 10.2 84.5 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.302 -0.721 . . . . 0.0 112.682 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.85 164.01 28.22 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.906 1.353 . . . . 0.0 112.81 -166.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.86 106.89 7.98 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.858 1.663 . . . . 0.0 107.963 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -73.05 148.12 44.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.264 1.826 . . . . 0.0 107.235 167.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 49.7 t -156.16 115.79 3.57 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.399 1.479 . . . . 0.0 108.854 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.94 138.3 33.72 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 123.903 0.881 . . . . 0.0 109.771 -175.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -142.51 126.71 17.51 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.445 1.098 . . . . 0.0 109.416 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 85.2 p -162.7 176.63 10.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 167.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -53.6 -31.43 46.9 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.599 1.559 . . . . 0.0 112.065 163.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.463 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -87.62 47.8 1.55 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.237 1.415 . . . . 0.0 112.058 -175.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 88.1 mt -131.3 61.3 1.64 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.794 1.238 . . . . 0.0 108.31 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -88.56 127.09 35.54 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -68.59 144.87 54.38 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 169.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.3 pt -137.44 168.24 17.37 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 126.304 1.842 . . . . 0.0 108.765 171.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -57.87 174.07 0.71 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.78 1.653 . . . . 0.0 110.806 158.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 11.9 mtp85 -46.8 -33.71 4.67 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.126 1.771 . . . . 0.0 113.778 -172.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -151.8 -65.08 0.18 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.583 1.953 . . . . 0.0 108.156 158.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -151.85 1.97 0.37 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 129.546 3.138 . . . . 0.0 110.668 -171.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.7 pp -55.15 -29.94 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 119.665 1.12 . . . . 0.0 113.862 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 116.824 -2.098 . . . . 0.0 109.457 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 . . . . . 0 N--CA 1.436 -1.132 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 pt -131.38 107.69 14.67 Favored Pre-proline 0 C--N 1.324 -0.5 0 C-N-CA 125.813 1.645 . . . . 0.0 108.393 -165.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.85 103.57 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.415 2.743 . . . . 0.0 109.483 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.6 mt -85.28 97.65 5.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -75.47 95.67 3.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.5 m -67.86 67.71 0.1 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.637 0.775 . . . . 0.0 108.92 159.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.11 -34.95 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.584 -0.697 . . . . 0.0 110.822 -170.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.38 -11.72 17.25 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.685 1.194 . . . . 0.0 114.088 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' A' ' 151' ' ' ASP . 35.9 ttmt -123.32 12.81 9.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.184 1.394 . . . . 0.0 110.66 172.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 30.9 68.21 0.11 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 129.915 3.286 . . . . 0.0 113.157 -164.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 mtp85 -131.5 165.36 23.74 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 172.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.9 t -144.1 98.58 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -92.84 103.47 15.81 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.5 ttt -77.88 89.08 4.08 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.656 0.662 . . . . 0.0 109.665 171.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.06 168.31 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 176.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -92.16 161.66 14.65 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.532 -1.355 . . . . 0.0 108.884 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -60.27 151.78 26.63 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.49 -0.756 . . . . 0.0 110.141 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.523 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 2.9 tp -65.87 130.4 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 172.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -153.95 120.03 5.37 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 129.109 2.964 . . . . 0.0 103.134 165.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.1 mt -143.89 175.29 10.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.542 1.537 . . . . 0.0 109.054 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.8 m -93.68 157.18 16.3 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 161.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.79 -36.24 64.69 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.137 0.975 . . . . 0.0 112.206 -174.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.35 -18.32 63.78 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -178.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -70.2 -43.75 70.09 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.609 1.164 . . . . 0.0 109.748 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -60.19 10.54 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.118 2.567 . . . . 0.0 115.542 -173.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.77 -9.89 3.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 172.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.82 -13.88 5.74 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 118.31 -0.853 . . . . 0.0 113.05 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.3 pt -113.44 -2.67 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.168 0.895 . . . . 0.0 112.45 171.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.23 173.34 7.98 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.074 0.949 . . . . 0.0 111.29 -171.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.47 133.83 70.64 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 162.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.72 -21.1 45.54 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.382 2.055 . . . . 0.0 112.731 -172.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -74.76 -31.29 61.75 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.986 171.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.404 ' HB2' HG12 ' A' ' 68' ' ' ILE . . . -58.18 -41.89 84.87 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 120.063 1.301 . . . . 0.0 110.54 -174.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -57.13 -48.4 78.74 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.071 0.948 . . . . 0.0 111.272 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -69.8 -46.5 65.58 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.665 0.666 . . . . 0.0 110.917 175.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.493 HG13 ' HA2' ' A' ' 47' ' ' GLY 0.261 6.3 t -58.88 -23.64 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 125.593 1.557 . . . . 0.0 111.364 -177.214 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.54 70.76 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 168.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.38 -36.46 13.8 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.906 1.23 . . . . 0.0 111.782 177.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -94.75 6.0 50.23 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.473 0.709 . . . . 0.0 112.876 -174.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.11 19.32 0.19 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.258 2.223 . . . . 0.0 113.857 -172.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.493 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . . . . . . 0 CA--C 1.526 0.771 0 C-N-CA 125.397 1.475 . . . . 0.0 114.652 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.4 t0 . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.137 0.494 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.94 -175.57 36.85 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.024 1.297 . . . . 0.0 113.099 174.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.6 pt -125.91 160.24 33.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 165.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -72.96 155.54 39.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 122.424 1.107 . . . . 0.0 109.498 171.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -129.89 109.95 11.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 127.491 2.316 . . . . 0.0 106.228 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.1 t -75.76 73.85 2.72 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.193 1.397 . . . . 0.0 107.983 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.454 HD12 ' HD3' ' A' ' 146' ' ' LYS . 7.7 tt -58.57 -16.8 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 127.114 2.166 . . . . 0.0 113.002 -170.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.3 t -74.91 -0.51 18.83 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.432 1.493 . . . . 0.0 112.231 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.8 p -152.41 -13.66 0.17 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 158.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.99 10.99 57.03 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 119.805 1.184 . . . . 0.0 113.34 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -63.14 163.23 10.44 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.601 1.16 . . . . 0.0 108.936 160.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -129.2 153.65 47.53 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 169.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -169.33 -163.23 0.39 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.913 1.685 . . . . 0.0 109.426 -173.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 20.54 91.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 130.675 3.59 . . . . 0.0 114.632 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -57.61 137.27 56.56 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.0 1.32 . . . . 0.0 110.286 173.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.8 m -59.52 -21.34 60.05 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -169.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.92 -20.95 64.34 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.647 1.112 . . . . 0.0 112.448 173.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.6 p -75.72 -12.42 60.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.263 1.025 . . . . 0.0 112.549 172.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -133.67 85.34 2.2 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 125.146 1.379 . . . . 0.0 110.219 -165.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -142.8 45.31 1.59 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.639 -0.663 . . . . 0.0 112.454 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.8 98.04 0.06 Allowed 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.8 m -76.3 113.01 13.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.212 0.605 . . . . 0.0 110.57 -158.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.19 -60.61 0.49 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -175.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.25 -53.92 50.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.383 1.073 . . . . 0.0 111.306 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 37.35 35.43 0.18 Allowed Glycine 0 C--N 1.337 0.635 0 C-N-CA 130.632 3.968 . . . . 0.0 114.395 -167.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.9 158.07 13.74 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.728 0.811 . . . . 0.0 110.506 167.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.35 78.45 1.21 Allowed 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.531 2.821 . . . . 0.0 111.102 177.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.1 p -139.95 157.31 45.89 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.487 165.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -136.26 169.84 17.0 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.104 1.762 . . . . 0.0 108.55 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -122.4 -6.71 8.73 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.336 1.054 . . . . 0.0 112.274 174.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -152.25 -179.45 7.55 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.166 1.386 . . . . 0.0 107.676 173.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 m -119.25 164.9 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.853 1.661 . . . . 0.0 111.027 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 94' ' ' VAL . 2.4 p -61.81 -49.83 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.466 1.106 . . . . 0.0 109.492 160.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.0 m 168.95 159.94 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 130.515 3.526 . . . . 0.0 107.912 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -70.02 81.97 0.49 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.134 1.373 . . . . 0.0 108.812 162.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -128.08 -60.44 1.14 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.611 0.764 . . . . 0.0 110.99 -175.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.23 26.52 10.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.628 1.171 . . . . 0.0 110.599 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.0 tt -132.74 158.15 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.794 1.638 . . . . 0.0 108.677 -171.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.436 ' HE3' ' OE2' ' A' ' 113' ' ' GLU . 2.9 tmtm? -135.18 119.52 17.87 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.327 1.451 . . . . 0.0 108.323 -171.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.5 mp -136.45 137.37 40.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.89 1.276 . . . . 0.0 111.919 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.503 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 1.9 mpt_? -125.48 119.49 28.37 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.104 2.562 . . . . 0.0 108.666 168.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.07 143.71 41.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.945 0.898 . . . . 0.0 110.64 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -145.9 -178.21 5.99 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.953 2.101 . . . . 0.0 106.915 167.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.44 11.73 18.53 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.173 1.789 . . . . 0.0 110.985 177.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.8 t -55.37 -3.96 0.08 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.836 3.255 . . . . 0.0 118.322 -158.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 pp -101.82 -10.37 19.96 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.68 1.127 . . . . 0.0 111.977 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.41 8.8 34.81 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 117.554 -1.692 . . . . 0.0 113.197 -165.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 43.9 tpp -148.92 -85.96 0.09 Allowed 'General case' 0 C--N 1.349 0.581 0 CA-C-N 120.481 2.141 . . . . 0.0 109.641 176.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.7 t -143.43 115.54 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 176.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -128.7 114.02 16.11 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 124.939 1.296 . . . . 0.0 108.571 171.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.577 ' HB3' HG13 ' A' ' 126' ' ' VAL . 22.7 t -121.87 136.17 54.92 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.387 1.075 . . . . 0.0 108.378 -175.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.503 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 25.6 pt-20 -65.37 159.79 23.31 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.735 1.152 . . . . 0.0 111.098 175.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 90.0 t -142.14 111.68 2.63 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 C-N-CA 124.961 1.304 . . . . 0.0 107.835 172.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.97 165.72 17.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.776 1.23 . . . . 0.0 108.273 170.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 35.2 t -69.64 162.65 27.23 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 164.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -86.54 -2.92 58.88 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.523 ' HG2' ' H ' ' A' ' 24' ' ' ILE . 28.2 tpt85 -142.64 -52.39 0.39 Allowed 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.322 0.965 . . . . 0.0 112.83 171.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 22.6 p -84.01 65.79 8.87 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 120.181 1.355 . . . . 0.0 108.248 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.61 53.94 0.08 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.598 2.759 . . . . 0.0 112.535 -170.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.43 -178.39 4.6 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.745 1.618 . . . . 0.0 110.802 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -39.38 -60.68 0.89 Allowed 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 128.218 2.607 . . . . 0.0 112.587 -173.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 48.53 -118.31 1.02 Allowed 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.807 1.643 . . . . 0.0 107.559 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.54 -110.11 0.29 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-N 118.124 0.42 . . . . 0.0 112.189 168.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.33 176.99 8.61 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.575 -0.368 . . . . 0.0 111.806 -165.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.62 HG21 ' HE2' ' A' ' 136' ' ' LYS . 3.1 p -127.56 138.58 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 124.826 1.251 . . . . 0.0 109.341 168.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -138.29 161.11 37.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.386 1.074 . . . . 0.0 110.95 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -66.93 112.58 4.39 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.675 1.59 . . . . 0.0 110.527 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -156.1 -28.2 0.1 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -78.12 154.15 40.6 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -173.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.21 -32.88 6.27 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 121.984 1.789 . . . . 0.0 112.15 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 164.07 166.0 0.06 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 131.511 3.925 . . . . 0.0 106.026 -170.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.12 -45.03 0.45 Allowed 'Cis proline' 0 C--N 1.349 0.57 0 CA-C-N 121.245 1.48 . . . . 0.0 112.005 -9.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.0 p -73.59 -22.18 60.12 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.863 1.265 . . . . 0.0 113.215 -172.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.54 -1.67 56.49 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.358 0.98 . . . . 0.0 113.356 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.62 ' HE2' HG21 ' A' ' 126' ' ' VAL . 12.7 ptmt -124.25 158.34 32.73 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 120.811 -1.405 . . . . 0.0 111.522 -162.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -125.98 108.8 11.75 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.824 2.05 . . . . 0.0 107.42 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -80.74 120.79 25.09 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 168.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 42.6 t -133.2 122.57 24.18 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.318 1.447 . . . . 0.0 107.794 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.7 ptp -141.94 161.87 36.88 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.309 1.044 . . . . 0.0 109.675 -176.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.99 132.68 16.87 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 126.816 2.047 . . . . 0.0 106.238 175.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 77.0 p -174.15 176.76 2.45 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.747 1.219 . . . . 0.0 108.604 165.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.478 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -63.95 -14.09 51.12 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.002 0.921 . . . . 0.0 112.972 162.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -75.84 6.71 4.68 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.005 1.275 . . . . 0.0 113.818 -171.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.1 mt -109.31 85.4 2.09 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.471 1.032 . . . . 0.0 110.407 -163.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.454 ' HD3' HD12 ' A' ' 68' ' ' ILE . 16.9 ttpt -112.75 167.13 10.74 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.804 0.842 . . . . 0.0 109.11 171.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -112.86 159.44 19.03 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.352 1.461 . . . . 0.0 108.44 168.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.0 pt -141.15 169.46 11.41 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 126.825 2.05 . . . . 0.0 107.595 163.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -58.26 174.07 0.82 Allowed 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.433 2.088 . . . . 0.0 111.588 160.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -47.02 -25.52 0.83 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.34 2.256 . . . . 0.0 116.744 -164.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.499 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -176.66 -60.03 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.965 1.706 . . . . 0.0 108.258 167.389 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -151.74 19.7 0.7 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.909 2.084 . . . . 0.0 110.266 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.26 -14.07 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 120.639 -1.288 . . . . 0.0 111.669 174.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.913 0 C-N-CA 128.006 2.717 . . . . 0.0 106.444 160.472 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.6 mtt85 . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.42 152.06 77.3 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 119.574 1.079 . . . . 0.0 111.68 170.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.35 124.6 5.96 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.256 1.97 . . . . 0.0 109.734 164.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.4 mm -88.6 147.42 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 159.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -146.3 91.95 2.12 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -171.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 m -71.04 86.59 0.73 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 118.899 -1.12 . . . . 0.0 110.09 172.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.53 -34.78 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 124.002 0.921 . . . . 0.0 110.834 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.44 -15.22 2.46 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.826 2.05 . . . . 0.0 113.769 173.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -131.19 7.8 4.65 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.975 2.11 . . . . 0.0 111.084 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 27.6 66.9 0.08 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 128.258 2.623 . . . . 0.0 111.678 -158.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -112.45 162.07 16.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.927 1.691 . . . . 0.0 108.06 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.2 t -143.48 123.16 8.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -139.59 98.79 3.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.534 1.934 . . . . 0.0 107.265 -174.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.5 ttp -68.72 139.0 55.35 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.636 -1.29 . . . . 0.0 109.817 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 t -135.98 135.18 50.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -62.93 167.77 4.48 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 120.946 -1.096 . . . . 0.0 111.208 165.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 mtm105 -78.01 -166.67 0.84 Allowed 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.448 -0.783 . . . . 0.0 113.031 -169.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.1 112.88 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 -178.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -142.43 98.41 3.3 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 -177.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.478 HD11 HD11 ' A' ' 34' ' ' ILE . 54.9 mt -136.19 172.76 12.53 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 126.652 1.981 . . . . 0.0 109.885 178.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.96 166.57 21.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.97 2.108 . . . . 0.0 107.936 160.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -62.99 -54.59 35.97 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.493 -0.754 . . . . 0.0 112.196 -175.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.45 -19.01 65.28 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -171.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -56.57 -40.7 75.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.041 0.936 . . . . 0.0 109.575 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -59.3 6.82 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.412 2.285 . . . . 0.0 116.599 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.06 -8.88 3.03 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 120.756 -1.215 . . . . 0.0 114.184 173.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -117.87 -22.45 7.93 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.423 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.478 HD11 HD11 ' A' ' 26' ' ' LEU . 1.1 pt -105.32 -9.5 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.456 1.025 . . . . 0.0 112.338 169.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.55 175.28 6.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.685 0.794 . . . . 0.0 111.135 -170.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.32 140.77 94.53 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 164.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.3 -12.25 27.41 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.337 2.691 . . . . 0.0 112.523 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -81.95 -38.97 24.39 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 126.76 2.024 . . . . 0.0 110.059 167.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.26 -44.5 96.4 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 119.776 1.171 . . . . 0.0 110.323 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -46.55 -57.23 4.94 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.202 1.401 . . . . 0.0 110.703 174.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 20.0 ptp180 -73.63 -49.52 25.61 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 118.084 -0.96 . . . . 0.0 108.784 -174.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.8 t -53.04 -32.85 18.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 119.08 0.854 . . . . 0.0 110.064 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.61 -28.4 68.49 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.81 -23.98 19.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.438 1.017 . . . . 0.0 112.128 175.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HE3' ' HB2' ' A' ' 41' ' ' ARG . 19.0 ptpt -111.26 -1.7 15.99 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -168.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 40.35 43.55 1.48 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.068 1.347 . . . . 0.0 111.002 -167.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.516 0 C-N-CA 125.781 1.658 . . . . 0.0 114.858 167.119 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 161.32 -167.43 36.21 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -164.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.544 HG22 ' HA ' ' A' ' 76' ' ' ASP . 22.2 pt -130.76 162.55 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.317 1.047 . . . . 0.0 110.25 174.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -79.91 155.25 27.83 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.726 0.811 . . . . 0.0 111.243 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 43.8 ttt180 -139.93 152.81 46.67 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.534 1.134 . . . . 0.0 110.197 176.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.9 t -103.3 93.01 4.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.478 1.511 . . . . 0.0 107.817 169.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.504 HG22 ' HA ' ' A' ' 144' ' ' ALA . 4.0 tt -61.09 -33.91 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 125.426 1.49 . . . . 0.0 111.733 -175.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.0 t -75.77 5.95 5.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.595 1.158 . . . . 0.0 111.613 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.1 p -140.96 15.48 2.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.795 0.838 . . . . 0.0 110.811 158.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.65 11.29 35.05 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.009 1.766 . . . . 0.0 115.271 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.0 m -118.85 137.91 53.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.745 1.773 . . . . 0.0 110.849 -159.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 8.9 p-10 -79.62 164.17 24.01 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.516 1.527 . . . . 0.0 113.481 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.268 0.2 OUTLIER -161.28 -101.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.983 0.913 . . . . 0.0 112.402 174.46 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -61.89 129.32 40.4 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -158.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.544 ' HA ' HG22 ' A' ' 64' ' ' ILE . 9.9 t0 -74.07 134.19 42.93 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 170.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.7 m -62.51 -18.12 61.24 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.153 0.981 . . . . 0.0 113.439 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -30.68 66.25 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.012 1.278 . . . . 0.0 111.635 172.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.7 p -69.53 -17.13 63.55 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.229 1.012 . . . . 0.0 112.694 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 87' ' ' TRP . 16.7 tttt -102.17 -163.73 1.03 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.701 1.6 . . . . 0.0 109.723 -164.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.47 21.66 4.34 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.566 0.951 . . . . 0.0 113.566 -175.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -53.87 118.31 3.87 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.756 1.222 . . . . 0.0 109.015 164.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 m 111.0 -23.5 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 131.621 3.968 . . . . 0.0 110.585 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -99.16 -52.01 1.29 Allowed Glycine 0 C--N 1.34 0.786 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 176.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.4 t -155.43 -6.72 0.13 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 168.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.99 17.69 52.29 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 119.794 1.179 . . . . 0.0 115.351 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.407 ' O ' ' HE2' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -63.15 150.49 88.68 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 118.022 0.911 . . . . 0.0 110.864 176.193 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -77.89 51.01 3.45 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.747 2.964 . . . . 0.0 111.489 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.4 p -129.74 146.39 51.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.676 0.791 . . . . 0.0 109.785 168.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.72 166.05 25.79 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.004 1.722 . . . . 0.0 108.568 -170.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -116.63 -9.27 11.36 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -172.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -149.65 -174.03 4.57 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 168.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 m -130.79 165.48 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 124.511 1.124 . . . . 0.0 111.475 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.3 p -52.7 -44.95 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.452 1.501 . . . . 0.0 110.877 168.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.4 m 157.14 158.33 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 130.258 3.423 . . . . 0.0 108.76 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -72.8 72.78 1.09 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 164.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -121.41 -56.19 1.9 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.379 1.072 . . . . 0.0 109.191 -174.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -118.01 13.41 13.91 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.363 1.865 . . . . 0.0 110.644 170.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.31 142.3 44.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 O-C-N 119.962 -1.711 . . . . 0.0 107.236 171.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -122.53 145.97 47.84 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.085 1.754 . . . . 0.0 107.963 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mp -128.12 157.37 40.94 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 125.092 1.357 . . . . 0.0 111.771 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.49 133.53 27.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 127.934 2.493 . . . . 0.0 106.094 167.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.461 ' CD ' HH21 ' A' ' 105' ' ' ARG . 6.8 tm-20 -76.94 144.49 38.8 Favored 'General case' 0 N--CA 1.459 0.021 0 C-N-CA 123.245 0.618 . . . . 0.0 110.878 177.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -150.9 177.73 9.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.044 2.138 . . . . 0.0 105.409 158.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.461 HH21 ' CD ' ' A' ' 103' ' ' GLU . 1.1 ptp180 -120.36 27.98 8.28 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.667 1.987 . . . . 0.0 111.072 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.03 21.3 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.961 2.905 . . . . 0.0 116.372 -168.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.64 0.57 3.29 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.539 1.136 . . . . 0.0 112.435 166.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.35 -0.13 55.79 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 117.696 -1.613 . . . . 0.0 112.842 -170.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -139.11 -88.97 0.21 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 119.854 1.827 . . . . 0.0 108.495 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 64.5 t -145.2 107.2 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -176.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -113.56 88.62 2.88 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.892 1.277 . . . . 0.0 108.757 167.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 53.5 m -86.06 133.32 33.9 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.05 159.58 30.55 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.311 0.96 . . . . 0.0 111.285 174.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.7 t -141.65 102.79 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 126.385 1.874 . . . . 0.0 107.163 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -133.09 159.66 39.45 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.551 0.614 . . . . 0.0 111.248 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 43.1 t -79.27 115.32 18.85 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.532 0.733 . . . . 0.0 111.021 -173.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.51 -24.83 65.61 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.671 1.188 . . . . 0.0 113.463 -171.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -59.2 -26.97 65.29 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.73 1.15 . . . . 0.0 112.749 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 2.8 p -137.71 -94.73 0.2 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -174.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 176.42 16.45 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.99 2.516 . . . . 0.0 112.238 -174.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.83 148.36 44.55 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -158.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -41.18 -65.65 0.41 Allowed 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 128.985 2.914 . . . . 0.0 113.99 -159.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 52.66 -108.1 0.38 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.868 1.667 . . . . 0.0 108.916 176.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.06 -115.51 0.5 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.145 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -160.21 177.15 10.95 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 122.762 -0.257 . . . . 0.0 110.792 -168.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.683 HG21 ' HE2' ' A' ' 136' ' ' LYS . 5.0 p -125.68 137.35 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.265 1.426 . . . . 0.0 108.888 173.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -132.25 159.11 40.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.098 0.959 . . . . 0.0 112.133 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -72.78 84.36 1.2 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.917 2.487 . . . . 0.0 110.942 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -160.04 7.22 0.09 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.355 1.062 . . . . 0.0 112.818 -172.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -97.71 170.36 25.28 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 119.872 -1.768 . . . . 0.0 112.755 -173.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.04 165.09 33.71 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.631 2.221 . . . . 0.0 110.146 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -62.45 151.92 81.57 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 162.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.05 -44.74 0.51 Allowed 'Cis proline' 0 C--N 1.347 0.452 0 CA-C-N 119.992 1.033 . . . . 0.0 113.806 8.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 26.9 p -72.8 -25.72 61.25 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -165.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.58 3.5 62.9 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.094 0.854 . . . . 0.0 113.552 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.683 ' HE2' HG21 ' A' ' 126' ' ' VAL . 9.7 ptmt -128.97 156.76 43.26 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.327 1.563 . . . . 0.0 111.877 -165.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.7 ttm105 -125.11 101.13 6.88 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.675 1.99 . . . . 0.0 107.399 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -67.26 135.48 53.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 162.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 20.9 t -143.81 141.34 30.33 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.704 1.138 . . . . 0.0 108.609 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -141.09 158.61 43.68 Favored 'General case' 0 C--O 1.231 0.079 0 C-N-CA 123.09 0.556 . . . . 0.0 111.494 -173.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -151.17 125.56 9.45 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.95 1.7 . . . . 0.0 108.093 161.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.8 t -149.5 148.97 30.03 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 158.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.24 -19.93 63.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.571 166.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.504 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -65.78 -12.26 52.62 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.755 1.222 . . . . 0.0 113.436 172.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 89.5 mt -75.45 106.09 6.82 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.946 1.248 . . . . 0.0 109.992 -176.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -109.82 167.62 10.02 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.31 1.444 . . . . 0.0 107.923 170.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -124.39 147.12 48.45 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 23.6 pt -138.77 166.66 23.53 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.287 1.435 . . . . 0.0 107.85 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -54.82 170.24 0.67 Allowed 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.497 2.132 . . . . 0.0 111.652 167.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -52.92 -27.15 17.4 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -171.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -165.05 -83.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 158.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -123.55 12.25 9.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.489 1.116 . . . . 0.0 110.597 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 154' ' ' GLY . 2.2 pp -65.12 -24.57 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -169.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.43 ' N ' HD12 ' A' ' 153' ' ' ILE . . . . . . . . 0 C--O 1.247 0.935 0 CA-C-O 116.939 -2.034 . . . . 0.0 109.597 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.5 mtt180 . . . . . 0 N--CA 1.439 -1.017 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.0 pt -116.14 113.45 41.51 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 126.882 2.073 . . . . 0.0 106.829 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.66 101.0 1.11 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.03 1.82 . . . . 0.0 107.652 168.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.18 147.01 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 170.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -141.75 160.98 39.07 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.302 1.841 . . . . 0.0 107.228 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.5 t -136.63 113.64 10.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 160.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.8 p -56.91 -45.34 83.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 119.148 0.885 . . . . 0.0 110.046 170.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.37 -31.02 61.43 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.36 1.864 . . . . 0.0 113.057 -174.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -118.75 0.41 11.44 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.059 1.344 . . . . 0.0 112.181 -175.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 41.43 41.12 1.46 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.648 1.579 . . . . 0.0 112.41 -159.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -74.46 150.92 39.7 Favored 'General case' 0 C--N 1.345 0.39 0 O-C-N 121.15 -0.969 . . . . 0.0 109.138 174.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.2 t -142.37 137.84 29.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 159.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -155.49 110.15 2.93 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.052 1.741 . . . . 0.0 109.61 173.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.2 ttt -79.79 129.34 34.4 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 120.34 -1.475 . . . . 0.0 110.192 174.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.0 t -122.8 155.24 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -79.58 162.55 25.26 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.401 -0.812 . . . . 0.0 110.61 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -75.28 160.6 30.16 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.582 -0.699 . . . . 0.0 110.688 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.6 tt -90.92 67.97 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 122.745 1.259 . . . . 0.0 112.133 -161.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -101.38 47.22 0.91 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.393 -169.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.5 mt -78.61 172.72 13.29 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.785 1.278 . . . . 0.0 110.984 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.23 153.57 28.45 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 127.205 2.202 . . . . 0.0 107.011 161.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -59.37 -39.05 82.06 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.216 1.371 . . . . 0.0 111.877 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.61 -22.73 62.24 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -174.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.79 -38.84 83.88 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.481 1.112 . . . . 0.0 109.563 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.6 m95 -62.85 8.3 0.06 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.731 2.412 . . . . 0.0 115.994 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.22 -2.05 3.98 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -129.7 -19.73 3.3 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.456 -0.783 . . . . 0.0 112.617 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 pt -107.31 1.78 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 119.033 0.833 . . . . 0.0 111.645 167.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -108.55 167.19 10.23 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.17 0.988 . . . . 0.0 110.894 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.39 140.04 79.77 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 166.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.17 -18.16 55.74 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.018 1.812 . . . . 0.0 111.49 168.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -70.37 -44.14 68.7 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 118.83 -0.605 . . . . 0.0 109.713 170.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.48 -43.82 93.18 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.18 0.9 . . . . 0.0 110.049 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -59.81 -45.22 93.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.84 0.856 . . . . 0.0 112.007 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -70.19 -48.38 57.44 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 119.095 0.862 . . . . 0.0 108.788 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.1 t -53.92 -32.58 22.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 124.871 1.269 . . . . 0.0 110.065 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.67 -26.35 67.97 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 175.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.5 ptt-85 -88.8 -27.62 20.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.752 1.16 . . . . 0.0 111.912 174.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -110.93 2.64 18.24 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -168.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.04 36.29 1.93 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.479 1.511 . . . . 0.0 111.621 -171.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.451 0 CA-C-O 117.967 -1.463 . . . . 0.0 113.411 174.901 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 CA--C 1.533 0.317 0 CA-C-O 120.769 0.319 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.19 178.31 38.59 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -159.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.509 HG22 ' HA ' ' A' ' 76' ' ' ASP . 37.6 pt -136.82 160.63 36.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.427 0.691 . . . . 0.0 109.555 173.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.71 158.28 28.36 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.132 0.967 . . . . 0.0 110.693 178.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 5.2 ttt180 -143.51 134.18 25.08 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.481 1.512 . . . . 0.0 110.057 -170.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.7 t -87.03 92.71 9.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 174.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.7 tt -62.01 -25.61 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 O-C-N 122.265 -0.272 . . . . 0.0 110.994 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 57.8 m -70.12 -0.35 7.59 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.267 1.827 . . . . 0.0 113.589 176.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 25.0 p -139.56 15.2 2.54 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.918 0.887 . . . . 0.0 110.606 158.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.11 9.43 5.77 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 118.031 -1.427 . . . . 0.0 114.201 -177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.1 m -110.29 141.57 43.1 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.308 1.554 . . . . 0.0 108.851 -164.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 7.8 p-10 -65.82 163.84 15.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.51 1.124 . . . . 0.0 113.679 176.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.309 0.2 OUTLIER -154.29 -110.01 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.604 165.214 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -52.83 115.65 1.93 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.319 1.448 . . . . 0.0 112.617 -162.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.509 ' HA ' HG22 ' A' ' 64' ' ' ILE . 13.2 t70 -65.96 151.16 47.41 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 170.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.37 -16.67 64.26 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 176.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -63.61 -13.4 41.73 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.787 1.631 . . . . 0.0 111.828 163.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.449 ' HA ' ' CD2' ' A' ' 90' ' ' PHE . 67.5 p -119.58 12.4 12.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.813 2.445 . . . . 0.0 111.703 172.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -156.16 91.97 1.31 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.021 0.929 . . . . 0.0 110.396 178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -141.68 147.69 37.88 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.988 1.715 . . . . 0.0 106.456 166.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -149.96 136.93 19.47 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 166.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.2 p -55.47 98.39 0.02 OUTLIER 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.805 2.042 . . . . 0.0 112.96 -158.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.9 11.95 26.75 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.832 1.206 . . . . 0.0 113.7 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.3 m -136.02 -34.45 0.8 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.218 1.007 . . . . 0.0 110.507 -159.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.7 25.82 59.25 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.428 -1.206 . . . . 0.0 114.659 172.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -59.5 140.65 88.6 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 119.223 1.511 . . . . 0.0 109.677 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -78.82 67.8 8.38 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.154 2.569 . . . . 0.0 113.301 -167.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.2 p -145.61 145.48 30.98 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.485 162.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CD2' ' HA ' ' A' ' 79' ' ' THR . 4.7 t80 -141.94 -156.56 0.69 Allowed 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.464 0.706 . . . . 0.0 110.195 171.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -133.14 4.33 3.75 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.036 0.835 . . . . 0.0 112.184 -172.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.569 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 1.1 t0 -151.38 -176.95 5.79 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.22 158.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.8 m -134.26 164.1 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 126.594 1.958 . . . . 0.0 109.23 173.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -73.1 -17.71 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -167.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.3 m 160.43 171.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 131.121 3.768 . . . . 0.0 108.253 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -91.65 100.67 13.35 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 158.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.5 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 10.6 p80 -141.84 -60.83 0.46 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.334 0.654 . . . . 0.0 109.92 -171.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.5 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 63.1 t30 -114.37 10.72 17.12 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.468 2.307 . . . . 0.0 110.005 171.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.57 150.22 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 127.5 2.32 . . . . 0.0 107.497 -177.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HD3' ' H ' ' A' ' 101' ' ' LEU . 14.4 tppt? -142.16 147.54 36.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.18 1.792 . . . . 0.0 110.517 -174.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.461 ' H ' ' HD3' ' A' ' 100' ' ' LYS . 1.8 mp -127.17 150.67 49.41 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 127.839 2.456 . . . . 0.0 111.78 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.568 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 1.3 mpt_? -131.4 152.89 50.24 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 129.927 3.291 . . . . 0.0 104.46 162.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -125.69 135.94 52.66 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 119.015 0.825 . . . . 0.0 111.008 -168.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.434 ' CG ' ' H ' ' A' ' 105' ' ' ARG . 33.4 t0 -144.82 -176.43 5.07 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.228 2.211 . . . . 0.0 108.863 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.434 ' H ' ' CG ' ' A' ' 104' ' ' ASP . 17.5 ptt-85 -112.73 15.87 19.79 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 128.734 2.814 . . . . 0.0 111.894 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.31 -33.28 41.65 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -158.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.1 pp -78.22 -10.36 59.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.045 0.839 . . . . 0.0 112.966 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.3 -1.44 26.66 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.431 -1.761 . . . . 0.0 112.885 -169.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.7 mmt -143.41 -88.05 0.13 Allowed 'General case' 0 C--N 1.347 0.463 0 CA-C-N 120.026 1.913 . . . . 0.0 108.215 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.2 t -138.55 112.09 7.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 CA-C-N 120.25 1.386 . . . . 0.0 107.604 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.5 ttt85 -121.95 117.45 26.46 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.525 0.73 . . . . 0.0 109.723 168.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.94 141.92 47.92 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.568 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 10.0 pt-20 -72.36 159.62 33.71 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.32 0.964 . . . . 0.0 109.981 176.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.9 t -138.6 103.51 2.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 170.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.7 mp -124.69 175.37 7.26 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 11.5 t -64.9 166.66 8.79 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.463 0.649 . . . . 0.0 110.136 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -100.42 -4.99 27.84 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.29 1.036 . . . . 0.0 110.808 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 34.7 tpt85 -131.85 -71.03 0.56 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 116.978 -1.487 . . . . 0.0 111.603 159.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.2 p -75.22 94.54 2.99 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 119.95 1.25 . . . . 0.0 109.148 -168.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -37.86 30.08 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.286 1 C-N-CA 133.965 4.906 . . . . 0.0 118.945 174.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.1 175.39 2.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.186 2.195 . . . . 0.0 111.895 174.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -71.14 -57.89 4.08 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 126.104 1.761 . . . . 0.0 111.171 -163.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.55 -112.06 0.64 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.014 1.726 . . . . 0.0 107.372 177.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.7 -104.88 0.2 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 119.051 0.841 . . . . 0.0 112.339 165.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -161.85 -177.26 5.72 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.751 0.31 . . . . 0.0 111.452 -163.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.15 140.71 43.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 126.575 1.95 . . . . 0.0 107.349 169.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -139.29 153.61 47.8 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.715 0.806 . . . . 0.0 110.768 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -64.12 119.74 10.76 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.694 0.679 . . . . 0.0 109.298 167.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -154.28 -28.74 0.12 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.253 1.021 . . . . 0.0 113.204 -177.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -95.97 -179.78 35.72 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.821 1.201 . . . . 0.0 111.428 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.64 -87.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.141 2.56 . . . . 0.0 112.085 -175.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.73 163.1 1.64 Allowed Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 127.277 2.231 . . . . 0.0 107.4 -176.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.11 -39.94 1.12 Allowed 'Cis proline' 0 C--N 1.35 0.627 0 CA-C-N 120.241 1.122 . . . . 0.0 109.817 -13.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.3 p -73.66 79.83 1.52 Allowed 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.611 1.565 . . . . 0.0 108.945 165.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -109.93 -3.05 30.15 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 126.832 2.158 . . . . 0.0 110.659 170.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 138.88 39.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 164.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -117.37 109.8 17.26 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.291 1.836 . . . . 0.0 108.303 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.569 ' CE1' ' HA ' ' A' ' 92' ' ' ASP . 50.2 m-85 -78.23 129.6 35.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 23.2 t -140.0 120.38 13.99 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.915 1.686 . . . . 0.0 108.771 -170.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 20.5 ptp -133.74 155.16 50.26 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.558 0.743 . . . . 0.0 109.854 -170.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -152.14 93.66 1.85 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.958 2.103 . . . . 0.0 107.003 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.7 p -143.3 152.94 42.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.09 -35.66 81.0 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.66 0.743 . . . . 0.0 109.421 165.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.4 75.87 0.26 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.874 1.67 . . . . 0.0 110.416 165.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 96.1 mt -144.83 46.97 1.35 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.009 2.524 . . . . 0.0 108.655 164.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -72.31 157.24 38.05 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -97.14 145.86 25.61 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.64 0.776 . . . . 0.0 109.711 164.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.497 ' HB ' ' HD2' ' A' ' 149' ' ' PRO . 0.1 OUTLIER -134.65 174.96 4.03 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 160.704 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 148' ' ' ILE . 57.0 Cg_endo -64.46 172.29 6.85 Favored 'Trans proline' 0 C--N 1.352 0.734 0 CA-C-N 121.504 1.573 . . . . 0.0 112.061 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -38.84 -44.26 1.02 Allowed 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 127.433 2.293 . . . . 0.0 114.012 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -144.34 -78.32 0.21 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.606 1.962 . . . . 0.0 107.945 172.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -144.55 2.62 1.1 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 128.692 2.797 . . . . 0.0 111.195 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.4 pp -55.3 -24.48 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -174.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 116.901 -2.055 . . . . 0.0 110.702 176.107 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 . . . . . 0 N--CA 1.438 -1.045 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.4 pt -123.13 108.89 31.89 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.013 1.725 . . . . 0.0 107.406 -169.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.22 104.26 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.932 2.421 . . . . 0.0 109.12 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.9 mm -84.15 154.59 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -134.69 152.25 51.63 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -176.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.2 m -129.08 77.99 1.82 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.11 -38.8 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.34 1.056 . . . . 0.0 111.89 -171.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.18 -14.57 11.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.237 1.415 . . . . 0.0 113.65 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.04 10.57 4.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.984 2.114 . . . . 0.0 110.608 175.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 34.53 40.99 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.776 2.83 . . . . 0.0 113.434 -164.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -83.07 164.17 20.46 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.275 -0.89 . . . . 0.0 108.995 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.5 t -136.32 132.42 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 168.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -135.63 103.6 5.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.534 1.534 . . . . 0.0 107.129 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.5 ttm -71.05 122.02 19.29 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 120.967 -1.083 . . . . 0.0 108.81 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.9 156.32 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 173.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -88.79 164.74 15.09 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.898 -1.126 . . . . 0.0 110.199 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.479 ' HG3' ' HD3' ' A' ' 118' ' ' ARG . 39.4 ttt-85 -65.87 144.25 56.93 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.769 -0.582 . . . . 0.0 110.506 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 tt -83.89 121.81 36.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -156.99 118.0 3.67 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 169.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.2 mt -135.73 177.54 7.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.987 2.515 . . . . 0.0 108.811 -172.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 p -85.62 178.7 7.29 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 164.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -60.1 -38.45 83.0 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.62 0.768 . . . . 0.0 111.083 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -18.46 59.26 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -166.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -71.07 -45.89 62.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.399 1.08 . . . . 0.0 110.154 -169.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -63.79 21.52 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.321 2.648 . . . . 0.0 114.805 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.99 -10.82 2.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 166.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -120.77 -18.05 7.78 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 119.223 0.919 . . . . 0.0 112.824 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 pt -111.08 24.97 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 119.226 0.921 . . . . 0.0 111.27 170.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -124.87 169.47 12.02 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.832 1.253 . . . . 0.0 110.903 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -62.65 144.08 96.24 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 168.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -68.37 -12.04 33.75 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.418 2.079 . . . . 0.0 111.741 168.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -78.84 -41.08 30.96 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 118.476 -0.773 . . . . 0.0 111.065 166.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.72 -39.42 80.78 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 120.231 1.378 . . . . 0.0 111.472 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -61.21 -37.74 84.06 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.799 0.84 . . . . 0.0 113.048 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.0 ptt-85 -78.15 -49.47 13.79 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.599 HG12 ' HB1' ' A' ' 143' ' ' ALA . 3.2 t -60.2 -24.16 29.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 O-C-N 121.396 -0.815 . . . . 0.0 111.488 -173.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.21 -24.26 67.3 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 171.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -105.69 -37.63 6.67 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.392 1.077 . . . . 0.0 111.548 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -90.47 10.68 24.31 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.251 0.932 . . . . 0.0 112.819 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 42.36 50.74 4.67 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.701 1.6 . . . . 0.0 111.564 -177.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.421 ' HA2' HG22 ' A' ' 42' ' ' VAL . . . . . . . . 0 C--N 1.336 0.564 0 CA-C-O 118.257 -1.302 . . . . 0.0 113.903 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 42.4 t0 . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 121.773 0.797 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.31 163.36 30.69 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 126.017 1.77 . . . . 0.0 111.763 168.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.7 pt -133.8 155.85 40.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 165.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -79.23 146.99 32.75 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.659 0.743 . . . . 0.0 109.489 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -110.93 110.92 21.7 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 128.613 2.765 . . . . 0.0 107.067 169.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.65 88.65 0.06 Allowed 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 165.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.6 tt -62.36 -28.13 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.591 0.71 . . . . 0.0 110.461 -170.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.91 -9.15 57.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 128.107 2.563 . . . . 0.0 113.129 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.1 p -139.5 15.29 2.55 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.754 0.821 . . . . 0.0 111.594 166.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.87 37.9 53.45 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 118.912 0.778 . . . . 0.0 112.045 176.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.0 m -132.18 146.39 51.99 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 125.971 1.708 . . . . 0.0 107.27 -171.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.3 173.52 12.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.36 0.982 . . . . 0.0 111.675 176.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -168.2 -118.15 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.689 1.995 . . . . 0.0 110.392 170.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -48.25 132.32 16.21 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.83 1.652 . . . . 0.0 114.306 -159.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -80.73 145.3 31.62 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.725 0.81 . . . . 0.0 110.068 172.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.6 m -54.6 -26.39 32.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 117.572 -1.204 . . . . 0.0 113.719 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -62.63 -21.25 65.52 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.798 1.635 . . . . 0.0 112.361 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.8 p -79.25 -10.64 59.86 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.547 0.739 . . . . 0.0 112.059 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -117.96 -177.97 3.39 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.327 1.451 . . . . 0.0 110.98 -161.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -140.76 25.24 2.17 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -162.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -56.06 -34.92 66.38 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 120.531 -1.356 . . . . 0.0 112.431 173.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.09 77.93 3.63 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 163.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 155.84 -68.02 0.29 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.601 1.096 . . . . 0.0 111.287 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.8 t -153.5 -11.58 0.15 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.455 1.279 . . . . 0.0 114.455 -173.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.06 18.5 57.6 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.781 1.173 . . . . 0.0 115.337 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.86 136.91 96.69 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 118.221 1.01 . . . . 0.0 110.708 -177.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.95 51.34 3.81 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.904 3.069 . . . . 0.0 111.771 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.3 p -138.38 117.64 12.73 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 168.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -104.33 179.77 4.18 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.62 1.968 . . . . 0.0 107.894 -170.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -119.37 -12.96 9.31 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 118.309 -0.853 . . . . 0.0 113.209 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -154.38 -178.49 7.18 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.897 1.226 . . . . 0.0 108.222 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.4 t -133.74 153.8 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.727 1.211 . . . . 0.0 110.061 -165.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -65.81 -56.72 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.154 0.982 . . . . 0.0 109.909 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.0 m 175.63 158.88 0.24 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 127.276 2.231 . . . . 0.0 107.656 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -76.36 85.23 3.12 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 160.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -119.7 -58.18 1.92 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.647 0.779 . . . . 0.0 109.561 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.71 -1.72 24.15 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.262 1.025 . . . . 0.0 111.296 169.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.06 153.86 32.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 126.393 1.877 . . . . 0.0 108.571 -169.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -140.39 134.54 30.99 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.324 1.449 . . . . 0.0 110.273 -167.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 pp -141.96 144.95 33.98 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 124.305 1.003 . . . . 0.0 113.258 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.544 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 1.5 mpt_? -137.24 123.95 21.13 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 129.522 3.129 . . . . 0.0 107.747 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -84.35 148.44 26.63 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.776 1.23 . . . . 0.0 111.206 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -153.99 173.32 16.15 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.21 2.604 . . . . 0.0 107.49 168.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.93 20.19 11.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.599 1.159 . . . . 0.0 112.763 173.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.97 -43.48 63.57 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -158.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pp -73.36 -7.58 52.23 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.84 3.69 45.8 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.485 1.517 . . . . 0.0 112.512 -169.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.0 mtp -142.07 -98.36 0.13 Allowed 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.091 1.445 . . . . 0.0 108.474 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.7 t -139.4 106.35 2.71 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.3 ttt-85 -110.42 113.69 26.54 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 42.7 t -119.77 124.32 45.87 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.544 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 16.8 pt-20 -62.54 162.26 10.68 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.221 0.464 . . . . 0.0 110.812 -174.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.8 t -137.24 106.28 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 169.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.36 168.88 15.62 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 170.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 30.4 t -70.6 138.93 51.25 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.54 -12.93 60.03 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.191 0.996 . . . . 0.0 112.297 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.479 ' HD3' ' HG3' ' A' ' 23' ' ' ARG . 38.4 tpt85 -123.26 -73.79 0.64 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 117.088 -1.434 . . . . 0.0 112.904 167.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 19.9 p -69.71 17.58 0.05 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 -158.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 68.09 -19.69 0.14 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.911 2.484 . . . . 0.0 116.087 162.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.06 165.33 18.24 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -161.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -37.12 -62.65 0.48 Allowed 'General case' 0 C--N 1.342 0.28 0 C-N-CA 129.247 3.019 . . . . 0.0 113.846 -169.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mt 46.43 -109.12 0.21 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.225 2.21 . . . . 0.0 110.604 -172.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.78 -126.47 1.03 Allowed Glycine 0 CA--C 1.521 0.456 0 CA-C-N 119.144 0.884 . . . . 0.0 113.913 175.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -167.08 168.39 13.71 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.967 0.907 . . . . 0.0 110.415 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.647 HG21 ' HE2' ' A' ' 136' ' ' LYS . 4.0 p -105.5 142.87 17.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 123.78 0.832 . . . . 0.0 110.152 170.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -140.72 166.32 25.07 Favored 'General case' 0 C--N 1.344 0.328 0 O-C-N 124.006 0.816 . . . . 0.0 111.569 172.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.24 67.94 1.43 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.056 1.742 . . . . 0.0 112.19 -172.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -142.7 25.38 1.82 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.439 1.096 . . . . 0.0 111.52 -174.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -103.2 167.43 16.91 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.971 -1.081 . . . . 0.0 111.637 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.7 167.81 25.6 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.509 2.139 . . . . 0.0 110.564 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 52.3 ptt85 -58.23 147.36 67.08 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 160.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.21 -54.28 0.15 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.525 0 CA-C-N 120.557 1.235 . . . . 0.0 113.764 7.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.1 t -79.21 -13.46 59.68 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -161.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.65 -1.36 45.42 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 119.963 1.256 . . . . 0.0 114.424 169.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.647 ' HE2' HG21 ' A' ' 126' ' ' VAL . 15.6 ptmt -119.44 156.11 30.79 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.084 1.442 . . . . 0.0 111.434 -169.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -128.03 98.91 5.29 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 126.089 1.755 . . . . 0.0 110.128 -169.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -75.58 92.96 2.97 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.685 2.394 . . . . 0.0 109.367 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 31.3 t -92.57 140.24 29.75 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.021 0.928 . . . . 0.0 109.963 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 9.1 ttp -144.37 146.92 32.81 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.981 0.912 . . . . 0.0 109.204 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -143.13 119.12 10.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.458 1.903 . . . . 0.0 107.756 174.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 80.3 p -172.86 -175.14 1.2 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.524 1.13 . . . . 0.0 107.963 165.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.599 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -57.77 -21.25 40.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.615 1.566 . . . . 0.0 114.0 163.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.27 25.76 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.09 2.156 . . . . 0.0 115.751 -164.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 95.5 mt -124.63 41.58 3.47 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.157 0.89 . . . . 0.0 112.258 -160.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -78.67 145.34 34.64 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 170.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -95.31 159.16 15.14 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.777 0.717 . . . . 0.0 109.546 167.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 14.2 pt -138.53 170.98 8.99 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 125.077 1.351 . . . . 0.0 107.663 158.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -46.47 167.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.524 3.482 . . . . 0.0 113.702 162.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -15.66 -49.01 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 129.284 3.034 . . . . 0.0 116.023 163.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -170.08 -156.63 0.14 Allowed 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 131.326 3.85 . . . . 0.0 101.255 -161.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -88.05 16.02 6.6 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 129.331 3.053 . . . . 0.0 110.133 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.2 pp -76.03 -10.69 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.121 1.768 . . . . 0.0 114.171 -162.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 CA-C-O 116.964 -2.02 . . . . 0.0 111.066 177.886 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 . . . . . 0 CA--C 1.54 0.575 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 pt -108.91 114.97 57.87 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 125.66 1.584 . . . . 0.0 111.041 -175.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.91 126.13 12.25 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.238 1.959 . . . . 0.0 109.287 164.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.9 mt -110.21 93.58 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -88.76 112.21 22.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.0 m -83.41 75.56 9.98 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 166.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.4 m -57.58 -30.14 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -170.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.21 -17.9 22.29 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.104 1.362 . . . . 0.0 113.059 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.27 15.76 5.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.811 1.644 . . . . 0.0 111.201 166.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 36.67 44.47 0.33 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.604 2.762 . . . . 0.0 112.638 -166.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.5 mtm105 -84.09 156.67 22.06 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 168.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.0 t -143.64 122.03 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -177.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -130.39 114.72 15.93 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.515 1.126 . . . . 0.0 108.064 171.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.5 ttm -81.96 135.19 35.4 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 121.173 -0.954 . . . . 0.0 109.197 172.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.3 t -135.46 159.17 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 126.024 1.73 . . . . 0.0 106.611 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -69.53 166.13 19.54 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.743 -1.223 . . . . 0.0 113.559 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.95 170.62 12.33 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 163.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.55 138.52 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -168.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -156.96 92.14 1.25 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 174.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.5 mt -126.57 -178.17 4.27 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 127.487 2.315 . . . . 0.0 108.436 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.8 p -87.45 -92.64 0.1 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.232 1.013 . . . . 0.0 109.95 176.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -150.41 -62.02 0.2 Allowed 'General case' 0 C--O 1.231 0.117 0 C-N-CA 126.564 1.946 . . . . 0.0 107.947 174.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -58.53 -21.89 53.7 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -175.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -53.2 -46.12 68.9 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.789 0.836 . . . . 0.0 110.658 173.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -68.2 40.91 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.338 2.255 . . . . 0.0 112.935 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.27 -44.42 0.13 Allowed 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 125.623 1.569 . . . . 0.0 109.351 159.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.4 -24.0 34.63 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 117.94 -1.029 . . . . 0.0 112.549 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.1 pt -105.65 21.99 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 119.936 1.244 . . . . 0.0 112.443 172.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.9 mt -108.22 166.01 11.07 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-O 122.036 0.922 . . . . 0.0 113.272 -177.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -56.15 151.01 28.18 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.942 1.297 . . . . 0.0 109.111 163.227 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.9 22.18 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.121 1 C-N-CA 125.331 4.021 . . . . 0.0 111.981 168.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.473 ' H ' ' C ' ' A' ' 36' ' ' ASP . 7.2 tt0 -133.32 -48.72 0.84 Allowed 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 126.867 2.067 . . . . 0.0 109.317 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.21 75.24 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 120.31 1.413 . . . . 0.0 111.9 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -56.18 -46.06 79.52 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 175.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -80.83 -51.06 9.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -175.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.627 HG13 ' HA2' ' A' ' 47' ' ' GLY 0.269 2.1 t -59.52 -23.92 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.413 1.085 . . . . 0.0 110.374 -178.102 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.47 -25.51 68.03 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 170.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -100.68 -34.79 9.72 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.035 1.288 . . . . 0.0 111.566 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -89.0 5.79 42.63 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.892 0.877 . . . . 0.0 112.092 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.42 51.29 16.65 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.852 1.661 . . . . 0.0 110.568 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.627 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . . . . . . 0 C--N 1.338 0.644 0 CA-C-O 118.778 -1.012 . . . . 0.0 114.513 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.3 t0 . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.39 -172.78 52.63 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 125.463 1.506 . . . . 0.0 111.96 162.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.517 HG22 ' HA ' ' A' ' 76' ' ' ASP . 36.4 pt -138.28 166.47 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 158.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -78.48 149.16 33.24 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.259 -0.901 . . . . 0.0 110.237 173.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.17 120.26 24.26 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.636 1.974 . . . . 0.0 107.002 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.0 t -73.76 86.6 1.7 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.832 1.653 . . . . 0.0 106.924 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 tt -66.35 -30.6 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.032 0.933 . . . . 0.0 111.099 -161.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.3 m -73.61 4.88 4.4 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.863 2.065 . . . . 0.0 112.462 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.553 ' HB3' ' HE ' ' A' ' 118' ' ' ARG . 30.7 p -148.47 16.54 1.02 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.878 1.271 . . . . 0.0 112.048 163.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.32 9.55 24.1 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.218 0.913 . . . . 0.0 115.172 176.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.2 m -108.53 122.54 47.28 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.928 1.364 . . . . 0.0 110.13 -159.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -64.94 151.85 44.74 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.486 0.715 . . . . 0.0 111.852 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.01 -101.43 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.863 0.865 . . . . 0.0 111.632 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -62.9 130.25 43.99 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.947 0.794 . . . . 0.0 111.15 -163.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.517 ' HA ' HG22 ' A' ' 64' ' ' ILE . 11.7 t70 -76.73 145.09 38.87 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.1 m -54.57 -27.59 39.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.152 -0.927 . . . . 0.0 112.549 176.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.99 -19.9 65.5 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.353 1.433 . . . . 0.0 112.96 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.4 p -79.95 -12.52 59.72 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.83 0.852 . . . . 0.0 112.046 174.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.446 ' HG2' ' H ' ' A' ' 81' ' ' PHE . 9.4 tttt -123.06 -171.36 2.28 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.408 1.883 . . . . 0.0 109.054 -166.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.446 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 74.0 m-85 -145.21 -179.79 6.87 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.668 1.987 . . . . 0.0 109.548 -177.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -155.94 -71.35 0.11 Allowed 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 127.499 2.319 . . . . 0.0 107.854 -168.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.63 53.33 2.65 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.863 0.839 . . . . 0.0 111.598 -159.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.99 -78.82 0.2 Allowed Glycine 0 CA--C 1.524 0.602 0 C-N-CA 127.083 2.277 . . . . 0.0 107.869 -173.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.2 m -77.07 53.66 0.98 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.389 1.076 . . . . 0.0 110.003 173.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.82 52.75 3.95 Favored Glycine 0 N--CA 1.45 -0.42 0 O-C-N 120.201 -1.562 . . . . 0.0 110.913 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.9 p-90 -135.11 164.67 42.28 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.673 1.189 . . . . 0.0 109.453 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.37 76.31 3.16 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.883 2.389 . . . . 0.0 112.191 -173.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.3 p -135.95 154.97 50.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.021 1.728 . . . . 0.0 109.399 167.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -143.75 168.71 19.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.22 1.408 . . . . 0.0 108.268 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -115.08 -13.83 11.83 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.001 -0.999 . . . . 0.0 113.14 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -158.16 176.65 12.22 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.39 1.45 . . . . 0.0 107.992 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.9 t -121.18 149.39 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 118.523 0.601 . . . . 0.0 111.46 -158.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -51.93 -58.72 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.114 1.766 . . . . 0.0 110.268 168.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.4 m 169.39 156.45 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 130.832 3.653 . . . . 0.0 105.205 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -79.33 79.87 5.74 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.826 1.194 . . . . 0.0 108.599 173.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -125.63 -53.65 1.56 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 122.994 0.518 . . . . 0.0 110.414 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -115.01 14.37 17.13 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.746 1.218 . . . . 0.0 112.347 171.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.1 tt -119.2 153.54 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 170.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.27 128.11 48.67 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 125.973 1.709 . . . . 0.0 106.899 168.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.68 146.94 51.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.921 1.289 . . . . 0.0 110.758 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.63 152.14 47.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 128.446 2.699 . . . . 0.0 105.064 174.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -131.79 130.39 41.76 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.807 0.843 . . . . 0.0 109.556 -169.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -137.06 -178.49 5.22 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.07 2.548 . . . . 0.0 107.355 -175.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -103.39 9.53 37.79 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.345 1.458 . . . . 0.0 111.045 174.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.4 t -59.81 14.46 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 129.669 3.188 . . . . 0.0 119.079 -161.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 pp -118.87 -9.61 10.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.501 1.52 . . . . 0.0 111.809 168.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 122.11 -23.36 7.32 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.94 2.21 . . . . 0.0 112.091 -166.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 28.0 ttm -136.25 -74.39 0.44 Allowed 'General case' 0 C--N 1.348 0.519 0 CA-C-N 119.541 1.67 . . . . 0.0 112.352 -168.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.9 p -155.24 100.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -111.71 128.78 56.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.616 ' SG ' HG13 ' A' ' 126' ' ' VAL . 0.0 OUTLIER -128.78 144.59 51.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -178.495 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -79.05 156.57 28.31 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 63.3 t -134.87 109.03 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 171.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.72 161.34 29.95 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.2 t -70.96 150.58 45.54 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.21 -52.14 44.76 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 172.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.553 ' HE ' ' HB3' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -65.12 -57.51 8.41 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 124.965 1.306 . . . . 0.0 112.667 177.634 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.0 p -121.11 77.53 1.32 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.548 1.139 . . . . 0.0 109.742 -158.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.31 20.62 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.005 1 C-N-CA 133.612 4.765 . . . . 0.0 115.572 -174.62 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.92 -58.08 6.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.333 1.853 . . . . 0.0 114.146 -159.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -158.37 -73.66 0.09 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.2 mt 49.62 -105.27 0.16 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.403 1.881 . . . . 0.0 110.462 -170.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.23 -115.55 0.54 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.481 172.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -149.47 177.05 10.06 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.195 0.522 . . . . 0.0 111.745 -167.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.616 HG13 ' SG ' ' A' ' 112' ' ' CYS . 0.5 OUTLIER -132.49 149.63 32.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.998 1.719 . . . . 0.0 109.029 161.263 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -147.0 161.47 40.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.797 1.239 . . . . 0.0 109.961 174.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -67.35 121.4 15.65 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.327 0.651 . . . . 0.0 109.767 171.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -160.91 -31.61 0.05 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -74.29 148.34 38.96 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -173.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.93 -14.35 19.21 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.323 2.015 . . . . 0.0 113.205 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 175.27 168.4 0.36 Allowed Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 131.568 3.947 . . . . 0.0 106.607 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.98 -71.77 0.02 OUTLIER 'Cis proline' 0 C--N 1.35 0.635 0 CA-C-N 121.136 1.441 . . . . 0.0 110.709 -13.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.8 t -70.28 -9.29 55.56 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.196 0.998 . . . . 0.0 113.623 -176.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.14 -14.88 41.95 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.25 1.405 . . . . 0.0 113.704 172.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -97.58 152.26 19.22 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 120.942 -1.328 . . . . 0.0 110.493 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -126.14 109.65 12.6 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 127.474 2.309 . . . . 0.0 106.335 -171.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -85.03 141.76 30.07 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.479 1.512 . . . . 0.0 107.737 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 18.5 t -146.29 144.77 30.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.883 0.873 . . . . 0.0 109.774 172.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 16.7 ptm -142.22 152.31 42.96 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.178 0.991 . . . . 0.0 110.351 -171.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -144.25 138.27 27.88 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.848 1.259 . . . . 0.0 108.371 164.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 63.5 p -179.21 175.11 0.98 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.18 1.392 . . . . 0.0 109.549 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -71.65 2.96 4.46 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.456 1.102 . . . . 0.0 113.139 160.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -81.84 -6.16 58.84 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 120.409 1.459 . . . . 0.0 112.837 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.93 113.3 21.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.125 0.97 . . . . 0.0 111.881 -170.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -141.34 156.85 45.79 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 158.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -92.24 162.68 14.2 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 163.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 18.3 pt -135.86 171.11 9.38 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.456 1.903 . . . . 0.0 106.966 159.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.56 171.82 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.392 2.062 . . . . 0.0 111.977 162.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -34.97 -38.23 0.08 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 128.843 2.857 . . . . 0.0 114.857 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -159.28 -102.83 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -115.21 8.75 15.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.534 1.134 . . . . 0.0 111.265 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.3 pp -69.41 -16.46 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -159.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 116.357 -2.357 . . . . 0.0 109.75 -172.925 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 79.3 mtp . . . . . 0 C--O 1.238 0.482 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -69.67 26.9 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.855 2.062 . . . . 0.0 114.774 -172.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -65.3 175.77 1.58 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.789 0.836 . . . . 0.0 109.532 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.522 ' HD3' ' HA ' ' A' ' 22' ' ' GLU . 3.5 mmt180 -122.72 153.22 39.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 166.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 pt -115.18 130.97 23.8 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.668 0.787 . . . . 0.0 109.695 -174.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.14 146.39 57.72 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 N-CA-C 108.993 -1.195 . . . . 0.0 108.993 167.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -124.97 105.75 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 166.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -98.31 101.1 12.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.9 m -67.18 74.45 0.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.478 1.111 . . . . 0.0 109.1 165.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.52 -46.89 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 124.853 1.261 . . . . 0.0 110.712 -168.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.24 -16.99 60.42 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.981 -174.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.458 ' HZ1' ' CG ' ' A' ' 76' ' ' ASP . 1.4 mtmp? -99.45 0.47 42.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.101 1.76 . . . . 0.0 110.549 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 39.72 59.44 1.86 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.344 2.658 . . . . 0.0 113.141 -167.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.73 165.83 16.59 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.334 0.654 . . . . 0.0 109.759 171.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -143.38 124.4 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -136.67 112.94 9.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.823 1.649 . . . . 0.0 107.023 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 46.0 ttm -79.5 146.15 32.84 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.775 -1.203 . . . . 0.0 108.855 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.4 t -137.7 157.41 33.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.522 ' HA ' ' HD3' ' A' ' 7' ' ' ARG . 3.3 mp0 -65.8 165.8 12.21 Favored 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 121.22 -0.925 . . . . 0.0 112.084 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.456 ' HG3' HH11 ' A' ' 23' ' ' ARG . 2.4 mmt85 -64.46 174.21 1.8 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.303 -0.873 . . . . 0.0 110.947 165.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.418 ' H ' ' HG3' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -72.85 103.63 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 169.67 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -134.95 103.94 5.78 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 166.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -136.85 177.47 7.83 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.856 1.663 . . . . 0.0 106.676 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.5 t -111.46 164.85 12.51 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 159.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.03 -27.32 43.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.579 1.552 . . . . 0.0 111.509 -175.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.21 -26.89 65.04 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -71.62 -43.35 66.34 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.33 1.052 . . . . 0.0 109.316 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -61.87 19.61 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.391 2.677 . . . . 0.0 114.932 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.78 1.1 2.5 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 165.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -133.37 -17.28 2.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 118.201 -0.904 . . . . 0.0 113.196 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 pt -110.53 -4.73 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 119.261 0.937 . . . . 0.0 112.491 171.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.511 HD22 ' CB ' ' A' ' 39' ' ' ALA . 2.5 mt -78.87 172.59 13.56 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.626 1.171 . . . . 0.0 110.78 174.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -78.52 155.62 78.66 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.084 0.953 . . . . 0.0 110.997 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -68.51 16.82 0.15 Allowed 'Trans proline' 0 CA--C 1.546 1.092 1 C-N-CA 126.213 4.608 . . . . 0.0 114.039 168.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -128.1 -31.8 2.33 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 127.376 2.271 . . . . 0.0 110.123 167.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.511 ' CB ' HD22 ' A' ' 35' ' ' LEU . . . -67.95 -38.71 83.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.123 0.874 . . . . 0.0 108.793 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -59.09 -45.82 89.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.099 0.408 . . . . 0.0 111.143 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.1 -48.9 31.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 116.718 -1.611 . . . . 0.0 107.922 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.1 t -49.5 -32.28 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 119.868 1.213 . . . . 0.0 110.384 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.46 -25.54 66.1 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 114.05 1.129 . . . . 0.0 114.05 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.78 -27.78 15.61 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.396 0.998 . . . . 0.0 111.865 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -113.35 -0.53 14.49 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -163.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.93 42.12 5.92 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.436 1.094 . . . . 0.0 110.846 -171.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.39 -58.07 0.46 Allowed Glycine 0 C--N 1.336 0.555 0 C-N-CA 125.479 1.514 . . . . 0.0 111.568 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.1 t -145.64 120.62 10.03 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.472 0.636 . . . . 0.0 110.297 -170.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -56.96 -64.19 2.8 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.214 1.406 . . . . 0.0 111.126 166.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -70.07 157.56 59.39 Favored 'Trans proline' 0 C--N 1.353 0.808 0 CA-C-N 121.595 1.605 . . . . 0.0 108.81 171.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.95 -18.45 52.19 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.651 2.234 . . . . 0.0 112.999 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -155.97 167.05 31.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.131 1.772 . . . . 0.0 107.83 170.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.2 t -139.34 7.86 2.41 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.812 0.845 . . . . 0.0 112.543 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 170.14 179.14 41.51 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -149.7 93.07 1.99 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -159.42 167.82 27.8 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.091 1.756 . . . . 0.0 107.753 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -165.24 85.98 0.39 Allowed 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 168.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.15 89.2 3.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 -161.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.6 mt -144.21 -173.84 4.13 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.094 1.357 . . . . 0.0 109.782 -168.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -154.97 170.01 22.74 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.367 2.267 . . . . 0.0 107.177 -176.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -77.55 74.85 4.11 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-O 122.911 1.339 . . . . 0.0 110.07 172.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -142.77 161.92 36.84 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 158.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.82 173.73 49.93 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.853 -172.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.656 HG22 ' HA ' ' A' ' 76' ' ' ASP . 40.8 pt -135.79 164.67 31.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.997 1.719 . . . . 0.0 108.696 170.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -72.88 148.09 44.74 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 2.8 tmt_? -141.12 112.71 7.57 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.098 0.959 . . . . 0.0 109.092 175.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.73 95.71 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.403 1.881 . . . . 0.0 109.082 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.2 tt -65.1 -16.22 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.188 0.595 . . . . 0.0 111.117 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.4 m -86.73 1.65 51.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.071 2.148 . . . . 0.0 112.741 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 22.0 p -150.23 -11.05 0.26 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 162.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.8 3.1 62.52 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 118.083 -1.398 . . . . 0.0 114.197 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.3 m -97.61 143.66 28.06 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.591 1.696 . . . . 0.0 111.281 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 11.7 p-10 -97.05 156.1 16.51 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.855 2.062 . . . . 0.0 112.128 177.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.265 0.2 OUTLIER -151.72 -95.79 0.06 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.172 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -60.25 111.07 1.4 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.993 0.917 . . . . 0.0 113.414 -159.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.656 ' HA ' HG22 ' A' ' 64' ' ' ILE . 1.7 m-20 -63.41 115.92 5.06 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.643 1.577 . . . . 0.0 107.749 166.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.6 m -56.12 -10.63 0.88 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 117.915 2.561 . . . . 0.0 117.915 -162.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -62.92 -25.69 68.45 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.686 1.585 . . . . 0.0 111.827 163.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.9 p -88.51 20.85 3.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.966 2.507 . . . . 0.0 111.817 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -118.51 179.55 4.09 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.878 2.071 . . . . 0.0 108.205 166.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -113.61 165.26 12.68 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 158.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -146.88 -65.23 0.28 Allowed 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 119.007 0.821 . . . . 0.0 109.466 171.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -57.29 161.64 3.18 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.832 0.825 . . . . 0.0 110.83 166.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.63 -62.74 3.49 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 119.261 -0.744 . . . . 0.0 111.511 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t -152.35 -10.67 0.18 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 47.13 23.64 1.79 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.872 1.701 . . . . 0.0 116.576 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -63.44 156.62 69.48 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 117.707 0.753 . . . . 0.0 111.811 -168.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -79.62 47.72 2.61 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.637 2.891 . . . . 0.0 110.634 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.01 144.57 31.09 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 126.418 1.887 . . . . 0.0 107.95 -176.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -158.8 177.09 11.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.645 1.178 . . . . 0.0 109.339 -161.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -128.62 0.49 5.52 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -165.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -161.48 -177.38 5.92 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.677 1.191 . . . . 0.0 108.079 166.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.4 m -140.87 165.77 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 118.873 0.76 . . . . 0.0 112.303 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 p -60.97 -54.7 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.405 1.482 . . . . 0.0 110.603 174.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.5 t 175.58 165.57 0.34 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.406 2.682 . . . . 0.0 107.921 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -75.61 79.22 2.6 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 162.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -126.82 -51.05 1.46 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.645 0.778 . . . . 0.0 109.967 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -117.13 1.55 12.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.697 1.599 . . . . 0.0 111.168 171.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.67 149.42 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 126.497 1.919 . . . . 0.0 106.942 174.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 101' ' ' LEU . 4.4 tmtm? -134.3 143.21 47.6 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.247 1.419 . . . . 0.0 108.918 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.46 ' N ' ' HD3' ' A' ' 100' ' ' LYS . 1.9 mp -120.68 152.16 38.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.883 2.073 . . . . 0.0 112.265 170.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.507 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -129.18 126.45 39.25 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 163.367 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -67.92 143.05 55.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.764 0.826 . . . . 0.0 110.354 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -146.03 173.48 12.13 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 158.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.35 22.13 16.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.442 2.297 . . . . 0.0 110.739 175.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.93 23.27 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.907 2.483 . . . . 0.0 116.843 -165.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 pp -131.13 -5.72 3.88 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.407 -1.433 . . . . 0.0 112.455 162.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.32 1.01 40.99 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 117.387 -1.785 . . . . 0.0 113.089 -167.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 55.4 mtm -140.92 -90.81 0.15 Allowed 'General case' 0 C--N 1.349 0.544 0 CA-C-N 120.383 2.092 . . . . 0.0 108.306 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.2 t -142.87 111.78 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.42 ' HE ' ' CD2' ' A' ' 125' ' ' HIS . 18.9 ttt180 -130.14 88.12 2.61 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.641 1.576 . . . . 0.0 111.047 175.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 7.9 m -89.12 144.09 26.38 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.507 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 22.0 pt-20 -66.52 162.36 20.94 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.218 0.917 . . . . 0.0 110.182 170.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.2 t -136.88 110.11 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 174.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.4 mt -131.29 160.33 35.25 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.52 1.128 . . . . 0.0 109.64 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.8 t -81.66 118.11 22.55 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.26 -6.31 4.36 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.971 1.308 . . . . 0.0 113.876 -175.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.418 ' HG3' ' H ' ' A' ' 24' ' ' ILE . 26.3 ttt-85 -115.13 -9.94 12.24 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.504 1.922 . . . . 0.0 113.645 171.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 22.5 p -164.37 81.58 0.4 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.46 1.482 . . . . 0.0 109.474 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -70.01 56.23 0.14 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.483 1.513 . . . . 0.0 113.039 -174.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -75.17 -49.5 19.26 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.709 1.204 . . . . 0.0 112.952 -166.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -159.71 -67.46 0.08 Allowed 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 122.981 0.512 . . . . 0.0 109.832 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 mt 44.98 -110.66 0.21 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.25 1.82 . . . . 0.0 110.074 -173.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.55 -123.69 0.86 Allowed Glycine 0 CA--C 1.521 0.441 0 CA-C-N 118.751 0.705 . . . . 0.0 112.636 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.42 ' CD2' ' HE ' ' A' ' 111' ' ' ARG . 42.6 p-80 -158.86 174.06 15.57 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.427 -0.455 . . . . 0.0 111.18 -173.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.4 p -122.83 141.37 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.219 1.408 . . . . 0.0 108.014 172.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -134.89 133.19 39.39 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.604 1.162 . . . . 0.0 108.808 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -65.16 107.36 1.54 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.809 0.844 . . . . 0.0 109.67 172.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -162.28 -5.18 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -161.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -110.4 179.28 20.29 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 119.959 -1.713 . . . . 0.0 112.455 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.2 146.69 41.14 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.038 2.492 . . . . 0.0 110.837 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.5 ptt-85 -59.71 153.23 53.48 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.588 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.86 -41.44 0.9 Allowed 'Cis proline' 0 C--N 1.35 0.618 0 CA-C-N 119.816 0.97 . . . . 0.0 111.573 -6.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.53 71.7 4.03 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 125.968 1.707 . . . . 0.0 109.663 176.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -103.95 5.96 47.04 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 112.372 -2.195 . . . . 0.0 111.291 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.75 157.39 27.13 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 116.661 -2.016 . . . . 0.0 107.189 166.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -132.14 94.54 3.48 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -65.72 143.77 57.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 164.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 12.5 t -142.28 135.19 28.52 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.061 1.745 . . . . 0.0 108.001 159.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -133.1 141.92 48.44 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.71 0.804 . . . . 0.0 109.379 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -140.6 87.52 2.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.859 1.264 . . . . 0.0 108.082 -163.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 80.2 p -153.2 177.15 11.15 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.505 0.722 . . . . 0.0 109.586 173.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.61 -8.19 45.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 170.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.06 -25.7 61.58 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.549 1.14 . . . . 0.0 113.141 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 64.2 mt -76.68 44.62 0.37 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.157 2.583 . . . . 0.0 115.35 -158.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -73.43 155.88 38.84 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 166.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -103.65 160.61 14.61 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.67 0.788 . . . . 0.0 109.233 168.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.9 pt -132.73 165.5 36.01 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.222 1.009 . . . . 0.0 108.713 160.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -50.49 150.74 11.14 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.931 2.421 . . . . 0.0 110.507 159.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.594 ' HD3' HG23 ' A' ' 64' ' ' ILE . 12.1 mmt180 -40.43 -44.45 2.01 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 126.444 1.898 . . . . 0.0 112.352 -164.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -145.8 -75.3 0.21 Allowed 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.525 1.13 . . . . 0.0 110.112 167.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -146.05 8.92 1.11 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.285 3.034 . . . . 0.0 109.83 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -59.2 -14.3 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.14 -0.975 . . . . 0.0 113.298 167.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.478 0 C-N-CA 128.16 2.791 . . . . 0.0 107.074 163.336 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 72.2 mtp . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -153.15 10.44 0.45 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.084 1.754 . . . . 0.0 109.859 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -88.55 155.23 19.76 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 128.266 2.626 . . . . 0.0 112.584 -160.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.423 ' HB3' ' HA ' ' A' ' 22' ' ' GLU . 12.0 ptt-85 -58.57 165.23 2.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.731 1.612 . . . . 0.0 113.475 -178.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.8 pt -111.88 91.88 16.36 Favored Pre-proline 0 N--CA 1.45 -0.461 0 C-N-CA 125.88 1.672 . . . . 0.0 106.759 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 73.6 Cg_endo -64.91 138.06 55.91 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 N-CA-C 107.413 -1.803 . . . . 0.0 107.413 168.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.9 mt -121.25 152.1 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -173.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -147.0 91.58 2.02 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.229 1.412 . . . . 0.0 107.441 -164.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.4 m -66.43 77.17 0.1 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.809 0.731 . . . . 0.0 109.53 165.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -60.68 -36.58 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.658 1.183 . . . . 0.0 111.546 -170.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.52 -11.53 53.15 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.231 1.012 . . . . 0.0 112.233 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -123.31 10.22 9.24 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.362 1.865 . . . . 0.0 110.798 174.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 27.58 52.01 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.572 3.149 . . . . 0.0 113.332 -161.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.95 169.87 17.27 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 118.846 -1.142 . . . . 0.0 111.173 167.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.52 136.72 43.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 158.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -145.01 107.36 4.37 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.46 1.904 . . . . 0.0 108.427 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.431 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 47.8 ttp -82.09 125.41 30.81 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.664 -1.273 . . . . 0.0 111.568 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.4 t -130.89 135.1 60.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 7' ' ' ARG . 7.8 mm-40 -55.81 166.74 0.67 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 166.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.0 mtp-105 -66.23 163.68 17.38 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.413 177.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.446 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 3.2 tt -90.2 122.66 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 169.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -149.33 112.67 4.97 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 167.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.7 mt -136.99 178.4 7.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.052 1.741 . . . . 0.0 108.316 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.31 -177.88 2.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.465 1.906 . . . . 0.0 107.843 159.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.3 -42.88 71.44 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.812 -1.18 . . . . 0.0 109.835 164.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.27 -18.97 30.58 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 128.834 2.853 . . . . 0.0 112.441 -161.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -86.9 -40.71 14.59 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 129.664 3.186 . . . . 0.0 110.378 -168.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -62.25 7.46 0.06 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.269 2.228 . . . . 0.0 114.784 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.85 -4.78 5.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.938 1.695 . . . . 0.0 113.837 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -132.01 -18.86 2.61 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.612 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 pt -109.16 8.97 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.096 0.862 . . . . 0.0 111.356 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -115.84 164.94 13.66 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.97 1.308 . . . . 0.0 110.219 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.421 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -58.22 149.02 60.13 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 122.932 0.493 . . . . 0.0 110.784 176.821 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -69.19 4.48 1.93 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.466 2.777 . . . . 0.0 112.249 164.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -93.07 -48.84 6.3 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.101 -1.0 . . . . 0.0 111.277 161.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.421 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -56.58 -44.47 81.07 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 120.274 1.397 . . . . 0.0 111.355 -172.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -58.14 -40.09 80.44 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.887 1.275 . . . . 0.0 112.432 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -80.98 -45.96 15.83 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 118.645 0.657 . . . . 0.0 109.646 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.635 HG13 ' HA2' ' A' ' 47' ' ' GLY 0.266 2.0 t -60.28 -24.44 30.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.771 1.228 . . . . 0.0 110.534 -177.7 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.13 -23.13 66.38 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 169.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -99.94 -40.66 7.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.309 1.413 . . . . 0.0 111.996 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -83.85 5.82 23.79 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.15 0.58 . . . . 0.0 111.791 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.43 49.01 20.54 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.892 1.677 . . . . 0.0 109.882 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.635 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . 71.0 -5.04 8.57 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 119.217 -0.768 . . . . 0.0 114.485 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.4 m -110.85 79.23 1.18 Allowed 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -159.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -78.87 151.7 76.67 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.339 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -70.76 118.13 5.53 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.364 2.043 . . . . 0.0 108.852 165.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.55 -32.58 7.65 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 121.868 1.712 . . . . 0.0 112.834 -172.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 7.8 t80 175.13 -62.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 128.658 2.783 . . . . 0.0 106.423 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 t -139.65 -58.03 0.57 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.397 1.479 . . . . 0.0 107.236 169.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -154.32 153.58 24.91 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 163.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -164.36 160.79 21.19 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.905 1.682 . . . . 0.0 106.795 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -143.22 167.2 22.69 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 159.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -153.34 96.72 2.08 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -176.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -88.01 168.53 12.76 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 158.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -146.71 -72.04 0.23 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 170.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -173.14 176.39 2.97 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.85 2.46 . . . . 0.0 105.855 169.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -91.89 54.67 2.48 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.381 1.073 . . . . 0.0 108.585 -159.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -128.67 162.91 26.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.335 2.654 . . . . 0.0 108.101 174.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.45 175.9 50.4 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -158.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.5 pt -141.9 -178.69 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.363 1.065 . . . . 0.0 108.624 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -98.43 162.13 13.32 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 122.307 1.051 . . . . 0.0 110.293 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.84 108.61 9.53 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 17.6 t -68.3 84.54 0.26 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 170.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 39' ' ' ALA . 14.1 tt -65.31 -25.89 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 122.062 -0.399 . . . . 0.0 110.204 -168.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.3 m -66.52 -1.87 4.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.37 2.268 . . . . 0.0 113.808 173.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 19.7 p -143.47 21.34 1.86 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.263 1.025 . . . . 0.0 110.843 158.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.63 12.02 51.06 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.588 1.09 . . . . 0.0 113.98 171.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 m -111.48 150.08 30.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.639 1.976 . . . . 0.0 110.636 -158.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -89.65 156.72 18.38 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.228 1.376 . . . . 0.0 113.082 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.06 -168.8 0.14 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.826 2.45 . . . . 0.0 109.361 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.9 t80 39.31 79.66 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 128.99 2.916 . . . . 0.0 112.607 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.7 148.43 49.26 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.92 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.8 t -71.34 -9.19 57.74 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -166.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -63.88 -39.84 95.14 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.732 1.213 . . . . 0.0 112.253 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.3 t -85.95 -18.16 33.4 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.276 0.631 . . . . 0.0 111.514 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -74.41 178.09 5.48 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.587 0.755 . . . . 0.0 109.815 168.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.32 151.72 51.25 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 105.102 -2.185 . . . . 0.0 105.102 158.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -131.93 -57.05 0.98 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.497 1.119 . . . . 0.0 110.038 -167.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.4 t -88.09 177.93 6.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.441 0.639 . . . . 0.0 109.898 163.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 55.86 -97.42 0.05 OUTLIER Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.6 1.571 . . . . 0.0 110.989 -173.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.2 m -60.24 -55.52 32.69 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.724 1.61 . . . . 0.0 110.667 177.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 43.64 44.3 6.73 Favored Glycine 0 C--N 1.343 0.932 0 C-N-CA 127.591 2.519 . . . . 0.0 113.837 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -118.62 152.61 51.47 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.239 1.415 . . . . 0.0 109.992 -169.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.08 46.88 1.85 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.779 2.986 . . . . 0.0 112.969 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.3 p -124.62 150.43 46.01 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.822 0.849 . . . . 0.0 109.501 166.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -141.43 178.56 7.35 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.034 1.334 . . . . 0.0 109.851 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -135.02 -0.62 2.75 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -172.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -159.96 177.81 10.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.452 1.101 . . . . 0.0 110.583 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.14 153.33 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 120.554 1.524 . . . . 0.0 111.544 -174.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.4 t -59.84 -63.43 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 127.976 2.51 . . . . 0.0 110.828 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.4 t -173.03 159.73 4.03 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.148 2.179 . . . . 0.0 106.326 -173.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -82.5 54.46 2.63 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.008 1.323 . . . . 0.0 108.167 173.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.469 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 15.6 p80 -102.8 -64.48 1.07 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 -159.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.469 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 16.3 t-20 -109.47 5.9 23.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.461 1.904 . . . . 0.0 112.33 173.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.1 tt -125.15 152.83 31.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 126.0 1.72 . . . . 0.0 107.22 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.471 ' HD3' ' H ' ' A' ' 101' ' ' LEU . 2.2 tmtt? -132.6 135.44 45.89 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.172 0.589 . . . . 0.0 109.475 173.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.471 ' H ' ' HD3' ' A' ' 100' ' ' LYS . 3.6 mp -125.15 146.38 49.52 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.623 2.369 . . . . 0.0 111.381 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -143.0 113.04 7.11 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 127.183 2.193 . . . . 0.0 107.468 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.56 158.54 20.11 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 122.538 1.161 . . . . 0.0 111.014 -177.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -164.39 176.99 8.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.127 2.571 . . . . 0.0 109.803 -172.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.271 0.0 OUTLIER -109.27 39.02 2.16 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.465 -1.397 . . . . 0.0 111.865 170.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.7 m -73.04 18.62 0.1 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 pp -130.66 0.91 4.42 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.172 -0.955 . . . . 0.0 111.542 158.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.67 1.94 60.08 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 117.747 -1.585 . . . . 0.0 113.665 -170.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.1 mmt -136.99 -95.68 0.22 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.366 1.583 . . . . 0.0 108.626 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.0 t -137.23 113.45 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 18.8 ttt180 -120.71 151.17 39.87 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 165.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.685 ' HB3' HG13 ' A' ' 126' ' ' VAL . 8.6 t -157.37 123.17 4.7 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -171.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -64.77 154.21 37.58 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.349 0.522 . . . . 0.0 110.522 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 78.5 t -134.39 107.91 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mp -129.44 172.45 11.52 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 171.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 42.4 t -66.56 148.35 52.01 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.05 -33.39 73.23 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 119.138 -0.458 . . . . 0.0 110.703 171.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.446 ' HG2' ' H ' ' A' ' 24' ' ' ILE . 10.4 tpt85 -106.23 -83.51 0.52 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 117.336 -1.316 . . . . 0.0 114.016 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 20.6 p -64.49 27.74 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 119.595 3.183 . . . . 0.0 119.595 -157.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 64.28 -19.59 0.07 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 158.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.65 164.32 23.64 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -159.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -38.09 -58.5 0.95 Allowed 'General case' 0 C--N 1.346 0.415 0 C-N-CA 128.42 2.688 . . . . 0.0 113.291 -174.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 45.01 -108.84 0.15 Allowed 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.752 2.021 . . . . 0.0 109.065 -173.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.69 -124.68 0.9 Allowed Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.792 170.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.21 166.24 30.0 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 122.953 0.501 . . . . 0.0 110.932 -175.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.685 HG13 ' HB3' ' A' ' 112' ' ' CYS . 2.3 p -115.38 143.28 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 126.176 1.79 . . . . 0.0 109.457 173.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -144.77 159.28 43.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.819 0.848 . . . . 0.0 110.906 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -67.86 76.07 0.21 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.109 2.164 . . . . 0.0 111.588 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -157.3 20.72 0.3 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.323 1.449 . . . . 0.0 111.601 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.74 171.44 17.13 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 120.414 -1.429 . . . . 0.0 113.278 -173.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.03 152.77 68.03 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.754 2.303 . . . . 0.0 110.15 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -63.32 151.95 86.06 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 162.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.8 -41.27 1.02 Allowed 'Cis proline' 0 C--N 1.347 0.465 0 CA-C-N 120.626 1.259 . . . . 0.0 113.848 11.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.2 p -67.97 -30.11 69.32 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -169.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.18 -1.89 39.0 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.649 1.118 . . . . 0.0 113.576 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -120.26 147.81 44.5 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.552 1.176 . . . . 0.0 110.011 -168.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -123.4 110.38 15.06 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 126.923 2.089 . . . . 0.0 107.753 -169.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -86.01 137.95 32.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.659 1.984 . . . . 0.0 107.026 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 17.1 t -140.11 138.64 35.44 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 168.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -145.64 153.01 40.56 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.326 0.65 . . . . 0.0 110.558 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -149.47 127.43 11.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.734 1.614 . . . . 0.0 108.827 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 97.2 p -166.79 175.17 7.99 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.799 0.84 . . . . 0.0 109.219 166.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.424 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -59.06 -13.89 8.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.872 0.869 . . . . 0.0 112.824 164.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.28 -12.01 60.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.484 1.038 . . . . 0.0 112.693 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 53.5 mt -84.53 81.93 8.63 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.902 1.228 . . . . 0.0 112.144 -170.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -92.42 126.73 37.63 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 162.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -75.72 146.73 39.89 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 162.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.7 pt -144.9 165.38 22.63 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 118.817 0.735 . . . . 0.0 110.868 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -60.21 174.87 1.24 Allowed 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.041 2.494 . . . . 0.0 111.675 159.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -55.02 -25.75 32.5 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -164.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -166.14 -61.71 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 128.192 2.597 . . . . 0.0 110.757 159.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -153.2 -0.41 0.24 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 130.669 3.587 . . . . 0.0 109.672 -163.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -62.08 -18.53 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.021 0.928 . . . . 0.0 112.003 169.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.404 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 158.968 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.1 tpt . . . . . 0 CA--C 1.544 0.729 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -162.73 55.69 0.21 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.728 1.604 . . . . 0.0 111.285 -169.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -159.3 177.4 11.05 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.03 0.919 . . . . 0.0 112.322 -159.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -125.1 148.05 48.72 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 128.21 2.604 . . . . 0.0 104.775 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.3 pt -138.67 145.13 44.87 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.412 0.685 . . . . 0.0 111.865 -158.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.56 117.33 3.68 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.274 2.649 . . . . 0.0 110.236 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.1 mm -79.56 101.15 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 163.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -108.96 109.54 20.62 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 t -82.88 96.21 8.19 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.72 -34.67 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 120.749 1.613 . . . . 0.0 109.118 173.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.81 -20.99 0.55 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 171.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -131.25 3.06 4.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.861 1.664 . . . . 0.0 112.184 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 t30 37.26 64.1 0.65 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.892 1.677 . . . . 0.0 111.224 -158.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.8 mtp-105 -107.38 157.99 17.52 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 168.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.12 137.32 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 158.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -134.27 156.52 48.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 159.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 33.6 ttm -112.95 131.9 55.56 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 68.9 t -136.08 155.68 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.726 1.611 . . . . 0.0 106.82 -170.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -68.53 154.44 41.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.63 -1.294 . . . . 0.0 111.288 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.429 ' HA ' ' HD3' ' A' ' 118' ' ' ARG . 0.8 OUTLIER -66.86 147.63 52.99 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 162.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.481 ' H ' ' HD2' ' A' ' 118' ' ' ARG . 8.1 tt -60.68 122.12 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.278 0.631 . . . . 0.0 109.484 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -148.19 108.1 4.03 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 104.235 -2.505 . . . . 0.0 104.235 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.4 mt -135.69 177.9 7.47 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.944 1.298 . . . . 0.0 109.361 -173.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 90.2 p -83.45 176.01 9.39 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 159.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -62.2 -48.59 79.33 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.731 -0.606 . . . . 0.0 110.804 176.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.36 -20.71 65.61 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -169.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -58.84 -42.16 88.65 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.804 0.842 . . . . 0.0 111.229 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -61.69 10.99 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.887 2.475 . . . . 0.0 115.852 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.54 -10.22 3.19 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.736 1.215 . . . . 0.0 113.858 171.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -119.99 -17.5 8.41 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.845 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 pt -112.04 4.88 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 119.342 0.974 . . . . 0.0 112.337 168.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -110.57 163.69 13.47 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.457 1.103 . . . . 0.0 110.826 -176.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.92 136.09 79.62 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 163.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.44 -17.08 53.13 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.081 1.854 . . . . 0.0 111.431 173.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -72.58 -41.33 65.79 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 118.53 -0.748 . . . . 0.0 110.114 170.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.32 -45.64 93.59 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 119.7 1.136 . . . . 0.0 110.091 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -55.92 -47.38 77.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.764 0.825 . . . . 0.0 111.588 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -73.26 -47.89 39.37 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 117.643 -1.17 . . . . 0.0 108.051 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.427 HG13 ' HA2' ' A' ' 47' ' ' GLY . 37.0 t -55.43 -29.6 24.31 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 124.516 1.126 . . . . 0.0 110.297 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.09 -22.57 66.95 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.47 -33.18 16.07 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.363 1.438 . . . . 0.0 111.304 175.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -102.02 -1.06 32.56 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 124.429 1.092 . . . . 0.0 112.34 -167.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 41.18 39.97 1.04 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.559 1.544 . . . . 0.0 111.15 -168.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.427 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . 94.89 -8.66 70.63 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-O 117.568 -1.685 . . . . 0.0 115.054 173.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 t -153.35 121.8 6.28 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 120.04 1.92 . . . . 0.0 111.223 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -51.46 -59.13 8.54 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.856 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.71 156.65 31.6 Favored 'Trans proline' 0 C--N 1.353 0.779 0 CA-C-N 121.495 1.57 . . . . 0.0 109.886 167.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.05 135.72 52.68 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.853 1.702 . . . . 0.0 109.049 168.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -151.07 171.78 16.79 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.573 1.149 . . . . 0.0 107.933 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.0 m -155.58 139.75 16.53 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.56 -177.76 12.33 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.757 0.694 . . . . 0.0 112.215 -173.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -171.29 167.13 7.01 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 126.631 1.972 . . . . 0.0 107.106 164.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -141.76 150.4 41.7 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 169.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -179.08 -178.28 0.51 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.335 2.654 . . . . 0.0 105.95 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -65.92 164.45 15.03 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.571 0.701 . . . . 0.0 110.498 167.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -153.53 157.97 40.58 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.905 1.282 . . . . 0.0 108.524 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -138.15 112.91 8.98 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 172.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.257 5.7 m-20 -103.41 36.25 2.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.719 0.808 . . . . 0.0 111.364 -173.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -113.87 103.47 11.22 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 159.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.1 -177.43 33.15 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -164.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.566 HG22 ' HA ' ' A' ' 76' ' ' ASP . 48.1 pt -133.91 155.29 39.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 121.578 0.704 . . . . 0.0 109.403 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -78.86 146.22 33.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 3.8 tmt_? -138.24 109.45 6.86 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.243 1.017 . . . . 0.0 108.45 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.19 101.34 0.4 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.504 1.522 . . . . 0.0 108.194 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 144' ' ' ALA . 4.8 tt -63.14 -28.4 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.626 0.77 . . . . 0.0 110.715 -170.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.0 m -83.45 11.87 6.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.478 1.911 . . . . 0.0 112.255 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.4 p -143.39 -7.11 0.79 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.577 0.751 . . . . 0.0 111.859 158.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.31 1.85 83.54 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.369 1.461 . . . . 0.0 113.131 177.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.0 m -119.82 147.57 44.5 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.228 1.514 . . . . 0.0 112.582 -159.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 10.1 p-10 -91.33 155.89 18.18 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.757 1.623 . . . . 0.0 113.221 -173.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.255 0.2 OUTLIER -162.34 -109.63 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.037 1.735 . . . . 0.0 110.013 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -51.62 120.3 5.04 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.338 1.055 . . . . 0.0 112.587 -159.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.566 ' HA ' HG22 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -72.31 139.63 48.09 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.135 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -20.62 65.82 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.99 -13.2 59.45 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.321 -1.487 . . . . 0.0 113.057 170.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.4 p -84.38 -19.39 33.64 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.991 -1.068 . . . . 0.0 112.564 166.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.28 86.78 2.25 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.707 1.603 . . . . 0.0 107.378 -166.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -135.0 133.52 39.53 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -142.07 114.17 8.15 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 168.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.6 p -70.78 71.93 0.53 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.024 1.729 . . . . 0.0 111.348 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.31 -44.55 1.08 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.098 1.333 . . . . 0.0 111.461 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.29 -46.6 17.42 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.181 0.99 . . . . 0.0 109.551 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 53.83 15.88 5.23 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.662 2.077 . . . . 0.0 115.882 -170.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -50.5 144.64 11.95 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 125.406 1.483 . . . . 0.0 112.782 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.98 65.02 6.06 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.375 3.384 . . . . 0.0 111.827 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.1 p -129.53 142.28 50.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.906 0.883 . . . . 0.0 109.041 164.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.4 167.53 21.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.973 1.709 . . . . 0.0 108.589 -168.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -122.42 -8.69 8.59 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.435 0.694 . . . . 0.0 112.679 -169.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -156.36 179.99 8.72 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.3 m -131.31 162.61 39.0 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-N 119.579 1.081 . . . . 0.0 112.305 -171.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.2 p -55.84 -38.41 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.211 1.405 . . . . 0.0 111.037 166.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.4 m 141.78 154.03 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 1 C-N-CA 132.194 4.198 . . . . 0.0 108.555 -173.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 53.3 mp0 -71.24 59.79 0.27 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.992 1.717 . . . . 0.0 109.914 166.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -105.46 -47.88 3.82 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.763 1.225 . . . . 0.0 108.526 -175.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.96 12.52 7.81 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 125.095 1.358 . . . . 0.0 112.28 170.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.89 145.82 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 125.369 1.468 . . . . 0.0 107.677 169.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -120.07 144.82 47.38 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.174 1.79 . . . . 0.0 108.329 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mp -131.74 157.21 44.4 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.89 1.276 . . . . 0.0 110.484 167.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.44 ' HE ' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -135.27 142.92 46.01 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 130.868 3.667 . . . . 0.0 102.817 164.42 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -126.76 130.76 50.94 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.936 1.294 . . . . 0.0 109.216 -165.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -144.55 -170.98 3.51 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.528 2.331 . . . . 0.0 108.419 -172.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -115.85 6.92 14.39 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.582 2.353 . . . . 0.0 112.119 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -65.98 31.64 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 130.154 3.382 . . . . 0.0 116.968 -163.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 pp -133.08 -7.13 3.05 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.509 1.524 . . . . 0.0 112.278 160.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.44 1.64 35.2 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 117.441 -1.755 . . . . 0.0 113.029 -168.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.3 mtt -141.94 -89.18 0.15 Allowed 'General case' 0 C--N 1.348 0.513 0 CA-C-N 120.322 2.061 . . . . 0.0 109.024 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.3 p -150.41 109.76 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -117.76 124.27 48.03 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.487 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.83 144.61 50.58 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.44 ' CD ' ' HE ' ' A' ' 102' ' ' ARG . 10.3 pt-20 -75.75 157.22 33.8 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 173.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.1 t -136.57 110.73 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -135.82 150.61 49.49 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 51.9 t -72.66 108.13 5.51 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.62 -30.13 67.03 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.225 1.41 . . . . 0.0 112.029 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.481 ' HD2' ' H ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -66.02 -21.07 66.37 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 118.805 -0.617 . . . . 0.0 112.422 176.025 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 5.6 p -121.44 -100.76 0.42 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 165.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.2 p30 156.02 30.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 128.489 2.716 . . . . 0.0 110.606 -165.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.9 166.11 10.95 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.253 1.021 . . . . 0.0 111.844 -167.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -30.35 -78.3 0.02 OUTLIER 'General case' 0 C--N 1.339 0.138 0 C-N-CA 129.585 3.154 . . . . 0.0 116.016 -159.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.2 mt 43.55 -111.55 0.2 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.588 1.555 . . . . 0.0 111.807 -170.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.37 -109.36 0.3 Allowed Glycine 0 C--N 1.336 0.532 0 CA-C-N 119.623 1.101 . . . . 0.0 113.333 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -147.01 179.83 7.33 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 112.147 -166.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.422 HG21 ' HE2' ' A' ' 136' ' ' LYS . 2.1 p -130.97 144.83 36.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.715 1.606 . . . . 0.0 108.289 159.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -136.0 161.67 35.02 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.446 1.098 . . . . 0.0 110.394 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.11 117.78 14.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.903 0.881 . . . . 0.0 109.538 172.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.57 -28.87 0.11 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.05 155.52 40.65 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.12 -13.98 21.0 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.52 2.147 . . . . 0.0 113.295 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.2 ptt-85 134.57 167.28 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.918 1 C-N-CA 133.97 4.908 . . . . 0.0 106.293 -163.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.94 -58.29 0.12 OUTLIER 'Cis proline' 0 C--N 1.351 0.681 0 CA-C-N 122.314 1.862 . . . . 0.0 111.875 -3.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.4 p -69.69 -25.07 63.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.474 1.51 . . . . 0.0 112.862 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.39 -6.64 28.99 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.961 1.267 . . . . 0.0 113.343 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.422 ' HE2' HG21 ' A' ' 126' ' ' VAL . 13.7 ptmt -115.69 152.52 33.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 120.914 -1.345 . . . . 0.0 110.017 -169.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -122.96 106.07 10.53 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.92 2.088 . . . . 0.0 107.452 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -70.15 133.93 47.61 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 162.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 23.3 t -140.71 129.45 22.97 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 174.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -129.83 147.24 51.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.28 0.632 . . . . 0.0 110.063 -175.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -139.34 99.96 3.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.4 p -138.9 166.88 23.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 162.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.27 -13.51 60.78 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.183 170.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.672 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -81.59 0.04 40.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 114.792 1.405 . . . . 0.0 114.792 -165.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 72.4 mt -79.5 54.23 1.71 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.715 1.606 . . . . 0.0 112.116 -164.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -70.59 145.1 50.95 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -85.38 156.31 20.92 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 166.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 30.6 pt -136.91 162.96 52.82 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 158.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.49 168.45 6.61 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.559 1.506 . . . . 0.0 111.238 164.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -31.66 -36.65 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 130.583 3.553 . . . . 0.0 118.21 -169.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -176.14 -57.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.564 1.946 . . . . 0.0 107.5 169.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -157.31 66.48 0.5 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -176.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -121.74 -2.55 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.686 1.194 . . . . 0.0 111.071 161.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 0 C-N-CA 129.369 3.366 . . . . 0.0 105.699 159.685 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.493 ' HG3' ' H ' ' A' ' 5' ' ' LYS . 8.6 tpt . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.493 ' H ' ' HG3' ' A' ' 4' ' ' MET . 73.6 mmtt -69.94 61.65 0.19 Allowed 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.88 -1.137 . . . . 0.0 109.47 164.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.06 -162.18 0.32 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.455 1.902 . . . . 0.0 109.268 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 7.0 mmm180 -107.73 160.16 15.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -161.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.2 pt -126.48 109.24 23.37 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 127.08 2.152 . . . . 0.0 109.383 -174.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.55 101.41 1.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.567 2.178 . . . . 0.0 108.52 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.1 mt -76.78 151.68 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -137.93 101.73 4.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.727 1.611 . . . . 0.0 106.859 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.0 m -68.35 73.74 0.23 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.177 0.899 . . . . 0.0 108.818 159.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.32 -30.8 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 121.772 -0.58 . . . . 0.0 110.438 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.4 -27.88 1.86 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.441 2.296 . . . . 0.0 113.64 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -130.73 15.62 5.34 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.081 2.153 . . . . 0.0 110.819 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 32.59 52.24 0.28 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.805 2.842 . . . . 0.0 113.604 -165.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -86.82 167.44 14.38 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.917 -0.49 . . . . 0.0 109.771 165.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.4 t -143.28 132.81 21.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -145.65 102.19 3.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.988 1.315 . . . . 0.0 108.713 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.3 ttt -82.86 118.99 23.82 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.436 -0.79 . . . . 0.0 111.019 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.2 t -113.78 -177.77 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 128.535 2.734 . . . . 0.0 106.524 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 4.1 pm0 -112.94 160.86 17.65 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.842 1.655 . . . . 0.0 112.103 177.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -56.74 154.86 8.43 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.9 1.28 . . . . 0.0 110.996 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -72.9 124.1 29.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -176.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.438 ' OE2' ' HE3' ' A' ' 5' ' ' LYS . 20.7 tt0 -148.12 115.7 6.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 163.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.432 HD11 HD11 ' A' ' 34' ' ' ILE . 38.3 mt -138.36 -177.81 5.01 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 128.669 2.788 . . . . 0.0 105.984 170.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.9 m -167.17 -24.39 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.431 ' C ' ' H ' ' A' ' 30' ' ' GLU . 4.4 t70 -91.73 -152.5 0.3 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.119 0.872 . . . . 0.0 109.462 -176.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.91 5.19 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.454 1.902 . . . . 0.0 114.101 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' A' ' 28' ' ' ASP . 36.4 mt-10 -60.43 -45.1 94.85 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 126.633 1.973 . . . . 0.0 110.58 -162.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -68.65 42.41 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.468 2.307 . . . . 0.0 113.104 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.9 -34.05 0.09 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.793 1.637 . . . . 0.0 110.634 160.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -91.08 -24.65 19.95 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.012 -0.994 . . . . 0.0 113.451 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.432 HD11 HD11 ' A' ' 26' ' ' LEU . 1.6 pt -108.43 15.53 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 120.203 1.365 . . . . 0.0 112.464 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.79 175.98 9.12 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.261 1.424 . . . . 0.0 109.837 -167.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.591 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -61.95 135.13 94.51 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 166.352 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -66.31 -12.4 35.47 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.929 1.753 . . . . 0.0 110.886 165.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -76.51 -43.05 41.08 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.367 167.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.591 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -57.38 -47.59 81.28 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 119.541 1.064 . . . . 0.0 109.841 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -48.1 -52.41 20.53 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.669 1.987 . . . . 0.0 111.603 175.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ptt-85 -76.08 -47.98 22.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.383 -0.818 . . . . 0.0 109.206 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.582 HG12 ' HB1' ' A' ' 143' ' ' ALA . 25.0 t -58.21 -27.11 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 124.91 1.284 . . . . 0.0 109.518 -176.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.44 -13.04 36.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 171.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -112.44 -26.06 8.89 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.417 1.462 . . . . 0.0 112.061 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt -112.48 14.5 20.26 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.989 1.716 . . . . 0.0 112.043 -172.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.67 -12.96 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 130.052 3.341 . . . . 0.0 116.408 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.54 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . 126.29 15.42 2.77 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.908 1.242 . . . . 0.0 113.956 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 m -149.19 130.85 14.97 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 120.298 2.049 . . . . 0.0 108.973 160.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -73.58 -55.16 3.58 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.698 1.599 . . . . 0.0 111.368 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -71.34 165.42 32.5 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 121.742 1.628 . . . . 0.0 110.798 167.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.27 -13.24 35.55 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.559 2.173 . . . . 0.0 113.032 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -77.39 68.12 3.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.843 1.257 . . . . 0.0 110.418 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.0 p -57.37 104.78 0.19 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.668 1.587 . . . . 0.0 109.317 174.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 179.79 -172.85 44.57 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -172.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -138.64 146.34 41.55 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.229 1.812 . . . . 0.0 106.511 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -64.6 -53.92 40.15 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.671 0.388 . . . . 0.0 111.629 -172.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -163.64 177.91 8.36 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.626 1.17 . . . . 0.0 108.557 173.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.98 171.2 12.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.998 2.119 . . . . 0.0 109.215 174.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -149.35 -67.2 0.22 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.052 167.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 141.25 107.69 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 130.455 3.502 . . . . 0.0 109.912 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -128.73 146.5 50.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 158.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -86.25 137.61 32.49 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 122.254 1.025 . . . . 0.0 110.935 -171.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.62 177.51 46.72 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.694 -161.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.434 HG22 ' HA ' ' A' ' 76' ' ' ASP . 46.3 pt -136.96 171.68 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.44 1.496 . . . . 0.0 108.538 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -96.56 136.04 37.63 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.994 0.518 . . . . 0.0 110.571 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 0.0 OUTLIER -102.32 120.09 39.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 163.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 35.1 t -65.79 90.7 0.13 Allowed 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 169.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.8 tt -66.57 -10.05 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.482 0.713 . . . . 0.0 111.735 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.7 t -77.94 -3.01 39.69 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.638 1.175 . . . . 0.0 111.759 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.3 p -154.68 -5.45 0.15 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 173.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.21 62.03 4.45 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -174.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.9 m -154.52 137.98 15.9 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 121.035 -1.274 . . . . 0.0 108.523 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 37.1 m-20 -101.19 157.21 16.95 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.942 0.792 . . . . 0.0 110.333 -167.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.25 0.3 OUTLIER -159.72 -103.16 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.377 1.071 . . . . 0.0 112.657 -179.516 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -52.65 121.2 6.7 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -158.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.434 ' HA ' HG22 ' A' ' 64' ' ' ILE . 5.5 m-20 -62.07 122.38 15.38 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.628 1.171 . . . . 0.0 108.754 168.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 t -66.61 -15.93 63.81 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -167.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -70.36 -16.8 63.02 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.41 1.084 . . . . 0.0 112.506 173.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.1 p -71.25 -22.64 61.95 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.366 -0.834 . . . . 0.0 111.484 167.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -98.63 -172.57 2.34 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.539 1.536 . . . . 0.0 109.839 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.73 8.14 16.07 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.659 1.183 . . . . 0.0 113.536 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -53.11 134.86 38.42 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 159.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.4 p 111.44 -36.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 1 C-N-CA 132.482 4.313 . . . . 0.0 111.29 -166.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.32 -69.27 0.39 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 -173.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.1 t -118.96 -21.21 7.81 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.722 0.809 . . . . 0.0 111.266 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.08 11.79 13.38 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.69 1.138 . . . . 0.0 114.525 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -62.82 130.84 94.18 Favored Pre-proline 0 C--O 1.237 0.439 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.63 70.03 5.84 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.895 3.063 . . . . 0.0 112.613 -165.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 72.3 p -138.01 154.18 49.34 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.019 1.728 . . . . 0.0 110.055 173.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -145.17 170.21 16.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.645 1.578 . . . . 0.0 109.08 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -128.06 -13.52 5.09 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -175.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -141.42 178.16 7.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 169.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.29 160.89 22.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.918 0.865 . . . . 0.0 111.439 -167.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 p -59.74 -40.15 81.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 125.55 1.54 . . . . 0.0 111.038 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.5 m 156.73 156.65 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.286 1 C-N-CA 131.747 4.019 . . . . 0.0 106.495 -176.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -75.61 48.79 0.47 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.72 2.008 . . . . 0.0 109.794 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.416 ' C ' HD22 ' A' ' 98' ' ' ASN . 8.1 p80 -110.4 -46.93 3.34 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.406 -0.808 . . . . 0.0 109.654 -159.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.416 HD22 ' C ' ' A' ' 97' ' ' HIS . 0.9 OUTLIER -124.56 17.69 8.84 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 124.17 0.988 . . . . 0.0 112.118 170.596 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.38 135.65 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 174.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.57 ' HD2' ' H ' ' A' ' 101' ' ' LEU . 39.0 tptt -108.56 144.24 36.52 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.306 1.842 . . . . 0.0 108.991 -173.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.57 ' H ' ' HD2' ' A' ' 100' ' ' LYS . 54.9 mt -138.39 128.79 26.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 130.355 3.462 . . . . 0.0 107.468 -167.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.449 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -133.39 114.7 13.99 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 128.716 2.806 . . . . 0.0 104.778 163.254 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -101.73 142.4 33.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 124.283 0.989 . . . . 0.0 110.822 -172.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -148.34 176.68 10.07 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.605 2.362 . . . . 0.0 107.577 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.83 10.24 36.03 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 119.977 -1.702 . . . . 0.0 112.494 172.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.0 t -58.31 16.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 130.157 3.383 . . . . 0.0 119.342 -158.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 pp -128.85 -6.25 5.06 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.694 1.198 . . . . 0.0 112.136 168.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.69 -1.66 32.19 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 117.246 -1.863 . . . . 0.0 113.38 -167.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -141.29 -91.15 0.15 Allowed 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.648 2.224 . . . . 0.0 108.74 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 56.8 t -141.72 114.59 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.435 HH21 ' CE1' ' A' ' 125' ' ' HIS . 22.2 ttt180 -118.86 127.82 53.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.359 1.037 . . . . 0.0 108.512 168.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 23.7 t -127.17 146.25 50.47 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 171.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 16.2 pt-20 -68.64 162.3 26.27 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.995 0.816 . . . . 0.0 110.508 172.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.2 t -142.43 100.52 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 174.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mp -130.82 162.22 30.04 Favored 'General case' 0 N--CA 1.461 0.116 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.45 ' HB3' ' H ' ' A' ' 119' ' ' CYS . 1.6 t -71.82 124.52 25.0 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.21 -9.01 20.02 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.396 0.678 . . . . 0.0 111.76 174.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.98 -25.5 15.36 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.54 1.936 . . . . 0.0 113.011 170.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.45 ' H ' ' HB3' ' A' ' 116' ' ' CYS . 31.2 p -159.71 95.38 1.2 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.6 1.56 . . . . 0.0 109.514 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.9 32.51 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.004 1 C-N-CA 131.79 4.036 . . . . 0.0 113.068 178.285 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.91 -63.57 1.25 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -158.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.401 ' H ' HD23 ' A' ' 123' ' ' LEU . 50.7 t-80 -158.0 -64.46 0.09 Allowed 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 174.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.401 HD23 ' H ' ' A' ' 122' ' ' HIS . 2.3 mm? 54.02 -106.32 0.3 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.153 2.181 . . . . 0.0 106.464 173.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 176.62 -120.43 0.74 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.228 -0.986 . . . . 0.0 112.685 167.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.435 ' CE1' HH21 ' A' ' 111' ' ' ARG . 22.6 p-80 -159.69 173.68 15.69 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.749 -0.266 . . . . 0.0 110.761 -168.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.4 p -123.61 143.38 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.579 1.552 . . . . 0.0 107.884 171.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -138.79 151.74 47.31 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.273 1.029 . . . . 0.0 109.413 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -65.83 118.5 9.76 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 170.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -142.57 -47.06 0.33 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.068 0.947 . . . . 0.0 113.511 -168.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -104.45 -179.78 24.77 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.096 1.332 . . . . 0.0 114.566 -159.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.22 147.16 83.22 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.108 2.539 . . . . 0.0 110.186 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -77.43 159.34 77.6 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 118.731 -0.652 . . . . 0.0 109.451 -174.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.35 -49.17 0.24 Allowed 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 120.037 1.049 . . . . 0.0 111.521 0.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.3 p -77.74 76.24 4.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 123.043 1.401 . . . . 0.0 109.907 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -110.0 7.53 31.17 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 128.138 2.78 . . . . 0.0 110.249 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -78.2 138.65 38.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.712 1.756 . . . . 0.0 106.754 163.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.21 101.05 10.56 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 173.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -67.74 143.4 55.91 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 161.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 36.3 t -146.6 137.44 24.07 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.139 1.375 . . . . 0.0 108.497 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -138.43 153.99 48.87 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.759 0.824 . . . . 0.0 111.262 -177.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -156.33 114.76 3.36 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.14 2.176 . . . . 0.0 107.334 173.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.0 p -171.87 177.82 3.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.472 1.509 . . . . 0.0 108.995 174.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.582 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -66.31 21.45 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.113 1.765 . . . . 0.0 113.1 165.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -90.91 -15.88 29.09 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.98 1.264 . . . . 0.0 113.286 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.4 mt -83.46 88.49 6.99 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.376 0.535 . . . . 0.0 111.802 -159.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -127.87 114.32 17.05 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.427 1.091 . . . . 0.0 108.915 167.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -68.86 145.47 53.68 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 163.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.2 pt -137.8 163.4 48.42 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 125.329 1.452 . . . . 0.0 109.382 168.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.18 161.13 11.64 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.232 1.954 . . . . 0.0 111.694 166.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -34.13 -24.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 131.543 3.937 . . . . 0.0 120.273 -167.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -167.42 -82.37 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.253 1.821 . . . . 0.0 107.289 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -141.73 9.63 1.98 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.967 2.107 . . . . 0.0 110.191 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.9 pp -69.81 -16.25 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -167.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 116.783 -2.121 . . . . 0.0 112.077 170.897 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.2 tpt . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -64.76 91.25 0.09 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 159.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.3 p30 -149.99 -161.8 1.42 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.412 1.101 . . . . 0.0 111.993 -161.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -108.63 172.57 6.77 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.149 2.179 . . . . 0.0 110.534 -170.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.451 HD13 ' HD3' ' A' ' 118' ' ' ARG . 1.3 pt -122.72 102.57 38.39 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 124.852 1.261 . . . . 0.0 110.447 -173.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.2 99.46 1.01 Allowed 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.375 2.05 . . . . 0.0 109.325 174.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.4 mt -79.85 88.31 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -78.26 97.31 5.5 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -69.55 72.0 0.33 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 160.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.1 t -56.26 -37.98 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 123.677 0.791 . . . . 0.0 111.506 -170.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.09 -12.17 25.07 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -125.54 7.12 7.6 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.248 1.819 . . . . 0.0 111.067 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 31.39 48.31 0.08 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 128.72 2.808 . . . . 0.0 112.81 -161.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -90.18 157.96 17.47 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 168.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.5 t -148.77 92.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 -176.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -100.48 102.96 14.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 32.9 ttm -80.05 87.41 5.44 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.669 173.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 80.8 t -84.47 174.7 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 125.853 1.661 . . . . 0.0 107.001 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -105.74 155.18 19.53 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 120.232 -1.542 . . . . 0.0 110.55 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.54 150.05 41.43 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.24 113.77 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -139.84 105.34 5.09 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 162.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.6 mt -133.12 171.89 13.39 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.492 1.517 . . . . 0.0 109.306 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.6 t -85.32 165.38 17.33 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 158.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.2 -38.8 74.22 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.138 0.881 . . . . 0.0 110.111 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.407 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -59.95 -25.78 65.46 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -170.43 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -67.56 -45.06 76.7 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.818 1.647 . . . . 0.0 109.846 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -61.2 10.93 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.058 2.143 . . . . 0.0 115.864 -174.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.407 ' NE ' ' HA ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -130.75 -5.79 4.07 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 173.013 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -128.7 -18.96 3.79 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.639 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 pt -104.97 4.41 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.88 0.763 . . . . 0.0 111.391 166.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mt -112.36 160.46 17.68 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.85 1.26 . . . . 0.0 110.372 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.4 145.51 75.23 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.65 -4.48 12.21 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.678 2.252 . . . . 0.0 112.33 166.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -77.93 -56.43 4.5 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.725 1.21 . . . . 0.0 109.996 162.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.74 -42.48 71.66 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.571 1.078 . . . . 0.0 111.223 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -58.03 -47.2 83.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.956 1.302 . . . . 0.0 111.613 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -75.69 -38.86 58.32 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 119.458 1.026 . . . . 0.0 110.572 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 t -55.05 -28.61 21.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.943 1.297 . . . . 0.0 111.068 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.88 -20.57 63.88 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 172.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -101.3 -45.11 5.44 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 119.722 1.146 . . . . 0.0 111.807 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.488 ' CD ' ' HG2' ' A' ' 49' ' ' GLU . 10.1 ptpt -89.93 12.55 17.11 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.591 1.087 . . . . 0.0 112.833 -174.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.37 36.75 1.16 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 128.082 2.553 . . . . 0.0 113.557 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.91 29.4 26.15 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-O 119.883 -0.398 . . . . 0.0 113.688 171.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.0 m -142.89 103.32 4.17 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 118.974 1.387 . . . . 0.0 109.061 166.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.488 ' HG2' ' CD ' ' A' ' 45' ' ' LYS . 11.1 mt-10 -72.06 169.24 17.11 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 161.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -61.79 157.08 44.66 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 121.474 1.449 . . . . 0.0 110.701 160.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.78 164.85 34.35 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.755 2.304 . . . . 0.0 112.054 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -145.82 170.56 16.31 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.556 1.542 . . . . 0.0 108.94 176.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.2 m -71.01 91.76 0.9 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.524 1.129 . . . . 0.0 110.495 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -65.96 158.61 47.44 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 161.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -154.59 -51.72 0.09 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 122.264 -0.551 . . . . 0.0 111.455 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -57.72 139.92 52.69 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 175.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -159.69 171.58 19.3 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.534 2.334 . . . . 0.0 106.533 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -148.9 -173.83 4.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 172.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.0 mp -130.98 27.21 4.9 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.113 1.765 . . . . 0.0 109.923 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.62 171.79 11.82 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.082 1.753 . . . . 0.0 109.497 174.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -74.89 36.58 0.11 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.955 2.902 . . . . 0.0 112.684 -173.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -75.64 143.24 42.34 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 121.803 0.811 . . . . 0.0 112.504 -172.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.63 151.83 24.72 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.684 1.611 . . . . 0.0 111.944 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.533 HG22 ' HA ' ' A' ' 76' ' ' ASP . 42.8 pt -132.85 161.94 40.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 125.171 1.388 . . . . 0.0 108.178 169.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -82.67 142.5 31.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.012 0.434 . . . . 0.0 110.144 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 0.0 OUTLIER -114.8 140.33 49.01 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 124.372 1.069 . . . . 0.0 110.2 160.274 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.2 t -70.6 84.49 0.62 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 162.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.9 tp -59.74 -13.37 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.044 1.338 . . . . 0.0 112.218 172.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.7 t -78.47 1.89 20.78 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.635 1.574 . . . . 0.0 111.737 173.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.6 p -159.02 -9.56 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 170.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.35 64.31 2.67 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -173.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.22 135.23 30.51 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.113 2.165 . . . . 0.0 106.238 176.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 5.7 p-10 -100.13 152.34 20.36 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.555 1.525 . . . . 0.0 112.222 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.419 HD23 ' H ' ' A' ' 75' ' ' PHE 0.283 0.0 OUTLIER -154.51 -107.97 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.387 1.075 . . . . 0.0 112.864 178.409 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.489 ' CE1' HG13 ' A' ' 93' ' ' VAL . 73.6 m-85 -50.49 121.69 6.06 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.467 1.907 . . . . 0.0 113.622 -160.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.533 ' HA ' HG22 ' A' ' 64' ' ' ILE . 18.2 t70 -86.95 156.84 19.63 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.139 0.976 . . . . 0.0 111.402 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.1 t -56.8 -17.71 10.17 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -63.55 -26.96 68.94 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.862 1.664 . . . . 0.0 111.43 170.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.1 p -92.05 -47.14 7.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.211 1.405 . . . . 0.0 109.177 174.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.35 112.55 15.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.793 1.237 . . . . 0.0 109.725 -159.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -52.59 145.73 11.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.959 0.904 . . . . 0.0 111.165 173.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -140.93 -69.62 0.38 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.789 1.236 . . . . 0.0 110.287 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.7 m -73.16 120.51 18.88 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.53 -158.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.92 -64.95 3.3 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.6 m -120.37 78.67 1.38 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.734 1.214 . . . . 0.0 108.703 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -77.76 32.84 1.67 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 123.884 0.754 . . . . 0.0 113.895 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -59.54 152.6 55.11 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 125.14 1.376 . . . . 0.0 112.002 -172.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.91 60.09 7.61 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.297 2.665 . . . . 0.0 109.657 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.1 p -145.49 145.92 31.26 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 163.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -153.69 175.45 13.24 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.578 1.151 . . . . 0.0 109.463 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -112.1 -12.87 13.62 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.619 0.768 . . . . 0.0 112.384 -164.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -154.49 -175.86 5.61 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -173.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.489 HG13 ' CE1' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -136.75 154.35 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 124.861 1.264 . . . . 0.0 109.478 -163.212 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.7 p -62.17 -32.34 54.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 122.581 0.352 . . . . 0.0 110.197 164.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.1 m 153.03 165.83 0.01 OUTLIER 'General case' 0 C--O 1.234 0.238 1 C-N-CA 132.943 4.497 . . . . 0.0 106.51 -175.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.423 ' HA ' ' CG2' ' A' ' 99' ' ' ILE . 99.3 mt-10 -107.96 75.97 1.03 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -132.46 -28.8 1.62 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.357 1.463 . . . . 0.0 112.597 -161.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.71 16.57 11.93 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.636 1.175 . . . . 0.0 111.876 167.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.613 HD11 HG13 ' A' ' 114' ' ' VAL . 12.0 tt -132.22 146.18 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 125.94 1.696 . . . . 0.0 108.114 -173.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -127.92 124.47 37.45 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.815 1.246 . . . . 0.0 108.834 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 mp -118.79 139.8 51.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.032 2.133 . . . . 0.0 108.756 -173.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -131.61 116.91 18.0 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.673 1.589 . . . . 0.0 106.715 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -79.19 135.67 36.87 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.693 1.235 . . . . 0.0 112.174 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 105' ' ' ARG . 19.2 t70 -143.41 -172.03 3.62 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.351 1.86 . . . . 0.0 110.697 170.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.454 ' H ' ' CG ' ' A' ' 104' ' ' ASP . 0.2 OUTLIER -122.7 7.16 9.41 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.537 2.735 . . . . 0.0 111.838 -173.439 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -65.65 30.42 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 129.928 3.291 . . . . 0.0 116.905 -161.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pp -131.09 -2.52 4.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.017 1.327 . . . . 0.0 112.023 161.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.14 3.31 51.36 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 117.908 -1.496 . . . . 0.0 112.415 -168.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.5 mtp -140.69 -95.35 0.15 Allowed 'General case' 0 C--N 1.347 0.494 0 CA-C-N 120.01 1.905 . . . . 0.0 107.993 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.8 t -142.64 111.4 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -119.03 100.72 7.53 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.768 1.227 . . . . 0.0 107.966 171.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 36.1 t -100.9 128.07 47.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.62 158.96 22.98 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.968 0.804 . . . . 0.0 110.099 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.613 HG13 HD11 ' A' ' 99' ' ' ILE . 95.0 t -141.65 98.95 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -176.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.3 mp -126.84 164.26 21.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 174.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.3 m -77.47 145.29 37.15 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.403 -1.436 . . . . 0.0 110.625 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -82.14 -22.89 35.9 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.09 0.956 . . . . 0.0 111.249 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.451 ' HD3' HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -76.8 -38.22 54.33 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 117.993 -1.003 . . . . 0.0 111.092 169.604 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.2 p -147.58 115.72 6.54 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 173.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.53 56.28 0.06 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.411 1.485 . . . . 0.0 111.304 176.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.14 168.38 16.89 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.242 1.817 . . . . 0.0 110.682 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -44.69 -64.04 0.78 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.756 2.022 . . . . 0.0 113.264 -161.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 50.94 -114.29 0.77 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.414 1.886 . . . . 0.0 107.983 174.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.22 -119.65 0.68 Allowed Glycine 0 CA--C 1.522 0.518 0 CA-C-N 118.653 0.66 . . . . 0.0 113.271 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 54.1 p-80 -161.18 170.7 19.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.237 0.615 . . . . 0.0 110.648 -170.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.586 HG21 ' HE2' ' A' ' 136' ' ' LYS . 3.6 p -115.2 139.61 40.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.161 1.384 . . . . 0.0 108.283 172.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -132.23 150.47 52.15 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 123.593 0.558 . . . . 0.0 110.812 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -66.42 108.59 2.42 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.732 1.213 . . . . 0.0 109.206 174.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.33 -44.47 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.683 1.193 . . . . 0.0 112.257 -170.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.74 -179.65 32.51 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.222 0.915 . . . . 0.0 114.94 -159.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.55 165.25 31.35 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.219 2.613 . . . . 0.0 110.629 171.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.72 154.87 84.14 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 164.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.46 -55.52 0.14 OUTLIER 'Cis proline' 0 C--N 1.348 0.55 0 CA-C-N 120.745 1.302 . . . . 0.0 113.751 10.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 19.1 p -66.7 -31.16 71.64 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.366 1.067 . . . . 0.0 113.149 -166.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 71.81 -2.37 25.08 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.052 0.834 . . . . 0.0 114.797 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.586 ' HE2' HG21 ' A' ' 126' ' ' VAL . 14.6 ptmt -103.38 159.09 15.87 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.3 1.05 . . . . 0.0 108.863 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.4 ttp85 -129.14 99.91 5.43 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.68 1.192 . . . . 0.0 108.856 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -62.5 132.15 51.52 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.656 1.582 . . . . 0.0 107.413 163.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 42.6 t -141.77 144.86 34.19 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.654 1.116 . . . . 0.0 109.386 173.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.5 ptp -149.76 158.19 43.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.457 0.646 . . . . 0.0 110.655 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.17 89.17 1.93 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.566 2.346 . . . . 0.0 106.096 -176.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.523 ' HB3' ' H ' ' A' ' 144' ' ' ALA . 2.8 m -147.2 162.27 39.23 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.31 1.444 . . . . 0.0 108.63 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.7 -20.31 65.62 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.355 1.062 . . . . 0.0 113.072 163.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.523 ' H ' ' HB3' ' A' ' 142' ' ' SER . . . -62.81 29.3 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 130.661 3.584 . . . . 0.0 114.881 -175.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 93.8 mt -132.81 47.41 2.51 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.283 1.833 . . . . 0.0 108.861 -168.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.6 tttt -74.43 122.45 23.01 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -66.95 131.9 46.82 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 165.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 17.2 pt -114.17 164.42 16.27 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 160.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -60.13 173.26 1.94 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 121.657 1.571 . . . . 0.0 110.038 160.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -41.77 -28.34 0.15 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -168.75 -83.53 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 170.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -146.14 26.98 1.18 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.169 1.788 . . . . 0.0 110.244 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -73.28 -12.61 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.97 1.308 . . . . 0.0 112.152 170.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.49 0 N-CA-C 106.977 -2.449 . . . . 0.0 106.977 160.483 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 95.4 mtp . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -122.15 33.86 5.34 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.291 1.436 . . . . 0.0 111.195 -177.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -74.07 -147.85 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 129.862 3.265 . . . . 0.0 111.913 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.7 mtt85 -145.53 166.03 26.9 Favored 'General case' 0 C--N 1.32 -0.689 1 C-N-CA 135.192 5.397 . . . . 0.0 105.228 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 42.0 pt -132.55 128.75 21.13 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.046 0.938 . . . . 0.0 110.395 -164.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.17 132.97 17.27 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.86 1.707 . . . . 0.0 110.256 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.9 mm -101.01 148.77 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 160.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.98 91.49 1.79 Allowed 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.872 1.269 . . . . 0.0 107.869 -169.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.9 m -71.37 80.22 0.76 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.579 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.39 -33.96 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.995 1.271 . . . . 0.0 111.09 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.05 -6.75 4.33 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 173.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -130.02 11.45 5.55 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.306 2.242 . . . . 0.0 110.512 170.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.3 t30 28.11 66.82 0.08 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.821 2.448 . . . . 0.0 112.248 -162.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -114.7 161.44 18.13 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.6 t -144.75 122.5 5.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -141.43 98.87 3.44 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -170.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 44.2 ttm -70.52 133.5 46.84 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.077 -1.014 . . . . 0.0 109.477 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.3 t -121.25 161.33 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 176.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -78.46 167.15 21.74 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.186 -1.571 . . . . 0.0 109.565 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.5 mtm105 -63.24 165.2 7.68 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.669 -0.644 . . . . 0.0 109.96 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.45 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 6.2 tp -70.28 120.61 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 167.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -152.43 118.17 5.39 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 160.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.1 mt -140.4 172.86 12.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.885 1.674 . . . . 0.0 108.442 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.453 ' H ' ' HG2' ' A' ' 30' ' ' GLU . 10.7 p -94.51 168.62 10.75 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.019 1.328 . . . . 0.0 109.67 171.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -77.66 70.05 3.99 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.791 0.805 . . . . 0.0 109.5 164.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -167.14 -26.81 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 125.286 1.435 . . . . 0.0 110.988 158.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.453 ' HG2' ' H ' ' A' ' 27' ' ' SER . 23.1 mm-40 -55.62 -45.24 77.56 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.309 0.644 . . . . 0.0 110.348 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -68.19 37.34 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.275 2.63 . . . . 0.0 112.767 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.56 -34.34 0.19 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.632 1.173 . . . . 0.0 111.402 161.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -92.24 -26.37 18.2 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.807 -1.092 . . . . 0.0 113.049 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.2 pt -100.81 23.44 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 120.186 1.357 . . . . 0.0 111.467 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.7 mt -122.25 161.49 23.19 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.443 1.097 . . . . 0.0 112.233 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -61.54 149.03 85.26 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.082 170.334 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -68.83 5.1 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.419 2.746 . . . . 0.0 112.657 167.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -102.79 -39.82 6.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.672 -1.156 . . . . 0.0 111.441 165.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.514 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -60.78 -43.68 97.75 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 121.421 1.919 . . . . 0.0 111.455 -173.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -57.66 -45.7 85.18 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.929 1.292 . . . . 0.0 111.549 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -76.33 -36.78 58.07 Favored 'General case' 0 C--O 1.221 -0.434 0 O-C-N 121.526 -0.734 . . . . 0.0 111.066 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.635 ' CG1' ' HB1' ' A' ' 143' ' ' ALA . 25.2 t -55.0 -27.99 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 120.701 -1.25 . . . . 0.0 111.143 175.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.45 -22.91 67.16 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -93.84 -41.82 9.43 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.514 1.506 . . . . 0.0 111.537 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -96.13 4.82 52.22 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.302 1.841 . . . . 0.0 112.884 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.04 15.58 1.84 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.939 1.695 . . . . 0.0 113.533 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.53 -0.24 30.82 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 117.702 -1.61 . . . . 0.0 114.805 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.0 m -150.19 116.42 5.7 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 121.622 2.711 . . . . 0.0 112.035 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -103.97 159.38 29.5 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 126.731 2.012 . . . . 0.0 107.063 169.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.36 153.84 76.51 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 121.281 1.321 . . . . 0.0 111.142 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -66.19 133.29 32.46 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.865 2.376 . . . . 0.0 110.376 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -153.28 -69.69 0.15 Allowed 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.7 m -68.67 163.83 22.95 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 158.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -128.85 171.08 19.86 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 172.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.3 ttmt -150.24 178.78 8.67 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.463 1.505 . . . . 0.0 107.258 174.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -136.74 164.58 27.93 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.884 1.674 . . . . 0.0 107.251 167.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -141.73 -40.24 0.37 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.704 1.602 . . . . 0.0 108.589 172.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -41.61 98.23 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 130.939 3.696 . . . . 0.0 111.652 158.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.1 mt -137.44 -38.99 0.59 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.521 1.528 . . . . 0.0 110.167 167.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -143.89 163.53 33.15 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 165.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -75.0 89.2 2.4 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 162.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -158.03 -178.22 7.14 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.457 1.503 . . . . 0.0 108.047 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.61 172.12 17.39 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 122.206 0.892 . . . . 0.0 114.978 166.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.514 HG22 ' HA ' ' A' ' 76' ' ' ASP . 14.2 pt -136.2 170.79 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.829 1.651 . . . . 0.0 109.618 176.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -96.95 111.04 23.43 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.457 1.103 . . . . 0.0 109.999 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.49 113.73 14.42 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 163.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 20.7 t -65.84 85.32 0.08 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.512 1.525 . . . . 0.0 109.14 166.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.1 tt -66.33 -11.61 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.704 1.602 . . . . 0.0 111.587 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.5 m -82.28 -1.44 49.47 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.309 1.844 . . . . 0.0 113.0 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.8 p -152.17 -16.43 0.18 Allowed 'General case' 0 C--N 1.338 0.104 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 165.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.66 65.84 1.59 Allowed Glycine 0 C--N 1.337 0.616 0 N-CA-C 107.593 -2.203 . . . . 0.0 107.593 -162.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.1 m -143.21 166.63 24.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 172.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -135.53 145.89 47.51 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.57 -102.82 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.666 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -54.4 108.01 0.34 Allowed 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.487 1.115 . . . . 0.0 112.815 -159.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.514 ' HA ' HG22 ' A' ' 64' ' ' ILE . 1.6 m-20 -68.37 135.86 52.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -10.11 57.31 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.38 0.991 . . . . 0.0 112.949 -171.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.91 -20.8 62.64 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.468 -1.395 . . . . 0.0 112.472 163.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.3 p -86.69 -20.14 28.17 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.659 1.184 . . . . 0.0 112.89 168.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -137.05 86.29 2.19 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.229 1.812 . . . . 0.0 107.471 -169.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -139.06 124.24 19.05 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -144.83 93.62 2.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -176.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.0 m -61.81 124.97 22.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.825 1.25 . . . . 0.0 111.14 -170.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.12 -60.88 4.8 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.79 -49.6 70.04 Favored 'General case' 0 CA--C 1.526 0.039 0 CA-C-N 117.941 0.87 . . . . 0.0 112.285 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 42.35 42.11 4.26 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.918 2.199 . . . . 0.0 115.657 -162.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -61.44 143.81 92.79 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 118.528 1.164 . . . . 0.0 108.874 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.14 70.44 6.69 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.02 2.48 . . . . 0.0 110.895 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.3 p -136.44 150.29 48.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.521 1.129 . . . . 0.0 110.967 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.25 166.77 22.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.901 2.08 . . . . 0.0 107.568 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -127.7 -6.9 5.66 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.393 0.677 . . . . 0.0 112.451 -170.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -151.96 -178.02 6.5 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 167.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.23 158.76 43.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 124.105 0.962 . . . . 0.0 111.825 -176.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 p -51.36 -42.44 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 127.271 2.228 . . . . 0.0 111.444 171.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.6 m 157.14 155.07 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.515 1 C-N-CA 131.959 4.104 . . . . 0.0 106.786 -176.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -74.06 75.51 1.73 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 161.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -114.8 -53.51 2.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.573 1.149 . . . . 0.0 108.991 177.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.82 14.33 7.45 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 173.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.5 tt -106.12 154.25 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 159.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -123.49 134.11 53.94 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 166.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 46.8 mt -117.41 148.97 41.29 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.855 2.062 . . . . 0.0 109.02 172.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.473 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 0.2 OUTLIER -133.17 115.69 15.34 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 162.422 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.96 143.44 56.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.221 1.409 . . . . 0.0 110.034 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -147.79 -178.97 6.55 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 158.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.95 14.7 9.95 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.024 2.13 . . . . 0.0 110.377 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.8 m -62.33 -21.81 65.57 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 126.194 1.798 . . . . 0.0 115.692 -158.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 pp -77.08 -14.72 59.77 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.556 1.071 . . . . 0.0 112.231 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.86 0.6 25.73 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 117.316 -1.824 . . . . 0.0 113.012 -168.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.0 mmt -143.31 -85.18 0.15 Allowed 'General case' 0 C--N 1.349 0.553 0 CA-C-N 120.456 2.128 . . . . 0.0 107.9 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.2 t -145.19 114.69 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -129.37 103.44 6.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.305 1.442 . . . . 0.0 110.186 172.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.4 ' HB2' ' CG1' ' A' ' 126' ' ' VAL . 2.6 m -106.85 151.87 24.64 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 23.9 pt-20 -70.43 163.68 26.21 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.354 0.979 . . . . 0.0 110.838 171.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.3 t -137.09 107.51 5.38 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 168.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.49 164.49 18.83 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 167.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 17.0 t -65.47 156.22 33.12 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 162.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.72 -28.91 66.21 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.45 ' HG2' ' H ' ' A' ' 24' ' ' ILE 0.285 0.0 OUTLIER -116.1 -52.45 2.6 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 179.451 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 15.9 p -77.51 77.68 4.03 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 121.077 1.762 . . . . 0.0 109.227 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -52.86 67.04 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 128.983 2.913 . . . . 0.0 111.071 166.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.4 -178.9 4.51 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.37 2.268 . . . . 0.0 110.264 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -43.75 -57.99 2.94 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.259 2.224 . . . . 0.0 113.366 -165.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 42.54 -112.08 0.19 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.616 1.966 . . . . 0.0 109.422 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -178.29 -125.3 0.91 Allowed Glycine 0 CA--C 1.519 0.328 0 CA-C-N 118.954 0.797 . . . . 0.0 113.767 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -158.46 174.87 14.44 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.076 0.55 . . . . 0.0 110.085 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.582 HG21 ' HE2' ' A' ' 136' ' ' LYS . 2.4 p -124.85 137.14 58.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 124.285 1.034 . . . . 0.0 108.774 171.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -135.07 147.15 49.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.193 0.597 . . . . 0.0 109.675 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -58.66 111.32 1.22 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.842 1.257 . . . . 0.0 109.442 170.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -153.94 -29.5 0.12 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -78.7 155.8 41.69 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.19 -30.02 7.34 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.141 1.894 . . . . 0.0 112.632 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 179.37 168.58 0.64 Allowed Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 128.744 2.818 . . . . 0.0 106.584 -172.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.11 -51.06 0.16 OUTLIER 'Cis proline' 0 C--N 1.349 0.589 0 CA-C-N 121.081 1.422 . . . . 0.0 111.407 -12.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.0 p -71.13 -23.43 62.08 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.686 1.595 . . . . 0.0 112.44 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.03 -8.85 21.08 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.499 1.523 . . . . 0.0 113.257 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.582 ' HE2' HG21 ' A' ' 126' ' ' VAL . 12.2 ptmt -105.76 152.84 22.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 120.64 -1.506 . . . . 0.0 109.977 -171.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -126.96 97.74 5.07 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.53 1.932 . . . . 0.0 107.033 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -67.74 140.21 56.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 164.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 45.7 t -140.65 149.23 42.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.448 1.099 . . . . 0.0 109.192 170.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.7 ptt? -140.84 148.95 41.35 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.317 1.447 . . . . 0.0 109.337 -176.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -147.65 88.77 1.71 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.999 2.12 . . . . 0.0 107.424 -173.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 88.7 p -165.28 178.44 6.9 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 121.551 -0.718 . . . . 0.0 109.549 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.635 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -63.62 -18.26 63.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.121 1.368 . . . . 0.0 114.169 167.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.82 22.68 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.539 1.936 . . . . 0.0 115.445 -159.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 28.3 mt -121.23 41.03 3.43 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -158.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -75.77 101.59 5.12 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -53.92 137.28 39.38 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 167.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 14.8 pt -136.2 166.59 26.83 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.242 1.417 . . . . 0.0 108.297 167.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.89 168.1 4.74 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.646 2.231 . . . . 0.0 112.435 164.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -18.87 -49.58 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 130.206 3.402 . . . . 0.0 118.118 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -165.42 -81.01 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.218 1.407 . . . . 0.0 107.609 -167.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -144.74 16.64 1.61 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.085 1.754 . . . . 0.0 111.412 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.79 -3.92 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.259 -0.901 . . . . 0.0 112.728 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.475 0 C-N-CA 128.117 2.77 . . . . 0.0 106.554 159.88 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -149.4 69.47 1.05 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 167.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -177.57 -168.3 0.18 Allowed 'General case' 0 C--O 1.239 0.541 0 C-N-CA 127.263 2.225 . . . . 0.0 106.623 -159.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 24.2 mtt180 -119.13 160.23 22.5 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -164.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.559 HD13 ' HD3' ' A' ' 118' ' ' ARG . 2.7 pt -132.01 112.83 14.73 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.439 1.495 . . . . 0.0 108.856 -162.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.08 106.34 2.01 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.52 2.146 . . . . 0.0 109.274 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.553 HD11 HD12 ' A' ' 8' ' ' ILE . 23.4 mm -78.72 80.69 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 173.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -83.66 89.54 7.14 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.328 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.7 m -71.41 83.57 0.8 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 173.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 p -56.42 -36.62 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.444 1.497 . . . . 0.0 111.842 -171.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -17.86 49.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.665 1.186 . . . . 0.0 112.648 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -129.11 12.44 6.11 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.602 1.961 . . . . 0.0 110.015 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 26.48 58.31 0.07 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 129.104 2.962 . . . . 0.0 111.32 -164.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.9 mtp85 -94.63 175.14 6.78 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 118.569 -1.252 . . . . 0.0 108.881 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -149.8 120.97 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 159.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.41 111.57 22.51 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 167.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.9 ttt -77.42 105.83 8.8 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.819 1.19 . . . . 0.0 108.808 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.94 178.96 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 16.1 pt-20 -130.96 168.82 16.69 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 120.292 -1.505 . . . . 0.0 112.516 172.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.89 139.61 57.24 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.659 0.784 . . . . 0.0 111.545 -171.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.476 ' H ' ' HD2' ' A' ' 118' ' ' ARG . 12.9 tt -73.72 115.38 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -175.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -139.0 99.52 3.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.4 mt -133.39 177.41 7.71 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.203 1.801 . . . . 0.0 108.805 -171.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.2 t -84.4 179.77 7.35 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 158.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -54.19 -36.99 64.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.846 0.748 . . . . 0.0 109.231 158.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 32' ' ' ARG . 18.6 m-20 -62.82 17.07 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 129.978 3.311 . . . . 0.0 117.269 -169.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -133.04 -46.9 0.85 Allowed 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -172.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -62.36 5.69 0.1 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.601 1.96 . . . . 0.0 114.922 -175.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 29' ' ' ASP . 3.7 ptt180 -124.75 -10.51 7.27 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.611 1.564 . . . . 0.0 113.869 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -134.66 -11.42 2.37 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.628 0.771 . . . . 0.0 112.19 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pt -119.55 11.39 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.828 0.851 . . . . 0.0 111.283 166.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -113.49 170.78 7.99 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.479 1.111 . . . . 0.0 111.825 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.42 142.41 90.7 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.902 0.881 . . . . 0.0 110.527 172.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.34 -7.2 20.66 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.556 2.837 . . . . 0.0 112.707 170.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -82.85 -45.32 14.41 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.504 1.121 . . . . 0.0 109.671 163.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.41 -42.47 98.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 120.579 1.536 . . . . 0.0 111.461 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -57.89 -45.75 85.92 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.029 0.532 . . . . 0.0 111.196 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -69.85 -49.6 50.88 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 119.304 -0.958 . . . . 0.0 109.642 172.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.471 HG22 ' HA2' ' A' ' 47' ' ' GLY . 5.7 t -55.89 -29.11 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 119.544 1.065 . . . . 0.0 111.01 -170.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.3 -28.31 69.64 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 174.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -100.46 -22.6 14.96 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.581 1.082 . . . . 0.0 113.12 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' CD ' ' HG2' ' A' ' 49' ' ' GLU . 10.8 ptpt -107.35 3.72 25.63 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.963 0.905 . . . . 0.0 112.712 -177.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.51 49.48 15.96 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.74 1.616 . . . . 0.0 111.047 -172.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 42' ' ' VAL . . . 90.35 -73.26 1.9 Allowed Glycine 0 C--N 1.335 0.495 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.2 m -74.48 107.24 6.5 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.784 -0.708 . . . . 0.0 111.412 -158.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.467 ' HG2' ' CD ' ' A' ' 45' ' ' LYS . 28.8 mt-10 -61.87 141.77 95.24 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 123.663 0.785 . . . . 0.0 111.814 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.42 163.8 30.95 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.322 2.014 . . . . 0.0 110.422 168.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.94 90.67 0.64 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.332 2.688 . . . . 0.0 112.056 -172.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -131.0 133.19 45.54 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.503 1.521 . . . . 0.0 108.1 170.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 m -75.01 51.93 0.53 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.199 2.2 . . . . 0.0 112.898 -166.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.22 69.68 0.21 Allowed Glycine 0 C--N 1.338 0.655 0 O-C-N 121.179 -0.951 . . . . 0.0 111.731 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.53 162.89 40.83 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.268 1.027 . . . . 0.0 110.366 177.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -162.84 167.33 22.94 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.111 1.764 . . . . 0.0 108.211 165.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -151.76 178.16 9.66 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 128.478 2.711 . . . . 0.0 104.548 163.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -139.39 158.76 43.6 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.626 1.103 . . . . 0.0 109.986 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.2 tt -154.46 118.36 4.67 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 129.09 2.956 . . . . 0.0 104.811 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -132.93 167.44 20.25 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.812 1.645 . . . . 0.0 107.586 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.33 24.6 0.18 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.05 1.74 . . . . 0.0 112.506 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -144.95 135.74 24.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.326 2.25 . . . . 0.0 107.407 170.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.54 178.44 25.41 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.415 HD12 ' HB2' ' A' ' 73' ' ' ASP . 21.1 pt -135.2 167.5 25.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 125.507 1.523 . . . . 0.0 107.859 167.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -84.07 127.8 34.14 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 122.239 1.019 . . . . 0.0 110.172 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -87.31 130.97 34.4 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 158.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.9 t -75.23 100.59 4.38 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 159.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 144' ' ' ALA . 3.6 tt -66.34 -18.59 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.435 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.9 t -82.11 7.62 12.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.653 0.781 . . . . 0.0 111.147 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.9 p -153.49 0.05 0.24 Allowed 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.965 -1.084 . . . . 0.0 113.87 168.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.82 55.24 23.49 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.4 m -153.8 154.45 34.01 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.067 -1.255 . . . . 0.0 109.259 -173.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.415 ' HB2' HD12 ' A' ' 64' ' ' ILE . 15.6 p-10 -85.95 152.21 23.13 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.07 0.948 . . . . 0.0 112.914 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.29 0.2 OUTLIER -146.89 -101.81 0.09 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.518 168.027 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -66.29 138.29 57.53 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.269 0.941 . . . . 0.0 111.19 -164.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -99.11 152.45 19.84 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.465 1.106 . . . . 0.0 108.63 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.66 -22.05 31.76 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.99 -29.66 57.69 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.706 1.139 . . . . 0.0 112.411 169.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 t -120.78 54.69 1.06 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.453 1.901 . . . . 0.0 109.466 168.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -140.79 162.21 35.98 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.504 -1.373 . . . . 0.0 110.073 159.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -104.23 120.27 40.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 163.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -138.15 -55.54 0.65 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.822 2.049 . . . . 0.0 108.287 -165.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 t -67.11 173.24 3.89 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.063 0.935 . . . . 0.0 110.167 159.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 52.38 -110.03 1.08 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.428 1.489 . . . . 0.0 110.966 -173.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -66.19 -37.76 86.38 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.455 1.102 . . . . 0.0 112.425 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.79 18.34 17.37 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.371 1.462 . . . . 0.0 116.33 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.86 151.09 97.43 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 117.679 0.74 . . . . 0.0 111.836 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.62 62.12 7.06 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.052 3.168 . . . . 0.0 110.968 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.6 p -135.79 155.87 49.69 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.859 0.863 . . . . 0.0 109.29 166.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -156.88 178.29 10.52 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.475 1.11 . . . . 0.0 110.762 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -117.75 -11.44 10.36 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -169.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -149.1 176.86 10.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.631 1.173 . . . . 0.0 110.895 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 m -129.25 156.54 41.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.133 0 O-C-N 121.136 -0.978 . . . . 0.0 111.371 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.1 p -60.94 -34.03 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.768 1.227 . . . . 0.0 111.166 173.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.2 m 164.6 166.4 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 131.614 3.966 . . . . 0.0 106.628 -175.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -96.4 77.2 2.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.152 1.781 . . . . 0.0 107.793 174.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.504 ' CD2' ' H ' ' A' ' 98' ' ' ASN . 5.4 p80 -133.93 -65.23 0.67 Allowed 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.64 -0.663 . . . . 0.0 111.619 -159.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.504 ' H ' ' CD2' ' A' ' 97' ' ' HIS . 0.9 OUTLIER -96.51 16.93 17.35 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.19 1.396 . . . . 0.0 108.935 167.017 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.03 140.64 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 128.315 2.646 . . . . 0.0 107.451 -174.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.417 ' HD3' ' H ' ' A' ' 101' ' ' LEU . 14.4 tppt? -129.24 151.43 49.91 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 128.226 2.61 . . . . 0.0 108.591 -173.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.417 ' H ' ' HD3' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -146.05 154.14 41.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.479 1.911 . . . . 0.0 107.875 -176.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.511 ' HG2' ' CG ' ' A' ' 113' ' ' GLU . 19.3 mmt180 -136.52 121.9 19.37 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -71.04 126.02 28.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.473 1.033 . . . . 0.0 110.274 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -128.4 176.98 7.3 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.866 0.841 . . . . 0.0 109.786 158.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.31 14.24 25.02 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.229 2.212 . . . . 0.0 111.542 173.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 t -46.96 -40.55 14.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.408 1.883 . . . . 0.0 115.44 -159.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.6 pp -73.36 -11.25 60.42 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 115.11 -4.81 22.11 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.158 1.837 . . . . 0.0 112.957 -169.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -141.61 -85.35 0.18 Allowed 'General case' 0 C--N 1.349 0.584 0 CA-C-N 120.143 1.971 . . . . 0.0 109.753 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.2 t -144.58 111.68 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -129.56 106.56 8.83 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.678 1.591 . . . . 0.0 108.79 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 10.1 m -106.28 141.94 36.78 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.602 -1.189 . . . . 0.0 107.88 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.511 ' CG ' ' HG2' ' A' ' 102' ' ' ARG . 22.2 pt-20 -67.71 160.97 26.98 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.791 1.632 . . . . 0.0 110.691 172.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.7 t -141.64 104.04 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.19 161.26 28.11 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.731 0.812 . . . . 0.0 109.078 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 13.5 m -77.73 106.71 9.72 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.79 -25.1 10.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.259 1.424 . . . . 0.0 113.177 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.559 ' HD3' HD13 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -80.72 -37.29 30.88 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 126.596 1.958 . . . . 0.0 113.149 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 3.9 p -153.82 69.88 0.81 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -161.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.27 58.0 0.25 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 128.086 2.554 . . . . 0.0 113.693 -159.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.7 -147.55 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.738 1.615 . . . . 0.0 112.319 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -70.12 -64.89 0.8 Allowed 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.282 1.433 . . . . 0.0 109.423 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 49.84 -116.84 0.94 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.421 1.889 . . . . 0.0 107.561 -177.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.76 -119.32 0.62 Allowed Glycine 0 CA--C 1.521 0.445 0 CA-C-N 118.501 0.591 . . . . 0.0 112.578 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -158.0 177.57 11.17 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 122.453 -0.44 . . . . 0.0 111.155 -170.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.1 p -124.64 145.02 32.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 124.663 1.185 . . . . 0.0 108.884 170.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -140.05 144.67 36.99 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.584 1.554 . . . . 0.0 108.668 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.08 121.12 19.67 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.403 0.547 . . . . 0.0 109.55 173.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.39 -45.15 0.22 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.624 2.37 . . . . 0.0 111.946 -165.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -90.53 -178.34 44.01 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.404 1.002 . . . . 0.0 112.935 -170.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.93 155.22 69.22 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.829 2.353 . . . . 0.0 111.017 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.48 ' HD2' ' H ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -68.89 154.06 95.33 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.908 174.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.07 -36.64 2.45 Favored 'Cis proline' 0 C--N 1.35 0.642 0 CA-C-N 119.506 0.859 . . . . 0.0 111.429 -5.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.51 59.19 1.87 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 127.826 2.451 . . . . 0.0 111.531 -175.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -88.33 -5.79 75.34 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.869 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -98.29 104.37 16.39 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 119.414 1.607 . . . . 0.0 111.048 -166.752 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.64 94.06 5.62 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.173 1.789 . . . . 0.0 108.347 -173.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -62.33 130.37 44.98 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 160.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 22.1 t -144.02 130.23 19.71 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.3 ptp -142.8 140.95 31.54 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.445 0.698 . . . . 0.0 110.395 -173.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.91 15.5 28.83 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.991 2.116 . . . . 0.0 110.647 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.2 p -65.96 112.0 3.6 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.023 1.729 . . . . 0.0 110.53 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -54.29 -24.84 20.54 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.54 1.136 . . . . 0.0 112.993 164.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -69.83 2.29 3.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.317 2.247 . . . . 0.0 116.351 -170.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 90.7 mt -87.26 87.02 7.32 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.091 0.859 . . . . 0.0 109.836 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -87.01 126.44 34.74 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.349 1.06 . . . . 0.0 108.785 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -70.87 135.22 47.89 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.327 0.967 . . . . 0.0 109.453 170.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.2 pt -136.44 163.6 48.76 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.33 1.052 . . . . 0.0 109.764 171.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.21 168.73 7.23 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.592 2.195 . . . . 0.0 111.646 161.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.414 ' HA ' ' HD2' ' A' ' 150' ' ' ARG . 6.8 mmm-85 -62.75 -4.74 2.23 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 119.51 3.152 . . . . 0.0 119.51 -158.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 178.11 -62.58 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.195 1 C-N-CA 132.905 4.482 . . . . 0.0 109.552 161.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -156.73 8.26 0.2 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.973 2.909 . . . . 0.0 110.831 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.9 pp -65.54 -14.54 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.872 1.214 . . . . 0.0 112.936 170.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 159.097 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -126.65 14.78 7.57 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.805 1.242 . . . . 0.0 111.102 171.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -75.38 131.02 39.93 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.993 1.317 . . . . 0.0 111.126 162.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -39.11 163.98 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.51 1 C-N-CA 135.839 5.656 . . . . 0.0 113.046 166.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.4 pt -129.33 136.97 29.97 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.401 1.08 . . . . 0.0 111.901 -168.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.0 120.92 3.87 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.997 2.464 . . . . 0.0 110.454 170.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.83 146.99 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 159.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -126.87 154.81 43.92 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 127.267 2.227 . . . . 0.0 105.621 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.53 91.94 2.53 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 171.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.08 -43.76 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 C-N-CA 123.346 0.659 . . . . 0.0 111.664 -171.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.97 -28.88 58.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.633 0.773 . . . . 0.0 110.904 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 152' ' ' GLN . 7.0 ttmm -87.39 -1.4 57.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.27 1.428 . . . . 0.0 111.091 170.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.8 t30 38.15 65.83 0.55 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 128.915 2.886 . . . . 0.0 112.427 -171.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.43 162.34 28.3 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.69 1.996 . . . . 0.0 109.44 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.7 t -138.9 134.47 42.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 164.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -141.53 97.58 3.19 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.684 1.594 . . . . 0.0 108.311 -172.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.4 ttp -78.94 133.29 36.91 Favored 'General case' 0 C--N 1.339 0.14 0 O-C-N 121.371 -0.831 . . . . 0.0 109.852 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.7 t -137.15 161.27 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.558 1.543 . . . . 0.0 107.063 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -58.32 170.26 0.74 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 123.03 1.395 . . . . 0.0 112.54 164.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 -69.49 176.42 3.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.858 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.56 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 2.4 tt -78.45 128.24 38.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 164.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -158.13 97.17 1.5 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.7 mt -138.29 176.21 8.9 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.936 1.294 . . . . 0.0 108.646 -167.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.8 p -88.11 -159.88 0.58 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 164.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.04 -48.69 56.93 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.888 1.222 . . . . 0.0 109.313 160.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.67 -12.53 16.68 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 126.58 1.952 . . . . 0.0 114.856 -159.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.41 ' C ' ' H ' ' A' ' 32' ' ' ARG . 12.9 mm-40 -85.0 -48.34 9.34 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 127.028 2.131 . . . . 0.0 110.316 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.437 ' CH2' HD13 ' A' ' 24' ' ' ILE . 61.0 m95 -60.61 8.94 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 128.135 2.574 . . . . 0.0 115.711 -168.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -139.06 -11.29 1.27 Allowed 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 128.928 2.891 . . . . 0.0 111.878 -164.037 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.9 -16.41 3.27 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 118.369 -0.824 . . . . 0.0 112.081 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pt -110.98 13.33 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 119.472 1.033 . . . . 0.0 111.958 172.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.01 167.94 14.02 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.006 0.923 . . . . 0.0 111.403 -171.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.2 137.8 74.19 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 123.89 0.876 . . . . 0.0 108.761 169.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -70.13 -3.69 12.76 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.398 2.732 . . . . 0.0 113.23 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -95.01 -30.04 14.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 127.233 2.213 . . . . 0.0 110.328 170.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.05 -48.46 81.66 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 120.975 1.716 . . . . 0.0 111.092 -174.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -59.07 -37.8 77.93 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.524 0.729 . . . . 0.0 111.885 -174.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -81.41 -45.81 15.53 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.869 -0.586 . . . . 0.0 109.827 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.581 HG12 ' HB1' ' A' ' 143' ' ' ALA . 2.8 t -58.59 -28.11 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 120.103 1.319 . . . . 0.0 110.005 -177.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.19 -8.29 23.33 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 173.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -119.26 -27.51 5.63 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.429 1.468 . . . . 0.0 111.12 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -105.0 12.35 32.39 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.07 1.748 . . . . 0.0 112.868 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.47 7.92 1.49 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.669 2.788 . . . . 0.0 115.374 171.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.496 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . 111.55 10.17 19.95 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 118.485 -1.175 . . . . 0.0 114.888 174.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.5 t -125.88 136.87 53.56 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 119.128 1.464 . . . . 0.0 107.596 158.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -89.08 172.12 7.94 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 159.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.28 164.22 31.36 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 122.698 2.265 . . . . 0.0 111.851 168.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.43 -7.91 20.54 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.222 2.615 . . . . 0.0 115.238 -167.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -53.87 -21.49 7.81 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.158 0.983 . . . . 0.0 112.841 171.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 t -128.27 17.05 6.6 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.588 1.155 . . . . 0.0 111.748 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -148.4 91.55 0.14 Allowed Glycine 0 C--N 1.341 0.817 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -174.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -140.54 -55.23 0.52 Allowed 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.61 0.764 . . . . 0.0 110.903 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -66.26 158.46 28.9 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 168.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -152.66 160.67 43.16 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 170.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -135.25 179.4 6.35 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.176 1.79 . . . . 0.0 109.19 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.4 tt -155.52 138.1 15.08 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 159.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.18 165.22 36.36 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.399 0.68 . . . . 0.0 109.273 169.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -76.57 39.38 0.21 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 129.129 2.971 . . . . 0.0 110.853 166.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -136.98 159.65 41.26 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.746 1.218 . . . . 0.0 109.561 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.67 169.78 46.23 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 125.894 1.711 . . . . 0.0 112.402 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.6 pt -128.19 173.32 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 162.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -94.56 119.04 32.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.889 1.275 . . . . 0.0 110.066 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.27 119.98 10.68 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 158.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 2.8 t -74.81 71.44 1.99 Allowed 'General case' 0 C--O 1.236 0.389 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 159.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 tt -62.9 -26.62 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.604 -162.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.6 t -77.65 3.15 14.6 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.334 1.454 . . . . 0.0 112.393 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.3 p -140.54 21.69 2.36 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.318 -0.864 . . . . 0.0 111.464 158.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.35 36.18 52.45 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.2 m -124.3 177.02 6.08 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.381 2.273 . . . . 0.0 106.907 -170.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -138.25 145.65 41.6 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.647 1.112 . . . . 0.0 109.235 -173.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.43 HD13 ' CD2' ' A' ' 75' ' ' PHE 0.305 0.2 OUTLIER -151.18 -102.2 0.06 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 178.377 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.43 ' CD2' HD13 ' A' ' 74' ' ' LEU . 38.8 m-85 -55.27 150.48 11.13 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -158.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -112.7 143.68 43.49 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.895 0.878 . . . . 0.0 110.726 -174.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.4 m -61.15 -16.63 46.54 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -56.7 -23.26 40.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 120.355 1.434 . . . . 0.0 112.18 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 91' ' ' TYR . 7.1 t -112.96 -3.73 14.02 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.759 0.823 . . . . 0.0 112.384 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.418 ' HE2' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -114.8 68.21 0.7 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.958 -1.089 . . . . 0.0 108.134 176.691 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -135.78 49.12 2.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.989 0.916 . . . . 0.0 109.965 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -72.53 95.15 1.77 Allowed 'General case' 0 C--N 1.341 0.206 0 O-C-N 121.626 -0.671 . . . . 0.0 109.505 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.2 t -58.89 134.4 56.89 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.859 0.463 . . . . 0.0 110.287 -175.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.98 -67.93 3.66 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.61 -55.54 17.04 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.03 0.915 . . . . 0.0 111.527 -174.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.02 16.03 12.0 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 129.373 3.368 . . . . 0.0 115.871 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.39 150.62 8.51 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 125.261 1.424 . . . . 0.0 112.137 171.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.71 71.69 4.7 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.77 2.98 . . . . 0.0 110.384 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.4 p -133.89 152.31 51.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 164.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -131.78 176.45 8.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.816 1.246 . . . . 0.0 109.433 -170.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 79' ' ' THR . 7.5 p90 -124.91 -3.08 7.7 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.239 1.015 . . . . 0.0 112.587 176.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -151.64 -173.26 4.46 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.711 2.004 . . . . 0.0 107.693 -176.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.84 155.34 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 C-N-CA 123.783 0.833 . . . . 0.0 109.304 178.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 p -61.46 -33.34 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.382 0.611 . . . . 0.0 110.486 170.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.8 m 168.02 159.82 0.04 OUTLIER 'General case' 0 C--O 1.234 0.279 1 C-N-CA 132.559 4.343 . . . . 0.0 105.075 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -101.04 80.9 2.18 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.411 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 17.9 p80 -125.43 -67.04 0.91 Allowed 'General case' 0 C--N 1.347 0.484 0 C-N-CA 126.443 1.897 . . . . 0.0 109.345 -165.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.411 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 0.7 OUTLIER -96.9 22.08 8.79 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 122.071 0.938 . . . . 0.0 112.429 179.525 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.9 tt -126.61 147.78 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 128.628 2.771 . . . . 0.0 104.847 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -125.14 138.35 54.15 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 122.803 0.441 . . . . 0.0 110.713 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mp -144.41 130.28 19.32 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.964 1.706 . . . . 0.0 109.07 -164.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.494 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 2.3 mpt_? -131.35 111.95 12.31 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 128.364 2.665 . . . . 0.0 105.345 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -74.41 128.44 35.54 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.629 1.571 . . . . 0.0 110.845 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 105' ' ' ARG . 32.0 t0 -134.2 178.01 7.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.095 1.358 . . . . 0.0 109.156 162.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.407 ' CZ ' ' HA ' ' A' ' 104' ' ' ASP . 0.0 OUTLIER -113.62 18.39 17.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.995 1.718 . . . . 0.0 110.544 -178.548 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.18 -30.56 60.16 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -158.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.85 -12.99 60.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.827 0.739 . . . . 0.0 112.617 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.5 -2.5 23.47 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 126.343 1.925 . . . . 0.0 112.936 -169.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 76.6 mtm -143.47 -81.91 0.18 Allowed 'General case' 0 C--N 1.35 0.605 0 CA-C-N 120.484 2.142 . . . . 0.0 109.629 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 42.9 t -143.08 116.6 3.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -125.44 111.2 14.83 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 126.33 1.852 . . . . 0.0 107.845 168.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.416 ' HB3' HG13 ' A' ' 126' ' ' VAL . 38.3 t -129.25 125.45 36.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -170.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.494 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 24.1 pt-20 -60.38 159.16 10.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.002 0.819 . . . . 0.0 111.387 -172.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -137.39 106.62 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 171.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.7 mp -120.67 170.28 9.58 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 164.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.1 163.34 12.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 118.927 -1.109 . . . . 0.0 108.592 164.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.46 -20.04 66.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.713 168.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.56 ' HG2' ' H ' ' A' ' 24' ' ' ILE . 30.7 tpt85 -148.46 -48.16 0.15 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -176.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 31.8 p -80.74 65.41 5.87 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.686 1.584 . . . . 0.0 108.453 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.39 57.33 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.217 2.607 . . . . 0.0 112.156 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.98 -47.38 52.55 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.648 0.779 . . . . 0.0 111.941 -164.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -169.07 -69.26 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 125.595 1.558 . . . . 0.0 107.601 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.4 mt 52.13 -114.02 0.79 Allowed 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 126.907 2.083 . . . . 0.0 110.846 -171.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.01 -119.45 0.72 Allowed Glycine 0 CA--C 1.525 0.692 0 CA-C-N 119.09 0.859 . . . . 0.0 112.367 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -159.47 163.55 35.22 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 122.299 -0.53 . . . . 0.0 111.17 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.561 HG21 ' HE2' ' A' ' 136' ' ' LYS . 5.5 p -101.49 132.96 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 168.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -131.53 155.57 47.22 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.369 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.06 112.7 3.1 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.253 1.021 . . . . 0.0 109.182 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -144.16 -24.45 0.55 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -171.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.45 163.77 13.56 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 123.349 0.5 . . . . 0.0 112.22 -167.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.86 -15.89 10.42 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.831 2.354 . . . . 0.0 114.353 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.5 ptt-85 142.63 165.08 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.945 1 C-N-CA 132.069 4.148 . . . . 0.0 107.181 -159.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.11 -53.11 0.15 OUTLIER 'Cis proline' 0 C--N 1.352 0.752 0 CA-C-N 121.624 1.616 . . . . 0.0 111.269 -9.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.9 p -73.76 -23.72 59.77 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.965 1.306 . . . . 0.0 112.743 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.74 5.37 68.9 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.282 0.944 . . . . 0.0 113.832 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.561 ' HE2' HG21 ' A' ' 126' ' ' VAL . 11.8 ptmt -125.44 162.17 25.44 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 119.647 1.723 . . . . 0.0 111.622 -167.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 ttm105 -125.23 109.53 12.95 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.642 1.577 . . . . 0.0 108.116 173.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -74.59 106.46 6.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.881 1.673 . . . . 0.0 106.977 165.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 18.2 t -121.94 135.55 54.87 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.561 1.073 . . . . 0.0 109.898 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.8 ptp -159.18 161.06 36.14 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.444 0.698 . . . . 0.0 110.754 -171.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -148.29 146.13 28.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.532 0.733 . . . . 0.0 109.426 161.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 91.0 p -171.78 -175.53 1.55 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.572 1.949 . . . . 0.0 107.208 158.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.581 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -60.87 -21.07 62.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.613 1.165 . . . . 0.0 113.163 165.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.53 22.03 0.06 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.735 1.614 . . . . 0.0 114.886 -169.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 88.9 mt -130.64 106.05 8.23 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.701 1.137 . . . . 0.0 110.018 -165.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -137.88 140.07 40.2 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.318 1.047 . . . . 0.0 108.788 174.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -76.95 141.38 40.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.219 0.918 . . . . 0.0 110.341 168.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.0 pt -137.01 170.53 10.54 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.077 1.751 . . . . 0.0 108.754 165.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.19 165.19 4.33 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.73 2.287 . . . . 0.0 112.783 167.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -45.05 -18.77 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 129.006 2.922 . . . . 0.0 118.341 -165.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -164.29 -78.71 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 171.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.418 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 31.8 mm-40 -149.71 42.05 0.87 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.99 2.516 . . . . 0.0 104.637 163.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.9 pp -76.39 -25.12 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 O-C-N 120.802 -1.186 . . . . 0.0 111.907 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 CA-C-O 117.306 -1.83 . . . . 0.0 110.542 175.528 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.2 tpt . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -74.9 134.71 41.56 Favored 'General case' 0 C--N 1.337 0.062 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 170.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -154.77 -173.36 4.54 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.027 1.331 . . . . 0.0 107.583 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -97.75 178.4 5.16 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.247 1.019 . . . . 0.0 109.059 162.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.419 HD13 ' CG ' ' A' ' 118' ' ' ARG . 1.3 pt -129.35 125.74 22.65 Favored Pre-proline 0 N--CA 1.452 -0.332 0 C-N-CA 125.595 1.558 . . . . 0.0 110.78 174.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.83 143.35 36.91 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.628 1.552 . . . . 0.0 110.384 164.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.8 mt -126.23 98.94 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.4 103.26 14.64 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.073 0.949 . . . . 0.0 108.546 -171.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.406 ' OG ' ' OD2' ' A' ' 151' ' ' ASP . 72.7 m -72.83 76.93 1.14 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.826 173.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.8 p -56.31 -39.63 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 118.709 0.686 . . . . 0.0 110.585 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.55 -12.66 10.55 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.301 1.84 . . . . 0.0 113.907 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' A' ' 151' ' ' ASP . 39.4 mtmt -128.68 7.73 5.74 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.503 1.521 . . . . 0.0 111.639 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.5 t30 32.76 74.0 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.948 2.499 . . . . 0.0 112.801 -159.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.41 167.86 20.55 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.52 142.97 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 164.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -125.15 165.59 17.97 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 158.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 46.7 ttm -132.47 133.97 44.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.4 t -137.98 161.0 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 -171.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -72.87 161.97 30.06 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.774 -1.829 . . . . 0.0 112.429 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.24 142.13 58.4 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 161.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.3 tt -60.48 137.07 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.002 1.321 . . . . 0.0 109.414 -176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -150.44 114.17 5.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 103.396 -2.816 . . . . 0.0 103.396 171.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.2 mt -137.87 -159.54 0.97 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.518 1.527 . . . . 0.0 108.357 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.0 m -144.56 175.31 10.23 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.437 -1.415 . . . . 0.0 107.65 162.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.28 -41.08 60.19 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.341 1.457 . . . . 0.0 113.363 -159.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.419 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 2.1 m-20 -77.06 -18.44 58.05 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -175.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -66.45 -47.27 73.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.965 0.802 . . . . 0.0 109.834 -176.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -62.12 15.23 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.285 2.234 . . . . 0.0 115.889 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.419 ' NE ' ' HA ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -133.22 -9.41 2.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 170.456 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -122.63 -17.56 6.88 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.19 0.905 . . . . 0.0 112.619 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 pt -110.75 19.01 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 118.949 0.795 . . . . 0.0 111.483 169.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -127.27 166.58 17.5 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.271 1.028 . . . . 0.0 111.534 -173.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.412 ' CG ' HH12 ' A' ' 66' ' ' ARG . 0.9 OUTLIER -58.62 137.56 86.22 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 163.352 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -67.83 -16.48 45.95 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.334 2.022 . . . . 0.0 112.245 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 3.7 tt0 -73.49 -42.47 61.8 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.753 -0.592 . . . . 0.0 109.856 170.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.51 -38.16 80.21 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.271 0.941 . . . . 0.0 111.125 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -54.92 -56.48 19.09 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.81 0.844 . . . . 0.0 110.824 172.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.41 ' HG2' ' HA ' ' A' ' 38' ' ' GLU . 27.6 ptt180 -63.65 -45.65 89.22 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.683 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.7 t -51.69 -37.8 20.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 125.091 1.356 . . . . 0.0 109.952 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.34 -10.84 18.28 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 176.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.62 -17.22 11.19 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.812 1.187 . . . . 0.0 113.46 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -116.1 8.77 14.57 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.254 1.022 . . . . 0.0 112.028 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.37 -30.77 0.08 Allowed 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 130.241 3.416 . . . . 0.0 113.561 -164.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -178.19 -87.89 0.07 OUTLIER Glycine 0 C--N 1.336 0.582 0 C-N-CA 126.365 1.936 . . . . 0.0 109.486 -170.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.1 t -123.72 117.65 25.45 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.307 -2.108 . . . . 0.0 105.307 164.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -55.72 132.15 72.26 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.263 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.47 119.87 5.95 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.874 2.382 . . . . 0.0 110.382 -175.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.19 -23.32 28.99 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.076 1.85 . . . . 0.0 112.376 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -161.94 -26.15 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.836 1.654 . . . . 0.0 111.064 168.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.5 t -143.0 169.86 16.78 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.981 1.313 . . . . 0.0 108.395 170.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -122.87 100.12 0.67 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.41 147.95 40.49 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.437 1.095 . . . . 0.0 108.293 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -152.76 159.33 43.11 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -141.03 157.77 44.87 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.976 1.71 . . . . 0.0 106.486 172.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -118.49 169.58 9.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.449 0.643 . . . . 0.0 110.081 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.8 mt -117.02 -171.73 2.08 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.002 1.721 . . . . 0.0 107.265 163.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -141.55 138.22 32.55 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -154.48 172.15 18.24 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.676 1.59 . . . . 0.0 108.408 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.59 107.63 3.02 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.335 1.454 . . . . 0.0 111.213 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.66 179.32 41.91 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -173.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.2 pt -122.72 170.9 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.522 0.729 . . . . 0.0 109.617 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -97.89 143.93 27.97 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.144 0.978 . . . . 0.0 109.858 -174.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 34.2 ttt180 -127.62 146.68 50.46 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.669 1.188 . . . . 0.0 109.139 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 10.6 t -102.04 94.42 5.76 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 175.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.488 HG22 ' HA ' ' A' ' 144' ' ' ALA . 5.2 tt -58.11 -31.07 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.82 1.248 . . . . 0.0 111.371 -174.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.1 t -75.78 5.7 5.95 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.266 1.826 . . . . 0.0 111.906 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.8 p -144.06 10.63 1.53 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.741 1.216 . . . . 0.0 111.57 162.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.4 11.08 45.93 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.384 1.945 . . . . 0.0 114.712 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.0 m -114.44 142.99 45.65 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.351 1.576 . . . . 0.0 110.646 -159.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.459 ' C ' HD23 ' A' ' 74' ' ' LEU . 9.7 p-10 -95.53 147.93 23.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.467 1.507 . . . . 0.0 112.584 -178.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.482 HD22 ' HB3' ' A' ' 98' ' ' ASN 0.311 0.2 OUTLIER -152.98 -98.16 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.34 1.056 . . . . 0.0 113.666 173.485 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -49.96 131.15 22.71 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -159.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -69.64 132.1 45.66 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.447 -0.783 . . . . 0.0 109.124 171.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.8 m -62.95 -20.57 65.36 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.14 -12.57 41.09 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.202 1.365 . . . . 0.0 113.264 172.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.3 p -74.32 -25.27 59.45 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.552 -0.718 . . . . 0.0 111.886 166.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -121.69 95.07 4.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.321 1.848 . . . . 0.0 109.564 -168.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -141.93 116.07 9.41 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -137.75 110.77 7.75 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 171.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.9 p -63.48 103.16 0.49 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.127 1.371 . . . . 0.0 111.295 -167.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.47 -47.63 1.43 Allowed Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.744 1.164 . . . . 0.0 111.245 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -53.99 25.16 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.401 0.68 . . . . 0.0 110.469 177.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 47.16 23.66 1.84 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.933 2.206 . . . . 0.0 115.196 -167.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -54.66 153.28 11.01 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 118.966 1.383 . . . . 0.0 112.338 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.35 71.71 2.35 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.866 3.044 . . . . 0.0 112.26 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.9 p -133.81 149.97 51.41 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 158.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -147.24 173.46 12.53 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.66 1.184 . . . . 0.0 109.095 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -113.34 -13.6 12.88 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.473 -0.775 . . . . 0.0 112.832 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -155.27 -179.05 7.71 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.222 1.409 . . . . 0.0 108.349 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.07 166.71 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.586 1.554 . . . . 0.0 111.153 -175.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.54 -50.46 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.592 0.757 . . . . 0.0 109.534 168.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.4 m 172.81 162.58 0.12 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 130.518 3.527 . . . . 0.0 106.362 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -85.45 65.88 9.41 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -111.78 -56.78 2.34 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 124.753 1.221 . . . . 0.0 108.173 -173.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.482 ' HB3' HD22 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -100.66 4.15 43.02 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 175.66 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.32 131.42 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -107.96 140.98 40.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.387 1.475 . . . . 0.0 107.562 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.01 155.33 49.38 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.572 1.549 . . . . 0.0 109.77 175.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.36 131.54 36.5 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 128.561 2.744 . . . . 0.0 104.138 165.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.42 150.15 45.25 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 171.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.408 ' OD2' ' OG ' ' A' ' 106' ' ' SER . 53.0 t0 -148.3 140.24 23.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 158.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 16.39 0.07 Allowed 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.644 -1.285 . . . . 0.0 112.355 172.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.408 ' OG ' ' OD2' ' A' ' 104' ' ' ASP . 0.4 OUTLIER -43.51 -61.56 1.34 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 127.419 2.288 . . . . 0.0 113.149 -158.675 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pp -58.95 -14.34 8.95 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.389 1.076 . . . . 0.0 113.618 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 118.83 -4.9 14.25 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 126.651 2.072 . . . . 0.0 111.893 -172.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -141.02 -84.64 0.2 Allowed 'General case' 0 C--N 1.348 0.538 0 CA-C-N 119.645 1.723 . . . . 0.0 109.018 -174.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.2 t -147.13 108.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -173.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.412 ' HE ' ' CD2' ' A' ' 125' ' ' HIS . 44.2 ttt180 -131.17 83.31 2.1 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.478 1.511 . . . . 0.0 110.785 176.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 1.4 m -85.14 137.16 33.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.879 -0.581 . . . . 0.0 109.771 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -67.05 157.33 33.8 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.21 0.914 . . . . 0.0 111.132 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.4 t -133.82 107.13 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -129.81 154.27 47.41 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 27.8 t -69.59 137.0 51.97 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -70.43 -17.37 63.0 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.419 ' CG ' HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -104.98 -37.22 7.05 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.205 1.802 . . . . 0.0 112.781 -173.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 29.6 p -135.04 74.64 1.53 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 123.551 1.644 . . . . 0.0 108.337 171.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.82 55.93 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 1 C-N-CA 133.697 4.799 . . . . 0.0 113.462 172.334 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -112.05 -57.95 2.2 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 -159.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -138.54 -89.26 0.22 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.257 0.935 . . . . 0.0 109.678 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.422 ' HA ' ' HG3' ' A' ' 140' ' ' MET . 3.8 mt 58.94 -120.24 1.08 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.705 2.002 . . . . 0.0 109.88 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -174.96 -125.07 0.84 Allowed Glycine 0 CA--C 1.522 0.509 0 CA-C-N 118.972 0.805 . . . . 0.0 112.962 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.412 ' CD2' ' HE ' ' A' ' 111' ' ' ARG . 31.9 p-80 -161.2 179.07 8.66 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.169 0.587 . . . . 0.0 110.569 -172.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.582 HG21 ' HE2' ' A' ' 136' ' ' LYS . 2.8 p -129.62 143.24 41.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.767 1.227 . . . . 0.0 108.936 172.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -139.37 154.77 47.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.841 1.256 . . . . 0.0 109.219 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.84 113.76 10.23 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -164.93 -46.97 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.461 1.504 . . . . 0.0 111.48 -168.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -64.52 167.91 27.74 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.249 0.452 . . . . 0.0 112.508 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.55 177.16 7.79 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.594 2.196 . . . . 0.0 110.999 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -57.0 146.48 59.76 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 160.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.18 -52.6 0.16 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.529 0 CA-C-N 120.103 1.073 . . . . 0.0 114.641 15.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 17.5 p -77.95 -24.07 48.29 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -164.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.65 5.72 86.38 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 119.278 -0.734 . . . . 0.0 113.684 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.582 ' HE2' HG21 ' A' ' 126' ' ' VAL . 8.6 ptmt -132.9 159.81 38.83 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.38 1.59 . . . . 0.0 111.787 -168.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.2 ttm105 -125.07 109.17 12.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.759 1.624 . . . . 0.0 106.69 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -72.04 128.45 35.74 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 160.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 17.5 t -135.73 135.88 40.36 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.786 1.234 . . . . 0.0 108.282 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.422 ' HG3' ' HA ' ' A' ' 123' ' ' LEU . 35.1 ttm -140.04 156.5 46.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 122.276 1.036 . . . . 0.0 109.824 -165.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.58 104.11 4.33 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.469 1.908 . . . . 0.0 105.921 173.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 58.1 p -153.65 157.49 39.69 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 162.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.14 -25.01 54.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.488 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -67.56 4.91 0.91 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.745 2.018 . . . . 0.0 115.855 -159.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 83.4 mt -90.84 87.97 6.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.084 1.354 . . . . 0.0 109.674 -159.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -93.26 133.68 36.24 Favored 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -71.43 146.33 48.72 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 159.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.6 pt -137.84 166.27 27.48 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.818 1.247 . . . . 0.0 107.977 166.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.36 173.3 0.71 Allowed 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.419 2.079 . . . . 0.0 111.696 164.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -52.66 -17.81 1.48 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 -163.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.416 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 5.0 t70 -175.66 -77.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.546 2.338 . . . . 0.0 107.199 170.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -144.4 17.67 1.7 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.353 2.261 . . . . 0.0 110.175 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -74.0 -9.74 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.205 -0.934 . . . . 0.0 112.348 173.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.513 0 N-CA-C 106.935 -2.466 . . . . 0.0 106.935 159.271 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 31.8 tpp . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -73.84 57.01 0.59 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.651 1.18 . . . . 0.0 110.802 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -151.08 -175.21 5.06 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.69 1.196 . . . . 0.0 108.344 165.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.59 169.48 0.32 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 128.73 2.812 . . . . 0.0 113.902 172.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.8 pt -123.46 128.22 25.3 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.953 1.301 . . . . 0.0 110.556 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.58 108.76 2.63 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.29 2.66 . . . . 0.0 109.747 172.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.473 ' HA ' ' HD1' ' A' ' 97' ' ' HIS . 2.5 mp -86.84 155.95 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 167.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -135.45 101.53 4.84 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.896 1.279 . . . . 0.0 108.71 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.8 m -65.84 79.61 0.08 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 161.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.5 p -56.21 -41.92 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.041 0.936 . . . . 0.0 110.54 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.07 -12.03 10.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.388 1.475 . . . . 0.0 114.216 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.93 12.47 6.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.387 1.475 . . . . 0.0 110.925 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 33.57 59.15 0.52 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.105 2.562 . . . . 0.0 112.208 -167.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.8 mtp85 -106.48 169.13 8.7 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 173.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.9 t -137.6 97.94 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 168.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -98.89 81.97 2.7 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.882 1.673 . . . . 0.0 108.286 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 43.4 ttp -66.51 127.9 34.12 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.639 -0.663 . . . . 0.0 110.551 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.7 t -129.47 142.42 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.164 1.386 . . . . 0.0 108.278 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -78.99 144.1 35.06 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.399 0.619 . . . . 0.0 110.211 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 mtm105 -65.74 148.16 52.21 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.204 -160.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.91 114.87 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.286 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 168.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -145.84 102.1 3.62 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 102.626 -3.101 . . . . 0.0 102.626 170.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.7 mt -136.65 175.27 9.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.719 0.808 . . . . 0.0 109.72 -168.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.1 t -102.16 163.71 12.09 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 162.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -54.88 -30.89 59.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.04 0.936 . . . . 0.0 111.182 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.91 -27.6 60.96 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.013 2.525 . . . . 0.0 112.634 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -85.51 -45.31 11.92 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.796 1.238 . . . . 0.0 110.68 -170.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -60.61 14.15 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.749 2.42 . . . . 0.0 115.443 -174.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.29 -14.35 5.39 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.143 1.377 . . . . 0.0 113.701 172.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.34 -12.75 4.47 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.43 -172.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 pt -112.82 14.62 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 118.732 0.696 . . . . 0.0 111.356 167.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -117.32 171.84 7.7 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.192 1.397 . . . . 0.0 110.415 -175.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.93 143.01 88.33 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 165.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -70.58 -10.66 28.37 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.974 2.45 . . . . 0.0 111.875 168.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -75.61 -46.62 30.63 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 125.004 1.322 . . . . 0.0 109.889 165.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.89 -41.62 87.61 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 119.859 1.209 . . . . 0.0 110.675 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -57.21 -44.21 83.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.713 1.205 . . . . 0.0 112.014 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -80.1 -41.6 25.21 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 118.79 0.723 . . . . 0.0 110.16 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.54 HG12 ' HB1' ' A' ' 143' ' ' ALA . 23.9 t -52.75 -31.78 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 126.355 1.862 . . . . 0.0 109.728 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.77 -19.6 64.16 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 173.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.98 -31.85 12.88 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.057 1.299 . . . . 0.0 111.594 173.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -103.16 1.48 33.23 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.46 1.104 . . . . 0.0 113.371 -169.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.23 3.08 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.998 2.519 . . . . 0.0 114.712 -168.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.416 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . 148.61 -38.09 1.01 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 125.893 1.711 . . . . 0.0 113.168 174.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.5 t -150.09 127.82 11.69 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.334 1.567 . . . . 0.0 110.476 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -67.46 -60.2 6.04 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.749 1.22 . . . . 0.0 110.105 167.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -80.77 168.58 17.49 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.305 2.003 . . . . 0.0 111.355 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.48 175.99 6.3 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.659 2.24 . . . . 0.0 110.45 159.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -137.49 166.04 24.82 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.308 1.043 . . . . 0.0 109.631 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.9 m -141.35 146.21 36.38 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -172.15 56.49 0.17 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -58.67 -25.87 63.25 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -175.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.03 166.88 31.65 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.186 2.194 . . . . 0.0 106.412 168.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -149.4 -60.37 0.22 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 169.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -145.71 -167.26 2.66 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.727 2.411 . . . . 0.0 107.115 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.9 tp -145.48 42.88 1.28 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.077 0.951 . . . . 0.0 110.167 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.35 -176.82 4.08 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.446 1.099 . . . . 0.0 111.545 -176.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -106.76 101.36 10.81 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 129.074 2.95 . . . . 0.0 109.593 -172.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -142.0 153.05 43.98 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 164.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.8 153.13 11.49 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 125.444 1.497 . . . . 0.0 113.031 158.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.7 pt -130.05 154.17 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 162.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.68 126.46 32.37 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -80.36 114.27 19.15 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 158.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 19.7 t -65.11 85.07 0.05 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 162.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.9 tt -66.78 -22.92 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 122.061 -0.399 . . . . 0.0 110.487 -169.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 143' ' ' ALA . 64.7 m -61.42 -8.65 4.28 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.797 1.639 . . . . 0.0 113.704 169.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 21.4 p -138.88 15.94 2.67 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.893 1.224 . . . . 0.0 111.647 160.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.99 17.11 21.27 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.293 -1.282 . . . . 0.0 113.961 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.1 m -121.23 143.07 49.34 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.14 1.47 . . . . 0.0 108.95 -164.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.9 167.93 19.99 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.453 HD13 ' CD2' ' A' ' 75' ' ' PHE . 0.3 OUTLIER 176.08 -160.1 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 131.35 3.86 . . . . 0.0 109.001 172.72 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.453 ' CD2' HD13 ' A' ' 74' ' ' LEU . 5.0 m-85 0.14 107.52 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 131.548 3.939 . . . . 0.0 117.023 -165.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.12 144.58 57.0 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.454 1.502 . . . . 0.0 111.13 171.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.8 m -56.46 -30.47 62.93 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.59 -22.14 66.89 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -175.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 p -93.0 -7.37 46.02 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.729 0.695 . . . . 0.0 111.637 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.93 47.63 2.38 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.86 2.064 . . . . 0.0 108.819 -159.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -117.39 60.92 0.75 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.967 0.907 . . . . 0.0 109.666 -167.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -68.3 97.24 0.72 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.0 m -57.3 117.93 4.59 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.147 0.979 . . . . 0.0 112.039 -164.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.88 -49.86 4.29 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.354 0.978 . . . . 0.0 112.102 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.7 -43.97 91.77 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.208 1.004 . . . . 0.0 111.878 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 41.5 35.76 1.38 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 128.833 3.111 . . . . 0.0 114.662 -159.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.5 150.11 5.07 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 126.063 1.745 . . . . 0.0 110.243 175.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.96 69.91 6.1 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.564 2.842 . . . . 0.0 110.769 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.6 p -144.96 152.39 40.1 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.752 1.621 . . . . 0.0 108.821 -177.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.95 168.48 19.61 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.88 1.272 . . . . 0.0 109.085 -176.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -115.84 -9.75 11.8 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 118.811 -0.614 . . . . 0.0 112.445 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -156.64 176.02 13.28 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.846 1.259 . . . . 0.0 107.925 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.6 t -125.99 149.12 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.627 0.771 . . . . 0.0 110.907 -162.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 p -56.54 -54.65 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 126.452 1.901 . . . . 0.0 110.769 171.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.0 m 169.8 164.1 0.06 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 130.669 3.588 . . . . 0.0 107.282 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 mp0 -76.92 64.55 2.45 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.823 1.649 . . . . 0.0 109.508 173.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.473 ' HD1' ' HA ' ' A' ' 10' ' ' ILE . 18.5 p80 -115.41 -54.79 2.51 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.879 0.872 . . . . 0.0 109.284 -170.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -121.38 14.24 11.16 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.463 1.105 . . . . 0.0 111.859 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.88 150.77 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.807 1.643 . . . . 0.0 108.846 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -123.27 150.32 43.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.876 2.07 . . . . 0.0 110.771 -174.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.4 mt -145.72 137.14 24.98 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.804 2.442 . . . . 0.0 110.298 -166.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.98 117.25 11.28 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 129.102 2.961 . . . . 0.0 105.879 159.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -104.08 144.26 31.8 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.242 1.017 . . . . 0.0 110.869 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -152.62 179.44 8.61 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.946 2.499 . . . . 0.0 108.11 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.51 27.52 8.29 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.704 -1.248 . . . . 0.0 111.43 173.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.74 -38.9 67.71 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -159.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 pp -75.86 -9.41 58.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.16 6.09 37.03 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 117.579 -1.678 . . . . 0.0 112.781 -168.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 13.3 tpt -145.67 -91.23 0.1 Allowed 'General case' 0 C--N 1.349 0.567 0 CA-C-N 120.298 2.049 . . . . 0.0 109.212 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.3 t -139.37 119.68 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 172.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.424 HH21 ' CE1' ' A' ' 125' ' ' HIS . 17.5 ttt180 -121.83 128.23 51.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 165.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 43.3 t -124.49 142.55 51.24 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 168.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -67.61 162.68 22.98 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.886 170.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 73.2 t -136.81 108.67 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 169.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -125.29 173.09 9.05 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 168.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 39.6 t -71.29 159.59 34.32 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.448 -0.783 . . . . 0.0 108.985 171.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -81.55 -13.89 57.51 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 170.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -115.94 -58.44 2.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 173.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.2 p -94.71 62.39 2.73 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.8 51.29 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 128.362 2.665 . . . . 0.0 113.434 -168.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.38 -71.77 0.59 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.787 1.235 . . . . 0.0 113.359 -167.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -130.79 -83.93 0.53 Allowed 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.761 0.824 . . . . 0.0 109.135 -165.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mt 50.66 -108.88 0.37 Allowed 'General case' 0 C--N 1.338 0.097 0 C-N-CA 126.89 2.076 . . . . 0.0 109.989 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.23 -125.42 0.94 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.586 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.424 ' CE1' HH21 ' A' ' 111' ' ' ARG . 20.3 p-80 -162.42 178.97 8.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.387 -0.478 . . . . 0.0 110.468 -170.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.571 HG21 ' HE2' ' A' ' 136' ' ' LYS . 2.9 p -129.5 143.25 41.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 124.72 1.208 . . . . 0.0 108.89 172.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -133.79 150.79 51.45 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 124.225 0.953 . . . . 0.0 110.744 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -64.13 106.83 1.14 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.048 1.339 . . . . 0.0 109.333 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -167.57 -48.53 0.02 OUTLIER 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.082 1.353 . . . . 0.0 111.472 -169.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -65.18 172.37 21.8 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.785 0.707 . . . . 0.0 113.408 -170.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -69.83 167.84 23.38 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.253 1.969 . . . . 0.0 111.348 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -61.63 151.6 77.73 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 162.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.33 -47.67 0.3 Allowed 'Cis proline' 0 C--N 1.347 0.472 0 CA-C-N 119.944 1.016 . . . . 0.0 114.182 14.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.2 p -73.96 -26.28 60.4 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -166.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.72 5.62 79.46 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 119.184 0.902 . . . . 0.0 113.678 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.571 ' HE2' HG21 ' A' ' 126' ' ' VAL . 10.3 ptmt -130.23 156.83 43.96 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.983 1.391 . . . . 0.0 111.275 -168.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 14.7 ttt85 -125.27 103.83 8.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.271 1.828 . . . . 0.0 108.234 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -73.89 141.19 46.06 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.105 1.362 . . . . 0.0 107.346 167.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 53.7 t -142.92 136.13 28.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.319 1.847 . . . . 0.0 107.703 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 6.8 ttt -144.71 141.54 29.37 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.744 0.818 . . . . 0.0 108.976 -174.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -148.11 93.48 2.18 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.589 1.156 . . . . 0.0 108.917 -170.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 77.3 p -163.27 -173.41 3.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 167.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.54 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -56.75 -21.31 27.32 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.225 1.41 . . . . 0.0 114.183 168.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.34 26.29 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.725 2.41 . . . . 0.0 115.98 -164.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 62.3 mt -121.33 38.33 4.11 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.744 1.218 . . . . 0.0 111.852 -162.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -75.47 108.99 8.64 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -64.19 140.18 58.84 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.477 -0.764 . . . . 0.0 109.207 163.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.3 pt -128.01 165.25 31.8 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 159.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -53.34 163.08 2.65 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.584 2.856 . . . . 0.0 112.976 166.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -15.76 -53.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 129.669 3.188 . . . . 0.0 114.865 173.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -157.08 -67.68 0.1 Allowed 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 127.313 2.245 . . . . 0.0 111.283 159.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -144.17 1.42 1.1 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.353 1.461 . . . . 0.0 110.9 -163.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.06 -19.03 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.189 1.796 . . . . 0.0 114.56 -170.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.958 0 CA-C-O 116.951 -2.027 . . . . 0.0 109.529 -177.523 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -146.55 58.51 1.2 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.913 1.285 . . . . 0.0 107.623 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -135.61 -158.51 0.88 Allowed 'General case' 0 C--O 1.232 0.184 0 C-N-CA 125.493 1.517 . . . . 0.0 108.505 -162.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 8.6 ttt85 -117.02 162.36 17.92 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 123.982 0.913 . . . . 0.0 110.019 169.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.509 HD11 ' HD3' ' A' ' 118' ' ' ARG . 7.7 pt -136.45 146.94 57.95 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 113.89 -1.505 . . . . 0.0 112.259 -177.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.86 134.12 10.56 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.71 2.94 . . . . 0.0 111.485 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.4 mm -114.58 100.11 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 127.053 2.141 . . . . 0.0 105.737 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -100.4 124.18 45.57 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.9 m -101.8 87.1 3.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -54.01 -39.3 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.679 0.791 . . . . 0.0 111.255 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.645 ' HB1' ' HD2' ' A' ' 150' ' ' ARG . . . -52.65 -25.58 11.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.286 2.234 . . . . 0.0 114.78 178.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -124.71 7.1 8.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.763 2.025 . . . . 0.0 111.348 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 33.44 63.1 0.37 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.53 2.332 . . . . 0.0 111.638 -161.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.5 mtp-105 -109.87 164.28 12.73 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.1 p -134.85 144.92 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 158.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -136.71 165.55 25.64 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 158.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.7 ttp -127.66 116.98 21.12 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -170.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.76 139.12 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.044 1.738 . . . . 0.0 107.64 -160.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 7' ' ' ARG 0.284 3.5 pm0 -89.53 148.87 23.15 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 122.234 1.016 . . . . 0.0 112.42 -169.873 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.484 HH11 ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -66.93 146.18 54.66 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.329 -162.503 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.13 118.81 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -167.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -137.73 101.83 4.57 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.487 1.515 . . . . 0.0 107.388 173.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.437 HD11 HD11 ' A' ' 34' ' ' ILE . 40.9 mt -134.15 177.83 7.44 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 127.227 2.211 . . . . 0.0 106.83 166.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.6 t -162.73 -14.84 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -176.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 30' ' ' GLU . 8.4 t70 -118.63 -146.51 0.39 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.623 1.102 . . . . 0.0 109.576 -171.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.7 5.35 0.12 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.841 1.657 . . . . 0.0 113.643 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 28' ' ' ASP . 27.8 mt-10 -62.79 -44.61 95.73 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 125.577 1.551 . . . . 0.0 110.728 -163.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -68.58 45.03 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 128.334 2.654 . . . . 0.0 112.179 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.38 -44.35 0.07 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.469 1.908 . . . . 0.0 108.878 160.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -75.22 -27.19 59.44 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.446 -0.788 . . . . 0.0 112.305 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.437 HD11 HD11 ' A' ' 26' ' ' LEU . 4.6 pt -110.83 28.18 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 119.377 0.99 . . . . 0.0 111.847 176.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mt -117.93 166.57 12.34 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 125.133 1.373 . . . . 0.0 111.511 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.506 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 5.2 m-20 -61.35 146.76 88.61 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 163.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -67.3 -9.71 26.15 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.471 2.114 . . . . 0.0 112.327 169.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -78.63 -51.83 9.32 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.973 1.709 . . . . 0.0 109.95 163.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.506 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -58.67 -37.93 77.08 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.45 1.477 . . . . 0.0 110.451 -176.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -52.6 -52.9 53.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.896 1.278 . . . . 0.0 111.84 173.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.402 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 19.4 ptp180 -77.21 -45.08 27.75 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.596 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.855 HG12 ' HB1' ' A' ' 143' ' ' ALA . 54.9 t -53.72 -31.15 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.56 1.144 . . . . 0.0 110.13 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.59 -18.31 64.77 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 174.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -102.34 -37.03 8.24 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.383 1.447 . . . . 0.0 112.43 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 41' ' ' ARG . 18.0 ptpt -97.29 2.95 51.34 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.798 1.239 . . . . 0.0 113.2 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.69 13.82 0.55 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.773 2.429 . . . . 0.0 114.437 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.45 -86.39 0.14 Allowed Glycine 0 C--N 1.339 0.711 0 C-N-CA 125.645 1.593 . . . . 0.0 109.381 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.1 m -129.49 122.8 30.01 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -170.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -57.16 -61.86 6.3 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.025 0.93 . . . . 0.0 110.268 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.42 172.03 17.12 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.767 2.311 . . . . 0.0 111.149 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -63.95 170.44 8.86 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.241 1.961 . . . . 0.0 111.14 165.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -141.13 168.72 19.11 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.152 0.981 . . . . 0.0 110.071 -173.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.6 m -143.69 155.52 44.25 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.63 1.572 . . . . 0.0 107.353 -172.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.02 34.89 0.4 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.436 1.494 . . . . 0.0 114.324 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.31 -36.13 52.41 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.732 2.013 . . . . 0.0 111.5 -171.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -73.65 -39.38 64.52 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 118.198 -0.906 . . . . 0.0 112.197 -174.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -168.21 131.44 1.54 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.014 0.824 . . . . 0.0 110.42 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -155.51 83.42 1.04 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 159.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 pp -158.46 -38.71 0.06 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -168.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -160.31 177.37 10.69 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.722 1.146 . . . . 0.0 108.364 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -86.58 63.3 7.9 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 127.624 2.37 . . . . 0.0 109.687 -159.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -136.34 159.97 40.14 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 122.109 0.957 . . . . 0.0 113.088 172.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.23 154.64 25.53 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 128.558 2.98 . . . . 0.0 110.1 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.6 pt -140.07 174.7 7.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.724 1.21 . . . . 0.0 109.327 173.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -99.79 108.34 20.61 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.564 1.146 . . . . 0.0 110.285 -177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.54 122.96 20.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 158.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.496 ' HB2' HD11 ' A' ' 74' ' ' LEU . 40.5 t -72.16 90.39 1.21 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 158.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.701 HD12 ' HD2' ' A' ' 146' ' ' LYS . 17.1 tt -65.15 -21.42 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 121.984 -0.447 . . . . 0.0 111.092 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.3 t -72.66 -0.25 12.52 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.12 1.768 . . . . 0.0 111.859 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.7 p -143.82 9.5 1.54 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.427 1.012 . . . . 0.0 113.334 160.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.76 55.36 30.44 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 -176.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 73' ' ' ASP . 49.2 m -151.95 179.08 8.77 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.75 -1.441 . . . . 0.0 108.467 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.44 ' C ' HD13 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -132.5 141.27 48.7 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.135 1.374 . . . . 0.0 108.487 -163.598 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 67' ' ' CYS 0.283 0.0 OUTLIER -151.23 -89.55 0.06 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 177.8 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -54.29 151.65 7.17 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.263 1.025 . . . . 0.0 112.96 -170.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.431 ' OD2' ' HB2' ' A' ' 14' ' ' ALA . 12.0 t70 -126.32 150.75 48.31 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.743 1.217 . . . . 0.0 111.099 -166.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.4 t -59.94 -23.06 63.25 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.053 -1.451 . . . . 0.0 113.739 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -60.54 -19.69 57.98 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 120.953 1.706 . . . . 0.0 112.583 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.422 ' HA ' ' CE2' ' A' ' 91' ' ' TYR 0.253 2.2 t -119.65 -3.76 10.32 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.401 1.48 . . . . 0.0 111.035 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -96.51 94.45 7.38 Favored 'General case' 0 C--N 1.344 0.36 0 O-C-N 120.739 -1.226 . . . . 0.0 109.781 -175.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -63.22 127.33 30.78 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 163.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.547 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 1.7 t70 -147.13 -58.92 0.27 Allowed 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 127.474 2.31 . . . . 0.0 107.322 -163.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.8 m -51.89 111.78 0.67 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.519 1.527 . . . . 0.0 111.401 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.07 -43.19 0.64 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.333 1.92 . . . . 0.0 114.743 174.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.3 m -81.93 -72.0 0.46 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.041 1.336 . . . . 0.0 108.88 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 82' ' ' ASP . . . 48.46 45.24 29.21 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 126.467 1.984 . . . . 0.0 114.26 170.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.21 148.07 34.96 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 113.801 -1.199 . . . . 0.0 107.952 166.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.67 68.59 7.03 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.836 2.357 . . . . 0.0 110.574 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.6 p -139.02 150.16 45.5 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.703 1.201 . . . . 0.0 109.222 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -130.04 166.2 20.62 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.629 1.972 . . . . 0.0 107.779 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.422 ' CE2' ' HA ' ' A' ' 79' ' ' THR . 41.7 p90 -123.57 -16.43 6.76 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.31 176.08 9.14 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.55 2.34 . . . . 0.0 106.073 175.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.9 p -145.5 155.86 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 121.681 -0.637 . . . . 0.0 110.982 -168.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 p -60.93 -36.27 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.397 1.479 . . . . 0.0 111.501 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.5 m 140.21 151.84 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 1 C-N-CA 131.794 4.038 . . . . 0.0 108.113 -169.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -75.9 52.17 0.68 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.981 1.712 . . . . 0.0 111.021 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -105.63 -49.1 3.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.274 1.029 . . . . 0.0 109.593 -167.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.505 ' HA ' ' HB3' ' A' ' 117' ' ' ALA . 38.5 t-20 -125.26 22.97 7.73 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.526 1.13 . . . . 0.0 111.346 165.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.03 125.52 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 163.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.47 148.97 25.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.996 2.118 . . . . 0.0 107.142 -178.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mp -134.58 160.6 37.57 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.576 1.151 . . . . 0.0 108.752 167.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.447 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 6.1 mpt_? -133.57 130.12 37.97 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 131.336 3.854 . . . . 0.0 102.903 162.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -66.07 140.63 58.26 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.4 0.619 . . . . 0.0 109.592 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -142.69 171.86 13.48 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 103.808 -2.664 . . . . 0.0 103.808 158.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -130.74 18.93 5.13 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.561 2.344 . . . . 0.0 110.281 -173.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 t -54.64 -38.35 66.78 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 128.332 2.653 . . . . 0.0 113.702 -159.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.0 pp -75.69 -8.38 56.68 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.16 4.06 41.43 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.338 1.446 . . . . 0.0 112.55 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 97.2 mtp -140.14 -99.17 0.15 Allowed 'General case' 0 C--N 1.346 0.43 0 CA-C-N 119.382 1.591 . . . . 0.0 107.915 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -143.97 100.98 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.272 0 CA-C-N 120.733 1.606 . . . . 0.0 108.225 -173.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -114.54 61.36 0.67 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.071 1.348 . . . . 0.0 111.085 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 46.7 m -70.07 137.7 51.44 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.447 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 18.8 pt-20 -64.58 158.32 24.61 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.95 0.796 . . . . 0.0 110.591 173.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.8 t -139.22 102.21 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -132.2 160.17 36.88 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.3 m -70.97 128.24 35.31 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.505 ' HB3' ' HA ' ' A' ' 98' ' ' ASN . . . -72.61 -18.84 61.56 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -169.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.509 ' HD3' HD11 ' A' ' 8' ' ' ILE . 1.8 tpt180 -78.87 -38.17 38.39 Favored 'General case' 0 CA--C 1.525 0.012 0 C-N-CA 126.483 1.913 . . . . 0.0 111.794 168.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 23.9 p -146.51 89.66 1.87 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.501 1.521 . . . . 0.0 107.846 -166.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.18 55.27 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.323 2.649 . . . . 0.0 112.127 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -74.76 -77.26 0.12 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -158.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.416 ' H ' ' CD2' ' A' ' 123' ' ' LEU . 55.4 t-80 -138.14 -73.19 0.41 Allowed 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.416 ' CD2' ' H ' ' A' ' 122' ' ' HIS . 1.9 mm? 56.83 -112.74 0.71 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.808 2.043 . . . . 0.0 108.228 169.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.72 -126.95 1.27 Allowed Glycine 0 CA--C 1.526 0.72 0 CA-C-N 119.504 1.047 . . . . 0.0 113.959 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -155.59 172.91 17.48 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.349 0.659 . . . . 0.0 111.227 -174.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.451 HG21 ' HE2' ' A' ' 136' ' ' LYS . 5.1 p -114.3 144.41 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 C-N-CA 124.516 1.126 . . . . 0.0 108.024 170.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -144.89 157.9 43.99 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.191 0.996 . . . . 0.0 110.627 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.15 102.34 2.48 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.378 1.871 . . . . 0.0 109.155 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -165.74 -48.7 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.335 1.054 . . . . 0.0 111.348 -171.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -66.18 173.08 24.81 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 123.173 0.416 . . . . 0.0 112.909 -173.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.42 168.26 24.77 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.698 2.266 . . . . 0.0 111.77 -171.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -61.06 151.44 75.09 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 161.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.44 -42.23 0.84 Allowed 'Cis proline' 0 C--N 1.345 0.383 0 CA-C-N 119.999 1.035 . . . . 0.0 114.655 16.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.3 p -77.29 -30.04 54.05 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -168.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.48 13.55 82.8 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 118.77 0.714 . . . . 0.0 113.767 -174.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.451 ' HE2' HG21 ' A' ' 126' ' ' VAL . 11.4 ptmt -128.71 154.56 46.21 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 119.172 1.486 . . . . 0.0 111.029 -171.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.3 ttm105 -120.82 106.19 11.43 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -71.99 126.98 31.14 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 160.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 23.6 t -135.82 126.85 27.84 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.607 1.094 . . . . 0.0 108.184 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -145.65 147.48 32.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.279 0.632 . . . . 0.0 109.632 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -140.89 130.36 23.88 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.2 p -168.98 174.66 6.22 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.686 1.594 . . . . 0.0 107.941 167.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.855 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -62.91 -9.15 8.72 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.301 1.04 . . . . 0.0 112.972 167.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.27 -20.43 63.05 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.692 1.197 . . . . 0.0 114.202 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.2 mt -83.12 74.38 10.0 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.112 0.869 . . . . 0.0 111.333 -161.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.701 ' HD2' HD12 ' A' ' 68' ' ' ILE . 66.8 tttt -98.3 119.16 36.49 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.045 0.938 . . . . 0.0 110.006 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.18 147.14 53.77 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.961 0.41 . . . . 0.0 110.192 164.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.7 pt -140.89 170.22 9.92 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 126.516 1.926 . . . . 0.0 108.42 162.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -54.86 177.19 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.541 3.494 . . . . 0.0 113.184 159.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.645 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 5.5 mmt-85 -32.39 -45.42 0.11 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.726 2.411 . . . . 0.0 115.989 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -165.42 -71.85 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.577 0.751 . . . . 0.0 108.988 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.9 9.19 0.77 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.906 1.282 . . . . 0.0 112.799 -176.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.5 pp -67.85 -30.68 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -169.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 CA-C-O 117.191 -1.894 . . . . 0.0 109.478 -175.711 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.2 mmt . . . . . 0 CA--C 1.536 0.414 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.27 31.24 0.39 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.853 0.861 . . . . 0.0 111.091 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -157.94 -174.4 4.82 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.779 1.232 . . . . 0.0 110.669 -158.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -103.74 178.08 4.66 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.213 1.805 . . . . 0.0 110.937 -162.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.2 pt -122.2 110.25 32.8 Favored Pre-proline 0 CA--C 1.536 0.435 0 O-C-N 120.715 -1.241 . . . . 0.0 110.842 -173.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.03 140.42 34.61 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.42 1.413 . . . . 0.0 109.016 171.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.6 mt -127.9 149.13 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -132.06 152.32 51.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -175.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.2 m -126.73 80.13 1.92 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 p -57.05 -39.2 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 123.005 0.522 . . . . 0.0 110.908 -169.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.75 2.81 3.74 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.333 1.053 . . . . 0.0 113.604 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -135.45 5.75 3.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.567 2.347 . . . . 0.0 110.274 171.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 34.09 42.6 0.06 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 128.375 2.67 . . . . 0.0 113.393 -162.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -87.09 161.99 17.82 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.315 -0.866 . . . . 0.0 108.995 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -135.96 132.19 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 167.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -133.83 107.05 7.64 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.868 1.667 . . . . 0.0 106.535 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 40.5 ttp -81.76 136.45 35.43 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.099 -1.001 . . . . 0.0 108.637 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.4 t -129.27 169.77 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.708 2.003 . . . . 0.0 106.067 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -99.95 152.82 19.73 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 120.526 -1.359 . . . . 0.0 110.37 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.426 ' CG ' ' HD3' ' A' ' 118' ' ' ARG . 25.0 ttm180 -68.18 137.2 54.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.02 1.728 . . . . 0.0 110.427 -168.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.2 tt -74.4 125.7 34.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.482 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.9 -170.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -154.37 110.67 3.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.9 mt -138.88 173.77 11.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.591 1.556 . . . . 0.0 109.256 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.63 159.02 21.66 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.042 2.137 . . . . 0.0 107.786 165.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.53 -35.09 76.75 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.562 -0.711 . . . . 0.0 112.607 -172.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.22 -28.62 65.41 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-O 121.051 0.453 . . . . 0.0 112.192 -174.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -59.72 -38.15 80.87 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.011 1.324 . . . . 0.0 110.048 -169.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -61.47 11.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.047 2.539 . . . . 0.0 116.61 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.89 -1.35 2.71 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 166.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -126.73 -20.59 4.25 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.825 -174.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 pt -109.13 -1.64 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.635 0.652 . . . . 0.0 111.704 165.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -101.72 163.72 12.11 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.306 1.042 . . . . 0.0 110.573 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.96 142.62 79.22 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.371 0.668 . . . . 0.0 109.772 168.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -65.84 -16.53 53.3 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.02 1.813 . . . . 0.0 111.453 166.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -71.57 -42.9 67.22 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 121.982 -0.449 . . . . 0.0 110.014 169.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.6 -44.47 96.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 121.225 -0.922 . . . . 0.0 109.912 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -56.8 -45.24 82.32 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.144 0.978 . . . . 0.0 112.336 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -76.44 -49.26 17.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -176.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.734 HG13 ' HA2' ' A' ' 47' ' ' GLY . 74.0 t -54.54 -33.41 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 125.156 1.382 . . . . 0.0 108.685 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.01 -18.95 63.88 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.44 -26.39 14.47 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.244 1.384 . . . . 0.0 112.192 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -108.86 -1.37 19.22 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 124.575 1.15 . . . . 0.0 112.779 -172.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.18 -2.4 0.05 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.18 2.592 . . . . 0.0 115.059 -169.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.734 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . 166.55 -66.51 0.2 Allowed Glycine 0 C--N 1.339 0.744 0 CA-C-N 119.417 1.008 . . . . 0.0 111.94 174.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.8 t -144.05 141.87 30.33 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 168.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -57.58 -48.65 96.88 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.31 -1.329 . . . . 0.0 114.207 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.43 165.77 30.64 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 CA-C-N 121.823 1.687 . . . . 0.0 111.033 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.96 152.32 77.02 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.165 1.243 . . . . 0.0 110.061 173.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -74.93 46.95 0.32 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.121 1.368 . . . . 0.0 111.808 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 36.1 p -75.54 78.6 2.56 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.855 -1.153 . . . . 0.0 109.284 175.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.59 144.2 10.52 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 173.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.56 114.1 3.21 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -142.3 144.95 33.49 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 169.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -158.65 163.64 36.72 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 174.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -146.72 -111.5 0.09 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 165.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.04 -178.35 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.874 2.07 . . . . 0.0 112.918 163.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -39.43 137.11 0.84 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.624 2.37 . . . . 0.0 111.883 175.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -57.78 170.52 0.59 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 128.391 2.676 . . . . 0.0 112.721 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -132.56 168.54 18.06 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 166.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.521 ' H ' ' HG2' ' A' ' 150' ' ' ARG . . . 100.53 168.41 28.82 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 125.116 1.341 . . . . 0.0 112.167 161.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 76' ' ' ASP . 38.6 pt -135.35 164.21 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 113.587 -1.307 . . . . 0.0 108.091 163.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -78.27 122.57 25.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.634 0.73 . . . . 0.0 109.306 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.79 117.48 23.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.234 1.814 . . . . 0.0 106.377 163.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 5.2 t -71.38 69.72 0.58 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.455 1.502 . . . . 0.0 108.746 171.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.4 tt -61.46 -19.39 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 125.512 1.525 . . . . 0.0 112.754 -169.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.1 t -70.89 -1.0 10.36 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.267 1.427 . . . . 0.0 112.617 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 9.6 p -146.19 -7.57 0.54 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.494 1.043 . . . . 0.0 113.246 158.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.9 -8.28 59.45 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.207 -1.329 . . . . 0.0 113.032 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.2 m -64.34 171.79 2.9 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.483 2.713 . . . . 0.0 111.137 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.93 152.43 51.08 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.767 1.627 . . . . 0.0 107.9 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.411 HD13 ' CD2' ' A' ' 75' ' ' PHE 0.28 0.3 OUTLIER -155.34 -98.85 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 178.996 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.411 ' CD2' HD13 ' A' ' 74' ' ' LEU . 28.2 m-85 -61.51 132.42 53.34 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.489 1.041 . . . . 0.0 113.723 -158.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.506 ' HA ' HG22 ' A' ' 64' ' ' ILE . 4.4 m-20 -79.46 136.6 36.97 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.52 1.128 . . . . 0.0 110.805 173.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 58.7 m -53.02 -33.6 52.48 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.448 1.099 . . . . 0.0 113.527 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.7 -17.48 63.02 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.147 0.979 . . . . 0.0 113.235 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.4 p -76.23 -23.31 54.53 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 121.705 -0.622 . . . . 0.0 112.037 172.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HE3' ' O ' ' A' ' 87' ' ' TRP . 1.3 mtpt -86.96 -169.81 2.79 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.524 1.53 . . . . 0.0 109.806 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -133.18 32.78 3.68 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.847 0.859 . . . . 0.0 113.051 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -54.96 -21.97 13.53 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.407 1.483 . . . . 0.0 112.424 166.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.0 p -66.54 58.67 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.293 2.237 . . . . 0.0 110.802 165.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.95 -32.91 2.8 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.555 1.55 . . . . 0.0 113.615 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.3 m -131.3 -60.41 0.95 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.549 1.674 . . . . 0.0 112.449 -167.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.08 7.29 87.25 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 115.586 0.994 . . . . 0.0 115.586 177.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.417 ' O ' ' HE3' ' A' ' 80' ' ' LYS . 2.8 t90 -67.01 144.9 98.76 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 118.44 1.12 . . . . 0.0 109.147 173.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.48 64.32 6.45 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.207 3.271 . . . . 0.0 112.393 -173.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 61.5 p -133.52 141.64 47.84 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.052 1.741 . . . . 0.0 108.983 173.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.83 168.22 19.14 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.82 1.648 . . . . 0.0 109.208 -175.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -129.4 -9.14 4.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -146.23 175.42 10.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 169.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.81 155.7 27.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 122.232 1.015 . . . . 0.0 111.682 -167.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.76 -36.44 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.898 1.679 . . . . 0.0 111.634 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.2 m 151.04 160.08 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 131.295 3.838 . . . . 0.0 108.642 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -77.26 66.54 3.05 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.151 0.98 . . . . 0.0 108.591 168.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -109.17 -54.05 2.58 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.163 0.585 . . . . 0.0 110.114 -173.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.75 23.49 3.96 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 174.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.52 138.31 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 125.813 1.645 . . . . 0.0 106.708 172.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -105.35 137.22 43.49 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 127.251 2.22 . . . . 0.0 109.061 -174.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mp -136.71 153.42 50.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.197 1.799 . . . . 0.0 111.101 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.465 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 0.9 OUTLIER -143.88 129.56 19.23 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 131.43 3.892 . . . . 0.0 104.332 164.093 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -62.18 145.44 53.46 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.559 1.144 . . . . 0.0 110.421 166.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -150.34 175.7 11.58 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 158.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.08 20.22 13.87 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.026 1.33 . . . . 0.0 110.917 175.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.9 m -64.68 26.89 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 129.803 3.241 . . . . 0.0 116.654 -169.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 pp -130.85 -7.29 3.99 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.086 1.354 . . . . 0.0 112.086 162.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.45 -1.73 32.66 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 117.08 -1.955 . . . . 0.0 113.09 -168.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.8 mtm -141.29 -87.59 0.17 Allowed 'General case' 0 C--N 1.35 0.599 0 CA-C-N 120.733 2.266 . . . . 0.0 109.442 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 49.1 t -145.92 113.78 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -123.63 94.36 4.22 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.001 1.72 . . . . 0.0 108.566 174.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 14.6 t -105.91 129.27 54.09 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -174.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.465 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 17.8 pt-20 -64.44 160.08 19.99 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.114 0.87 . . . . 0.0 112.119 -174.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.5 t -138.73 105.93 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -126.93 173.79 9.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.051 0.94 . . . . 0.0 108.607 170.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.5 t -70.18 149.02 47.96 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.165 -0.959 . . . . 0.0 109.161 165.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.07 -16.48 63.7 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.426 ' HD3' ' CG ' ' A' ' 23' ' ' ARG . 28.2 tpt85 -117.72 -70.07 0.81 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-O 118.27 -0.871 . . . . 0.0 113.243 170.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 17.0 p -68.13 18.72 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 118.664 2.838 . . . . 0.0 118.664 -158.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 61.79 -11.44 0.07 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.955 2.502 . . . . 0.0 116.464 166.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.48 150.12 40.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.924 0.89 . . . . 0.0 112.388 -163.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -33.39 -59.84 0.37 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 128.734 2.814 . . . . 0.0 113.224 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 45.52 -106.01 0.11 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.875 2.07 . . . . 0.0 109.365 -173.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.29 -119.56 0.69 Allowed Glycine 0 CA--C 1.522 0.491 0 CA-C-N 118.081 0.4 . . . . 0.0 112.209 171.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -163.84 172.27 14.29 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.166 0.586 . . . . 0.0 110.412 -172.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.645 HG21 ' HE2' ' A' ' 136' ' ' LYS . 3.5 p -115.45 139.54 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.423 1.489 . . . . 0.0 108.828 171.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -131.29 148.93 52.73 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.214 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.79 82.66 1.63 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.076 1.751 . . . . 0.0 109.991 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -156.51 -0.91 0.13 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.678 1.191 . . . . 0.0 112.682 -166.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.66 179.24 34.28 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 120.382 -1.449 . . . . 0.0 113.116 -169.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.44 158.84 53.14 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.707 2.272 . . . . 0.0 110.731 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 45.9 mtp85 -64.56 154.75 83.64 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 164.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.02 -41.49 0.96 Allowed 'Cis proline' 0 C--N 1.348 0.532 0 CA-C-N 119.922 1.008 . . . . 0.0 113.787 8.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.6 p -69.32 -30.08 68.06 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -168.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.94 3.88 75.71 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.817 0.722 . . . . 0.0 113.455 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.645 ' HE2' HG21 ' A' ' 126' ' ' VAL . 13.2 ptmt -123.27 152.66 41.14 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.458 1.629 . . . . 0.0 111.222 -166.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 27.3 ttm105 -125.56 99.07 5.85 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.968 1.707 . . . . 0.0 106.751 -177.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -70.06 139.17 52.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 163.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 35.1 t -143.66 140.49 30.11 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.5 1.12 . . . . 0.0 108.322 174.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -148.36 157.83 43.72 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.689 0.395 . . . . 0.0 111.312 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -155.96 126.45 6.75 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.599 1.56 . . . . 0.0 108.607 170.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 91.6 p -171.29 -179.8 2.75 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.214 1.406 . . . . 0.0 109.044 163.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.51 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -60.48 -17.17 43.31 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 165.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.79 8.93 0.76 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 120.694 1.588 . . . . 0.0 114.093 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.0 mt -115.6 69.47 0.73 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.63 1.172 . . . . 0.0 110.189 -164.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -97.52 129.69 44.66 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -75.55 145.62 41.11 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.575 0.625 . . . . 0.0 109.55 167.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 28.1 pt -138.13 168.06 17.6 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 126.256 1.823 . . . . 0.0 108.294 167.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -54.07 160.84 5.65 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.657 2.905 . . . . 0.0 112.124 163.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.521 ' HG2' ' H ' ' A' ' 63' ' ' GLY . 1.6 mmt180 -47.69 -26.27 1.48 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -165.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -161.45 -70.33 0.06 Allowed 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 128.728 2.811 . . . . 0.0 108.998 159.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -148.97 7.58 0.72 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.881 2.472 . . . . 0.0 110.126 -173.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.7 pp -56.77 -24.47 19.72 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 C-N-CA 124.877 1.271 . . . . 0.0 113.938 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 CA-C-O 116.969 -2.017 . . . . 0.0 109.271 174.998 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -120.49 155.68 33.07 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 106.322 -1.732 . . . . 0.0 106.322 164.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -152.77 178.19 9.9 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.856 1.262 . . . . 0.0 109.081 -161.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.581 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -102.8 164.68 11.49 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 158.651 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.7 pt -128.9 117.64 19.39 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 125.831 1.652 . . . . 0.0 108.918 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.99 136.11 22.15 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.488 1.458 . . . . 0.0 108.403 166.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.1 mt -117.93 111.58 34.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -113.52 97.28 6.35 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.149 1.38 . . . . 0.0 108.488 -176.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -68.98 83.39 0.32 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.559 0.744 . . . . 0.0 109.234 170.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.4 p -55.07 -39.12 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 118.41 0.55 . . . . 0.0 111.159 -173.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -14.53 20.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.844 1.258 . . . . 0.0 113.98 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -126.64 2.87 6.81 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 126.318 1.847 . . . . 0.0 111.059 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 36.08 44.11 0.24 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.406 1.882 . . . . 0.0 111.665 -159.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.69 160.4 30.82 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 117.676 -1.609 . . . . 0.0 108.654 168.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.5 t -140.85 128.41 22.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 103.96 -2.607 . . . . 0.0 103.96 162.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -142.67 119.69 11.35 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.441 1.496 . . . . 0.0 107.62 169.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 28.9 ttp -83.58 142.98 30.45 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 172.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.5 t -140.94 177.23 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 129.42 3.088 . . . . 0.0 103.19 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 15.7 pt-20 -108.17 169.4 8.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 120.373 1.442 . . . . 0.0 114.052 174.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.97 171.24 1.28 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.636 0.774 . . . . 0.0 110.038 176.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.32 131.63 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.553 1.141 . . . . 0.0 111.416 -169.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -157.15 99.97 1.83 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.829 0.851 . . . . 0.0 109.357 173.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.6 mt -143.9 169.48 17.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.428 2.291 . . . . 0.0 108.612 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.503 ' H ' ' CG ' ' A' ' 30' ' ' GLU . 0.7 OUTLIER -90.35 164.23 14.41 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 127.098 2.159 . . . . 0.0 109.878 176.527 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.22 57.9 1.52 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.382 1.087 . . . . 0.0 110.055 160.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.06 -12.06 0.22 Allowed 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 124.694 1.198 . . . . 0.0 111.869 158.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.503 ' CG ' ' H ' ' A' ' 27' ' ' SER . 45.0 mm-40 -81.92 -49.09 10.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.545 -0.722 . . . . 0.0 109.976 -170.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.441 ' CE3' ' CD1' ' A' ' 35' ' ' LEU . 62.5 m95 -60.72 9.37 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.45 1.9 . . . . 0.0 114.9 -175.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.68 -0.66 4.33 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.441 1.497 . . . . 0.0 114.879 177.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.97 -23.11 2.01 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.592 173.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 pt -103.33 16.96 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 119.306 0.957 . . . . 0.0 110.517 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.461 HD22 ' CB ' ' A' ' 39' ' ' ALA . 3.4 mt -139.67 160.16 40.5 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.078 0.951 . . . . 0.0 112.138 -174.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.479 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 2.4 m-20 -59.36 148.52 72.68 Favored Pre-proline 0 C--O 1.238 0.489 0 C-N-CA 124.353 1.061 . . . . 0.0 110.159 172.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -63.08 -18.37 64.79 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.749 1.633 . . . . 0.0 111.328 165.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -72.21 -50.68 25.67 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 119.323 -0.37 . . . . 0.0 110.119 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.479 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -58.14 -44.17 87.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 119.068 0.849 . . . . 0.0 110.509 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -53.95 -51.84 62.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.034 1.334 . . . . 0.0 111.911 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.411 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 41.1 ptt180 -68.72 -51.11 45.01 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.376 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.7 t -61.15 -28.63 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 118.805 -0.617 . . . . 0.0 109.664 -170.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.5 -17.64 64.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -107.41 -32.37 7.77 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.435 1.016 . . . . 0.0 112.346 174.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 41' ' ' ARG . 17.0 ptpt -103.74 0.35 30.38 Favored 'General case' 0 C--N 1.343 0.292 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -174.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.29 45.57 7.28 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.031 1.332 . . . . 0.0 111.819 -170.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.87 -69.22 0.27 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 168.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.5 t -141.75 117.59 10.48 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -175.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 35.1 mt-10 -55.76 -57.49 21.17 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.929 170.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 49' ' ' GLU . 5.6 Cg_exo -83.95 160.58 13.83 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.919 1.746 . . . . 0.0 110.906 -172.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.75 66.23 5.8 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.504 2.803 . . . . 0.0 110.617 172.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -140.69 165.14 28.31 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.116 1.366 . . . . 0.0 108.787 170.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.3 p -126.47 160.9 29.23 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.726 1.21 . . . . 0.0 110.257 -173.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -169.52 113.83 0.53 Allowed Glycine 0 C--N 1.335 0.477 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.33 167.18 22.65 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -137.07 123.39 20.65 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -167.44 175.13 7.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 128.327 2.651 . . . . 0.0 106.107 167.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -136.72 -89.78 0.27 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 171.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.5 pp -143.3 126.28 16.3 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.895 1.278 . . . . 0.0 108.213 163.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.91 161.52 42.54 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.991 0.916 . . . . 0.0 112.264 177.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -138.7 87.73 2.24 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 158.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -150.34 -179.94 7.61 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 166.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.75 -171.72 39.78 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 124.115 0.864 . . . . 0.0 112.644 171.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.2 pt -140.49 179.04 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 158.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -89.1 147.65 24.11 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.061 -1.024 . . . . 0.0 110.726 169.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -120.39 141.99 49.6 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.978 0.894 . . . . 0.0 111.207 158.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 25.5 t -92.6 93.96 8.79 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 113.48 -1.691 . . . . 0.0 107.214 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.458 HG22 ' HA ' ' A' ' 144' ' ' ALA . 4.2 tt -63.32 -29.81 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 123.861 0.864 . . . . 0.0 111.322 -164.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.9 m -77.44 0.53 22.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.118 1.767 . . . . 0.0 112.503 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 6.6 p -132.0 -10.41 3.4 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.242 1.017 . . . . 0.0 112.92 163.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.7 6.13 84.49 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.002 1.286 . . . . 0.0 112.71 -172.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.2 m -106.17 132.1 52.63 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 118.442 1.121 . . . . 0.0 109.887 -164.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -75.92 165.23 25.29 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.325 1.85 . . . . 0.0 112.967 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 177.23 -171.96 0.1 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 129.048 2.939 . . . . 0.0 108.775 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 27.3 95.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 129.964 3.305 . . . . 0.0 116.109 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.55 150.43 43.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.328 1.051 . . . . 0.0 111.692 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.6 m -62.19 -24.14 67.04 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -174.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.18 -16.99 63.75 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.3 t -98.64 -9.68 24.38 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.7 -0.625 . . . . 0.0 111.293 169.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.691 ' HE2' ' H ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -84.48 179.1 7.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.12 1.368 . . . . 0.0 108.682 172.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.691 ' H ' ' HE2' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -141.24 -173.57 3.78 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.013 1.725 . . . . 0.0 107.618 174.537 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -158.82 -86.97 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -158.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.6 t -58.39 129.96 44.51 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 166.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.48 -87.68 0.52 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.8 m -81.96 50.06 1.49 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.405 1.097 . . . . 0.0 111.408 -175.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.37 32.23 3.65 Favored Glycine 0 CA--C 1.524 0.649 0 O-C-N 120.025 -1.672 . . . . 0.0 112.07 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -122.33 166.68 16.31 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.764 2.026 . . . . 0.0 108.557 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.32 71.44 6.76 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.559 2.173 . . . . 0.0 113.752 -160.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.6 p -136.86 162.09 34.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.827 1.251 . . . . 0.0 111.236 166.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -145.19 178.45 8.06 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.922 2.489 . . . . 0.0 109.471 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -128.61 -4.64 5.29 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -157.78 178.81 9.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.119 2.167 . . . . 0.0 108.146 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.0 t -134.14 151.09 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 119.182 0.901 . . . . 0.0 110.846 -168.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 p -55.01 -47.4 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.349 1.86 . . . . 0.0 111.546 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.3 m 165.22 170.24 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 131.069 3.748 . . . . 0.0 106.593 -174.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -90.4 97.15 11.01 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 159.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -131.08 -60.36 0.96 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.292 0.637 . . . . 0.0 110.804 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -115.47 18.74 15.83 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.087 1.355 . . . . 0.0 111.388 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.3 tt -130.64 163.93 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.117 2.567 . . . . 0.0 106.98 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.485 ' HD3' ' N ' ' A' ' 101' ' ' LEU . 2.7 tmtm? -135.96 128.79 31.1 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.137 0.975 . . . . 0.0 109.028 174.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.485 ' N ' ' HD3' ' A' ' 100' ' ' LYS . 1.7 mp -114.15 143.95 43.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.792 2.837 . . . . 0.0 111.256 176.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.27 113.85 8.25 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.102 1.761 . . . . 0.0 109.107 168.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -81.31 125.22 30.08 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.423 0.689 . . . . 0.0 111.498 -176.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -130.62 -175.99 3.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.501 1.921 . . . . 0.0 108.753 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.95 19.62 17.72 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.518 1.527 . . . . 0.0 111.477 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.45 20.73 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 129.102 2.961 . . . . 0.0 118.155 -165.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.6 pp -132.06 -2.17 3.63 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.821 -1.174 . . . . 0.0 112.253 167.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.4 8.68 56.11 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 117.871 -1.516 . . . . 0.0 112.851 -168.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 16.1 tpt -142.23 -92.13 0.13 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 119.867 1.834 . . . . 0.0 108.507 174.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 81.5 t -143.01 114.77 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -119.09 113.8 21.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.646 1.178 . . . . 0.0 108.183 169.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.452 ' HB3' ' CG1' ' A' ' 126' ' ' VAL . 31.5 t -106.15 122.33 45.97 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.03 151.03 44.06 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 172.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 75.6 t -136.46 111.49 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 C-N-CA 125.016 1.326 . . . . 0.0 107.572 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 mp -127.8 164.97 21.02 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.28 1.032 . . . . 0.0 109.195 175.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 18.1 t -71.88 154.2 41.39 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.445 -0.785 . . . . 0.0 109.3 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -82.96 -20.96 34.21 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 122.055 -0.403 . . . . 0.0 112.05 172.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.22 -42.79 3.46 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.639 1.176 . . . . 0.0 112.496 -162.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 27.9 p -123.54 81.08 1.86 Allowed 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 167.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.49 40.77 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.014 1 C-N-CA 132.533 4.333 . . . . 0.0 114.888 -163.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.21 -174.44 3.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.154 2.582 . . . . 0.0 112.434 -170.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -30.4 -70.11 0.06 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 130.012 3.325 . . . . 0.0 114.716 -164.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 mt 42.16 -111.13 0.15 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.277 2.231 . . . . 0.0 109.984 -170.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.59 -114.26 0.46 Allowed Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 118.884 0.765 . . . . 0.0 112.623 171.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -164.76 179.08 6.77 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.826 0.45 . . . . 0.0 110.298 -170.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.547 HG21 ' HE2' ' A' ' 136' ' ' LYS . 2.7 p -124.49 144.93 32.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 124.795 1.238 . . . . 0.0 108.463 167.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -131.48 147.23 52.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 124.109 0.881 . . . . 0.0 109.566 175.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -65.89 115.35 5.89 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.01 -34.36 0.15 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -171.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -83.91 172.32 49.7 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -174.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.7 -84.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.685 2.256 . . . . 0.0 110.353 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.62 169.53 9.88 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 129.062 2.945 . . . . 0.0 104.887 176.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.3 -54.49 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.629 0 CA-C-N 121.572 1.597 . . . . 0.0 111.93 -2.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.8 p -69.35 -25.61 64.28 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.37 0.668 . . . . 0.0 112.442 -174.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 68.22 10.77 60.28 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.895 0.76 . . . . 0.0 113.453 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.547 ' HE2' HG21 ' A' ' 126' ' ' VAL . 14.7 ptmt -130.29 158.57 39.42 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 119.281 1.54 . . . . 0.0 111.561 -169.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.83 103.36 7.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.941 1.696 . . . . 0.0 108.499 -175.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -73.15 135.28 44.65 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 168.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 27.0 t -142.19 133.58 26.47 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.707 1.203 . . . . 0.0 108.5 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 6.9 ptm -133.16 156.25 47.81 Favored 'General case' 0 CA--C 1.528 0.098 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -137.4 97.82 3.56 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.5 m -157.74 158.38 35.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 173.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -77.22 -30.19 54.49 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.07 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -74.46 54.17 0.57 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.863 2.065 . . . . 0.0 113.183 -170.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.8 mt -120.0 63.59 0.83 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.014 0.926 . . . . 0.0 108.73 -176.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -79.63 101.84 8.57 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -57.8 133.8 55.72 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 165.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.3 pt -136.99 165.72 32.72 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.567 1.147 . . . . 0.0 108.888 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.32 170.94 2.71 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.484 2.123 . . . . 0.0 111.38 162.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -50.09 -11.51 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 128.814 2.846 . . . . 0.0 118.185 -166.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.4 t0 177.31 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 128.675 2.79 . . . . 0.0 107.296 159.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.32 11.89 0.63 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.962 2.105 . . . . 0.0 112.0 -174.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -71.71 -11.58 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 O-C-N 121.186 -0.946 . . . . 0.0 112.328 173.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.543 0 C-N-CA 127.888 2.661 . . . . 0.0 106.532 159.199 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.9 ttp . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 119.07 -0.49 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -133.51 109.02 8.98 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 176.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.87 173.73 11.24 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -159.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -137.22 160.91 37.64 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.024 2.13 . . . . 0.0 105.571 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.8 pt -136.24 137.28 24.17 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.147 0.979 . . . . 0.0 111.431 -171.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.12 114.31 3.88 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.51 2.14 . . . . 0.0 110.342 170.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.446 HD12 HG23 ' A' ' 72' ' ' THR . 5.5 mm -87.64 132.29 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 159.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -132.28 96.09 3.8 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 -175.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 m -68.56 61.26 0.09 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 167.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.8 t -52.21 -36.67 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 120.863 -1.148 . . . . 0.0 109.486 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.54 -18.52 65.06 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.83 -174.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -108.53 1.98 21.87 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 129.812 3.245 . . . . 0.0 111.581 169.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.0 t30 37.7 61.57 1.0 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.046 2.538 . . . . 0.0 113.164 -158.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.98 169.11 11.49 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.765 1.226 . . . . 0.0 108.949 169.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -148.39 124.35 2.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 126.401 1.88 . . . . 0.0 106.305 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -144.19 95.15 2.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.032 1.333 . . . . 0.0 107.948 -173.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 12.1 ttt -69.63 137.62 52.39 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.513 -1.367 . . . . 0.0 109.968 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.9 t -135.08 160.02 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.049 1.34 . . . . 0.0 107.385 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -68.22 155.76 39.02 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.045 -1.659 . . . . 0.0 110.961 170.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.548 HH12 ' CD ' ' A' ' 25' ' ' GLU . 41.6 ptt85 -74.93 154.11 38.3 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 121.749 -0.594 . . . . 0.0 109.421 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.61 134.53 25.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.548 ' CD ' HH12 ' A' ' 23' ' ' ARG . 0.3 OUTLIER -162.52 123.56 2.54 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 102.008 -3.33 . . . . 0.0 102.008 159.029 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.1 mt -140.49 -178.96 5.75 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.963 1.705 . . . . 0.0 106.821 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.1 t -161.58 -10.94 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -118.94 -144.22 0.37 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.58 1.082 . . . . 0.0 110.211 -172.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.24 3.02 0.69 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.603 1.161 . . . . 0.0 113.281 175.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -59.47 -46.5 88.6 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 125.994 1.718 . . . . 0.0 110.974 -163.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.414 ' CE3' HD13 ' A' ' 35' ' ' LEU . 93.2 m95 -69.29 45.64 0.06 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.32 2.248 . . . . 0.0 112.344 174.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.67 -36.25 0.05 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.084 2.154 . . . . 0.0 109.915 159.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -84.68 -25.85 28.16 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.109 -0.948 . . . . 0.0 112.309 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 pt -109.67 18.69 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 119.773 1.17 . . . . 0.0 112.176 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.414 HD13 ' CE3' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -145.51 174.91 10.74 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.478 1.111 . . . . 0.0 110.875 -169.726 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.91 141.78 96.96 Favored Pre-proline 0 C--O 1.237 0.417 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 169.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -68.57 -14.53 39.81 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.744 2.296 . . . . 0.0 111.589 171.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -79.14 -44.04 22.79 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 122.999 0.52 . . . . 0.0 109.97 168.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.98 -39.7 90.62 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.58 1.082 . . . . 0.0 110.64 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -46.9 -58.29 4.09 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.953 2.101 . . . . 0.0 111.175 171.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 8.3 ptp85 -72.73 -42.06 64.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.883 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.469 HG13 ' HA2' ' A' ' 47' ' ' GLY . 44.5 t -52.56 -35.36 20.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 124.595 1.158 . . . . 0.0 110.405 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.71 -8.78 11.29 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -116.23 -38.68 3.53 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.376 0.989 . . . . 0.0 111.936 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 41' ' ' ARG . 19.3 ptpt -87.15 9.43 20.02 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.304 0.956 . . . . 0.0 113.151 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.58 -36.62 0.23 Allowed 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 129.143 2.977 . . . . 0.0 113.636 -167.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.469 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . 177.63 -73.4 0.07 OUTLIER Glycine 0 C--N 1.335 0.511 0 C-N-CA 127.023 2.249 . . . . 0.0 108.861 -166.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.7 p -132.9 127.89 35.35 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -47.04 -57.52 9.06 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.488 170.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.41 166.35 20.19 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.249 1.966 . . . . 0.0 110.962 166.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -74.64 58.01 4.5 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.806 3.004 . . . . 0.0 111.001 169.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -75.26 88.61 2.53 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.187 -0.946 . . . . 0.0 109.436 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.3 m -68.26 73.46 0.21 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.801 1.241 . . . . 0.0 109.935 171.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.98 72.26 0.71 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.437 1.494 . . . . 0.0 110.929 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -73.97 65.09 1.06 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.121 1.368 . . . . 0.0 110.953 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -70.14 78.16 0.51 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.344 1.457 . . . . 0.0 109.069 174.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -89.18 2.62 53.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.621 1.569 . . . . 0.0 114.292 -165.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -73.55 148.67 42.79 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.917 0.78 . . . . 0.0 110.669 -174.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.6 mt -149.67 96.58 2.5 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 127.359 2.264 . . . . 0.0 105.163 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -126.92 -74.56 0.59 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.105 0.962 . . . . 0.0 109.641 -166.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -78.03 -178.28 5.47 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.334 1.854 . . . . 0.0 109.606 164.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -69.76 167.95 16.05 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.874 -0.516 . . . . 0.0 111.8 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.39 162.83 12.82 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.875 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.423 HG22 ' HA ' ' A' ' 76' ' ' ASP . 38.5 pt -143.51 175.21 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 126.274 1.829 . . . . 0.0 109.131 -179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -93.35 122.51 35.84 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.295 0.569 . . . . 0.0 111.934 173.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.91 115.05 21.61 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 158.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.8 t -70.55 94.53 0.99 Allowed 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 166.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.455 HG22 ' HA ' ' A' ' 144' ' ' ALA . 2.0 tt -58.85 -33.0 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.599 1.16 . . . . 0.0 111.155 -165.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.4 t -82.48 5.14 21.62 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.949 1.3 . . . . 0.0 111.891 -169.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.72 18.63 1.83 Allowed 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.43 -0.794 . . . . 0.0 111.557 158.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.7 25.83 56.41 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 123.343 0.497 . . . . 0.0 112.744 174.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.446 HG23 HD12 ' A' ' 10' ' ' ILE . 28.4 m -120.55 124.54 45.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.863 1.265 . . . . 0.0 108.021 -164.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -64.63 145.27 56.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.408 1.083 . . . . 0.0 111.448 170.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.466 HD23 ' H ' ' A' ' 75' ' ' PHE 0.281 0.0 OUTLIER -148.88 -107.42 0.08 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.953 160.657 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.466 ' H ' HD23 ' A' ' 74' ' ' LEU . 19.4 m-85 -54.38 127.15 26.16 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.307 1.443 . . . . 0.0 112.416 -159.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.423 ' HA ' HG22 ' A' ' 64' ' ' ILE . 8.8 t70 -89.47 150.54 22.43 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.223 1.009 . . . . 0.0 109.494 -176.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.1 m -59.47 -26.83 65.57 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.088 172.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -70.1 -17.78 63.23 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.914 1.234 . . . . 0.0 112.449 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.8 p -96.44 -22.86 16.88 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.809 1.244 . . . . 0.0 112.196 170.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.477 ' HE2' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -125.56 79.09 1.79 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.566 1.946 . . . . 0.0 107.653 -170.482 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -127.43 118.64 24.45 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -135.68 163.65 29.67 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 104.71 -2.329 . . . . 0.0 104.71 159.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.6 t -136.48 135.89 38.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.385 0.993 . . . . 0.0 109.785 -164.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.99 -53.28 1.36 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -164.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.92 -68.96 0.28 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.26 1.424 . . . . 0.0 110.021 168.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 53.7 12.31 2.43 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 126.177 1.846 . . . . 0.0 116.225 -170.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -51.19 155.04 2.44 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 127.021 2.128 . . . . 0.0 112.307 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -73.55 68.09 4.49 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.864 3.042 . . . . 0.0 111.532 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.2 p -131.04 143.76 50.94 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.238 1.415 . . . . 0.0 108.508 167.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.92 160.22 38.97 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.659 1.584 . . . . 0.0 108.035 -171.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -123.27 7.04 9.08 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.453 -171.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -159.61 176.65 11.77 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 159.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -100.64 157.91 4.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 119.1 0.864 . . . . 0.0 110.268 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.3 p -66.25 -45.63 89.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 169.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.6 m -179.81 161.46 0.98 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 129.73 3.212 . . . . 0.0 106.714 167.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -76.74 56.99 1.22 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.03 1.732 . . . . 0.0 110.085 175.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -111.56 -61.51 1.69 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.629 0.772 . . . . 0.0 109.251 -168.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . 0.25 0.7 OUTLIER -113.09 21.23 15.57 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 175.48 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.8 tt -111.74 153.21 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 167.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -122.22 145.26 48.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.482 1.113 . . . . 0.0 108.815 169.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.5 mt -149.52 133.34 16.96 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 128.87 2.868 . . . . 0.0 108.602 -159.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.56 101.9 4.47 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 129.105 2.962 . . . . 0.0 108.503 168.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -73.8 143.8 45.84 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.604 0.762 . . . . 0.0 111.899 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -154.94 178.0 10.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 129.407 3.083 . . . . 0.0 107.989 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.456 ' HD2' ' H ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -103.13 25.12 9.84 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 120.366 -1.459 . . . . 0.0 113.135 178.05 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.45 19.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -166.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.14 2.03 2.76 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.985 -1.072 . . . . 0.0 112.449 165.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.05 -3.55 51.9 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.061 -1.41 . . . . 0.0 113.042 -169.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -139.11 -98.32 0.17 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.416 1.608 . . . . 0.0 109.175 -174.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.6 m -135.12 110.28 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.41 ' HE ' ' CD2' ' A' ' 125' ' ' HIS . 4.8 ttt180 -106.33 142.06 36.63 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 161.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.508 ' HB3' ' CG1' ' A' ' 126' ' ' VAL . 20.8 t -137.39 138.99 40.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 166.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -61.25 153.43 26.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 169.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.3 t -134.09 107.98 10.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -125.43 165.37 18.55 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 172.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 26.8 t -73.92 146.64 43.83 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 168.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.78 -45.46 86.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.745 -0.645 . . . . 0.0 109.337 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.3 tpt85 -84.41 -77.64 0.26 Allowed 'General case' 0 C--N 1.35 0.589 0 CA-C-O 116.257 -1.83 . . . . 0.0 111.775 162.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.6 p -78.34 75.32 4.87 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.859 1.209 . . . . 0.0 110.746 -158.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -59.76 77.22 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.509 1.924 . . . . 0.0 112.536 171.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.26 -155.62 0.45 Allowed 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 112.861 -1.972 . . . . 0.0 109.748 161.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -70.11 -60.6 2.19 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 125.525 1.53 . . . . 0.0 111.296 -168.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 50.24 -113.11 0.64 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.503 1.921 . . . . 0.0 108.511 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 174.11 -128.4 1.46 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 119.815 -1.183 . . . . 0.0 113.664 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.41 ' CD2' ' HE ' ' A' ' 111' ' ' ARG . 38.2 p-80 -157.78 175.65 13.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.01 0.524 . . . . 0.0 110.044 -174.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.508 ' CG1' ' HB3' ' A' ' 112' ' ' CYS . 3.0 p -122.06 143.86 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.288 1.435 . . . . 0.0 108.776 172.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -142.1 164.95 28.78 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.619 1.168 . . . . 0.0 111.516 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -72.06 102.93 3.11 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.468 1.907 . . . . 0.0 109.452 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -162.75 -50.8 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.709 2.004 . . . . 0.0 110.21 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -63.85 157.77 41.85 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 123.311 0.382 . . . . 0.0 112.29 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.12 177.64 8.5 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.651 2.234 . . . . 0.0 112.684 -169.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -50.19 145.62 9.63 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.792 159.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -84.55 -25.36 9.03 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 CA-C-N 119.462 0.844 . . . . 0.0 113.253 18.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.261 0.9 OUTLIER -107.46 -14.01 14.95 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.463 0.705 . . . . 0.0 112.18 -159.182 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.23 16.66 79.31 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 121.465 -0.772 . . . . 0.0 114.974 159.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -146.98 159.37 43.64 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 118.579 1.189 . . . . 0.0 110.486 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 ttm105 -119.56 108.88 15.04 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 126.052 1.741 . . . . 0.0 107.18 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -73.77 138.72 44.74 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 163.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 19.3 t -141.29 133.47 27.91 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.081 0.855 . . . . 0.0 108.74 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -130.18 105.11 7.71 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 122.15 0.976 . . . . 0.0 109.336 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -83.82 68.17 9.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 169.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 p -113.91 142.59 45.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.284 1.433 . . . . 0.0 110.463 -176.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.59 91.44 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.036 0.934 . . . . 0.0 111.907 170.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.455 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -66.73 16.74 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.44 2.696 . . . . 0.0 116.649 -160.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 87.9 mt -92.61 75.68 5.05 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.419 1.088 . . . . 0.0 111.275 -162.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -86.14 110.94 19.9 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -62.83 144.41 56.61 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 164.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 4.9 pt -142.79 169.6 10.45 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 126.179 1.792 . . . . 0.0 108.111 171.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -56.96 177.2 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.903 2.402 . . . . 0.0 111.142 159.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -50.93 8.56 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 119.867 3.284 . . . . 0.0 119.867 -172.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.7 t70 145.08 -72.85 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.159 1 C-N-CA 133.549 4.739 . . . . 0.0 107.308 163.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -154.69 43.02 0.49 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.172 2.589 . . . . 0.0 107.083 -176.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.3 pt -77.19 -19.73 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.076 -1.015 . . . . 0.0 110.562 161.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 1 C-N-CA 130.849 4.071 . . . . 0.0 105.832 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 59.7 ttm . . . . . 0 CA--C 1.528 0.129 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.9 mttp -155.69 144.59 20.56 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.871 0.869 . . . . 0.0 108.909 168.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.77 32.58 0.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 129.937 3.295 . . . . 0.0 111.337 -172.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 4.2 mtt180 -143.5 -172.42 3.71 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 126.405 1.882 . . . . 0.0 109.225 -171.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 pt -138.93 140.56 27.35 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.801 2.04 . . . . 0.0 109.665 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.471 ' O ' HD13 ' A' ' 10' ' ' ILE . 90.1 Cg_endo -80.78 143.0 14.47 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.062 2.508 . . . . 0.0 111.015 174.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.808 HD12 HG23 ' A' ' 72' ' ' THR . 17.2 mm -135.86 122.02 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 125.816 1.647 . . . . 0.0 107.254 -168.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -132.47 98.51 4.39 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.905 0.775 . . . . 0.0 110.299 -165.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.5 m -69.73 74.84 0.43 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.827 0.851 . . . . 0.0 109.602 170.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.86 -39.24 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.686 1.194 . . . . 0.0 112.074 -174.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.67 -15.64 8.33 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.162 2.185 . . . . 0.0 113.724 175.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.412 ' HE3' ' CD ' ' A' ' 17' ' ' ARG . 4.7 ttpt -133.1 15.58 4.19 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.738 2.415 . . . . 0.0 110.12 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 24.38 45.58 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 131.133 3.773 . . . . 0.0 114.375 -163.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.412 ' CD ' ' HE3' ' A' ' 15' ' ' LYS . 19.2 mtp-105 -90.95 171.63 9.15 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.003 175.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.0 p -140.34 154.4 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 158.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -144.35 170.99 14.96 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 127.984 2.514 . . . . 0.0 106.903 158.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 43.6 ttm -127.46 92.3 3.47 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.757 0.823 . . . . 0.0 109.499 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.6 t -77.16 155.94 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -79.13 174.24 11.77 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.06 -1.025 . . . . 0.0 112.476 175.925 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -77.86 163.24 26.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.533 0.733 . . . . 0.0 110.413 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.288 2.8 tp -89.15 69.12 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 123.324 1.535 . . . . 0.0 111.784 -169.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.9 89.87 3.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.018 1.727 . . . . 0.0 106.532 -173.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.8 mt -130.33 -176.21 3.88 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.107 2.163 . . . . 0.0 109.952 -175.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.0 t -112.91 162.66 15.58 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.741 1.617 . . . . 0.0 107.885 163.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -52.28 -36.89 54.06 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.14 0.882 . . . . 0.0 111.514 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -46.87 -34.63 5.57 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 129.25 3.02 . . . . 0.0 111.714 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -81.92 -46.88 13.45 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.193 1.797 . . . . 0.0 111.212 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.418 ' C ' HD12 ' A' ' 35' ' ' LEU . 91.3 m95 -64.01 40.5 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 129.844 3.258 . . . . 0.0 113.503 -174.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -169.29 -18.68 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.166 2.187 . . . . 0.0 113.24 -170.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -127.24 -13.69 5.53 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.31 -0.852 . . . . 0.0 112.807 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pt -109.31 3.95 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 119.061 0.846 . . . . 0.0 111.906 170.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.418 HD12 ' C ' ' A' ' 31' ' ' TRP . 12.3 mt -97.74 170.67 8.83 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.423 1.489 . . . . 0.0 111.014 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.18 144.73 90.95 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 159.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -63.64 -15.01 46.17 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.889 1.726 . . . . 0.0 111.761 166.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -70.94 -41.9 70.53 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 122.523 0.329 . . . . 0.0 110.587 170.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.441 ' HB2' HG12 ' A' ' 68' ' ' ILE . . . -62.55 -40.51 97.06 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.29 0.566 . . . . 0.0 109.914 -172.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -53.48 -52.61 59.0 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.576 1.15 . . . . 0.0 112.057 172.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 42' ' ' VAL . 3.8 ptp180 -76.92 -47.07 22.07 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -172.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' A' ' 39' ' ' ALA . 4.1 p -62.52 -24.39 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -174.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.23 -9.51 32.97 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 115.157 1.539 . . . . 0.0 115.157 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.78 -41.28 2.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.881 1.219 . . . . 0.0 110.849 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.413 ' H ' ' HG2' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -89.08 3.44 51.77 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.623 1.169 . . . . 0.0 113.317 176.346 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.33 2.44 0.09 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.16 2.584 . . . . 0.0 115.663 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.88 -71.4 0.02 OUTLIER Glycine 0 C--N 1.344 1.022 0 N-CA-C 118.242 2.057 . . . . 0.0 118.242 -163.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 t -158.12 156.53 31.11 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -73.76 162.62 73.31 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 158.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -70.53 152.66 65.46 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.012 1.808 . . . . 0.0 111.241 177.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.0 168.26 25.22 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.913 2.409 . . . . 0.0 110.889 172.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -139.99 172.14 13.19 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.618 1.567 . . . . 0.0 108.418 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.0 p -63.51 107.61 1.17 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.819 1.248 . . . . 0.0 109.28 175.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -171.08 -165.71 28.82 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 108.219 -1.952 . . . . 0.0 108.219 -177.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -138.09 160.29 39.77 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 117.706 0.753 . . . . 0.0 110.023 174.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -154.53 149.33 26.6 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 127.034 2.133 . . . . 0.0 105.791 168.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -154.84 171.72 19.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 158.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -144.83 -160.14 1.09 Allowed 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 163.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.29 39.1 0.66 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.523 1.129 . . . . 0.0 110.556 170.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.18 162.28 16.73 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.154 0.582 . . . . 0.0 112.17 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -149.32 62.56 1.03 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.62 1.968 . . . . 0.0 106.139 170.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -153.23 169.02 24.05 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.111 2.164 . . . . 0.0 106.187 -175.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.96 169.5 14.76 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.909 1.242 . . . . 0.0 112.63 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.474 HG22 ' HA ' ' A' ' 76' ' ' ASP . 35.0 pt -138.49 172.41 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.794 1.638 . . . . 0.0 110.427 -172.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -86.6 137.51 32.43 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.893 0.477 . . . . 0.0 111.207 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.51 121.06 44.17 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.671 1.188 . . . . 0.0 109.765 164.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.424 ' HB2' HD11 ' A' ' 74' ' ' LEU . 16.9 t -70.16 87.64 0.59 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.309 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.463 HG22 ' HA ' ' A' ' 144' ' ' ALA . 2.6 tt -52.89 -26.28 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -171.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.0 t -75.5 -0.86 21.7 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.838 0.855 . . . . 0.0 111.684 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.3 p -149.37 20.29 0.95 Allowed 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.69 -1.256 . . . . 0.0 111.926 161.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.1 -4.93 0.45 Allowed Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.565 1.555 . . . . 0.0 116.021 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.808 HG23 HD12 ' A' ' 10' ' ' ILE . 97.3 m -71.03 142.9 50.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.778 1.631 . . . . 0.0 109.577 -171.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -89.87 135.4 33.65 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.687 0.795 . . . . 0.0 111.739 165.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' A' ' 67' ' ' CYS 0.326 0.0 OUTLIER -137.26 -92.91 0.23 Allowed 'General case' 0 C--N 1.344 0.336 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 178.17 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -61.59 118.01 6.51 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.554 0.615 . . . . 0.0 110.851 -165.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.474 ' HA ' HG22 ' A' ' 64' ' ' ILE . 22.2 t70 -70.5 152.41 44.03 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 168.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.3 m -55.94 -25.8 45.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.217 -1.373 . . . . 0.0 113.565 175.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.59 -25.17 64.38 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 121.426 1.921 . . . . 0.0 111.282 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.3 p -95.87 18.52 13.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.081 1.353 . . . . 0.0 112.129 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -151.27 35.57 0.58 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.82 1.248 . . . . 0.0 111.492 161.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -84.35 57.42 4.26 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.621 0.724 . . . . 0.0 111.421 -164.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -98.75 110.24 22.87 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.169 0.587 . . . . 0.0 109.988 -172.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.6 m -50.04 102.14 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.371 1.868 . . . . 0.0 112.951 -169.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.72 -49.69 3.95 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.6 1.095 . . . . 0.0 112.305 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.9 m -59.52 -45.88 90.46 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.246 1.018 . . . . 0.0 110.967 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 49.58 26.43 7.52 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 128.034 2.73 . . . . 0.0 115.12 171.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -56.81 147.52 52.65 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.237 1.015 . . . . 0.0 111.139 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -78.97 57.62 6.54 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.163 3.242 . . . . 0.0 110.126 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.1 p -160.6 121.28 2.9 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -172.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.88 -160.78 1.1 Allowed 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 124.455 1.102 . . . . 0.0 109.082 -172.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -115.75 4.8 14.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 118.429 0.559 . . . . 0.0 112.074 -161.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -155.35 -179.18 7.84 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.144 0.578 . . . . 0.0 110.359 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 m -137.02 167.17 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 127.287 2.235 . . . . 0.0 110.114 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.5 p -58.48 -51.1 75.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.52 1.128 . . . . 0.0 111.926 -178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.4 m 159.74 151.37 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 129.216 3.006 . . . . 0.0 108.038 -169.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -74.29 79.68 1.84 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.888 0.475 . . . . 0.0 109.842 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -118.92 -56.23 2.12 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.81 0.844 . . . . 0.0 110.919 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.51 HD22 HG21 ' A' ' 72' ' ' THR . 27.9 t-20 -128.28 33.07 4.77 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.14 0.976 . . . . 0.0 111.352 170.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.7 tt -118.78 144.29 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 163.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.423 ' HD3' ' H ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -127.81 141.07 51.67 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.889 1.276 . . . . 0.0 107.698 171.418 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.423 ' H ' ' HD3' ' A' ' 100' ' ' LYS . 1.8 mp -127.85 140.8 51.8 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.452 1.901 . . . . 0.0 107.629 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.516 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 5.6 mpt_? -120.86 125.68 48.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 171.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -106.9 126.94 52.96 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.237 0.615 . . . . 0.0 110.769 -167.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -132.45 178.59 6.71 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.714 2.006 . . . . 0.0 109.912 176.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -106.63 11.35 30.53 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.423 1.889 . . . . 0.0 112.992 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 m -46.9 -43.44 18.86 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.616 1.566 . . . . 0.0 115.182 -159.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 pp -68.5 -12.2 60.89 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.49 4.95 30.23 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 117.615 -1.659 . . . . 0.0 112.757 -169.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.2 ttp -147.88 -86.94 0.09 Allowed 'General case' 0 C--N 1.348 0.511 0 CA-C-N 120.258 2.029 . . . . 0.0 109.172 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.8 p -148.61 114.32 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -120.56 112.1 18.5 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.221 1.808 . . . . 0.0 107.822 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.01 134.79 54.89 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.516 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 9.1 pt-20 -71.41 165.67 23.29 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.495 1.043 . . . . 0.0 110.661 174.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.62 108.41 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mp -131.17 167.47 19.1 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 167.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.1 t -66.53 149.2 50.8 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 98' ' ' ASN . . . -76.6 -17.4 59.21 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 44.8 tpt85 -111.74 -58.48 2.12 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 118.627 -0.701 . . . . 0.0 111.74 170.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.8 p -84.98 77.13 10.18 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.54 74.99 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.599 1.16 . . . . 0.0 110.01 172.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -97.61 -73.6 0.6 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.909 1.284 . . . . 0.0 112.323 -165.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.68 -80.95 0.17 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.54 1.136 . . . . 0.0 109.674 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt 45.56 -110.88 0.25 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.775 1.63 . . . . 0.0 111.15 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.95 -111.79 0.39 Allowed Glycine 0 C--N 1.332 0.318 0 CA-C-N 118.88 0.764 . . . . 0.0 112.843 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -164.02 -176.45 4.53 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -166.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.88 147.53 29.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 127.163 2.185 . . . . 0.0 108.632 169.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -137.91 143.41 40.81 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.98 0.912 . . . . 0.0 108.63 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.95 111.81 9.46 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -167.82 -45.35 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.977 2.111 . . . . 0.0 110.776 -160.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.31 178.38 38.13 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.391 0.996 . . . . 0.0 113.606 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.76 162.0 42.35 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.664 2.243 . . . . 0.0 111.883 -175.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -60.72 154.37 57.79 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 163.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.66 -42.9 0.71 Allowed 'Cis proline' 0 C--N 1.346 0.432 0 CA-C-N 120.812 1.326 . . . . 0.0 113.693 12.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.2 p -70.88 -30.59 67.0 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.41 10.2 84.5 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.302 -0.721 . . . . 0.0 112.682 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.85 164.01 28.22 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.906 1.353 . . . . 0.0 112.81 -166.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.86 106.89 7.98 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.858 1.663 . . . . 0.0 107.963 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -73.05 148.12 44.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.264 1.826 . . . . 0.0 107.235 167.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 49.7 t -156.16 115.79 3.57 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.399 1.479 . . . . 0.0 108.854 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.94 138.3 33.72 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 123.903 0.881 . . . . 0.0 109.771 -175.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -142.51 126.71 17.51 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.445 1.098 . . . . 0.0 109.416 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 85.2 p -162.7 176.63 10.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 167.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -53.6 -31.43 46.9 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.599 1.559 . . . . 0.0 112.065 163.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.463 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -87.62 47.8 1.55 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.237 1.415 . . . . 0.0 112.058 -175.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 88.1 mt -131.3 61.3 1.64 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.794 1.238 . . . . 0.0 108.31 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -88.56 127.09 35.54 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -68.59 144.87 54.38 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 169.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.3 pt -137.44 168.24 17.37 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 126.304 1.842 . . . . 0.0 108.765 171.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -57.87 174.07 0.71 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.78 1.653 . . . . 0.0 110.806 158.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 11.9 mtp85 -46.8 -33.71 4.67 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.126 1.771 . . . . 0.0 113.778 -172.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -151.8 -65.08 0.18 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.583 1.953 . . . . 0.0 108.156 158.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -151.85 1.97 0.37 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 129.546 3.138 . . . . 0.0 110.668 -171.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.7 pp -55.15 -29.94 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 119.665 1.12 . . . . 0.0 113.862 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 116.824 -2.098 . . . . 0.0 109.457 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.9 ptp . . . . . 0 C--O 1.239 0.531 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -58.51 164.87 2.39 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.27 1.028 . . . . 0.0 109.829 177.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -77.25 21.38 0.25 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 123.192 1.472 . . . . 0.0 114.379 -177.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -142.63 154.53 44.46 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 128.857 2.863 . . . . 0.0 106.724 -170.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 pt -131.38 107.69 14.67 Favored Pre-proline 0 C--N 1.324 -0.5 0 C-N-CA 125.813 1.645 . . . . 0.0 108.393 -165.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.85 103.57 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.415 2.743 . . . . 0.0 109.483 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.6 mt -85.28 97.65 5.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -75.47 95.67 3.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.5 m -67.86 67.71 0.1 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.637 0.775 . . . . 0.0 108.92 159.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.11 -34.95 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.584 -0.697 . . . . 0.0 110.822 -170.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.38 -11.72 17.25 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.685 1.194 . . . . 0.0 114.088 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' A' ' 151' ' ' ASP . 35.9 ttmt -123.32 12.81 9.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.184 1.394 . . . . 0.0 110.66 172.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 30.9 68.21 0.11 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 129.915 3.286 . . . . 0.0 113.157 -164.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 mtp85 -131.5 165.36 23.74 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 172.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.9 t -144.1 98.58 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -92.84 103.47 15.81 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.5 ttt -77.88 89.08 4.08 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.656 0.662 . . . . 0.0 109.665 171.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.06 168.31 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 176.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -92.16 161.66 14.65 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.532 -1.355 . . . . 0.0 108.884 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -60.27 151.78 26.63 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.49 -0.756 . . . . 0.0 110.141 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.523 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 2.9 tp -65.87 130.4 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 172.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -153.95 120.03 5.37 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 129.109 2.964 . . . . 0.0 103.134 165.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.1 mt -143.89 175.29 10.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.542 1.537 . . . . 0.0 109.054 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.8 m -93.68 157.18 16.3 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 161.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.79 -36.24 64.69 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.137 0.975 . . . . 0.0 112.206 -174.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.35 -18.32 63.78 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -178.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -70.2 -43.75 70.09 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.609 1.164 . . . . 0.0 109.748 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -60.19 10.54 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.118 2.567 . . . . 0.0 115.542 -173.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.77 -9.89 3.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 172.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.82 -13.88 5.74 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 118.31 -0.853 . . . . 0.0 113.05 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.3 pt -113.44 -2.67 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.168 0.895 . . . . 0.0 112.45 171.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.23 173.34 7.98 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.074 0.949 . . . . 0.0 111.29 -171.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.47 133.83 70.64 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 162.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.72 -21.1 45.54 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.382 2.055 . . . . 0.0 112.731 -172.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -74.76 -31.29 61.75 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.986 171.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.404 ' HB2' HG12 ' A' ' 68' ' ' ILE . . . -58.18 -41.89 84.87 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 120.063 1.301 . . . . 0.0 110.54 -174.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -57.13 -48.4 78.74 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.071 0.948 . . . . 0.0 111.272 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -69.8 -46.5 65.58 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.665 0.666 . . . . 0.0 110.917 175.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.493 HG13 ' HA2' ' A' ' 47' ' ' GLY 0.261 6.3 t -58.88 -23.64 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 125.593 1.557 . . . . 0.0 111.364 -177.214 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.54 70.76 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 168.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.38 -36.46 13.8 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.906 1.23 . . . . 0.0 111.782 177.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -94.75 6.0 50.23 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.473 0.709 . . . . 0.0 112.876 -174.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.11 19.32 0.19 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.258 2.223 . . . . 0.0 113.857 -172.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.493 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . 112.65 -18.22 22.6 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.397 1.475 . . . . 0.0 114.652 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.6 m -163.99 115.61 1.35 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.708 2.254 . . . . 0.0 109.104 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -55.62 147.83 38.3 Favored Pre-proline 0 N--CA 1.47 0.534 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.806 168.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.2 121.38 8.67 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.207 1.938 . . . . 0.0 109.36 170.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -70.53 158.09 56.97 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.061 1.841 . . . . 0.0 110.499 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -146.62 -59.26 0.29 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.068 0.547 . . . . 0.0 109.756 176.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.6 p -118.09 67.84 0.76 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.007 0.923 . . . . 0.0 110.016 -172.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 155.37 171.97 22.5 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -151.0 157.79 43.32 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.115 1.366 . . . . 0.0 107.584 171.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -147.98 -179.26 6.78 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.796 2.038 . . . . 0.0 107.283 166.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -165.97 165.93 17.72 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.986 1.714 . . . . 0.0 108.397 160.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -126.56 168.49 14.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.294 1.438 . . . . 0.0 108.553 168.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.8 tt -156.08 114.11 3.34 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 170.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.27 168.85 19.44 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.473 1.909 . . . . 0.0 107.733 168.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -126.37 23.03 7.01 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 128.218 2.607 . . . . 0.0 111.242 -177.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -122.21 164.71 17.36 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.99 2.116 . . . . 0.0 110.077 -165.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.94 -175.57 36.85 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.024 1.297 . . . . 0.0 113.099 174.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.6 pt -125.91 160.24 33.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 165.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -72.96 155.54 39.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 122.424 1.107 . . . . 0.0 109.498 171.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -129.89 109.95 11.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 127.491 2.316 . . . . 0.0 106.228 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.1 t -75.76 73.85 2.72 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.193 1.397 . . . . 0.0 107.983 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.454 HD12 ' HD3' ' A' ' 146' ' ' LYS . 7.7 tt -58.57 -16.8 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 127.114 2.166 . . . . 0.0 113.002 -170.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.3 t -74.91 -0.51 18.83 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.432 1.493 . . . . 0.0 112.231 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.8 p -152.41 -13.66 0.17 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 158.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.99 10.99 57.03 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 119.805 1.184 . . . . 0.0 113.34 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -63.14 163.23 10.44 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.601 1.16 . . . . 0.0 108.936 160.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -129.2 153.65 47.53 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 169.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -169.33 -163.23 0.39 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.913 1.685 . . . . 0.0 109.426 -173.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 20.54 91.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 130.675 3.59 . . . . 0.0 114.632 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -57.61 137.27 56.56 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.0 1.32 . . . . 0.0 110.286 173.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.8 m -59.52 -21.34 60.05 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -169.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.92 -20.95 64.34 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.647 1.112 . . . . 0.0 112.448 173.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.6 p -75.72 -12.42 60.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.263 1.025 . . . . 0.0 112.549 172.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -133.67 85.34 2.2 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 125.146 1.379 . . . . 0.0 110.219 -165.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -142.8 45.31 1.59 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.639 -0.663 . . . . 0.0 112.454 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.8 98.04 0.06 Allowed 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.8 m -76.3 113.01 13.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.212 0.605 . . . . 0.0 110.57 -158.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.19 -60.61 0.49 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -175.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.25 -53.92 50.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.383 1.073 . . . . 0.0 111.306 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 37.35 35.43 0.18 Allowed Glycine 0 C--N 1.337 0.635 0 C-N-CA 130.632 3.968 . . . . 0.0 114.395 -167.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.9 158.07 13.74 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.728 0.811 . . . . 0.0 110.506 167.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.35 78.45 1.21 Allowed 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.531 2.821 . . . . 0.0 111.102 177.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.1 p -139.95 157.31 45.89 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.487 165.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -136.26 169.84 17.0 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.104 1.762 . . . . 0.0 108.55 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -122.4 -6.71 8.73 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.336 1.054 . . . . 0.0 112.274 174.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -152.25 -179.45 7.55 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.166 1.386 . . . . 0.0 107.676 173.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 m -119.25 164.9 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.853 1.661 . . . . 0.0 111.027 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 94' ' ' VAL . 2.4 p -61.81 -49.83 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.466 1.106 . . . . 0.0 109.492 160.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.0 m 168.95 159.94 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 130.515 3.526 . . . . 0.0 107.912 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -70.02 81.97 0.49 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.134 1.373 . . . . 0.0 108.812 162.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -128.08 -60.44 1.14 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.611 0.764 . . . . 0.0 110.99 -175.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.23 26.52 10.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.628 1.171 . . . . 0.0 110.599 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.0 tt -132.74 158.15 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.794 1.638 . . . . 0.0 108.677 -171.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.436 ' HE3' ' OE2' ' A' ' 113' ' ' GLU . 2.9 tmtm? -135.18 119.52 17.87 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.327 1.451 . . . . 0.0 108.323 -171.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.5 mp -136.45 137.37 40.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.89 1.276 . . . . 0.0 111.919 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.503 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 1.9 mpt_? -125.48 119.49 28.37 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.104 2.562 . . . . 0.0 108.666 168.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.07 143.71 41.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.945 0.898 . . . . 0.0 110.64 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -145.9 -178.21 5.99 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.953 2.101 . . . . 0.0 106.915 167.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.44 11.73 18.53 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.173 1.789 . . . . 0.0 110.985 177.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.8 t -55.37 -3.96 0.08 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.836 3.255 . . . . 0.0 118.322 -158.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 pp -101.82 -10.37 19.96 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.68 1.127 . . . . 0.0 111.977 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.41 8.8 34.81 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 117.554 -1.692 . . . . 0.0 113.197 -165.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 43.9 tpp -148.92 -85.96 0.09 Allowed 'General case' 0 C--N 1.349 0.581 0 CA-C-N 120.481 2.141 . . . . 0.0 109.641 176.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.7 t -143.43 115.54 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 176.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -128.7 114.02 16.11 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 124.939 1.296 . . . . 0.0 108.571 171.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.577 ' HB3' HG13 ' A' ' 126' ' ' VAL . 22.7 t -121.87 136.17 54.92 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.387 1.075 . . . . 0.0 108.378 -175.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.503 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 25.6 pt-20 -65.37 159.79 23.31 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.735 1.152 . . . . 0.0 111.098 175.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 90.0 t -142.14 111.68 2.63 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 C-N-CA 124.961 1.304 . . . . 0.0 107.835 172.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.97 165.72 17.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.776 1.23 . . . . 0.0 108.273 170.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 35.2 t -69.64 162.65 27.23 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 164.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -86.54 -2.92 58.88 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.523 ' HG2' ' H ' ' A' ' 24' ' ' ILE . 28.2 tpt85 -142.64 -52.39 0.39 Allowed 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.322 0.965 . . . . 0.0 112.83 171.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 22.6 p -84.01 65.79 8.87 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 120.181 1.355 . . . . 0.0 108.248 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.61 53.94 0.08 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.598 2.759 . . . . 0.0 112.535 -170.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.43 -178.39 4.6 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.745 1.618 . . . . 0.0 110.802 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -39.38 -60.68 0.89 Allowed 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 128.218 2.607 . . . . 0.0 112.587 -173.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 48.53 -118.31 1.02 Allowed 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.807 1.643 . . . . 0.0 107.559 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.54 -110.11 0.29 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-N 118.124 0.42 . . . . 0.0 112.189 168.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.33 176.99 8.61 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.575 -0.368 . . . . 0.0 111.806 -165.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.62 HG21 ' HE2' ' A' ' 136' ' ' LYS . 3.1 p -127.56 138.58 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 124.826 1.251 . . . . 0.0 109.341 168.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -138.29 161.11 37.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.386 1.074 . . . . 0.0 110.95 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -66.93 112.58 4.39 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.675 1.59 . . . . 0.0 110.527 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -156.1 -28.2 0.1 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -78.12 154.15 40.6 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -173.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.21 -32.88 6.27 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 121.984 1.789 . . . . 0.0 112.15 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 164.07 166.0 0.06 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 131.511 3.925 . . . . 0.0 106.026 -170.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.12 -45.03 0.45 Allowed 'Cis proline' 0 C--N 1.349 0.57 0 CA-C-N 121.245 1.48 . . . . 0.0 112.005 -9.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.0 p -73.59 -22.18 60.12 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.863 1.265 . . . . 0.0 113.215 -172.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.54 -1.67 56.49 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.358 0.98 . . . . 0.0 113.356 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.62 ' HE2' HG21 ' A' ' 126' ' ' VAL . 12.7 ptmt -124.25 158.34 32.73 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 120.811 -1.405 . . . . 0.0 111.522 -162.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -125.98 108.8 11.75 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.824 2.05 . . . . 0.0 107.42 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -80.74 120.79 25.09 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 168.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 42.6 t -133.2 122.57 24.18 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.318 1.447 . . . . 0.0 107.794 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.7 ptp -141.94 161.87 36.88 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.309 1.044 . . . . 0.0 109.675 -176.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.99 132.68 16.87 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 126.816 2.047 . . . . 0.0 106.238 175.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 77.0 p -174.15 176.76 2.45 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.747 1.219 . . . . 0.0 108.604 165.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.478 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -63.95 -14.09 51.12 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.002 0.921 . . . . 0.0 112.972 162.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -75.84 6.71 4.68 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.005 1.275 . . . . 0.0 113.818 -171.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.1 mt -109.31 85.4 2.09 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.471 1.032 . . . . 0.0 110.407 -163.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.454 ' HD3' HD12 ' A' ' 68' ' ' ILE . 16.9 ttpt -112.75 167.13 10.74 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.804 0.842 . . . . 0.0 109.11 171.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -112.86 159.44 19.03 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.352 1.461 . . . . 0.0 108.44 168.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.0 pt -141.15 169.46 11.41 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 126.825 2.05 . . . . 0.0 107.595 163.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -58.26 174.07 0.82 Allowed 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.433 2.088 . . . . 0.0 111.588 160.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -47.02 -25.52 0.83 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.34 2.256 . . . . 0.0 116.744 -164.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.499 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -176.66 -60.03 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.965 1.706 . . . . 0.0 108.258 167.389 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -151.74 19.7 0.7 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.909 2.084 . . . . 0.0 110.266 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.26 -14.07 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 120.639 -1.288 . . . . 0.0 111.669 174.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.913 0 C-N-CA 128.006 2.717 . . . . 0.0 106.444 160.472 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.7 mtm . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -161.03 32.75 0.14 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.095 1.358 . . . . 0.0 110.634 -166.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.461 ' H ' HH21 ' A' ' 23' ' ' ARG . 1.2 p30 -150.8 -165.99 2.42 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.698 1.199 . . . . 0.0 113.275 -157.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.6 mtt85 -120.11 177.32 5.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 130.432 3.493 . . . . 0.0 108.452 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.42 152.06 77.3 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 119.574 1.079 . . . . 0.0 111.68 170.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.35 124.6 5.96 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.256 1.97 . . . . 0.0 109.734 164.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.4 mm -88.6 147.42 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 159.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -146.3 91.95 2.12 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -171.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 m -71.04 86.59 0.73 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 118.899 -1.12 . . . . 0.0 110.09 172.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.53 -34.78 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 124.002 0.921 . . . . 0.0 110.834 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.44 -15.22 2.46 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.826 2.05 . . . . 0.0 113.769 173.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -131.19 7.8 4.65 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.975 2.11 . . . . 0.0 111.084 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 27.6 66.9 0.08 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 128.258 2.623 . . . . 0.0 111.678 -158.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -112.45 162.07 16.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.927 1.691 . . . . 0.0 108.06 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.2 t -143.48 123.16 8.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -139.59 98.79 3.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.534 1.934 . . . . 0.0 107.265 -174.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.5 ttp -68.72 139.0 55.35 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.636 -1.29 . . . . 0.0 109.817 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 t -135.98 135.18 50.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -62.93 167.77 4.48 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 120.946 -1.096 . . . . 0.0 111.208 165.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.461 HH21 ' H ' ' A' ' 6' ' ' ASP . 12.8 mtm105 -78.01 -166.67 0.84 Allowed 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.448 -0.783 . . . . 0.0 113.031 -169.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.1 112.88 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 -178.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -142.43 98.41 3.3 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 -177.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.478 HD11 HD11 ' A' ' 34' ' ' ILE . 54.9 mt -136.19 172.76 12.53 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 126.652 1.981 . . . . 0.0 109.885 178.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.96 166.57 21.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.97 2.108 . . . . 0.0 107.936 160.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -62.99 -54.59 35.97 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.493 -0.754 . . . . 0.0 112.196 -175.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.45 -19.01 65.28 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -171.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -56.57 -40.7 75.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.041 0.936 . . . . 0.0 109.575 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -59.3 6.82 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.412 2.285 . . . . 0.0 116.599 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.06 -8.88 3.03 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 120.756 -1.215 . . . . 0.0 114.184 173.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -117.87 -22.45 7.93 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.423 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.478 HD11 HD11 ' A' ' 26' ' ' LEU . 1.1 pt -105.32 -9.5 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.456 1.025 . . . . 0.0 112.338 169.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.55 175.28 6.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.685 0.794 . . . . 0.0 111.135 -170.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.32 140.77 94.53 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 164.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.3 -12.25 27.41 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.337 2.691 . . . . 0.0 112.523 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -81.95 -38.97 24.39 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 126.76 2.024 . . . . 0.0 110.059 167.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.26 -44.5 96.4 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 119.776 1.171 . . . . 0.0 110.323 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -46.55 -57.23 4.94 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.202 1.401 . . . . 0.0 110.703 174.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 20.0 ptp180 -73.63 -49.52 25.61 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 118.084 -0.96 . . . . 0.0 108.784 -174.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.8 t -53.04 -32.85 18.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 119.08 0.854 . . . . 0.0 110.064 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.61 -28.4 68.49 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.81 -23.98 19.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.438 1.017 . . . . 0.0 112.128 175.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HE3' ' HB2' ' A' ' 41' ' ' ARG . 19.0 ptpt -111.26 -1.7 15.99 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -168.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 40.35 43.55 1.48 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.068 1.347 . . . . 0.0 111.002 -167.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.8 -26.27 23.83 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 125.781 1.658 . . . . 0.0 114.858 167.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.7 m -157.85 121.36 4.03 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 120.999 2.399 . . . . 0.0 110.204 176.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' CD ' ' HE2' ' A' ' 45' ' ' LYS . 18.3 mt-10 -57.03 -62.69 4.69 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.25 1.42 . . . . 0.0 112.13 172.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.43 166.65 29.17 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 121.687 1.591 . . . . 0.0 110.531 166.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -65.38 154.22 74.64 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.453 1.435 . . . . 0.0 110.031 168.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -72.95 168.16 19.56 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.495 0.664 . . . . 0.0 109.996 171.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.3 m -165.01 -51.74 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.529 1.532 . . . . 0.0 106.964 171.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.2 172.83 43.8 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 164.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -141.1 177.09 8.31 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.137 1.775 . . . . 0.0 108.654 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -66.6 153.2 43.68 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.399 0.619 . . . . 0.0 110.486 167.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -85.51 158.56 20.13 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.209 1.403 . . . . 0.0 109.122 164.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.12 135.86 56.37 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.929 1.692 . . . . 0.0 108.745 168.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.83 -171.69 2.79 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.719 1.208 . . . . 0.0 109.72 -166.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -72.47 66.92 0.71 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 160.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -77.67 59.63 2.03 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.952 1.701 . . . . 0.0 109.977 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -126.94 117.13 21.91 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.614 1.966 . . . . 0.0 107.616 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 161.32 -167.43 36.21 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -164.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.544 HG22 ' HA ' ' A' ' 76' ' ' ASP . 22.2 pt -130.76 162.55 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.317 1.047 . . . . 0.0 110.25 174.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -79.91 155.25 27.83 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.726 0.811 . . . . 0.0 111.243 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 43.8 ttt180 -139.93 152.81 46.67 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.534 1.134 . . . . 0.0 110.197 176.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.9 t -103.3 93.01 4.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.478 1.511 . . . . 0.0 107.817 169.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.504 HG22 ' HA ' ' A' ' 144' ' ' ALA . 4.0 tt -61.09 -33.91 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 125.426 1.49 . . . . 0.0 111.733 -175.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.0 t -75.77 5.95 5.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.595 1.158 . . . . 0.0 111.613 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.1 p -140.96 15.48 2.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.795 0.838 . . . . 0.0 110.811 158.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.65 11.29 35.05 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.009 1.766 . . . . 0.0 115.271 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.0 m -118.85 137.91 53.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.745 1.773 . . . . 0.0 110.849 -159.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 8.9 p-10 -79.62 164.17 24.01 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.516 1.527 . . . . 0.0 113.481 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.268 0.2 OUTLIER -161.28 -101.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.983 0.913 . . . . 0.0 112.402 174.46 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -61.89 129.32 40.4 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -158.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.544 ' HA ' HG22 ' A' ' 64' ' ' ILE . 9.9 t0 -74.07 134.19 42.93 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 170.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.7 m -62.51 -18.12 61.24 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.153 0.981 . . . . 0.0 113.439 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -30.68 66.25 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.012 1.278 . . . . 0.0 111.635 172.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.7 p -69.53 -17.13 63.55 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.229 1.012 . . . . 0.0 112.694 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 87' ' ' TRP . 16.7 tttt -102.17 -163.73 1.03 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.701 1.6 . . . . 0.0 109.723 -164.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.47 21.66 4.34 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.566 0.951 . . . . 0.0 113.566 -175.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -53.87 118.31 3.87 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.756 1.222 . . . . 0.0 109.015 164.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 m 111.0 -23.5 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 131.621 3.968 . . . . 0.0 110.585 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -99.16 -52.01 1.29 Allowed Glycine 0 C--N 1.34 0.786 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 176.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.4 t -155.43 -6.72 0.13 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 168.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.99 17.69 52.29 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 119.794 1.179 . . . . 0.0 115.351 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.407 ' O ' ' HE2' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -63.15 150.49 88.68 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 118.022 0.911 . . . . 0.0 110.864 176.193 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -77.89 51.01 3.45 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.747 2.964 . . . . 0.0 111.489 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.4 p -129.74 146.39 51.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.676 0.791 . . . . 0.0 109.785 168.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.72 166.05 25.79 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.004 1.722 . . . . 0.0 108.568 -170.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -116.63 -9.27 11.36 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -172.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -149.65 -174.03 4.57 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 168.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 m -130.79 165.48 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 124.511 1.124 . . . . 0.0 111.475 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.3 p -52.7 -44.95 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.452 1.501 . . . . 0.0 110.877 168.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.4 m 157.14 158.33 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 130.258 3.423 . . . . 0.0 108.76 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -72.8 72.78 1.09 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 164.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -121.41 -56.19 1.9 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.379 1.072 . . . . 0.0 109.191 -174.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -118.01 13.41 13.91 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.363 1.865 . . . . 0.0 110.644 170.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.31 142.3 44.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 O-C-N 119.962 -1.711 . . . . 0.0 107.236 171.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -122.53 145.97 47.84 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.085 1.754 . . . . 0.0 107.963 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mp -128.12 157.37 40.94 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 125.092 1.357 . . . . 0.0 111.771 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.49 133.53 27.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 127.934 2.493 . . . . 0.0 106.094 167.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.461 ' CD ' HH21 ' A' ' 105' ' ' ARG . 6.8 tm-20 -76.94 144.49 38.8 Favored 'General case' 0 N--CA 1.459 0.021 0 C-N-CA 123.245 0.618 . . . . 0.0 110.878 177.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -150.9 177.73 9.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.044 2.138 . . . . 0.0 105.409 158.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.461 HH21 ' CD ' ' A' ' 103' ' ' GLU . 1.1 ptp180 -120.36 27.98 8.28 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.667 1.987 . . . . 0.0 111.072 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.03 21.3 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.961 2.905 . . . . 0.0 116.372 -168.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.64 0.57 3.29 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.539 1.136 . . . . 0.0 112.435 166.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.35 -0.13 55.79 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 117.696 -1.613 . . . . 0.0 112.842 -170.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -139.11 -88.97 0.21 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 119.854 1.827 . . . . 0.0 108.495 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 64.5 t -145.2 107.2 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -176.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -113.56 88.62 2.88 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.892 1.277 . . . . 0.0 108.757 167.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 53.5 m -86.06 133.32 33.9 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.05 159.58 30.55 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.311 0.96 . . . . 0.0 111.285 174.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.7 t -141.65 102.79 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 126.385 1.874 . . . . 0.0 107.163 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -133.09 159.66 39.45 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.551 0.614 . . . . 0.0 111.248 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 43.1 t -79.27 115.32 18.85 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.532 0.733 . . . . 0.0 111.021 -173.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.51 -24.83 65.61 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.671 1.188 . . . . 0.0 113.463 -171.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -59.2 -26.97 65.29 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.73 1.15 . . . . 0.0 112.749 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 2.8 p -137.71 -94.73 0.2 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -174.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 176.42 16.45 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.99 2.516 . . . . 0.0 112.238 -174.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.83 148.36 44.55 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -158.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -41.18 -65.65 0.41 Allowed 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 128.985 2.914 . . . . 0.0 113.99 -159.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 52.66 -108.1 0.38 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.868 1.667 . . . . 0.0 108.916 176.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.06 -115.51 0.5 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.145 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -160.21 177.15 10.95 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 122.762 -0.257 . . . . 0.0 110.792 -168.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.683 HG21 ' HE2' ' A' ' 136' ' ' LYS . 5.0 p -125.68 137.35 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.265 1.426 . . . . 0.0 108.888 173.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -132.25 159.11 40.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.098 0.959 . . . . 0.0 112.133 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -72.78 84.36 1.2 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.917 2.487 . . . . 0.0 110.942 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -160.04 7.22 0.09 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.355 1.062 . . . . 0.0 112.818 -172.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -97.71 170.36 25.28 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 119.872 -1.768 . . . . 0.0 112.755 -173.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.04 165.09 33.71 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.631 2.221 . . . . 0.0 110.146 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -62.45 151.92 81.57 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 162.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.05 -44.74 0.51 Allowed 'Cis proline' 0 C--N 1.347 0.452 0 CA-C-N 119.992 1.033 . . . . 0.0 113.806 8.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 26.9 p -72.8 -25.72 61.25 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -165.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.58 3.5 62.9 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.094 0.854 . . . . 0.0 113.552 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.683 ' HE2' HG21 ' A' ' 126' ' ' VAL . 9.7 ptmt -128.97 156.76 43.26 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.327 1.563 . . . . 0.0 111.877 -165.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.7 ttm105 -125.11 101.13 6.88 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.675 1.99 . . . . 0.0 107.399 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -67.26 135.48 53.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 162.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 20.9 t -143.81 141.34 30.33 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.704 1.138 . . . . 0.0 108.609 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -141.09 158.61 43.68 Favored 'General case' 0 C--O 1.231 0.079 0 C-N-CA 123.09 0.556 . . . . 0.0 111.494 -173.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -151.17 125.56 9.45 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.95 1.7 . . . . 0.0 108.093 161.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.8 t -149.5 148.97 30.03 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 158.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.24 -19.93 63.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.571 166.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.504 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -65.78 -12.26 52.62 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.755 1.222 . . . . 0.0 113.436 172.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 89.5 mt -75.45 106.09 6.82 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.946 1.248 . . . . 0.0 109.992 -176.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -109.82 167.62 10.02 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.31 1.444 . . . . 0.0 107.923 170.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -124.39 147.12 48.45 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 23.6 pt -138.77 166.66 23.53 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.287 1.435 . . . . 0.0 107.85 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -54.82 170.24 0.67 Allowed 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.497 2.132 . . . . 0.0 111.652 167.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -52.92 -27.15 17.4 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -171.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -165.05 -83.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 158.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -123.55 12.25 9.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.489 1.116 . . . . 0.0 110.597 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 154' ' ' GLY . 2.2 pp -65.12 -24.57 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -169.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.43 ' N ' HD12 ' A' ' 153' ' ' ILE . . . . . . . . 0 C--O 1.247 0.935 0 CA-C-O 116.939 -2.034 . . . . 0.0 109.597 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -142.52 153.46 43.63 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.033 1.333 . . . . 0.0 109.057 174.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.03 25.99 0.21 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 128.48 2.712 . . . . 0.0 112.344 -177.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.5 mtt180 -142.26 157.87 44.35 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 127.588 2.355 . . . . 0.0 109.3 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.0 pt -116.14 113.45 41.51 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 126.882 2.073 . . . . 0.0 106.829 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.66 101.0 1.11 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.03 1.82 . . . . 0.0 107.652 168.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.18 147.01 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 170.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -141.75 160.98 39.07 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.302 1.841 . . . . 0.0 107.228 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.5 t -136.63 113.64 10.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 160.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.8 p -56.91 -45.34 83.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 119.148 0.885 . . . . 0.0 110.046 170.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.37 -31.02 61.43 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.36 1.864 . . . . 0.0 113.057 -174.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -118.75 0.41 11.44 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.059 1.344 . . . . 0.0 112.181 -175.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 41.43 41.12 1.46 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.648 1.579 . . . . 0.0 112.41 -159.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -74.46 150.92 39.7 Favored 'General case' 0 C--N 1.345 0.39 0 O-C-N 121.15 -0.969 . . . . 0.0 109.138 174.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.2 t -142.37 137.84 29.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 159.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -155.49 110.15 2.93 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.052 1.741 . . . . 0.0 109.61 173.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.2 ttt -79.79 129.34 34.4 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 120.34 -1.475 . . . . 0.0 110.192 174.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.0 t -122.8 155.24 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -79.58 162.55 25.26 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.401 -0.812 . . . . 0.0 110.61 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -75.28 160.6 30.16 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.582 -0.699 . . . . 0.0 110.688 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.6 tt -90.92 67.97 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 122.745 1.259 . . . . 0.0 112.133 -161.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -101.38 47.22 0.91 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.393 -169.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.5 mt -78.61 172.72 13.29 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.785 1.278 . . . . 0.0 110.984 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.23 153.57 28.45 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 127.205 2.202 . . . . 0.0 107.011 161.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -59.37 -39.05 82.06 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.216 1.371 . . . . 0.0 111.877 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.61 -22.73 62.24 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -174.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.79 -38.84 83.88 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.481 1.112 . . . . 0.0 109.563 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.6 m95 -62.85 8.3 0.06 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.731 2.412 . . . . 0.0 115.994 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.22 -2.05 3.98 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -129.7 -19.73 3.3 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.456 -0.783 . . . . 0.0 112.617 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 pt -107.31 1.78 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 119.033 0.833 . . . . 0.0 111.645 167.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -108.55 167.19 10.23 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.17 0.988 . . . . 0.0 110.894 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.39 140.04 79.77 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 166.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.17 -18.16 55.74 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.018 1.812 . . . . 0.0 111.49 168.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -70.37 -44.14 68.7 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 118.83 -0.605 . . . . 0.0 109.713 170.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.48 -43.82 93.18 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.18 0.9 . . . . 0.0 110.049 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -59.81 -45.22 93.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.84 0.856 . . . . 0.0 112.007 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -70.19 -48.38 57.44 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 119.095 0.862 . . . . 0.0 108.788 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.1 t -53.92 -32.58 22.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 124.871 1.269 . . . . 0.0 110.065 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.67 -26.35 67.97 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 175.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.5 ptt-85 -88.8 -27.62 20.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.752 1.16 . . . . 0.0 111.912 174.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -110.93 2.64 18.24 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -168.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.04 36.29 1.93 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.479 1.511 . . . . 0.0 111.621 -171.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.27 -31.87 8.17 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-O 117.967 -1.463 . . . . 0.0 113.411 174.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.7 t -153.4 118.27 5.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 119.443 1.621 . . . . 0.0 111.192 -175.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -55.31 -57.55 19.77 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.641 1.176 . . . . 0.0 112.023 167.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.39 138.88 36.8 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 CA-C-N 121.399 1.535 . . . . 0.0 108.981 169.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.32 -14.38 22.89 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.74 2.293 . . . . 0.0 112.956 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -65.65 123.74 20.51 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.228 1.011 . . . . 0.0 109.08 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.1 t -145.75 -176.57 5.18 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.866 1.266 . . . . 0.0 108.779 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.82 77.37 1.37 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 -167.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.19 171.92 13.86 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.164 1.385 . . . . 0.0 108.123 -177.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -137.64 167.01 22.53 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.205 2.202 . . . . 0.0 106.424 170.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -134.05 17.04 3.81 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.978 0.894 . . . . 0.0 110.655 174.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -145.46 151.93 38.98 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 128.79 2.836 . . . . 0.0 107.631 -158.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.9 tp -154.14 20.86 0.5 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.588 0.755 . . . . 0.0 111.094 -174.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -147.16 145.11 29.42 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.64 35.65 0.15 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 128.214 2.606 . . . . 0.0 112.356 -170.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -137.96 176.57 8.58 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.718 0.807 . . . . 0.0 111.807 -173.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.19 178.31 38.59 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -159.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.509 HG22 ' HA ' ' A' ' 76' ' ' ASP . 37.6 pt -136.82 160.63 36.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.427 0.691 . . . . 0.0 109.555 173.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.71 158.28 28.36 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.132 0.967 . . . . 0.0 110.693 178.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 5.2 ttt180 -143.51 134.18 25.08 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.481 1.512 . . . . 0.0 110.057 -170.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.7 t -87.03 92.71 9.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 174.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.7 tt -62.01 -25.61 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 O-C-N 122.265 -0.272 . . . . 0.0 110.994 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 57.8 m -70.12 -0.35 7.59 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.267 1.827 . . . . 0.0 113.589 176.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 25.0 p -139.56 15.2 2.54 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.918 0.887 . . . . 0.0 110.606 158.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.11 9.43 5.77 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 118.031 -1.427 . . . . 0.0 114.201 -177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.1 m -110.29 141.57 43.1 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.308 1.554 . . . . 0.0 108.851 -164.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 7.8 p-10 -65.82 163.84 15.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.51 1.124 . . . . 0.0 113.679 176.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.309 0.2 OUTLIER -154.29 -110.01 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.604 165.214 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -52.83 115.65 1.93 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.319 1.448 . . . . 0.0 112.617 -162.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.509 ' HA ' HG22 ' A' ' 64' ' ' ILE . 13.2 t70 -65.96 151.16 47.41 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 170.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.37 -16.67 64.26 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 176.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -63.61 -13.4 41.73 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.787 1.631 . . . . 0.0 111.828 163.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.449 ' HA ' ' CD2' ' A' ' 90' ' ' PHE . 67.5 p -119.58 12.4 12.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.813 2.445 . . . . 0.0 111.703 172.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -156.16 91.97 1.31 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.021 0.929 . . . . 0.0 110.396 178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -141.68 147.69 37.88 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.988 1.715 . . . . 0.0 106.456 166.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -149.96 136.93 19.47 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 166.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.2 p -55.47 98.39 0.02 OUTLIER 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.805 2.042 . . . . 0.0 112.96 -158.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.9 11.95 26.75 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.832 1.206 . . . . 0.0 113.7 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.3 m -136.02 -34.45 0.8 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.218 1.007 . . . . 0.0 110.507 -159.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.7 25.82 59.25 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.428 -1.206 . . . . 0.0 114.659 172.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -59.5 140.65 88.6 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 119.223 1.511 . . . . 0.0 109.677 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -78.82 67.8 8.38 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.154 2.569 . . . . 0.0 113.301 -167.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.2 p -145.61 145.48 30.98 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.485 162.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CD2' ' HA ' ' A' ' 79' ' ' THR . 4.7 t80 -141.94 -156.56 0.69 Allowed 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.464 0.706 . . . . 0.0 110.195 171.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -133.14 4.33 3.75 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.036 0.835 . . . . 0.0 112.184 -172.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.569 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 1.1 t0 -151.38 -176.95 5.79 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.22 158.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.8 m -134.26 164.1 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 126.594 1.958 . . . . 0.0 109.23 173.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -73.1 -17.71 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -167.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.3 m 160.43 171.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 131.121 3.768 . . . . 0.0 108.253 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -91.65 100.67 13.35 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 158.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.5 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 10.6 p80 -141.84 -60.83 0.46 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.334 0.654 . . . . 0.0 109.92 -171.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.5 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 63.1 t30 -114.37 10.72 17.12 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.468 2.307 . . . . 0.0 110.005 171.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.57 150.22 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 127.5 2.32 . . . . 0.0 107.497 -177.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HD3' ' H ' ' A' ' 101' ' ' LEU . 14.4 tppt? -142.16 147.54 36.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.18 1.792 . . . . 0.0 110.517 -174.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.461 ' H ' ' HD3' ' A' ' 100' ' ' LYS . 1.8 mp -127.17 150.67 49.41 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 127.839 2.456 . . . . 0.0 111.78 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.568 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 1.3 mpt_? -131.4 152.89 50.24 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 129.927 3.291 . . . . 0.0 104.46 162.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -125.69 135.94 52.66 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 119.015 0.825 . . . . 0.0 111.008 -168.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.434 ' CG ' ' H ' ' A' ' 105' ' ' ARG . 33.4 t0 -144.82 -176.43 5.07 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.228 2.211 . . . . 0.0 108.863 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.434 ' H ' ' CG ' ' A' ' 104' ' ' ASP . 17.5 ptt-85 -112.73 15.87 19.79 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 128.734 2.814 . . . . 0.0 111.894 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.31 -33.28 41.65 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -158.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.1 pp -78.22 -10.36 59.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.045 0.839 . . . . 0.0 112.966 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.3 -1.44 26.66 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.431 -1.761 . . . . 0.0 112.885 -169.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.7 mmt -143.41 -88.05 0.13 Allowed 'General case' 0 C--N 1.347 0.463 0 CA-C-N 120.026 1.913 . . . . 0.0 108.215 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.2 t -138.55 112.09 7.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 CA-C-N 120.25 1.386 . . . . 0.0 107.604 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.5 ttt85 -121.95 117.45 26.46 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.525 0.73 . . . . 0.0 109.723 168.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.94 141.92 47.92 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.568 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 10.0 pt-20 -72.36 159.62 33.71 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.32 0.964 . . . . 0.0 109.981 176.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.9 t -138.6 103.51 2.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 170.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.7 mp -124.69 175.37 7.26 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 11.5 t -64.9 166.66 8.79 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.463 0.649 . . . . 0.0 110.136 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -100.42 -4.99 27.84 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.29 1.036 . . . . 0.0 110.808 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 34.7 tpt85 -131.85 -71.03 0.56 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 116.978 -1.487 . . . . 0.0 111.603 159.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.2 p -75.22 94.54 2.99 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 119.95 1.25 . . . . 0.0 109.148 -168.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -37.86 30.08 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.286 1 C-N-CA 133.965 4.906 . . . . 0.0 118.945 174.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.1 175.39 2.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.186 2.195 . . . . 0.0 111.895 174.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -71.14 -57.89 4.08 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 126.104 1.761 . . . . 0.0 111.171 -163.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.55 -112.06 0.64 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.014 1.726 . . . . 0.0 107.372 177.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.7 -104.88 0.2 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 119.051 0.841 . . . . 0.0 112.339 165.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -161.85 -177.26 5.72 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.751 0.31 . . . . 0.0 111.452 -163.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.15 140.71 43.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 126.575 1.95 . . . . 0.0 107.349 169.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -139.29 153.61 47.8 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.715 0.806 . . . . 0.0 110.768 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -64.12 119.74 10.76 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.694 0.679 . . . . 0.0 109.298 167.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -154.28 -28.74 0.12 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.253 1.021 . . . . 0.0 113.204 -177.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -95.97 -179.78 35.72 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.821 1.201 . . . . 0.0 111.428 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.64 -87.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.141 2.56 . . . . 0.0 112.085 -175.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.73 163.1 1.64 Allowed Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 127.277 2.231 . . . . 0.0 107.4 -176.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.11 -39.94 1.12 Allowed 'Cis proline' 0 C--N 1.35 0.627 0 CA-C-N 120.241 1.122 . . . . 0.0 109.817 -13.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.3 p -73.66 79.83 1.52 Allowed 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.611 1.565 . . . . 0.0 108.945 165.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -109.93 -3.05 30.15 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 126.832 2.158 . . . . 0.0 110.659 170.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 138.88 39.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 164.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -117.37 109.8 17.26 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.291 1.836 . . . . 0.0 108.303 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.569 ' CE1' ' HA ' ' A' ' 92' ' ' ASP . 50.2 m-85 -78.23 129.6 35.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 23.2 t -140.0 120.38 13.99 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.915 1.686 . . . . 0.0 108.771 -170.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 20.5 ptp -133.74 155.16 50.26 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.558 0.743 . . . . 0.0 109.854 -170.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -152.14 93.66 1.85 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.958 2.103 . . . . 0.0 107.003 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.7 p -143.3 152.94 42.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.09 -35.66 81.0 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.66 0.743 . . . . 0.0 109.421 165.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.4 75.87 0.26 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.874 1.67 . . . . 0.0 110.416 165.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 96.1 mt -144.83 46.97 1.35 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.009 2.524 . . . . 0.0 108.655 164.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -72.31 157.24 38.05 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -97.14 145.86 25.61 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.64 0.776 . . . . 0.0 109.711 164.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.497 ' HB ' ' HD2' ' A' ' 149' ' ' PRO . 0.1 OUTLIER -134.65 174.96 4.03 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 160.704 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 148' ' ' ILE . 57.0 Cg_endo -64.46 172.29 6.85 Favored 'Trans proline' 0 C--N 1.352 0.734 0 CA-C-N 121.504 1.573 . . . . 0.0 112.061 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -38.84 -44.26 1.02 Allowed 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 127.433 2.293 . . . . 0.0 114.012 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -144.34 -78.32 0.21 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.606 1.962 . . . . 0.0 107.945 172.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -144.55 2.62 1.1 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 128.692 2.797 . . . . 0.0 111.195 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.4 pp -55.3 -24.48 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -174.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 116.901 -2.055 . . . . 0.0 110.702 176.107 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 60.3 mtt . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -88.78 124.41 34.12 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 170.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 52.8 p30 -145.0 -157.73 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.264 1.426 . . . . 0.0 110.927 -159.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -133.04 159.35 40.32 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 127.511 2.324 . . . . 0.0 107.272 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.4 pt -123.13 108.89 31.89 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.013 1.725 . . . . 0.0 107.406 -169.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.22 104.26 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.932 2.421 . . . . 0.0 109.12 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.9 mm -84.15 154.59 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -134.69 152.25 51.63 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -176.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.2 m -129.08 77.99 1.82 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.11 -38.8 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.34 1.056 . . . . 0.0 111.89 -171.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.18 -14.57 11.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.237 1.415 . . . . 0.0 113.65 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.04 10.57 4.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.984 2.114 . . . . 0.0 110.608 175.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 34.53 40.99 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.776 2.83 . . . . 0.0 113.434 -164.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -83.07 164.17 20.46 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.275 -0.89 . . . . 0.0 108.995 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.5 t -136.32 132.42 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 168.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -135.63 103.6 5.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.534 1.534 . . . . 0.0 107.129 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.5 ttm -71.05 122.02 19.29 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 120.967 -1.083 . . . . 0.0 108.81 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.9 156.32 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 173.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -88.79 164.74 15.09 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.898 -1.126 . . . . 0.0 110.199 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.479 ' HG3' ' HD3' ' A' ' 118' ' ' ARG . 39.4 ttt-85 -65.87 144.25 56.93 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.769 -0.582 . . . . 0.0 110.506 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 tt -83.89 121.81 36.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -156.99 118.0 3.67 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 169.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.2 mt -135.73 177.54 7.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.987 2.515 . . . . 0.0 108.811 -172.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 p -85.62 178.7 7.29 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 164.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -60.1 -38.45 83.0 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.62 0.768 . . . . 0.0 111.083 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -18.46 59.26 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -166.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -71.07 -45.89 62.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.399 1.08 . . . . 0.0 110.154 -169.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -63.79 21.52 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.321 2.648 . . . . 0.0 114.805 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.99 -10.82 2.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 166.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -120.77 -18.05 7.78 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 119.223 0.919 . . . . 0.0 112.824 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 pt -111.08 24.97 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 119.226 0.921 . . . . 0.0 111.27 170.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -124.87 169.47 12.02 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.832 1.253 . . . . 0.0 110.903 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -62.65 144.08 96.24 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 168.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -68.37 -12.04 33.75 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.418 2.079 . . . . 0.0 111.741 168.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -78.84 -41.08 30.96 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 118.476 -0.773 . . . . 0.0 111.065 166.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.72 -39.42 80.78 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 120.231 1.378 . . . . 0.0 111.472 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -61.21 -37.74 84.06 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.799 0.84 . . . . 0.0 113.048 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.0 ptt-85 -78.15 -49.47 13.79 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.599 HG12 ' HB1' ' A' ' 143' ' ' ALA . 3.2 t -60.2 -24.16 29.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 O-C-N 121.396 -0.815 . . . . 0.0 111.488 -173.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.21 -24.26 67.3 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 171.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -105.69 -37.63 6.67 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.392 1.077 . . . . 0.0 111.548 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -90.47 10.68 24.31 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.251 0.932 . . . . 0.0 112.819 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 42.36 50.74 4.67 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.701 1.6 . . . . 0.0 111.564 -177.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.421 ' HA2' HG22 ' A' ' 42' ' ' VAL . . . 80.08 -6.89 58.29 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-O 118.257 -1.302 . . . . 0.0 113.903 173.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 p -140.83 106.3 5.07 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.19 1.495 . . . . 0.0 111.211 -160.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -63.59 -49.84 75.41 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-O 117.594 -1.193 . . . . 0.0 112.974 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.61 155.93 49.59 Favored 'Trans proline' 0 C--N 1.353 0.802 0 CA-C-N 121.258 1.485 . . . . 0.0 111.456 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.75 -1.32 10.99 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.658 2.905 . . . . 0.0 113.848 -178.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.94 160.36 40.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.783 1.633 . . . . 0.0 107.859 176.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.4 p -63.79 113.13 3.21 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.169 0.988 . . . . 0.0 110.022 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.27 173.2 6.78 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 160.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.57 160.95 29.18 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -147.96 166.97 26.1 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.555 1.542 . . . . 0.0 107.293 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.47 146.36 25.86 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.467 1.507 . . . . 0.0 107.465 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -139.83 171.03 14.8 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.326 0.584 . . . . 0.0 112.031 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.5 mt -135.72 2.72 2.93 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.822 2.449 . . . . 0.0 111.161 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -133.47 106.06 7.26 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.153 1.381 . . . . 0.0 108.386 -175.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -70.25 39.83 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.279 2.232 . . . . 0.0 112.836 -177.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -87.78 168.68 12.73 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.76 1.224 . . . . 0.0 111.001 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.31 163.36 30.69 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 126.017 1.77 . . . . 0.0 111.763 168.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.7 pt -133.8 155.85 40.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 165.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -79.23 146.99 32.75 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.659 0.743 . . . . 0.0 109.489 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -110.93 110.92 21.7 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 128.613 2.765 . . . . 0.0 107.067 169.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.65 88.65 0.06 Allowed 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 165.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.6 tt -62.36 -28.13 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.591 0.71 . . . . 0.0 110.461 -170.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.91 -9.15 57.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 128.107 2.563 . . . . 0.0 113.129 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.1 p -139.5 15.29 2.55 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.754 0.821 . . . . 0.0 111.594 166.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.87 37.9 53.45 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 118.912 0.778 . . . . 0.0 112.045 176.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.0 m -132.18 146.39 51.99 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 125.971 1.708 . . . . 0.0 107.27 -171.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.3 173.52 12.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.36 0.982 . . . . 0.0 111.675 176.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -168.2 -118.15 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.689 1.995 . . . . 0.0 110.392 170.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -48.25 132.32 16.21 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.83 1.652 . . . . 0.0 114.306 -159.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -80.73 145.3 31.62 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.725 0.81 . . . . 0.0 110.068 172.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.6 m -54.6 -26.39 32.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 117.572 -1.204 . . . . 0.0 113.719 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -62.63 -21.25 65.52 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.798 1.635 . . . . 0.0 112.361 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.8 p -79.25 -10.64 59.86 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.547 0.739 . . . . 0.0 112.059 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -117.96 -177.97 3.39 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.327 1.451 . . . . 0.0 110.98 -161.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -140.76 25.24 2.17 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -162.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -56.06 -34.92 66.38 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 120.531 -1.356 . . . . 0.0 112.431 173.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.09 77.93 3.63 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 163.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 155.84 -68.02 0.29 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.601 1.096 . . . . 0.0 111.287 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.8 t -153.5 -11.58 0.15 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.455 1.279 . . . . 0.0 114.455 -173.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.06 18.5 57.6 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.781 1.173 . . . . 0.0 115.337 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.86 136.91 96.69 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 118.221 1.01 . . . . 0.0 110.708 -177.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.95 51.34 3.81 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.904 3.069 . . . . 0.0 111.771 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.3 p -138.38 117.64 12.73 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 168.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -104.33 179.77 4.18 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.62 1.968 . . . . 0.0 107.894 -170.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -119.37 -12.96 9.31 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 118.309 -0.853 . . . . 0.0 113.209 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -154.38 -178.49 7.18 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.897 1.226 . . . . 0.0 108.222 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.4 t -133.74 153.8 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.727 1.211 . . . . 0.0 110.061 -165.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -65.81 -56.72 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.154 0.982 . . . . 0.0 109.909 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.0 m 175.63 158.88 0.24 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 127.276 2.231 . . . . 0.0 107.656 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -76.36 85.23 3.12 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 160.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -119.7 -58.18 1.92 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.647 0.779 . . . . 0.0 109.561 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.71 -1.72 24.15 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.262 1.025 . . . . 0.0 111.296 169.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.06 153.86 32.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 126.393 1.877 . . . . 0.0 108.571 -169.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -140.39 134.54 30.99 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.324 1.449 . . . . 0.0 110.273 -167.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 pp -141.96 144.95 33.98 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 124.305 1.003 . . . . 0.0 113.258 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.544 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 1.5 mpt_? -137.24 123.95 21.13 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 129.522 3.129 . . . . 0.0 107.747 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -84.35 148.44 26.63 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.776 1.23 . . . . 0.0 111.206 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -153.99 173.32 16.15 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.21 2.604 . . . . 0.0 107.49 168.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.93 20.19 11.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.599 1.159 . . . . 0.0 112.763 173.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.97 -43.48 63.57 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -158.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pp -73.36 -7.58 52.23 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.84 3.69 45.8 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.485 1.517 . . . . 0.0 112.512 -169.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.0 mtp -142.07 -98.36 0.13 Allowed 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.091 1.445 . . . . 0.0 108.474 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.7 t -139.4 106.35 2.71 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.3 ttt-85 -110.42 113.69 26.54 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 42.7 t -119.77 124.32 45.87 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.544 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 16.8 pt-20 -62.54 162.26 10.68 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.221 0.464 . . . . 0.0 110.812 -174.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.8 t -137.24 106.28 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 169.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.36 168.88 15.62 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 170.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 30.4 t -70.6 138.93 51.25 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.54 -12.93 60.03 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.191 0.996 . . . . 0.0 112.297 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.479 ' HD3' ' HG3' ' A' ' 23' ' ' ARG . 38.4 tpt85 -123.26 -73.79 0.64 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 117.088 -1.434 . . . . 0.0 112.904 167.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 19.9 p -69.71 17.58 0.05 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 -158.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 68.09 -19.69 0.14 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.911 2.484 . . . . 0.0 116.087 162.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.06 165.33 18.24 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -161.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -37.12 -62.65 0.48 Allowed 'General case' 0 C--N 1.342 0.28 0 C-N-CA 129.247 3.019 . . . . 0.0 113.846 -169.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mt 46.43 -109.12 0.21 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.225 2.21 . . . . 0.0 110.604 -172.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.78 -126.47 1.03 Allowed Glycine 0 CA--C 1.521 0.456 0 CA-C-N 119.144 0.884 . . . . 0.0 113.913 175.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -167.08 168.39 13.71 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.967 0.907 . . . . 0.0 110.415 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.647 HG21 ' HE2' ' A' ' 136' ' ' LYS . 4.0 p -105.5 142.87 17.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 123.78 0.832 . . . . 0.0 110.152 170.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -140.72 166.32 25.07 Favored 'General case' 0 C--N 1.344 0.328 0 O-C-N 124.006 0.816 . . . . 0.0 111.569 172.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.24 67.94 1.43 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.056 1.742 . . . . 0.0 112.19 -172.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -142.7 25.38 1.82 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.439 1.096 . . . . 0.0 111.52 -174.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -103.2 167.43 16.91 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.971 -1.081 . . . . 0.0 111.637 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.7 167.81 25.6 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.509 2.139 . . . . 0.0 110.564 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 52.3 ptt85 -58.23 147.36 67.08 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 160.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.21 -54.28 0.15 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.525 0 CA-C-N 120.557 1.235 . . . . 0.0 113.764 7.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.1 t -79.21 -13.46 59.68 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -161.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.65 -1.36 45.42 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 119.963 1.256 . . . . 0.0 114.424 169.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.647 ' HE2' HG21 ' A' ' 126' ' ' VAL . 15.6 ptmt -119.44 156.11 30.79 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.084 1.442 . . . . 0.0 111.434 -169.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -128.03 98.91 5.29 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 126.089 1.755 . . . . 0.0 110.128 -169.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -75.58 92.96 2.97 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.685 2.394 . . . . 0.0 109.367 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 31.3 t -92.57 140.24 29.75 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.021 0.928 . . . . 0.0 109.963 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 9.1 ttp -144.37 146.92 32.81 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.981 0.912 . . . . 0.0 109.204 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -143.13 119.12 10.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.458 1.903 . . . . 0.0 107.756 174.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 80.3 p -172.86 -175.14 1.2 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.524 1.13 . . . . 0.0 107.963 165.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.599 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -57.77 -21.25 40.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.615 1.566 . . . . 0.0 114.0 163.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.27 25.76 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.09 2.156 . . . . 0.0 115.751 -164.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 95.5 mt -124.63 41.58 3.47 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.157 0.89 . . . . 0.0 112.258 -160.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -78.67 145.34 34.64 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 170.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -95.31 159.16 15.14 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.777 0.717 . . . . 0.0 109.546 167.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 14.2 pt -138.53 170.98 8.99 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 125.077 1.351 . . . . 0.0 107.663 158.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -46.47 167.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.524 3.482 . . . . 0.0 113.702 162.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -15.66 -49.01 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 129.284 3.034 . . . . 0.0 116.023 163.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -170.08 -156.63 0.14 Allowed 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 131.326 3.85 . . . . 0.0 101.255 -161.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -88.05 16.02 6.6 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 129.331 3.053 . . . . 0.0 110.133 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.2 pp -76.03 -10.69 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.121 1.768 . . . . 0.0 114.171 -162.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 CA-C-O 116.964 -2.02 . . . . 0.0 111.066 177.886 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.414 ' C ' ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 121.474 0.654 . . . . 0.0 111.326 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -69.56 43.53 0.05 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.808 1.643 . . . . 0.0 110.334 163.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 4' ' ' MET . 3.2 p30 -80.24 -169.79 2.23 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 127.322 2.249 . . . . 0.0 110.085 -178.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -138.33 154.13 48.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.825 2.45 . . . . 0.0 106.649 -169.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 pt -108.91 114.97 57.87 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 125.66 1.584 . . . . 0.0 111.041 -175.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.91 126.13 12.25 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.238 1.959 . . . . 0.0 109.287 164.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.9 mt -110.21 93.58 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -88.76 112.21 22.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.0 m -83.41 75.56 9.98 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 166.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.4 m -57.58 -30.14 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -170.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.21 -17.9 22.29 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.104 1.362 . . . . 0.0 113.059 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.27 15.76 5.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.811 1.644 . . . . 0.0 111.201 166.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 36.67 44.47 0.33 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.604 2.762 . . . . 0.0 112.638 -166.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.5 mtm105 -84.09 156.67 22.06 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 168.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.0 t -143.64 122.03 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -177.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -130.39 114.72 15.93 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.515 1.126 . . . . 0.0 108.064 171.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.5 ttm -81.96 135.19 35.4 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 121.173 -0.954 . . . . 0.0 109.197 172.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.3 t -135.46 159.17 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 126.024 1.73 . . . . 0.0 106.611 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -69.53 166.13 19.54 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.743 -1.223 . . . . 0.0 113.559 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.95 170.62 12.33 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 163.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.55 138.52 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -168.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -156.96 92.14 1.25 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 174.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.5 mt -126.57 -178.17 4.27 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 127.487 2.315 . . . . 0.0 108.436 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.8 p -87.45 -92.64 0.1 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.232 1.013 . . . . 0.0 109.95 176.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -150.41 -62.02 0.2 Allowed 'General case' 0 C--O 1.231 0.117 0 C-N-CA 126.564 1.946 . . . . 0.0 107.947 174.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -58.53 -21.89 53.7 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -175.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -53.2 -46.12 68.9 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.789 0.836 . . . . 0.0 110.658 173.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -68.2 40.91 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.338 2.255 . . . . 0.0 112.935 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.27 -44.42 0.13 Allowed 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 125.623 1.569 . . . . 0.0 109.351 159.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.4 -24.0 34.63 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 117.94 -1.029 . . . . 0.0 112.549 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.1 pt -105.65 21.99 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 119.936 1.244 . . . . 0.0 112.443 172.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.9 mt -108.22 166.01 11.07 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-O 122.036 0.922 . . . . 0.0 113.272 -177.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -56.15 151.01 28.18 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.942 1.297 . . . . 0.0 109.111 163.227 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.9 22.18 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.121 1 C-N-CA 125.331 4.021 . . . . 0.0 111.981 168.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.473 ' H ' ' C ' ' A' ' 36' ' ' ASP . 7.2 tt0 -133.32 -48.72 0.84 Allowed 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 126.867 2.067 . . . . 0.0 109.317 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.21 75.24 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 120.31 1.413 . . . . 0.0 111.9 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -56.18 -46.06 79.52 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 175.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -80.83 -51.06 9.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -175.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.627 HG13 ' HA2' ' A' ' 47' ' ' GLY 0.269 2.1 t -59.52 -23.92 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.413 1.085 . . . . 0.0 110.374 -178.102 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.47 -25.51 68.03 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 170.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -100.68 -34.79 9.72 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.035 1.288 . . . . 0.0 111.566 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -89.0 5.79 42.63 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.892 0.877 . . . . 0.0 112.092 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.42 51.29 16.65 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.852 1.661 . . . . 0.0 110.568 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.627 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . 69.75 -1.54 15.32 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-O 118.778 -1.012 . . . . 0.0 114.513 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.1 m -119.5 86.96 2.65 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 118.467 1.133 . . . . 0.0 108.606 -159.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -78.13 155.61 79.68 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.899 -173.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.81 154.35 73.29 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 121.989 1.793 . . . . 0.0 110.802 174.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.31 151.7 48.88 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.648 2.232 . . . . 0.0 111.879 -174.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -144.66 171.94 13.69 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.89 2.076 . . . . 0.0 107.26 170.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.3 t -77.16 172.83 12.61 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 164.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.55 85.37 0.79 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -173.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.09 169.5 17.5 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.285 1.034 . . . . 0.0 109.815 -177.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -131.31 178.46 6.69 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.805 1.642 . . . . 0.0 109.327 -175.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -136.12 -68.36 0.5 Allowed 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -81.36 160.22 24.17 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.254 1.822 . . . . 0.0 109.185 158.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.2 tp -149.52 -176.75 5.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.889 1.676 . . . . 0.0 108.603 170.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -67.83 120.53 14.3 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.293 -0.879 . . . . 0.0 108.742 165.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -71.09 110.41 5.75 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 163.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -159.71 178.71 9.54 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.098 1.759 . . . . 0.0 106.83 -173.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.39 -172.78 52.63 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 125.463 1.506 . . . . 0.0 111.96 162.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.517 HG22 ' HA ' ' A' ' 76' ' ' ASP . 36.4 pt -138.28 166.47 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 158.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -78.48 149.16 33.24 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.259 -0.901 . . . . 0.0 110.237 173.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.17 120.26 24.26 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.636 1.974 . . . . 0.0 107.002 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.0 t -73.76 86.6 1.7 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.832 1.653 . . . . 0.0 106.924 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 tt -66.35 -30.6 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.032 0.933 . . . . 0.0 111.099 -161.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.3 m -73.61 4.88 4.4 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.863 2.065 . . . . 0.0 112.462 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.553 ' HB3' ' HE ' ' A' ' 118' ' ' ARG . 30.7 p -148.47 16.54 1.02 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.878 1.271 . . . . 0.0 112.048 163.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.32 9.55 24.1 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.218 0.913 . . . . 0.0 115.172 176.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.2 m -108.53 122.54 47.28 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.928 1.364 . . . . 0.0 110.13 -159.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -64.94 151.85 44.74 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.486 0.715 . . . . 0.0 111.852 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.01 -101.43 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.863 0.865 . . . . 0.0 111.632 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -62.9 130.25 43.99 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.947 0.794 . . . . 0.0 111.15 -163.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.517 ' HA ' HG22 ' A' ' 64' ' ' ILE . 11.7 t70 -76.73 145.09 38.87 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.1 m -54.57 -27.59 39.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.152 -0.927 . . . . 0.0 112.549 176.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.99 -19.9 65.5 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.353 1.433 . . . . 0.0 112.96 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.4 p -79.95 -12.52 59.72 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.83 0.852 . . . . 0.0 112.046 174.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.446 ' HG2' ' H ' ' A' ' 81' ' ' PHE . 9.4 tttt -123.06 -171.36 2.28 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.408 1.883 . . . . 0.0 109.054 -166.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.446 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 74.0 m-85 -145.21 -179.79 6.87 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.668 1.987 . . . . 0.0 109.548 -177.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -155.94 -71.35 0.11 Allowed 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 127.499 2.319 . . . . 0.0 107.854 -168.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.63 53.33 2.65 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.863 0.839 . . . . 0.0 111.598 -159.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.99 -78.82 0.2 Allowed Glycine 0 CA--C 1.524 0.602 0 C-N-CA 127.083 2.277 . . . . 0.0 107.869 -173.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.2 m -77.07 53.66 0.98 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.389 1.076 . . . . 0.0 110.003 173.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.82 52.75 3.95 Favored Glycine 0 N--CA 1.45 -0.42 0 O-C-N 120.201 -1.562 . . . . 0.0 110.913 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.9 p-90 -135.11 164.67 42.28 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.673 1.189 . . . . 0.0 109.453 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.37 76.31 3.16 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.883 2.389 . . . . 0.0 112.191 -173.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.3 p -135.95 154.97 50.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.021 1.728 . . . . 0.0 109.399 167.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -143.75 168.71 19.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.22 1.408 . . . . 0.0 108.268 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -115.08 -13.83 11.83 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.001 -0.999 . . . . 0.0 113.14 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -158.16 176.65 12.22 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.39 1.45 . . . . 0.0 107.992 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.9 t -121.18 149.39 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 118.523 0.601 . . . . 0.0 111.46 -158.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -51.93 -58.72 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.114 1.766 . . . . 0.0 110.268 168.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.4 m 169.39 156.45 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 130.832 3.653 . . . . 0.0 105.205 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -79.33 79.87 5.74 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.826 1.194 . . . . 0.0 108.599 173.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -125.63 -53.65 1.56 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 122.994 0.518 . . . . 0.0 110.414 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -115.01 14.37 17.13 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.746 1.218 . . . . 0.0 112.347 171.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.1 tt -119.2 153.54 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 170.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.27 128.11 48.67 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 125.973 1.709 . . . . 0.0 106.899 168.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.68 146.94 51.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.921 1.289 . . . . 0.0 110.758 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.63 152.14 47.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 128.446 2.699 . . . . 0.0 105.064 174.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -131.79 130.39 41.76 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.807 0.843 . . . . 0.0 109.556 -169.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -137.06 -178.49 5.22 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.07 2.548 . . . . 0.0 107.355 -175.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -103.39 9.53 37.79 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.345 1.458 . . . . 0.0 111.045 174.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.4 t -59.81 14.46 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 129.669 3.188 . . . . 0.0 119.079 -161.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 pp -118.87 -9.61 10.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.501 1.52 . . . . 0.0 111.809 168.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 122.11 -23.36 7.32 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.94 2.21 . . . . 0.0 112.091 -166.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 28.0 ttm -136.25 -74.39 0.44 Allowed 'General case' 0 C--N 1.348 0.519 0 CA-C-N 119.541 1.67 . . . . 0.0 112.352 -168.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.9 p -155.24 100.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -111.71 128.78 56.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.616 ' SG ' HG13 ' A' ' 126' ' ' VAL . 0.0 OUTLIER -128.78 144.59 51.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -178.495 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -79.05 156.57 28.31 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 63.3 t -134.87 109.03 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 171.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.72 161.34 29.95 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.2 t -70.96 150.58 45.54 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.21 -52.14 44.76 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 172.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.553 ' HE ' ' HB3' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -65.12 -57.51 8.41 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 124.965 1.306 . . . . 0.0 112.667 177.634 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.0 p -121.11 77.53 1.32 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.548 1.139 . . . . 0.0 109.742 -158.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.31 20.62 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.005 1 C-N-CA 133.612 4.765 . . . . 0.0 115.572 -174.62 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.92 -58.08 6.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.333 1.853 . . . . 0.0 114.146 -159.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -158.37 -73.66 0.09 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.2 mt 49.62 -105.27 0.16 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.403 1.881 . . . . 0.0 110.462 -170.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.23 -115.55 0.54 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.481 172.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -149.47 177.05 10.06 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.195 0.522 . . . . 0.0 111.745 -167.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.616 HG13 ' SG ' ' A' ' 112' ' ' CYS . 0.5 OUTLIER -132.49 149.63 32.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.998 1.719 . . . . 0.0 109.029 161.263 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -147.0 161.47 40.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.797 1.239 . . . . 0.0 109.961 174.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -67.35 121.4 15.65 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.327 0.651 . . . . 0.0 109.767 171.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -160.91 -31.61 0.05 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -74.29 148.34 38.96 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -173.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.93 -14.35 19.21 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.323 2.015 . . . . 0.0 113.205 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 175.27 168.4 0.36 Allowed Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 131.568 3.947 . . . . 0.0 106.607 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.98 -71.77 0.02 OUTLIER 'Cis proline' 0 C--N 1.35 0.635 0 CA-C-N 121.136 1.441 . . . . 0.0 110.709 -13.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.8 t -70.28 -9.29 55.56 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.196 0.998 . . . . 0.0 113.623 -176.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.14 -14.88 41.95 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.25 1.405 . . . . 0.0 113.704 172.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -97.58 152.26 19.22 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 120.942 -1.328 . . . . 0.0 110.493 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -126.14 109.65 12.6 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 127.474 2.309 . . . . 0.0 106.335 -171.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -85.03 141.76 30.07 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.479 1.512 . . . . 0.0 107.737 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 18.5 t -146.29 144.77 30.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.883 0.873 . . . . 0.0 109.774 172.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 16.7 ptm -142.22 152.31 42.96 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.178 0.991 . . . . 0.0 110.351 -171.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -144.25 138.27 27.88 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.848 1.259 . . . . 0.0 108.371 164.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 63.5 p -179.21 175.11 0.98 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.18 1.392 . . . . 0.0 109.549 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -71.65 2.96 4.46 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.456 1.102 . . . . 0.0 113.139 160.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -81.84 -6.16 58.84 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 120.409 1.459 . . . . 0.0 112.837 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.93 113.3 21.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.125 0.97 . . . . 0.0 111.881 -170.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -141.34 156.85 45.79 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 158.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -92.24 162.68 14.2 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 163.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 18.3 pt -135.86 171.11 9.38 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.456 1.903 . . . . 0.0 106.966 159.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.56 171.82 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.392 2.062 . . . . 0.0 111.977 162.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -34.97 -38.23 0.08 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 128.843 2.857 . . . . 0.0 114.857 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -159.28 -102.83 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -115.21 8.75 15.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.534 1.134 . . . . 0.0 111.265 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.3 pp -69.41 -16.46 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -159.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 116.357 -2.357 . . . . 0.0 109.75 -172.925 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.522 ' HD3' ' HA ' ' A' ' 22' ' ' GLU . 3.5 mmt180 . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 pt -115.18 130.97 23.8 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.668 0.787 . . . . 0.0 109.695 -174.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.14 146.39 57.72 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 N-CA-C 108.993 -1.195 . . . . 0.0 108.993 167.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -124.97 105.75 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 166.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -98.31 101.1 12.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.9 m -67.18 74.45 0.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.478 1.111 . . . . 0.0 109.1 165.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.52 -46.89 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 124.853 1.261 . . . . 0.0 110.712 -168.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.24 -16.99 60.42 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.981 -174.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.458 ' HZ1' ' CG ' ' A' ' 76' ' ' ASP . 1.4 mtmp? -99.45 0.47 42.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.101 1.76 . . . . 0.0 110.549 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 39.72 59.44 1.86 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.344 2.658 . . . . 0.0 113.141 -167.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.73 165.83 16.59 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.334 0.654 . . . . 0.0 109.759 171.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -143.38 124.4 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -136.67 112.94 9.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.823 1.649 . . . . 0.0 107.023 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 46.0 ttm -79.5 146.15 32.84 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.775 -1.203 . . . . 0.0 108.855 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.4 t -137.7 157.41 33.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.522 ' HA ' ' HD3' ' A' ' 7' ' ' ARG . 3.3 mp0 -65.8 165.8 12.21 Favored 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 121.22 -0.925 . . . . 0.0 112.084 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.456 ' HG3' HH11 ' A' ' 23' ' ' ARG . 2.4 mmt85 -64.46 174.21 1.8 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.303 -0.873 . . . . 0.0 110.947 165.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.418 ' H ' ' HG3' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -72.85 103.63 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 169.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -134.95 103.94 5.78 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 166.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -136.85 177.47 7.83 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.856 1.663 . . . . 0.0 106.676 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.5 t -111.46 164.85 12.51 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 159.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.03 -27.32 43.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.579 1.552 . . . . 0.0 111.509 -175.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.21 -26.89 65.04 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -71.62 -43.35 66.34 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.33 1.052 . . . . 0.0 109.316 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -61.87 19.61 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.391 2.677 . . . . 0.0 114.932 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.78 1.1 2.5 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 165.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -133.37 -17.28 2.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 118.201 -0.904 . . . . 0.0 113.196 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 pt -110.53 -4.73 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 119.261 0.937 . . . . 0.0 112.491 171.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.511 HD22 ' CB ' ' A' ' 39' ' ' ALA . 2.5 mt -78.87 172.59 13.56 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.626 1.171 . . . . 0.0 110.78 174.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -78.52 155.62 78.66 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.084 0.953 . . . . 0.0 110.997 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -68.51 16.82 0.15 Allowed 'Trans proline' 0 CA--C 1.546 1.092 1 C-N-CA 126.213 4.608 . . . . 0.0 114.039 168.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -128.1 -31.8 2.33 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 127.376 2.271 . . . . 0.0 110.123 167.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.511 ' CB ' HD22 ' A' ' 35' ' ' LEU . . . -67.95 -38.71 83.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.123 0.874 . . . . 0.0 108.793 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -59.09 -45.82 89.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.099 0.408 . . . . 0.0 111.143 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.1 -48.9 31.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 116.718 -1.611 . . . . 0.0 107.922 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.1 t -49.5 -32.28 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 119.868 1.213 . . . . 0.0 110.384 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.46 -25.54 66.1 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 114.05 1.129 . . . . 0.0 114.05 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.78 -27.78 15.61 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.396 0.998 . . . . 0.0 111.865 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -113.35 -0.53 14.49 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -163.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.93 42.12 5.92 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.436 1.094 . . . . 0.0 110.846 -171.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.555 0 C-N-CA 125.479 1.514 . . . . 0.0 111.568 172.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 p30 . . . . . 0 N--CA 1.424 -1.768 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.82 173.73 49.93 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.853 -172.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.656 HG22 ' HA ' ' A' ' 76' ' ' ASP . 40.8 pt -135.79 164.67 31.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.997 1.719 . . . . 0.0 108.696 170.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -72.88 148.09 44.74 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 2.8 tmt_? -141.12 112.71 7.57 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.098 0.959 . . . . 0.0 109.092 175.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.73 95.71 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.403 1.881 . . . . 0.0 109.082 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.2 tt -65.1 -16.22 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.188 0.595 . . . . 0.0 111.117 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.4 m -86.73 1.65 51.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.071 2.148 . . . . 0.0 112.741 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 22.0 p -150.23 -11.05 0.26 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 162.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.8 3.1 62.52 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 118.083 -1.398 . . . . 0.0 114.197 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.3 m -97.61 143.66 28.06 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.591 1.696 . . . . 0.0 111.281 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 11.7 p-10 -97.05 156.1 16.51 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.855 2.062 . . . . 0.0 112.128 177.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.265 0.2 OUTLIER -151.72 -95.79 0.06 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.172 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -60.25 111.07 1.4 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.993 0.917 . . . . 0.0 113.414 -159.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.656 ' HA ' HG22 ' A' ' 64' ' ' ILE . 1.7 m-20 -63.41 115.92 5.06 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.643 1.577 . . . . 0.0 107.749 166.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.6 m -56.12 -10.63 0.88 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 117.915 2.561 . . . . 0.0 117.915 -162.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -62.92 -25.69 68.45 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.686 1.585 . . . . 0.0 111.827 163.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.9 p -88.51 20.85 3.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.966 2.507 . . . . 0.0 111.817 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -118.51 179.55 4.09 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.878 2.071 . . . . 0.0 108.205 166.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -113.61 165.26 12.68 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 158.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -146.88 -65.23 0.28 Allowed 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 119.007 0.821 . . . . 0.0 109.466 171.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -57.29 161.64 3.18 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.832 0.825 . . . . 0.0 110.83 166.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.63 -62.74 3.49 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 119.261 -0.744 . . . . 0.0 111.511 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t -152.35 -10.67 0.18 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 47.13 23.64 1.79 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.872 1.701 . . . . 0.0 116.576 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -63.44 156.62 69.48 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 117.707 0.753 . . . . 0.0 111.811 -168.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -79.62 47.72 2.61 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.637 2.891 . . . . 0.0 110.634 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.01 144.57 31.09 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 126.418 1.887 . . . . 0.0 107.95 -176.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -158.8 177.09 11.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.645 1.178 . . . . 0.0 109.339 -161.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -128.62 0.49 5.52 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -165.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -161.48 -177.38 5.92 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.677 1.191 . . . . 0.0 108.079 166.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.4 m -140.87 165.77 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 118.873 0.76 . . . . 0.0 112.303 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 p -60.97 -54.7 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.405 1.482 . . . . 0.0 110.603 174.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.5 t 175.58 165.57 0.34 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.406 2.682 . . . . 0.0 107.921 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -75.61 79.22 2.6 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 162.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -126.82 -51.05 1.46 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.645 0.778 . . . . 0.0 109.967 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -117.13 1.55 12.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.697 1.599 . . . . 0.0 111.168 171.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.67 149.42 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 126.497 1.919 . . . . 0.0 106.942 174.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 101' ' ' LEU . 4.4 tmtm? -134.3 143.21 47.6 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.247 1.419 . . . . 0.0 108.918 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.46 ' N ' ' HD3' ' A' ' 100' ' ' LYS . 1.9 mp -120.68 152.16 38.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.883 2.073 . . . . 0.0 112.265 170.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.507 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -129.18 126.45 39.25 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 163.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -67.92 143.05 55.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.764 0.826 . . . . 0.0 110.354 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -146.03 173.48 12.13 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 158.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.35 22.13 16.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.442 2.297 . . . . 0.0 110.739 175.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.93 23.27 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.907 2.483 . . . . 0.0 116.843 -165.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 pp -131.13 -5.72 3.88 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.407 -1.433 . . . . 0.0 112.455 162.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.32 1.01 40.99 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 117.387 -1.785 . . . . 0.0 113.089 -167.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 55.4 mtm -140.92 -90.81 0.15 Allowed 'General case' 0 C--N 1.349 0.544 0 CA-C-N 120.383 2.092 . . . . 0.0 108.306 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.2 t -142.87 111.78 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.42 ' HE ' ' CD2' ' A' ' 125' ' ' HIS . 18.9 ttt180 -130.14 88.12 2.61 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.641 1.576 . . . . 0.0 111.047 175.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 7.9 m -89.12 144.09 26.38 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.507 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 22.0 pt-20 -66.52 162.36 20.94 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.218 0.917 . . . . 0.0 110.182 170.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.2 t -136.88 110.11 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 174.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.4 mt -131.29 160.33 35.25 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.52 1.128 . . . . 0.0 109.64 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.8 t -81.66 118.11 22.55 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.26 -6.31 4.36 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.971 1.308 . . . . 0.0 113.876 -175.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.418 ' HG3' ' H ' ' A' ' 24' ' ' ILE . 26.3 ttt-85 -115.13 -9.94 12.24 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.504 1.922 . . . . 0.0 113.645 171.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 22.5 p -164.37 81.58 0.4 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.46 1.482 . . . . 0.0 109.474 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -70.01 56.23 0.14 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.483 1.513 . . . . 0.0 113.039 -174.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -75.17 -49.5 19.26 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.709 1.204 . . . . 0.0 112.952 -166.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -159.71 -67.46 0.08 Allowed 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 122.981 0.512 . . . . 0.0 109.832 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 mt 44.98 -110.66 0.21 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.25 1.82 . . . . 0.0 110.074 -173.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.55 -123.69 0.86 Allowed Glycine 0 CA--C 1.521 0.441 0 CA-C-N 118.751 0.705 . . . . 0.0 112.636 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.42 ' CD2' ' HE ' ' A' ' 111' ' ' ARG . 42.6 p-80 -158.86 174.06 15.57 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.427 -0.455 . . . . 0.0 111.18 -173.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.4 p -122.83 141.37 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.219 1.408 . . . . 0.0 108.014 172.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -134.89 133.19 39.39 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.604 1.162 . . . . 0.0 108.808 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -65.16 107.36 1.54 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.809 0.844 . . . . 0.0 109.67 172.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -162.28 -5.18 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -161.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -110.4 179.28 20.29 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 119.959 -1.713 . . . . 0.0 112.455 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.2 146.69 41.14 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.038 2.492 . . . . 0.0 110.837 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.5 ptt-85 -59.71 153.23 53.48 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.588 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.86 -41.44 0.9 Allowed 'Cis proline' 0 C--N 1.35 0.618 0 CA-C-N 119.816 0.97 . . . . 0.0 111.573 -6.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.53 71.7 4.03 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 125.968 1.707 . . . . 0.0 109.663 176.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -103.95 5.96 47.04 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 112.372 -2.195 . . . . 0.0 111.291 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.75 157.39 27.13 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 116.661 -2.016 . . . . 0.0 107.189 166.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -132.14 94.54 3.48 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -65.72 143.77 57.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 164.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 12.5 t -142.28 135.19 28.52 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.061 1.745 . . . . 0.0 108.001 159.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -133.1 141.92 48.44 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.71 0.804 . . . . 0.0 109.379 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -140.6 87.52 2.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.859 1.264 . . . . 0.0 108.082 -163.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 80.2 p -153.2 177.15 11.15 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.505 0.722 . . . . 0.0 109.586 173.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.61 -8.19 45.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 170.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.06 -25.7 61.58 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.549 1.14 . . . . 0.0 113.141 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 64.2 mt -76.68 44.62 0.37 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.157 2.583 . . . . 0.0 115.35 -158.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -73.43 155.88 38.84 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 166.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -103.65 160.61 14.61 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.67 0.788 . . . . 0.0 109.233 168.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.9 pt -132.73 165.5 36.01 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.222 1.009 . . . . 0.0 108.713 160.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -50.49 150.74 11.14 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.931 2.421 . . . . 0.0 110.507 159.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.594 ' HD3' HG23 ' A' ' 64' ' ' ILE . 12.1 mmt180 -40.43 -44.45 2.01 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 126.444 1.898 . . . . 0.0 112.352 -164.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -145.8 -75.3 0.21 Allowed 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.525 1.13 . . . . 0.0 110.112 167.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -146.05 8.92 1.11 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.285 3.034 . . . . 0.0 109.83 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -59.2 -14.3 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.14 -0.975 . . . . 0.0 113.298 167.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.478 0 C-N-CA 128.16 2.791 . . . . 0.0 107.074 163.336 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.423 ' HB3' ' HA ' ' A' ' 22' ' ' GLU . 12.0 ptt-85 . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.8 pt -111.88 91.88 16.36 Favored Pre-proline 0 N--CA 1.45 -0.461 0 C-N-CA 125.88 1.672 . . . . 0.0 106.759 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 73.6 Cg_endo -64.91 138.06 55.91 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 N-CA-C 107.413 -1.803 . . . . 0.0 107.413 168.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.9 mt -121.25 152.1 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -173.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -147.0 91.58 2.02 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.229 1.412 . . . . 0.0 107.441 -164.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.4 m -66.43 77.17 0.1 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.809 0.731 . . . . 0.0 109.53 165.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -60.68 -36.58 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.658 1.183 . . . . 0.0 111.546 -170.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.52 -11.53 53.15 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.231 1.012 . . . . 0.0 112.233 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -123.31 10.22 9.24 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.362 1.865 . . . . 0.0 110.798 174.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 27.58 52.01 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.572 3.149 . . . . 0.0 113.332 -161.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.95 169.87 17.27 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 118.846 -1.142 . . . . 0.0 111.173 167.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.52 136.72 43.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 158.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -145.01 107.36 4.37 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.46 1.904 . . . . 0.0 108.427 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.431 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 47.8 ttp -82.09 125.41 30.81 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.664 -1.273 . . . . 0.0 111.568 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.4 t -130.89 135.1 60.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 7' ' ' ARG . 7.8 mm-40 -55.81 166.74 0.67 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 166.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.0 mtp-105 -66.23 163.68 17.38 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.413 177.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.446 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 3.2 tt -90.2 122.66 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 169.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -149.33 112.67 4.97 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 167.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.7 mt -136.99 178.4 7.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.052 1.741 . . . . 0.0 108.316 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.31 -177.88 2.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.465 1.906 . . . . 0.0 107.843 159.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.3 -42.88 71.44 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.812 -1.18 . . . . 0.0 109.835 164.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.27 -18.97 30.58 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 128.834 2.853 . . . . 0.0 112.441 -161.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -86.9 -40.71 14.59 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 129.664 3.186 . . . . 0.0 110.378 -168.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -62.25 7.46 0.06 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.269 2.228 . . . . 0.0 114.784 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.85 -4.78 5.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.938 1.695 . . . . 0.0 113.837 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -132.01 -18.86 2.61 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.612 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 pt -109.16 8.97 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.096 0.862 . . . . 0.0 111.356 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -115.84 164.94 13.66 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.97 1.308 . . . . 0.0 110.219 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.421 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -58.22 149.02 60.13 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 122.932 0.493 . . . . 0.0 110.784 176.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -69.19 4.48 1.93 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.466 2.777 . . . . 0.0 112.249 164.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -93.07 -48.84 6.3 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.101 -1.0 . . . . 0.0 111.277 161.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.421 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -56.58 -44.47 81.07 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 120.274 1.397 . . . . 0.0 111.355 -172.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -58.14 -40.09 80.44 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.887 1.275 . . . . 0.0 112.432 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -80.98 -45.96 15.83 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 118.645 0.657 . . . . 0.0 109.646 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.635 HG13 ' HA2' ' A' ' 47' ' ' GLY 0.266 2.0 t -60.28 -24.44 30.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.771 1.228 . . . . 0.0 110.534 -177.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.13 -23.13 66.38 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 169.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -99.94 -40.66 7.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.309 1.413 . . . . 0.0 111.996 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -83.85 5.82 23.79 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.15 0.58 . . . . 0.0 111.791 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.43 49.01 20.54 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.892 1.677 . . . . 0.0 109.882 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.635 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . . . . . . 0 C--N 1.338 0.663 0 CA-C-O 119.217 -0.768 . . . . 0.0 114.485 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.7 t0 . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.45 175.9 50.4 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -158.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.5 pt -141.9 -178.69 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.363 1.065 . . . . 0.0 108.624 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -98.43 162.13 13.32 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 122.307 1.051 . . . . 0.0 110.293 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.84 108.61 9.53 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 17.6 t -68.3 84.54 0.26 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 170.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 39' ' ' ALA . 14.1 tt -65.31 -25.89 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 122.062 -0.399 . . . . 0.0 110.204 -168.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.3 m -66.52 -1.87 4.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.37 2.268 . . . . 0.0 113.808 173.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 19.7 p -143.47 21.34 1.86 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.263 1.025 . . . . 0.0 110.843 158.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.63 12.02 51.06 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.588 1.09 . . . . 0.0 113.98 171.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 m -111.48 150.08 30.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.639 1.976 . . . . 0.0 110.636 -158.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -89.65 156.72 18.38 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.228 1.376 . . . . 0.0 113.082 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.06 -168.8 0.14 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.826 2.45 . . . . 0.0 109.361 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.9 t80 39.31 79.66 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 128.99 2.916 . . . . 0.0 112.607 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.7 148.43 49.26 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.92 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.8 t -71.34 -9.19 57.74 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -166.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -63.88 -39.84 95.14 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.732 1.213 . . . . 0.0 112.253 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.3 t -85.95 -18.16 33.4 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.276 0.631 . . . . 0.0 111.514 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -74.41 178.09 5.48 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.587 0.755 . . . . 0.0 109.815 168.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.32 151.72 51.25 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 105.102 -2.185 . . . . 0.0 105.102 158.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -131.93 -57.05 0.98 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.497 1.119 . . . . 0.0 110.038 -167.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.4 t -88.09 177.93 6.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.441 0.639 . . . . 0.0 109.898 163.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 55.86 -97.42 0.05 OUTLIER Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.6 1.571 . . . . 0.0 110.989 -173.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.2 m -60.24 -55.52 32.69 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.724 1.61 . . . . 0.0 110.667 177.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 43.64 44.3 6.73 Favored Glycine 0 C--N 1.343 0.932 0 C-N-CA 127.591 2.519 . . . . 0.0 113.837 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -118.62 152.61 51.47 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.239 1.415 . . . . 0.0 109.992 -169.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.08 46.88 1.85 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.779 2.986 . . . . 0.0 112.969 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.3 p -124.62 150.43 46.01 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.822 0.849 . . . . 0.0 109.501 166.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -141.43 178.56 7.35 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.034 1.334 . . . . 0.0 109.851 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -135.02 -0.62 2.75 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -172.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -159.96 177.81 10.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.452 1.101 . . . . 0.0 110.583 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.14 153.33 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 120.554 1.524 . . . . 0.0 111.544 -174.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.4 t -59.84 -63.43 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 127.976 2.51 . . . . 0.0 110.828 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.4 t -173.03 159.73 4.03 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.148 2.179 . . . . 0.0 106.326 -173.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -82.5 54.46 2.63 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.008 1.323 . . . . 0.0 108.167 173.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.469 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 15.6 p80 -102.8 -64.48 1.07 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 -159.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.469 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 16.3 t-20 -109.47 5.9 23.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.461 1.904 . . . . 0.0 112.33 173.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.1 tt -125.15 152.83 31.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 126.0 1.72 . . . . 0.0 107.22 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.471 ' HD3' ' H ' ' A' ' 101' ' ' LEU . 2.2 tmtt? -132.6 135.44 45.89 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.172 0.589 . . . . 0.0 109.475 173.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.471 ' H ' ' HD3' ' A' ' 100' ' ' LYS . 3.6 mp -125.15 146.38 49.52 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.623 2.369 . . . . 0.0 111.381 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -143.0 113.04 7.11 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 127.183 2.193 . . . . 0.0 107.468 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.56 158.54 20.11 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 122.538 1.161 . . . . 0.0 111.014 -177.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -164.39 176.99 8.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.127 2.571 . . . . 0.0 109.803 -172.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.271 0.0 OUTLIER -109.27 39.02 2.16 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.465 -1.397 . . . . 0.0 111.865 170.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.7 m -73.04 18.62 0.1 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 pp -130.66 0.91 4.42 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.172 -0.955 . . . . 0.0 111.542 158.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.67 1.94 60.08 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 117.747 -1.585 . . . . 0.0 113.665 -170.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.1 mmt -136.99 -95.68 0.22 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.366 1.583 . . . . 0.0 108.626 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.0 t -137.23 113.45 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 18.8 ttt180 -120.71 151.17 39.87 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 165.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.685 ' HB3' HG13 ' A' ' 126' ' ' VAL . 8.6 t -157.37 123.17 4.7 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -171.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -64.77 154.21 37.58 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.349 0.522 . . . . 0.0 110.522 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 78.5 t -134.39 107.91 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mp -129.44 172.45 11.52 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 171.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 42.4 t -66.56 148.35 52.01 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.05 -33.39 73.23 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 119.138 -0.458 . . . . 0.0 110.703 171.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.446 ' HG2' ' H ' ' A' ' 24' ' ' ILE . 10.4 tpt85 -106.23 -83.51 0.52 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 117.336 -1.316 . . . . 0.0 114.016 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 20.6 p -64.49 27.74 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 119.595 3.183 . . . . 0.0 119.595 -157.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 64.28 -19.59 0.07 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 158.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.65 164.32 23.64 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -159.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -38.09 -58.5 0.95 Allowed 'General case' 0 C--N 1.346 0.415 0 C-N-CA 128.42 2.688 . . . . 0.0 113.291 -174.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 45.01 -108.84 0.15 Allowed 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.752 2.021 . . . . 0.0 109.065 -173.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.69 -124.68 0.9 Allowed Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.792 170.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.21 166.24 30.0 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 122.953 0.501 . . . . 0.0 110.932 -175.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.685 HG13 ' HB3' ' A' ' 112' ' ' CYS . 2.3 p -115.38 143.28 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 126.176 1.79 . . . . 0.0 109.457 173.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -144.77 159.28 43.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.819 0.848 . . . . 0.0 110.906 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -67.86 76.07 0.21 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.109 2.164 . . . . 0.0 111.588 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -157.3 20.72 0.3 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.323 1.449 . . . . 0.0 111.601 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.74 171.44 17.13 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 120.414 -1.429 . . . . 0.0 113.278 -173.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.03 152.77 68.03 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.754 2.303 . . . . 0.0 110.15 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -63.32 151.95 86.06 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 162.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.8 -41.27 1.02 Allowed 'Cis proline' 0 C--N 1.347 0.465 0 CA-C-N 120.626 1.259 . . . . 0.0 113.848 11.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.2 p -67.97 -30.11 69.32 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -169.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.18 -1.89 39.0 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.649 1.118 . . . . 0.0 113.576 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -120.26 147.81 44.5 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.552 1.176 . . . . 0.0 110.011 -168.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -123.4 110.38 15.06 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 126.923 2.089 . . . . 0.0 107.753 -169.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -86.01 137.95 32.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.659 1.984 . . . . 0.0 107.026 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 17.1 t -140.11 138.64 35.44 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 168.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -145.64 153.01 40.56 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.326 0.65 . . . . 0.0 110.558 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -149.47 127.43 11.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.734 1.614 . . . . 0.0 108.827 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 97.2 p -166.79 175.17 7.99 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.799 0.84 . . . . 0.0 109.219 166.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.424 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -59.06 -13.89 8.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.872 0.869 . . . . 0.0 112.824 164.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.28 -12.01 60.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.484 1.038 . . . . 0.0 112.693 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 53.5 mt -84.53 81.93 8.63 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.902 1.228 . . . . 0.0 112.144 -170.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -92.42 126.73 37.63 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 162.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -75.72 146.73 39.89 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 162.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.7 pt -144.9 165.38 22.63 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 118.817 0.735 . . . . 0.0 110.868 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -60.21 174.87 1.24 Allowed 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.041 2.494 . . . . 0.0 111.675 159.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -55.02 -25.75 32.5 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -164.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -166.14 -61.71 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 128.192 2.597 . . . . 0.0 110.757 159.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -153.2 -0.41 0.24 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 130.669 3.587 . . . . 0.0 109.672 -163.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -62.08 -18.53 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.021 0.928 . . . . 0.0 112.003 169.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.404 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 158.968 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.3 pt -138.67 145.13 44.87 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.412 0.685 . . . . 0.0 111.865 -158.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.56 117.33 3.68 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.274 2.649 . . . . 0.0 110.236 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.1 mm -79.56 101.15 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 163.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -108.96 109.54 20.62 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 t -82.88 96.21 8.19 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.72 -34.67 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 120.749 1.613 . . . . 0.0 109.118 173.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.81 -20.99 0.55 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 171.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -131.25 3.06 4.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.861 1.664 . . . . 0.0 112.184 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 t30 37.26 64.1 0.65 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.892 1.677 . . . . 0.0 111.224 -158.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.8 mtp-105 -107.38 157.99 17.52 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 168.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.12 137.32 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 158.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -134.27 156.52 48.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 159.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 33.6 ttm -112.95 131.9 55.56 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 68.9 t -136.08 155.68 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.726 1.611 . . . . 0.0 106.82 -170.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -68.53 154.44 41.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.63 -1.294 . . . . 0.0 111.288 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.429 ' HA ' ' HD3' ' A' ' 118' ' ' ARG . 0.8 OUTLIER -66.86 147.63 52.99 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 162.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.481 ' H ' ' HD2' ' A' ' 118' ' ' ARG . 8.1 tt -60.68 122.12 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.278 0.631 . . . . 0.0 109.484 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -148.19 108.1 4.03 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 104.235 -2.505 . . . . 0.0 104.235 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.4 mt -135.69 177.9 7.47 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.944 1.298 . . . . 0.0 109.361 -173.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 90.2 p -83.45 176.01 9.39 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 159.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -62.2 -48.59 79.33 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.731 -0.606 . . . . 0.0 110.804 176.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.36 -20.71 65.61 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -169.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -58.84 -42.16 88.65 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.804 0.842 . . . . 0.0 111.229 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -61.69 10.99 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.887 2.475 . . . . 0.0 115.852 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.54 -10.22 3.19 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.736 1.215 . . . . 0.0 113.858 171.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -119.99 -17.5 8.41 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.845 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 pt -112.04 4.88 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 119.342 0.974 . . . . 0.0 112.337 168.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -110.57 163.69 13.47 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.457 1.103 . . . . 0.0 110.826 -176.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.92 136.09 79.62 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 163.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.44 -17.08 53.13 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.081 1.854 . . . . 0.0 111.431 173.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -72.58 -41.33 65.79 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 118.53 -0.748 . . . . 0.0 110.114 170.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.32 -45.64 93.59 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 119.7 1.136 . . . . 0.0 110.091 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -55.92 -47.38 77.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.764 0.825 . . . . 0.0 111.588 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -73.26 -47.89 39.37 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 117.643 -1.17 . . . . 0.0 108.051 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.427 HG13 ' HA2' ' A' ' 47' ' ' GLY . 37.0 t -55.43 -29.6 24.31 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 124.516 1.126 . . . . 0.0 110.297 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.09 -22.57 66.95 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.47 -33.18 16.07 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.363 1.438 . . . . 0.0 111.304 175.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -102.02 -1.06 32.56 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 124.429 1.092 . . . . 0.0 112.34 -167.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 41.18 39.97 1.04 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.559 1.544 . . . . 0.0 111.15 -168.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.427 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . . . . . . 0 C--N 1.335 0.499 0 CA-C-O 117.568 -1.685 . . . . 0.0 115.054 173.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 t70 . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.1 -177.43 33.15 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -164.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.566 HG22 ' HA ' ' A' ' 76' ' ' ASP . 48.1 pt -133.91 155.29 39.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 121.578 0.704 . . . . 0.0 109.403 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -78.86 146.22 33.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 3.8 tmt_? -138.24 109.45 6.86 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.243 1.017 . . . . 0.0 108.45 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.19 101.34 0.4 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.504 1.522 . . . . 0.0 108.194 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 144' ' ' ALA . 4.8 tt -63.14 -28.4 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.626 0.77 . . . . 0.0 110.715 -170.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.0 m -83.45 11.87 6.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.478 1.911 . . . . 0.0 112.255 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.4 p -143.39 -7.11 0.79 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.577 0.751 . . . . 0.0 111.859 158.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.31 1.85 83.54 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.369 1.461 . . . . 0.0 113.131 177.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.0 m -119.82 147.57 44.5 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.228 1.514 . . . . 0.0 112.582 -159.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 10.1 p-10 -91.33 155.89 18.18 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.757 1.623 . . . . 0.0 113.221 -173.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.255 0.2 OUTLIER -162.34 -109.63 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.037 1.735 . . . . 0.0 110.013 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -51.62 120.3 5.04 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.338 1.055 . . . . 0.0 112.587 -159.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.566 ' HA ' HG22 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -72.31 139.63 48.09 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.135 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -20.62 65.82 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.99 -13.2 59.45 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.321 -1.487 . . . . 0.0 113.057 170.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.4 p -84.38 -19.39 33.64 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.991 -1.068 . . . . 0.0 112.564 166.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.28 86.78 2.25 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.707 1.603 . . . . 0.0 107.378 -166.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -135.0 133.52 39.53 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -142.07 114.17 8.15 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 168.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.6 p -70.78 71.93 0.53 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.024 1.729 . . . . 0.0 111.348 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.31 -44.55 1.08 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.098 1.333 . . . . 0.0 111.461 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.29 -46.6 17.42 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.181 0.99 . . . . 0.0 109.551 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 53.83 15.88 5.23 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.662 2.077 . . . . 0.0 115.882 -170.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -50.5 144.64 11.95 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 125.406 1.483 . . . . 0.0 112.782 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.98 65.02 6.06 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.375 3.384 . . . . 0.0 111.827 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.1 p -129.53 142.28 50.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.906 0.883 . . . . 0.0 109.041 164.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.4 167.53 21.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.973 1.709 . . . . 0.0 108.589 -168.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -122.42 -8.69 8.59 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.435 0.694 . . . . 0.0 112.679 -169.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -156.36 179.99 8.72 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.3 m -131.31 162.61 39.0 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-N 119.579 1.081 . . . . 0.0 112.305 -171.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.2 p -55.84 -38.41 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.211 1.405 . . . . 0.0 111.037 166.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.4 m 141.78 154.03 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 1 C-N-CA 132.194 4.198 . . . . 0.0 108.555 -173.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 53.3 mp0 -71.24 59.79 0.27 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.992 1.717 . . . . 0.0 109.914 166.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -105.46 -47.88 3.82 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.763 1.225 . . . . 0.0 108.526 -175.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.96 12.52 7.81 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 125.095 1.358 . . . . 0.0 112.28 170.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.89 145.82 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 125.369 1.468 . . . . 0.0 107.677 169.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -120.07 144.82 47.38 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.174 1.79 . . . . 0.0 108.329 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mp -131.74 157.21 44.4 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.89 1.276 . . . . 0.0 110.484 167.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.44 ' HE ' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -135.27 142.92 46.01 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 130.868 3.667 . . . . 0.0 102.817 164.42 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -126.76 130.76 50.94 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.936 1.294 . . . . 0.0 109.216 -165.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -144.55 -170.98 3.51 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.528 2.331 . . . . 0.0 108.419 -172.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -115.85 6.92 14.39 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.582 2.353 . . . . 0.0 112.119 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -65.98 31.64 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 130.154 3.382 . . . . 0.0 116.968 -163.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 pp -133.08 -7.13 3.05 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.509 1.524 . . . . 0.0 112.278 160.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.44 1.64 35.2 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 117.441 -1.755 . . . . 0.0 113.029 -168.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.3 mtt -141.94 -89.18 0.15 Allowed 'General case' 0 C--N 1.348 0.513 0 CA-C-N 120.322 2.061 . . . . 0.0 109.024 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.3 p -150.41 109.76 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -117.76 124.27 48.03 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.487 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.83 144.61 50.58 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.44 ' CD ' ' HE ' ' A' ' 102' ' ' ARG . 10.3 pt-20 -75.75 157.22 33.8 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 173.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.1 t -136.57 110.73 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -135.82 150.61 49.49 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 51.9 t -72.66 108.13 5.51 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.62 -30.13 67.03 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.225 1.41 . . . . 0.0 112.029 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.481 ' HD2' ' H ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -66.02 -21.07 66.37 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 118.805 -0.617 . . . . 0.0 112.422 176.025 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 5.6 p -121.44 -100.76 0.42 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 165.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.2 p30 156.02 30.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 128.489 2.716 . . . . 0.0 110.606 -165.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.9 166.11 10.95 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.253 1.021 . . . . 0.0 111.844 -167.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -30.35 -78.3 0.02 OUTLIER 'General case' 0 C--N 1.339 0.138 0 C-N-CA 129.585 3.154 . . . . 0.0 116.016 -159.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.2 mt 43.55 -111.55 0.2 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.588 1.555 . . . . 0.0 111.807 -170.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.37 -109.36 0.3 Allowed Glycine 0 C--N 1.336 0.532 0 CA-C-N 119.623 1.101 . . . . 0.0 113.333 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -147.01 179.83 7.33 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 112.147 -166.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.422 HG21 ' HE2' ' A' ' 136' ' ' LYS . 2.1 p -130.97 144.83 36.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.715 1.606 . . . . 0.0 108.289 159.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -136.0 161.67 35.02 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.446 1.098 . . . . 0.0 110.394 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.11 117.78 14.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.903 0.881 . . . . 0.0 109.538 172.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.57 -28.87 0.11 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.05 155.52 40.65 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.12 -13.98 21.0 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.52 2.147 . . . . 0.0 113.295 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.2 ptt-85 134.57 167.28 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.918 1 C-N-CA 133.97 4.908 . . . . 0.0 106.293 -163.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.94 -58.29 0.12 OUTLIER 'Cis proline' 0 C--N 1.351 0.681 0 CA-C-N 122.314 1.862 . . . . 0.0 111.875 -3.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.4 p -69.69 -25.07 63.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.474 1.51 . . . . 0.0 112.862 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.39 -6.64 28.99 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.961 1.267 . . . . 0.0 113.343 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.422 ' HE2' HG21 ' A' ' 126' ' ' VAL . 13.7 ptmt -115.69 152.52 33.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 120.914 -1.345 . . . . 0.0 110.017 -169.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -122.96 106.07 10.53 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.92 2.088 . . . . 0.0 107.452 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -70.15 133.93 47.61 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 162.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 23.3 t -140.71 129.45 22.97 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 174.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -129.83 147.24 51.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.28 0.632 . . . . 0.0 110.063 -175.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -139.34 99.96 3.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.4 p -138.9 166.88 23.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 162.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.27 -13.51 60.78 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.183 170.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.672 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -81.59 0.04 40.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 114.792 1.405 . . . . 0.0 114.792 -165.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 72.4 mt -79.5 54.23 1.71 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.715 1.606 . . . . 0.0 112.116 -164.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -70.59 145.1 50.95 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -85.38 156.31 20.92 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 166.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 30.6 pt -136.91 162.96 52.82 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 158.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.49 168.45 6.61 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.559 1.506 . . . . 0.0 111.238 164.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -31.66 -36.65 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 130.583 3.553 . . . . 0.0 118.21 -169.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -176.14 -57.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.564 1.946 . . . . 0.0 107.5 169.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -157.31 66.48 0.5 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -176.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -121.74 -2.55 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.686 1.194 . . . . 0.0 111.071 161.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 0 C-N-CA 129.369 3.366 . . . . 0.0 105.699 159.685 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 7.0 mmm180 . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.2 pt -126.48 109.24 23.37 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 127.08 2.152 . . . . 0.0 109.383 -174.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.55 101.41 1.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.567 2.178 . . . . 0.0 108.52 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.1 mt -76.78 151.68 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -137.93 101.73 4.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.727 1.611 . . . . 0.0 106.859 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.0 m -68.35 73.74 0.23 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.177 0.899 . . . . 0.0 108.818 159.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.32 -30.8 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 121.772 -0.58 . . . . 0.0 110.438 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.4 -27.88 1.86 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.441 2.296 . . . . 0.0 113.64 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -130.73 15.62 5.34 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.081 2.153 . . . . 0.0 110.819 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 32.59 52.24 0.28 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.805 2.842 . . . . 0.0 113.604 -165.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -86.82 167.44 14.38 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.917 -0.49 . . . . 0.0 109.771 165.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.4 t -143.28 132.81 21.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -145.65 102.19 3.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.988 1.315 . . . . 0.0 108.713 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.3 ttt -82.86 118.99 23.82 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.436 -0.79 . . . . 0.0 111.019 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.2 t -113.78 -177.77 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 128.535 2.734 . . . . 0.0 106.524 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 4.1 pm0 -112.94 160.86 17.65 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.842 1.655 . . . . 0.0 112.103 177.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -56.74 154.86 8.43 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.9 1.28 . . . . 0.0 110.996 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -72.9 124.1 29.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -176.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -148.12 115.7 6.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 163.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.432 HD11 HD11 ' A' ' 34' ' ' ILE . 38.3 mt -138.36 -177.81 5.01 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 128.669 2.788 . . . . 0.0 105.984 170.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.9 m -167.17 -24.39 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.431 ' C ' ' H ' ' A' ' 30' ' ' GLU . 4.4 t70 -91.73 -152.5 0.3 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.119 0.872 . . . . 0.0 109.462 -176.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.91 5.19 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.454 1.902 . . . . 0.0 114.101 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' A' ' 28' ' ' ASP . 36.4 mt-10 -60.43 -45.1 94.85 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 126.633 1.973 . . . . 0.0 110.58 -162.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -68.65 42.41 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.468 2.307 . . . . 0.0 113.104 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.9 -34.05 0.09 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.793 1.637 . . . . 0.0 110.634 160.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -91.08 -24.65 19.95 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.012 -0.994 . . . . 0.0 113.451 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.432 HD11 HD11 ' A' ' 26' ' ' LEU . 1.6 pt -108.43 15.53 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 120.203 1.365 . . . . 0.0 112.464 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.79 175.98 9.12 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.261 1.424 . . . . 0.0 109.837 -167.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.591 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -61.95 135.13 94.51 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 166.352 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -66.31 -12.4 35.47 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.929 1.753 . . . . 0.0 110.886 165.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -76.51 -43.05 41.08 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.367 167.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.591 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -57.38 -47.59 81.28 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 119.541 1.064 . . . . 0.0 109.841 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -48.1 -52.41 20.53 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.669 1.987 . . . . 0.0 111.603 175.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ptt-85 -76.08 -47.98 22.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.383 -0.818 . . . . 0.0 109.206 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.582 HG12 ' HB1' ' A' ' 143' ' ' ALA . 25.0 t -58.21 -27.11 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 124.91 1.284 . . . . 0.0 109.518 -176.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.44 -13.04 36.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 171.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -112.44 -26.06 8.89 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.417 1.462 . . . . 0.0 112.061 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt -112.48 14.5 20.26 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.989 1.716 . . . . 0.0 112.043 -172.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.67 -12.96 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 130.052 3.341 . . . . 0.0 116.408 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.54 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . . . . . . 0 CA--C 1.525 0.684 0 C-N-CA 124.908 1.242 . . . . 0.0 113.956 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 122.254 1.025 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.62 177.51 46.72 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.694 -161.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.434 HG22 ' HA ' ' A' ' 76' ' ' ASP . 46.3 pt -136.96 171.68 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.44 1.496 . . . . 0.0 108.538 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -96.56 136.04 37.63 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.994 0.518 . . . . 0.0 110.571 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 0.0 OUTLIER -102.32 120.09 39.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 163.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 35.1 t -65.79 90.7 0.13 Allowed 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 169.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.8 tt -66.57 -10.05 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.482 0.713 . . . . 0.0 111.735 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.7 t -77.94 -3.01 39.69 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.638 1.175 . . . . 0.0 111.759 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.3 p -154.68 -5.45 0.15 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 173.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.21 62.03 4.45 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -174.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.9 m -154.52 137.98 15.9 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 121.035 -1.274 . . . . 0.0 108.523 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 37.1 m-20 -101.19 157.21 16.95 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.942 0.792 . . . . 0.0 110.333 -167.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.25 0.3 OUTLIER -159.72 -103.16 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.377 1.071 . . . . 0.0 112.657 -179.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -52.65 121.2 6.7 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -158.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.434 ' HA ' HG22 ' A' ' 64' ' ' ILE . 5.5 m-20 -62.07 122.38 15.38 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.628 1.171 . . . . 0.0 108.754 168.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 t -66.61 -15.93 63.81 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -167.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -70.36 -16.8 63.02 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.41 1.084 . . . . 0.0 112.506 173.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.1 p -71.25 -22.64 61.95 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.366 -0.834 . . . . 0.0 111.484 167.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -98.63 -172.57 2.34 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.539 1.536 . . . . 0.0 109.839 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.73 8.14 16.07 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.659 1.183 . . . . 0.0 113.536 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -53.11 134.86 38.42 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 159.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.4 p 111.44 -36.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 1 C-N-CA 132.482 4.313 . . . . 0.0 111.29 -166.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.32 -69.27 0.39 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 -173.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.1 t -118.96 -21.21 7.81 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.722 0.809 . . . . 0.0 111.266 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.08 11.79 13.38 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.69 1.138 . . . . 0.0 114.525 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -62.82 130.84 94.18 Favored Pre-proline 0 C--O 1.237 0.439 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.63 70.03 5.84 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.895 3.063 . . . . 0.0 112.613 -165.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 72.3 p -138.01 154.18 49.34 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.019 1.728 . . . . 0.0 110.055 173.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -145.17 170.21 16.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.645 1.578 . . . . 0.0 109.08 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -128.06 -13.52 5.09 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -175.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -141.42 178.16 7.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 169.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.29 160.89 22.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.918 0.865 . . . . 0.0 111.439 -167.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 p -59.74 -40.15 81.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 125.55 1.54 . . . . 0.0 111.038 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.5 m 156.73 156.65 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.286 1 C-N-CA 131.747 4.019 . . . . 0.0 106.495 -176.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -75.61 48.79 0.47 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.72 2.008 . . . . 0.0 109.794 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.416 ' C ' HD22 ' A' ' 98' ' ' ASN . 8.1 p80 -110.4 -46.93 3.34 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.406 -0.808 . . . . 0.0 109.654 -159.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.416 HD22 ' C ' ' A' ' 97' ' ' HIS . 0.9 OUTLIER -124.56 17.69 8.84 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 124.17 0.988 . . . . 0.0 112.118 170.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.38 135.65 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 174.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.57 ' HD2' ' H ' ' A' ' 101' ' ' LEU . 39.0 tptt -108.56 144.24 36.52 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.306 1.842 . . . . 0.0 108.991 -173.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.57 ' H ' ' HD2' ' A' ' 100' ' ' LYS . 54.9 mt -138.39 128.79 26.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 130.355 3.462 . . . . 0.0 107.468 -167.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.449 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -133.39 114.7 13.99 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 128.716 2.806 . . . . 0.0 104.778 163.254 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -101.73 142.4 33.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 124.283 0.989 . . . . 0.0 110.822 -172.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -148.34 176.68 10.07 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.605 2.362 . . . . 0.0 107.577 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.83 10.24 36.03 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 119.977 -1.702 . . . . 0.0 112.494 172.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.0 t -58.31 16.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 130.157 3.383 . . . . 0.0 119.342 -158.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 pp -128.85 -6.25 5.06 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.694 1.198 . . . . 0.0 112.136 168.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.69 -1.66 32.19 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 117.246 -1.863 . . . . 0.0 113.38 -167.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -141.29 -91.15 0.15 Allowed 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.648 2.224 . . . . 0.0 108.74 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 56.8 t -141.72 114.59 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.435 HH21 ' CE1' ' A' ' 125' ' ' HIS . 22.2 ttt180 -118.86 127.82 53.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.359 1.037 . . . . 0.0 108.512 168.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 23.7 t -127.17 146.25 50.47 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 171.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 16.2 pt-20 -68.64 162.3 26.27 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.995 0.816 . . . . 0.0 110.508 172.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.2 t -142.43 100.52 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 174.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mp -130.82 162.22 30.04 Favored 'General case' 0 N--CA 1.461 0.116 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.45 ' HB3' ' H ' ' A' ' 119' ' ' CYS . 1.6 t -71.82 124.52 25.0 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.21 -9.01 20.02 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.396 0.678 . . . . 0.0 111.76 174.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.98 -25.5 15.36 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.54 1.936 . . . . 0.0 113.011 170.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.45 ' H ' ' HB3' ' A' ' 116' ' ' CYS . 31.2 p -159.71 95.38 1.2 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.6 1.56 . . . . 0.0 109.514 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.9 32.51 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.004 1 C-N-CA 131.79 4.036 . . . . 0.0 113.068 178.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.91 -63.57 1.25 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -158.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.401 ' H ' HD23 ' A' ' 123' ' ' LEU . 50.7 t-80 -158.0 -64.46 0.09 Allowed 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 174.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.401 HD23 ' H ' ' A' ' 122' ' ' HIS . 2.3 mm? 54.02 -106.32 0.3 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.153 2.181 . . . . 0.0 106.464 173.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 176.62 -120.43 0.74 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.228 -0.986 . . . . 0.0 112.685 167.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.435 ' CE1' HH21 ' A' ' 111' ' ' ARG . 22.6 p-80 -159.69 173.68 15.69 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.749 -0.266 . . . . 0.0 110.761 -168.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.4 p -123.61 143.38 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.579 1.552 . . . . 0.0 107.884 171.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -138.79 151.74 47.31 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.273 1.029 . . . . 0.0 109.413 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -65.83 118.5 9.76 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 170.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -142.57 -47.06 0.33 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.068 0.947 . . . . 0.0 113.511 -168.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -104.45 -179.78 24.77 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.096 1.332 . . . . 0.0 114.566 -159.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.22 147.16 83.22 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.108 2.539 . . . . 0.0 110.186 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -77.43 159.34 77.6 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 118.731 -0.652 . . . . 0.0 109.451 -174.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.35 -49.17 0.24 Allowed 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 120.037 1.049 . . . . 0.0 111.521 0.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.3 p -77.74 76.24 4.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 123.043 1.401 . . . . 0.0 109.907 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -110.0 7.53 31.17 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 128.138 2.78 . . . . 0.0 110.249 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -78.2 138.65 38.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.712 1.756 . . . . 0.0 106.754 163.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.21 101.05 10.56 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 173.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -67.74 143.4 55.91 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 161.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 36.3 t -146.6 137.44 24.07 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.139 1.375 . . . . 0.0 108.497 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -138.43 153.99 48.87 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.759 0.824 . . . . 0.0 111.262 -177.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -156.33 114.76 3.36 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.14 2.176 . . . . 0.0 107.334 173.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.0 p -171.87 177.82 3.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.472 1.509 . . . . 0.0 108.995 174.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.582 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -66.31 21.45 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.113 1.765 . . . . 0.0 113.1 165.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -90.91 -15.88 29.09 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.98 1.264 . . . . 0.0 113.286 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.4 mt -83.46 88.49 6.99 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.376 0.535 . . . . 0.0 111.802 -159.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -127.87 114.32 17.05 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.427 1.091 . . . . 0.0 108.915 167.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -68.86 145.47 53.68 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 163.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.2 pt -137.8 163.4 48.42 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 125.329 1.452 . . . . 0.0 109.382 168.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.18 161.13 11.64 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.232 1.954 . . . . 0.0 111.694 166.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -34.13 -24.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 131.543 3.937 . . . . 0.0 120.273 -167.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -167.42 -82.37 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.253 1.821 . . . . 0.0 107.289 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -141.73 9.63 1.98 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.967 2.107 . . . . 0.0 110.191 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.9 pp -69.81 -16.25 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -167.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 116.783 -2.121 . . . . 0.0 112.077 170.897 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 121.413 0.625 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.451 HD13 ' HD3' ' A' ' 118' ' ' ARG . 1.3 pt -122.72 102.57 38.39 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 124.852 1.261 . . . . 0.0 110.447 -173.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.2 99.46 1.01 Allowed 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.375 2.05 . . . . 0.0 109.325 174.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.4 mt -79.85 88.31 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -78.26 97.31 5.5 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -69.55 72.0 0.33 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 160.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.1 t -56.26 -37.98 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 123.677 0.791 . . . . 0.0 111.506 -170.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.09 -12.17 25.07 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -125.54 7.12 7.6 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.248 1.819 . . . . 0.0 111.067 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 31.39 48.31 0.08 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 128.72 2.808 . . . . 0.0 112.81 -161.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -90.18 157.96 17.47 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 168.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.5 t -148.77 92.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 -176.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -100.48 102.96 14.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 32.9 ttm -80.05 87.41 5.44 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.669 173.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 80.8 t -84.47 174.7 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 125.853 1.661 . . . . 0.0 107.001 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -105.74 155.18 19.53 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 120.232 -1.542 . . . . 0.0 110.55 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.54 150.05 41.43 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.24 113.77 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -139.84 105.34 5.09 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 162.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.6 mt -133.12 171.89 13.39 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.492 1.517 . . . . 0.0 109.306 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.6 t -85.32 165.38 17.33 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 158.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.2 -38.8 74.22 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.138 0.881 . . . . 0.0 110.111 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.407 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -59.95 -25.78 65.46 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -170.43 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -67.56 -45.06 76.7 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.818 1.647 . . . . 0.0 109.846 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -61.2 10.93 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.058 2.143 . . . . 0.0 115.864 -174.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.407 ' NE ' ' HA ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -130.75 -5.79 4.07 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 173.013 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -128.7 -18.96 3.79 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.639 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 pt -104.97 4.41 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.88 0.763 . . . . 0.0 111.391 166.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mt -112.36 160.46 17.68 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.85 1.26 . . . . 0.0 110.372 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.4 145.51 75.23 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.65 -4.48 12.21 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.678 2.252 . . . . 0.0 112.33 166.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -77.93 -56.43 4.5 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.725 1.21 . . . . 0.0 109.996 162.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.74 -42.48 71.66 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.571 1.078 . . . . 0.0 111.223 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -58.03 -47.2 83.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.956 1.302 . . . . 0.0 111.613 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -75.69 -38.86 58.32 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 119.458 1.026 . . . . 0.0 110.572 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 t -55.05 -28.61 21.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.943 1.297 . . . . 0.0 111.068 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.88 -20.57 63.88 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 172.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -101.3 -45.11 5.44 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 119.722 1.146 . . . . 0.0 111.807 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -89.93 12.55 17.11 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.591 1.087 . . . . 0.0 112.833 -174.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.37 36.75 1.16 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 128.082 2.553 . . . . 0.0 113.557 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.697 0 CA-C-O 119.883 -0.398 . . . . 0.0 113.688 171.128 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.6 t70 . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 121.803 0.811 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.63 151.83 24.72 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.684 1.611 . . . . 0.0 111.944 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.533 HG22 ' HA ' ' A' ' 76' ' ' ASP . 42.8 pt -132.85 161.94 40.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 125.171 1.388 . . . . 0.0 108.178 169.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -82.67 142.5 31.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.012 0.434 . . . . 0.0 110.144 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 0.0 OUTLIER -114.8 140.33 49.01 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 124.372 1.069 . . . . 0.0 110.2 160.274 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.2 t -70.6 84.49 0.62 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 162.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.9 tp -59.74 -13.37 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.044 1.338 . . . . 0.0 112.218 172.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.7 t -78.47 1.89 20.78 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.635 1.574 . . . . 0.0 111.737 173.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.6 p -159.02 -9.56 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 170.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.35 64.31 2.67 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -173.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.22 135.23 30.51 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.113 2.165 . . . . 0.0 106.238 176.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 5.7 p-10 -100.13 152.34 20.36 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.555 1.525 . . . . 0.0 112.222 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.419 HD23 ' H ' ' A' ' 75' ' ' PHE 0.283 0.0 OUTLIER -154.51 -107.97 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.387 1.075 . . . . 0.0 112.864 178.409 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.489 ' CE1' HG13 ' A' ' 93' ' ' VAL . 73.6 m-85 -50.49 121.69 6.06 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.467 1.907 . . . . 0.0 113.622 -160.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.533 ' HA ' HG22 ' A' ' 64' ' ' ILE . 18.2 t70 -86.95 156.84 19.63 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.139 0.976 . . . . 0.0 111.402 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.1 t -56.8 -17.71 10.17 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -63.55 -26.96 68.94 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.862 1.664 . . . . 0.0 111.43 170.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.1 p -92.05 -47.14 7.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.211 1.405 . . . . 0.0 109.177 174.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.35 112.55 15.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.793 1.237 . . . . 0.0 109.725 -159.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -52.59 145.73 11.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.959 0.904 . . . . 0.0 111.165 173.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -140.93 -69.62 0.38 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.789 1.236 . . . . 0.0 110.287 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.7 m -73.16 120.51 18.88 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.53 -158.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.92 -64.95 3.3 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.6 m -120.37 78.67 1.38 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.734 1.214 . . . . 0.0 108.703 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -77.76 32.84 1.67 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 123.884 0.754 . . . . 0.0 113.895 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -59.54 152.6 55.11 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 125.14 1.376 . . . . 0.0 112.002 -172.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.91 60.09 7.61 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.297 2.665 . . . . 0.0 109.657 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.1 p -145.49 145.92 31.26 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 163.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -153.69 175.45 13.24 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.578 1.151 . . . . 0.0 109.463 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -112.1 -12.87 13.62 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.619 0.768 . . . . 0.0 112.384 -164.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -154.49 -175.86 5.61 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -173.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.489 HG13 ' CE1' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -136.75 154.35 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 124.861 1.264 . . . . 0.0 109.478 -163.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.7 p -62.17 -32.34 54.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 122.581 0.352 . . . . 0.0 110.197 164.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.1 m 153.03 165.83 0.01 OUTLIER 'General case' 0 C--O 1.234 0.238 1 C-N-CA 132.943 4.497 . . . . 0.0 106.51 -175.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.423 ' HA ' ' CG2' ' A' ' 99' ' ' ILE . 99.3 mt-10 -107.96 75.97 1.03 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -132.46 -28.8 1.62 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.357 1.463 . . . . 0.0 112.597 -161.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.71 16.57 11.93 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.636 1.175 . . . . 0.0 111.876 167.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.613 HD11 HG13 ' A' ' 114' ' ' VAL . 12.0 tt -132.22 146.18 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 125.94 1.696 . . . . 0.0 108.114 -173.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -127.92 124.47 37.45 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.815 1.246 . . . . 0.0 108.834 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 mp -118.79 139.8 51.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.032 2.133 . . . . 0.0 108.756 -173.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -131.61 116.91 18.0 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.673 1.589 . . . . 0.0 106.715 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -79.19 135.67 36.87 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.693 1.235 . . . . 0.0 112.174 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 105' ' ' ARG . 19.2 t70 -143.41 -172.03 3.62 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.351 1.86 . . . . 0.0 110.697 170.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.454 ' H ' ' CG ' ' A' ' 104' ' ' ASP . 0.2 OUTLIER -122.7 7.16 9.41 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.537 2.735 . . . . 0.0 111.838 -173.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -65.65 30.42 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 129.928 3.291 . . . . 0.0 116.905 -161.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pp -131.09 -2.52 4.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.017 1.327 . . . . 0.0 112.023 161.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.14 3.31 51.36 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 117.908 -1.496 . . . . 0.0 112.415 -168.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.5 mtp -140.69 -95.35 0.15 Allowed 'General case' 0 C--N 1.347 0.494 0 CA-C-N 120.01 1.905 . . . . 0.0 107.993 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.8 t -142.64 111.4 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -119.03 100.72 7.53 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.768 1.227 . . . . 0.0 107.966 171.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 36.1 t -100.9 128.07 47.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.62 158.96 22.98 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.968 0.804 . . . . 0.0 110.099 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.613 HG13 HD11 ' A' ' 99' ' ' ILE . 95.0 t -141.65 98.95 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -176.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.3 mp -126.84 164.26 21.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 174.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.3 m -77.47 145.29 37.15 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.403 -1.436 . . . . 0.0 110.625 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -82.14 -22.89 35.9 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.09 0.956 . . . . 0.0 111.249 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.451 ' HD3' HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -76.8 -38.22 54.33 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 117.993 -1.003 . . . . 0.0 111.092 169.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.2 p -147.58 115.72 6.54 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 173.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.53 56.28 0.06 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.411 1.485 . . . . 0.0 111.304 176.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.14 168.38 16.89 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.242 1.817 . . . . 0.0 110.682 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -44.69 -64.04 0.78 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.756 2.022 . . . . 0.0 113.264 -161.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 50.94 -114.29 0.77 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.414 1.886 . . . . 0.0 107.983 174.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.22 -119.65 0.68 Allowed Glycine 0 CA--C 1.522 0.518 0 CA-C-N 118.653 0.66 . . . . 0.0 113.271 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 54.1 p-80 -161.18 170.7 19.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.237 0.615 . . . . 0.0 110.648 -170.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.586 HG21 ' HE2' ' A' ' 136' ' ' LYS . 3.6 p -115.2 139.61 40.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.161 1.384 . . . . 0.0 108.283 172.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -132.23 150.47 52.15 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 123.593 0.558 . . . . 0.0 110.812 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -66.42 108.59 2.42 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.732 1.213 . . . . 0.0 109.206 174.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.33 -44.47 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.683 1.193 . . . . 0.0 112.257 -170.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.74 -179.65 32.51 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.222 0.915 . . . . 0.0 114.94 -159.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.55 165.25 31.35 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.219 2.613 . . . . 0.0 110.629 171.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.72 154.87 84.14 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 164.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.46 -55.52 0.14 OUTLIER 'Cis proline' 0 C--N 1.348 0.55 0 CA-C-N 120.745 1.302 . . . . 0.0 113.751 10.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 19.1 p -66.7 -31.16 71.64 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.366 1.067 . . . . 0.0 113.149 -166.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 71.81 -2.37 25.08 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.052 0.834 . . . . 0.0 114.797 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.586 ' HE2' HG21 ' A' ' 126' ' ' VAL . 14.6 ptmt -103.38 159.09 15.87 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.3 1.05 . . . . 0.0 108.863 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.4 ttp85 -129.14 99.91 5.43 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.68 1.192 . . . . 0.0 108.856 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -62.5 132.15 51.52 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.656 1.582 . . . . 0.0 107.413 163.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 42.6 t -141.77 144.86 34.19 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.654 1.116 . . . . 0.0 109.386 173.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.5 ptp -149.76 158.19 43.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.457 0.646 . . . . 0.0 110.655 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.17 89.17 1.93 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.566 2.346 . . . . 0.0 106.096 -176.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.523 ' HB3' ' H ' ' A' ' 144' ' ' ALA . 2.8 m -147.2 162.27 39.23 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.31 1.444 . . . . 0.0 108.63 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.7 -20.31 65.62 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.355 1.062 . . . . 0.0 113.072 163.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.523 ' H ' ' HB3' ' A' ' 142' ' ' SER . . . -62.81 29.3 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 130.661 3.584 . . . . 0.0 114.881 -175.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 93.8 mt -132.81 47.41 2.51 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.283 1.833 . . . . 0.0 108.861 -168.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.6 tttt -74.43 122.45 23.01 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -66.95 131.9 46.82 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 165.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 17.2 pt -114.17 164.42 16.27 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 160.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -60.13 173.26 1.94 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 121.657 1.571 . . . . 0.0 110.038 160.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -41.77 -28.34 0.15 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -168.75 -83.53 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 170.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -146.14 26.98 1.18 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.169 1.788 . . . . 0.0 110.244 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -73.28 -12.61 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.97 1.308 . . . . 0.0 112.152 170.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.49 0 N-CA-C 106.977 -2.449 . . . . 0.0 106.977 160.483 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.7 mtt85 . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.449 ' HB ' HD21 ' A' ' 98' ' ' ASN . 42.0 pt -132.55 128.75 21.13 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.046 0.938 . . . . 0.0 110.395 -164.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.17 132.97 17.27 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.86 1.707 . . . . 0.0 110.256 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.9 mm -101.01 148.77 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 160.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.98 91.49 1.79 Allowed 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.872 1.269 . . . . 0.0 107.869 -169.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.9 m -71.37 80.22 0.76 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.579 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.39 -33.96 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.995 1.271 . . . . 0.0 111.09 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.05 -6.75 4.33 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 173.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -130.02 11.45 5.55 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.306 2.242 . . . . 0.0 110.512 170.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.3 t30 28.11 66.82 0.08 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.821 2.448 . . . . 0.0 112.248 -162.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -114.7 161.44 18.13 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.6 t -144.75 122.5 5.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -141.43 98.87 3.44 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -170.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 44.2 ttm -70.52 133.5 46.84 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.077 -1.014 . . . . 0.0 109.477 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.3 t -121.25 161.33 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 176.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -78.46 167.15 21.74 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.186 -1.571 . . . . 0.0 109.565 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.5 mtm105 -63.24 165.2 7.68 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.669 -0.644 . . . . 0.0 109.96 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.45 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 6.2 tp -70.28 120.61 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 167.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -152.43 118.17 5.39 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 160.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.1 mt -140.4 172.86 12.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.885 1.674 . . . . 0.0 108.442 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.453 ' H ' ' HG2' ' A' ' 30' ' ' GLU . 10.7 p -94.51 168.62 10.75 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.019 1.328 . . . . 0.0 109.67 171.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -77.66 70.05 3.99 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.791 0.805 . . . . 0.0 109.5 164.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -167.14 -26.81 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 125.286 1.435 . . . . 0.0 110.988 158.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.453 ' HG2' ' H ' ' A' ' 27' ' ' SER . 23.1 mm-40 -55.62 -45.24 77.56 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.309 0.644 . . . . 0.0 110.348 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -68.19 37.34 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.275 2.63 . . . . 0.0 112.767 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.56 -34.34 0.19 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.632 1.173 . . . . 0.0 111.402 161.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -92.24 -26.37 18.2 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.807 -1.092 . . . . 0.0 113.049 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.2 pt -100.81 23.44 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 120.186 1.357 . . . . 0.0 111.467 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.7 mt -122.25 161.49 23.19 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.443 1.097 . . . . 0.0 112.233 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.514 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -61.54 149.03 85.26 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.082 170.334 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -68.83 5.1 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.419 2.746 . . . . 0.0 112.657 167.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -102.79 -39.82 6.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.672 -1.156 . . . . 0.0 111.441 165.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.514 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -60.78 -43.68 97.75 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 121.421 1.919 . . . . 0.0 111.455 -173.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -57.66 -45.7 85.18 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.929 1.292 . . . . 0.0 111.549 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -76.33 -36.78 58.07 Favored 'General case' 0 C--O 1.221 -0.434 0 O-C-N 121.526 -0.734 . . . . 0.0 111.066 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.635 ' CG1' ' HB1' ' A' ' 143' ' ' ALA . 25.2 t -55.0 -27.99 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 120.701 -1.25 . . . . 0.0 111.143 175.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.45 -22.91 67.16 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -93.84 -41.82 9.43 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.514 1.506 . . . . 0.0 111.537 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -96.13 4.82 52.22 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.302 1.841 . . . . 0.0 112.884 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.04 15.58 1.84 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.939 1.695 . . . . 0.0 113.533 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.792 0 CA-C-O 117.702 -1.61 . . . . 0.0 114.805 -179.779 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.61 172.12 17.39 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 122.206 0.892 . . . . 0.0 114.978 166.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.514 HG22 ' HA ' ' A' ' 76' ' ' ASP . 14.2 pt -136.2 170.79 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.829 1.651 . . . . 0.0 109.618 176.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -96.95 111.04 23.43 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.457 1.103 . . . . 0.0 109.999 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.49 113.73 14.42 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 163.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 20.7 t -65.84 85.32 0.08 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.512 1.525 . . . . 0.0 109.14 166.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.1 tt -66.33 -11.61 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.704 1.602 . . . . 0.0 111.587 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.5 m -82.28 -1.44 49.47 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.309 1.844 . . . . 0.0 113.0 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.8 p -152.17 -16.43 0.18 Allowed 'General case' 0 C--N 1.338 0.104 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 165.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.66 65.84 1.59 Allowed Glycine 0 C--N 1.337 0.616 0 N-CA-C 107.593 -2.203 . . . . 0.0 107.593 -162.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.1 m -143.21 166.63 24.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 172.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -135.53 145.89 47.51 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.57 -102.82 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.666 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -54.4 108.01 0.34 Allowed 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.487 1.115 . . . . 0.0 112.815 -159.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.514 ' HA ' HG22 ' A' ' 64' ' ' ILE . 1.6 m-20 -68.37 135.86 52.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -10.11 57.31 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.38 0.991 . . . . 0.0 112.949 -171.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.91 -20.8 62.64 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.468 -1.395 . . . . 0.0 112.472 163.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.3 p -86.69 -20.14 28.17 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.659 1.184 . . . . 0.0 112.89 168.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -137.05 86.29 2.19 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.229 1.812 . . . . 0.0 107.471 -169.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -139.06 124.24 19.05 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -144.83 93.62 2.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -176.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.0 m -61.81 124.97 22.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.825 1.25 . . . . 0.0 111.14 -170.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.12 -60.88 4.8 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.79 -49.6 70.04 Favored 'General case' 0 CA--C 1.526 0.039 0 CA-C-N 117.941 0.87 . . . . 0.0 112.285 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 42.35 42.11 4.26 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.918 2.199 . . . . 0.0 115.657 -162.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -61.44 143.81 92.79 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 118.528 1.164 . . . . 0.0 108.874 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.14 70.44 6.69 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.02 2.48 . . . . 0.0 110.895 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.3 p -136.44 150.29 48.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.521 1.129 . . . . 0.0 110.967 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.25 166.77 22.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.901 2.08 . . . . 0.0 107.568 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -127.7 -6.9 5.66 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.393 0.677 . . . . 0.0 112.451 -170.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -151.96 -178.02 6.5 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 167.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.23 158.76 43.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 124.105 0.962 . . . . 0.0 111.825 -176.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 p -51.36 -42.44 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 127.271 2.228 . . . . 0.0 111.444 171.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.6 m 157.14 155.07 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.515 1 C-N-CA 131.959 4.104 . . . . 0.0 106.786 -176.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -74.06 75.51 1.73 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 161.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -114.8 -53.51 2.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.573 1.149 . . . . 0.0 108.991 177.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.449 HD21 ' HB ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER -126.82 14.33 7.45 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 173.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.5 tt -106.12 154.25 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 159.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -123.49 134.11 53.94 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 166.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 46.8 mt -117.41 148.97 41.29 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.855 2.062 . . . . 0.0 109.02 172.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.473 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 0.2 OUTLIER -133.17 115.69 15.34 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 162.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.96 143.44 56.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.221 1.409 . . . . 0.0 110.034 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -147.79 -178.97 6.55 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 158.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.95 14.7 9.95 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.024 2.13 . . . . 0.0 110.377 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.8 m -62.33 -21.81 65.57 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 126.194 1.798 . . . . 0.0 115.692 -158.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 pp -77.08 -14.72 59.77 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.556 1.071 . . . . 0.0 112.231 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.86 0.6 25.73 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 117.316 -1.824 . . . . 0.0 113.012 -168.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.0 mmt -143.31 -85.18 0.15 Allowed 'General case' 0 C--N 1.349 0.553 0 CA-C-N 120.456 2.128 . . . . 0.0 107.9 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.2 t -145.19 114.69 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -129.37 103.44 6.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.305 1.442 . . . . 0.0 110.186 172.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.4 ' HB2' ' CG1' ' A' ' 126' ' ' VAL . 2.6 m -106.85 151.87 24.64 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 23.9 pt-20 -70.43 163.68 26.21 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.354 0.979 . . . . 0.0 110.838 171.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.3 t -137.09 107.51 5.38 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 168.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.49 164.49 18.83 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 167.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 17.0 t -65.47 156.22 33.12 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 162.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.72 -28.91 66.21 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.45 ' HG2' ' H ' ' A' ' 24' ' ' ILE 0.285 0.0 OUTLIER -116.1 -52.45 2.6 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 179.451 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 15.9 p -77.51 77.68 4.03 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 121.077 1.762 . . . . 0.0 109.227 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -52.86 67.04 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 128.983 2.913 . . . . 0.0 111.071 166.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.4 -178.9 4.51 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.37 2.268 . . . . 0.0 110.264 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -43.75 -57.99 2.94 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.259 2.224 . . . . 0.0 113.366 -165.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 42.54 -112.08 0.19 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.616 1.966 . . . . 0.0 109.422 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -178.29 -125.3 0.91 Allowed Glycine 0 CA--C 1.519 0.328 0 CA-C-N 118.954 0.797 . . . . 0.0 113.767 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -158.46 174.87 14.44 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.076 0.55 . . . . 0.0 110.085 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.582 HG21 ' HE2' ' A' ' 136' ' ' LYS . 2.4 p -124.85 137.14 58.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 124.285 1.034 . . . . 0.0 108.774 171.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -135.07 147.15 49.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.193 0.597 . . . . 0.0 109.675 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -58.66 111.32 1.22 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.842 1.257 . . . . 0.0 109.442 170.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -153.94 -29.5 0.12 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -78.7 155.8 41.69 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.19 -30.02 7.34 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.141 1.894 . . . . 0.0 112.632 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 179.37 168.58 0.64 Allowed Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 128.744 2.818 . . . . 0.0 106.584 -172.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.11 -51.06 0.16 OUTLIER 'Cis proline' 0 C--N 1.349 0.589 0 CA-C-N 121.081 1.422 . . . . 0.0 111.407 -12.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.0 p -71.13 -23.43 62.08 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.686 1.595 . . . . 0.0 112.44 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.03 -8.85 21.08 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.499 1.523 . . . . 0.0 113.257 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.582 ' HE2' HG21 ' A' ' 126' ' ' VAL . 12.2 ptmt -105.76 152.84 22.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 120.64 -1.506 . . . . 0.0 109.977 -171.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -126.96 97.74 5.07 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.53 1.932 . . . . 0.0 107.033 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -67.74 140.21 56.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 164.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 45.7 t -140.65 149.23 42.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.448 1.099 . . . . 0.0 109.192 170.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.7 ptt? -140.84 148.95 41.35 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.317 1.447 . . . . 0.0 109.337 -176.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -147.65 88.77 1.71 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.999 2.12 . . . . 0.0 107.424 -173.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 88.7 p -165.28 178.44 6.9 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 121.551 -0.718 . . . . 0.0 109.549 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.635 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -63.62 -18.26 63.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.121 1.368 . . . . 0.0 114.169 167.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.82 22.68 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.539 1.936 . . . . 0.0 115.445 -159.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 28.3 mt -121.23 41.03 3.43 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -158.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -75.77 101.59 5.12 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -53.92 137.28 39.38 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 167.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 14.8 pt -136.2 166.59 26.83 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.242 1.417 . . . . 0.0 108.297 167.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.89 168.1 4.74 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.646 2.231 . . . . 0.0 112.435 164.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -18.87 -49.58 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 130.206 3.402 . . . . 0.0 118.118 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -165.42 -81.01 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.218 1.407 . . . . 0.0 107.609 -167.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -144.74 16.64 1.61 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.085 1.754 . . . . 0.0 111.412 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.79 -3.92 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.259 -0.901 . . . . 0.0 112.728 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.475 0 C-N-CA 128.117 2.77 . . . . 0.0 106.554 159.88 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 24.2 mtt180 . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.559 HD13 ' HD3' ' A' ' 118' ' ' ARG . 2.7 pt -132.01 112.83 14.73 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.439 1.495 . . . . 0.0 108.856 -162.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.08 106.34 2.01 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.52 2.146 . . . . 0.0 109.274 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.553 HD11 HD12 ' A' ' 8' ' ' ILE . 23.4 mm -78.72 80.69 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 173.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -83.66 89.54 7.14 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.328 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.7 m -71.41 83.57 0.8 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 173.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 p -56.42 -36.62 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.444 1.497 . . . . 0.0 111.842 -171.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -17.86 49.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.665 1.186 . . . . 0.0 112.648 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -129.11 12.44 6.11 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.602 1.961 . . . . 0.0 110.015 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 26.48 58.31 0.07 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 129.104 2.962 . . . . 0.0 111.32 -164.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.9 mtp85 -94.63 175.14 6.78 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 118.569 -1.252 . . . . 0.0 108.881 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -149.8 120.97 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 159.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.41 111.57 22.51 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 167.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.9 ttt -77.42 105.83 8.8 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.819 1.19 . . . . 0.0 108.808 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.94 178.96 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 16.1 pt-20 -130.96 168.82 16.69 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 120.292 -1.505 . . . . 0.0 112.516 172.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.89 139.61 57.24 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.659 0.784 . . . . 0.0 111.545 -171.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.476 ' H ' ' HD2' ' A' ' 118' ' ' ARG . 12.9 tt -73.72 115.38 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -175.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -139.0 99.52 3.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.4 mt -133.39 177.41 7.71 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.203 1.801 . . . . 0.0 108.805 -171.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.2 t -84.4 179.77 7.35 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 158.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -54.19 -36.99 64.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.846 0.748 . . . . 0.0 109.231 158.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 32' ' ' ARG . 18.6 m-20 -62.82 17.07 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 129.978 3.311 . . . . 0.0 117.269 -169.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -133.04 -46.9 0.85 Allowed 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -172.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -62.36 5.69 0.1 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.601 1.96 . . . . 0.0 114.922 -175.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 29' ' ' ASP . 3.7 ptt180 -124.75 -10.51 7.27 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.611 1.564 . . . . 0.0 113.869 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -134.66 -11.42 2.37 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.628 0.771 . . . . 0.0 112.19 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pt -119.55 11.39 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.828 0.851 . . . . 0.0 111.283 166.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -113.49 170.78 7.99 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.479 1.111 . . . . 0.0 111.825 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.42 142.41 90.7 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.902 0.881 . . . . 0.0 110.527 172.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.34 -7.2 20.66 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.556 2.837 . . . . 0.0 112.707 170.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -82.85 -45.32 14.41 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.504 1.121 . . . . 0.0 109.671 163.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.41 -42.47 98.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 120.579 1.536 . . . . 0.0 111.461 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -57.89 -45.75 85.92 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.029 0.532 . . . . 0.0 111.196 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -69.85 -49.6 50.88 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 119.304 -0.958 . . . . 0.0 109.642 172.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.471 HG22 ' HA2' ' A' ' 47' ' ' GLY . 5.7 t -55.89 -29.11 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 119.544 1.065 . . . . 0.0 111.01 -170.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.3 -28.31 69.64 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 174.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -100.46 -22.6 14.96 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.581 1.082 . . . . 0.0 113.12 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -107.35 3.72 25.63 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.963 0.905 . . . . 0.0 112.712 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.51 49.48 15.96 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.74 1.616 . . . . 0.0 111.047 -172.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 42' ' ' VAL . . . . . . . . 0 C--N 1.335 0.495 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.4 t70 . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.54 178.44 25.41 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.415 HD12 ' HB2' ' A' ' 73' ' ' ASP . 21.1 pt -135.2 167.5 25.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 125.507 1.523 . . . . 0.0 107.859 167.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -84.07 127.8 34.14 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 122.239 1.019 . . . . 0.0 110.172 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -87.31 130.97 34.4 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 158.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.9 t -75.23 100.59 4.38 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 159.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 144' ' ' ALA . 3.6 tt -66.34 -18.59 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.435 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.9 t -82.11 7.62 12.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.653 0.781 . . . . 0.0 111.147 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.9 p -153.49 0.05 0.24 Allowed 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.965 -1.084 . . . . 0.0 113.87 168.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.82 55.24 23.49 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.4 m -153.8 154.45 34.01 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.067 -1.255 . . . . 0.0 109.259 -173.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.415 ' HB2' HD12 ' A' ' 64' ' ' ILE . 15.6 p-10 -85.95 152.21 23.13 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.07 0.948 . . . . 0.0 112.914 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.29 0.2 OUTLIER -146.89 -101.81 0.09 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.518 168.027 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -66.29 138.29 57.53 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.269 0.941 . . . . 0.0 111.19 -164.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -99.11 152.45 19.84 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.465 1.106 . . . . 0.0 108.63 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.66 -22.05 31.76 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.99 -29.66 57.69 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.706 1.139 . . . . 0.0 112.411 169.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 t -120.78 54.69 1.06 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.453 1.901 . . . . 0.0 109.466 168.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -140.79 162.21 35.98 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.504 -1.373 . . . . 0.0 110.073 159.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -104.23 120.27 40.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 163.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -138.15 -55.54 0.65 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.822 2.049 . . . . 0.0 108.287 -165.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 t -67.11 173.24 3.89 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.063 0.935 . . . . 0.0 110.167 159.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 52.38 -110.03 1.08 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.428 1.489 . . . . 0.0 110.966 -173.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -66.19 -37.76 86.38 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.455 1.102 . . . . 0.0 112.425 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.79 18.34 17.37 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.371 1.462 . . . . 0.0 116.33 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.86 151.09 97.43 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 117.679 0.74 . . . . 0.0 111.836 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.62 62.12 7.06 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.052 3.168 . . . . 0.0 110.968 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.6 p -135.79 155.87 49.69 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.859 0.863 . . . . 0.0 109.29 166.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -156.88 178.29 10.52 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.475 1.11 . . . . 0.0 110.762 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -117.75 -11.44 10.36 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -169.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -149.1 176.86 10.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.631 1.173 . . . . 0.0 110.895 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 m -129.25 156.54 41.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.133 0 O-C-N 121.136 -0.978 . . . . 0.0 111.371 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.1 p -60.94 -34.03 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.768 1.227 . . . . 0.0 111.166 173.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.2 m 164.6 166.4 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 131.614 3.966 . . . . 0.0 106.628 -175.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -96.4 77.2 2.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.152 1.781 . . . . 0.0 107.793 174.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.504 ' CD2' ' H ' ' A' ' 98' ' ' ASN . 5.4 p80 -133.93 -65.23 0.67 Allowed 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.64 -0.663 . . . . 0.0 111.619 -159.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.504 ' H ' ' CD2' ' A' ' 97' ' ' HIS . 0.9 OUTLIER -96.51 16.93 17.35 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.19 1.396 . . . . 0.0 108.935 167.017 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.03 140.64 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 128.315 2.646 . . . . 0.0 107.451 -174.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.417 ' HD3' ' H ' ' A' ' 101' ' ' LEU . 14.4 tppt? -129.24 151.43 49.91 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 128.226 2.61 . . . . 0.0 108.591 -173.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.417 ' H ' ' HD3' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -146.05 154.14 41.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.479 1.911 . . . . 0.0 107.875 -176.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.511 ' HG2' ' CG ' ' A' ' 113' ' ' GLU . 19.3 mmt180 -136.52 121.9 19.37 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -71.04 126.02 28.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.473 1.033 . . . . 0.0 110.274 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -128.4 176.98 7.3 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.866 0.841 . . . . 0.0 109.786 158.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.31 14.24 25.02 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.229 2.212 . . . . 0.0 111.542 173.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 t -46.96 -40.55 14.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.408 1.883 . . . . 0.0 115.44 -159.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.6 pp -73.36 -11.25 60.42 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 115.11 -4.81 22.11 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.158 1.837 . . . . 0.0 112.957 -169.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -141.61 -85.35 0.18 Allowed 'General case' 0 C--N 1.349 0.584 0 CA-C-N 120.143 1.971 . . . . 0.0 109.753 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.2 t -144.58 111.68 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -129.56 106.56 8.83 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.678 1.591 . . . . 0.0 108.79 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 10.1 m -106.28 141.94 36.78 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.602 -1.189 . . . . 0.0 107.88 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.511 ' CG ' ' HG2' ' A' ' 102' ' ' ARG . 22.2 pt-20 -67.71 160.97 26.98 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.791 1.632 . . . . 0.0 110.691 172.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.7 t -141.64 104.04 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.19 161.26 28.11 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.731 0.812 . . . . 0.0 109.078 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 13.5 m -77.73 106.71 9.72 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.79 -25.1 10.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.259 1.424 . . . . 0.0 113.177 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.559 ' HD3' HD13 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -80.72 -37.29 30.88 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 126.596 1.958 . . . . 0.0 113.149 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 3.9 p -153.82 69.88 0.81 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -161.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.27 58.0 0.25 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 128.086 2.554 . . . . 0.0 113.693 -159.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.7 -147.55 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.738 1.615 . . . . 0.0 112.319 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -70.12 -64.89 0.8 Allowed 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.282 1.433 . . . . 0.0 109.423 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 49.84 -116.84 0.94 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.421 1.889 . . . . 0.0 107.561 -177.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.76 -119.32 0.62 Allowed Glycine 0 CA--C 1.521 0.445 0 CA-C-N 118.501 0.591 . . . . 0.0 112.578 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -158.0 177.57 11.17 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 122.453 -0.44 . . . . 0.0 111.155 -170.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.1 p -124.64 145.02 32.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 124.663 1.185 . . . . 0.0 108.884 170.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -140.05 144.67 36.99 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.584 1.554 . . . . 0.0 108.668 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.08 121.12 19.67 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.403 0.547 . . . . 0.0 109.55 173.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.39 -45.15 0.22 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.624 2.37 . . . . 0.0 111.946 -165.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -90.53 -178.34 44.01 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.404 1.002 . . . . 0.0 112.935 -170.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.93 155.22 69.22 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.829 2.353 . . . . 0.0 111.017 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.48 ' H ' ' HD2' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -68.89 154.06 95.33 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.908 174.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.07 -36.64 2.45 Favored 'Cis proline' 0 C--N 1.35 0.642 0 CA-C-N 119.506 0.859 . . . . 0.0 111.429 -5.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.51 59.19 1.87 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 127.826 2.451 . . . . 0.0 111.531 -175.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -88.33 -5.79 75.34 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.869 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -98.29 104.37 16.39 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 119.414 1.607 . . . . 0.0 111.048 -166.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.64 94.06 5.62 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.173 1.789 . . . . 0.0 108.347 -173.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -62.33 130.37 44.98 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 160.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 22.1 t -144.02 130.23 19.71 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.3 ptp -142.8 140.95 31.54 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.445 0.698 . . . . 0.0 110.395 -173.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.91 15.5 28.83 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.991 2.116 . . . . 0.0 110.647 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.2 p -65.96 112.0 3.6 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.023 1.729 . . . . 0.0 110.53 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -54.29 -24.84 20.54 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.54 1.136 . . . . 0.0 112.993 164.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -69.83 2.29 3.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.317 2.247 . . . . 0.0 116.351 -170.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 90.7 mt -87.26 87.02 7.32 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.091 0.859 . . . . 0.0 109.836 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -87.01 126.44 34.74 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.349 1.06 . . . . 0.0 108.785 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -70.87 135.22 47.89 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.327 0.967 . . . . 0.0 109.453 170.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.2 pt -136.44 163.6 48.76 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.33 1.052 . . . . 0.0 109.764 171.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.21 168.73 7.23 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.592 2.195 . . . . 0.0 111.646 161.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.414 ' HA ' ' HD2' ' A' ' 150' ' ' ARG . 6.8 mmm-85 -62.75 -4.74 2.23 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 119.51 3.152 . . . . 0.0 119.51 -158.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 178.11 -62.58 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.195 1 C-N-CA 132.905 4.482 . . . . 0.0 109.552 161.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -156.73 8.26 0.2 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.973 2.909 . . . . 0.0 110.831 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.9 pp -65.54 -14.54 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.872 1.214 . . . . 0.0 112.936 170.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 159.097 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.4 pt -129.33 136.97 29.97 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.401 1.08 . . . . 0.0 111.901 -168.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.0 120.92 3.87 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.997 2.464 . . . . 0.0 110.454 170.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.83 146.99 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 159.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -126.87 154.81 43.92 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 127.267 2.227 . . . . 0.0 105.621 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.53 91.94 2.53 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 171.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.08 -43.76 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 C-N-CA 123.346 0.659 . . . . 0.0 111.664 -171.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.97 -28.88 58.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.633 0.773 . . . . 0.0 110.904 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 152' ' ' GLN . 7.0 ttmm -87.39 -1.4 57.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.27 1.428 . . . . 0.0 111.091 170.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.8 t30 38.15 65.83 0.55 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 128.915 2.886 . . . . 0.0 112.427 -171.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.43 162.34 28.3 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.69 1.996 . . . . 0.0 109.44 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.7 t -138.9 134.47 42.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 164.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -141.53 97.58 3.19 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.684 1.594 . . . . 0.0 108.311 -172.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.4 ttp -78.94 133.29 36.91 Favored 'General case' 0 C--N 1.339 0.14 0 O-C-N 121.371 -0.831 . . . . 0.0 109.852 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.7 t -137.15 161.27 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.558 1.543 . . . . 0.0 107.063 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -58.32 170.26 0.74 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 123.03 1.395 . . . . 0.0 112.54 164.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 -69.49 176.42 3.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.858 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.56 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 2.4 tt -78.45 128.24 38.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 164.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -158.13 97.17 1.5 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.7 mt -138.29 176.21 8.9 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.936 1.294 . . . . 0.0 108.646 -167.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.8 p -88.11 -159.88 0.58 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 164.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.04 -48.69 56.93 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.888 1.222 . . . . 0.0 109.313 160.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.67 -12.53 16.68 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 126.58 1.952 . . . . 0.0 114.856 -159.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.41 ' C ' ' H ' ' A' ' 32' ' ' ARG . 12.9 mm-40 -85.0 -48.34 9.34 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 127.028 2.131 . . . . 0.0 110.316 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.437 ' CH2' HD13 ' A' ' 24' ' ' ILE . 61.0 m95 -60.61 8.94 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 128.135 2.574 . . . . 0.0 115.711 -168.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -139.06 -11.29 1.27 Allowed 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 128.928 2.891 . . . . 0.0 111.878 -164.037 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.9 -16.41 3.27 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 118.369 -0.824 . . . . 0.0 112.081 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pt -110.98 13.33 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 119.472 1.033 . . . . 0.0 111.958 172.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.01 167.94 14.02 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.006 0.923 . . . . 0.0 111.403 -171.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.2 137.8 74.19 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 123.89 0.876 . . . . 0.0 108.761 169.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -70.13 -3.69 12.76 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.398 2.732 . . . . 0.0 113.23 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -95.01 -30.04 14.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 127.233 2.213 . . . . 0.0 110.328 170.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.05 -48.46 81.66 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 120.975 1.716 . . . . 0.0 111.092 -174.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -59.07 -37.8 77.93 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.524 0.729 . . . . 0.0 111.885 -174.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -81.41 -45.81 15.53 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.869 -0.586 . . . . 0.0 109.827 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.581 HG12 ' HB1' ' A' ' 143' ' ' ALA . 2.8 t -58.59 -28.11 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 120.103 1.319 . . . . 0.0 110.005 -177.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.19 -8.29 23.33 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 173.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -119.26 -27.51 5.63 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.429 1.468 . . . . 0.0 111.12 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -105.0 12.35 32.39 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.07 1.748 . . . . 0.0 112.868 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.47 7.92 1.49 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.669 2.788 . . . . 0.0 115.374 171.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.496 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . . . . . . 0 CA--C 1.526 0.74 0 CA-C-O 118.485 -1.175 . . . . 0.0 114.888 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 t0 . . . . . 0 C--O 1.234 0.28 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.67 169.78 46.23 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 125.894 1.711 . . . . 0.0 112.402 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.6 pt -128.19 173.32 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 162.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -94.56 119.04 32.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.889 1.275 . . . . 0.0 110.066 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.27 119.98 10.68 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 158.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 2.8 t -74.81 71.44 1.99 Allowed 'General case' 0 C--O 1.236 0.389 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 159.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 tt -62.9 -26.62 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.604 -162.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.6 t -77.65 3.15 14.6 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.334 1.454 . . . . 0.0 112.393 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.3 p -140.54 21.69 2.36 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.318 -0.864 . . . . 0.0 111.464 158.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.35 36.18 52.45 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.2 m -124.3 177.02 6.08 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.381 2.273 . . . . 0.0 106.907 -170.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -138.25 145.65 41.6 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.647 1.112 . . . . 0.0 109.235 -173.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.43 HD13 ' CD2' ' A' ' 75' ' ' PHE 0.305 0.2 OUTLIER -151.18 -102.2 0.06 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 178.377 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.43 ' CD2' HD13 ' A' ' 74' ' ' LEU . 38.8 m-85 -55.27 150.48 11.13 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -158.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -112.7 143.68 43.49 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.895 0.878 . . . . 0.0 110.726 -174.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.4 m -61.15 -16.63 46.54 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -56.7 -23.26 40.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 120.355 1.434 . . . . 0.0 112.18 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 91' ' ' TYR . 7.1 t -112.96 -3.73 14.02 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.759 0.823 . . . . 0.0 112.384 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.418 ' HE2' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -114.8 68.21 0.7 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.958 -1.089 . . . . 0.0 108.134 176.691 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -135.78 49.12 2.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.989 0.916 . . . . 0.0 109.965 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -72.53 95.15 1.77 Allowed 'General case' 0 C--N 1.341 0.206 0 O-C-N 121.626 -0.671 . . . . 0.0 109.505 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.2 t -58.89 134.4 56.89 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.859 0.463 . . . . 0.0 110.287 -175.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.98 -67.93 3.66 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.61 -55.54 17.04 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.03 0.915 . . . . 0.0 111.527 -174.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.02 16.03 12.0 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 129.373 3.368 . . . . 0.0 115.871 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.39 150.62 8.51 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 125.261 1.424 . . . . 0.0 112.137 171.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.71 71.69 4.7 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.77 2.98 . . . . 0.0 110.384 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.4 p -133.89 152.31 51.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 164.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -131.78 176.45 8.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.816 1.246 . . . . 0.0 109.433 -170.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 79' ' ' THR . 7.5 p90 -124.91 -3.08 7.7 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.239 1.015 . . . . 0.0 112.587 176.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -151.64 -173.26 4.46 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.711 2.004 . . . . 0.0 107.693 -176.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.84 155.34 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 C-N-CA 123.783 0.833 . . . . 0.0 109.304 178.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 p -61.46 -33.34 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.382 0.611 . . . . 0.0 110.486 170.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.8 m 168.02 159.82 0.04 OUTLIER 'General case' 0 C--O 1.234 0.279 1 C-N-CA 132.559 4.343 . . . . 0.0 105.075 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -101.04 80.9 2.18 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.411 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 17.9 p80 -125.43 -67.04 0.91 Allowed 'General case' 0 C--N 1.347 0.484 0 C-N-CA 126.443 1.897 . . . . 0.0 109.345 -165.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.411 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 0.7 OUTLIER -96.9 22.08 8.79 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 122.071 0.938 . . . . 0.0 112.429 179.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.9 tt -126.61 147.78 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 128.628 2.771 . . . . 0.0 104.847 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -125.14 138.35 54.15 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 122.803 0.441 . . . . 0.0 110.713 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mp -144.41 130.28 19.32 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.964 1.706 . . . . 0.0 109.07 -164.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.494 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 2.3 mpt_? -131.35 111.95 12.31 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 128.364 2.665 . . . . 0.0 105.345 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -74.41 128.44 35.54 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.629 1.571 . . . . 0.0 110.845 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 105' ' ' ARG . 32.0 t0 -134.2 178.01 7.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.095 1.358 . . . . 0.0 109.156 162.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.407 ' CZ ' ' HA ' ' A' ' 104' ' ' ASP . 0.0 OUTLIER -113.62 18.39 17.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.995 1.718 . . . . 0.0 110.544 -178.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.18 -30.56 60.16 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -158.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.85 -12.99 60.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.827 0.739 . . . . 0.0 112.617 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.5 -2.5 23.47 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 126.343 1.925 . . . . 0.0 112.936 -169.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 76.6 mtm -143.47 -81.91 0.18 Allowed 'General case' 0 C--N 1.35 0.605 0 CA-C-N 120.484 2.142 . . . . 0.0 109.629 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 42.9 t -143.08 116.6 3.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -125.44 111.2 14.83 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 126.33 1.852 . . . . 0.0 107.845 168.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.416 ' HB3' HG13 ' A' ' 126' ' ' VAL . 38.3 t -129.25 125.45 36.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -170.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.494 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 24.1 pt-20 -60.38 159.16 10.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.002 0.819 . . . . 0.0 111.387 -172.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -137.39 106.62 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 171.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.7 mp -120.67 170.28 9.58 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 164.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.1 163.34 12.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 118.927 -1.109 . . . . 0.0 108.592 164.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.46 -20.04 66.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.713 168.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.56 ' HG2' ' H ' ' A' ' 24' ' ' ILE . 30.7 tpt85 -148.46 -48.16 0.15 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -176.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 31.8 p -80.74 65.41 5.87 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.686 1.584 . . . . 0.0 108.453 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.39 57.33 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.217 2.607 . . . . 0.0 112.156 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.98 -47.38 52.55 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.648 0.779 . . . . 0.0 111.941 -164.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -169.07 -69.26 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 125.595 1.558 . . . . 0.0 107.601 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.4 mt 52.13 -114.02 0.79 Allowed 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 126.907 2.083 . . . . 0.0 110.846 -171.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.01 -119.45 0.72 Allowed Glycine 0 CA--C 1.525 0.692 0 CA-C-N 119.09 0.859 . . . . 0.0 112.367 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -159.47 163.55 35.22 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 122.299 -0.53 . . . . 0.0 111.17 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.561 HG21 ' HE2' ' A' ' 136' ' ' LYS . 5.5 p -101.49 132.96 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 168.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -131.53 155.57 47.22 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.369 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.06 112.7 3.1 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.253 1.021 . . . . 0.0 109.182 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -144.16 -24.45 0.55 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -171.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.45 163.77 13.56 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 123.349 0.5 . . . . 0.0 112.22 -167.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.86 -15.89 10.42 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.831 2.354 . . . . 0.0 114.353 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.5 ptt-85 142.63 165.08 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.945 1 C-N-CA 132.069 4.148 . . . . 0.0 107.181 -159.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.11 -53.11 0.15 OUTLIER 'Cis proline' 0 C--N 1.352 0.752 0 CA-C-N 121.624 1.616 . . . . 0.0 111.269 -9.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.9 p -73.76 -23.72 59.77 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.965 1.306 . . . . 0.0 112.743 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.74 5.37 68.9 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.282 0.944 . . . . 0.0 113.832 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.561 ' HE2' HG21 ' A' ' 126' ' ' VAL . 11.8 ptmt -125.44 162.17 25.44 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 119.647 1.723 . . . . 0.0 111.622 -167.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 ttm105 -125.23 109.53 12.95 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.642 1.577 . . . . 0.0 108.116 173.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -74.59 106.46 6.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.881 1.673 . . . . 0.0 106.977 165.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 18.2 t -121.94 135.55 54.87 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.561 1.073 . . . . 0.0 109.898 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.8 ptp -159.18 161.06 36.14 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.444 0.698 . . . . 0.0 110.754 -171.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -148.29 146.13 28.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.532 0.733 . . . . 0.0 109.426 161.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 91.0 p -171.78 -175.53 1.55 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.572 1.949 . . . . 0.0 107.208 158.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.581 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -60.87 -21.07 62.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.613 1.165 . . . . 0.0 113.163 165.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.53 22.03 0.06 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.735 1.614 . . . . 0.0 114.886 -169.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 88.9 mt -130.64 106.05 8.23 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.701 1.137 . . . . 0.0 110.018 -165.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -137.88 140.07 40.2 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.318 1.047 . . . . 0.0 108.788 174.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -76.95 141.38 40.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.219 0.918 . . . . 0.0 110.341 168.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.0 pt -137.01 170.53 10.54 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.077 1.751 . . . . 0.0 108.754 165.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.19 165.19 4.33 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.73 2.287 . . . . 0.0 112.783 167.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -45.05 -18.77 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 129.006 2.922 . . . . 0.0 118.341 -165.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -164.29 -78.71 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 171.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.418 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 31.8 mm-40 -149.71 42.05 0.87 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.99 2.516 . . . . 0.0 104.637 163.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.9 pp -76.39 -25.12 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 O-C-N 120.802 -1.186 . . . . 0.0 111.907 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 CA-C-O 117.306 -1.83 . . . . 0.0 110.542 175.528 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 . . . . . 0 N--CA 1.447 -0.604 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.576 HD12 HD21 ' A' ' 98' ' ' ASN . 1.3 pt -129.35 125.74 22.65 Favored Pre-proline 0 N--CA 1.452 -0.332 0 C-N-CA 125.595 1.558 . . . . 0.0 110.78 174.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.83 143.35 36.91 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.628 1.552 . . . . 0.0 110.384 164.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.8 mt -126.23 98.94 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.4 103.26 14.64 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.073 0.949 . . . . 0.0 108.546 -171.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.406 ' OG ' ' OD2' ' A' ' 151' ' ' ASP . 72.7 m -72.83 76.93 1.14 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.826 173.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.8 p -56.31 -39.63 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 118.709 0.686 . . . . 0.0 110.585 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.55 -12.66 10.55 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.301 1.84 . . . . 0.0 113.907 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' A' ' 151' ' ' ASP . 39.4 mtmt -128.68 7.73 5.74 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.503 1.521 . . . . 0.0 111.639 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.5 t30 32.76 74.0 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.948 2.499 . . . . 0.0 112.801 -159.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.41 167.86 20.55 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.52 142.97 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 164.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -125.15 165.59 17.97 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 158.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 46.7 ttm -132.47 133.97 44.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.4 t -137.98 161.0 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 -171.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -72.87 161.97 30.06 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.774 -1.829 . . . . 0.0 112.429 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.24 142.13 58.4 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 161.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.3 tt -60.48 137.07 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.002 1.321 . . . . 0.0 109.414 -176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -150.44 114.17 5.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 103.396 -2.816 . . . . 0.0 103.396 171.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.2 mt -137.87 -159.54 0.97 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.518 1.527 . . . . 0.0 108.357 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.0 m -144.56 175.31 10.23 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.437 -1.415 . . . . 0.0 107.65 162.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.28 -41.08 60.19 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.341 1.457 . . . . 0.0 113.363 -159.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.419 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 2.1 m-20 -77.06 -18.44 58.05 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -175.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -66.45 -47.27 73.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.965 0.802 . . . . 0.0 109.834 -176.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -62.12 15.23 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.285 2.234 . . . . 0.0 115.889 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.419 ' NE ' ' HA ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -133.22 -9.41 2.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 170.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -122.63 -17.56 6.88 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.19 0.905 . . . . 0.0 112.619 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 pt -110.75 19.01 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 118.949 0.795 . . . . 0.0 111.483 169.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -127.27 166.58 17.5 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.271 1.028 . . . . 0.0 111.534 -173.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.412 ' CG ' HH12 ' A' ' 66' ' ' ARG . 0.9 OUTLIER -58.62 137.56 86.22 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 163.352 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -67.83 -16.48 45.95 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.334 2.022 . . . . 0.0 112.245 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 3.7 tt0 -73.49 -42.47 61.8 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.753 -0.592 . . . . 0.0 109.856 170.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.51 -38.16 80.21 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.271 0.941 . . . . 0.0 111.125 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -54.92 -56.48 19.09 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.81 0.844 . . . . 0.0 110.824 172.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.41 ' HG2' ' HA ' ' A' ' 38' ' ' GLU . 27.6 ptt180 -63.65 -45.65 89.22 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.683 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.7 t -51.69 -37.8 20.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 125.091 1.356 . . . . 0.0 109.952 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.34 -10.84 18.28 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 176.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.62 -17.22 11.19 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.812 1.187 . . . . 0.0 113.46 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -116.1 8.77 14.57 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.254 1.022 . . . . 0.0 112.028 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.37 -30.77 0.08 Allowed 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 130.241 3.416 . . . . 0.0 113.561 -164.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.582 0 C-N-CA 126.365 1.936 . . . . 0.0 109.486 -170.527 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 CA--C 1.532 0.261 0 CA-C-O 121.606 0.717 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.66 179.32 41.91 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -173.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.2 pt -122.72 170.9 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.522 0.729 . . . . 0.0 109.617 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -97.89 143.93 27.97 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.144 0.978 . . . . 0.0 109.858 -174.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 34.2 ttt180 -127.62 146.68 50.46 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.669 1.188 . . . . 0.0 109.139 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 10.6 t -102.04 94.42 5.76 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 175.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.488 HG22 ' HA ' ' A' ' 144' ' ' ALA . 5.2 tt -58.11 -31.07 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.82 1.248 . . . . 0.0 111.371 -174.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.1 t -75.78 5.7 5.95 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.266 1.826 . . . . 0.0 111.906 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.8 p -144.06 10.63 1.53 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.741 1.216 . . . . 0.0 111.57 162.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.4 11.08 45.93 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.384 1.945 . . . . 0.0 114.712 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.0 m -114.44 142.99 45.65 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.351 1.576 . . . . 0.0 110.646 -159.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.459 ' C ' HD23 ' A' ' 74' ' ' LEU . 9.7 p-10 -95.53 147.93 23.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.467 1.507 . . . . 0.0 112.584 -178.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.482 HD22 ' HB3' ' A' ' 98' ' ' ASN 0.311 0.2 OUTLIER -152.98 -98.16 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.34 1.056 . . . . 0.0 113.666 173.485 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -49.96 131.15 22.71 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -159.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -69.64 132.1 45.66 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.447 -0.783 . . . . 0.0 109.124 171.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.8 m -62.95 -20.57 65.36 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.14 -12.57 41.09 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.202 1.365 . . . . 0.0 113.264 172.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.3 p -74.32 -25.27 59.45 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.552 -0.718 . . . . 0.0 111.886 166.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -121.69 95.07 4.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.321 1.848 . . . . 0.0 109.564 -168.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -141.93 116.07 9.41 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -137.75 110.77 7.75 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 171.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.9 p -63.48 103.16 0.49 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.127 1.371 . . . . 0.0 111.295 -167.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.47 -47.63 1.43 Allowed Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.744 1.164 . . . . 0.0 111.245 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -53.99 25.16 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.401 0.68 . . . . 0.0 110.469 177.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 47.16 23.66 1.84 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.933 2.206 . . . . 0.0 115.196 -167.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -54.66 153.28 11.01 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 118.966 1.383 . . . . 0.0 112.338 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.35 71.71 2.35 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.866 3.044 . . . . 0.0 112.26 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.9 p -133.81 149.97 51.41 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 158.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -147.24 173.46 12.53 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.66 1.184 . . . . 0.0 109.095 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -113.34 -13.6 12.88 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.473 -0.775 . . . . 0.0 112.832 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -155.27 -179.05 7.71 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.222 1.409 . . . . 0.0 108.349 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.07 166.71 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.586 1.554 . . . . 0.0 111.153 -175.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.54 -50.46 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.592 0.757 . . . . 0.0 109.534 168.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.4 m 172.81 162.58 0.12 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 130.518 3.527 . . . . 0.0 106.362 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -85.45 65.88 9.41 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -111.78 -56.78 2.34 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 124.753 1.221 . . . . 0.0 108.173 -173.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.576 HD21 HD12 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -100.66 4.15 43.02 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 175.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.32 131.42 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -107.96 140.98 40.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.387 1.475 . . . . 0.0 107.562 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.01 155.33 49.38 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.572 1.549 . . . . 0.0 109.77 175.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.36 131.54 36.5 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 128.561 2.744 . . . . 0.0 104.138 165.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.42 150.15 45.25 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 171.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.408 ' OD2' ' OG ' ' A' ' 106' ' ' SER . 53.0 t0 -148.3 140.24 23.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 158.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 16.39 0.07 Allowed 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.644 -1.285 . . . . 0.0 112.355 172.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.408 ' OG ' ' OD2' ' A' ' 104' ' ' ASP . 0.4 OUTLIER -43.51 -61.56 1.34 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 127.419 2.288 . . . . 0.0 113.149 -158.675 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pp -58.95 -14.34 8.95 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.389 1.076 . . . . 0.0 113.618 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 118.83 -4.9 14.25 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 126.651 2.072 . . . . 0.0 111.893 -172.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -141.02 -84.64 0.2 Allowed 'General case' 0 C--N 1.348 0.538 0 CA-C-N 119.645 1.723 . . . . 0.0 109.018 -174.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.2 t -147.13 108.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -173.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.412 ' HE ' ' CD2' ' A' ' 125' ' ' HIS . 44.2 ttt180 -131.17 83.31 2.1 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.478 1.511 . . . . 0.0 110.785 176.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 1.4 m -85.14 137.16 33.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.879 -0.581 . . . . 0.0 109.771 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -67.05 157.33 33.8 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.21 0.914 . . . . 0.0 111.132 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.4 t -133.82 107.13 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -129.81 154.27 47.41 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 27.8 t -69.59 137.0 51.97 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -70.43 -17.37 63.0 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.419 ' CG ' HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -104.98 -37.22 7.05 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.205 1.802 . . . . 0.0 112.781 -173.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 29.6 p -135.04 74.64 1.53 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 123.551 1.644 . . . . 0.0 108.337 171.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.82 55.93 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 1 C-N-CA 133.697 4.799 . . . . 0.0 113.462 172.334 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -112.05 -57.95 2.2 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 -159.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -138.54 -89.26 0.22 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.257 0.935 . . . . 0.0 109.678 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.422 ' HA ' ' HG3' ' A' ' 140' ' ' MET . 3.8 mt 58.94 -120.24 1.08 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.705 2.002 . . . . 0.0 109.88 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -174.96 -125.07 0.84 Allowed Glycine 0 CA--C 1.522 0.509 0 CA-C-N 118.972 0.805 . . . . 0.0 112.962 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.412 ' CD2' ' HE ' ' A' ' 111' ' ' ARG . 31.9 p-80 -161.2 179.07 8.66 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.169 0.587 . . . . 0.0 110.569 -172.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.582 HG21 ' HE2' ' A' ' 136' ' ' LYS . 2.8 p -129.62 143.24 41.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.767 1.227 . . . . 0.0 108.936 172.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -139.37 154.77 47.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.841 1.256 . . . . 0.0 109.219 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.84 113.76 10.23 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -164.93 -46.97 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.461 1.504 . . . . 0.0 111.48 -168.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -64.52 167.91 27.74 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.249 0.452 . . . . 0.0 112.508 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.55 177.16 7.79 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.594 2.196 . . . . 0.0 110.999 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -57.0 146.48 59.76 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 160.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.18 -52.6 0.16 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.529 0 CA-C-N 120.103 1.073 . . . . 0.0 114.641 15.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 17.5 p -77.95 -24.07 48.29 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -164.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.65 5.72 86.38 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 119.278 -0.734 . . . . 0.0 113.684 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.582 ' HE2' HG21 ' A' ' 126' ' ' VAL . 8.6 ptmt -132.9 159.81 38.83 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.38 1.59 . . . . 0.0 111.787 -168.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.2 ttm105 -125.07 109.17 12.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.759 1.624 . . . . 0.0 106.69 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -72.04 128.45 35.74 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 160.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 17.5 t -135.73 135.88 40.36 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.786 1.234 . . . . 0.0 108.282 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.422 ' HG3' ' HA ' ' A' ' 123' ' ' LEU . 35.1 ttm -140.04 156.5 46.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 122.276 1.036 . . . . 0.0 109.824 -165.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.58 104.11 4.33 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.469 1.908 . . . . 0.0 105.921 173.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 58.1 p -153.65 157.49 39.69 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 162.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.14 -25.01 54.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.488 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -67.56 4.91 0.91 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.745 2.018 . . . . 0.0 115.855 -159.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 83.4 mt -90.84 87.97 6.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.084 1.354 . . . . 0.0 109.674 -159.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -93.26 133.68 36.24 Favored 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -71.43 146.33 48.72 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 159.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.6 pt -137.84 166.27 27.48 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.818 1.247 . . . . 0.0 107.977 166.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.36 173.3 0.71 Allowed 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.419 2.079 . . . . 0.0 111.696 164.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -52.66 -17.81 1.48 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 -163.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.416 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 5.0 t70 -175.66 -77.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.546 2.338 . . . . 0.0 107.199 170.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -144.4 17.67 1.7 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.353 2.261 . . . . 0.0 110.175 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -74.0 -9.74 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.205 -0.934 . . . . 0.0 112.348 173.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.513 0 N-CA-C 106.935 -2.466 . . . . 0.0 106.935 159.271 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.8 pt -123.46 128.22 25.3 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.953 1.301 . . . . 0.0 110.556 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.58 108.76 2.63 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.29 2.66 . . . . 0.0 109.747 172.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.473 ' HA ' ' HD1' ' A' ' 97' ' ' HIS . 2.5 mp -86.84 155.95 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 167.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -135.45 101.53 4.84 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.896 1.279 . . . . 0.0 108.71 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.8 m -65.84 79.61 0.08 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 161.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.5 p -56.21 -41.92 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.041 0.936 . . . . 0.0 110.54 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.07 -12.03 10.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.388 1.475 . . . . 0.0 114.216 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.93 12.47 6.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.387 1.475 . . . . 0.0 110.925 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 33.57 59.15 0.52 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.105 2.562 . . . . 0.0 112.208 -167.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.8 mtp85 -106.48 169.13 8.7 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 173.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.9 t -137.6 97.94 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 168.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -98.89 81.97 2.7 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.882 1.673 . . . . 0.0 108.286 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 43.4 ttp -66.51 127.9 34.12 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.639 -0.663 . . . . 0.0 110.551 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.7 t -129.47 142.42 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.164 1.386 . . . . 0.0 108.278 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -78.99 144.1 35.06 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.399 0.619 . . . . 0.0 110.211 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 mtm105 -65.74 148.16 52.21 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.204 -160.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.91 114.87 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.286 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 168.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -145.84 102.1 3.62 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 102.626 -3.101 . . . . 0.0 102.626 170.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.7 mt -136.65 175.27 9.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.719 0.808 . . . . 0.0 109.72 -168.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.1 t -102.16 163.71 12.09 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 162.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -54.88 -30.89 59.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.04 0.936 . . . . 0.0 111.182 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.91 -27.6 60.96 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.013 2.525 . . . . 0.0 112.634 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -85.51 -45.31 11.92 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.796 1.238 . . . . 0.0 110.68 -170.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -60.61 14.15 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.749 2.42 . . . . 0.0 115.443 -174.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.29 -14.35 5.39 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.143 1.377 . . . . 0.0 113.701 172.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.34 -12.75 4.47 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.43 -172.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 pt -112.82 14.62 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 118.732 0.696 . . . . 0.0 111.356 167.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -117.32 171.84 7.7 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.192 1.397 . . . . 0.0 110.415 -175.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.93 143.01 88.33 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 165.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -70.58 -10.66 28.37 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.974 2.45 . . . . 0.0 111.875 168.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -75.61 -46.62 30.63 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 125.004 1.322 . . . . 0.0 109.889 165.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.89 -41.62 87.61 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 119.859 1.209 . . . . 0.0 110.675 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -57.21 -44.21 83.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.713 1.205 . . . . 0.0 112.014 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -80.1 -41.6 25.21 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 118.79 0.723 . . . . 0.0 110.16 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.54 HG12 ' HB1' ' A' ' 143' ' ' ALA . 23.9 t -52.75 -31.78 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 126.355 1.862 . . . . 0.0 109.728 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.77 -19.6 64.16 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 173.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.98 -31.85 12.88 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.057 1.299 . . . . 0.0 111.594 173.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -103.16 1.48 33.23 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.46 1.104 . . . . 0.0 113.371 -169.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.23 3.08 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.998 2.519 . . . . 0.0 114.712 -168.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.416 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . . . . . . 0 C--N 1.338 0.673 0 C-N-CA 125.893 1.711 . . . . 0.0 113.168 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.8 t0 . . . . . 0 C--O 1.235 0.309 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.8 153.13 11.49 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 125.444 1.497 . . . . 0.0 113.031 158.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.7 pt -130.05 154.17 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 162.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.68 126.46 32.37 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -80.36 114.27 19.15 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 158.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 19.7 t -65.11 85.07 0.05 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 162.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.9 tt -66.78 -22.92 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 122.061 -0.399 . . . . 0.0 110.487 -169.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 143' ' ' ALA . 64.7 m -61.42 -8.65 4.28 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.797 1.639 . . . . 0.0 113.704 169.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 21.4 p -138.88 15.94 2.67 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.893 1.224 . . . . 0.0 111.647 160.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.99 17.11 21.27 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.293 -1.282 . . . . 0.0 113.961 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.1 m -121.23 143.07 49.34 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.14 1.47 . . . . 0.0 108.95 -164.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.9 167.93 19.99 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.453 HD13 ' CD2' ' A' ' 75' ' ' PHE . 0.3 OUTLIER 176.08 -160.1 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 131.35 3.86 . . . . 0.0 109.001 172.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.453 ' CD2' HD13 ' A' ' 74' ' ' LEU . 5.0 m-85 0.14 107.52 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 131.548 3.939 . . . . 0.0 117.023 -165.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.12 144.58 57.0 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.454 1.502 . . . . 0.0 111.13 171.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.8 m -56.46 -30.47 62.93 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.59 -22.14 66.89 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -175.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 p -93.0 -7.37 46.02 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.729 0.695 . . . . 0.0 111.637 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.93 47.63 2.38 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.86 2.064 . . . . 0.0 108.819 -159.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -117.39 60.92 0.75 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.967 0.907 . . . . 0.0 109.666 -167.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -68.3 97.24 0.72 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.0 m -57.3 117.93 4.59 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.147 0.979 . . . . 0.0 112.039 -164.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.88 -49.86 4.29 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.354 0.978 . . . . 0.0 112.102 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.7 -43.97 91.77 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.208 1.004 . . . . 0.0 111.878 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 41.5 35.76 1.38 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 128.833 3.111 . . . . 0.0 114.662 -159.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.5 150.11 5.07 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 126.063 1.745 . . . . 0.0 110.243 175.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.96 69.91 6.1 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.564 2.842 . . . . 0.0 110.769 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.6 p -144.96 152.39 40.1 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.752 1.621 . . . . 0.0 108.821 -177.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.95 168.48 19.61 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.88 1.272 . . . . 0.0 109.085 -176.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -115.84 -9.75 11.8 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 118.811 -0.614 . . . . 0.0 112.445 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -156.64 176.02 13.28 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.846 1.259 . . . . 0.0 107.925 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.6 t -125.99 149.12 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.627 0.771 . . . . 0.0 110.907 -162.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 p -56.54 -54.65 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 126.452 1.901 . . . . 0.0 110.769 171.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.0 m 169.8 164.1 0.06 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 130.669 3.588 . . . . 0.0 107.282 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 mp0 -76.92 64.55 2.45 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.823 1.649 . . . . 0.0 109.508 173.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.473 ' HD1' ' HA ' ' A' ' 10' ' ' ILE . 18.5 p80 -115.41 -54.79 2.51 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.879 0.872 . . . . 0.0 109.284 -170.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -121.38 14.24 11.16 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.463 1.105 . . . . 0.0 111.859 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.88 150.77 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.807 1.643 . . . . 0.0 108.846 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -123.27 150.32 43.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.876 2.07 . . . . 0.0 110.771 -174.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.4 mt -145.72 137.14 24.98 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.804 2.442 . . . . 0.0 110.298 -166.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.98 117.25 11.28 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 129.102 2.961 . . . . 0.0 105.879 159.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -104.08 144.26 31.8 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.242 1.017 . . . . 0.0 110.869 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -152.62 179.44 8.61 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.946 2.499 . . . . 0.0 108.11 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.51 27.52 8.29 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.704 -1.248 . . . . 0.0 111.43 173.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.74 -38.9 67.71 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -159.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 pp -75.86 -9.41 58.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.16 6.09 37.03 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 117.579 -1.678 . . . . 0.0 112.781 -168.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 13.3 tpt -145.67 -91.23 0.1 Allowed 'General case' 0 C--N 1.349 0.567 0 CA-C-N 120.298 2.049 . . . . 0.0 109.212 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.3 t -139.37 119.68 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 172.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.424 HH21 ' CE1' ' A' ' 125' ' ' HIS . 17.5 ttt180 -121.83 128.23 51.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 165.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 43.3 t -124.49 142.55 51.24 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 168.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -67.61 162.68 22.98 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.886 170.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 73.2 t -136.81 108.67 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 169.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -125.29 173.09 9.05 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 168.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 39.6 t -71.29 159.59 34.32 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.448 -0.783 . . . . 0.0 108.985 171.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -81.55 -13.89 57.51 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 170.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -115.94 -58.44 2.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 173.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.2 p -94.71 62.39 2.73 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.8 51.29 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 128.362 2.665 . . . . 0.0 113.434 -168.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.38 -71.77 0.59 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.787 1.235 . . . . 0.0 113.359 -167.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -130.79 -83.93 0.53 Allowed 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.761 0.824 . . . . 0.0 109.135 -165.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mt 50.66 -108.88 0.37 Allowed 'General case' 0 C--N 1.338 0.097 0 C-N-CA 126.89 2.076 . . . . 0.0 109.989 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.23 -125.42 0.94 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.586 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.424 ' CE1' HH21 ' A' ' 111' ' ' ARG . 20.3 p-80 -162.42 178.97 8.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.387 -0.478 . . . . 0.0 110.468 -170.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.571 HG21 ' HE2' ' A' ' 136' ' ' LYS . 2.9 p -129.5 143.25 41.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 124.72 1.208 . . . . 0.0 108.89 172.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -133.79 150.79 51.45 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 124.225 0.953 . . . . 0.0 110.744 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -64.13 106.83 1.14 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.048 1.339 . . . . 0.0 109.333 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -167.57 -48.53 0.02 OUTLIER 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.082 1.353 . . . . 0.0 111.472 -169.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -65.18 172.37 21.8 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.785 0.707 . . . . 0.0 113.408 -170.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -69.83 167.84 23.38 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.253 1.969 . . . . 0.0 111.348 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -61.63 151.6 77.73 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 162.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.33 -47.67 0.3 Allowed 'Cis proline' 0 C--N 1.347 0.472 0 CA-C-N 119.944 1.016 . . . . 0.0 114.182 14.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.2 p -73.96 -26.28 60.4 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -166.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.72 5.62 79.46 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 119.184 0.902 . . . . 0.0 113.678 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.571 ' HE2' HG21 ' A' ' 126' ' ' VAL . 10.3 ptmt -130.23 156.83 43.96 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.983 1.391 . . . . 0.0 111.275 -168.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 14.7 ttt85 -125.27 103.83 8.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.271 1.828 . . . . 0.0 108.234 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -73.89 141.19 46.06 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.105 1.362 . . . . 0.0 107.346 167.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 53.7 t -142.92 136.13 28.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.319 1.847 . . . . 0.0 107.703 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 6.8 ttt -144.71 141.54 29.37 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.744 0.818 . . . . 0.0 108.976 -174.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -148.11 93.48 2.18 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.589 1.156 . . . . 0.0 108.917 -170.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 77.3 p -163.27 -173.41 3.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 167.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.54 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -56.75 -21.31 27.32 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.225 1.41 . . . . 0.0 114.183 168.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.34 26.29 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.725 2.41 . . . . 0.0 115.98 -164.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 62.3 mt -121.33 38.33 4.11 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.744 1.218 . . . . 0.0 111.852 -162.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -75.47 108.99 8.64 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -64.19 140.18 58.84 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.477 -0.764 . . . . 0.0 109.207 163.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.3 pt -128.01 165.25 31.8 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 159.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -53.34 163.08 2.65 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.584 2.856 . . . . 0.0 112.976 166.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -15.76 -53.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 129.669 3.188 . . . . 0.0 114.865 173.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -157.08 -67.68 0.1 Allowed 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 127.313 2.245 . . . . 0.0 111.283 159.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -144.17 1.42 1.1 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.353 1.461 . . . . 0.0 110.9 -163.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.06 -19.03 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.189 1.796 . . . . 0.0 114.56 -170.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.958 0 CA-C-O 116.951 -2.027 . . . . 0.0 109.529 -177.523 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 8.6 ttt85 . . . . . 0 CA--C 1.508 -0.659 0 CA-C-O 121.291 0.567 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.509 HD11 ' HD3' ' A' ' 118' ' ' ARG . 7.7 pt -136.45 146.94 57.95 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 113.89 -1.505 . . . . 0.0 112.259 -177.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.86 134.12 10.56 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.71 2.94 . . . . 0.0 111.485 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.4 mm -114.58 100.11 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 127.053 2.141 . . . . 0.0 105.737 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -100.4 124.18 45.57 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.9 m -101.8 87.1 3.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -54.01 -39.3 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.679 0.791 . . . . 0.0 111.255 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.645 ' HB1' ' HD2' ' A' ' 150' ' ' ARG . . . -52.65 -25.58 11.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.286 2.234 . . . . 0.0 114.78 178.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -124.71 7.1 8.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.763 2.025 . . . . 0.0 111.348 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 33.44 63.1 0.37 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.53 2.332 . . . . 0.0 111.638 -161.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.5 mtp-105 -109.87 164.28 12.73 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.1 p -134.85 144.92 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 158.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -136.71 165.55 25.64 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 158.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.7 ttp -127.66 116.98 21.12 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -170.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.76 139.12 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.044 1.738 . . . . 0.0 107.64 -160.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 7' ' ' ARG 0.284 3.5 pm0 -89.53 148.87 23.15 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 122.234 1.016 . . . . 0.0 112.42 -169.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.484 ' HG2' HH11 ' A' ' 23' ' ' ARG . 0.0 OUTLIER -66.93 146.18 54.66 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.329 -162.503 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.13 118.81 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -167.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -137.73 101.83 4.57 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.487 1.515 . . . . 0.0 107.388 173.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.437 HD11 HD11 ' A' ' 34' ' ' ILE . 40.9 mt -134.15 177.83 7.44 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 127.227 2.211 . . . . 0.0 106.83 166.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.6 t -162.73 -14.84 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -176.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 30' ' ' GLU . 8.4 t70 -118.63 -146.51 0.39 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.623 1.102 . . . . 0.0 109.576 -171.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.7 5.35 0.12 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.841 1.657 . . . . 0.0 113.643 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 28' ' ' ASP . 27.8 mt-10 -62.79 -44.61 95.73 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 125.577 1.551 . . . . 0.0 110.728 -163.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -68.58 45.03 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 128.334 2.654 . . . . 0.0 112.179 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.38 -44.35 0.07 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.469 1.908 . . . . 0.0 108.878 160.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -75.22 -27.19 59.44 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.446 -0.788 . . . . 0.0 112.305 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.437 HD11 HD11 ' A' ' 26' ' ' LEU . 4.6 pt -110.83 28.18 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 119.377 0.99 . . . . 0.0 111.847 176.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mt -117.93 166.57 12.34 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 125.133 1.373 . . . . 0.0 111.511 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.506 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 5.2 m-20 -61.35 146.76 88.61 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 163.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -67.3 -9.71 26.15 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.471 2.114 . . . . 0.0 112.327 169.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -78.63 -51.83 9.32 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.973 1.709 . . . . 0.0 109.95 163.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.506 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -58.67 -37.93 77.08 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.45 1.477 . . . . 0.0 110.451 -176.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -52.6 -52.9 53.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.896 1.278 . . . . 0.0 111.84 173.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.402 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 19.4 ptp180 -77.21 -45.08 27.75 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.596 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.855 HG12 ' HB1' ' A' ' 143' ' ' ALA . 54.9 t -53.72 -31.15 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.56 1.144 . . . . 0.0 110.13 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.59 -18.31 64.77 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 174.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -102.34 -37.03 8.24 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.383 1.447 . . . . 0.0 112.43 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 41' ' ' ARG . 18.0 ptpt -97.29 2.95 51.34 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.798 1.239 . . . . 0.0 113.2 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.69 13.82 0.55 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.773 2.429 . . . . 0.0 114.437 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.711 0 C-N-CA 125.645 1.593 . . . . 0.0 109.381 177.492 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.8 t0 . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 122.109 0.957 . . . . 0.0 113.088 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.23 154.64 25.53 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 128.558 2.98 . . . . 0.0 110.1 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.6 pt -140.07 174.7 7.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.724 1.21 . . . . 0.0 109.327 173.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -99.79 108.34 20.61 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.564 1.146 . . . . 0.0 110.285 -177.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.54 122.96 20.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 158.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.496 ' HB2' HD11 ' A' ' 74' ' ' LEU . 40.5 t -72.16 90.39 1.21 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 158.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.701 HD12 ' HD2' ' A' ' 146' ' ' LYS . 17.1 tt -65.15 -21.42 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 121.984 -0.447 . . . . 0.0 111.092 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.3 t -72.66 -0.25 12.52 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.12 1.768 . . . . 0.0 111.859 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.7 p -143.82 9.5 1.54 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.427 1.012 . . . . 0.0 113.334 160.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.76 55.36 30.44 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 -176.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 73' ' ' ASP . 49.2 m -151.95 179.08 8.77 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.75 -1.441 . . . . 0.0 108.467 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.44 ' C ' HD13 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -132.5 141.27 48.7 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.135 1.374 . . . . 0.0 108.487 -163.598 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 67' ' ' CYS 0.283 0.0 OUTLIER -151.23 -89.55 0.06 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 177.8 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -54.29 151.65 7.17 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.263 1.025 . . . . 0.0 112.96 -170.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.431 ' OD2' ' HB2' ' A' ' 14' ' ' ALA . 12.0 t70 -126.32 150.75 48.31 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.743 1.217 . . . . 0.0 111.099 -166.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.4 t -59.94 -23.06 63.25 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.053 -1.451 . . . . 0.0 113.739 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -60.54 -19.69 57.98 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 120.953 1.706 . . . . 0.0 112.583 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.422 ' HA ' ' CE2' ' A' ' 91' ' ' TYR 0.253 2.2 t -119.65 -3.76 10.32 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.401 1.48 . . . . 0.0 111.035 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -96.51 94.45 7.38 Favored 'General case' 0 C--N 1.344 0.36 0 O-C-N 120.739 -1.226 . . . . 0.0 109.781 -175.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -63.22 127.33 30.78 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 163.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.547 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 1.7 t70 -147.13 -58.92 0.27 Allowed 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 127.474 2.31 . . . . 0.0 107.322 -163.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.8 m -51.89 111.78 0.67 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.519 1.527 . . . . 0.0 111.401 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.07 -43.19 0.64 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.333 1.92 . . . . 0.0 114.743 174.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.3 m -81.93 -72.0 0.46 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.041 1.336 . . . . 0.0 108.88 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 82' ' ' ASP . . . 48.46 45.24 29.21 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 126.467 1.984 . . . . 0.0 114.26 170.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.21 148.07 34.96 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 113.801 -1.199 . . . . 0.0 107.952 166.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.67 68.59 7.03 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.836 2.357 . . . . 0.0 110.574 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.6 p -139.02 150.16 45.5 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.703 1.201 . . . . 0.0 109.222 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -130.04 166.2 20.62 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.629 1.972 . . . . 0.0 107.779 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.422 ' CE2' ' HA ' ' A' ' 79' ' ' THR . 41.7 p90 -123.57 -16.43 6.76 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.31 176.08 9.14 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.55 2.34 . . . . 0.0 106.073 175.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.9 p -145.5 155.86 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 121.681 -0.637 . . . . 0.0 110.982 -168.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 p -60.93 -36.27 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.397 1.479 . . . . 0.0 111.501 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.5 m 140.21 151.84 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 1 C-N-CA 131.794 4.038 . . . . 0.0 108.113 -169.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -75.9 52.17 0.68 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.981 1.712 . . . . 0.0 111.021 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -105.63 -49.1 3.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.274 1.029 . . . . 0.0 109.593 -167.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.505 ' HA ' ' HB3' ' A' ' 117' ' ' ALA . 38.5 t-20 -125.26 22.97 7.73 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.526 1.13 . . . . 0.0 111.346 165.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.03 125.52 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 163.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.47 148.97 25.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.996 2.118 . . . . 0.0 107.142 -178.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mp -134.58 160.6 37.57 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.576 1.151 . . . . 0.0 108.752 167.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.447 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 6.1 mpt_? -133.57 130.12 37.97 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 131.336 3.854 . . . . 0.0 102.903 162.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -66.07 140.63 58.26 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.4 0.619 . . . . 0.0 109.592 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -142.69 171.86 13.48 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 103.808 -2.664 . . . . 0.0 103.808 158.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -130.74 18.93 5.13 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.561 2.344 . . . . 0.0 110.281 -173.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 t -54.64 -38.35 66.78 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 128.332 2.653 . . . . 0.0 113.702 -159.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.0 pp -75.69 -8.38 56.68 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.16 4.06 41.43 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.338 1.446 . . . . 0.0 112.55 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 97.2 mtp -140.14 -99.17 0.15 Allowed 'General case' 0 C--N 1.346 0.43 0 CA-C-N 119.382 1.591 . . . . 0.0 107.915 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -143.97 100.98 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.272 0 CA-C-N 120.733 1.606 . . . . 0.0 108.225 -173.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -114.54 61.36 0.67 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.071 1.348 . . . . 0.0 111.085 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 46.7 m -70.07 137.7 51.44 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.447 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 18.8 pt-20 -64.58 158.32 24.61 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.95 0.796 . . . . 0.0 110.591 173.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.8 t -139.22 102.21 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -132.2 160.17 36.88 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.3 m -70.97 128.24 35.31 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.505 ' HB3' ' HA ' ' A' ' 98' ' ' ASN . . . -72.61 -18.84 61.56 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -169.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.509 ' HD3' HD11 ' A' ' 8' ' ' ILE . 1.8 tpt180 -78.87 -38.17 38.39 Favored 'General case' 0 CA--C 1.525 0.012 0 C-N-CA 126.483 1.913 . . . . 0.0 111.794 168.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 23.9 p -146.51 89.66 1.87 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.501 1.521 . . . . 0.0 107.846 -166.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.18 55.27 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.323 2.649 . . . . 0.0 112.127 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -74.76 -77.26 0.12 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -158.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.416 ' H ' ' CD2' ' A' ' 123' ' ' LEU . 55.4 t-80 -138.14 -73.19 0.41 Allowed 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.416 ' CD2' ' H ' ' A' ' 122' ' ' HIS . 1.9 mm? 56.83 -112.74 0.71 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.808 2.043 . . . . 0.0 108.228 169.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.72 -126.95 1.27 Allowed Glycine 0 CA--C 1.526 0.72 0 CA-C-N 119.504 1.047 . . . . 0.0 113.959 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -155.59 172.91 17.48 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.349 0.659 . . . . 0.0 111.227 -174.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.451 HG21 ' HE2' ' A' ' 136' ' ' LYS . 5.1 p -114.3 144.41 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 C-N-CA 124.516 1.126 . . . . 0.0 108.024 170.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -144.89 157.9 43.99 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.191 0.996 . . . . 0.0 110.627 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.15 102.34 2.48 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.378 1.871 . . . . 0.0 109.155 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -165.74 -48.7 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.335 1.054 . . . . 0.0 111.348 -171.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -66.18 173.08 24.81 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 123.173 0.416 . . . . 0.0 112.909 -173.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.42 168.26 24.77 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.698 2.266 . . . . 0.0 111.77 -171.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -61.06 151.44 75.09 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 161.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.44 -42.23 0.84 Allowed 'Cis proline' 0 C--N 1.345 0.383 0 CA-C-N 119.999 1.035 . . . . 0.0 114.655 16.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.3 p -77.29 -30.04 54.05 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -168.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.48 13.55 82.8 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 118.77 0.714 . . . . 0.0 113.767 -174.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.451 ' HE2' HG21 ' A' ' 126' ' ' VAL . 11.4 ptmt -128.71 154.56 46.21 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 119.172 1.486 . . . . 0.0 111.029 -171.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.3 ttm105 -120.82 106.19 11.43 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -71.99 126.98 31.14 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 160.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 23.6 t -135.82 126.85 27.84 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.607 1.094 . . . . 0.0 108.184 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -145.65 147.48 32.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.279 0.632 . . . . 0.0 109.632 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -140.89 130.36 23.88 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.2 p -168.98 174.66 6.22 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.686 1.594 . . . . 0.0 107.941 167.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.855 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -62.91 -9.15 8.72 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.301 1.04 . . . . 0.0 112.972 167.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.27 -20.43 63.05 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.692 1.197 . . . . 0.0 114.202 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.2 mt -83.12 74.38 10.0 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.112 0.869 . . . . 0.0 111.333 -161.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.701 ' HD2' HD12 ' A' ' 68' ' ' ILE . 66.8 tttt -98.3 119.16 36.49 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.045 0.938 . . . . 0.0 110.006 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.18 147.14 53.77 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.961 0.41 . . . . 0.0 110.192 164.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.7 pt -140.89 170.22 9.92 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 126.516 1.926 . . . . 0.0 108.42 162.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -54.86 177.19 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.541 3.494 . . . . 0.0 113.184 159.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.645 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 5.5 mmt-85 -32.39 -45.42 0.11 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.726 2.411 . . . . 0.0 115.989 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -165.42 -71.85 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.577 0.751 . . . . 0.0 108.988 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.9 9.19 0.77 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.906 1.282 . . . . 0.0 112.799 -176.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.5 pp -67.85 -30.68 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -169.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 CA-C-O 117.191 -1.894 . . . . 0.0 109.478 -175.711 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 119.846 -0.121 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.483 ' HB ' HD21 ' A' ' 98' ' ' ASN . 47.2 pt -122.2 110.25 32.8 Favored Pre-proline 0 CA--C 1.536 0.435 0 O-C-N 120.715 -1.241 . . . . 0.0 110.842 -173.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.03 140.42 34.61 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.42 1.413 . . . . 0.0 109.016 171.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.6 mt -127.9 149.13 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -132.06 152.32 51.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -175.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.2 m -126.73 80.13 1.92 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 p -57.05 -39.2 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 123.005 0.522 . . . . 0.0 110.908 -169.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.75 2.81 3.74 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.333 1.053 . . . . 0.0 113.604 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -135.45 5.75 3.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.567 2.347 . . . . 0.0 110.274 171.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 34.09 42.6 0.06 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 128.375 2.67 . . . . 0.0 113.393 -162.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -87.09 161.99 17.82 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.315 -0.866 . . . . 0.0 108.995 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -135.96 132.19 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 167.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -133.83 107.05 7.64 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.868 1.667 . . . . 0.0 106.535 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 40.5 ttp -81.76 136.45 35.43 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.099 -1.001 . . . . 0.0 108.637 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.4 t -129.27 169.77 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.708 2.003 . . . . 0.0 106.067 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -99.95 152.82 19.73 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 120.526 -1.359 . . . . 0.0 110.37 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.426 ' CG ' ' HD3' ' A' ' 118' ' ' ARG . 25.0 ttm180 -68.18 137.2 54.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.02 1.728 . . . . 0.0 110.427 -168.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.2 tt -74.4 125.7 34.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.482 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.9 -170.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -154.37 110.67 3.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.9 mt -138.88 173.77 11.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.591 1.556 . . . . 0.0 109.256 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.63 159.02 21.66 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.042 2.137 . . . . 0.0 107.786 165.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.53 -35.09 76.75 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.562 -0.711 . . . . 0.0 112.607 -172.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.22 -28.62 65.41 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-O 121.051 0.453 . . . . 0.0 112.192 -174.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -59.72 -38.15 80.87 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.011 1.324 . . . . 0.0 110.048 -169.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -61.47 11.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.047 2.539 . . . . 0.0 116.61 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.89 -1.35 2.71 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 166.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -126.73 -20.59 4.25 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.825 -174.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 pt -109.13 -1.64 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.635 0.652 . . . . 0.0 111.704 165.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -101.72 163.72 12.11 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.306 1.042 . . . . 0.0 110.573 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.96 142.62 79.22 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.371 0.668 . . . . 0.0 109.772 168.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -65.84 -16.53 53.3 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.02 1.813 . . . . 0.0 111.453 166.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -71.57 -42.9 67.22 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 121.982 -0.449 . . . . 0.0 110.014 169.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.6 -44.47 96.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 121.225 -0.922 . . . . 0.0 109.912 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -56.8 -45.24 82.32 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.144 0.978 . . . . 0.0 112.336 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -76.44 -49.26 17.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -176.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.734 HG13 ' HA2' ' A' ' 47' ' ' GLY . 74.0 t -54.54 -33.41 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 125.156 1.382 . . . . 0.0 108.685 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.01 -18.95 63.88 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.44 -26.39 14.47 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.244 1.384 . . . . 0.0 112.192 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -108.86 -1.37 19.22 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 124.575 1.15 . . . . 0.0 112.779 -172.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.18 -2.4 0.05 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.18 2.592 . . . . 0.0 115.059 -169.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.734 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . . . . . . 0 C--N 1.339 0.744 0 CA-C-N 119.417 1.008 . . . . 0.0 111.94 174.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.5 t0 . . . . . 0 C--O 1.238 0.469 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.521 ' H ' ' HG2' ' A' ' 150' ' ' ARG . . . 100.53 168.41 28.82 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 125.116 1.341 . . . . 0.0 112.167 161.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 76' ' ' ASP . 38.6 pt -135.35 164.21 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 113.587 -1.307 . . . . 0.0 108.091 163.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -78.27 122.57 25.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.634 0.73 . . . . 0.0 109.306 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.79 117.48 23.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.234 1.814 . . . . 0.0 106.377 163.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 5.2 t -71.38 69.72 0.58 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.455 1.502 . . . . 0.0 108.746 171.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.4 tt -61.46 -19.39 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 125.512 1.525 . . . . 0.0 112.754 -169.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.1 t -70.89 -1.0 10.36 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.267 1.427 . . . . 0.0 112.617 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 9.6 p -146.19 -7.57 0.54 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.494 1.043 . . . . 0.0 113.246 158.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.9 -8.28 59.45 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.207 -1.329 . . . . 0.0 113.032 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.2 m -64.34 171.79 2.9 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.483 2.713 . . . . 0.0 111.137 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.93 152.43 51.08 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.767 1.627 . . . . 0.0 107.9 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.411 HD13 ' CD2' ' A' ' 75' ' ' PHE 0.28 0.3 OUTLIER -155.34 -98.85 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 178.996 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.411 ' CD2' HD13 ' A' ' 74' ' ' LEU . 28.2 m-85 -61.51 132.42 53.34 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.489 1.041 . . . . 0.0 113.723 -158.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.506 ' HA ' HG22 ' A' ' 64' ' ' ILE . 4.4 m-20 -79.46 136.6 36.97 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.52 1.128 . . . . 0.0 110.805 173.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 58.7 m -53.02 -33.6 52.48 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.448 1.099 . . . . 0.0 113.527 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.7 -17.48 63.02 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.147 0.979 . . . . 0.0 113.235 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.4 p -76.23 -23.31 54.53 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 121.705 -0.622 . . . . 0.0 112.037 172.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HE3' ' O ' ' A' ' 87' ' ' TRP . 1.3 mtpt -86.96 -169.81 2.79 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.524 1.53 . . . . 0.0 109.806 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -133.18 32.78 3.68 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.847 0.859 . . . . 0.0 113.051 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -54.96 -21.97 13.53 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.407 1.483 . . . . 0.0 112.424 166.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.0 p -66.54 58.67 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.293 2.237 . . . . 0.0 110.802 165.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.95 -32.91 2.8 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.555 1.55 . . . . 0.0 113.615 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.3 m -131.3 -60.41 0.95 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.549 1.674 . . . . 0.0 112.449 -167.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.08 7.29 87.25 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 115.586 0.994 . . . . 0.0 115.586 177.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.417 ' O ' ' HE3' ' A' ' 80' ' ' LYS . 2.8 t90 -67.01 144.9 98.76 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 118.44 1.12 . . . . 0.0 109.147 173.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.48 64.32 6.45 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.207 3.271 . . . . 0.0 112.393 -173.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 61.5 p -133.52 141.64 47.84 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.052 1.741 . . . . 0.0 108.983 173.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.83 168.22 19.14 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.82 1.648 . . . . 0.0 109.208 -175.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -129.4 -9.14 4.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -146.23 175.42 10.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 169.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.81 155.7 27.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 122.232 1.015 . . . . 0.0 111.682 -167.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.76 -36.44 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.898 1.679 . . . . 0.0 111.634 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.2 m 151.04 160.08 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 131.295 3.838 . . . . 0.0 108.642 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -77.26 66.54 3.05 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.151 0.98 . . . . 0.0 108.591 168.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -109.17 -54.05 2.58 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.163 0.585 . . . . 0.0 110.114 -173.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.483 HD21 ' HB ' ' A' ' 8' ' ' ILE . 1.0 OUTLIER -133.75 23.49 3.96 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 174.336 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.52 138.31 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 125.813 1.645 . . . . 0.0 106.708 172.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -105.35 137.22 43.49 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 127.251 2.22 . . . . 0.0 109.061 -174.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mp -136.71 153.42 50.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.197 1.799 . . . . 0.0 111.101 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.465 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 0.9 OUTLIER -143.88 129.56 19.23 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 131.43 3.892 . . . . 0.0 104.332 164.093 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -62.18 145.44 53.46 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.559 1.144 . . . . 0.0 110.421 166.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -150.34 175.7 11.58 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 158.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.08 20.22 13.87 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.026 1.33 . . . . 0.0 110.917 175.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.9 m -64.68 26.89 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 129.803 3.241 . . . . 0.0 116.654 -169.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 pp -130.85 -7.29 3.99 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.086 1.354 . . . . 0.0 112.086 162.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.45 -1.73 32.66 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 117.08 -1.955 . . . . 0.0 113.09 -168.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.8 mtm -141.29 -87.59 0.17 Allowed 'General case' 0 C--N 1.35 0.599 0 CA-C-N 120.733 2.266 . . . . 0.0 109.442 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 49.1 t -145.92 113.78 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -123.63 94.36 4.22 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.001 1.72 . . . . 0.0 108.566 174.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 14.6 t -105.91 129.27 54.09 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -174.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.465 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 17.8 pt-20 -64.44 160.08 19.99 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.114 0.87 . . . . 0.0 112.119 -174.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.5 t -138.73 105.93 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -126.93 173.79 9.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.051 0.94 . . . . 0.0 108.607 170.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.5 t -70.18 149.02 47.96 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.165 -0.959 . . . . 0.0 109.161 165.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.07 -16.48 63.7 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.426 ' HD3' ' CG ' ' A' ' 23' ' ' ARG . 28.2 tpt85 -117.72 -70.07 0.81 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-O 118.27 -0.871 . . . . 0.0 113.243 170.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 17.0 p -68.13 18.72 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 118.664 2.838 . . . . 0.0 118.664 -158.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 61.79 -11.44 0.07 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.955 2.502 . . . . 0.0 116.464 166.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.48 150.12 40.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.924 0.89 . . . . 0.0 112.388 -163.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -33.39 -59.84 0.37 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 128.734 2.814 . . . . 0.0 113.224 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 45.52 -106.01 0.11 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.875 2.07 . . . . 0.0 109.365 -173.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.29 -119.56 0.69 Allowed Glycine 0 CA--C 1.522 0.491 0 CA-C-N 118.081 0.4 . . . . 0.0 112.209 171.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -163.84 172.27 14.29 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.166 0.586 . . . . 0.0 110.412 -172.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.645 HG21 ' HE2' ' A' ' 136' ' ' LYS . 3.5 p -115.45 139.54 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.423 1.489 . . . . 0.0 108.828 171.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -131.29 148.93 52.73 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.214 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.79 82.66 1.63 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.076 1.751 . . . . 0.0 109.991 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -156.51 -0.91 0.13 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.678 1.191 . . . . 0.0 112.682 -166.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.66 179.24 34.28 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 120.382 -1.449 . . . . 0.0 113.116 -169.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.44 158.84 53.14 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.707 2.272 . . . . 0.0 110.731 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 45.9 mtp85 -64.56 154.75 83.64 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 164.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.02 -41.49 0.96 Allowed 'Cis proline' 0 C--N 1.348 0.532 0 CA-C-N 119.922 1.008 . . . . 0.0 113.787 8.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.6 p -69.32 -30.08 68.06 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -168.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.94 3.88 75.71 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.817 0.722 . . . . 0.0 113.455 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.645 ' HE2' HG21 ' A' ' 126' ' ' VAL . 13.2 ptmt -123.27 152.66 41.14 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.458 1.629 . . . . 0.0 111.222 -166.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 27.3 ttm105 -125.56 99.07 5.85 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.968 1.707 . . . . 0.0 106.751 -177.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -70.06 139.17 52.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 163.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 35.1 t -143.66 140.49 30.11 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.5 1.12 . . . . 0.0 108.322 174.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -148.36 157.83 43.72 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.689 0.395 . . . . 0.0 111.312 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -155.96 126.45 6.75 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.599 1.56 . . . . 0.0 108.607 170.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 91.6 p -171.29 -179.8 2.75 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.214 1.406 . . . . 0.0 109.044 163.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.51 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -60.48 -17.17 43.31 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 165.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.79 8.93 0.76 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 120.694 1.588 . . . . 0.0 114.093 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.0 mt -115.6 69.47 0.73 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.63 1.172 . . . . 0.0 110.189 -164.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -97.52 129.69 44.66 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -75.55 145.62 41.11 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.575 0.625 . . . . 0.0 109.55 167.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 28.1 pt -138.13 168.06 17.6 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 126.256 1.823 . . . . 0.0 108.294 167.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -54.07 160.84 5.65 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.657 2.905 . . . . 0.0 112.124 163.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.521 ' HG2' ' H ' ' A' ' 63' ' ' GLY . 1.6 mmt180 -47.69 -26.27 1.48 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -165.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -161.45 -70.33 0.06 Allowed 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 128.728 2.811 . . . . 0.0 108.998 159.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -148.97 7.58 0.72 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.881 2.472 . . . . 0.0 110.126 -173.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.7 pp -56.77 -24.47 19.72 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 C-N-CA 124.877 1.271 . . . . 0.0 113.938 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 CA-C-O 116.969 -2.017 . . . . 0.0 109.271 174.998 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.581 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.7 pt -128.9 117.64 19.39 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 125.831 1.652 . . . . 0.0 108.918 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.99 136.11 22.15 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.488 1.458 . . . . 0.0 108.403 166.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.1 mt -117.93 111.58 34.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -113.52 97.28 6.35 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.149 1.38 . . . . 0.0 108.488 -176.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -68.98 83.39 0.32 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.559 0.744 . . . . 0.0 109.234 170.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.4 p -55.07 -39.12 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 118.41 0.55 . . . . 0.0 111.159 -173.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -14.53 20.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.844 1.258 . . . . 0.0 113.98 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -126.64 2.87 6.81 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 126.318 1.847 . . . . 0.0 111.059 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 36.08 44.11 0.24 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.406 1.882 . . . . 0.0 111.665 -159.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.69 160.4 30.82 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 117.676 -1.609 . . . . 0.0 108.654 168.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.5 t -140.85 128.41 22.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 103.96 -2.607 . . . . 0.0 103.96 162.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -142.67 119.69 11.35 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.441 1.496 . . . . 0.0 107.62 169.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 28.9 ttp -83.58 142.98 30.45 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 172.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.5 t -140.94 177.23 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 129.42 3.088 . . . . 0.0 103.19 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 15.7 pt-20 -108.17 169.4 8.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 120.373 1.442 . . . . 0.0 114.052 174.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.97 171.24 1.28 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.636 0.774 . . . . 0.0 110.038 176.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.32 131.63 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.553 1.141 . . . . 0.0 111.416 -169.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -157.15 99.97 1.83 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.829 0.851 . . . . 0.0 109.357 173.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.6 mt -143.9 169.48 17.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.428 2.291 . . . . 0.0 108.612 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.503 ' H ' ' CG ' ' A' ' 30' ' ' GLU . 0.7 OUTLIER -90.35 164.23 14.41 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 127.098 2.159 . . . . 0.0 109.878 176.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.22 57.9 1.52 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.382 1.087 . . . . 0.0 110.055 160.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.06 -12.06 0.22 Allowed 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 124.694 1.198 . . . . 0.0 111.869 158.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.503 ' CG ' ' H ' ' A' ' 27' ' ' SER . 45.0 mm-40 -81.92 -49.09 10.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.545 -0.722 . . . . 0.0 109.976 -170.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.441 ' CE3' ' CD1' ' A' ' 35' ' ' LEU . 62.5 m95 -60.72 9.37 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.45 1.9 . . . . 0.0 114.9 -175.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.68 -0.66 4.33 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.441 1.497 . . . . 0.0 114.879 177.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.97 -23.11 2.01 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.592 173.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 pt -103.33 16.96 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 119.306 0.957 . . . . 0.0 110.517 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.461 HD22 ' CB ' ' A' ' 39' ' ' ALA . 3.4 mt -139.67 160.16 40.5 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.078 0.951 . . . . 0.0 112.138 -174.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.479 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 2.4 m-20 -59.36 148.52 72.68 Favored Pre-proline 0 C--O 1.238 0.489 0 C-N-CA 124.353 1.061 . . . . 0.0 110.159 172.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -63.08 -18.37 64.79 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.749 1.633 . . . . 0.0 111.328 165.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -72.21 -50.68 25.67 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 119.323 -0.37 . . . . 0.0 110.119 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.479 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -58.14 -44.17 87.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 119.068 0.849 . . . . 0.0 110.509 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -53.95 -51.84 62.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.034 1.334 . . . . 0.0 111.911 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.411 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 41.1 ptt180 -68.72 -51.11 45.01 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.376 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.7 t -61.15 -28.63 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 118.805 -0.617 . . . . 0.0 109.664 -170.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.5 -17.64 64.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -107.41 -32.37 7.77 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.435 1.016 . . . . 0.0 112.346 174.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 41' ' ' ARG . 17.0 ptpt -103.74 0.35 30.38 Favored 'General case' 0 C--N 1.343 0.292 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -174.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.29 45.57 7.28 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.031 1.332 . . . . 0.0 111.819 -170.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 168.666 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 C--O 1.236 0.379 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.75 -171.72 39.78 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 124.115 0.864 . . . . 0.0 112.644 171.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.2 pt -140.49 179.04 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 158.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -89.1 147.65 24.11 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.061 -1.024 . . . . 0.0 110.726 169.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -120.39 141.99 49.6 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.978 0.894 . . . . 0.0 111.207 158.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 25.5 t -92.6 93.96 8.79 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 113.48 -1.691 . . . . 0.0 107.214 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.458 HG22 ' HA ' ' A' ' 144' ' ' ALA . 4.2 tt -63.32 -29.81 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 123.861 0.864 . . . . 0.0 111.322 -164.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.9 m -77.44 0.53 22.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.118 1.767 . . . . 0.0 112.503 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 6.6 p -132.0 -10.41 3.4 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.242 1.017 . . . . 0.0 112.92 163.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.7 6.13 84.49 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.002 1.286 . . . . 0.0 112.71 -172.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.2 m -106.17 132.1 52.63 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 118.442 1.121 . . . . 0.0 109.887 -164.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -75.92 165.23 25.29 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.325 1.85 . . . . 0.0 112.967 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 177.23 -171.96 0.1 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 129.048 2.939 . . . . 0.0 108.775 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 27.3 95.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 129.964 3.305 . . . . 0.0 116.109 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.55 150.43 43.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.328 1.051 . . . . 0.0 111.692 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.6 m -62.19 -24.14 67.04 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -174.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.18 -16.99 63.75 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.3 t -98.64 -9.68 24.38 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.7 -0.625 . . . . 0.0 111.293 169.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.691 ' HE2' ' H ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -84.48 179.1 7.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.12 1.368 . . . . 0.0 108.682 172.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.691 ' H ' ' HE2' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -141.24 -173.57 3.78 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.013 1.725 . . . . 0.0 107.618 174.537 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -158.82 -86.97 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -158.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.6 t -58.39 129.96 44.51 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 166.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.48 -87.68 0.52 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.8 m -81.96 50.06 1.49 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.405 1.097 . . . . 0.0 111.408 -175.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.37 32.23 3.65 Favored Glycine 0 CA--C 1.524 0.649 0 O-C-N 120.025 -1.672 . . . . 0.0 112.07 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -122.33 166.68 16.31 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.764 2.026 . . . . 0.0 108.557 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.32 71.44 6.76 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.559 2.173 . . . . 0.0 113.752 -160.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.6 p -136.86 162.09 34.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.827 1.251 . . . . 0.0 111.236 166.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -145.19 178.45 8.06 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.922 2.489 . . . . 0.0 109.471 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -128.61 -4.64 5.29 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -157.78 178.81 9.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.119 2.167 . . . . 0.0 108.146 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.0 t -134.14 151.09 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 119.182 0.901 . . . . 0.0 110.846 -168.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 p -55.01 -47.4 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.349 1.86 . . . . 0.0 111.546 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.3 m 165.22 170.24 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 131.069 3.748 . . . . 0.0 106.593 -174.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -90.4 97.15 11.01 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 159.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -131.08 -60.36 0.96 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.292 0.637 . . . . 0.0 110.804 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -115.47 18.74 15.83 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.087 1.355 . . . . 0.0 111.388 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.3 tt -130.64 163.93 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.117 2.567 . . . . 0.0 106.98 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.485 ' HD3' ' N ' ' A' ' 101' ' ' LEU . 2.7 tmtm? -135.96 128.79 31.1 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.137 0.975 . . . . 0.0 109.028 174.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.485 ' N ' ' HD3' ' A' ' 100' ' ' LYS . 1.7 mp -114.15 143.95 43.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.792 2.837 . . . . 0.0 111.256 176.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.27 113.85 8.25 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.102 1.761 . . . . 0.0 109.107 168.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -81.31 125.22 30.08 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.423 0.689 . . . . 0.0 111.498 -176.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -130.62 -175.99 3.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.501 1.921 . . . . 0.0 108.753 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.95 19.62 17.72 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.518 1.527 . . . . 0.0 111.477 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.45 20.73 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 129.102 2.961 . . . . 0.0 118.155 -165.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.6 pp -132.06 -2.17 3.63 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.821 -1.174 . . . . 0.0 112.253 167.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.4 8.68 56.11 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 117.871 -1.516 . . . . 0.0 112.851 -168.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 16.1 tpt -142.23 -92.13 0.13 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 119.867 1.834 . . . . 0.0 108.507 174.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 81.5 t -143.01 114.77 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -119.09 113.8 21.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.646 1.178 . . . . 0.0 108.183 169.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.452 ' HB3' ' CG1' ' A' ' 126' ' ' VAL . 31.5 t -106.15 122.33 45.97 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.03 151.03 44.06 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 172.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 75.6 t -136.46 111.49 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 C-N-CA 125.016 1.326 . . . . 0.0 107.572 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 mp -127.8 164.97 21.02 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.28 1.032 . . . . 0.0 109.195 175.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 18.1 t -71.88 154.2 41.39 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.445 -0.785 . . . . 0.0 109.3 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -82.96 -20.96 34.21 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 122.055 -0.403 . . . . 0.0 112.05 172.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.22 -42.79 3.46 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.639 1.176 . . . . 0.0 112.496 -162.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 27.9 p -123.54 81.08 1.86 Allowed 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 167.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.49 40.77 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.014 1 C-N-CA 132.533 4.333 . . . . 0.0 114.888 -163.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.21 -174.44 3.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.154 2.582 . . . . 0.0 112.434 -170.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -30.4 -70.11 0.06 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 130.012 3.325 . . . . 0.0 114.716 -164.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 mt 42.16 -111.13 0.15 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.277 2.231 . . . . 0.0 109.984 -170.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.59 -114.26 0.46 Allowed Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 118.884 0.765 . . . . 0.0 112.623 171.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -164.76 179.08 6.77 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.826 0.45 . . . . 0.0 110.298 -170.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.547 HG21 ' HE2' ' A' ' 136' ' ' LYS . 2.7 p -124.49 144.93 32.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 124.795 1.238 . . . . 0.0 108.463 167.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -131.48 147.23 52.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 124.109 0.881 . . . . 0.0 109.566 175.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -65.89 115.35 5.89 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.01 -34.36 0.15 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -171.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -83.91 172.32 49.7 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -174.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.7 -84.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.685 2.256 . . . . 0.0 110.353 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.62 169.53 9.88 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 129.062 2.945 . . . . 0.0 104.887 176.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.3 -54.49 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.629 0 CA-C-N 121.572 1.597 . . . . 0.0 111.93 -2.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.8 p -69.35 -25.61 64.28 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.37 0.668 . . . . 0.0 112.442 -174.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 68.22 10.77 60.28 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.895 0.76 . . . . 0.0 113.453 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.547 ' HE2' HG21 ' A' ' 126' ' ' VAL . 14.7 ptmt -130.29 158.57 39.42 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 119.281 1.54 . . . . 0.0 111.561 -169.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.83 103.36 7.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.941 1.696 . . . . 0.0 108.499 -175.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -73.15 135.28 44.65 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 168.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 27.0 t -142.19 133.58 26.47 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.707 1.203 . . . . 0.0 108.5 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 6.9 ptm -133.16 156.25 47.81 Favored 'General case' 0 CA--C 1.528 0.098 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -137.4 97.82 3.56 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.5 m -157.74 158.38 35.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 173.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -77.22 -30.19 54.49 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.07 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -74.46 54.17 0.57 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.863 2.065 . . . . 0.0 113.183 -170.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.8 mt -120.0 63.59 0.83 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.014 0.926 . . . . 0.0 108.73 -176.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -79.63 101.84 8.57 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -57.8 133.8 55.72 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 165.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.3 pt -136.99 165.72 32.72 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.567 1.147 . . . . 0.0 108.888 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.32 170.94 2.71 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.484 2.123 . . . . 0.0 111.38 162.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -50.09 -11.51 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 128.814 2.846 . . . . 0.0 118.185 -166.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.4 t0 177.31 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 128.675 2.79 . . . . 0.0 107.296 159.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.32 11.89 0.63 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.962 2.105 . . . . 0.0 112.0 -174.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -71.71 -11.58 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 O-C-N 121.186 -0.946 . . . . 0.0 112.328 173.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.543 0 C-N-CA 127.888 2.661 . . . . 0.0 106.532 159.199 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 . . . . . 0 CA--C 1.538 0.491 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.488 ' HB ' HD21 ' A' ' 98' ' ' ASN . 18.8 pt -136.24 137.28 24.17 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.147 0.979 . . . . 0.0 111.431 -171.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.12 114.31 3.88 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.51 2.14 . . . . 0.0 110.342 170.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.446 HD12 HG23 ' A' ' 72' ' ' THR . 5.5 mm -87.64 132.29 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 159.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -132.28 96.09 3.8 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 -175.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 m -68.56 61.26 0.09 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 167.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.8 t -52.21 -36.67 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 120.863 -1.148 . . . . 0.0 109.486 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.54 -18.52 65.06 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.83 -174.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -108.53 1.98 21.87 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 129.812 3.245 . . . . 0.0 111.581 169.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.0 t30 37.7 61.57 1.0 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.046 2.538 . . . . 0.0 113.164 -158.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.98 169.11 11.49 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.765 1.226 . . . . 0.0 108.949 169.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -148.39 124.35 2.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 126.401 1.88 . . . . 0.0 106.305 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -144.19 95.15 2.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.032 1.333 . . . . 0.0 107.948 -173.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 12.1 ttt -69.63 137.62 52.39 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.513 -1.367 . . . . 0.0 109.968 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.9 t -135.08 160.02 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.049 1.34 . . . . 0.0 107.385 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -68.22 155.76 39.02 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.045 -1.659 . . . . 0.0 110.961 170.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.548 HH12 ' CD ' ' A' ' 25' ' ' GLU . 41.6 ptt85 -74.93 154.11 38.3 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 121.749 -0.594 . . . . 0.0 109.421 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.61 134.53 25.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.548 ' CD ' HH12 ' A' ' 23' ' ' ARG . 0.3 OUTLIER -162.52 123.56 2.54 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 102.008 -3.33 . . . . 0.0 102.008 159.029 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.1 mt -140.49 -178.96 5.75 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.963 1.705 . . . . 0.0 106.821 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.1 t -161.58 -10.94 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -118.94 -144.22 0.37 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.58 1.082 . . . . 0.0 110.211 -172.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.24 3.02 0.69 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.603 1.161 . . . . 0.0 113.281 175.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -59.47 -46.5 88.6 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 125.994 1.718 . . . . 0.0 110.974 -163.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.414 ' CE3' HD13 ' A' ' 35' ' ' LEU . 93.2 m95 -69.29 45.64 0.06 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.32 2.248 . . . . 0.0 112.344 174.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.67 -36.25 0.05 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.084 2.154 . . . . 0.0 109.915 159.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -84.68 -25.85 28.16 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.109 -0.948 . . . . 0.0 112.309 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 pt -109.67 18.69 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 119.773 1.17 . . . . 0.0 112.176 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.414 HD13 ' CE3' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -145.51 174.91 10.74 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.478 1.111 . . . . 0.0 110.875 -169.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.91 141.78 96.96 Favored Pre-proline 0 C--O 1.237 0.417 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 169.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -68.57 -14.53 39.81 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.744 2.296 . . . . 0.0 111.589 171.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -79.14 -44.04 22.79 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 122.999 0.52 . . . . 0.0 109.97 168.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.98 -39.7 90.62 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.58 1.082 . . . . 0.0 110.64 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -46.9 -58.29 4.09 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.953 2.101 . . . . 0.0 111.175 171.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 8.3 ptp85 -72.73 -42.06 64.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.883 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.469 HG13 ' HA2' ' A' ' 47' ' ' GLY . 44.5 t -52.56 -35.36 20.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 124.595 1.158 . . . . 0.0 110.405 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.71 -8.78 11.29 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -116.23 -38.68 3.53 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.376 0.989 . . . . 0.0 111.936 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 41' ' ' ARG . 19.3 ptpt -87.15 9.43 20.02 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.304 0.956 . . . . 0.0 113.151 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.58 -36.62 0.23 Allowed 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 129.143 2.977 . . . . 0.0 113.636 -167.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.469 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . . . . . . 0 C--N 1.335 0.511 0 C-N-CA 127.023 2.249 . . . . 0.0 108.861 -166.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 p30 . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 120.912 0.386 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.39 162.83 12.82 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.875 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.423 HG22 ' HA ' ' A' ' 76' ' ' ASP . 38.5 pt -143.51 175.21 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 126.274 1.829 . . . . 0.0 109.131 -179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -93.35 122.51 35.84 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.295 0.569 . . . . 0.0 111.934 173.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.91 115.05 21.61 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 158.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.8 t -70.55 94.53 0.99 Allowed 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 166.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.455 HG22 ' HA ' ' A' ' 144' ' ' ALA . 2.0 tt -58.85 -33.0 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.599 1.16 . . . . 0.0 111.155 -165.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.4 t -82.48 5.14 21.62 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.949 1.3 . . . . 0.0 111.891 -169.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.72 18.63 1.83 Allowed 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.43 -0.794 . . . . 0.0 111.557 158.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.7 25.83 56.41 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 123.343 0.497 . . . . 0.0 112.744 174.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.446 HG23 HD12 ' A' ' 10' ' ' ILE . 28.4 m -120.55 124.54 45.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.863 1.265 . . . . 0.0 108.021 -164.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -64.63 145.27 56.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.408 1.083 . . . . 0.0 111.448 170.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.466 HD23 ' H ' ' A' ' 75' ' ' PHE 0.281 0.0 OUTLIER -148.88 -107.42 0.08 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.953 160.657 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.466 ' H ' HD23 ' A' ' 74' ' ' LEU . 19.4 m-85 -54.38 127.15 26.16 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.307 1.443 . . . . 0.0 112.416 -159.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.423 ' HA ' HG22 ' A' ' 64' ' ' ILE . 8.8 t70 -89.47 150.54 22.43 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.223 1.009 . . . . 0.0 109.494 -176.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.1 m -59.47 -26.83 65.57 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.088 172.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -70.1 -17.78 63.23 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.914 1.234 . . . . 0.0 112.449 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.8 p -96.44 -22.86 16.88 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.809 1.244 . . . . 0.0 112.196 170.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.477 ' HE2' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -125.56 79.09 1.79 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.566 1.946 . . . . 0.0 107.653 -170.482 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -127.43 118.64 24.45 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -135.68 163.65 29.67 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 104.71 -2.329 . . . . 0.0 104.71 159.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.6 t -136.48 135.89 38.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.385 0.993 . . . . 0.0 109.785 -164.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.99 -53.28 1.36 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -164.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.92 -68.96 0.28 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.26 1.424 . . . . 0.0 110.021 168.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 53.7 12.31 2.43 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 126.177 1.846 . . . . 0.0 116.225 -170.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -51.19 155.04 2.44 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 127.021 2.128 . . . . 0.0 112.307 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -73.55 68.09 4.49 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.864 3.042 . . . . 0.0 111.532 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.2 p -131.04 143.76 50.94 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.238 1.415 . . . . 0.0 108.508 167.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.92 160.22 38.97 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.659 1.584 . . . . 0.0 108.035 -171.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -123.27 7.04 9.08 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.453 -171.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -159.61 176.65 11.77 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 159.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -100.64 157.91 4.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 119.1 0.864 . . . . 0.0 110.268 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.3 p -66.25 -45.63 89.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 169.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.6 m -179.81 161.46 0.98 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 129.73 3.212 . . . . 0.0 106.714 167.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -76.74 56.99 1.22 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.03 1.732 . . . . 0.0 110.085 175.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -111.56 -61.51 1.69 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.629 0.772 . . . . 0.0 109.251 -168.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.488 HD21 ' HB ' ' A' ' 8' ' ' ILE 0.25 0.8 OUTLIER -113.09 21.23 15.57 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 175.48 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.8 tt -111.74 153.21 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 167.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -122.22 145.26 48.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.482 1.113 . . . . 0.0 108.815 169.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.5 mt -149.52 133.34 16.96 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 128.87 2.868 . . . . 0.0 108.602 -159.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.56 101.9 4.47 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 129.105 2.962 . . . . 0.0 108.503 168.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -73.8 143.8 45.84 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.604 0.762 . . . . 0.0 111.899 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -154.94 178.0 10.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 129.407 3.083 . . . . 0.0 107.989 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.456 ' H ' ' HD2' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -103.13 25.12 9.84 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 120.366 -1.459 . . . . 0.0 113.135 178.05 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.45 19.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -166.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.14 2.03 2.76 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.985 -1.072 . . . . 0.0 112.449 165.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.05 -3.55 51.9 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.061 -1.41 . . . . 0.0 113.042 -169.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -139.11 -98.32 0.17 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.416 1.608 . . . . 0.0 109.175 -174.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.6 m -135.12 110.28 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.41 ' HE ' ' CD2' ' A' ' 125' ' ' HIS . 4.8 ttt180 -106.33 142.06 36.63 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 161.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.508 ' HB3' ' CG1' ' A' ' 126' ' ' VAL . 20.8 t -137.39 138.99 40.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 166.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -61.25 153.43 26.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 169.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.3 t -134.09 107.98 10.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -125.43 165.37 18.55 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 172.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 26.8 t -73.92 146.64 43.83 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 168.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.78 -45.46 86.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.745 -0.645 . . . . 0.0 109.337 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.3 tpt85 -84.41 -77.64 0.26 Allowed 'General case' 0 C--N 1.35 0.589 0 CA-C-O 116.257 -1.83 . . . . 0.0 111.775 162.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.6 p -78.34 75.32 4.87 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.859 1.209 . . . . 0.0 110.746 -158.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -59.76 77.22 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.509 1.924 . . . . 0.0 112.536 171.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.26 -155.62 0.45 Allowed 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 112.861 -1.972 . . . . 0.0 109.748 161.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -70.11 -60.6 2.19 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 125.525 1.53 . . . . 0.0 111.296 -168.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 50.24 -113.11 0.64 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.503 1.921 . . . . 0.0 108.511 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 174.11 -128.4 1.46 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 119.815 -1.183 . . . . 0.0 113.664 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.41 ' CD2' ' HE ' ' A' ' 111' ' ' ARG . 38.2 p-80 -157.78 175.65 13.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.01 0.524 . . . . 0.0 110.044 -174.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.508 ' CG1' ' HB3' ' A' ' 112' ' ' CYS . 3.0 p -122.06 143.86 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.288 1.435 . . . . 0.0 108.776 172.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -142.1 164.95 28.78 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.619 1.168 . . . . 0.0 111.516 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -72.06 102.93 3.11 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.468 1.907 . . . . 0.0 109.452 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -162.75 -50.8 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.709 2.004 . . . . 0.0 110.21 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -63.85 157.77 41.85 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 123.311 0.382 . . . . 0.0 112.29 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.12 177.64 8.5 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.651 2.234 . . . . 0.0 112.684 -169.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -50.19 145.62 9.63 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.792 159.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -84.55 -25.36 9.03 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 CA-C-N 119.462 0.844 . . . . 0.0 113.253 18.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.261 0.9 OUTLIER -107.46 -14.01 14.95 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.463 0.705 . . . . 0.0 112.18 -159.182 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.23 16.66 79.31 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 121.465 -0.772 . . . . 0.0 114.974 159.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -146.98 159.37 43.64 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 118.579 1.189 . . . . 0.0 110.486 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 ttm105 -119.56 108.88 15.04 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 126.052 1.741 . . . . 0.0 107.18 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -73.77 138.72 44.74 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 163.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 19.3 t -141.29 133.47 27.91 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.081 0.855 . . . . 0.0 108.74 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -130.18 105.11 7.71 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 122.15 0.976 . . . . 0.0 109.336 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -83.82 68.17 9.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 169.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 p -113.91 142.59 45.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.284 1.433 . . . . 0.0 110.463 -176.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.59 91.44 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.036 0.934 . . . . 0.0 111.907 170.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.455 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -66.73 16.74 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.44 2.696 . . . . 0.0 116.649 -160.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 87.9 mt -92.61 75.68 5.05 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.419 1.088 . . . . 0.0 111.275 -162.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -86.14 110.94 19.9 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -62.83 144.41 56.61 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 164.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 4.9 pt -142.79 169.6 10.45 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 126.179 1.792 . . . . 0.0 108.111 171.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -56.96 177.2 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.903 2.402 . . . . 0.0 111.142 159.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -50.93 8.56 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 119.867 3.284 . . . . 0.0 119.867 -172.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.7 t70 145.08 -72.85 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.159 1 C-N-CA 133.549 4.739 . . . . 0.0 107.308 163.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -154.69 43.02 0.49 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.172 2.589 . . . . 0.0 107.083 -176.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.3 pt -77.19 -19.73 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.076 -1.015 . . . . 0.0 110.562 161.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 1 C-N-CA 130.849 4.071 . . . . 0.0 105.832 171.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 4.2 mtt180 . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 pt -138.93 140.56 27.35 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.801 2.04 . . . . 0.0 109.665 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.471 ' O ' HD13 ' A' ' 10' ' ' ILE . 90.1 Cg_endo -80.78 143.0 14.47 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.062 2.508 . . . . 0.0 111.015 174.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.808 HD12 HG23 ' A' ' 72' ' ' THR . 17.2 mm -135.86 122.02 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 125.816 1.647 . . . . 0.0 107.254 -168.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -132.47 98.51 4.39 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.905 0.775 . . . . 0.0 110.299 -165.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.5 m -69.73 74.84 0.43 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.827 0.851 . . . . 0.0 109.602 170.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.86 -39.24 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.686 1.194 . . . . 0.0 112.074 -174.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.67 -15.64 8.33 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.162 2.185 . . . . 0.0 113.724 175.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.412 ' HE3' ' CD ' ' A' ' 17' ' ' ARG . 4.7 ttpt -133.1 15.58 4.19 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.738 2.415 . . . . 0.0 110.12 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 24.38 45.58 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 131.133 3.773 . . . . 0.0 114.375 -163.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.412 ' CD ' ' HE3' ' A' ' 15' ' ' LYS . 19.2 mtp-105 -90.95 171.63 9.15 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.003 175.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.0 p -140.34 154.4 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 158.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -144.35 170.99 14.96 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 127.984 2.514 . . . . 0.0 106.903 158.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 43.6 ttm -127.46 92.3 3.47 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.757 0.823 . . . . 0.0 109.499 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.6 t -77.16 155.94 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -79.13 174.24 11.77 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.06 -1.025 . . . . 0.0 112.476 175.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -77.86 163.24 26.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.533 0.733 . . . . 0.0 110.413 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.288 2.8 tp -89.15 69.12 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 123.324 1.535 . . . . 0.0 111.784 -169.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.9 89.87 3.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.018 1.727 . . . . 0.0 106.532 -173.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.8 mt -130.33 -176.21 3.88 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.107 2.163 . . . . 0.0 109.952 -175.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.0 t -112.91 162.66 15.58 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.741 1.617 . . . . 0.0 107.885 163.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -52.28 -36.89 54.06 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.14 0.882 . . . . 0.0 111.514 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -46.87 -34.63 5.57 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 129.25 3.02 . . . . 0.0 111.714 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -81.92 -46.88 13.45 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.193 1.797 . . . . 0.0 111.212 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.418 ' C ' HD12 ' A' ' 35' ' ' LEU . 91.3 m95 -64.01 40.5 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 129.844 3.258 . . . . 0.0 113.503 -174.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -169.29 -18.68 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.166 2.187 . . . . 0.0 113.24 -170.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -127.24 -13.69 5.53 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.31 -0.852 . . . . 0.0 112.807 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pt -109.31 3.95 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 119.061 0.846 . . . . 0.0 111.906 170.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.418 HD12 ' C ' ' A' ' 31' ' ' TRP . 12.3 mt -97.74 170.67 8.83 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.423 1.489 . . . . 0.0 111.014 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.18 144.73 90.95 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 159.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -63.64 -15.01 46.17 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.889 1.726 . . . . 0.0 111.761 166.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -70.94 -41.9 70.53 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 122.523 0.329 . . . . 0.0 110.587 170.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.441 ' HB2' HG12 ' A' ' 68' ' ' ILE . . . -62.55 -40.51 97.06 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.29 0.566 . . . . 0.0 109.914 -172.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -53.48 -52.61 59.0 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.576 1.15 . . . . 0.0 112.057 172.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 42' ' ' VAL . 3.8 ptp180 -76.92 -47.07 22.07 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -172.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' A' ' 39' ' ' ALA . 4.1 p -62.52 -24.39 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -174.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.23 -9.51 32.97 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 115.157 1.539 . . . . 0.0 115.157 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.78 -41.28 2.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.881 1.219 . . . . 0.0 110.849 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.413 ' H ' ' HG2' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -89.08 3.44 51.77 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.623 1.169 . . . . 0.0 113.317 176.346 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.33 2.44 0.09 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.16 2.584 . . . . 0.0 115.663 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 1.022 0 N-CA-C 118.242 2.057 . . . . 0.0 118.242 -163.721 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.3 t0 . . . . . 0 CA--C 1.537 0.475 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.96 169.5 14.76 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.909 1.242 . . . . 0.0 112.63 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.474 HG22 ' HA ' ' A' ' 76' ' ' ASP . 35.0 pt -138.49 172.41 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.794 1.638 . . . . 0.0 110.427 -172.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -86.6 137.51 32.43 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.893 0.477 . . . . 0.0 111.207 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.51 121.06 44.17 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.671 1.188 . . . . 0.0 109.765 164.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.424 ' HB2' HD11 ' A' ' 74' ' ' LEU . 16.9 t -70.16 87.64 0.59 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.309 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.463 HG22 ' HA ' ' A' ' 144' ' ' ALA . 2.6 tt -52.89 -26.28 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -171.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.0 t -75.5 -0.86 21.7 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.838 0.855 . . . . 0.0 111.684 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.3 p -149.37 20.29 0.95 Allowed 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.69 -1.256 . . . . 0.0 111.926 161.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.1 -4.93 0.45 Allowed Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.565 1.555 . . . . 0.0 116.021 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.808 HG23 HD12 ' A' ' 10' ' ' ILE . 97.3 m -71.03 142.9 50.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.778 1.631 . . . . 0.0 109.577 -171.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -89.87 135.4 33.65 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.687 0.795 . . . . 0.0 111.739 165.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' A' ' 67' ' ' CYS 0.326 0.0 OUTLIER -137.26 -92.91 0.23 Allowed 'General case' 0 C--N 1.344 0.336 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 178.17 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -61.59 118.01 6.51 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.554 0.615 . . . . 0.0 110.851 -165.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.474 ' HA ' HG22 ' A' ' 64' ' ' ILE . 22.2 t70 -70.5 152.41 44.03 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 168.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.3 m -55.94 -25.8 45.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.217 -1.373 . . . . 0.0 113.565 175.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.59 -25.17 64.38 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 121.426 1.921 . . . . 0.0 111.282 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.3 p -95.87 18.52 13.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.081 1.353 . . . . 0.0 112.129 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -151.27 35.57 0.58 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.82 1.248 . . . . 0.0 111.492 161.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -84.35 57.42 4.26 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.621 0.724 . . . . 0.0 111.421 -164.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -98.75 110.24 22.87 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.169 0.587 . . . . 0.0 109.988 -172.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.6 m -50.04 102.14 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.371 1.868 . . . . 0.0 112.951 -169.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.72 -49.69 3.95 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.6 1.095 . . . . 0.0 112.305 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.9 m -59.52 -45.88 90.46 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.246 1.018 . . . . 0.0 110.967 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 49.58 26.43 7.52 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 128.034 2.73 . . . . 0.0 115.12 171.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -56.81 147.52 52.65 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.237 1.015 . . . . 0.0 111.139 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -78.97 57.62 6.54 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.163 3.242 . . . . 0.0 110.126 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.1 p -160.6 121.28 2.9 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -172.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.88 -160.78 1.1 Allowed 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 124.455 1.102 . . . . 0.0 109.082 -172.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -115.75 4.8 14.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 118.429 0.559 . . . . 0.0 112.074 -161.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -155.35 -179.18 7.84 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.144 0.578 . . . . 0.0 110.359 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 m -137.02 167.17 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 127.287 2.235 . . . . 0.0 110.114 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.5 p -58.48 -51.1 75.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.52 1.128 . . . . 0.0 111.926 -178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.4 m 159.74 151.37 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 129.216 3.006 . . . . 0.0 108.038 -169.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -74.29 79.68 1.84 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.888 0.475 . . . . 0.0 109.842 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -118.92 -56.23 2.12 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.81 0.844 . . . . 0.0 110.919 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.51 HD22 HG21 ' A' ' 72' ' ' THR . 27.9 t-20 -128.28 33.07 4.77 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.14 0.976 . . . . 0.0 111.352 170.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.7 tt -118.78 144.29 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 163.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.423 ' HD3' ' H ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -127.81 141.07 51.67 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.889 1.276 . . . . 0.0 107.698 171.418 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.423 ' H ' ' HD3' ' A' ' 100' ' ' LYS . 1.8 mp -127.85 140.8 51.8 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.452 1.901 . . . . 0.0 107.629 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.516 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 5.6 mpt_? -120.86 125.68 48.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 171.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -106.9 126.94 52.96 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.237 0.615 . . . . 0.0 110.769 -167.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -132.45 178.59 6.71 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.714 2.006 . . . . 0.0 109.912 176.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -106.63 11.35 30.53 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.423 1.889 . . . . 0.0 112.992 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 m -46.9 -43.44 18.86 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.616 1.566 . . . . 0.0 115.182 -159.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 pp -68.5 -12.2 60.89 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.49 4.95 30.23 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 117.615 -1.659 . . . . 0.0 112.757 -169.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.2 ttp -147.88 -86.94 0.09 Allowed 'General case' 0 C--N 1.348 0.511 0 CA-C-N 120.258 2.029 . . . . 0.0 109.172 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.8 p -148.61 114.32 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -120.56 112.1 18.5 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.221 1.808 . . . . 0.0 107.822 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.01 134.79 54.89 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.516 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 9.1 pt-20 -71.41 165.67 23.29 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.495 1.043 . . . . 0.0 110.661 174.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.62 108.41 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mp -131.17 167.47 19.1 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 167.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.1 t -66.53 149.2 50.8 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 98' ' ' ASN . . . -76.6 -17.4 59.21 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 44.8 tpt85 -111.74 -58.48 2.12 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 118.627 -0.701 . . . . 0.0 111.74 170.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.8 p -84.98 77.13 10.18 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.54 74.99 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.599 1.16 . . . . 0.0 110.01 172.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -97.61 -73.6 0.6 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.909 1.284 . . . . 0.0 112.323 -165.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.68 -80.95 0.17 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.54 1.136 . . . . 0.0 109.674 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt 45.56 -110.88 0.25 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.775 1.63 . . . . 0.0 111.15 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.95 -111.79 0.39 Allowed Glycine 0 C--N 1.332 0.318 0 CA-C-N 118.88 0.764 . . . . 0.0 112.843 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -164.02 -176.45 4.53 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -166.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.88 147.53 29.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 127.163 2.185 . . . . 0.0 108.632 169.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -137.91 143.41 40.81 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.98 0.912 . . . . 0.0 108.63 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.95 111.81 9.46 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -167.82 -45.35 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.977 2.111 . . . . 0.0 110.776 -160.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.31 178.38 38.13 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.391 0.996 . . . . 0.0 113.606 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.76 162.0 42.35 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.664 2.243 . . . . 0.0 111.883 -175.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -60.72 154.37 57.79 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 163.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.66 -42.9 0.71 Allowed 'Cis proline' 0 C--N 1.346 0.432 0 CA-C-N 120.812 1.326 . . . . 0.0 113.693 12.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.2 p -70.88 -30.59 67.0 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.41 10.2 84.5 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.302 -0.721 . . . . 0.0 112.682 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.85 164.01 28.22 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.906 1.353 . . . . 0.0 112.81 -166.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.86 106.89 7.98 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.858 1.663 . . . . 0.0 107.963 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -73.05 148.12 44.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.264 1.826 . . . . 0.0 107.235 167.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 49.7 t -156.16 115.79 3.57 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.399 1.479 . . . . 0.0 108.854 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.94 138.3 33.72 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 123.903 0.881 . . . . 0.0 109.771 -175.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -142.51 126.71 17.51 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.445 1.098 . . . . 0.0 109.416 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 85.2 p -162.7 176.63 10.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 167.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -53.6 -31.43 46.9 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.599 1.559 . . . . 0.0 112.065 163.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.463 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -87.62 47.8 1.55 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.237 1.415 . . . . 0.0 112.058 -175.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 88.1 mt -131.3 61.3 1.64 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.794 1.238 . . . . 0.0 108.31 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -88.56 127.09 35.54 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -68.59 144.87 54.38 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 169.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.3 pt -137.44 168.24 17.37 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 126.304 1.842 . . . . 0.0 108.765 171.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -57.87 174.07 0.71 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.78 1.653 . . . . 0.0 110.806 158.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 11.9 mtp85 -46.8 -33.71 4.67 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.126 1.771 . . . . 0.0 113.778 -172.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -151.8 -65.08 0.18 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.583 1.953 . . . . 0.0 108.156 158.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -151.85 1.97 0.37 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 129.546 3.138 . . . . 0.0 110.668 -171.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.7 pp -55.15 -29.94 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 119.665 1.12 . . . . 0.0 113.862 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 116.824 -2.098 . . . . 0.0 109.457 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 . . . . . 0 N--CA 1.436 -1.132 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 pt -131.38 107.69 14.67 Favored Pre-proline 0 C--N 1.324 -0.5 0 C-N-CA 125.813 1.645 . . . . 0.0 108.393 -165.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.85 103.57 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.415 2.743 . . . . 0.0 109.483 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.6 mt -85.28 97.65 5.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -75.47 95.67 3.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.5 m -67.86 67.71 0.1 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.637 0.775 . . . . 0.0 108.92 159.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.11 -34.95 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.584 -0.697 . . . . 0.0 110.822 -170.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.38 -11.72 17.25 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.685 1.194 . . . . 0.0 114.088 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' A' ' 151' ' ' ASP . 35.9 ttmt -123.32 12.81 9.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.184 1.394 . . . . 0.0 110.66 172.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 30.9 68.21 0.11 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 129.915 3.286 . . . . 0.0 113.157 -164.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 mtp85 -131.5 165.36 23.74 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 172.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.9 t -144.1 98.58 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -92.84 103.47 15.81 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.5 ttt -77.88 89.08 4.08 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.656 0.662 . . . . 0.0 109.665 171.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.06 168.31 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 176.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -92.16 161.66 14.65 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.532 -1.355 . . . . 0.0 108.884 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -60.27 151.78 26.63 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.49 -0.756 . . . . 0.0 110.141 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.523 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 2.9 tp -65.87 130.4 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 172.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -153.95 120.03 5.37 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 129.109 2.964 . . . . 0.0 103.134 165.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.1 mt -143.89 175.29 10.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.542 1.537 . . . . 0.0 109.054 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.8 m -93.68 157.18 16.3 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 161.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.79 -36.24 64.69 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.137 0.975 . . . . 0.0 112.206 -174.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.35 -18.32 63.78 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -178.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -70.2 -43.75 70.09 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.609 1.164 . . . . 0.0 109.748 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -60.19 10.54 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.118 2.567 . . . . 0.0 115.542 -173.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.77 -9.89 3.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 172.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.82 -13.88 5.74 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 118.31 -0.853 . . . . 0.0 113.05 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.3 pt -113.44 -2.67 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.168 0.895 . . . . 0.0 112.45 171.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.23 173.34 7.98 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.074 0.949 . . . . 0.0 111.29 -171.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.47 133.83 70.64 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 162.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.72 -21.1 45.54 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.382 2.055 . . . . 0.0 112.731 -172.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -74.76 -31.29 61.75 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.986 171.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.404 ' HB2' HG12 ' A' ' 68' ' ' ILE . . . -58.18 -41.89 84.87 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 120.063 1.301 . . . . 0.0 110.54 -174.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -57.13 -48.4 78.74 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.071 0.948 . . . . 0.0 111.272 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -69.8 -46.5 65.58 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.665 0.666 . . . . 0.0 110.917 175.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.493 HG13 ' HA2' ' A' ' 47' ' ' GLY 0.261 6.3 t -58.88 -23.64 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 125.593 1.557 . . . . 0.0 111.364 -177.214 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.54 70.76 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 168.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.38 -36.46 13.8 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.906 1.23 . . . . 0.0 111.782 177.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -94.75 6.0 50.23 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.473 0.709 . . . . 0.0 112.876 -174.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.11 19.32 0.19 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.258 2.223 . . . . 0.0 113.857 -172.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.493 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . . . . . . 0 CA--C 1.526 0.771 0 C-N-CA 125.397 1.475 . . . . 0.0 114.652 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.4 t0 . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.137 0.494 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.94 -175.57 36.85 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.024 1.297 . . . . 0.0 113.099 174.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.6 pt -125.91 160.24 33.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 165.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -72.96 155.54 39.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 122.424 1.107 . . . . 0.0 109.498 171.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -129.89 109.95 11.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 127.491 2.316 . . . . 0.0 106.228 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.1 t -75.76 73.85 2.72 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.193 1.397 . . . . 0.0 107.983 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.454 HD12 ' HD3' ' A' ' 146' ' ' LYS . 7.7 tt -58.57 -16.8 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 127.114 2.166 . . . . 0.0 113.002 -170.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.3 t -74.91 -0.51 18.83 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.432 1.493 . . . . 0.0 112.231 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.8 p -152.41 -13.66 0.17 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 158.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.99 10.99 57.03 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 119.805 1.184 . . . . 0.0 113.34 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -63.14 163.23 10.44 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.601 1.16 . . . . 0.0 108.936 160.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -129.2 153.65 47.53 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 169.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -169.33 -163.23 0.39 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.913 1.685 . . . . 0.0 109.426 -173.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 20.54 91.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 130.675 3.59 . . . . 0.0 114.632 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -57.61 137.27 56.56 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.0 1.32 . . . . 0.0 110.286 173.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.8 m -59.52 -21.34 60.05 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -169.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.92 -20.95 64.34 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.647 1.112 . . . . 0.0 112.448 173.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.6 p -75.72 -12.42 60.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.263 1.025 . . . . 0.0 112.549 172.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -133.67 85.34 2.2 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 125.146 1.379 . . . . 0.0 110.219 -165.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -142.8 45.31 1.59 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.639 -0.663 . . . . 0.0 112.454 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.8 98.04 0.06 Allowed 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.8 m -76.3 113.01 13.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.212 0.605 . . . . 0.0 110.57 -158.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.19 -60.61 0.49 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -175.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.25 -53.92 50.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.383 1.073 . . . . 0.0 111.306 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 37.35 35.43 0.18 Allowed Glycine 0 C--N 1.337 0.635 0 C-N-CA 130.632 3.968 . . . . 0.0 114.395 -167.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.9 158.07 13.74 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.728 0.811 . . . . 0.0 110.506 167.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.35 78.45 1.21 Allowed 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.531 2.821 . . . . 0.0 111.102 177.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.1 p -139.95 157.31 45.89 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.487 165.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -136.26 169.84 17.0 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.104 1.762 . . . . 0.0 108.55 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -122.4 -6.71 8.73 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.336 1.054 . . . . 0.0 112.274 174.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -152.25 -179.45 7.55 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.166 1.386 . . . . 0.0 107.676 173.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 m -119.25 164.9 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.853 1.661 . . . . 0.0 111.027 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 94' ' ' VAL . 2.4 p -61.81 -49.83 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.466 1.106 . . . . 0.0 109.492 160.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.0 m 168.95 159.94 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 130.515 3.526 . . . . 0.0 107.912 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -70.02 81.97 0.49 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.134 1.373 . . . . 0.0 108.812 162.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -128.08 -60.44 1.14 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.611 0.764 . . . . 0.0 110.99 -175.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.23 26.52 10.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.628 1.171 . . . . 0.0 110.599 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.0 tt -132.74 158.15 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.794 1.638 . . . . 0.0 108.677 -171.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.436 ' HE3' ' OE2' ' A' ' 113' ' ' GLU . 2.9 tmtm? -135.18 119.52 17.87 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.327 1.451 . . . . 0.0 108.323 -171.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.5 mp -136.45 137.37 40.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.89 1.276 . . . . 0.0 111.919 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.503 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 1.9 mpt_? -125.48 119.49 28.37 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.104 2.562 . . . . 0.0 108.666 168.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.07 143.71 41.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.945 0.898 . . . . 0.0 110.64 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -145.9 -178.21 5.99 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.953 2.101 . . . . 0.0 106.915 167.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.44 11.73 18.53 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.173 1.789 . . . . 0.0 110.985 177.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.8 t -55.37 -3.96 0.08 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.836 3.255 . . . . 0.0 118.322 -158.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 pp -101.82 -10.37 19.96 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.68 1.127 . . . . 0.0 111.977 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.41 8.8 34.81 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 117.554 -1.692 . . . . 0.0 113.197 -165.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 43.9 tpp -148.92 -85.96 0.09 Allowed 'General case' 0 C--N 1.349 0.581 0 CA-C-N 120.481 2.141 . . . . 0.0 109.641 176.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.7 t -143.43 115.54 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 176.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -128.7 114.02 16.11 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 124.939 1.296 . . . . 0.0 108.571 171.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.577 ' HB3' HG13 ' A' ' 126' ' ' VAL . 22.7 t -121.87 136.17 54.92 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.387 1.075 . . . . 0.0 108.378 -175.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.503 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 25.6 pt-20 -65.37 159.79 23.31 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.735 1.152 . . . . 0.0 111.098 175.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 90.0 t -142.14 111.68 2.63 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 C-N-CA 124.961 1.304 . . . . 0.0 107.835 172.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.97 165.72 17.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.776 1.23 . . . . 0.0 108.273 170.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 35.2 t -69.64 162.65 27.23 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 164.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -86.54 -2.92 58.88 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.523 ' HG2' ' H ' ' A' ' 24' ' ' ILE . 28.2 tpt85 -142.64 -52.39 0.39 Allowed 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.322 0.965 . . . . 0.0 112.83 171.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 22.6 p -84.01 65.79 8.87 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 120.181 1.355 . . . . 0.0 108.248 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.61 53.94 0.08 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.598 2.759 . . . . 0.0 112.535 -170.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.43 -178.39 4.6 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.745 1.618 . . . . 0.0 110.802 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -39.38 -60.68 0.89 Allowed 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 128.218 2.607 . . . . 0.0 112.587 -173.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 48.53 -118.31 1.02 Allowed 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.807 1.643 . . . . 0.0 107.559 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.54 -110.11 0.29 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-N 118.124 0.42 . . . . 0.0 112.189 168.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.33 176.99 8.61 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.575 -0.368 . . . . 0.0 111.806 -165.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.62 HG21 ' HE2' ' A' ' 136' ' ' LYS . 3.1 p -127.56 138.58 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 124.826 1.251 . . . . 0.0 109.341 168.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -138.29 161.11 37.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.386 1.074 . . . . 0.0 110.95 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -66.93 112.58 4.39 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.675 1.59 . . . . 0.0 110.527 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -156.1 -28.2 0.1 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -78.12 154.15 40.6 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -173.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.21 -32.88 6.27 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 121.984 1.789 . . . . 0.0 112.15 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 164.07 166.0 0.06 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 131.511 3.925 . . . . 0.0 106.026 -170.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.12 -45.03 0.45 Allowed 'Cis proline' 0 C--N 1.349 0.57 0 CA-C-N 121.245 1.48 . . . . 0.0 112.005 -9.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.0 p -73.59 -22.18 60.12 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.863 1.265 . . . . 0.0 113.215 -172.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.54 -1.67 56.49 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.358 0.98 . . . . 0.0 113.356 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.62 ' HE2' HG21 ' A' ' 126' ' ' VAL . 12.7 ptmt -124.25 158.34 32.73 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 120.811 -1.405 . . . . 0.0 111.522 -162.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -125.98 108.8 11.75 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.824 2.05 . . . . 0.0 107.42 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -80.74 120.79 25.09 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 168.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 42.6 t -133.2 122.57 24.18 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.318 1.447 . . . . 0.0 107.794 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.7 ptp -141.94 161.87 36.88 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.309 1.044 . . . . 0.0 109.675 -176.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.99 132.68 16.87 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 126.816 2.047 . . . . 0.0 106.238 175.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 77.0 p -174.15 176.76 2.45 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.747 1.219 . . . . 0.0 108.604 165.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.478 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -63.95 -14.09 51.12 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.002 0.921 . . . . 0.0 112.972 162.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -75.84 6.71 4.68 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.005 1.275 . . . . 0.0 113.818 -171.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.1 mt -109.31 85.4 2.09 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.471 1.032 . . . . 0.0 110.407 -163.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.454 ' HD3' HD12 ' A' ' 68' ' ' ILE . 16.9 ttpt -112.75 167.13 10.74 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.804 0.842 . . . . 0.0 109.11 171.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -112.86 159.44 19.03 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.352 1.461 . . . . 0.0 108.44 168.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.0 pt -141.15 169.46 11.41 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 126.825 2.05 . . . . 0.0 107.595 163.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -58.26 174.07 0.82 Allowed 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.433 2.088 . . . . 0.0 111.588 160.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -47.02 -25.52 0.83 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.34 2.256 . . . . 0.0 116.744 -164.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.499 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -176.66 -60.03 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.965 1.706 . . . . 0.0 108.258 167.389 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -151.74 19.7 0.7 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.909 2.084 . . . . 0.0 110.266 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.26 -14.07 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 120.639 -1.288 . . . . 0.0 111.669 174.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.913 0 C-N-CA 128.006 2.717 . . . . 0.0 106.444 160.472 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.6 mtt85 . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.42 152.06 77.3 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 119.574 1.079 . . . . 0.0 111.68 170.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.35 124.6 5.96 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.256 1.97 . . . . 0.0 109.734 164.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.4 mm -88.6 147.42 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 159.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -146.3 91.95 2.12 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -171.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 m -71.04 86.59 0.73 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 118.899 -1.12 . . . . 0.0 110.09 172.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.53 -34.78 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 124.002 0.921 . . . . 0.0 110.834 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.44 -15.22 2.46 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.826 2.05 . . . . 0.0 113.769 173.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -131.19 7.8 4.65 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.975 2.11 . . . . 0.0 111.084 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 27.6 66.9 0.08 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 128.258 2.623 . . . . 0.0 111.678 -158.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -112.45 162.07 16.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.927 1.691 . . . . 0.0 108.06 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.2 t -143.48 123.16 8.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -139.59 98.79 3.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.534 1.934 . . . . 0.0 107.265 -174.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.5 ttp -68.72 139.0 55.35 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.636 -1.29 . . . . 0.0 109.817 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 t -135.98 135.18 50.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -62.93 167.77 4.48 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 120.946 -1.096 . . . . 0.0 111.208 165.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.8 mtm105 -78.01 -166.67 0.84 Allowed 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.448 -0.783 . . . . 0.0 113.031 -169.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.1 112.88 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 -178.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -142.43 98.41 3.3 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 -177.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.478 HD11 HD11 ' A' ' 34' ' ' ILE . 54.9 mt -136.19 172.76 12.53 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 126.652 1.981 . . . . 0.0 109.885 178.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.96 166.57 21.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.97 2.108 . . . . 0.0 107.936 160.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -62.99 -54.59 35.97 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.493 -0.754 . . . . 0.0 112.196 -175.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.45 -19.01 65.28 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -171.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -56.57 -40.7 75.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.041 0.936 . . . . 0.0 109.575 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -59.3 6.82 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.412 2.285 . . . . 0.0 116.599 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.06 -8.88 3.03 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 120.756 -1.215 . . . . 0.0 114.184 173.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -117.87 -22.45 7.93 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.423 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.478 HD11 HD11 ' A' ' 26' ' ' LEU . 1.1 pt -105.32 -9.5 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.456 1.025 . . . . 0.0 112.338 169.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.55 175.28 6.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.685 0.794 . . . . 0.0 111.135 -170.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.32 140.77 94.53 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 164.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.3 -12.25 27.41 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.337 2.691 . . . . 0.0 112.523 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -81.95 -38.97 24.39 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 126.76 2.024 . . . . 0.0 110.059 167.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.26 -44.5 96.4 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 119.776 1.171 . . . . 0.0 110.323 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -46.55 -57.23 4.94 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.202 1.401 . . . . 0.0 110.703 174.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 20.0 ptp180 -73.63 -49.52 25.61 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 118.084 -0.96 . . . . 0.0 108.784 -174.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.8 t -53.04 -32.85 18.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 119.08 0.854 . . . . 0.0 110.064 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.61 -28.4 68.49 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.81 -23.98 19.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.438 1.017 . . . . 0.0 112.128 175.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HE3' ' HB2' ' A' ' 41' ' ' ARG . 19.0 ptpt -111.26 -1.7 15.99 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -168.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 40.35 43.55 1.48 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.068 1.347 . . . . 0.0 111.002 -167.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.516 0 C-N-CA 125.781 1.658 . . . . 0.0 114.858 167.119 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 161.32 -167.43 36.21 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -164.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.544 HG22 ' HA ' ' A' ' 76' ' ' ASP . 22.2 pt -130.76 162.55 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.317 1.047 . . . . 0.0 110.25 174.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -79.91 155.25 27.83 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.726 0.811 . . . . 0.0 111.243 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 43.8 ttt180 -139.93 152.81 46.67 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.534 1.134 . . . . 0.0 110.197 176.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.9 t -103.3 93.01 4.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.478 1.511 . . . . 0.0 107.817 169.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.504 HG22 ' HA ' ' A' ' 144' ' ' ALA . 4.0 tt -61.09 -33.91 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 125.426 1.49 . . . . 0.0 111.733 -175.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.0 t -75.77 5.95 5.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.595 1.158 . . . . 0.0 111.613 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.1 p -140.96 15.48 2.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.795 0.838 . . . . 0.0 110.811 158.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.65 11.29 35.05 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.009 1.766 . . . . 0.0 115.271 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.0 m -118.85 137.91 53.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.745 1.773 . . . . 0.0 110.849 -159.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 8.9 p-10 -79.62 164.17 24.01 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.516 1.527 . . . . 0.0 113.481 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.268 0.2 OUTLIER -161.28 -101.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.983 0.913 . . . . 0.0 112.402 174.46 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -61.89 129.32 40.4 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -158.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.544 ' HA ' HG22 ' A' ' 64' ' ' ILE . 9.9 t0 -74.07 134.19 42.93 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 170.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.7 m -62.51 -18.12 61.24 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.153 0.981 . . . . 0.0 113.439 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -30.68 66.25 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.012 1.278 . . . . 0.0 111.635 172.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.7 p -69.53 -17.13 63.55 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.229 1.012 . . . . 0.0 112.694 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 87' ' ' TRP . 16.7 tttt -102.17 -163.73 1.03 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.701 1.6 . . . . 0.0 109.723 -164.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.47 21.66 4.34 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.566 0.951 . . . . 0.0 113.566 -175.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -53.87 118.31 3.87 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.756 1.222 . . . . 0.0 109.015 164.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 m 111.0 -23.5 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 131.621 3.968 . . . . 0.0 110.585 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -99.16 -52.01 1.29 Allowed Glycine 0 C--N 1.34 0.786 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 176.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.4 t -155.43 -6.72 0.13 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 168.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.99 17.69 52.29 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 119.794 1.179 . . . . 0.0 115.351 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.407 ' O ' ' HE2' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -63.15 150.49 88.68 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 118.022 0.911 . . . . 0.0 110.864 176.193 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -77.89 51.01 3.45 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.747 2.964 . . . . 0.0 111.489 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.4 p -129.74 146.39 51.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.676 0.791 . . . . 0.0 109.785 168.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.72 166.05 25.79 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.004 1.722 . . . . 0.0 108.568 -170.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -116.63 -9.27 11.36 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -172.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -149.65 -174.03 4.57 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 168.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 m -130.79 165.48 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 124.511 1.124 . . . . 0.0 111.475 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.3 p -52.7 -44.95 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.452 1.501 . . . . 0.0 110.877 168.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.4 m 157.14 158.33 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 130.258 3.423 . . . . 0.0 108.76 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -72.8 72.78 1.09 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 164.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -121.41 -56.19 1.9 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.379 1.072 . . . . 0.0 109.191 -174.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -118.01 13.41 13.91 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.363 1.865 . . . . 0.0 110.644 170.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.31 142.3 44.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 O-C-N 119.962 -1.711 . . . . 0.0 107.236 171.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -122.53 145.97 47.84 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.085 1.754 . . . . 0.0 107.963 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mp -128.12 157.37 40.94 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 125.092 1.357 . . . . 0.0 111.771 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.49 133.53 27.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 127.934 2.493 . . . . 0.0 106.094 167.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.461 ' CD ' HH21 ' A' ' 105' ' ' ARG . 6.8 tm-20 -76.94 144.49 38.8 Favored 'General case' 0 N--CA 1.459 0.021 0 C-N-CA 123.245 0.618 . . . . 0.0 110.878 177.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -150.9 177.73 9.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.044 2.138 . . . . 0.0 105.409 158.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.461 HH21 ' CD ' ' A' ' 103' ' ' GLU . 1.1 ptp180 -120.36 27.98 8.28 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.667 1.987 . . . . 0.0 111.072 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.03 21.3 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.961 2.905 . . . . 0.0 116.372 -168.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.64 0.57 3.29 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.539 1.136 . . . . 0.0 112.435 166.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.35 -0.13 55.79 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 117.696 -1.613 . . . . 0.0 112.842 -170.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -139.11 -88.97 0.21 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 119.854 1.827 . . . . 0.0 108.495 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 64.5 t -145.2 107.2 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -176.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -113.56 88.62 2.88 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.892 1.277 . . . . 0.0 108.757 167.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 53.5 m -86.06 133.32 33.9 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.05 159.58 30.55 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.311 0.96 . . . . 0.0 111.285 174.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.7 t -141.65 102.79 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 126.385 1.874 . . . . 0.0 107.163 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -133.09 159.66 39.45 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.551 0.614 . . . . 0.0 111.248 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 43.1 t -79.27 115.32 18.85 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.532 0.733 . . . . 0.0 111.021 -173.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.51 -24.83 65.61 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.671 1.188 . . . . 0.0 113.463 -171.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -59.2 -26.97 65.29 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.73 1.15 . . . . 0.0 112.749 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 2.8 p -137.71 -94.73 0.2 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -174.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 176.42 16.45 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.99 2.516 . . . . 0.0 112.238 -174.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.83 148.36 44.55 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -158.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -41.18 -65.65 0.41 Allowed 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 128.985 2.914 . . . . 0.0 113.99 -159.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 52.66 -108.1 0.38 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.868 1.667 . . . . 0.0 108.916 176.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.06 -115.51 0.5 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.145 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -160.21 177.15 10.95 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 122.762 -0.257 . . . . 0.0 110.792 -168.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.683 HG21 ' HE2' ' A' ' 136' ' ' LYS . 5.0 p -125.68 137.35 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.265 1.426 . . . . 0.0 108.888 173.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -132.25 159.11 40.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.098 0.959 . . . . 0.0 112.133 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -72.78 84.36 1.2 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.917 2.487 . . . . 0.0 110.942 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -160.04 7.22 0.09 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.355 1.062 . . . . 0.0 112.818 -172.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -97.71 170.36 25.28 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 119.872 -1.768 . . . . 0.0 112.755 -173.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.04 165.09 33.71 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.631 2.221 . . . . 0.0 110.146 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -62.45 151.92 81.57 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 162.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.05 -44.74 0.51 Allowed 'Cis proline' 0 C--N 1.347 0.452 0 CA-C-N 119.992 1.033 . . . . 0.0 113.806 8.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 26.9 p -72.8 -25.72 61.25 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -165.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.58 3.5 62.9 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.094 0.854 . . . . 0.0 113.552 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.683 ' HE2' HG21 ' A' ' 126' ' ' VAL . 9.7 ptmt -128.97 156.76 43.26 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.327 1.563 . . . . 0.0 111.877 -165.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.7 ttm105 -125.11 101.13 6.88 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.675 1.99 . . . . 0.0 107.399 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -67.26 135.48 53.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 162.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 20.9 t -143.81 141.34 30.33 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.704 1.138 . . . . 0.0 108.609 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -141.09 158.61 43.68 Favored 'General case' 0 C--O 1.231 0.079 0 C-N-CA 123.09 0.556 . . . . 0.0 111.494 -173.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -151.17 125.56 9.45 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.95 1.7 . . . . 0.0 108.093 161.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.8 t -149.5 148.97 30.03 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 158.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.24 -19.93 63.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.571 166.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.504 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -65.78 -12.26 52.62 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.755 1.222 . . . . 0.0 113.436 172.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 89.5 mt -75.45 106.09 6.82 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.946 1.248 . . . . 0.0 109.992 -176.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -109.82 167.62 10.02 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.31 1.444 . . . . 0.0 107.923 170.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -124.39 147.12 48.45 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 23.6 pt -138.77 166.66 23.53 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.287 1.435 . . . . 0.0 107.85 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -54.82 170.24 0.67 Allowed 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.497 2.132 . . . . 0.0 111.652 167.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -52.92 -27.15 17.4 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -171.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -165.05 -83.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 158.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -123.55 12.25 9.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.489 1.116 . . . . 0.0 110.597 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 154' ' ' GLY . 2.2 pp -65.12 -24.57 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -169.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.43 ' N ' HD12 ' A' ' 153' ' ' ILE . . . . . . . . 0 C--O 1.247 0.935 0 CA-C-O 116.939 -2.034 . . . . 0.0 109.597 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.5 mtt180 . . . . . 0 N--CA 1.439 -1.017 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.0 pt -116.14 113.45 41.51 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 126.882 2.073 . . . . 0.0 106.829 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.66 101.0 1.11 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.03 1.82 . . . . 0.0 107.652 168.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.18 147.01 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 170.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -141.75 160.98 39.07 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.302 1.841 . . . . 0.0 107.228 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.5 t -136.63 113.64 10.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 160.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.8 p -56.91 -45.34 83.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 119.148 0.885 . . . . 0.0 110.046 170.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.37 -31.02 61.43 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.36 1.864 . . . . 0.0 113.057 -174.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -118.75 0.41 11.44 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.059 1.344 . . . . 0.0 112.181 -175.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 41.43 41.12 1.46 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.648 1.579 . . . . 0.0 112.41 -159.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -74.46 150.92 39.7 Favored 'General case' 0 C--N 1.345 0.39 0 O-C-N 121.15 -0.969 . . . . 0.0 109.138 174.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.2 t -142.37 137.84 29.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 159.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -155.49 110.15 2.93 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.052 1.741 . . . . 0.0 109.61 173.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.2 ttt -79.79 129.34 34.4 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 120.34 -1.475 . . . . 0.0 110.192 174.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.0 t -122.8 155.24 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -79.58 162.55 25.26 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.401 -0.812 . . . . 0.0 110.61 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -75.28 160.6 30.16 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.582 -0.699 . . . . 0.0 110.688 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.6 tt -90.92 67.97 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 122.745 1.259 . . . . 0.0 112.133 -161.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -101.38 47.22 0.91 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.393 -169.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.5 mt -78.61 172.72 13.29 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.785 1.278 . . . . 0.0 110.984 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.23 153.57 28.45 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 127.205 2.202 . . . . 0.0 107.011 161.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -59.37 -39.05 82.06 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.216 1.371 . . . . 0.0 111.877 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.61 -22.73 62.24 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -174.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.79 -38.84 83.88 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.481 1.112 . . . . 0.0 109.563 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.6 m95 -62.85 8.3 0.06 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.731 2.412 . . . . 0.0 115.994 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.22 -2.05 3.98 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -129.7 -19.73 3.3 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.456 -0.783 . . . . 0.0 112.617 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 pt -107.31 1.78 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 119.033 0.833 . . . . 0.0 111.645 167.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -108.55 167.19 10.23 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.17 0.988 . . . . 0.0 110.894 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.39 140.04 79.77 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 166.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.17 -18.16 55.74 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.018 1.812 . . . . 0.0 111.49 168.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -70.37 -44.14 68.7 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 118.83 -0.605 . . . . 0.0 109.713 170.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.48 -43.82 93.18 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.18 0.9 . . . . 0.0 110.049 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -59.81 -45.22 93.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.84 0.856 . . . . 0.0 112.007 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -70.19 -48.38 57.44 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 119.095 0.862 . . . . 0.0 108.788 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.1 t -53.92 -32.58 22.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 124.871 1.269 . . . . 0.0 110.065 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.67 -26.35 67.97 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 175.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.5 ptt-85 -88.8 -27.62 20.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.752 1.16 . . . . 0.0 111.912 174.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -110.93 2.64 18.24 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -168.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.04 36.29 1.93 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.479 1.511 . . . . 0.0 111.621 -171.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.451 0 CA-C-O 117.967 -1.463 . . . . 0.0 113.411 174.901 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 CA--C 1.533 0.317 0 CA-C-O 120.769 0.319 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.19 178.31 38.59 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -159.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.509 HG22 ' HA ' ' A' ' 76' ' ' ASP . 37.6 pt -136.82 160.63 36.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.427 0.691 . . . . 0.0 109.555 173.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.71 158.28 28.36 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.132 0.967 . . . . 0.0 110.693 178.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 5.2 ttt180 -143.51 134.18 25.08 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.481 1.512 . . . . 0.0 110.057 -170.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.7 t -87.03 92.71 9.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 174.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.7 tt -62.01 -25.61 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 O-C-N 122.265 -0.272 . . . . 0.0 110.994 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 57.8 m -70.12 -0.35 7.59 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.267 1.827 . . . . 0.0 113.589 176.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 25.0 p -139.56 15.2 2.54 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.918 0.887 . . . . 0.0 110.606 158.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.11 9.43 5.77 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 118.031 -1.427 . . . . 0.0 114.201 -177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.1 m -110.29 141.57 43.1 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.308 1.554 . . . . 0.0 108.851 -164.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 7.8 p-10 -65.82 163.84 15.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.51 1.124 . . . . 0.0 113.679 176.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.309 0.2 OUTLIER -154.29 -110.01 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.604 165.214 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -52.83 115.65 1.93 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.319 1.448 . . . . 0.0 112.617 -162.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.509 ' HA ' HG22 ' A' ' 64' ' ' ILE . 13.2 t70 -65.96 151.16 47.41 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 170.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.37 -16.67 64.26 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 176.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -63.61 -13.4 41.73 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.787 1.631 . . . . 0.0 111.828 163.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.449 ' HA ' ' CD2' ' A' ' 90' ' ' PHE . 67.5 p -119.58 12.4 12.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.813 2.445 . . . . 0.0 111.703 172.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -156.16 91.97 1.31 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.021 0.929 . . . . 0.0 110.396 178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -141.68 147.69 37.88 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.988 1.715 . . . . 0.0 106.456 166.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -149.96 136.93 19.47 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 166.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.2 p -55.47 98.39 0.02 OUTLIER 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.805 2.042 . . . . 0.0 112.96 -158.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.9 11.95 26.75 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.832 1.206 . . . . 0.0 113.7 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.3 m -136.02 -34.45 0.8 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.218 1.007 . . . . 0.0 110.507 -159.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.7 25.82 59.25 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.428 -1.206 . . . . 0.0 114.659 172.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -59.5 140.65 88.6 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 119.223 1.511 . . . . 0.0 109.677 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -78.82 67.8 8.38 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.154 2.569 . . . . 0.0 113.301 -167.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.2 p -145.61 145.48 30.98 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.485 162.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CD2' ' HA ' ' A' ' 79' ' ' THR . 4.7 t80 -141.94 -156.56 0.69 Allowed 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.464 0.706 . . . . 0.0 110.195 171.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -133.14 4.33 3.75 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.036 0.835 . . . . 0.0 112.184 -172.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.569 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 1.1 t0 -151.38 -176.95 5.79 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.22 158.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.8 m -134.26 164.1 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 126.594 1.958 . . . . 0.0 109.23 173.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -73.1 -17.71 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -167.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.3 m 160.43 171.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 131.121 3.768 . . . . 0.0 108.253 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -91.65 100.67 13.35 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 158.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.5 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 10.6 p80 -141.84 -60.83 0.46 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.334 0.654 . . . . 0.0 109.92 -171.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.5 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 63.1 t30 -114.37 10.72 17.12 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.468 2.307 . . . . 0.0 110.005 171.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.57 150.22 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 127.5 2.32 . . . . 0.0 107.497 -177.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HD3' ' H ' ' A' ' 101' ' ' LEU . 14.4 tppt? -142.16 147.54 36.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.18 1.792 . . . . 0.0 110.517 -174.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.461 ' H ' ' HD3' ' A' ' 100' ' ' LYS . 1.8 mp -127.17 150.67 49.41 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 127.839 2.456 . . . . 0.0 111.78 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.568 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 1.3 mpt_? -131.4 152.89 50.24 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 129.927 3.291 . . . . 0.0 104.46 162.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -125.69 135.94 52.66 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 119.015 0.825 . . . . 0.0 111.008 -168.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.434 ' CG ' ' H ' ' A' ' 105' ' ' ARG . 33.4 t0 -144.82 -176.43 5.07 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.228 2.211 . . . . 0.0 108.863 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.434 ' H ' ' CG ' ' A' ' 104' ' ' ASP . 17.5 ptt-85 -112.73 15.87 19.79 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 128.734 2.814 . . . . 0.0 111.894 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.31 -33.28 41.65 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -158.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.1 pp -78.22 -10.36 59.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.045 0.839 . . . . 0.0 112.966 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.3 -1.44 26.66 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.431 -1.761 . . . . 0.0 112.885 -169.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.7 mmt -143.41 -88.05 0.13 Allowed 'General case' 0 C--N 1.347 0.463 0 CA-C-N 120.026 1.913 . . . . 0.0 108.215 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.2 t -138.55 112.09 7.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 CA-C-N 120.25 1.386 . . . . 0.0 107.604 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.5 ttt85 -121.95 117.45 26.46 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.525 0.73 . . . . 0.0 109.723 168.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.94 141.92 47.92 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.568 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 10.0 pt-20 -72.36 159.62 33.71 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.32 0.964 . . . . 0.0 109.981 176.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.9 t -138.6 103.51 2.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 170.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.7 mp -124.69 175.37 7.26 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 11.5 t -64.9 166.66 8.79 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.463 0.649 . . . . 0.0 110.136 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -100.42 -4.99 27.84 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.29 1.036 . . . . 0.0 110.808 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 34.7 tpt85 -131.85 -71.03 0.56 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 116.978 -1.487 . . . . 0.0 111.603 159.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.2 p -75.22 94.54 2.99 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 119.95 1.25 . . . . 0.0 109.148 -168.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -37.86 30.08 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.286 1 C-N-CA 133.965 4.906 . . . . 0.0 118.945 174.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.1 175.39 2.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.186 2.195 . . . . 0.0 111.895 174.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -71.14 -57.89 4.08 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 126.104 1.761 . . . . 0.0 111.171 -163.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.55 -112.06 0.64 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.014 1.726 . . . . 0.0 107.372 177.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.7 -104.88 0.2 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 119.051 0.841 . . . . 0.0 112.339 165.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -161.85 -177.26 5.72 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.751 0.31 . . . . 0.0 111.452 -163.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.15 140.71 43.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 126.575 1.95 . . . . 0.0 107.349 169.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -139.29 153.61 47.8 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.715 0.806 . . . . 0.0 110.768 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -64.12 119.74 10.76 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.694 0.679 . . . . 0.0 109.298 167.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -154.28 -28.74 0.12 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.253 1.021 . . . . 0.0 113.204 -177.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -95.97 -179.78 35.72 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.821 1.201 . . . . 0.0 111.428 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.64 -87.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.141 2.56 . . . . 0.0 112.085 -175.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.73 163.1 1.64 Allowed Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 127.277 2.231 . . . . 0.0 107.4 -176.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.11 -39.94 1.12 Allowed 'Cis proline' 0 C--N 1.35 0.627 0 CA-C-N 120.241 1.122 . . . . 0.0 109.817 -13.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.3 p -73.66 79.83 1.52 Allowed 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.611 1.565 . . . . 0.0 108.945 165.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -109.93 -3.05 30.15 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 126.832 2.158 . . . . 0.0 110.659 170.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 138.88 39.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 164.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -117.37 109.8 17.26 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.291 1.836 . . . . 0.0 108.303 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.569 ' CE1' ' HA ' ' A' ' 92' ' ' ASP . 50.2 m-85 -78.23 129.6 35.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 23.2 t -140.0 120.38 13.99 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.915 1.686 . . . . 0.0 108.771 -170.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 20.5 ptp -133.74 155.16 50.26 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.558 0.743 . . . . 0.0 109.854 -170.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -152.14 93.66 1.85 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.958 2.103 . . . . 0.0 107.003 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.7 p -143.3 152.94 42.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.09 -35.66 81.0 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.66 0.743 . . . . 0.0 109.421 165.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.4 75.87 0.26 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.874 1.67 . . . . 0.0 110.416 165.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 96.1 mt -144.83 46.97 1.35 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.009 2.524 . . . . 0.0 108.655 164.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -72.31 157.24 38.05 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -97.14 145.86 25.61 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.64 0.776 . . . . 0.0 109.711 164.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.497 ' HB ' ' HD2' ' A' ' 149' ' ' PRO . 0.1 OUTLIER -134.65 174.96 4.03 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 160.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 148' ' ' ILE . 57.0 Cg_endo -64.46 172.29 6.85 Favored 'Trans proline' 0 C--N 1.352 0.734 0 CA-C-N 121.504 1.573 . . . . 0.0 112.061 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -38.84 -44.26 1.02 Allowed 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 127.433 2.293 . . . . 0.0 114.012 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -144.34 -78.32 0.21 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.606 1.962 . . . . 0.0 107.945 172.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -144.55 2.62 1.1 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 128.692 2.797 . . . . 0.0 111.195 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.4 pp -55.3 -24.48 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -174.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 116.901 -2.055 . . . . 0.0 110.702 176.107 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 . . . . . 0 N--CA 1.438 -1.045 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.4 pt -123.13 108.89 31.89 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.013 1.725 . . . . 0.0 107.406 -169.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.22 104.26 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.932 2.421 . . . . 0.0 109.12 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.9 mm -84.15 154.59 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -134.69 152.25 51.63 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -176.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.2 m -129.08 77.99 1.82 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.11 -38.8 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.34 1.056 . . . . 0.0 111.89 -171.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.18 -14.57 11.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.237 1.415 . . . . 0.0 113.65 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.04 10.57 4.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.984 2.114 . . . . 0.0 110.608 175.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 34.53 40.99 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.776 2.83 . . . . 0.0 113.434 -164.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -83.07 164.17 20.46 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.275 -0.89 . . . . 0.0 108.995 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.5 t -136.32 132.42 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 168.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -135.63 103.6 5.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.534 1.534 . . . . 0.0 107.129 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.5 ttm -71.05 122.02 19.29 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 120.967 -1.083 . . . . 0.0 108.81 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.9 156.32 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 173.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -88.79 164.74 15.09 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.898 -1.126 . . . . 0.0 110.199 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.479 ' HG3' ' HD3' ' A' ' 118' ' ' ARG . 39.4 ttt-85 -65.87 144.25 56.93 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.769 -0.582 . . . . 0.0 110.506 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 tt -83.89 121.81 36.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -156.99 118.0 3.67 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 169.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.2 mt -135.73 177.54 7.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.987 2.515 . . . . 0.0 108.811 -172.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 p -85.62 178.7 7.29 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 164.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -60.1 -38.45 83.0 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.62 0.768 . . . . 0.0 111.083 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -18.46 59.26 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -166.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -71.07 -45.89 62.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.399 1.08 . . . . 0.0 110.154 -169.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -63.79 21.52 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.321 2.648 . . . . 0.0 114.805 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.99 -10.82 2.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 166.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -120.77 -18.05 7.78 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 119.223 0.919 . . . . 0.0 112.824 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 pt -111.08 24.97 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 119.226 0.921 . . . . 0.0 111.27 170.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -124.87 169.47 12.02 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.832 1.253 . . . . 0.0 110.903 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -62.65 144.08 96.24 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 168.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -68.37 -12.04 33.75 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.418 2.079 . . . . 0.0 111.741 168.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -78.84 -41.08 30.96 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 118.476 -0.773 . . . . 0.0 111.065 166.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.72 -39.42 80.78 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 120.231 1.378 . . . . 0.0 111.472 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -61.21 -37.74 84.06 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.799 0.84 . . . . 0.0 113.048 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.0 ptt-85 -78.15 -49.47 13.79 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.599 HG12 ' HB1' ' A' ' 143' ' ' ALA . 3.2 t -60.2 -24.16 29.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 O-C-N 121.396 -0.815 . . . . 0.0 111.488 -173.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.21 -24.26 67.3 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 171.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -105.69 -37.63 6.67 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.392 1.077 . . . . 0.0 111.548 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -90.47 10.68 24.31 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.251 0.932 . . . . 0.0 112.819 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 42.36 50.74 4.67 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.701 1.6 . . . . 0.0 111.564 -177.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.421 ' HA2' HG22 ' A' ' 42' ' ' VAL . . . . . . . . 0 C--N 1.336 0.564 0 CA-C-O 118.257 -1.302 . . . . 0.0 113.903 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 42.4 t0 . . . . . 0 CA--C 1.534 0.328 0 CA-C-O 121.773 0.797 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.31 163.36 30.69 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 126.017 1.77 . . . . 0.0 111.763 168.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.7 pt -133.8 155.85 40.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 165.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -79.23 146.99 32.75 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.659 0.743 . . . . 0.0 109.489 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -110.93 110.92 21.7 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 128.613 2.765 . . . . 0.0 107.067 169.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.65 88.65 0.06 Allowed 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 165.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.6 tt -62.36 -28.13 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.591 0.71 . . . . 0.0 110.461 -170.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.91 -9.15 57.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 128.107 2.563 . . . . 0.0 113.129 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.1 p -139.5 15.29 2.55 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.754 0.821 . . . . 0.0 111.594 166.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.87 37.9 53.45 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 118.912 0.778 . . . . 0.0 112.045 176.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.0 m -132.18 146.39 51.99 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 125.971 1.708 . . . . 0.0 107.27 -171.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.3 173.52 12.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.36 0.982 . . . . 0.0 111.675 176.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -168.2 -118.15 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.689 1.995 . . . . 0.0 110.392 170.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -48.25 132.32 16.21 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.83 1.652 . . . . 0.0 114.306 -159.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -80.73 145.3 31.62 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.725 0.81 . . . . 0.0 110.068 172.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.6 m -54.6 -26.39 32.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 117.572 -1.204 . . . . 0.0 113.719 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -62.63 -21.25 65.52 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.798 1.635 . . . . 0.0 112.361 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.8 p -79.25 -10.64 59.86 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.547 0.739 . . . . 0.0 112.059 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -117.96 -177.97 3.39 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.327 1.451 . . . . 0.0 110.98 -161.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -140.76 25.24 2.17 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -162.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -56.06 -34.92 66.38 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 120.531 -1.356 . . . . 0.0 112.431 173.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.09 77.93 3.63 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 163.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 155.84 -68.02 0.29 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.601 1.096 . . . . 0.0 111.287 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.8 t -153.5 -11.58 0.15 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.455 1.279 . . . . 0.0 114.455 -173.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.06 18.5 57.6 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.781 1.173 . . . . 0.0 115.337 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.86 136.91 96.69 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 118.221 1.01 . . . . 0.0 110.708 -177.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.95 51.34 3.81 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.904 3.069 . . . . 0.0 111.771 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.3 p -138.38 117.64 12.73 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 168.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -104.33 179.77 4.18 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.62 1.968 . . . . 0.0 107.894 -170.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -119.37 -12.96 9.31 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 118.309 -0.853 . . . . 0.0 113.209 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -154.38 -178.49 7.18 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.897 1.226 . . . . 0.0 108.222 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.4 t -133.74 153.8 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.727 1.211 . . . . 0.0 110.061 -165.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -65.81 -56.72 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.154 0.982 . . . . 0.0 109.909 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.0 m 175.63 158.88 0.24 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 127.276 2.231 . . . . 0.0 107.656 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -76.36 85.23 3.12 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 160.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -119.7 -58.18 1.92 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.647 0.779 . . . . 0.0 109.561 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.71 -1.72 24.15 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.262 1.025 . . . . 0.0 111.296 169.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.06 153.86 32.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 126.393 1.877 . . . . 0.0 108.571 -169.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -140.39 134.54 30.99 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.324 1.449 . . . . 0.0 110.273 -167.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 pp -141.96 144.95 33.98 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 124.305 1.003 . . . . 0.0 113.258 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.544 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 1.5 mpt_? -137.24 123.95 21.13 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 129.522 3.129 . . . . 0.0 107.747 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -84.35 148.44 26.63 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.776 1.23 . . . . 0.0 111.206 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -153.99 173.32 16.15 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.21 2.604 . . . . 0.0 107.49 168.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.93 20.19 11.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.599 1.159 . . . . 0.0 112.763 173.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.97 -43.48 63.57 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -158.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pp -73.36 -7.58 52.23 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.84 3.69 45.8 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.485 1.517 . . . . 0.0 112.512 -169.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.0 mtp -142.07 -98.36 0.13 Allowed 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.091 1.445 . . . . 0.0 108.474 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.7 t -139.4 106.35 2.71 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.3 ttt-85 -110.42 113.69 26.54 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 42.7 t -119.77 124.32 45.87 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.544 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 16.8 pt-20 -62.54 162.26 10.68 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.221 0.464 . . . . 0.0 110.812 -174.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.8 t -137.24 106.28 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 169.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.36 168.88 15.62 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 170.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 30.4 t -70.6 138.93 51.25 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.54 -12.93 60.03 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.191 0.996 . . . . 0.0 112.297 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.479 ' HD3' ' HG3' ' A' ' 23' ' ' ARG . 38.4 tpt85 -123.26 -73.79 0.64 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 117.088 -1.434 . . . . 0.0 112.904 167.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 19.9 p -69.71 17.58 0.05 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 -158.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 68.09 -19.69 0.14 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.911 2.484 . . . . 0.0 116.087 162.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.06 165.33 18.24 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -161.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -37.12 -62.65 0.48 Allowed 'General case' 0 C--N 1.342 0.28 0 C-N-CA 129.247 3.019 . . . . 0.0 113.846 -169.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mt 46.43 -109.12 0.21 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.225 2.21 . . . . 0.0 110.604 -172.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.78 -126.47 1.03 Allowed Glycine 0 CA--C 1.521 0.456 0 CA-C-N 119.144 0.884 . . . . 0.0 113.913 175.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -167.08 168.39 13.71 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.967 0.907 . . . . 0.0 110.415 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.647 HG21 ' HE2' ' A' ' 136' ' ' LYS . 4.0 p -105.5 142.87 17.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 123.78 0.832 . . . . 0.0 110.152 170.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -140.72 166.32 25.07 Favored 'General case' 0 C--N 1.344 0.328 0 O-C-N 124.006 0.816 . . . . 0.0 111.569 172.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.24 67.94 1.43 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.056 1.742 . . . . 0.0 112.19 -172.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -142.7 25.38 1.82 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.439 1.096 . . . . 0.0 111.52 -174.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -103.2 167.43 16.91 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.971 -1.081 . . . . 0.0 111.637 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.7 167.81 25.6 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.509 2.139 . . . . 0.0 110.564 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 52.3 ptt85 -58.23 147.36 67.08 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 160.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.21 -54.28 0.15 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.525 0 CA-C-N 120.557 1.235 . . . . 0.0 113.764 7.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.1 t -79.21 -13.46 59.68 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -161.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.65 -1.36 45.42 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 119.963 1.256 . . . . 0.0 114.424 169.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.647 ' HE2' HG21 ' A' ' 126' ' ' VAL . 15.6 ptmt -119.44 156.11 30.79 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.084 1.442 . . . . 0.0 111.434 -169.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -128.03 98.91 5.29 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 126.089 1.755 . . . . 0.0 110.128 -169.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -75.58 92.96 2.97 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.685 2.394 . . . . 0.0 109.367 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 31.3 t -92.57 140.24 29.75 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.021 0.928 . . . . 0.0 109.963 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 9.1 ttp -144.37 146.92 32.81 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.981 0.912 . . . . 0.0 109.204 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -143.13 119.12 10.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.458 1.903 . . . . 0.0 107.756 174.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 80.3 p -172.86 -175.14 1.2 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.524 1.13 . . . . 0.0 107.963 165.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.599 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -57.77 -21.25 40.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.615 1.566 . . . . 0.0 114.0 163.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.27 25.76 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.09 2.156 . . . . 0.0 115.751 -164.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 95.5 mt -124.63 41.58 3.47 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.157 0.89 . . . . 0.0 112.258 -160.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -78.67 145.34 34.64 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 170.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -95.31 159.16 15.14 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.777 0.717 . . . . 0.0 109.546 167.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 14.2 pt -138.53 170.98 8.99 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 125.077 1.351 . . . . 0.0 107.663 158.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -46.47 167.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.524 3.482 . . . . 0.0 113.702 162.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -15.66 -49.01 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 129.284 3.034 . . . . 0.0 116.023 163.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -170.08 -156.63 0.14 Allowed 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 131.326 3.85 . . . . 0.0 101.255 -161.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -88.05 16.02 6.6 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 129.331 3.053 . . . . 0.0 110.133 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.2 pp -76.03 -10.69 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.121 1.768 . . . . 0.0 114.171 -162.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 CA-C-O 116.964 -2.02 . . . . 0.0 111.066 177.886 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 . . . . . 0 CA--C 1.54 0.575 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 pt -108.91 114.97 57.87 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 125.66 1.584 . . . . 0.0 111.041 -175.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.91 126.13 12.25 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.238 1.959 . . . . 0.0 109.287 164.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.9 mt -110.21 93.58 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -88.76 112.21 22.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.0 m -83.41 75.56 9.98 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 166.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.4 m -57.58 -30.14 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -170.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.21 -17.9 22.29 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.104 1.362 . . . . 0.0 113.059 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.27 15.76 5.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.811 1.644 . . . . 0.0 111.201 166.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 36.67 44.47 0.33 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.604 2.762 . . . . 0.0 112.638 -166.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.5 mtm105 -84.09 156.67 22.06 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 168.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.0 t -143.64 122.03 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -177.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -130.39 114.72 15.93 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.515 1.126 . . . . 0.0 108.064 171.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.5 ttm -81.96 135.19 35.4 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 121.173 -0.954 . . . . 0.0 109.197 172.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.3 t -135.46 159.17 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 126.024 1.73 . . . . 0.0 106.611 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -69.53 166.13 19.54 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.743 -1.223 . . . . 0.0 113.559 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.95 170.62 12.33 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 163.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.55 138.52 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -168.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -156.96 92.14 1.25 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 174.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.5 mt -126.57 -178.17 4.27 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 127.487 2.315 . . . . 0.0 108.436 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.8 p -87.45 -92.64 0.1 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.232 1.013 . . . . 0.0 109.95 176.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -150.41 -62.02 0.2 Allowed 'General case' 0 C--O 1.231 0.117 0 C-N-CA 126.564 1.946 . . . . 0.0 107.947 174.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -58.53 -21.89 53.7 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -175.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -53.2 -46.12 68.9 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.789 0.836 . . . . 0.0 110.658 173.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -68.2 40.91 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.338 2.255 . . . . 0.0 112.935 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.27 -44.42 0.13 Allowed 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 125.623 1.569 . . . . 0.0 109.351 159.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.4 -24.0 34.63 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 117.94 -1.029 . . . . 0.0 112.549 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.1 pt -105.65 21.99 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 119.936 1.244 . . . . 0.0 112.443 172.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.9 mt -108.22 166.01 11.07 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-O 122.036 0.922 . . . . 0.0 113.272 -177.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -56.15 151.01 28.18 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.942 1.297 . . . . 0.0 109.111 163.227 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.9 22.18 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.121 1 C-N-CA 125.331 4.021 . . . . 0.0 111.981 168.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.473 ' H ' ' C ' ' A' ' 36' ' ' ASP . 7.2 tt0 -133.32 -48.72 0.84 Allowed 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 126.867 2.067 . . . . 0.0 109.317 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.21 75.24 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 120.31 1.413 . . . . 0.0 111.9 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -56.18 -46.06 79.52 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 175.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -80.83 -51.06 9.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -175.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.627 HG13 ' HA2' ' A' ' 47' ' ' GLY 0.269 2.1 t -59.52 -23.92 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.413 1.085 . . . . 0.0 110.374 -178.102 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.47 -25.51 68.03 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 170.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -100.68 -34.79 9.72 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.035 1.288 . . . . 0.0 111.566 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -89.0 5.79 42.63 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.892 0.877 . . . . 0.0 112.092 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.42 51.29 16.65 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.852 1.661 . . . . 0.0 110.568 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.627 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . . . . . . 0 C--N 1.338 0.644 0 CA-C-O 118.778 -1.012 . . . . 0.0 114.513 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.3 t0 . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.39 -172.78 52.63 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 125.463 1.506 . . . . 0.0 111.96 162.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.517 HG22 ' HA ' ' A' ' 76' ' ' ASP . 36.4 pt -138.28 166.47 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 158.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -78.48 149.16 33.24 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.259 -0.901 . . . . 0.0 110.237 173.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.17 120.26 24.26 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.636 1.974 . . . . 0.0 107.002 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.0 t -73.76 86.6 1.7 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.832 1.653 . . . . 0.0 106.924 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 tt -66.35 -30.6 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.032 0.933 . . . . 0.0 111.099 -161.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.3 m -73.61 4.88 4.4 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.863 2.065 . . . . 0.0 112.462 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.553 ' HB3' ' HE ' ' A' ' 118' ' ' ARG . 30.7 p -148.47 16.54 1.02 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.878 1.271 . . . . 0.0 112.048 163.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.32 9.55 24.1 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.218 0.913 . . . . 0.0 115.172 176.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.2 m -108.53 122.54 47.28 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.928 1.364 . . . . 0.0 110.13 -159.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -64.94 151.85 44.74 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.486 0.715 . . . . 0.0 111.852 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.01 -101.43 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.863 0.865 . . . . 0.0 111.632 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -62.9 130.25 43.99 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.947 0.794 . . . . 0.0 111.15 -163.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.517 ' HA ' HG22 ' A' ' 64' ' ' ILE . 11.7 t70 -76.73 145.09 38.87 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.1 m -54.57 -27.59 39.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.152 -0.927 . . . . 0.0 112.549 176.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.99 -19.9 65.5 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.353 1.433 . . . . 0.0 112.96 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.4 p -79.95 -12.52 59.72 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.83 0.852 . . . . 0.0 112.046 174.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.446 ' HG2' ' H ' ' A' ' 81' ' ' PHE . 9.4 tttt -123.06 -171.36 2.28 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.408 1.883 . . . . 0.0 109.054 -166.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.446 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 74.0 m-85 -145.21 -179.79 6.87 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.668 1.987 . . . . 0.0 109.548 -177.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -155.94 -71.35 0.11 Allowed 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 127.499 2.319 . . . . 0.0 107.854 -168.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.63 53.33 2.65 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.863 0.839 . . . . 0.0 111.598 -159.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.99 -78.82 0.2 Allowed Glycine 0 CA--C 1.524 0.602 0 C-N-CA 127.083 2.277 . . . . 0.0 107.869 -173.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.2 m -77.07 53.66 0.98 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.389 1.076 . . . . 0.0 110.003 173.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.82 52.75 3.95 Favored Glycine 0 N--CA 1.45 -0.42 0 O-C-N 120.201 -1.562 . . . . 0.0 110.913 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.9 p-90 -135.11 164.67 42.28 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.673 1.189 . . . . 0.0 109.453 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.37 76.31 3.16 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.883 2.389 . . . . 0.0 112.191 -173.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.3 p -135.95 154.97 50.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.021 1.728 . . . . 0.0 109.399 167.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -143.75 168.71 19.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.22 1.408 . . . . 0.0 108.268 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -115.08 -13.83 11.83 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.001 -0.999 . . . . 0.0 113.14 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -158.16 176.65 12.22 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.39 1.45 . . . . 0.0 107.992 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.9 t -121.18 149.39 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 118.523 0.601 . . . . 0.0 111.46 -158.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -51.93 -58.72 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.114 1.766 . . . . 0.0 110.268 168.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.4 m 169.39 156.45 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 130.832 3.653 . . . . 0.0 105.205 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -79.33 79.87 5.74 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.826 1.194 . . . . 0.0 108.599 173.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -125.63 -53.65 1.56 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 122.994 0.518 . . . . 0.0 110.414 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -115.01 14.37 17.13 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.746 1.218 . . . . 0.0 112.347 171.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.1 tt -119.2 153.54 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 170.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.27 128.11 48.67 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 125.973 1.709 . . . . 0.0 106.899 168.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.68 146.94 51.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.921 1.289 . . . . 0.0 110.758 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.63 152.14 47.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 128.446 2.699 . . . . 0.0 105.064 174.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -131.79 130.39 41.76 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.807 0.843 . . . . 0.0 109.556 -169.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -137.06 -178.49 5.22 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.07 2.548 . . . . 0.0 107.355 -175.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -103.39 9.53 37.79 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.345 1.458 . . . . 0.0 111.045 174.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.4 t -59.81 14.46 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 129.669 3.188 . . . . 0.0 119.079 -161.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 pp -118.87 -9.61 10.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.501 1.52 . . . . 0.0 111.809 168.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 122.11 -23.36 7.32 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.94 2.21 . . . . 0.0 112.091 -166.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 28.0 ttm -136.25 -74.39 0.44 Allowed 'General case' 0 C--N 1.348 0.519 0 CA-C-N 119.541 1.67 . . . . 0.0 112.352 -168.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.9 p -155.24 100.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -111.71 128.78 56.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.616 ' SG ' HG13 ' A' ' 126' ' ' VAL . 0.0 OUTLIER -128.78 144.59 51.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -178.495 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -79.05 156.57 28.31 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 63.3 t -134.87 109.03 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 171.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.72 161.34 29.95 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.2 t -70.96 150.58 45.54 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.21 -52.14 44.76 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 172.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.553 ' HE ' ' HB3' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -65.12 -57.51 8.41 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 124.965 1.306 . . . . 0.0 112.667 177.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.0 p -121.11 77.53 1.32 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.548 1.139 . . . . 0.0 109.742 -158.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.31 20.62 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.005 1 C-N-CA 133.612 4.765 . . . . 0.0 115.572 -174.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.92 -58.08 6.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.333 1.853 . . . . 0.0 114.146 -159.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -158.37 -73.66 0.09 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.2 mt 49.62 -105.27 0.16 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.403 1.881 . . . . 0.0 110.462 -170.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.23 -115.55 0.54 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.481 172.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -149.47 177.05 10.06 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.195 0.522 . . . . 0.0 111.745 -167.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.616 HG13 ' SG ' ' A' ' 112' ' ' CYS . 0.5 OUTLIER -132.49 149.63 32.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.998 1.719 . . . . 0.0 109.029 161.263 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -147.0 161.47 40.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.797 1.239 . . . . 0.0 109.961 174.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -67.35 121.4 15.65 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.327 0.651 . . . . 0.0 109.767 171.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -160.91 -31.61 0.05 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -74.29 148.34 38.96 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -173.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.93 -14.35 19.21 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.323 2.015 . . . . 0.0 113.205 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 175.27 168.4 0.36 Allowed Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 131.568 3.947 . . . . 0.0 106.607 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.98 -71.77 0.02 OUTLIER 'Cis proline' 0 C--N 1.35 0.635 0 CA-C-N 121.136 1.441 . . . . 0.0 110.709 -13.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.8 t -70.28 -9.29 55.56 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.196 0.998 . . . . 0.0 113.623 -176.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.14 -14.88 41.95 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.25 1.405 . . . . 0.0 113.704 172.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -97.58 152.26 19.22 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 120.942 -1.328 . . . . 0.0 110.493 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -126.14 109.65 12.6 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 127.474 2.309 . . . . 0.0 106.335 -171.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -85.03 141.76 30.07 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.479 1.512 . . . . 0.0 107.737 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 18.5 t -146.29 144.77 30.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.883 0.873 . . . . 0.0 109.774 172.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 16.7 ptm -142.22 152.31 42.96 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.178 0.991 . . . . 0.0 110.351 -171.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -144.25 138.27 27.88 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.848 1.259 . . . . 0.0 108.371 164.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 63.5 p -179.21 175.11 0.98 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.18 1.392 . . . . 0.0 109.549 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -71.65 2.96 4.46 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.456 1.102 . . . . 0.0 113.139 160.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -81.84 -6.16 58.84 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 120.409 1.459 . . . . 0.0 112.837 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.93 113.3 21.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.125 0.97 . . . . 0.0 111.881 -170.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -141.34 156.85 45.79 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 158.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -92.24 162.68 14.2 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 163.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 18.3 pt -135.86 171.11 9.38 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.456 1.903 . . . . 0.0 106.966 159.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.56 171.82 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.392 2.062 . . . . 0.0 111.977 162.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -34.97 -38.23 0.08 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 128.843 2.857 . . . . 0.0 114.857 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -159.28 -102.83 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -115.21 8.75 15.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.534 1.134 . . . . 0.0 111.265 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.3 pp -69.41 -16.46 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -159.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 116.357 -2.357 . . . . 0.0 109.75 -172.925 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 79.3 mtp . . . . . 0 C--O 1.238 0.482 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -69.67 26.9 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.855 2.062 . . . . 0.0 114.774 -172.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -65.3 175.77 1.58 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.789 0.836 . . . . 0.0 109.532 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.522 ' HD3' ' HA ' ' A' ' 22' ' ' GLU . 3.5 mmt180 -122.72 153.22 39.74 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 166.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 pt -115.18 130.97 23.8 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.668 0.787 . . . . 0.0 109.695 -174.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.14 146.39 57.72 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 N-CA-C 108.993 -1.195 . . . . 0.0 108.993 167.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mt -124.97 105.75 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 166.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -98.31 101.1 12.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.9 m -67.18 74.45 0.13 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.478 1.111 . . . . 0.0 109.1 165.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.52 -46.89 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 124.853 1.261 . . . . 0.0 110.712 -168.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.24 -16.99 60.42 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.981 -174.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.458 ' HZ1' ' CG ' ' A' ' 76' ' ' ASP . 1.4 mtmp? -99.45 0.47 42.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.101 1.76 . . . . 0.0 110.549 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 39.72 59.44 1.86 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.344 2.658 . . . . 0.0 113.141 -167.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.73 165.83 16.59 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.334 0.654 . . . . 0.0 109.759 171.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -143.38 124.4 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -136.67 112.94 9.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.823 1.649 . . . . 0.0 107.023 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 46.0 ttm -79.5 146.15 32.84 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.775 -1.203 . . . . 0.0 108.855 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 74.4 t -137.7 157.41 33.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.522 ' HA ' ' HD3' ' A' ' 7' ' ' ARG . 3.3 mp0 -65.8 165.8 12.21 Favored 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 121.22 -0.925 . . . . 0.0 112.084 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.456 ' HG3' HH11 ' A' ' 23' ' ' ARG . 2.4 mmt85 -64.46 174.21 1.8 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.303 -0.873 . . . . 0.0 110.947 165.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.418 ' H ' ' HG3' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -72.85 103.63 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 169.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -134.95 103.94 5.78 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 166.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.9 mt -136.85 177.47 7.83 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.856 1.663 . . . . 0.0 106.676 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.5 t -111.46 164.85 12.51 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 159.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.03 -27.32 43.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.579 1.552 . . . . 0.0 111.509 -175.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.21 -26.89 65.04 Favored 'General case' 0 C--O 1.225 -0.215 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -71.62 -43.35 66.34 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.33 1.052 . . . . 0.0 109.316 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -61.87 19.61 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 128.391 2.677 . . . . 0.0 114.932 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.78 1.1 2.5 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 165.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -133.37 -17.28 2.33 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 118.201 -0.904 . . . . 0.0 113.196 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 pt -110.53 -4.73 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 119.261 0.937 . . . . 0.0 112.491 171.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.511 HD22 ' CB ' ' A' ' 39' ' ' ALA . 2.5 mt -78.87 172.59 13.56 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.626 1.171 . . . . 0.0 110.78 174.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -78.52 155.62 78.66 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 124.084 0.953 . . . . 0.0 110.997 175.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -68.51 16.82 0.15 Allowed 'Trans proline' 0 CA--C 1.546 1.092 1 C-N-CA 126.213 4.608 . . . . 0.0 114.039 168.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -128.1 -31.8 2.33 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 127.376 2.271 . . . . 0.0 110.123 167.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.511 ' CB ' HD22 ' A' ' 35' ' ' LEU . . . -67.95 -38.71 83.14 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.123 0.874 . . . . 0.0 108.793 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -59.09 -45.82 89.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.099 0.408 . . . . 0.0 111.143 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.1 -48.9 31.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 116.718 -1.611 . . . . 0.0 107.922 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.1 t -49.5 -32.28 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 119.868 1.213 . . . . 0.0 110.384 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.46 -25.54 66.1 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 114.05 1.129 . . . . 0.0 114.05 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.78 -27.78 15.61 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.396 0.998 . . . . 0.0 111.865 176.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -113.35 -0.53 14.49 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -163.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.93 42.12 5.92 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.436 1.094 . . . . 0.0 110.846 -171.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.39 -58.07 0.46 Allowed Glycine 0 C--N 1.336 0.555 0 C-N-CA 125.479 1.514 . . . . 0.0 111.568 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.1 t -145.64 120.62 10.03 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.472 0.636 . . . . 0.0 110.297 -170.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -56.96 -64.19 2.8 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.214 1.406 . . . . 0.0 111.126 166.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -70.07 157.56 59.39 Favored 'Trans proline' 0 C--N 1.353 0.808 0 CA-C-N 121.595 1.605 . . . . 0.0 108.81 171.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.95 -18.45 52.19 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.651 2.234 . . . . 0.0 112.999 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -155.97 167.05 31.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.131 1.772 . . . . 0.0 107.83 170.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.2 t -139.34 7.86 2.41 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.812 0.845 . . . . 0.0 112.543 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 170.14 179.14 41.51 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -149.7 93.07 1.99 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -159.42 167.82 27.8 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.091 1.756 . . . . 0.0 107.753 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -165.24 85.98 0.39 Allowed 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 168.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -124.15 89.2 3.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 -161.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.6 mt -144.21 -173.84 4.13 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.094 1.357 . . . . 0.0 109.782 -168.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -154.97 170.01 22.74 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.367 2.267 . . . . 0.0 107.177 -176.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -77.55 74.85 4.11 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-O 122.911 1.339 . . . . 0.0 110.07 172.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -142.77 161.92 36.84 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 158.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.82 173.73 49.93 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.853 -172.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.656 HG22 ' HA ' ' A' ' 76' ' ' ASP . 40.8 pt -135.79 164.67 31.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 125.997 1.719 . . . . 0.0 108.696 170.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -72.88 148.09 44.74 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 2.8 tmt_? -141.12 112.71 7.57 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 124.098 0.959 . . . . 0.0 109.092 175.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.73 95.71 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.403 1.881 . . . . 0.0 109.082 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.2 tt -65.1 -16.22 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.188 0.595 . . . . 0.0 111.117 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.4 m -86.73 1.65 51.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.071 2.148 . . . . 0.0 112.741 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 22.0 p -150.23 -11.05 0.26 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 162.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.8 3.1 62.52 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 118.083 -1.398 . . . . 0.0 114.197 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.3 m -97.61 143.66 28.06 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.591 1.696 . . . . 0.0 111.281 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 11.7 p-10 -97.05 156.1 16.51 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.855 2.062 . . . . 0.0 112.128 177.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.265 0.2 OUTLIER -151.72 -95.79 0.06 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.172 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -60.25 111.07 1.4 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.993 0.917 . . . . 0.0 113.414 -159.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.656 ' HA ' HG22 ' A' ' 64' ' ' ILE . 1.7 m-20 -63.41 115.92 5.06 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.643 1.577 . . . . 0.0 107.749 166.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.6 m -56.12 -10.63 0.88 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 117.915 2.561 . . . . 0.0 117.915 -162.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -62.92 -25.69 68.45 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.686 1.585 . . . . 0.0 111.827 163.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.9 p -88.51 20.85 3.16 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.966 2.507 . . . . 0.0 111.817 169.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -118.51 179.55 4.09 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.878 2.071 . . . . 0.0 108.205 166.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -113.61 165.26 12.68 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 158.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -146.88 -65.23 0.28 Allowed 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 119.007 0.821 . . . . 0.0 109.466 171.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -57.29 161.64 3.18 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.832 0.825 . . . . 0.0 110.83 166.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.63 -62.74 3.49 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 119.261 -0.744 . . . . 0.0 111.511 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.8 t -152.35 -10.67 0.18 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 47.13 23.64 1.79 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.872 1.701 . . . . 0.0 116.576 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -63.44 156.62 69.48 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 117.707 0.753 . . . . 0.0 111.811 -168.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -79.62 47.72 2.61 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.637 2.891 . . . . 0.0 110.634 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.01 144.57 31.09 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 126.418 1.887 . . . . 0.0 107.95 -176.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -158.8 177.09 11.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.645 1.178 . . . . 0.0 109.339 -161.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -128.62 0.49 5.52 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -165.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -161.48 -177.38 5.92 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.677 1.191 . . . . 0.0 108.079 166.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.4 m -140.87 165.77 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 118.873 0.76 . . . . 0.0 112.303 -173.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 p -60.97 -54.7 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.405 1.482 . . . . 0.0 110.603 174.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.5 t 175.58 165.57 0.34 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.406 2.682 . . . . 0.0 107.921 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -75.61 79.22 2.6 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 162.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -126.82 -51.05 1.46 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.645 0.778 . . . . 0.0 109.967 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -117.13 1.55 12.54 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.697 1.599 . . . . 0.0 111.168 171.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.67 149.42 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 126.497 1.919 . . . . 0.0 106.942 174.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 101' ' ' LEU . 4.4 tmtm? -134.3 143.21 47.6 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.247 1.419 . . . . 0.0 108.918 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.46 ' N ' ' HD3' ' A' ' 100' ' ' LYS . 1.9 mp -120.68 152.16 38.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.883 2.073 . . . . 0.0 112.265 170.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.507 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -129.18 126.45 39.25 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 163.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -67.92 143.05 55.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.764 0.826 . . . . 0.0 110.354 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -146.03 173.48 12.13 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 158.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.35 22.13 16.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.442 2.297 . . . . 0.0 110.739 175.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.93 23.27 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 127.907 2.483 . . . . 0.0 116.843 -165.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 pp -131.13 -5.72 3.88 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.407 -1.433 . . . . 0.0 112.455 162.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.32 1.01 40.99 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 117.387 -1.785 . . . . 0.0 113.089 -167.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 55.4 mtm -140.92 -90.81 0.15 Allowed 'General case' 0 C--N 1.349 0.544 0 CA-C-N 120.383 2.092 . . . . 0.0 108.306 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.2 t -142.87 111.78 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.42 ' HE ' ' CD2' ' A' ' 125' ' ' HIS . 18.9 ttt180 -130.14 88.12 2.61 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.641 1.576 . . . . 0.0 111.047 175.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 7.9 m -89.12 144.09 26.38 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.507 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 22.0 pt-20 -66.52 162.36 20.94 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.218 0.917 . . . . 0.0 110.182 170.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.2 t -136.88 110.11 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 174.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.4 mt -131.29 160.33 35.25 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.52 1.128 . . . . 0.0 109.64 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.8 t -81.66 118.11 22.55 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.26 -6.31 4.36 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.971 1.308 . . . . 0.0 113.876 -175.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.418 ' HG3' ' H ' ' A' ' 24' ' ' ILE . 26.3 ttt-85 -115.13 -9.94 12.24 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.504 1.922 . . . . 0.0 113.645 171.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 22.5 p -164.37 81.58 0.4 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 120.46 1.482 . . . . 0.0 109.474 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -70.01 56.23 0.14 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.483 1.513 . . . . 0.0 113.039 -174.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -75.17 -49.5 19.26 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.709 1.204 . . . . 0.0 112.952 -166.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -159.71 -67.46 0.08 Allowed 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 122.981 0.512 . . . . 0.0 109.832 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 mt 44.98 -110.66 0.21 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.25 1.82 . . . . 0.0 110.074 -173.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.55 -123.69 0.86 Allowed Glycine 0 CA--C 1.521 0.441 0 CA-C-N 118.751 0.705 . . . . 0.0 112.636 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.42 ' CD2' ' HE ' ' A' ' 111' ' ' ARG . 42.6 p-80 -158.86 174.06 15.57 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.427 -0.455 . . . . 0.0 111.18 -173.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.4 p -122.83 141.37 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.219 1.408 . . . . 0.0 108.014 172.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -134.89 133.19 39.39 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.604 1.162 . . . . 0.0 108.808 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -65.16 107.36 1.54 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.809 0.844 . . . . 0.0 109.67 172.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -162.28 -5.18 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -161.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -110.4 179.28 20.29 Favored Glycine 0 CA--C 1.536 1.35 0 O-C-N 119.959 -1.713 . . . . 0.0 112.455 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.2 146.69 41.14 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.038 2.492 . . . . 0.0 110.837 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.5 ptt-85 -59.71 153.23 53.48 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 118.606 -0.711 . . . . 0.0 110.588 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.86 -41.44 0.9 Allowed 'Cis proline' 0 C--N 1.35 0.618 0 CA-C-N 119.816 0.97 . . . . 0.0 111.573 -6.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.53 71.7 4.03 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 125.968 1.707 . . . . 0.0 109.663 176.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -103.95 5.96 47.04 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 112.372 -2.195 . . . . 0.0 111.291 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.75 157.39 27.13 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 116.661 -2.016 . . . . 0.0 107.189 166.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -132.14 94.54 3.48 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -65.72 143.77 57.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 164.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 12.5 t -142.28 135.19 28.52 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.061 1.745 . . . . 0.0 108.001 159.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -133.1 141.92 48.44 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.71 0.804 . . . . 0.0 109.379 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -140.6 87.52 2.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.859 1.264 . . . . 0.0 108.082 -163.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 80.2 p -153.2 177.15 11.15 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.505 0.722 . . . . 0.0 109.586 173.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.61 -8.19 45.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 170.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.06 -25.7 61.58 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.549 1.14 . . . . 0.0 113.141 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 64.2 mt -76.68 44.62 0.37 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.157 2.583 . . . . 0.0 115.35 -158.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -73.43 155.88 38.84 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 166.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -103.65 160.61 14.61 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.67 0.788 . . . . 0.0 109.233 168.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 32.9 pt -132.73 165.5 36.01 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.222 1.009 . . . . 0.0 108.713 160.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -50.49 150.74 11.14 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.931 2.421 . . . . 0.0 110.507 159.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.594 ' HD3' HG23 ' A' ' 64' ' ' ILE . 12.1 mmt180 -40.43 -44.45 2.01 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 126.444 1.898 . . . . 0.0 112.352 -164.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -145.8 -75.3 0.21 Allowed 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.525 1.13 . . . . 0.0 110.112 167.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -146.05 8.92 1.11 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.285 3.034 . . . . 0.0 109.83 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -59.2 -14.3 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 121.14 -0.975 . . . . 0.0 113.298 167.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.478 0 C-N-CA 128.16 2.791 . . . . 0.0 107.074 163.336 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 72.2 mtp . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -153.15 10.44 0.45 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.084 1.754 . . . . 0.0 109.859 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -88.55 155.23 19.76 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 128.266 2.626 . . . . 0.0 112.584 -160.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.423 ' HB3' ' HA ' ' A' ' 22' ' ' GLU . 12.0 ptt-85 -58.57 165.23 2.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.731 1.612 . . . . 0.0 113.475 -178.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.8 pt -111.88 91.88 16.36 Favored Pre-proline 0 N--CA 1.45 -0.461 0 C-N-CA 125.88 1.672 . . . . 0.0 106.759 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 20' ' ' MET . 73.6 Cg_endo -64.91 138.06 55.91 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 N-CA-C 107.413 -1.803 . . . . 0.0 107.413 168.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.9 mt -121.25 152.1 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -173.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -147.0 91.58 2.02 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.229 1.412 . . . . 0.0 107.441 -164.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.4 m -66.43 77.17 0.1 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.809 0.731 . . . . 0.0 109.53 165.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -60.68 -36.58 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 124.658 1.183 . . . . 0.0 111.546 -170.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.52 -11.53 53.15 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.231 1.012 . . . . 0.0 112.233 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -123.31 10.22 9.24 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.362 1.865 . . . . 0.0 110.798 174.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 27.58 52.01 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.572 3.149 . . . . 0.0 113.332 -161.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.95 169.87 17.27 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 118.846 -1.142 . . . . 0.0 111.173 167.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.52 136.72 43.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 158.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -145.01 107.36 4.37 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.46 1.904 . . . . 0.0 108.427 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.431 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 47.8 ttp -82.09 125.41 30.81 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.664 -1.273 . . . . 0.0 111.568 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.4 t -130.89 135.1 60.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 7' ' ' ARG . 7.8 mm-40 -55.81 166.74 0.67 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 166.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.0 mtp-105 -66.23 163.68 17.38 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.413 177.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.446 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 3.2 tt -90.2 122.66 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 169.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -149.33 112.67 4.97 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 167.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.7 mt -136.99 178.4 7.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.052 1.741 . . . . 0.0 108.316 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.31 -177.88 2.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.465 1.906 . . . . 0.0 107.843 159.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.3 -42.88 71.44 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.812 -1.18 . . . . 0.0 109.835 164.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -58.27 -18.97 30.58 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 128.834 2.853 . . . . 0.0 112.441 -161.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -86.9 -40.71 14.59 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 129.664 3.186 . . . . 0.0 110.378 -168.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -62.25 7.46 0.06 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.269 2.228 . . . . 0.0 114.784 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.85 -4.78 5.14 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.938 1.695 . . . . 0.0 113.837 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -132.01 -18.86 2.61 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.612 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 pt -109.16 8.97 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 119.096 0.862 . . . . 0.0 111.356 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -115.84 164.94 13.66 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.97 1.308 . . . . 0.0 110.219 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.421 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -58.22 149.02 60.13 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 122.932 0.493 . . . . 0.0 110.784 176.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -69.19 4.48 1.93 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.466 2.777 . . . . 0.0 112.249 164.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -93.07 -48.84 6.3 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.101 -1.0 . . . . 0.0 111.277 161.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.421 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -56.58 -44.47 81.07 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 120.274 1.397 . . . . 0.0 111.355 -172.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -58.14 -40.09 80.44 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.887 1.275 . . . . 0.0 112.432 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -80.98 -45.96 15.83 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 118.645 0.657 . . . . 0.0 109.646 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.635 HG13 ' HA2' ' A' ' 47' ' ' GLY 0.266 2.0 t -60.28 -24.44 30.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.771 1.228 . . . . 0.0 110.534 -177.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.13 -23.13 66.38 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 169.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -99.94 -40.66 7.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.309 1.413 . . . . 0.0 111.996 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -83.85 5.82 23.79 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.15 0.58 . . . . 0.0 111.791 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.43 49.01 20.54 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.892 1.677 . . . . 0.0 109.882 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.635 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . 71.0 -5.04 8.57 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 119.217 -0.768 . . . . 0.0 114.485 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.4 m -110.85 79.23 1.18 Allowed 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -159.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -78.87 151.7 76.67 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.339 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -70.76 118.13 5.53 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.364 2.043 . . . . 0.0 108.852 165.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.55 -32.58 7.65 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 121.868 1.712 . . . . 0.0 112.834 -172.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 7.8 t80 175.13 -62.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 128.658 2.783 . . . . 0.0 106.423 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 t -139.65 -58.03 0.57 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.397 1.479 . . . . 0.0 107.236 169.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -154.32 153.58 24.91 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 163.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -164.36 160.79 21.19 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.905 1.682 . . . . 0.0 106.795 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -143.22 167.2 22.69 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 159.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -153.34 96.72 2.08 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -176.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -88.01 168.53 12.76 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 158.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -146.71 -72.04 0.23 Allowed 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 170.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -173.14 176.39 2.97 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.85 2.46 . . . . 0.0 105.855 169.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -91.89 54.67 2.48 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.381 1.073 . . . . 0.0 108.585 -159.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -128.67 162.91 26.25 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.335 2.654 . . . . 0.0 108.101 174.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 85.45 175.9 50.4 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -158.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.5 pt -141.9 -178.69 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.363 1.065 . . . . 0.0 108.624 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -98.43 162.13 13.32 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 122.307 1.051 . . . . 0.0 110.293 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.84 108.61 9.53 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 17.6 t -68.3 84.54 0.26 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 170.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 39' ' ' ALA . 14.1 tt -65.31 -25.89 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 122.062 -0.399 . . . . 0.0 110.204 -168.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.3 m -66.52 -1.87 4.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.37 2.268 . . . . 0.0 113.808 173.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 19.7 p -143.47 21.34 1.86 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.263 1.025 . . . . 0.0 110.843 158.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.63 12.02 51.06 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.588 1.09 . . . . 0.0 113.98 171.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 m -111.48 150.08 30.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.639 1.976 . . . . 0.0 110.636 -158.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -89.65 156.72 18.38 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.228 1.376 . . . . 0.0 113.082 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.06 -168.8 0.14 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.826 2.45 . . . . 0.0 109.361 -177.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.9 t80 39.31 79.66 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 128.99 2.916 . . . . 0.0 112.607 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.7 148.43 49.26 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.92 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.8 t -71.34 -9.19 57.74 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -166.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -63.88 -39.84 95.14 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.732 1.213 . . . . 0.0 112.253 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.3 t -85.95 -18.16 33.4 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.276 0.631 . . . . 0.0 111.514 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -74.41 178.09 5.48 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.587 0.755 . . . . 0.0 109.815 168.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -131.32 151.72 51.25 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 105.102 -2.185 . . . . 0.0 105.102 158.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -131.93 -57.05 0.98 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.497 1.119 . . . . 0.0 110.038 -167.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.4 t -88.09 177.93 6.78 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.441 0.639 . . . . 0.0 109.898 163.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 55.86 -97.42 0.05 OUTLIER Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.6 1.571 . . . . 0.0 110.989 -173.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.2 m -60.24 -55.52 32.69 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.724 1.61 . . . . 0.0 110.667 177.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 43.64 44.3 6.73 Favored Glycine 0 C--N 1.343 0.932 0 C-N-CA 127.591 2.519 . . . . 0.0 113.837 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -118.62 152.61 51.47 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.239 1.415 . . . . 0.0 109.992 -169.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.08 46.88 1.85 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.779 2.986 . . . . 0.0 112.969 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.3 p -124.62 150.43 46.01 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.822 0.849 . . . . 0.0 109.501 166.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -141.43 178.56 7.35 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.034 1.334 . . . . 0.0 109.851 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -135.02 -0.62 2.75 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -172.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -159.96 177.81 10.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.452 1.101 . . . . 0.0 110.583 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.14 153.33 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 120.554 1.524 . . . . 0.0 111.544 -174.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.4 t -59.84 -63.43 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 127.976 2.51 . . . . 0.0 110.828 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.4 t -173.03 159.73 4.03 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.148 2.179 . . . . 0.0 106.326 -173.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -82.5 54.46 2.63 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.008 1.323 . . . . 0.0 108.167 173.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.469 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 15.6 p80 -102.8 -64.48 1.07 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 -159.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.469 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 16.3 t-20 -109.47 5.9 23.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.461 1.904 . . . . 0.0 112.33 173.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.1 tt -125.15 152.83 31.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 126.0 1.72 . . . . 0.0 107.22 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.471 ' HD3' ' H ' ' A' ' 101' ' ' LEU . 2.2 tmtt? -132.6 135.44 45.89 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.172 0.589 . . . . 0.0 109.475 173.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.471 ' H ' ' HD3' ' A' ' 100' ' ' LYS . 3.6 mp -125.15 146.38 49.52 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.623 2.369 . . . . 0.0 111.381 177.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -143.0 113.04 7.11 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 127.183 2.193 . . . . 0.0 107.468 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.56 158.54 20.11 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 122.538 1.161 . . . . 0.0 111.014 -177.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -164.39 176.99 8.56 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.127 2.571 . . . . 0.0 109.803 -172.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.271 0.0 OUTLIER -109.27 39.02 2.16 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.465 -1.397 . . . . 0.0 111.865 170.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.7 m -73.04 18.62 0.1 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 pp -130.66 0.91 4.42 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.172 -0.955 . . . . 0.0 111.542 158.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.67 1.94 60.08 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 117.747 -1.585 . . . . 0.0 113.665 -170.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.1 mmt -136.99 -95.68 0.22 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 119.366 1.583 . . . . 0.0 108.626 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.0 t -137.23 113.45 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 18.8 ttt180 -120.71 151.17 39.87 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 165.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.685 ' HB3' HG13 ' A' ' 126' ' ' VAL . 8.6 t -157.37 123.17 4.7 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -171.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -64.77 154.21 37.58 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.349 0.522 . . . . 0.0 110.522 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 78.5 t -134.39 107.91 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mp -129.44 172.45 11.52 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 171.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 42.4 t -66.56 148.35 52.01 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.05 -33.39 73.23 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 119.138 -0.458 . . . . 0.0 110.703 171.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.446 ' HG2' ' H ' ' A' ' 24' ' ' ILE . 10.4 tpt85 -106.23 -83.51 0.52 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 117.336 -1.316 . . . . 0.0 114.016 174.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 20.6 p -64.49 27.74 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 119.595 3.183 . . . . 0.0 119.595 -157.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 64.28 -19.59 0.07 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 118.354 2.724 . . . . 0.0 118.354 158.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.65 164.32 23.64 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -159.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -38.09 -58.5 0.95 Allowed 'General case' 0 C--N 1.346 0.415 0 C-N-CA 128.42 2.688 . . . . 0.0 113.291 -174.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 45.01 -108.84 0.15 Allowed 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 126.752 2.021 . . . . 0.0 109.065 -173.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.69 -124.68 0.9 Allowed Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.792 170.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.21 166.24 30.0 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 122.953 0.501 . . . . 0.0 110.932 -175.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.685 HG13 ' HB3' ' A' ' 112' ' ' CYS . 2.3 p -115.38 143.28 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 126.176 1.79 . . . . 0.0 109.457 173.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -144.77 159.28 43.12 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.819 0.848 . . . . 0.0 110.906 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -67.86 76.07 0.21 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.109 2.164 . . . . 0.0 111.588 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -157.3 20.72 0.3 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.323 1.449 . . . . 0.0 111.601 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.74 171.44 17.13 Favored Glycine 0 CA--C 1.528 0.849 0 O-C-N 120.414 -1.429 . . . . 0.0 113.278 -173.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.03 152.77 68.03 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.754 2.303 . . . . 0.0 110.15 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -63.32 151.95 86.06 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 162.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.8 -41.27 1.02 Allowed 'Cis proline' 0 C--N 1.347 0.465 0 CA-C-N 120.626 1.259 . . . . 0.0 113.848 11.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.2 p -67.97 -30.11 69.32 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -169.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.18 -1.89 39.0 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.649 1.118 . . . . 0.0 113.576 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -120.26 147.81 44.5 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.552 1.176 . . . . 0.0 110.011 -168.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -123.4 110.38 15.06 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 126.923 2.089 . . . . 0.0 107.753 -169.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -86.01 137.95 32.33 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.659 1.984 . . . . 0.0 107.026 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 17.1 t -140.11 138.64 35.44 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 168.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -145.64 153.01 40.56 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.326 0.65 . . . . 0.0 110.558 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -149.47 127.43 11.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.734 1.614 . . . . 0.0 108.827 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 97.2 p -166.79 175.17 7.99 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.799 0.84 . . . . 0.0 109.219 166.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.424 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -59.06 -13.89 8.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.872 0.869 . . . . 0.0 112.824 164.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.28 -12.01 60.7 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.484 1.038 . . . . 0.0 112.693 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 53.5 mt -84.53 81.93 8.63 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.902 1.228 . . . . 0.0 112.144 -170.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -92.42 126.73 37.63 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 162.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -75.72 146.73 39.89 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 162.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.7 pt -144.9 165.38 22.63 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 118.817 0.735 . . . . 0.0 110.868 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -60.21 174.87 1.24 Allowed 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 123.041 2.494 . . . . 0.0 111.675 159.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -55.02 -25.75 32.5 Favored 'General case' 0 C--O 1.221 -0.41 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -164.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -166.14 -61.71 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 128.192 2.597 . . . . 0.0 110.757 159.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -153.2 -0.41 0.24 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 130.669 3.587 . . . . 0.0 109.672 -163.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -62.08 -18.53 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.021 0.928 . . . . 0.0 112.003 169.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.404 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 158.968 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.1 tpt . . . . . 0 CA--C 1.544 0.729 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -162.73 55.69 0.21 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.728 1.604 . . . . 0.0 111.285 -169.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -159.3 177.4 11.05 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.03 0.919 . . . . 0.0 112.322 -159.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -125.1 148.05 48.72 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 128.21 2.604 . . . . 0.0 104.775 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.3 pt -138.67 145.13 44.87 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.412 0.685 . . . . 0.0 111.865 -158.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.56 117.33 3.68 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.274 2.649 . . . . 0.0 110.236 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.1 mm -79.56 101.15 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 163.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -108.96 109.54 20.62 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 t -82.88 96.21 8.19 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.72 -34.67 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 120.749 1.613 . . . . 0.0 109.118 173.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.81 -20.99 0.55 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 171.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -131.25 3.06 4.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.861 1.664 . . . . 0.0 112.184 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 t30 37.26 64.1 0.65 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.892 1.677 . . . . 0.0 111.224 -158.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.8 mtp-105 -107.38 157.99 17.52 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 168.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.12 137.32 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 158.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -134.27 156.52 48.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 159.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 33.6 ttm -112.95 131.9 55.56 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 68.9 t -136.08 155.68 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.726 1.611 . . . . 0.0 106.82 -170.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -68.53 154.44 41.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.63 -1.294 . . . . 0.0 111.288 175.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.429 ' HA ' ' HD3' ' A' ' 118' ' ' ARG . 0.8 OUTLIER -66.86 147.63 52.99 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 162.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.481 ' H ' ' HD2' ' A' ' 118' ' ' ARG . 8.1 tt -60.68 122.12 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.278 0.631 . . . . 0.0 109.484 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -148.19 108.1 4.03 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 104.235 -2.505 . . . . 0.0 104.235 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.4 mt -135.69 177.9 7.47 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.944 1.298 . . . . 0.0 109.361 -173.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 90.2 p -83.45 176.01 9.39 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 159.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -62.2 -48.59 79.33 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.731 -0.606 . . . . 0.0 110.804 176.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.36 -20.71 65.61 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -169.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -58.84 -42.16 88.65 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 123.804 0.842 . . . . 0.0 111.229 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -61.69 10.99 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.887 2.475 . . . . 0.0 115.852 -174.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.54 -10.22 3.19 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.736 1.215 . . . . 0.0 113.858 171.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -119.99 -17.5 8.41 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.845 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 pt -112.04 4.88 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 119.342 0.974 . . . . 0.0 112.337 168.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -110.57 163.69 13.47 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.457 1.103 . . . . 0.0 110.826 -176.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.92 136.09 79.62 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 163.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.44 -17.08 53.13 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.081 1.854 . . . . 0.0 111.431 173.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -72.58 -41.33 65.79 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 118.53 -0.748 . . . . 0.0 110.114 170.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.32 -45.64 93.59 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 119.7 1.136 . . . . 0.0 110.091 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -55.92 -47.38 77.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.764 0.825 . . . . 0.0 111.588 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -73.26 -47.89 39.37 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 117.643 -1.17 . . . . 0.0 108.051 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.427 HG13 ' HA2' ' A' ' 47' ' ' GLY . 37.0 t -55.43 -29.6 24.31 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 124.516 1.126 . . . . 0.0 110.297 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.09 -22.57 66.95 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 115.27 1.582 . . . . 0.0 115.27 173.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.47 -33.18 16.07 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.363 1.438 . . . . 0.0 111.304 175.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -102.02 -1.06 32.56 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 124.429 1.092 . . . . 0.0 112.34 -167.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 41.18 39.97 1.04 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.559 1.544 . . . . 0.0 111.15 -168.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.427 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . 94.89 -8.66 70.63 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-O 117.568 -1.685 . . . . 0.0 115.054 173.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 t -153.35 121.8 6.28 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 120.04 1.92 . . . . 0.0 111.223 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -51.46 -59.13 8.54 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.787 -1.102 . . . . 0.0 111.856 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -77.71 156.65 31.6 Favored 'Trans proline' 0 C--N 1.353 0.779 0 CA-C-N 121.495 1.57 . . . . 0.0 109.886 167.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.05 135.72 52.68 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.853 1.702 . . . . 0.0 109.049 168.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -151.07 171.78 16.79 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.573 1.149 . . . . 0.0 107.933 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.0 m -155.58 139.75 16.53 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.56 -177.76 12.33 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.757 0.694 . . . . 0.0 112.215 -173.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -171.29 167.13 7.01 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 126.631 1.972 . . . . 0.0 107.106 164.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -141.76 150.4 41.7 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 169.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -179.08 -178.28 0.51 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.335 2.654 . . . . 0.0 105.95 -176.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -65.92 164.45 15.03 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.571 0.701 . . . . 0.0 110.498 167.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -153.53 157.97 40.58 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.905 1.282 . . . . 0.0 108.524 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -138.15 112.91 8.98 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 172.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . 0.257 5.7 m-20 -103.41 36.25 2.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.719 0.808 . . . . 0.0 111.364 -173.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -113.87 103.47 11.22 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 159.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.1 -177.43 33.15 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -164.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.566 HG22 ' HA ' ' A' ' 76' ' ' ASP . 48.1 pt -133.91 155.29 39.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 121.578 0.704 . . . . 0.0 109.403 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -78.86 146.22 33.76 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 3.8 tmt_? -138.24 109.45 6.86 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.243 1.017 . . . . 0.0 108.45 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.19 101.34 0.4 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.504 1.522 . . . . 0.0 108.194 -178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 144' ' ' ALA . 4.8 tt -63.14 -28.4 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 123.626 0.77 . . . . 0.0 110.715 -170.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.0 m -83.45 11.87 6.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.478 1.911 . . . . 0.0 112.255 -177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 30.4 p -143.39 -7.11 0.79 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.577 0.751 . . . . 0.0 111.859 158.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.31 1.85 83.54 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.369 1.461 . . . . 0.0 113.131 177.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.0 m -119.82 147.57 44.5 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.228 1.514 . . . . 0.0 112.582 -159.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 10.1 p-10 -91.33 155.89 18.18 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.757 1.623 . . . . 0.0 113.221 -173.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.255 0.2 OUTLIER -162.34 -109.63 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.037 1.735 . . . . 0.0 110.013 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -51.62 120.3 5.04 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.338 1.055 . . . . 0.0 112.587 -159.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.566 ' HA ' HG22 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -72.31 139.63 48.09 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.135 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -20.62 65.82 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.99 -13.2 59.45 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.321 -1.487 . . . . 0.0 113.057 170.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.4 p -84.38 -19.39 33.64 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.991 -1.068 . . . . 0.0 112.564 166.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.28 86.78 2.25 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.707 1.603 . . . . 0.0 107.378 -166.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -135.0 133.52 39.53 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -142.07 114.17 8.15 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 168.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.6 p -70.78 71.93 0.53 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.024 1.729 . . . . 0.0 111.348 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.31 -44.55 1.08 Allowed Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.098 1.333 . . . . 0.0 111.461 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.29 -46.6 17.42 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 118.181 0.99 . . . . 0.0 109.551 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 53.83 15.88 5.23 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.662 2.077 . . . . 0.0 115.882 -170.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -50.5 144.64 11.95 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 125.406 1.483 . . . . 0.0 112.782 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.98 65.02 6.06 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.375 3.384 . . . . 0.0 111.827 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.1 p -129.53 142.28 50.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.906 0.883 . . . . 0.0 109.041 164.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.4 167.53 21.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.973 1.709 . . . . 0.0 108.589 -168.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -122.42 -8.69 8.59 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.435 0.694 . . . . 0.0 112.679 -169.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -156.36 179.99 8.72 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.3 m -131.31 162.61 39.0 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-N 119.579 1.081 . . . . 0.0 112.305 -171.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.2 p -55.84 -38.41 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.211 1.405 . . . . 0.0 111.037 166.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.4 m 141.78 154.03 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.409 1 C-N-CA 132.194 4.198 . . . . 0.0 108.555 -173.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 53.3 mp0 -71.24 59.79 0.27 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.992 1.717 . . . . 0.0 109.914 166.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -105.46 -47.88 3.82 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.763 1.225 . . . . 0.0 108.526 -175.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.96 12.52 7.81 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 125.095 1.358 . . . . 0.0 112.28 170.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.89 145.82 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 125.369 1.468 . . . . 0.0 107.677 169.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -120.07 144.82 47.38 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 126.174 1.79 . . . . 0.0 108.329 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mp -131.74 157.21 44.4 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.89 1.276 . . . . 0.0 110.484 167.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.44 ' HE ' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -135.27 142.92 46.01 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 130.868 3.667 . . . . 0.0 102.817 164.42 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -126.76 130.76 50.94 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.936 1.294 . . . . 0.0 109.216 -165.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -144.55 -170.98 3.51 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.528 2.331 . . . . 0.0 108.419 -172.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -115.85 6.92 14.39 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.582 2.353 . . . . 0.0 112.119 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.8 m -65.98 31.64 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 130.154 3.382 . . . . 0.0 116.968 -163.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 pp -133.08 -7.13 3.05 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.509 1.524 . . . . 0.0 112.278 160.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.44 1.64 35.2 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 117.441 -1.755 . . . . 0.0 113.029 -168.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.3 mtt -141.94 -89.18 0.15 Allowed 'General case' 0 C--N 1.348 0.513 0 CA-C-N 120.322 2.061 . . . . 0.0 109.024 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.3 p -150.41 109.76 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -117.76 124.27 48.03 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.122 -1.399 . . . . 0.0 107.487 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.83 144.61 50.58 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.44 ' CD ' ' HE ' ' A' ' 102' ' ' ARG . 10.3 pt-20 -75.75 157.22 33.8 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 173.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 44.1 t -136.57 110.73 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -135.82 150.61 49.49 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 51.9 t -72.66 108.13 5.51 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.62 -30.13 67.03 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.225 1.41 . . . . 0.0 112.029 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.481 ' HD2' ' H ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -66.02 -21.07 66.37 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 118.805 -0.617 . . . . 0.0 112.422 176.025 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 5.6 p -121.44 -100.76 0.42 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 165.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.2 p30 156.02 30.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 128.489 2.716 . . . . 0.0 110.606 -165.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -107.9 166.11 10.95 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.253 1.021 . . . . 0.0 111.844 -167.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -30.35 -78.3 0.02 OUTLIER 'General case' 0 C--N 1.339 0.138 0 C-N-CA 129.585 3.154 . . . . 0.0 116.016 -159.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 12.2 mt 43.55 -111.55 0.2 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.588 1.555 . . . . 0.0 111.807 -170.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.37 -109.36 0.3 Allowed Glycine 0 C--N 1.336 0.532 0 CA-C-N 119.623 1.101 . . . . 0.0 113.333 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -147.01 179.83 7.33 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 112.147 -166.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.422 HG21 ' HE2' ' A' ' 136' ' ' LYS . 2.1 p -130.97 144.83 36.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 125.715 1.606 . . . . 0.0 108.289 159.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -136.0 161.67 35.02 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.446 1.098 . . . . 0.0 110.394 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -72.11 117.78 14.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.903 0.881 . . . . 0.0 109.538 172.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.57 -28.87 0.11 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.05 155.52 40.65 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -174.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.12 -13.98 21.0 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.52 2.147 . . . . 0.0 113.295 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.2 ptt-85 134.57 167.28 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.918 1 C-N-CA 133.97 4.908 . . . . 0.0 106.293 -163.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.94 -58.29 0.12 OUTLIER 'Cis proline' 0 C--N 1.351 0.681 0 CA-C-N 122.314 1.862 . . . . 0.0 111.875 -3.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.4 p -69.69 -25.07 63.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.474 1.51 . . . . 0.0 112.862 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.39 -6.64 28.99 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.961 1.267 . . . . 0.0 113.343 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.422 ' HE2' HG21 ' A' ' 126' ' ' VAL . 13.7 ptmt -115.69 152.52 33.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 120.914 -1.345 . . . . 0.0 110.017 -169.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.7 tpp85 -122.96 106.07 10.53 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.92 2.088 . . . . 0.0 107.452 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -70.15 133.93 47.61 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 162.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 23.3 t -140.71 129.45 22.97 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 174.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -129.83 147.24 51.58 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.28 0.632 . . . . 0.0 110.063 -175.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -139.34 99.96 3.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.4 p -138.9 166.88 23.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 162.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.27 -13.51 60.78 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.183 170.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.672 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -81.59 0.04 40.15 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 114.792 1.405 . . . . 0.0 114.792 -165.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 72.4 mt -79.5 54.23 1.71 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.715 1.606 . . . . 0.0 112.116 -164.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -70.59 145.1 50.95 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -85.38 156.31 20.92 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 166.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 30.6 pt -136.91 162.96 52.82 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 158.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.49 168.45 6.61 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.559 1.506 . . . . 0.0 111.238 164.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -31.66 -36.65 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 130.583 3.553 . . . . 0.0 118.21 -169.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -176.14 -57.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.564 1.946 . . . . 0.0 107.5 169.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -157.31 66.48 0.5 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -176.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -121.74 -2.55 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.686 1.194 . . . . 0.0 111.071 161.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 0 C-N-CA 129.369 3.366 . . . . 0.0 105.699 159.685 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.493 ' HG3' ' H ' ' A' ' 5' ' ' LYS . 8.6 tpt . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.493 ' H ' ' HG3' ' A' ' 4' ' ' MET . 73.6 mmtt -69.94 61.65 0.19 Allowed 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.88 -1.137 . . . . 0.0 109.47 164.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.06 -162.18 0.32 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.455 1.902 . . . . 0.0 109.268 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 7.0 mmm180 -107.73 160.16 15.93 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -161.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.2 pt -126.48 109.24 23.37 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 127.08 2.152 . . . . 0.0 109.383 -174.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.55 101.41 1.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.567 2.178 . . . . 0.0 108.52 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.1 mt -76.78 151.68 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -137.93 101.73 4.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.727 1.611 . . . . 0.0 106.859 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.0 m -68.35 73.74 0.23 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.177 0.899 . . . . 0.0 108.818 159.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.32 -30.8 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 121.772 -0.58 . . . . 0.0 110.438 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.4 -27.88 1.86 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.441 2.296 . . . . 0.0 113.64 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -130.73 15.62 5.34 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.081 2.153 . . . . 0.0 110.819 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 32.59 52.24 0.28 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.805 2.842 . . . . 0.0 113.604 -165.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -86.82 167.44 14.38 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.917 -0.49 . . . . 0.0 109.771 165.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.4 t -143.28 132.81 21.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -145.65 102.19 3.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.988 1.315 . . . . 0.0 108.713 -174.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.3 ttt -82.86 118.99 23.82 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.436 -0.79 . . . . 0.0 111.019 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.2 t -113.78 -177.77 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 128.535 2.734 . . . . 0.0 106.524 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 4.1 pm0 -112.94 160.86 17.65 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.842 1.655 . . . . 0.0 112.103 177.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -56.74 154.86 8.43 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.9 1.28 . . . . 0.0 110.996 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -72.9 124.1 29.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -176.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.438 ' OE2' ' HE3' ' A' ' 5' ' ' LYS . 20.7 tt0 -148.12 115.7 6.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 163.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.432 HD11 HD11 ' A' ' 34' ' ' ILE . 38.3 mt -138.36 -177.81 5.01 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 128.669 2.788 . . . . 0.0 105.984 170.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.9 m -167.17 -24.39 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.431 ' C ' ' H ' ' A' ' 30' ' ' GLU . 4.4 t70 -91.73 -152.5 0.3 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.119 0.872 . . . . 0.0 109.462 -176.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.91 5.19 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.454 1.902 . . . . 0.0 114.101 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' A' ' 28' ' ' ASP . 36.4 mt-10 -60.43 -45.1 94.85 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 126.633 1.973 . . . . 0.0 110.58 -162.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -68.65 42.41 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.468 2.307 . . . . 0.0 113.104 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.9 -34.05 0.09 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.793 1.637 . . . . 0.0 110.634 160.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -91.08 -24.65 19.95 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.012 -0.994 . . . . 0.0 113.451 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.432 HD11 HD11 ' A' ' 26' ' ' LEU . 1.6 pt -108.43 15.53 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 120.203 1.365 . . . . 0.0 112.464 178.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.79 175.98 9.12 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 125.261 1.424 . . . . 0.0 109.837 -167.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.591 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -61.95 135.13 94.51 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 166.352 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -66.31 -12.4 35.47 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.929 1.753 . . . . 0.0 110.886 165.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -76.51 -43.05 41.08 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.367 167.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.591 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -57.38 -47.59 81.28 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 119.541 1.064 . . . . 0.0 109.841 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -48.1 -52.41 20.53 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 126.669 1.987 . . . . 0.0 111.603 175.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ptt-85 -76.08 -47.98 22.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 118.383 -0.818 . . . . 0.0 109.206 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.582 HG12 ' HB1' ' A' ' 143' ' ' ALA . 25.0 t -58.21 -27.11 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 124.91 1.284 . . . . 0.0 109.518 -176.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.44 -13.04 36.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 171.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -112.44 -26.06 8.89 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.417 1.462 . . . . 0.0 112.061 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 ptmt -112.48 14.5 20.26 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.989 1.716 . . . . 0.0 112.043 -172.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.67 -12.96 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 130.052 3.341 . . . . 0.0 116.408 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.54 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . 126.29 15.42 2.77 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.908 1.242 . . . . 0.0 113.956 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 m -149.19 130.85 14.97 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 120.298 2.049 . . . . 0.0 108.973 160.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -73.58 -55.16 3.58 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.698 1.599 . . . . 0.0 111.368 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -71.34 165.42 32.5 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 121.742 1.628 . . . . 0.0 110.798 167.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.27 -13.24 35.55 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.559 2.173 . . . . 0.0 113.032 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -77.39 68.12 3.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.843 1.257 . . . . 0.0 110.418 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 41.0 p -57.37 104.78 0.19 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.668 1.587 . . . . 0.0 109.317 174.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 179.79 -172.85 44.57 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -172.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -138.64 146.34 41.55 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.229 1.812 . . . . 0.0 106.511 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -64.6 -53.92 40.15 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.671 0.388 . . . . 0.0 111.629 -172.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -163.64 177.91 8.36 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.626 1.17 . . . . 0.0 108.557 173.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.98 171.2 12.05 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.998 2.119 . . . . 0.0 109.215 174.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -149.35 -67.2 0.22 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.052 167.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 141.25 107.69 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 130.455 3.502 . . . . 0.0 109.912 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -128.73 146.5 50.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 158.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -86.25 137.61 32.49 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 122.254 1.025 . . . . 0.0 110.935 -171.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.62 177.51 46.72 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.694 -161.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.434 HG22 ' HA ' ' A' ' 76' ' ' ASP . 46.3 pt -136.96 171.68 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.44 1.496 . . . . 0.0 108.538 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -96.56 136.04 37.63 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.994 0.518 . . . . 0.0 110.571 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 0.0 OUTLIER -102.32 120.09 39.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 163.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 35.1 t -65.79 90.7 0.13 Allowed 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 169.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.8 tt -66.57 -10.05 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.482 0.713 . . . . 0.0 111.735 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.7 t -77.94 -3.01 39.69 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.638 1.175 . . . . 0.0 111.759 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.3 p -154.68 -5.45 0.15 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 173.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.21 62.03 4.45 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -174.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.9 m -154.52 137.98 15.9 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 121.035 -1.274 . . . . 0.0 108.523 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 37.1 m-20 -101.19 157.21 16.95 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.942 0.792 . . . . 0.0 110.333 -167.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.25 0.3 OUTLIER -159.72 -103.16 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.377 1.071 . . . . 0.0 112.657 -179.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -52.65 121.2 6.7 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -158.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.434 ' HA ' HG22 ' A' ' 64' ' ' ILE . 5.5 m-20 -62.07 122.38 15.38 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.628 1.171 . . . . 0.0 108.754 168.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 t -66.61 -15.93 63.81 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -167.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -70.36 -16.8 63.02 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.41 1.084 . . . . 0.0 112.506 173.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.1 p -71.25 -22.64 61.95 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.366 -0.834 . . . . 0.0 111.484 167.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -98.63 -172.57 2.34 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.539 1.536 . . . . 0.0 109.839 -170.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.73 8.14 16.07 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.659 1.183 . . . . 0.0 113.536 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -53.11 134.86 38.42 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 159.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.4 p 111.44 -36.14 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 1 C-N-CA 132.482 4.313 . . . . 0.0 111.29 -166.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.32 -69.27 0.39 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 -173.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.1 t -118.96 -21.21 7.81 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.722 0.809 . . . . 0.0 111.266 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.08 11.79 13.38 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.69 1.138 . . . . 0.0 114.525 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -62.82 130.84 94.18 Favored Pre-proline 0 C--O 1.237 0.439 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.63 70.03 5.84 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.895 3.063 . . . . 0.0 112.613 -165.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 72.3 p -138.01 154.18 49.34 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.019 1.728 . . . . 0.0 110.055 173.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -145.17 170.21 16.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.645 1.578 . . . . 0.0 109.08 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -128.06 -13.52 5.09 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -175.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -141.42 178.16 7.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 169.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.29 160.89 22.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.918 0.865 . . . . 0.0 111.439 -167.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 p -59.74 -40.15 81.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 125.55 1.54 . . . . 0.0 111.038 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.5 m 156.73 156.65 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.286 1 C-N-CA 131.747 4.019 . . . . 0.0 106.495 -176.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -75.61 48.79 0.47 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.72 2.008 . . . . 0.0 109.794 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.416 ' C ' HD22 ' A' ' 98' ' ' ASN . 8.1 p80 -110.4 -46.93 3.34 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.406 -0.808 . . . . 0.0 109.654 -159.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.416 HD22 ' C ' ' A' ' 97' ' ' HIS . 0.9 OUTLIER -124.56 17.69 8.84 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 124.17 0.988 . . . . 0.0 112.118 170.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.38 135.65 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 174.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.57 ' HD2' ' H ' ' A' ' 101' ' ' LEU . 39.0 tptt -108.56 144.24 36.52 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.306 1.842 . . . . 0.0 108.991 -173.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.57 ' H ' ' HD2' ' A' ' 100' ' ' LYS . 54.9 mt -138.39 128.79 26.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 130.355 3.462 . . . . 0.0 107.468 -167.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.449 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -133.39 114.7 13.99 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 128.716 2.806 . . . . 0.0 104.778 163.254 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -101.73 142.4 33.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 124.283 0.989 . . . . 0.0 110.822 -172.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -148.34 176.68 10.07 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.605 2.362 . . . . 0.0 107.577 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.83 10.24 36.03 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 119.977 -1.702 . . . . 0.0 112.494 172.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.0 t -58.31 16.63 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 130.157 3.383 . . . . 0.0 119.342 -158.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 pp -128.85 -6.25 5.06 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.694 1.198 . . . . 0.0 112.136 168.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.69 -1.66 32.19 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 117.246 -1.863 . . . . 0.0 113.38 -167.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -141.29 -91.15 0.15 Allowed 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.648 2.224 . . . . 0.0 108.74 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 56.8 t -141.72 114.59 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.435 HH21 ' CE1' ' A' ' 125' ' ' HIS . 22.2 ttt180 -118.86 127.82 53.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 124.359 1.037 . . . . 0.0 108.512 168.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 23.7 t -127.17 146.25 50.47 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 171.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 16.2 pt-20 -68.64 162.3 26.27 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.995 0.816 . . . . 0.0 110.508 172.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 79.2 t -142.43 100.52 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 174.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mp -130.82 162.22 30.04 Favored 'General case' 0 N--CA 1.461 0.116 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.45 ' HB3' ' H ' ' A' ' 119' ' ' CYS . 1.6 t -71.82 124.52 25.0 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.21 -9.01 20.02 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.396 0.678 . . . . 0.0 111.76 174.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.98 -25.5 15.36 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.54 1.936 . . . . 0.0 113.011 170.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.45 ' H ' ' HB3' ' A' ' 116' ' ' CYS . 31.2 p -159.71 95.38 1.2 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.6 1.56 . . . . 0.0 109.514 -178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.9 32.51 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.004 1 C-N-CA 131.79 4.036 . . . . 0.0 113.068 178.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.91 -63.57 1.25 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -158.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.401 ' H ' HD23 ' A' ' 123' ' ' LEU . 50.7 t-80 -158.0 -64.46 0.09 Allowed 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 174.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.401 HD23 ' H ' ' A' ' 122' ' ' HIS . 2.3 mm? 54.02 -106.32 0.3 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.153 2.181 . . . . 0.0 106.464 173.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 176.62 -120.43 0.74 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.228 -0.986 . . . . 0.0 112.685 167.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.435 ' CE1' HH21 ' A' ' 111' ' ' ARG . 22.6 p-80 -159.69 173.68 15.69 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.749 -0.266 . . . . 0.0 110.761 -168.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.4 p -123.61 143.38 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.579 1.552 . . . . 0.0 107.884 171.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -138.79 151.74 47.31 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.273 1.029 . . . . 0.0 109.413 176.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -65.83 118.5 9.76 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 170.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -142.57 -47.06 0.33 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.068 0.947 . . . . 0.0 113.511 -168.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -104.45 -179.78 24.77 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.096 1.332 . . . . 0.0 114.566 -159.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -66.22 147.16 83.22 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.108 2.539 . . . . 0.0 110.186 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -77.43 159.34 77.6 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 118.731 -0.652 . . . . 0.0 109.451 -174.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.35 -49.17 0.24 Allowed 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 120.037 1.049 . . . . 0.0 111.521 0.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 6.3 p -77.74 76.24 4.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 123.043 1.401 . . . . 0.0 109.907 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -110.0 7.53 31.17 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 128.138 2.78 . . . . 0.0 110.249 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -78.2 138.65 38.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 119.712 1.756 . . . . 0.0 106.754 163.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -106.21 101.05 10.56 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 173.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -67.74 143.4 55.91 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 161.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 36.3 t -146.6 137.44 24.07 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.139 1.375 . . . . 0.0 108.497 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -138.43 153.99 48.87 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.759 0.824 . . . . 0.0 111.262 -177.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -156.33 114.76 3.36 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.14 2.176 . . . . 0.0 107.334 173.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.0 p -171.87 177.82 3.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.472 1.509 . . . . 0.0 108.995 174.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.582 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -66.31 21.45 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.113 1.765 . . . . 0.0 113.1 165.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -90.91 -15.88 29.09 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.98 1.264 . . . . 0.0 113.286 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.4 mt -83.46 88.49 6.99 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.376 0.535 . . . . 0.0 111.802 -159.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -127.87 114.32 17.05 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.427 1.091 . . . . 0.0 108.915 167.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -68.86 145.47 53.68 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 163.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 27.2 pt -137.8 163.4 48.42 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 125.329 1.452 . . . . 0.0 109.382 168.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.18 161.13 11.64 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.232 1.954 . . . . 0.0 111.694 166.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -34.13 -24.45 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 131.543 3.937 . . . . 0.0 120.273 -167.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -167.42 -82.37 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 126.253 1.821 . . . . 0.0 107.289 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -141.73 9.63 1.98 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.967 2.107 . . . . 0.0 110.191 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.9 pp -69.81 -16.25 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -167.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 116.783 -2.121 . . . . 0.0 112.077 170.897 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.2 tpt . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -64.76 91.25 0.09 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.221 -1.399 . . . . 0.0 107.221 159.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.3 p30 -149.99 -161.8 1.42 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.412 1.101 . . . . 0.0 111.993 -161.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -108.63 172.57 6.77 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.149 2.179 . . . . 0.0 110.534 -170.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.451 HD13 ' HD3' ' A' ' 118' ' ' ARG . 1.3 pt -122.72 102.57 38.39 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 124.852 1.261 . . . . 0.0 110.447 -173.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.2 99.46 1.01 Allowed 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.375 2.05 . . . . 0.0 109.325 174.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.4 mt -79.85 88.31 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -78.26 97.31 5.5 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 m -69.55 72.0 0.33 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 160.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.1 t -56.26 -37.98 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 123.677 0.791 . . . . 0.0 111.506 -170.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.09 -12.17 25.07 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -125.54 7.12 7.6 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.248 1.819 . . . . 0.0 111.067 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 31.39 48.31 0.08 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 128.72 2.808 . . . . 0.0 112.81 -161.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -90.18 157.96 17.47 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 168.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.5 t -148.77 92.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 -176.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -100.48 102.96 14.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 32.9 ttm -80.05 87.41 5.44 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.669 173.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 80.8 t -84.47 174.7 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 125.853 1.661 . . . . 0.0 107.001 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -105.74 155.18 19.53 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 120.232 -1.542 . . . . 0.0 110.55 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.54 150.05 41.43 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.24 113.77 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -139.84 105.34 5.09 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 162.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.6 mt -133.12 171.89 13.39 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.492 1.517 . . . . 0.0 109.306 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.6 t -85.32 165.38 17.33 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 158.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.2 -38.8 74.22 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.138 0.881 . . . . 0.0 110.111 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.407 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -59.95 -25.78 65.46 Favored 'General case' 0 C--N 1.344 0.335 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -170.43 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -67.56 -45.06 76.7 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.818 1.647 . . . . 0.0 109.846 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -61.2 10.93 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.058 2.143 . . . . 0.0 115.864 -174.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.407 ' NE ' ' HA ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -130.75 -5.79 4.07 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 173.013 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -128.7 -18.96 3.79 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.639 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 pt -104.97 4.41 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.88 0.763 . . . . 0.0 111.391 166.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 mt -112.36 160.46 17.68 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.85 1.26 . . . . 0.0 110.372 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.4 145.51 75.23 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 172.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -67.65 -4.48 12.21 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.678 2.252 . . . . 0.0 112.33 166.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -77.93 -56.43 4.5 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.725 1.21 . . . . 0.0 109.996 162.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.74 -42.48 71.66 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.571 1.078 . . . . 0.0 111.223 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -58.03 -47.2 83.81 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.956 1.302 . . . . 0.0 111.613 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -75.69 -38.86 58.32 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 119.458 1.026 . . . . 0.0 110.572 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 t -55.05 -28.61 21.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.943 1.297 . . . . 0.0 111.068 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.88 -20.57 63.88 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 172.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -101.3 -45.11 5.44 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 119.722 1.146 . . . . 0.0 111.807 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.488 ' CD ' ' HG2' ' A' ' 49' ' ' GLU . 10.1 ptpt -89.93 12.55 17.11 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.591 1.087 . . . . 0.0 112.833 -174.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.37 36.75 1.16 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 128.082 2.553 . . . . 0.0 113.557 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.91 29.4 26.15 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-O 119.883 -0.398 . . . . 0.0 113.688 171.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.0 m -142.89 103.32 4.17 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 118.974 1.387 . . . . 0.0 109.061 166.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.488 ' HG2' ' CD ' ' A' ' 45' ' ' LYS . 11.1 mt-10 -72.06 169.24 17.11 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 161.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -61.79 157.08 44.66 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 121.474 1.449 . . . . 0.0 110.701 160.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.78 164.85 34.35 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.755 2.304 . . . . 0.0 112.054 -176.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -145.82 170.56 16.31 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.556 1.542 . . . . 0.0 108.94 176.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.2 m -71.01 91.76 0.9 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.524 1.129 . . . . 0.0 110.495 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -65.96 158.61 47.44 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 161.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -154.59 -51.72 0.09 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 122.264 -0.551 . . . . 0.0 111.455 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -57.72 139.92 52.69 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 175.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -159.69 171.58 19.3 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.534 2.334 . . . . 0.0 106.533 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -148.9 -173.83 4.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 172.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.0 mp -130.98 27.21 4.9 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.113 1.765 . . . . 0.0 109.923 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.62 171.79 11.82 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.082 1.753 . . . . 0.0 109.497 174.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -74.89 36.58 0.11 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.955 2.902 . . . . 0.0 112.684 -173.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -75.64 143.24 42.34 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 121.803 0.811 . . . . 0.0 112.504 -172.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.63 151.83 24.72 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.684 1.611 . . . . 0.0 111.944 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.533 HG22 ' HA ' ' A' ' 76' ' ' ASP . 42.8 pt -132.85 161.94 40.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 125.171 1.388 . . . . 0.0 108.178 169.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -82.67 142.5 31.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.012 0.434 . . . . 0.0 110.144 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 0.0 OUTLIER -114.8 140.33 49.01 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 124.372 1.069 . . . . 0.0 110.2 160.274 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.2 t -70.6 84.49 0.62 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 162.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.9 tp -59.74 -13.37 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.044 1.338 . . . . 0.0 112.218 172.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.7 t -78.47 1.89 20.78 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.635 1.574 . . . . 0.0 111.737 173.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 11.6 p -159.02 -9.56 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 170.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 72.35 64.31 2.67 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -173.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.22 135.23 30.51 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.113 2.165 . . . . 0.0 106.238 176.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 5.7 p-10 -100.13 152.34 20.36 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.555 1.525 . . . . 0.0 112.222 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.419 HD23 ' H ' ' A' ' 75' ' ' PHE 0.283 0.0 OUTLIER -154.51 -107.97 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.387 1.075 . . . . 0.0 112.864 178.409 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.489 ' CE1' HG13 ' A' ' 93' ' ' VAL . 73.6 m-85 -50.49 121.69 6.06 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.467 1.907 . . . . 0.0 113.622 -160.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.533 ' HA ' HG22 ' A' ' 64' ' ' ILE . 18.2 t70 -86.95 156.84 19.63 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.139 0.976 . . . . 0.0 111.402 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.1 t -56.8 -17.71 10.17 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -63.55 -26.96 68.94 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.862 1.664 . . . . 0.0 111.43 170.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.1 p -92.05 -47.14 7.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.211 1.405 . . . . 0.0 109.177 174.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.35 112.55 15.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.793 1.237 . . . . 0.0 109.725 -159.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -52.59 145.73 11.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.959 0.904 . . . . 0.0 111.165 173.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -140.93 -69.62 0.38 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.789 1.236 . . . . 0.0 110.287 -175.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.7 m -73.16 120.51 18.88 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.53 -158.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.92 -64.95 3.3 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.6 m -120.37 78.67 1.38 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.734 1.214 . . . . 0.0 108.703 -173.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -77.76 32.84 1.67 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 123.884 0.754 . . . . 0.0 113.895 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -59.54 152.6 55.11 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 125.14 1.376 . . . . 0.0 112.002 -172.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.91 60.09 7.61 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.297 2.665 . . . . 0.0 109.657 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.1 p -145.49 145.92 31.26 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 163.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -153.69 175.45 13.24 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.578 1.151 . . . . 0.0 109.463 -173.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -112.1 -12.87 13.62 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.619 0.768 . . . . 0.0 112.384 -164.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -154.49 -175.86 5.61 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -173.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.489 HG13 ' CE1' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -136.75 154.35 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 124.861 1.264 . . . . 0.0 109.478 -163.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.7 p -62.17 -32.34 54.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 122.581 0.352 . . . . 0.0 110.197 164.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.1 m 153.03 165.83 0.01 OUTLIER 'General case' 0 C--O 1.234 0.238 1 C-N-CA 132.943 4.497 . . . . 0.0 106.51 -175.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.423 ' HA ' ' CG2' ' A' ' 99' ' ' ILE . 99.3 mt-10 -107.96 75.97 1.03 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -132.46 -28.8 1.62 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.357 1.463 . . . . 0.0 112.597 -161.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.71 16.57 11.93 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.636 1.175 . . . . 0.0 111.876 167.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.613 HD11 HG13 ' A' ' 114' ' ' VAL . 12.0 tt -132.22 146.18 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 125.94 1.696 . . . . 0.0 108.114 -173.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -127.92 124.47 37.45 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.815 1.246 . . . . 0.0 108.834 -174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 mp -118.79 139.8 51.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.032 2.133 . . . . 0.0 108.756 -173.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -131.61 116.91 18.0 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.673 1.589 . . . . 0.0 106.715 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -79.19 135.67 36.87 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.693 1.235 . . . . 0.0 112.174 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 105' ' ' ARG . 19.2 t70 -143.41 -172.03 3.62 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.351 1.86 . . . . 0.0 110.697 170.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.454 ' H ' ' CG ' ' A' ' 104' ' ' ASP . 0.2 OUTLIER -122.7 7.16 9.41 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.537 2.735 . . . . 0.0 111.838 -173.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.7 m -65.65 30.42 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 129.928 3.291 . . . . 0.0 116.905 -161.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pp -131.09 -2.52 4.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.017 1.327 . . . . 0.0 112.023 161.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.14 3.31 51.36 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 117.908 -1.496 . . . . 0.0 112.415 -168.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.5 mtp -140.69 -95.35 0.15 Allowed 'General case' 0 C--N 1.347 0.494 0 CA-C-N 120.01 1.905 . . . . 0.0 107.993 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 61.8 t -142.64 111.4 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -119.03 100.72 7.53 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.768 1.227 . . . . 0.0 107.966 171.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 36.1 t -100.9 128.07 47.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -64.62 158.96 22.98 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.968 0.804 . . . . 0.0 110.099 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.613 HG13 HD11 ' A' ' 99' ' ' ILE . 95.0 t -141.65 98.95 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -176.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.3 mp -126.84 164.26 21.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 174.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.3 m -77.47 145.29 37.15 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.403 -1.436 . . . . 0.0 110.625 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -82.14 -22.89 35.9 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.09 0.956 . . . . 0.0 111.249 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.451 ' HD3' HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -76.8 -38.22 54.33 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 117.993 -1.003 . . . . 0.0 111.092 169.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.2 p -147.58 115.72 6.54 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 173.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -67.53 56.28 0.06 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.411 1.485 . . . . 0.0 111.304 176.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.14 168.38 16.89 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.242 1.817 . . . . 0.0 110.682 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -44.69 -64.04 0.78 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.756 2.022 . . . . 0.0 113.264 -161.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 50.94 -114.29 0.77 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.414 1.886 . . . . 0.0 107.983 174.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.22 -119.65 0.68 Allowed Glycine 0 CA--C 1.522 0.518 0 CA-C-N 118.653 0.66 . . . . 0.0 113.271 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 54.1 p-80 -161.18 170.7 19.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.237 0.615 . . . . 0.0 110.648 -170.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.586 HG21 ' HE2' ' A' ' 136' ' ' LYS . 3.6 p -115.2 139.61 40.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 125.161 1.384 . . . . 0.0 108.283 172.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -132.23 150.47 52.15 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 123.593 0.558 . . . . 0.0 110.812 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -66.42 108.59 2.42 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.732 1.213 . . . . 0.0 109.206 174.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.33 -44.47 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.683 1.193 . . . . 0.0 112.257 -170.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.74 -179.65 32.51 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.222 0.915 . . . . 0.0 114.94 -159.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.55 165.25 31.35 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.219 2.613 . . . . 0.0 110.629 171.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.72 154.87 84.14 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 164.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.46 -55.52 0.14 OUTLIER 'Cis proline' 0 C--N 1.348 0.55 0 CA-C-N 120.745 1.302 . . . . 0.0 113.751 10.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 19.1 p -66.7 -31.16 71.64 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.366 1.067 . . . . 0.0 113.149 -166.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 71.81 -2.37 25.08 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.052 0.834 . . . . 0.0 114.797 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.586 ' HE2' HG21 ' A' ' 126' ' ' VAL . 14.6 ptmt -103.38 159.09 15.87 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 118.3 1.05 . . . . 0.0 108.863 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.4 ttp85 -129.14 99.91 5.43 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.68 1.192 . . . . 0.0 108.856 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -62.5 132.15 51.52 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.656 1.582 . . . . 0.0 107.413 163.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 42.6 t -141.77 144.86 34.19 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.654 1.116 . . . . 0.0 109.386 173.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.5 ptp -149.76 158.19 43.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.457 0.646 . . . . 0.0 110.655 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.17 89.17 1.93 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.566 2.346 . . . . 0.0 106.096 -176.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.523 ' HB3' ' H ' ' A' ' 144' ' ' ALA . 2.8 m -147.2 162.27 39.23 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.31 1.444 . . . . 0.0 108.63 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.7 -20.31 65.62 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.355 1.062 . . . . 0.0 113.072 163.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.523 ' H ' ' HB3' ' A' ' 142' ' ' SER . . . -62.81 29.3 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 130.661 3.584 . . . . 0.0 114.881 -175.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 93.8 mt -132.81 47.41 2.51 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.283 1.833 . . . . 0.0 108.861 -168.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.6 tttt -74.43 122.45 23.01 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -66.95 131.9 46.82 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 165.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 17.2 pt -114.17 164.42 16.27 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 160.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -60.13 173.26 1.94 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 121.657 1.571 . . . . 0.0 110.038 160.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -41.77 -28.34 0.15 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -168.75 -83.53 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 170.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -146.14 26.98 1.18 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.169 1.788 . . . . 0.0 110.244 -178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -73.28 -12.61 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.97 1.308 . . . . 0.0 112.152 170.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.49 0 N-CA-C 106.977 -2.449 . . . . 0.0 106.977 160.483 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 95.4 mtp . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -122.15 33.86 5.34 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.291 1.436 . . . . 0.0 111.195 -177.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -74.07 -147.85 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 129.862 3.265 . . . . 0.0 111.913 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 70.7 mtt85 -145.53 166.03 26.9 Favored 'General case' 0 C--N 1.32 -0.689 1 C-N-CA 135.192 5.397 . . . . 0.0 105.228 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.449 ' HB ' HD21 ' A' ' 98' ' ' ASN . 42.0 pt -132.55 128.75 21.13 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.046 0.938 . . . . 0.0 110.395 -164.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.17 132.97 17.27 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.86 1.707 . . . . 0.0 110.256 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.9 mm -101.01 148.77 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 160.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.98 91.49 1.79 Allowed 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.872 1.269 . . . . 0.0 107.869 -169.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.9 m -71.37 80.22 0.76 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.579 170.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.39 -33.96 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 119.995 1.271 . . . . 0.0 111.09 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.05 -6.75 4.33 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 173.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -130.02 11.45 5.55 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.306 2.242 . . . . 0.0 110.512 170.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.3 t30 28.11 66.82 0.08 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.821 2.448 . . . . 0.0 112.248 -162.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -114.7 161.44 18.13 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.6 t -144.75 122.5 5.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -141.43 98.87 3.44 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -170.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 44.2 ttm -70.52 133.5 46.84 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.077 -1.014 . . . . 0.0 109.477 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 95.3 t -121.25 161.33 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 176.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -78.46 167.15 21.74 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.186 -1.571 . . . . 0.0 109.565 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.5 mtm105 -63.24 165.2 7.68 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 121.669 -0.644 . . . . 0.0 109.96 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.45 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 6.2 tp -70.28 120.61 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 167.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -152.43 118.17 5.39 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 160.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 90.1 mt -140.4 172.86 12.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.885 1.674 . . . . 0.0 108.442 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.453 ' H ' ' HG2' ' A' ' 30' ' ' GLU . 10.7 p -94.51 168.62 10.75 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.019 1.328 . . . . 0.0 109.67 171.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -77.66 70.05 3.99 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.791 0.805 . . . . 0.0 109.5 164.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -167.14 -26.81 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 125.286 1.435 . . . . 0.0 110.988 158.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.453 ' HG2' ' H ' ' A' ' 27' ' ' SER . 23.1 mm-40 -55.62 -45.24 77.56 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.309 0.644 . . . . 0.0 110.348 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -68.19 37.34 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.275 2.63 . . . . 0.0 112.767 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.56 -34.34 0.19 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.632 1.173 . . . . 0.0 111.402 161.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -92.24 -26.37 18.2 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.807 -1.092 . . . . 0.0 113.049 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.2 pt -100.81 23.44 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 120.186 1.357 . . . . 0.0 111.467 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.7 mt -122.25 161.49 23.19 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 124.443 1.097 . . . . 0.0 112.233 -174.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -61.54 149.03 85.26 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.082 170.334 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -68.83 5.1 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.419 2.746 . . . . 0.0 112.657 167.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -102.79 -39.82 6.84 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.672 -1.156 . . . . 0.0 111.441 165.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.514 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -60.78 -43.68 97.75 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 121.421 1.919 . . . . 0.0 111.455 -173.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -57.66 -45.7 85.18 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.929 1.292 . . . . 0.0 111.549 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -76.33 -36.78 58.07 Favored 'General case' 0 C--O 1.221 -0.434 0 O-C-N 121.526 -0.734 . . . . 0.0 111.066 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.635 ' CG1' ' HB1' ' A' ' 143' ' ' ALA . 25.2 t -55.0 -27.99 19.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 120.701 -1.25 . . . . 0.0 111.143 175.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.45 -22.91 67.16 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -93.84 -41.82 9.43 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.514 1.506 . . . . 0.0 111.537 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -96.13 4.82 52.22 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.302 1.841 . . . . 0.0 112.884 -172.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.04 15.58 1.84 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.939 1.695 . . . . 0.0 113.533 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.53 -0.24 30.82 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 117.702 -1.61 . . . . 0.0 114.805 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.0 m -150.19 116.42 5.7 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 121.622 2.711 . . . . 0.0 112.035 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -103.97 159.38 29.5 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 126.731 2.012 . . . . 0.0 107.063 169.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.36 153.84 76.51 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 121.281 1.321 . . . . 0.0 111.142 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -66.19 133.29 32.46 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.865 2.376 . . . . 0.0 110.376 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -153.28 -69.69 0.15 Allowed 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.7 m -68.67 163.83 22.95 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 158.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -128.85 171.08 19.86 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 172.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.3 ttmt -150.24 178.78 8.67 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.463 1.505 . . . . 0.0 107.258 174.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -136.74 164.58 27.93 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.884 1.674 . . . . 0.0 107.251 167.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -141.73 -40.24 0.37 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.704 1.602 . . . . 0.0 108.589 172.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -41.61 98.23 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 130.939 3.696 . . . . 0.0 111.652 158.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.1 mt -137.44 -38.99 0.59 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.521 1.528 . . . . 0.0 110.167 167.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -143.89 163.53 33.15 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 165.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -75.0 89.2 2.4 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 162.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -158.03 -178.22 7.14 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.457 1.503 . . . . 0.0 108.047 176.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.61 172.12 17.39 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 122.206 0.892 . . . . 0.0 114.978 166.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.514 HG22 ' HA ' ' A' ' 76' ' ' ASP . 14.2 pt -136.2 170.79 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.829 1.651 . . . . 0.0 109.618 176.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -96.95 111.04 23.43 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.457 1.103 . . . . 0.0 109.999 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.49 113.73 14.42 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 163.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 20.7 t -65.84 85.32 0.08 Allowed 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.512 1.525 . . . . 0.0 109.14 166.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.1 tt -66.33 -11.61 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.704 1.602 . . . . 0.0 111.587 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.5 m -82.28 -1.44 49.47 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.309 1.844 . . . . 0.0 113.0 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.8 p -152.17 -16.43 0.18 Allowed 'General case' 0 C--N 1.338 0.104 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 165.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.66 65.84 1.59 Allowed Glycine 0 C--N 1.337 0.616 0 N-CA-C 107.593 -2.203 . . . . 0.0 107.593 -162.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.1 m -143.21 166.63 24.18 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 172.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -135.53 145.89 47.51 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.57 -102.82 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.666 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -54.4 108.01 0.34 Allowed 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.487 1.115 . . . . 0.0 112.815 -159.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.514 ' HA ' HG22 ' A' ' 64' ' ' ILE . 1.6 m-20 -68.37 135.86 52.47 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 172.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.88 -10.11 57.31 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.38 0.991 . . . . 0.0 112.949 -171.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.91 -20.8 62.64 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.468 -1.395 . . . . 0.0 112.472 163.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 42.3 p -86.69 -20.14 28.17 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.659 1.184 . . . . 0.0 112.89 168.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -137.05 86.29 2.19 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.229 1.812 . . . . 0.0 107.471 -169.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -139.06 124.24 19.05 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -144.83 93.62 2.43 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -176.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.0 m -61.81 124.97 22.21 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.825 1.25 . . . . 0.0 111.14 -170.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.12 -60.88 4.8 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.79 -49.6 70.04 Favored 'General case' 0 CA--C 1.526 0.039 0 CA-C-N 117.941 0.87 . . . . 0.0 112.285 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 42.35 42.11 4.26 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 126.918 2.199 . . . . 0.0 115.657 -162.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -61.44 143.81 92.79 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 118.528 1.164 . . . . 0.0 108.874 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.14 70.44 6.69 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.02 2.48 . . . . 0.0 110.895 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.3 p -136.44 150.29 48.67 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.521 1.129 . . . . 0.0 110.967 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.25 166.77 22.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.901 2.08 . . . . 0.0 107.568 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -127.7 -6.9 5.66 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.393 0.677 . . . . 0.0 112.451 -170.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -151.96 -178.02 6.5 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 167.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.23 158.76 43.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.101 0 C-N-CA 124.105 0.962 . . . . 0.0 111.825 -176.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.2 p -51.36 -42.44 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 127.271 2.228 . . . . 0.0 111.444 171.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.6 m 157.14 155.07 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.515 1 C-N-CA 131.959 4.104 . . . . 0.0 106.786 -176.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -74.06 75.51 1.73 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 161.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -114.8 -53.51 2.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.573 1.149 . . . . 0.0 108.991 177.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.449 HD21 ' HB ' ' A' ' 8' ' ' ILE . 0.5 OUTLIER -126.82 14.33 7.45 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 173.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.5 tt -106.12 154.25 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 159.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -123.49 134.11 53.94 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 166.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 46.8 mt -117.41 148.97 41.29 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.855 2.062 . . . . 0.0 109.02 172.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.473 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 0.2 OUTLIER -133.17 115.69 15.34 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 162.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -61.96 143.44 56.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.221 1.409 . . . . 0.0 110.034 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -147.79 -178.97 6.55 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 158.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.95 14.7 9.95 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.024 2.13 . . . . 0.0 110.377 -176.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.8 m -62.33 -21.81 65.57 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 126.194 1.798 . . . . 0.0 115.692 -158.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 pp -77.08 -14.72 59.77 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.556 1.071 . . . . 0.0 112.231 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.86 0.6 25.73 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 117.316 -1.824 . . . . 0.0 113.012 -168.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 24.0 mmt -143.31 -85.18 0.15 Allowed 'General case' 0 C--N 1.349 0.553 0 CA-C-N 120.456 2.128 . . . . 0.0 107.9 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.2 t -145.19 114.69 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -129.37 103.44 6.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.305 1.442 . . . . 0.0 110.186 172.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.4 ' HB2' ' CG1' ' A' ' 126' ' ' VAL . 2.6 m -106.85 151.87 24.64 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 23.9 pt-20 -70.43 163.68 26.21 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.354 0.979 . . . . 0.0 110.838 171.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.3 t -137.09 107.51 5.38 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 168.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.49 164.49 18.83 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 167.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 17.0 t -65.47 156.22 33.12 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 162.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.72 -28.91 66.21 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.45 ' HG2' ' H ' ' A' ' 24' ' ' ILE 0.285 0.0 OUTLIER -116.1 -52.45 2.6 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 179.451 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 15.9 p -77.51 77.68 4.03 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 121.077 1.762 . . . . 0.0 109.227 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -52.86 67.04 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 128.983 2.913 . . . . 0.0 111.071 166.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -126.4 -178.9 4.51 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.37 2.268 . . . . 0.0 110.264 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -43.75 -57.99 2.94 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.259 2.224 . . . . 0.0 113.366 -165.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 42.54 -112.08 0.19 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.616 1.966 . . . . 0.0 109.422 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -178.29 -125.3 0.91 Allowed Glycine 0 CA--C 1.519 0.328 0 CA-C-N 118.954 0.797 . . . . 0.0 113.767 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -158.46 174.87 14.44 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.076 0.55 . . . . 0.0 110.085 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.582 HG21 ' HE2' ' A' ' 136' ' ' LYS . 2.4 p -124.85 137.14 58.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 124.285 1.034 . . . . 0.0 108.774 171.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -135.07 147.15 49.5 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.193 0.597 . . . . 0.0 109.675 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -58.66 111.32 1.22 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.842 1.257 . . . . 0.0 109.442 170.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -153.94 -29.5 0.12 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -78.7 155.8 41.69 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.19 -30.02 7.34 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.141 1.894 . . . . 0.0 112.632 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 179.37 168.58 0.64 Allowed Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 128.744 2.818 . . . . 0.0 106.584 -172.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.11 -51.06 0.16 OUTLIER 'Cis proline' 0 C--N 1.349 0.589 0 CA-C-N 121.081 1.422 . . . . 0.0 111.407 -12.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.0 p -71.13 -23.43 62.08 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.686 1.595 . . . . 0.0 112.44 -177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 76.03 -8.85 21.08 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.499 1.523 . . . . 0.0 113.257 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.582 ' HE2' HG21 ' A' ' 126' ' ' VAL . 12.2 ptmt -105.76 152.84 22.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 120.64 -1.506 . . . . 0.0 109.977 -171.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -126.96 97.74 5.07 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.53 1.932 . . . . 0.0 107.033 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -67.74 140.21 56.71 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 164.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 45.7 t -140.65 149.23 42.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.448 1.099 . . . . 0.0 109.192 170.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.7 ptt? -140.84 148.95 41.35 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.317 1.447 . . . . 0.0 109.337 -176.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -147.65 88.77 1.71 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.999 2.12 . . . . 0.0 107.424 -173.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 88.7 p -165.28 178.44 6.9 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 121.551 -0.718 . . . . 0.0 109.549 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.635 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -63.62 -18.26 63.74 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.121 1.368 . . . . 0.0 114.169 167.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.82 22.68 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.539 1.936 . . . . 0.0 115.445 -159.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 28.3 mt -121.23 41.03 3.43 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -158.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -75.77 101.59 5.12 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -53.92 137.28 39.38 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 167.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 14.8 pt -136.2 166.59 26.83 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.242 1.417 . . . . 0.0 108.297 167.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.89 168.1 4.74 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.646 2.231 . . . . 0.0 112.435 164.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -18.87 -49.58 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 130.206 3.402 . . . . 0.0 118.118 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -165.42 -81.01 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.218 1.407 . . . . 0.0 107.609 -167.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -144.74 16.64 1.61 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.085 1.754 . . . . 0.0 111.412 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.79 -3.92 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 121.259 -0.901 . . . . 0.0 112.728 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.475 0 C-N-CA 128.117 2.77 . . . . 0.0 106.554 159.88 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -149.4 69.47 1.05 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 167.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -177.57 -168.3 0.18 Allowed 'General case' 0 C--O 1.239 0.541 0 C-N-CA 127.263 2.225 . . . . 0.0 106.623 -159.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 24.2 mtt180 -119.13 160.23 22.5 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -164.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.559 HD13 ' HD3' ' A' ' 118' ' ' ARG . 2.7 pt -132.01 112.83 14.73 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.439 1.495 . . . . 0.0 108.856 -162.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.08 106.34 2.01 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.52 2.146 . . . . 0.0 109.274 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.553 HD11 HD12 ' A' ' 8' ' ' ILE . 23.4 mm -78.72 80.69 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 173.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -83.66 89.54 7.14 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.328 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.7 m -71.41 83.57 0.8 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 173.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.2 p -56.42 -36.62 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.444 1.497 . . . . 0.0 111.842 -171.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -17.86 49.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.665 1.186 . . . . 0.0 112.648 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -129.11 12.44 6.11 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.602 1.961 . . . . 0.0 110.015 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 26.48 58.31 0.07 Allowed 'General case' 0 C--O 1.237 0.404 0 C-N-CA 129.104 2.962 . . . . 0.0 111.32 -164.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.9 mtp85 -94.63 175.14 6.78 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 118.569 -1.252 . . . . 0.0 108.881 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -149.8 120.97 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 159.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.41 111.57 22.51 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 167.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.9 ttt -77.42 105.83 8.8 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.819 1.19 . . . . 0.0 108.808 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.94 178.96 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 173.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 16.1 pt-20 -130.96 168.82 16.69 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 120.292 -1.505 . . . . 0.0 112.516 172.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.89 139.61 57.24 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.659 0.784 . . . . 0.0 111.545 -171.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.476 ' H ' ' HD2' ' A' ' 118' ' ' ARG . 12.9 tt -73.72 115.38 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -175.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -139.0 99.52 3.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 -173.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.4 mt -133.39 177.41 7.71 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.203 1.801 . . . . 0.0 108.805 -171.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.2 t -84.4 179.77 7.35 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 158.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -54.19 -36.99 64.01 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.846 0.748 . . . . 0.0 109.231 158.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 32' ' ' ARG . 18.6 m-20 -62.82 17.07 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 129.978 3.311 . . . . 0.0 117.269 -169.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -133.04 -46.9 0.85 Allowed 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -172.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -62.36 5.69 0.1 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.601 1.96 . . . . 0.0 114.922 -175.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 29' ' ' ASP . 3.7 ptt180 -124.75 -10.51 7.27 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.611 1.564 . . . . 0.0 113.869 176.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -134.66 -11.42 2.37 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 123.628 0.771 . . . . 0.0 112.19 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pt -119.55 11.39 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 123.828 0.851 . . . . 0.0 111.283 166.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -113.49 170.78 7.99 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 124.479 1.111 . . . . 0.0 111.825 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -60.42 142.41 90.7 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.902 0.881 . . . . 0.0 110.527 172.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.34 -7.2 20.66 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.556 2.837 . . . . 0.0 112.707 170.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -82.85 -45.32 14.41 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.504 1.121 . . . . 0.0 109.671 163.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.41 -42.47 98.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 120.579 1.536 . . . . 0.0 111.461 -178.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -57.89 -45.75 85.92 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.029 0.532 . . . . 0.0 111.196 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -69.85 -49.6 50.88 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 119.304 -0.958 . . . . 0.0 109.642 172.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.471 HG22 ' HA2' ' A' ' 47' ' ' GLY . 5.7 t -55.89 -29.11 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-N 119.544 1.065 . . . . 0.0 111.01 -170.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.3 -28.31 69.64 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 174.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -100.46 -22.6 14.96 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.581 1.082 . . . . 0.0 113.12 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' CD ' ' HG2' ' A' ' 49' ' ' GLU . 10.8 ptpt -107.35 3.72 25.63 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.963 0.905 . . . . 0.0 112.712 -177.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.51 49.48 15.96 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.74 1.616 . . . . 0.0 111.047 -172.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 42' ' ' VAL . . . 90.35 -73.26 1.9 Allowed Glycine 0 C--N 1.335 0.495 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.2 m -74.48 107.24 6.5 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.784 -0.708 . . . . 0.0 111.412 -158.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.467 ' HG2' ' CD ' ' A' ' 45' ' ' LYS . 28.8 mt-10 -61.87 141.77 95.24 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 123.663 0.785 . . . . 0.0 111.814 178.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.42 163.8 30.95 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.322 2.014 . . . . 0.0 110.422 168.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.94 90.67 0.64 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.332 2.688 . . . . 0.0 112.056 -172.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -131.0 133.19 45.54 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.503 1.521 . . . . 0.0 108.1 170.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 m -75.01 51.93 0.53 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.199 2.2 . . . . 0.0 112.898 -166.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.22 69.68 0.21 Allowed Glycine 0 C--N 1.338 0.655 0 O-C-N 121.179 -0.951 . . . . 0.0 111.731 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.53 162.89 40.83 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.268 1.027 . . . . 0.0 110.366 177.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -162.84 167.33 22.94 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.111 1.764 . . . . 0.0 108.211 165.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -151.76 178.16 9.66 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 128.478 2.711 . . . . 0.0 104.548 163.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -139.39 158.76 43.6 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.626 1.103 . . . . 0.0 109.986 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.2 tt -154.46 118.36 4.67 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 129.09 2.956 . . . . 0.0 104.811 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -132.93 167.44 20.25 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.812 1.645 . . . . 0.0 107.586 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.33 24.6 0.18 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.05 1.74 . . . . 0.0 112.506 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -144.95 135.74 24.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.326 2.25 . . . . 0.0 107.407 170.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.54 178.44 25.41 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.415 HD12 ' HB2' ' A' ' 73' ' ' ASP . 21.1 pt -135.2 167.5 25.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 125.507 1.523 . . . . 0.0 107.859 167.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -84.07 127.8 34.14 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 122.239 1.019 . . . . 0.0 110.172 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -87.31 130.97 34.4 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 158.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.9 t -75.23 100.59 4.38 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 159.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 144' ' ' ALA . 3.6 tt -66.34 -18.59 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.435 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.9 t -82.11 7.62 12.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.653 0.781 . . . . 0.0 111.147 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 28.9 p -153.49 0.05 0.24 Allowed 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.965 -1.084 . . . . 0.0 113.87 168.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.82 55.24 23.49 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.4 m -153.8 154.45 34.01 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.067 -1.255 . . . . 0.0 109.259 -173.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.415 ' HB2' HD12 ' A' ' 64' ' ' ILE . 15.6 p-10 -85.95 152.21 23.13 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.07 0.948 . . . . 0.0 112.914 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.29 0.2 OUTLIER -146.89 -101.81 0.09 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.518 168.027 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -66.29 138.29 57.53 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.269 0.941 . . . . 0.0 111.19 -164.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -99.11 152.45 19.84 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.465 1.106 . . . . 0.0 108.63 175.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.66 -22.05 31.76 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.99 -29.66 57.69 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.706 1.139 . . . . 0.0 112.411 169.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 t -120.78 54.69 1.06 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.453 1.901 . . . . 0.0 109.466 168.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -140.79 162.21 35.98 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.504 -1.373 . . . . 0.0 110.073 159.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -104.23 120.27 40.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 163.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -138.15 -55.54 0.65 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.822 2.049 . . . . 0.0 108.287 -165.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 t -67.11 173.24 3.89 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.063 0.935 . . . . 0.0 110.167 159.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 52.38 -110.03 1.08 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.428 1.489 . . . . 0.0 110.966 -173.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -66.19 -37.76 86.38 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.455 1.102 . . . . 0.0 112.425 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.79 18.34 17.37 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.371 1.462 . . . . 0.0 116.33 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.86 151.09 97.43 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 117.679 0.74 . . . . 0.0 111.836 -176.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -76.62 62.12 7.06 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.052 3.168 . . . . 0.0 110.968 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.6 p -135.79 155.87 49.69 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.859 0.863 . . . . 0.0 109.29 166.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -156.88 178.29 10.52 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.475 1.11 . . . . 0.0 110.762 -178.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -117.75 -11.44 10.36 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -169.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -149.1 176.86 10.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.631 1.173 . . . . 0.0 110.895 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 4.8 m -129.25 156.54 41.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.133 0 O-C-N 121.136 -0.978 . . . . 0.0 111.371 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.1 p -60.94 -34.03 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.768 1.227 . . . . 0.0 111.166 173.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.2 m 164.6 166.4 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 131.614 3.966 . . . . 0.0 106.628 -175.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -96.4 77.2 2.97 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.152 1.781 . . . . 0.0 107.793 174.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.504 ' CD2' ' H ' ' A' ' 98' ' ' ASN . 5.4 p80 -133.93 -65.23 0.67 Allowed 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.64 -0.663 . . . . 0.0 111.619 -159.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.504 ' H ' ' CD2' ' A' ' 97' ' ' HIS . 0.9 OUTLIER -96.51 16.93 17.35 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.19 1.396 . . . . 0.0 108.935 167.017 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.03 140.64 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 128.315 2.646 . . . . 0.0 107.451 -174.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.417 ' HD3' ' H ' ' A' ' 101' ' ' LEU . 14.4 tppt? -129.24 151.43 49.91 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 128.226 2.61 . . . . 0.0 108.591 -173.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.417 ' H ' ' HD3' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -146.05 154.14 41.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.479 1.911 . . . . 0.0 107.875 -176.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.511 ' HG2' ' CG ' ' A' ' 113' ' ' GLU . 19.3 mmt180 -136.52 121.9 19.37 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -71.04 126.02 28.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 119.473 1.033 . . . . 0.0 110.274 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -128.4 176.98 7.3 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.866 0.841 . . . . 0.0 109.786 158.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.31 14.24 25.02 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.229 2.212 . . . . 0.0 111.542 173.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 t -46.96 -40.55 14.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.408 1.883 . . . . 0.0 115.44 -159.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.6 pp -73.36 -11.25 60.42 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 115.11 -4.81 22.11 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.158 1.837 . . . . 0.0 112.957 -169.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -141.61 -85.35 0.18 Allowed 'General case' 0 C--N 1.349 0.584 0 CA-C-N 120.143 1.971 . . . . 0.0 109.753 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.2 t -144.58 111.68 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -129.56 106.56 8.83 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.678 1.591 . . . . 0.0 108.79 175.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 10.1 m -106.28 141.94 36.78 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.602 -1.189 . . . . 0.0 107.88 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.511 ' CG ' ' HG2' ' A' ' 102' ' ' ARG . 22.2 pt-20 -67.71 160.97 26.98 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.791 1.632 . . . . 0.0 110.691 172.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 99.7 t -141.64 104.04 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 mp -126.19 161.26 28.11 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 123.731 0.812 . . . . 0.0 109.078 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 13.5 m -77.73 106.71 9.72 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 169.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.79 -25.1 10.31 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.259 1.424 . . . . 0.0 113.177 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.559 ' HD3' HD13 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -80.72 -37.29 30.88 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 126.596 1.958 . . . . 0.0 113.149 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 3.9 p -153.82 69.88 0.81 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -161.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.27 58.0 0.25 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 128.086 2.554 . . . . 0.0 113.693 -159.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.7 -147.55 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.738 1.615 . . . . 0.0 112.319 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -70.12 -64.89 0.8 Allowed 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.282 1.433 . . . . 0.0 109.423 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 49.84 -116.84 0.94 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.421 1.889 . . . . 0.0 107.561 -177.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.76 -119.32 0.62 Allowed Glycine 0 CA--C 1.521 0.445 0 CA-C-N 118.501 0.591 . . . . 0.0 112.578 169.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -158.0 177.57 11.17 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 122.453 -0.44 . . . . 0.0 111.155 -170.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.1 p -124.64 145.02 32.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 124.663 1.185 . . . . 0.0 108.884 170.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -140.05 144.67 36.99 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.584 1.554 . . . . 0.0 108.668 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.08 121.12 19.67 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.403 0.547 . . . . 0.0 109.55 173.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.39 -45.15 0.22 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.624 2.37 . . . . 0.0 111.946 -165.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -90.53 -178.34 44.01 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 124.404 1.002 . . . . 0.0 112.935 -170.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.93 155.22 69.22 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.829 2.353 . . . . 0.0 111.017 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.48 ' H ' ' HD2' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -68.89 154.06 95.33 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.908 174.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.07 -36.64 2.45 Favored 'Cis proline' 0 C--N 1.35 0.642 0 CA-C-N 119.506 0.859 . . . . 0.0 111.429 -5.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.51 59.19 1.87 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 127.826 2.451 . . . . 0.0 111.531 -175.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -88.33 -5.79 75.34 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.869 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -98.29 104.37 16.39 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 119.414 1.607 . . . . 0.0 111.048 -166.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.64 94.06 5.62 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.173 1.789 . . . . 0.0 108.347 -173.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -62.33 130.37 44.98 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 160.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 22.1 t -144.02 130.23 19.71 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.3 ptp -142.8 140.95 31.54 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.445 0.698 . . . . 0.0 110.395 -173.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.91 15.5 28.83 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.991 2.116 . . . . 0.0 110.647 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.2 p -65.96 112.0 3.6 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.023 1.729 . . . . 0.0 110.53 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -54.29 -24.84 20.54 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.54 1.136 . . . . 0.0 112.993 164.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.452 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -69.83 2.29 3.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.317 2.247 . . . . 0.0 116.351 -170.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 90.7 mt -87.26 87.02 7.32 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.091 0.859 . . . . 0.0 109.836 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -87.01 126.44 34.74 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.349 1.06 . . . . 0.0 108.785 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -70.87 135.22 47.89 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.327 0.967 . . . . 0.0 109.453 170.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.2 pt -136.44 163.6 48.76 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.33 1.052 . . . . 0.0 109.764 171.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.21 168.73 7.23 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.592 2.195 . . . . 0.0 111.646 161.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.414 ' HA ' ' HD2' ' A' ' 150' ' ' ARG . 6.8 mmm-85 -62.75 -4.74 2.23 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 119.51 3.152 . . . . 0.0 119.51 -158.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 178.11 -62.58 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.195 1 C-N-CA 132.905 4.482 . . . . 0.0 109.552 161.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -156.73 8.26 0.2 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.973 2.909 . . . . 0.0 110.831 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.9 pp -65.54 -14.54 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 119.872 1.214 . . . . 0.0 112.936 170.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 N-CA-C 107.655 -2.178 . . . . 0.0 107.655 159.097 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -126.65 14.78 7.57 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.805 1.242 . . . . 0.0 111.102 171.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -75.38 131.02 39.93 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.993 1.317 . . . . 0.0 111.126 162.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -39.11 163.98 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.51 1 C-N-CA 135.839 5.656 . . . . 0.0 113.046 166.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.4 pt -129.33 136.97 29.97 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.401 1.08 . . . . 0.0 111.901 -168.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.0 120.92 3.87 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.997 2.464 . . . . 0.0 110.454 170.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.83 146.99 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 159.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -126.87 154.81 43.92 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 127.267 2.227 . . . . 0.0 105.621 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.53 91.94 2.53 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 171.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.08 -43.76 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 C-N-CA 123.346 0.659 . . . . 0.0 111.664 -171.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.97 -28.88 58.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.633 0.773 . . . . 0.0 110.904 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 152' ' ' GLN . 7.0 ttmm -87.39 -1.4 57.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.27 1.428 . . . . 0.0 111.091 170.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 53.8 t30 38.15 65.83 0.55 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 128.915 2.886 . . . . 0.0 112.427 -171.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.43 162.34 28.3 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.69 1.996 . . . . 0.0 109.44 176.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 81.7 t -138.9 134.47 42.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 164.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -141.53 97.58 3.19 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.684 1.594 . . . . 0.0 108.311 -172.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.4 ttp -78.94 133.29 36.91 Favored 'General case' 0 C--N 1.339 0.14 0 O-C-N 121.371 -0.831 . . . . 0.0 109.852 175.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.7 t -137.15 161.27 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.558 1.543 . . . . 0.0 107.063 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -58.32 170.26 0.74 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 123.03 1.395 . . . . 0.0 112.54 164.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 -69.49 176.42 3.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.858 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.56 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 2.4 tt -78.45 128.24 38.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 164.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -158.13 97.17 1.5 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.7 mt -138.29 176.21 8.9 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.936 1.294 . . . . 0.0 108.646 -167.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.8 p -88.11 -159.88 0.58 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 164.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -70.04 -48.69 56.93 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.888 1.222 . . . . 0.0 109.313 160.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.67 -12.53 16.68 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 126.58 1.952 . . . . 0.0 114.856 -159.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.41 ' C ' ' H ' ' A' ' 32' ' ' ARG . 12.9 mm-40 -85.0 -48.34 9.34 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 127.028 2.131 . . . . 0.0 110.316 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.437 ' CH2' HD13 ' A' ' 24' ' ' ILE . 61.0 m95 -60.61 8.94 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 128.135 2.574 . . . . 0.0 115.711 -168.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -139.06 -11.29 1.27 Allowed 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 128.928 2.891 . . . . 0.0 111.878 -164.037 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.9 -16.41 3.27 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 118.369 -0.824 . . . . 0.0 112.081 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pt -110.98 13.33 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 119.472 1.033 . . . . 0.0 111.958 172.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -125.01 167.94 14.02 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.006 0.923 . . . . 0.0 111.403 -171.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.2 137.8 74.19 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 123.89 0.876 . . . . 0.0 108.761 169.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -70.13 -3.69 12.76 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.398 2.732 . . . . 0.0 113.23 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -95.01 -30.04 14.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 127.233 2.213 . . . . 0.0 110.328 170.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.05 -48.46 81.66 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 120.975 1.716 . . . . 0.0 111.092 -174.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -59.07 -37.8 77.93 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.524 0.729 . . . . 0.0 111.885 -174.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -81.41 -45.81 15.53 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.869 -0.586 . . . . 0.0 109.827 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.581 HG12 ' HB1' ' A' ' 143' ' ' ALA . 2.8 t -58.59 -28.11 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 120.103 1.319 . . . . 0.0 110.005 -177.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.19 -8.29 23.33 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 173.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.7 ptp180 -119.26 -27.51 5.63 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.429 1.468 . . . . 0.0 111.12 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.6 ptmt -105.0 12.35 32.39 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.07 1.748 . . . . 0.0 112.868 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.47 7.92 1.49 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.669 2.788 . . . . 0.0 115.374 171.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.496 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . 111.55 10.17 19.95 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 118.485 -1.175 . . . . 0.0 114.888 174.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.5 t -125.88 136.87 53.56 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 119.128 1.464 . . . . 0.0 107.596 158.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -89.08 172.12 7.94 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 159.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.28 164.22 31.36 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 122.698 2.265 . . . . 0.0 111.851 168.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.43 -7.91 20.54 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.222 2.615 . . . . 0.0 115.238 -167.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -53.87 -21.49 7.81 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.158 0.983 . . . . 0.0 112.841 171.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 t -128.27 17.05 6.6 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.588 1.155 . . . . 0.0 111.748 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -148.4 91.55 0.14 Allowed Glycine 0 C--N 1.341 0.817 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -174.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -140.54 -55.23 0.52 Allowed 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.61 0.764 . . . . 0.0 110.903 -177.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -66.26 158.46 28.9 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 168.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -152.66 160.67 43.16 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 170.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -135.25 179.4 6.35 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.176 1.79 . . . . 0.0 109.19 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.4 tt -155.52 138.1 15.08 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 159.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.18 165.22 36.36 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.399 0.68 . . . . 0.0 109.273 169.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -76.57 39.38 0.21 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 129.129 2.971 . . . . 0.0 110.853 166.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -136.98 159.65 41.26 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.746 1.218 . . . . 0.0 109.561 -173.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.67 169.78 46.23 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 125.894 1.711 . . . . 0.0 112.402 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.6 pt -128.19 173.32 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 162.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -94.56 119.04 32.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.889 1.275 . . . . 0.0 110.066 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.27 119.98 10.68 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 158.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 2.8 t -74.81 71.44 1.99 Allowed 'General case' 0 C--O 1.236 0.389 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 159.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 tt -62.9 -26.62 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.604 -162.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.6 t -77.65 3.15 14.6 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.334 1.454 . . . . 0.0 112.393 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.3 p -140.54 21.69 2.36 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.318 -0.864 . . . . 0.0 111.464 158.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.35 36.18 52.45 Favored Glycine 0 C--N 1.344 1.026 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.2 m -124.3 177.02 6.08 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.381 2.273 . . . . 0.0 106.907 -170.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -138.25 145.65 41.6 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.647 1.112 . . . . 0.0 109.235 -173.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.43 HD13 ' CD2' ' A' ' 75' ' ' PHE 0.305 0.2 OUTLIER -151.18 -102.2 0.06 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 178.377 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.43 ' CD2' HD13 ' A' ' 74' ' ' LEU . 38.8 m-85 -55.27 150.48 11.13 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -158.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -112.7 143.68 43.49 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.895 0.878 . . . . 0.0 110.726 -174.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.4 m -61.15 -16.63 46.54 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -56.7 -23.26 40.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 120.355 1.434 . . . . 0.0 112.18 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 91' ' ' TYR . 7.1 t -112.96 -3.73 14.02 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.759 0.823 . . . . 0.0 112.384 175.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.418 ' HE2' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -114.8 68.21 0.7 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.958 -1.089 . . . . 0.0 108.134 176.691 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -135.78 49.12 2.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.989 0.916 . . . . 0.0 109.965 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -72.53 95.15 1.77 Allowed 'General case' 0 C--N 1.341 0.206 0 O-C-N 121.626 -0.671 . . . . 0.0 109.505 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.2 t -58.89 134.4 56.89 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.859 0.463 . . . . 0.0 110.287 -175.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.98 -67.93 3.66 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.61 -55.54 17.04 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.03 0.915 . . . . 0.0 111.527 -174.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 56.02 16.03 12.0 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 129.373 3.368 . . . . 0.0 115.871 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -52.39 150.62 8.51 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 125.261 1.424 . . . . 0.0 112.137 171.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.71 71.69 4.7 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.77 2.98 . . . . 0.0 110.384 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.4 p -133.89 152.31 51.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 164.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -131.78 176.45 8.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.816 1.246 . . . . 0.0 109.433 -170.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 79' ' ' THR . 7.5 p90 -124.91 -3.08 7.7 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.239 1.015 . . . . 0.0 112.587 176.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -151.64 -173.26 4.46 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.711 2.004 . . . . 0.0 107.693 -176.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.84 155.34 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 C-N-CA 123.783 0.833 . . . . 0.0 109.304 178.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.6 p -61.46 -33.34 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.382 0.611 . . . . 0.0 110.486 170.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.8 m 168.02 159.82 0.04 OUTLIER 'General case' 0 C--O 1.234 0.279 1 C-N-CA 132.559 4.343 . . . . 0.0 105.075 177.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -101.04 80.9 2.18 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.411 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 17.9 p80 -125.43 -67.04 0.91 Allowed 'General case' 0 C--N 1.347 0.484 0 C-N-CA 126.443 1.897 . . . . 0.0 109.345 -165.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.411 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 0.7 OUTLIER -96.9 22.08 8.79 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 122.071 0.938 . . . . 0.0 112.429 179.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.9 tt -126.61 147.78 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 128.628 2.771 . . . . 0.0 104.847 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -125.14 138.35 54.15 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 122.803 0.441 . . . . 0.0 110.713 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mp -144.41 130.28 19.32 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.964 1.706 . . . . 0.0 109.07 -164.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.494 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 2.3 mpt_? -131.35 111.95 12.31 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 128.364 2.665 . . . . 0.0 105.345 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -74.41 128.44 35.54 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.629 1.571 . . . . 0.0 110.845 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 105' ' ' ARG . 32.0 t0 -134.2 178.01 7.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.095 1.358 . . . . 0.0 109.156 162.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.407 ' CZ ' ' HA ' ' A' ' 104' ' ' ASP . 0.0 OUTLIER -113.62 18.39 17.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.995 1.718 . . . . 0.0 110.544 -178.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.18 -30.56 60.16 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -158.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.85 -12.99 60.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.827 0.739 . . . . 0.0 112.617 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.5 -2.5 23.47 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 126.343 1.925 . . . . 0.0 112.936 -169.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 76.6 mtm -143.47 -81.91 0.18 Allowed 'General case' 0 C--N 1.35 0.605 0 CA-C-N 120.484 2.142 . . . . 0.0 109.629 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 42.9 t -143.08 116.6 3.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -125.44 111.2 14.83 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 126.33 1.852 . . . . 0.0 107.845 168.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.416 ' HB3' HG13 ' A' ' 126' ' ' VAL . 38.3 t -129.25 125.45 36.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 -170.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.494 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 24.1 pt-20 -60.38 159.16 10.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.002 0.819 . . . . 0.0 111.387 -172.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -137.39 106.62 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 171.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.7 mp -120.67 170.28 9.58 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 164.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.1 163.34 12.62 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 118.927 -1.109 . . . . 0.0 108.592 164.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.46 -20.04 66.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.713 168.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.56 ' HG2' ' H ' ' A' ' 24' ' ' ILE . 30.7 tpt85 -148.46 -48.16 0.15 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -176.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 31.8 p -80.74 65.41 5.87 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.686 1.584 . . . . 0.0 108.453 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.39 57.33 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.217 2.607 . . . . 0.0 112.156 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.98 -47.38 52.55 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.648 0.779 . . . . 0.0 111.941 -164.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -169.07 -69.26 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 125.595 1.558 . . . . 0.0 107.601 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.4 mt 52.13 -114.02 0.79 Allowed 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 126.907 2.083 . . . . 0.0 110.846 -171.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.01 -119.45 0.72 Allowed Glycine 0 CA--C 1.525 0.692 0 CA-C-N 119.09 0.859 . . . . 0.0 112.367 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -159.47 163.55 35.22 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 122.299 -0.53 . . . . 0.0 111.17 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.561 HG21 ' HE2' ' A' ' 136' ' ' LYS . 5.5 p -101.49 132.96 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 168.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -131.53 155.57 47.22 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.369 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.06 112.7 3.1 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.253 1.021 . . . . 0.0 109.182 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -144.16 -24.45 0.55 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -171.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -106.45 163.77 13.56 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 123.349 0.5 . . . . 0.0 112.22 -167.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.86 -15.89 10.42 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.831 2.354 . . . . 0.0 114.353 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.5 ptt-85 142.63 165.08 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.945 1 C-N-CA 132.069 4.148 . . . . 0.0 107.181 -159.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.11 -53.11 0.15 OUTLIER 'Cis proline' 0 C--N 1.352 0.752 0 CA-C-N 121.624 1.616 . . . . 0.0 111.269 -9.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.9 p -73.76 -23.72 59.77 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.965 1.306 . . . . 0.0 112.743 -177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.74 5.37 68.9 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.282 0.944 . . . . 0.0 113.832 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.561 ' HE2' HG21 ' A' ' 126' ' ' VAL . 11.8 ptmt -125.44 162.17 25.44 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 119.647 1.723 . . . . 0.0 111.622 -167.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 ttm105 -125.23 109.53 12.95 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.642 1.577 . . . . 0.0 108.116 173.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -74.59 106.46 6.18 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.881 1.673 . . . . 0.0 106.977 165.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 18.2 t -121.94 135.55 54.87 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.561 1.073 . . . . 0.0 109.898 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 13.8 ptp -159.18 161.06 36.14 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.444 0.698 . . . . 0.0 110.754 -171.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -148.29 146.13 28.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.532 0.733 . . . . 0.0 109.426 161.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 91.0 p -171.78 -175.53 1.55 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.572 1.949 . . . . 0.0 107.208 158.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.581 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -60.87 -21.07 62.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.613 1.165 . . . . 0.0 113.163 165.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -72.53 22.03 0.06 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.735 1.614 . . . . 0.0 114.886 -169.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 88.9 mt -130.64 106.05 8.23 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.701 1.137 . . . . 0.0 110.018 -165.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -137.88 140.07 40.2 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.318 1.047 . . . . 0.0 108.788 174.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -76.95 141.38 40.48 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.219 0.918 . . . . 0.0 110.341 168.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.0 pt -137.01 170.53 10.54 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.077 1.751 . . . . 0.0 108.754 165.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.19 165.19 4.33 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.73 2.287 . . . . 0.0 112.783 167.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -45.05 -18.77 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 129.006 2.922 . . . . 0.0 118.341 -165.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -164.29 -78.71 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 171.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.418 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 31.8 mm-40 -149.71 42.05 0.87 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.99 2.516 . . . . 0.0 104.637 163.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.9 pp -76.39 -25.12 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 O-C-N 120.802 -1.186 . . . . 0.0 111.907 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.935 0 CA-C-O 117.306 -1.83 . . . . 0.0 110.542 175.528 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 9.2 tpt . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -74.9 134.71 41.56 Favored 'General case' 0 C--N 1.337 0.062 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 170.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -154.77 -173.36 4.54 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.027 1.331 . . . . 0.0 107.583 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -97.75 178.4 5.16 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.247 1.019 . . . . 0.0 109.059 162.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.576 HD12 HD21 ' A' ' 98' ' ' ASN . 1.3 pt -129.35 125.74 22.65 Favored Pre-proline 0 N--CA 1.452 -0.332 0 C-N-CA 125.595 1.558 . . . . 0.0 110.78 174.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.83 143.35 36.91 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 121.628 1.552 . . . . 0.0 110.384 164.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.8 mt -126.23 98.94 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.4 103.26 14.64 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.073 0.949 . . . . 0.0 108.546 -171.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.406 ' OG ' ' OD2' ' A' ' 151' ' ' ASP . 72.7 m -72.83 76.93 1.14 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.826 173.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.8 p -56.31 -39.63 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 118.709 0.686 . . . . 0.0 110.585 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.55 -12.66 10.55 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.301 1.84 . . . . 0.0 113.907 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' A' ' 151' ' ' ASP . 39.4 mtmt -128.68 7.73 5.74 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.503 1.521 . . . . 0.0 111.639 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.5 t30 32.76 74.0 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.948 2.499 . . . . 0.0 112.801 -159.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.41 167.86 20.55 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.9 p -139.52 142.97 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 164.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -125.15 165.59 17.97 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 158.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 46.7 ttm -132.47 133.97 44.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.4 t -137.98 161.0 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 -171.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -72.87 161.97 30.06 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 119.774 -1.829 . . . . 0.0 112.429 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.24 142.13 58.4 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 161.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.3 tt -60.48 137.07 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 125.002 1.321 . . . . 0.0 109.414 -176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -150.44 114.17 5.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 103.396 -2.816 . . . . 0.0 103.396 171.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.2 mt -137.87 -159.54 0.97 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.518 1.527 . . . . 0.0 108.357 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.0 m -144.56 175.31 10.23 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.437 -1.415 . . . . 0.0 107.65 162.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.28 -41.08 60.19 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.341 1.457 . . . . 0.0 113.363 -159.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.419 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 2.1 m-20 -77.06 -18.44 58.05 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -175.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -66.45 -47.27 73.71 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.965 0.802 . . . . 0.0 109.834 -176.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -62.12 15.23 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.285 2.234 . . . . 0.0 115.889 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.419 ' NE ' ' HA ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -133.22 -9.41 2.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 170.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -122.63 -17.56 6.88 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.19 0.905 . . . . 0.0 112.619 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 pt -110.75 19.01 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 118.949 0.795 . . . . 0.0 111.483 169.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -127.27 166.58 17.5 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.271 1.028 . . . . 0.0 111.534 -173.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.412 ' CG ' HH12 ' A' ' 66' ' ' ARG . 0.9 OUTLIER -58.62 137.56 86.22 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 163.352 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -67.83 -16.48 45.95 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.334 2.022 . . . . 0.0 112.245 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 3.7 tt0 -73.49 -42.47 61.8 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.753 -0.592 . . . . 0.0 109.856 170.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.51 -38.16 80.21 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.271 0.941 . . . . 0.0 111.125 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -54.92 -56.48 19.09 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.81 0.844 . . . . 0.0 110.824 172.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.41 ' HG2' ' HA ' ' A' ' 38' ' ' GLU . 27.6 ptt180 -63.65 -45.65 89.22 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.683 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.7 t -51.69 -37.8 20.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 125.091 1.356 . . . . 0.0 109.952 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.34 -10.84 18.28 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 176.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.62 -17.22 11.19 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.812 1.187 . . . . 0.0 113.46 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -116.1 8.77 14.57 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.254 1.022 . . . . 0.0 112.028 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.37 -30.77 0.08 Allowed 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 130.241 3.416 . . . . 0.0 113.561 -164.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -178.19 -87.89 0.07 OUTLIER Glycine 0 C--N 1.336 0.582 0 C-N-CA 126.365 1.936 . . . . 0.0 109.486 -170.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.1 t -123.72 117.65 25.45 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 105.307 -2.108 . . . . 0.0 105.307 164.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -55.72 132.15 72.26 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.263 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.47 119.87 5.95 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.874 2.382 . . . . 0.0 110.382 -175.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.19 -23.32 28.99 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.076 1.85 . . . . 0.0 112.376 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -161.94 -26.15 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.836 1.654 . . . . 0.0 111.064 168.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.5 t -143.0 169.86 16.78 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.981 1.313 . . . . 0.0 108.395 170.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -122.87 100.12 0.67 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.41 147.95 40.49 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.437 1.095 . . . . 0.0 108.293 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -152.76 159.33 43.11 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -141.03 157.77 44.87 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.976 1.71 . . . . 0.0 106.486 172.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -118.49 169.58 9.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.449 0.643 . . . . 0.0 110.081 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.8 mt -117.02 -171.73 2.08 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.002 1.721 . . . . 0.0 107.265 163.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -141.55 138.22 32.55 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -154.48 172.15 18.24 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.676 1.59 . . . . 0.0 108.408 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.59 107.63 3.02 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.335 1.454 . . . . 0.0 111.213 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 170.66 179.32 41.91 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -173.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.2 pt -122.72 170.9 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.522 0.729 . . . . 0.0 109.617 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -97.89 143.93 27.97 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.144 0.978 . . . . 0.0 109.858 -174.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 34.2 ttt180 -127.62 146.68 50.46 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.669 1.188 . . . . 0.0 109.139 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 10.6 t -102.04 94.42 5.76 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 175.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.488 HG22 ' HA ' ' A' ' 144' ' ' ALA . 5.2 tt -58.11 -31.07 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 124.82 1.248 . . . . 0.0 111.371 -174.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.1 t -75.78 5.7 5.95 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.266 1.826 . . . . 0.0 111.906 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.8 p -144.06 10.63 1.53 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.741 1.216 . . . . 0.0 111.57 162.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.4 11.08 45.93 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.384 1.945 . . . . 0.0 114.712 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.0 m -114.44 142.99 45.65 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.351 1.576 . . . . 0.0 110.646 -159.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.459 ' C ' HD23 ' A' ' 74' ' ' LEU . 9.7 p-10 -95.53 147.93 23.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.467 1.507 . . . . 0.0 112.584 -178.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.482 HD22 ' HB3' ' A' ' 98' ' ' ASN 0.311 0.2 OUTLIER -152.98 -98.16 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.34 1.056 . . . . 0.0 113.666 173.485 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -49.96 131.15 22.71 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -159.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -69.64 132.1 45.66 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.447 -0.783 . . . . 0.0 109.124 171.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.8 m -62.95 -20.57 65.36 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.14 -12.57 41.09 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.202 1.365 . . . . 0.0 113.264 172.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 73.3 p -74.32 -25.27 59.45 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.552 -0.718 . . . . 0.0 111.886 166.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -121.69 95.07 4.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.321 1.848 . . . . 0.0 109.564 -168.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -141.93 116.07 9.41 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -137.75 110.77 7.75 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 171.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.9 p -63.48 103.16 0.49 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.127 1.371 . . . . 0.0 111.295 -167.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.47 -47.63 1.43 Allowed Glycine 0 CA--C 1.523 0.589 0 C-N-CA 124.744 1.164 . . . . 0.0 111.245 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -53.99 25.16 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.401 0.68 . . . . 0.0 110.469 177.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 47.16 23.66 1.84 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.933 2.206 . . . . 0.0 115.196 -167.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -54.66 153.28 11.01 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 118.966 1.383 . . . . 0.0 112.338 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.35 71.71 2.35 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.866 3.044 . . . . 0.0 112.26 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.9 p -133.81 149.97 51.41 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 158.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -147.24 173.46 12.53 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.66 1.184 . . . . 0.0 109.095 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -113.34 -13.6 12.88 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.473 -0.775 . . . . 0.0 112.832 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -155.27 -179.05 7.71 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.222 1.409 . . . . 0.0 108.349 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.07 166.71 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.586 1.554 . . . . 0.0 111.153 -175.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.54 -50.46 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.592 0.757 . . . . 0.0 109.534 168.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.4 m 172.81 162.58 0.12 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 130.518 3.527 . . . . 0.0 106.362 176.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -85.45 65.88 9.41 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -111.78 -56.78 2.34 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 124.753 1.221 . . . . 0.0 108.173 -173.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.576 HD21 HD12 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -100.66 4.15 43.02 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 175.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.32 131.42 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -107.96 140.98 40.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.387 1.475 . . . . 0.0 107.562 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.01 155.33 49.38 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.572 1.549 . . . . 0.0 109.77 175.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.36 131.54 36.5 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 128.561 2.744 . . . . 0.0 104.138 165.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.42 150.15 45.25 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 171.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.408 ' OD2' ' OG ' ' A' ' 106' ' ' SER . 53.0 t0 -148.3 140.24 23.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 158.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 16.39 0.07 Allowed 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.644 -1.285 . . . . 0.0 112.355 172.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.408 ' OG ' ' OD2' ' A' ' 104' ' ' ASP . 0.4 OUTLIER -43.51 -61.56 1.34 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 127.419 2.288 . . . . 0.0 113.149 -158.675 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pp -58.95 -14.34 8.95 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.389 1.076 . . . . 0.0 113.618 -177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 118.83 -4.9 14.25 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 126.651 2.072 . . . . 0.0 111.893 -172.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -141.02 -84.64 0.2 Allowed 'General case' 0 C--N 1.348 0.538 0 CA-C-N 119.645 1.723 . . . . 0.0 109.018 -174.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.2 t -147.13 108.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -173.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.412 ' HE ' ' CD2' ' A' ' 125' ' ' HIS . 44.2 ttt180 -131.17 83.31 2.1 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.478 1.511 . . . . 0.0 110.785 176.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 1.4 m -85.14 137.16 33.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.879 -0.581 . . . . 0.0 109.771 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -67.05 157.33 33.8 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.21 0.914 . . . . 0.0 111.132 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.4 t -133.82 107.13 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -129.81 154.27 47.41 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 27.8 t -69.59 137.0 51.97 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -70.43 -17.37 63.0 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.419 ' CG ' HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -104.98 -37.22 7.05 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.205 1.802 . . . . 0.0 112.781 -173.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 29.6 p -135.04 74.64 1.53 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 123.551 1.644 . . . . 0.0 108.337 171.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.82 55.93 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 1 C-N-CA 133.697 4.799 . . . . 0.0 113.462 172.334 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -112.05 -57.95 2.2 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 114.992 1.478 . . . . 0.0 114.992 -159.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -138.54 -89.26 0.22 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.257 0.935 . . . . 0.0 109.678 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.422 ' HA ' ' HG3' ' A' ' 140' ' ' MET . 3.8 mt 58.94 -120.24 1.08 Allowed 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.705 2.002 . . . . 0.0 109.88 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -174.96 -125.07 0.84 Allowed Glycine 0 CA--C 1.522 0.509 0 CA-C-N 118.972 0.805 . . . . 0.0 112.962 -176.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.412 ' CD2' ' HE ' ' A' ' 111' ' ' ARG . 31.9 p-80 -161.2 179.07 8.66 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.169 0.587 . . . . 0.0 110.569 -172.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.582 HG21 ' HE2' ' A' ' 136' ' ' LYS . 2.8 p -129.62 143.24 41.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.767 1.227 . . . . 0.0 108.936 172.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -139.37 154.77 47.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.841 1.256 . . . . 0.0 109.219 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -72.84 113.76 10.23 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -164.93 -46.97 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.461 1.504 . . . . 0.0 111.48 -168.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -64.52 167.91 27.74 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.249 0.452 . . . . 0.0 112.508 -176.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.55 177.16 7.79 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.594 2.196 . . . . 0.0 110.999 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -57.0 146.48 59.76 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 160.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.18 -52.6 0.16 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.529 0 CA-C-N 120.103 1.073 . . . . 0.0 114.641 15.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 17.5 p -77.95 -24.07 48.29 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -164.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.65 5.72 86.38 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-O 119.278 -0.734 . . . . 0.0 113.684 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.582 ' HE2' HG21 ' A' ' 126' ' ' VAL . 8.6 ptmt -132.9 159.81 38.83 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 119.38 1.59 . . . . 0.0 111.787 -168.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.2 ttm105 -125.07 109.17 12.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.759 1.624 . . . . 0.0 106.69 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -72.04 128.45 35.74 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 160.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 17.5 t -135.73 135.88 40.36 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.786 1.234 . . . . 0.0 108.282 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.422 ' HG3' ' HA ' ' A' ' 123' ' ' LEU . 35.1 ttm -140.04 156.5 46.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 122.276 1.036 . . . . 0.0 109.824 -165.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.58 104.11 4.33 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 126.469 1.908 . . . . 0.0 105.921 173.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 58.1 p -153.65 157.49 39.69 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 162.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.14 -25.01 54.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.488 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -67.56 4.91 0.91 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.745 2.018 . . . . 0.0 115.855 -159.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 83.4 mt -90.84 87.97 6.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.084 1.354 . . . . 0.0 109.674 -159.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -93.26 133.68 36.24 Favored 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -71.43 146.33 48.72 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 159.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 19.6 pt -137.84 166.27 27.48 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.818 1.247 . . . . 0.0 107.977 166.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.36 173.3 0.71 Allowed 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.419 2.079 . . . . 0.0 111.696 164.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -52.66 -17.81 1.48 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 117.98 2.585 . . . . 0.0 117.98 -163.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.416 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 5.0 t70 -175.66 -77.28 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.546 2.338 . . . . 0.0 107.199 170.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -144.4 17.67 1.7 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.353 2.261 . . . . 0.0 110.175 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -74.0 -9.74 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.205 -0.934 . . . . 0.0 112.348 173.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.513 0 N-CA-C 106.935 -2.466 . . . . 0.0 106.935 159.271 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 31.8 tpp . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -73.84 57.01 0.59 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.651 1.18 . . . . 0.0 110.802 174.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -151.08 -175.21 5.06 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.69 1.196 . . . . 0.0 108.344 165.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.59 169.48 0.32 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 128.73 2.812 . . . . 0.0 113.902 172.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 15.8 pt -123.46 128.22 25.3 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.953 1.301 . . . . 0.0 110.556 -171.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.58 108.76 2.63 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.29 2.66 . . . . 0.0 109.747 172.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.473 ' HA ' ' HD1' ' A' ' 97' ' ' HIS . 2.5 mp -86.84 155.95 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 167.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -135.45 101.53 4.84 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.896 1.279 . . . . 0.0 108.71 -175.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.8 m -65.84 79.61 0.08 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 161.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.5 p -56.21 -41.92 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.041 0.936 . . . . 0.0 110.54 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.07 -12.03 10.55 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.388 1.475 . . . . 0.0 114.216 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.93 12.47 6.2 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.387 1.475 . . . . 0.0 110.925 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 33.57 59.15 0.52 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.105 2.562 . . . . 0.0 112.208 -167.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.8 mtp85 -106.48 169.13 8.7 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 173.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.9 t -137.6 97.94 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 168.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -98.89 81.97 2.7 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.882 1.673 . . . . 0.0 108.286 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 43.4 ttp -66.51 127.9 34.12 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.639 -0.663 . . . . 0.0 110.551 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 63.7 t -129.47 142.42 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 125.164 1.386 . . . . 0.0 108.278 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -78.99 144.1 35.06 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.399 0.619 . . . . 0.0 110.211 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 mtm105 -65.74 148.16 52.21 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.204 -160.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.91 114.87 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.286 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 168.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -145.84 102.1 3.62 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 102.626 -3.101 . . . . 0.0 102.626 170.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.7 mt -136.65 175.27 9.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.719 0.808 . . . . 0.0 109.72 -168.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.1 t -102.16 163.71 12.09 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 162.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -54.88 -30.89 59.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.04 0.936 . . . . 0.0 111.182 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.91 -27.6 60.96 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.013 2.525 . . . . 0.0 112.634 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -85.51 -45.31 11.92 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.796 1.238 . . . . 0.0 110.68 -170.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -60.61 14.15 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.749 2.42 . . . . 0.0 115.443 -174.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.29 -14.35 5.39 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.143 1.377 . . . . 0.0 113.701 172.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.34 -12.75 4.47 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.43 -172.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 pt -112.82 14.62 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 118.732 0.696 . . . . 0.0 111.356 167.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -117.32 171.84 7.7 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.192 1.397 . . . . 0.0 110.415 -175.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.93 143.01 88.33 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 165.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -70.58 -10.66 28.37 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.974 2.45 . . . . 0.0 111.875 168.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -75.61 -46.62 30.63 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 125.004 1.322 . . . . 0.0 109.889 165.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.89 -41.62 87.61 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 119.859 1.209 . . . . 0.0 110.675 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -57.21 -44.21 83.51 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.713 1.205 . . . . 0.0 112.014 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -80.1 -41.6 25.21 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 118.79 0.723 . . . . 0.0 110.16 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.54 HG12 ' HB1' ' A' ' 143' ' ' ALA . 23.9 t -52.75 -31.78 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 126.355 1.862 . . . . 0.0 109.728 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.77 -19.6 64.16 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 173.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.98 -31.85 12.88 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 120.057 1.299 . . . . 0.0 111.594 173.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -103.16 1.48 33.23 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.46 1.104 . . . . 0.0 113.371 -169.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.23 3.08 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.998 2.519 . . . . 0.0 114.712 -168.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.416 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . 148.61 -38.09 1.01 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 125.893 1.711 . . . . 0.0 113.168 174.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.5 t -150.09 127.82 11.69 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.334 1.567 . . . . 0.0 110.476 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -67.46 -60.2 6.04 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.749 1.22 . . . . 0.0 110.105 167.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -80.77 168.58 17.49 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.305 2.003 . . . . 0.0 111.355 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -68.48 175.99 6.3 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.659 2.24 . . . . 0.0 110.45 159.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -137.49 166.04 24.82 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.308 1.043 . . . . 0.0 109.631 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.9 m -141.35 146.21 36.38 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -172.15 56.49 0.17 Allowed Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -58.67 -25.87 63.25 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -175.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.03 166.88 31.65 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.186 2.194 . . . . 0.0 106.412 168.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -149.4 -60.37 0.22 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 169.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -145.71 -167.26 2.66 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.727 2.411 . . . . 0.0 107.115 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.9 tp -145.48 42.88 1.28 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.077 0.951 . . . . 0.0 110.167 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.35 -176.82 4.08 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.446 1.099 . . . . 0.0 111.545 -176.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -106.76 101.36 10.81 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 129.074 2.95 . . . . 0.0 109.593 -172.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -142.0 153.05 43.98 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 164.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.8 153.13 11.49 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 125.444 1.497 . . . . 0.0 113.031 158.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.7 pt -130.05 154.17 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 162.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.68 126.46 32.37 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -80.36 114.27 19.15 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 158.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 19.7 t -65.11 85.07 0.05 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 162.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.9 tt -66.78 -22.92 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 122.061 -0.399 . . . . 0.0 110.487 -169.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 143' ' ' ALA . 64.7 m -61.42 -8.65 4.28 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.797 1.639 . . . . 0.0 113.704 169.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 21.4 p -138.88 15.94 2.67 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.893 1.224 . . . . 0.0 111.647 160.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.99 17.11 21.27 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.293 -1.282 . . . . 0.0 113.961 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.1 m -121.23 143.07 49.34 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.14 1.47 . . . . 0.0 108.95 -164.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.9 167.93 19.99 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.453 HD13 ' CD2' ' A' ' 75' ' ' PHE . 0.3 OUTLIER 176.08 -160.1 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 131.35 3.86 . . . . 0.0 109.001 172.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.453 ' CD2' HD13 ' A' ' 74' ' ' LEU . 5.0 m-85 0.14 107.52 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 131.548 3.939 . . . . 0.0 117.023 -165.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.12 144.58 57.0 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.454 1.502 . . . . 0.0 111.13 171.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.8 m -56.46 -30.47 62.93 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.59 -22.14 66.89 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -175.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 p -93.0 -7.37 46.02 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.729 0.695 . . . . 0.0 111.637 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.93 47.63 2.38 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.86 2.064 . . . . 0.0 108.819 -159.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -117.39 60.92 0.75 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.967 0.907 . . . . 0.0 109.666 -167.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -68.3 97.24 0.72 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.0 m -57.3 117.93 4.59 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.147 0.979 . . . . 0.0 112.039 -164.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.88 -49.86 4.29 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 124.354 0.978 . . . . 0.0 112.102 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.7 -43.97 91.77 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.208 1.004 . . . . 0.0 111.878 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 41.5 35.76 1.38 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 128.833 3.111 . . . . 0.0 114.662 -159.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.5 150.11 5.07 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 126.063 1.745 . . . . 0.0 110.243 175.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -75.96 69.91 6.1 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.564 2.842 . . . . 0.0 110.769 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.6 p -144.96 152.39 40.1 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.752 1.621 . . . . 0.0 108.821 -177.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -142.95 168.48 19.61 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.88 1.272 . . . . 0.0 109.085 -176.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -115.84 -9.75 11.8 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 118.811 -0.614 . . . . 0.0 112.445 178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -156.64 176.02 13.28 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.846 1.259 . . . . 0.0 107.925 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.6 t -125.99 149.12 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.627 0.771 . . . . 0.0 110.907 -162.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.6 p -56.54 -54.65 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 126.452 1.901 . . . . 0.0 110.769 171.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.0 m 169.8 164.1 0.06 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 130.669 3.588 . . . . 0.0 107.282 175.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 mp0 -76.92 64.55 2.45 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.823 1.649 . . . . 0.0 109.508 173.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.473 ' HD1' ' HA ' ' A' ' 10' ' ' ILE . 18.5 p80 -115.41 -54.79 2.51 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.879 0.872 . . . . 0.0 109.284 -170.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -121.38 14.24 11.16 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.463 1.105 . . . . 0.0 111.859 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.88 150.77 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.807 1.643 . . . . 0.0 108.846 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -123.27 150.32 43.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.876 2.07 . . . . 0.0 110.771 -174.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 65.4 mt -145.72 137.14 24.98 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 127.804 2.442 . . . . 0.0 110.298 -166.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.98 117.25 11.28 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 129.102 2.961 . . . . 0.0 105.879 159.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -104.08 144.26 31.8 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.242 1.017 . . . . 0.0 110.869 -174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -152.62 179.44 8.61 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.946 2.499 . . . . 0.0 108.11 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.51 27.52 8.29 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.704 -1.248 . . . . 0.0 111.43 173.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.74 -38.9 67.71 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -159.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 pp -75.86 -9.41 58.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.16 6.09 37.03 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 117.579 -1.678 . . . . 0.0 112.781 -168.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 13.3 tpt -145.67 -91.23 0.1 Allowed 'General case' 0 C--N 1.349 0.567 0 CA-C-N 120.298 2.049 . . . . 0.0 109.212 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.3 t -139.37 119.68 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 172.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.424 HH21 ' CE1' ' A' ' 125' ' ' HIS . 17.5 ttt180 -121.83 128.23 51.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 165.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 43.3 t -124.49 142.55 51.24 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 168.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -67.61 162.68 22.98 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.886 170.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 73.2 t -136.81 108.67 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 169.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -125.29 173.09 9.05 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 168.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 39.6 t -71.29 159.59 34.32 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.448 -0.783 . . . . 0.0 108.985 171.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -81.55 -13.89 57.51 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 170.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -115.94 -58.44 2.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 173.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.2 p -94.71 62.39 2.73 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.8 51.29 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 128.362 2.665 . . . . 0.0 113.434 -168.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -89.38 -71.77 0.59 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.787 1.235 . . . . 0.0 113.359 -167.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -130.79 -83.93 0.53 Allowed 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.761 0.824 . . . . 0.0 109.135 -165.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mt 50.66 -108.88 0.37 Allowed 'General case' 0 C--N 1.338 0.097 0 C-N-CA 126.89 2.076 . . . . 0.0 109.989 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.23 -125.42 0.94 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.586 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.424 ' CE1' HH21 ' A' ' 111' ' ' ARG . 20.3 p-80 -162.42 178.97 8.17 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.387 -0.478 . . . . 0.0 110.468 -170.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.571 HG21 ' HE2' ' A' ' 136' ' ' LYS . 2.9 p -129.5 143.25 41.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 124.72 1.208 . . . . 0.0 108.89 172.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -133.79 150.79 51.45 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 124.225 0.953 . . . . 0.0 110.744 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -64.13 106.83 1.14 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.048 1.339 . . . . 0.0 109.333 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -167.57 -48.53 0.02 OUTLIER 'General case' 0 C--N 1.342 0.281 0 C-N-CA 125.082 1.353 . . . . 0.0 111.472 -169.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -65.18 172.37 21.8 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.785 0.707 . . . . 0.0 113.408 -170.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -69.83 167.84 23.38 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.253 1.969 . . . . 0.0 111.348 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -61.63 151.6 77.73 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 162.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.33 -47.67 0.3 Allowed 'Cis proline' 0 C--N 1.347 0.472 0 CA-C-N 119.944 1.016 . . . . 0.0 114.182 14.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.2 p -73.96 -26.28 60.4 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -166.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.72 5.62 79.46 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 119.184 0.902 . . . . 0.0 113.678 -178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.571 ' HE2' HG21 ' A' ' 126' ' ' VAL . 10.3 ptmt -130.23 156.83 43.96 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.983 1.391 . . . . 0.0 111.275 -168.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 14.7 ttt85 -125.27 103.83 8.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.271 1.828 . . . . 0.0 108.234 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -73.89 141.19 46.06 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.105 1.362 . . . . 0.0 107.346 167.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 53.7 t -142.92 136.13 28.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.319 1.847 . . . . 0.0 107.703 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 6.8 ttt -144.71 141.54 29.37 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.744 0.818 . . . . 0.0 108.976 -174.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -148.11 93.48 2.18 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.589 1.156 . . . . 0.0 108.917 -170.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 77.3 p -163.27 -173.41 3.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 167.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.54 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -56.75 -21.31 27.32 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.225 1.41 . . . . 0.0 114.183 168.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.34 26.29 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.725 2.41 . . . . 0.0 115.98 -164.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 62.3 mt -121.33 38.33 4.11 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.744 1.218 . . . . 0.0 111.852 -162.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -75.47 108.99 8.64 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 174.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -64.19 140.18 58.84 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.477 -0.764 . . . . 0.0 109.207 163.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 13.3 pt -128.01 165.25 31.8 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 159.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -53.34 163.08 2.65 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.584 2.856 . . . . 0.0 112.976 166.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -15.76 -53.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 129.669 3.188 . . . . 0.0 114.865 173.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -157.08 -67.68 0.1 Allowed 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 127.313 2.245 . . . . 0.0 111.283 159.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -144.17 1.42 1.1 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.353 1.461 . . . . 0.0 110.9 -163.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.06 -19.03 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.189 1.796 . . . . 0.0 114.56 -170.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.958 0 CA-C-O 116.951 -2.027 . . . . 0.0 109.529 -177.523 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -146.55 58.51 1.2 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.913 1.285 . . . . 0.0 107.623 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -135.61 -158.51 0.88 Allowed 'General case' 0 C--O 1.232 0.184 0 C-N-CA 125.493 1.517 . . . . 0.0 108.505 -162.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 8.6 ttt85 -117.02 162.36 17.92 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 123.982 0.913 . . . . 0.0 110.019 169.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.509 HD11 ' HD3' ' A' ' 118' ' ' ARG . 7.7 pt -136.45 146.94 57.95 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 113.89 -1.505 . . . . 0.0 112.259 -177.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.86 134.12 10.56 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.71 2.94 . . . . 0.0 111.485 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.4 mm -114.58 100.11 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 127.053 2.141 . . . . 0.0 105.737 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -100.4 124.18 45.57 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.9 m -101.8 87.1 3.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -54.01 -39.3 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.679 0.791 . . . . 0.0 111.255 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.645 ' HB1' ' HD2' ' A' ' 150' ' ' ARG . . . -52.65 -25.58 11.21 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.286 2.234 . . . . 0.0 114.78 178.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -124.71 7.1 8.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.763 2.025 . . . . 0.0 111.348 175.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 33.44 63.1 0.37 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.53 2.332 . . . . 0.0 111.638 -161.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 38.5 mtp-105 -109.87 164.28 12.73 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.1 p -134.85 144.92 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 158.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -136.71 165.55 25.64 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 158.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.7 ttp -127.66 116.98 21.12 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -170.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.4 t -126.76 139.12 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.044 1.738 . . . . 0.0 107.64 -160.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 7' ' ' ARG 0.284 3.5 pm0 -89.53 148.87 23.15 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 122.234 1.016 . . . . 0.0 112.42 -169.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.484 ' HG2' HH11 ' A' ' 23' ' ' ARG . 0.0 OUTLIER -66.93 146.18 54.66 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.329 -162.503 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.13 118.81 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -167.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -137.73 101.83 4.57 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.487 1.515 . . . . 0.0 107.388 173.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.437 HD11 HD11 ' A' ' 34' ' ' ILE . 40.9 mt -134.15 177.83 7.44 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 127.227 2.211 . . . . 0.0 106.83 166.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.6 t -162.73 -14.84 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 -176.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 30' ' ' GLU . 8.4 t70 -118.63 -146.51 0.39 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.623 1.102 . . . . 0.0 109.576 -171.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.7 5.35 0.12 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.841 1.657 . . . . 0.0 113.643 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 28' ' ' ASP . 27.8 mt-10 -62.79 -44.61 95.73 Favored 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 125.577 1.551 . . . . 0.0 110.728 -163.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -68.58 45.03 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 128.334 2.654 . . . . 0.0 112.179 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.38 -44.35 0.07 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.469 1.908 . . . . 0.0 108.878 160.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -75.22 -27.19 59.44 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.446 -0.788 . . . . 0.0 112.305 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.437 HD11 HD11 ' A' ' 26' ' ' LEU . 4.6 pt -110.83 28.18 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 119.377 0.99 . . . . 0.0 111.847 176.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.3 mt -117.93 166.57 12.34 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 125.133 1.373 . . . . 0.0 111.511 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.506 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 5.2 m-20 -61.35 146.76 88.61 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 163.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -67.3 -9.71 26.15 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.471 2.114 . . . . 0.0 112.327 169.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -78.63 -51.83 9.32 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.973 1.709 . . . . 0.0 109.95 163.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.506 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -58.67 -37.93 77.08 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.45 1.477 . . . . 0.0 110.451 -176.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -52.6 -52.9 53.2 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.896 1.278 . . . . 0.0 111.84 173.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.402 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 19.4 ptp180 -77.21 -45.08 27.75 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.596 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.855 HG12 ' HB1' ' A' ' 143' ' ' ALA . 54.9 t -53.72 -31.15 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.56 1.144 . . . . 0.0 110.13 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.59 -18.31 64.77 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 174.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -102.34 -37.03 8.24 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 120.383 1.447 . . . . 0.0 112.43 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 41' ' ' ARG . 18.0 ptpt -97.29 2.95 51.34 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.798 1.239 . . . . 0.0 113.2 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.69 13.82 0.55 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.773 2.429 . . . . 0.0 114.437 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.45 -86.39 0.14 Allowed Glycine 0 C--N 1.339 0.711 0 C-N-CA 125.645 1.593 . . . . 0.0 109.381 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.1 m -129.49 122.8 30.01 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -170.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -57.16 -61.86 6.3 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.025 0.93 . . . . 0.0 110.268 173.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.42 172.03 17.12 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.767 2.311 . . . . 0.0 111.149 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -63.95 170.44 8.86 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.241 1.961 . . . . 0.0 111.14 165.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -141.13 168.72 19.11 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.152 0.981 . . . . 0.0 110.071 -173.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.6 m -143.69 155.52 44.25 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.63 1.572 . . . . 0.0 107.353 -172.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.02 34.89 0.4 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.436 1.494 . . . . 0.0 114.324 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.31 -36.13 52.41 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.732 2.013 . . . . 0.0 111.5 -171.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -73.65 -39.38 64.52 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 118.198 -0.906 . . . . 0.0 112.197 -174.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -168.21 131.44 1.54 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.014 0.824 . . . . 0.0 110.42 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -155.51 83.42 1.04 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 159.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 pp -158.46 -38.71 0.06 Allowed 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -168.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -160.31 177.37 10.69 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.722 1.146 . . . . 0.0 108.364 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -86.58 63.3 7.9 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 127.624 2.37 . . . . 0.0 109.687 -159.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -136.34 159.97 40.14 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 122.109 0.957 . . . . 0.0 113.088 172.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.23 154.64 25.53 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 128.558 2.98 . . . . 0.0 110.1 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.6 pt -140.07 174.7 7.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.724 1.21 . . . . 0.0 109.327 173.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -99.79 108.34 20.61 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.564 1.146 . . . . 0.0 110.285 -177.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.54 122.96 20.08 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 158.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.496 ' HB2' HD11 ' A' ' 74' ' ' LEU . 40.5 t -72.16 90.39 1.21 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 158.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.701 HD12 ' HD2' ' A' ' 146' ' ' LYS . 17.1 tt -65.15 -21.42 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 O-C-N 121.984 -0.447 . . . . 0.0 111.092 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.3 t -72.66 -0.25 12.52 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.12 1.768 . . . . 0.0 111.859 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.7 p -143.82 9.5 1.54 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.427 1.012 . . . . 0.0 113.334 160.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 56.76 55.36 30.44 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 -176.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 73' ' ' ASP . 49.2 m -151.95 179.08 8.77 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.75 -1.441 . . . . 0.0 108.467 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.44 ' C ' HD13 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -132.5 141.27 48.7 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.135 1.374 . . . . 0.0 108.487 -163.598 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 67' ' ' CYS 0.283 0.0 OUTLIER -151.23 -89.55 0.06 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 177.8 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -54.29 151.65 7.17 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.263 1.025 . . . . 0.0 112.96 -170.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.431 ' OD2' ' HB2' ' A' ' 14' ' ' ALA . 12.0 t70 -126.32 150.75 48.31 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.743 1.217 . . . . 0.0 111.099 -166.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.4 t -59.94 -23.06 63.25 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.053 -1.451 . . . . 0.0 113.739 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -60.54 -19.69 57.98 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 120.953 1.706 . . . . 0.0 112.583 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.422 ' HA ' ' CE2' ' A' ' 91' ' ' TYR 0.253 2.2 t -119.65 -3.76 10.32 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.401 1.48 . . . . 0.0 111.035 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -96.51 94.45 7.38 Favored 'General case' 0 C--N 1.344 0.36 0 O-C-N 120.739 -1.226 . . . . 0.0 109.781 -175.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -63.22 127.33 30.78 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 163.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.547 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 1.7 t70 -147.13 -58.92 0.27 Allowed 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 127.474 2.31 . . . . 0.0 107.322 -163.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.8 m -51.89 111.78 0.67 Allowed 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.519 1.527 . . . . 0.0 111.401 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.07 -43.19 0.64 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 126.333 1.92 . . . . 0.0 114.743 174.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.3 m -81.93 -72.0 0.46 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.041 1.336 . . . . 0.0 108.88 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 82' ' ' ASP . . . 48.46 45.24 29.21 Favored Glycine 0 C--N 1.341 0.848 0 C-N-CA 126.467 1.984 . . . . 0.0 114.26 170.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.21 148.07 34.96 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 113.801 -1.199 . . . . 0.0 107.952 166.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.67 68.59 7.03 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.836 2.357 . . . . 0.0 110.574 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.6 p -139.02 150.16 45.5 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.703 1.201 . . . . 0.0 109.222 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -130.04 166.2 20.62 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.629 1.972 . . . . 0.0 107.779 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.422 ' CE2' ' HA ' ' A' ' 79' ' ' THR . 41.7 p90 -123.57 -16.43 6.76 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.31 176.08 9.14 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.55 2.34 . . . . 0.0 106.073 175.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.9 p -145.5 155.86 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 121.681 -0.637 . . . . 0.0 110.982 -168.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 p -60.93 -36.27 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.397 1.479 . . . . 0.0 111.501 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.5 m 140.21 151.84 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.596 1 C-N-CA 131.794 4.038 . . . . 0.0 108.113 -169.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -75.9 52.17 0.68 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.981 1.712 . . . . 0.0 111.021 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -105.63 -49.1 3.49 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.274 1.029 . . . . 0.0 109.593 -167.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.505 ' HA ' ' HB3' ' A' ' 117' ' ' ALA . 38.5 t-20 -125.26 22.97 7.73 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.526 1.13 . . . . 0.0 111.346 165.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.03 125.52 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 163.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.47 148.97 25.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.996 2.118 . . . . 0.0 107.142 -178.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mp -134.58 160.6 37.57 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.576 1.151 . . . . 0.0 108.752 167.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.447 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 6.1 mpt_? -133.57 130.12 37.97 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 131.336 3.854 . . . . 0.0 102.903 162.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -66.07 140.63 58.26 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.4 0.619 . . . . 0.0 109.592 172.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -142.69 171.86 13.48 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 103.808 -2.664 . . . . 0.0 103.808 158.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -130.74 18.93 5.13 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.561 2.344 . . . . 0.0 110.281 -173.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 t -54.64 -38.35 66.78 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 128.332 2.653 . . . . 0.0 113.702 -159.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.0 pp -75.69 -8.38 56.68 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.16 4.06 41.43 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.338 1.446 . . . . 0.0 112.55 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 97.2 mtp -140.14 -99.17 0.15 Allowed 'General case' 0 C--N 1.346 0.43 0 CA-C-N 119.382 1.591 . . . . 0.0 107.915 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -143.97 100.98 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.272 0 CA-C-N 120.733 1.606 . . . . 0.0 108.225 -173.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -114.54 61.36 0.67 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.071 1.348 . . . . 0.0 111.085 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 46.7 m -70.07 137.7 51.44 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.447 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 18.8 pt-20 -64.58 158.32 24.61 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.95 0.796 . . . . 0.0 110.591 173.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.8 t -139.22 102.21 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -132.2 160.17 36.88 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.3 m -70.97 128.24 35.31 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.505 ' HB3' ' HA ' ' A' ' 98' ' ' ASN . . . -72.61 -18.84 61.56 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -169.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.509 ' HD3' HD11 ' A' ' 8' ' ' ILE . 1.8 tpt180 -78.87 -38.17 38.39 Favored 'General case' 0 CA--C 1.525 0.012 0 C-N-CA 126.483 1.913 . . . . 0.0 111.794 168.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 23.9 p -146.51 89.66 1.87 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.501 1.521 . . . . 0.0 107.846 -166.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.18 55.27 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.323 2.649 . . . . 0.0 112.127 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -74.76 -77.26 0.12 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -158.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.416 ' H ' ' CD2' ' A' ' 123' ' ' LEU . 55.4 t-80 -138.14 -73.19 0.41 Allowed 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.416 ' CD2' ' H ' ' A' ' 122' ' ' HIS . 1.9 mm? 56.83 -112.74 0.71 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.808 2.043 . . . . 0.0 108.228 169.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.72 -126.95 1.27 Allowed Glycine 0 CA--C 1.526 0.72 0 CA-C-N 119.504 1.047 . . . . 0.0 113.959 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -155.59 172.91 17.48 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.349 0.659 . . . . 0.0 111.227 -174.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.451 HG21 ' HE2' ' A' ' 136' ' ' LYS . 5.1 p -114.3 144.41 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 C-N-CA 124.516 1.126 . . . . 0.0 108.024 170.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -144.89 157.9 43.99 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.191 0.996 . . . . 0.0 110.627 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.15 102.34 2.48 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.378 1.871 . . . . 0.0 109.155 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -165.74 -48.7 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.335 1.054 . . . . 0.0 111.348 -171.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -66.18 173.08 24.81 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 123.173 0.416 . . . . 0.0 112.909 -173.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.42 168.26 24.77 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.698 2.266 . . . . 0.0 111.77 -171.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -61.06 151.44 75.09 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 161.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.44 -42.23 0.84 Allowed 'Cis proline' 0 C--N 1.345 0.383 0 CA-C-N 119.999 1.035 . . . . 0.0 114.655 16.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.3 p -77.29 -30.04 54.05 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -168.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.48 13.55 82.8 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 118.77 0.714 . . . . 0.0 113.767 -174.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.451 ' HE2' HG21 ' A' ' 126' ' ' VAL . 11.4 ptmt -128.71 154.56 46.21 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 119.172 1.486 . . . . 0.0 111.029 -171.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.3 ttm105 -120.82 106.19 11.43 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -71.99 126.98 31.14 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 160.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 23.6 t -135.82 126.85 27.84 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.607 1.094 . . . . 0.0 108.184 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -145.65 147.48 32.04 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.279 0.632 . . . . 0.0 109.632 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -140.89 130.36 23.88 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.2 p -168.98 174.66 6.22 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.686 1.594 . . . . 0.0 107.941 167.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.855 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -62.91 -9.15 8.72 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.301 1.04 . . . . 0.0 112.972 167.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.27 -20.43 63.05 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.692 1.197 . . . . 0.0 114.202 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.2 mt -83.12 74.38 10.0 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.112 0.869 . . . . 0.0 111.333 -161.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.701 ' HD2' HD12 ' A' ' 68' ' ' ILE . 66.8 tttt -98.3 119.16 36.49 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.045 0.938 . . . . 0.0 110.006 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -66.18 147.14 53.77 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.961 0.41 . . . . 0.0 110.192 164.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.7 pt -140.89 170.22 9.92 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 126.516 1.926 . . . . 0.0 108.42 162.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -54.86 177.19 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.541 3.494 . . . . 0.0 113.184 159.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.645 ' HD2' ' HB1' ' A' ' 14' ' ' ALA . 5.5 mmt-85 -32.39 -45.42 0.11 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.726 2.411 . . . . 0.0 115.989 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -165.42 -71.85 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.577 0.751 . . . . 0.0 108.988 -178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.9 9.19 0.77 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.906 1.282 . . . . 0.0 112.799 -176.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 1.5 pp -67.85 -30.68 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -169.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 CA-C-O 117.191 -1.894 . . . . 0.0 109.478 -175.711 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.2 mmt . . . . . 0 CA--C 1.536 0.414 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.27 31.24 0.39 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.853 0.861 . . . . 0.0 111.091 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -157.94 -174.4 4.82 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.779 1.232 . . . . 0.0 110.669 -158.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -103.74 178.08 4.66 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.213 1.805 . . . . 0.0 110.937 -162.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.483 ' HB ' HD21 ' A' ' 98' ' ' ASN . 47.2 pt -122.2 110.25 32.8 Favored Pre-proline 0 CA--C 1.536 0.435 0 O-C-N 120.715 -1.241 . . . . 0.0 110.842 -173.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.03 140.42 34.61 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.42 1.413 . . . . 0.0 109.016 171.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.6 mt -127.9 149.13 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 104.813 -2.291 . . . . 0.0 104.813 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -132.06 152.32 51.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -175.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.2 m -126.73 80.13 1.92 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 p -57.05 -39.2 64.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 123.005 0.522 . . . . 0.0 110.908 -169.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.75 2.81 3.74 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.333 1.053 . . . . 0.0 113.604 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -135.45 5.75 3.22 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.567 2.347 . . . . 0.0 110.274 171.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 34.09 42.6 0.06 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 128.375 2.67 . . . . 0.0 113.393 -162.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -87.09 161.99 17.82 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.315 -0.866 . . . . 0.0 108.995 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -135.96 132.19 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 167.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -133.83 107.05 7.64 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.868 1.667 . . . . 0.0 106.535 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 40.5 ttp -81.76 136.45 35.43 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.099 -1.001 . . . . 0.0 108.637 172.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 93.4 t -129.27 169.77 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.708 2.003 . . . . 0.0 106.067 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -99.95 152.82 19.73 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 120.526 -1.359 . . . . 0.0 110.37 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.426 ' CG ' ' HD3' ' A' ' 118' ' ' ARG . 25.0 ttm180 -68.18 137.2 54.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.02 1.728 . . . . 0.0 110.427 -168.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.2 tt -74.4 125.7 34.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.482 0 C-N-CA 119.677 -0.809 . . . . 0.0 108.9 -170.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -154.37 110.67 3.26 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.9 mt -138.88 173.77 11.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.591 1.556 . . . . 0.0 109.256 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.63 159.02 21.66 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.042 2.137 . . . . 0.0 107.786 165.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.53 -35.09 76.75 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.562 -0.711 . . . . 0.0 112.607 -172.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.22 -28.62 65.41 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-O 121.051 0.453 . . . . 0.0 112.192 -174.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -59.72 -38.15 80.87 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.011 1.324 . . . . 0.0 110.048 -169.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -61.47 11.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.047 2.539 . . . . 0.0 116.61 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.89 -1.35 2.71 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 166.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -126.73 -20.59 4.25 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 118.787 -0.625 . . . . 0.0 111.825 -174.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 pt -109.13 -1.64 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.635 0.652 . . . . 0.0 111.704 165.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 mt -101.72 163.72 12.11 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.306 1.042 . . . . 0.0 110.573 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.96 142.62 79.22 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.371 0.668 . . . . 0.0 109.772 168.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -65.84 -16.53 53.3 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.02 1.813 . . . . 0.0 111.453 166.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -71.57 -42.9 67.22 Favored 'General case' 0 N--CA 1.439 -0.995 0 O-C-N 121.982 -0.449 . . . . 0.0 110.014 169.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.6 -44.47 96.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 121.225 -0.922 . . . . 0.0 109.912 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -56.8 -45.24 82.32 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.144 0.978 . . . . 0.0 112.336 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -76.44 -49.26 17.09 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -176.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.734 HG13 ' HA2' ' A' ' 47' ' ' GLY . 74.0 t -54.54 -33.41 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 125.156 1.382 . . . . 0.0 108.685 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.01 -18.95 63.88 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.44 -26.39 14.47 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.244 1.384 . . . . 0.0 112.192 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -108.86 -1.37 19.22 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 124.575 1.15 . . . . 0.0 112.779 -172.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.18 -2.4 0.05 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.18 2.592 . . . . 0.0 115.059 -169.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.734 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . 166.55 -66.51 0.2 Allowed Glycine 0 C--N 1.339 0.744 0 CA-C-N 119.417 1.008 . . . . 0.0 111.94 174.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.8 t -144.05 141.87 30.33 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 168.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -57.58 -48.65 96.88 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.31 -1.329 . . . . 0.0 114.207 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.43 165.77 30.64 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 CA-C-N 121.823 1.687 . . . . 0.0 111.033 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.96 152.32 77.02 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.165 1.243 . . . . 0.0 110.061 173.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -74.93 46.95 0.32 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.121 1.368 . . . . 0.0 111.808 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 36.1 p -75.54 78.6 2.56 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 120.855 -1.153 . . . . 0.0 109.284 175.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.59 144.2 10.52 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 173.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.56 114.1 3.21 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -142.3 144.95 33.49 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 169.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -158.65 163.64 36.72 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 174.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -146.72 -111.5 0.09 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 165.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.04 -178.35 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.874 2.07 . . . . 0.0 112.918 163.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -39.43 137.11 0.84 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.624 2.37 . . . . 0.0 111.883 175.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -57.78 170.52 0.59 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 128.391 2.676 . . . . 0.0 112.721 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -132.56 168.54 18.06 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 166.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.521 ' H ' ' HG2' ' A' ' 150' ' ' ARG . . . 100.53 168.41 28.82 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 125.116 1.341 . . . . 0.0 112.167 161.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 76' ' ' ASP . 38.6 pt -135.35 164.21 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 113.587 -1.307 . . . . 0.0 108.091 163.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -78.27 122.57 25.88 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.634 0.73 . . . . 0.0 109.306 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.79 117.48 23.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.234 1.814 . . . . 0.0 106.377 163.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 5.2 t -71.38 69.72 0.58 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.455 1.502 . . . . 0.0 108.746 171.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.4 tt -61.46 -19.39 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 125.512 1.525 . . . . 0.0 112.754 -169.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.1 t -70.89 -1.0 10.36 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.267 1.427 . . . . 0.0 112.617 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 9.6 p -146.19 -7.57 0.54 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.494 1.043 . . . . 0.0 113.246 158.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.9 -8.28 59.45 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.207 -1.329 . . . . 0.0 113.032 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.2 m -64.34 171.79 2.9 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.483 2.713 . . . . 0.0 111.137 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.93 152.43 51.08 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.767 1.627 . . . . 0.0 107.9 178.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.411 HD13 ' CD2' ' A' ' 75' ' ' PHE 0.28 0.3 OUTLIER -155.34 -98.85 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 178.996 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.411 ' CD2' HD13 ' A' ' 74' ' ' LEU . 28.2 m-85 -61.51 132.42 53.34 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.489 1.041 . . . . 0.0 113.723 -158.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.506 ' HA ' HG22 ' A' ' 64' ' ' ILE . 4.4 m-20 -79.46 136.6 36.97 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.52 1.128 . . . . 0.0 110.805 173.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 58.7 m -53.02 -33.6 52.48 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.448 1.099 . . . . 0.0 113.527 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -63.7 -17.48 63.02 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.147 0.979 . . . . 0.0 113.235 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.4 p -76.23 -23.31 54.53 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 121.705 -0.622 . . . . 0.0 112.037 172.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HE3' ' O ' ' A' ' 87' ' ' TRP . 1.3 mtpt -86.96 -169.81 2.79 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.524 1.53 . . . . 0.0 109.806 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -133.18 32.78 3.68 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.847 0.859 . . . . 0.0 113.051 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -54.96 -21.97 13.53 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.407 1.483 . . . . 0.0 112.424 166.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 91.0 p -66.54 58.67 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.293 2.237 . . . . 0.0 110.802 165.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 131.95 -32.91 2.8 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.555 1.55 . . . . 0.0 113.615 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.3 m -131.3 -60.41 0.95 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.549 1.674 . . . . 0.0 112.449 -167.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.08 7.29 87.25 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 115.586 0.994 . . . . 0.0 115.586 177.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.417 ' O ' ' HE3' ' A' ' 80' ' ' LYS . 2.8 t90 -67.01 144.9 98.76 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 118.44 1.12 . . . . 0.0 109.147 173.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -75.48 64.32 6.45 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.207 3.271 . . . . 0.0 112.393 -173.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 61.5 p -133.52 141.64 47.84 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.052 1.741 . . . . 0.0 108.983 173.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -133.83 168.22 19.14 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.82 1.648 . . . . 0.0 109.208 -175.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -129.4 -9.14 4.67 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -146.23 175.42 10.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 169.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.81 155.7 27.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 122.232 1.015 . . . . 0.0 111.682 -167.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.1 p -59.76 -36.44 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 125.898 1.679 . . . . 0.0 111.634 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.2 m 151.04 160.08 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 131.295 3.838 . . . . 0.0 108.642 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -77.26 66.54 3.05 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.151 0.98 . . . . 0.0 108.591 168.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -109.17 -54.05 2.58 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.163 0.585 . . . . 0.0 110.114 -173.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.483 HD21 ' HB ' ' A' ' 8' ' ' ILE . 1.0 OUTLIER -133.75 23.49 3.96 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 174.336 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.52 138.31 47.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 125.813 1.645 . . . . 0.0 106.708 172.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -105.35 137.22 43.49 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 127.251 2.22 . . . . 0.0 109.061 -174.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mp -136.71 153.42 50.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.197 1.799 . . . . 0.0 111.101 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.465 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 0.9 OUTLIER -143.88 129.56 19.23 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 131.43 3.892 . . . . 0.0 104.332 164.093 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -62.18 145.44 53.46 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.559 1.144 . . . . 0.0 110.421 166.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -150.34 175.7 11.58 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 158.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.08 20.22 13.87 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.026 1.33 . . . . 0.0 110.917 175.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 12.9 m -64.68 26.89 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 129.803 3.241 . . . . 0.0 116.654 -169.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 pp -130.85 -7.29 3.99 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.086 1.354 . . . . 0.0 112.086 162.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.45 -1.73 32.66 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 117.08 -1.955 . . . . 0.0 113.09 -168.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.8 mtm -141.29 -87.59 0.17 Allowed 'General case' 0 C--N 1.35 0.599 0 CA-C-N 120.733 2.266 . . . . 0.0 109.442 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 49.1 t -145.92 113.78 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -123.63 94.36 4.22 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.001 1.72 . . . . 0.0 108.566 174.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 14.6 t -105.91 129.27 54.09 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -174.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.465 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 17.8 pt-20 -64.44 160.08 19.99 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.114 0.87 . . . . 0.0 112.119 -174.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.5 t -138.73 105.93 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -126.93 173.79 9.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.051 0.94 . . . . 0.0 108.607 170.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.5 t -70.18 149.02 47.96 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.165 -0.959 . . . . 0.0 109.161 165.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.07 -16.48 63.7 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.426 ' HD3' ' CG ' ' A' ' 23' ' ' ARG . 28.2 tpt85 -117.72 -70.07 0.81 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-O 118.27 -0.871 . . . . 0.0 113.243 170.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 17.0 p -68.13 18.72 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 118.664 2.838 . . . . 0.0 118.664 -158.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 61.79 -11.44 0.07 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.955 2.502 . . . . 0.0 116.464 166.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.48 150.12 40.95 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.924 0.89 . . . . 0.0 112.388 -163.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -33.39 -59.84 0.37 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 128.734 2.814 . . . . 0.0 113.224 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 45.52 -106.01 0.11 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.875 2.07 . . . . 0.0 109.365 -173.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.29 -119.56 0.69 Allowed Glycine 0 CA--C 1.522 0.491 0 CA-C-N 118.081 0.4 . . . . 0.0 112.209 171.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -163.84 172.27 14.29 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.166 0.586 . . . . 0.0 110.412 -172.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.645 HG21 ' HE2' ' A' ' 136' ' ' LYS . 3.5 p -115.45 139.54 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.423 1.489 . . . . 0.0 108.828 171.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -131.29 148.93 52.73 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.214 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.79 82.66 1.63 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.076 1.751 . . . . 0.0 109.991 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -156.51 -0.91 0.13 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.678 1.191 . . . . 0.0 112.682 -166.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -96.66 179.24 34.28 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 120.382 -1.449 . . . . 0.0 113.116 -169.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.44 158.84 53.14 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.707 2.272 . . . . 0.0 110.731 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 45.9 mtp85 -64.56 154.75 83.64 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 164.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.02 -41.49 0.96 Allowed 'Cis proline' 0 C--N 1.348 0.532 0 CA-C-N 119.922 1.008 . . . . 0.0 113.787 8.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 20.6 p -69.32 -30.08 68.06 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -168.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.94 3.88 75.71 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.817 0.722 . . . . 0.0 113.455 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.645 ' HE2' HG21 ' A' ' 126' ' ' VAL . 13.2 ptmt -123.27 152.66 41.14 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.458 1.629 . . . . 0.0 111.222 -166.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 27.3 ttm105 -125.56 99.07 5.85 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.968 1.707 . . . . 0.0 106.751 -177.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -70.06 139.17 52.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 163.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 35.1 t -143.66 140.49 30.11 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.5 1.12 . . . . 0.0 108.322 174.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -148.36 157.83 43.72 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.689 0.395 . . . . 0.0 111.312 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -155.96 126.45 6.75 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.599 1.56 . . . . 0.0 108.607 170.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 91.6 p -171.29 -179.8 2.75 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.214 1.406 . . . . 0.0 109.044 163.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.51 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -60.48 -17.17 43.31 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 165.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.79 8.93 0.76 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 120.694 1.588 . . . . 0.0 114.093 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.0 mt -115.6 69.47 0.73 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.63 1.172 . . . . 0.0 110.189 -164.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -97.52 129.69 44.66 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -75.55 145.62 41.11 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.575 0.625 . . . . 0.0 109.55 167.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 28.1 pt -138.13 168.06 17.6 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 126.256 1.823 . . . . 0.0 108.294 167.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -54.07 160.84 5.65 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.657 2.905 . . . . 0.0 112.124 163.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.521 ' HG2' ' H ' ' A' ' 63' ' ' GLY . 1.6 mmt180 -47.69 -26.27 1.48 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -165.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -161.45 -70.33 0.06 Allowed 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 128.728 2.811 . . . . 0.0 108.998 159.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -148.97 7.58 0.72 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.881 2.472 . . . . 0.0 110.126 -173.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.7 pp -56.77 -24.47 19.72 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 C-N-CA 124.877 1.271 . . . . 0.0 113.938 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 CA-C-O 116.969 -2.017 . . . . 0.0 109.271 174.998 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -120.49 155.68 33.07 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 106.322 -1.732 . . . . 0.0 106.322 164.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -152.77 178.19 9.9 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.856 1.262 . . . . 0.0 109.081 -161.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.581 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -102.8 164.68 11.49 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 158.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.7 pt -128.9 117.64 19.39 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 125.831 1.652 . . . . 0.0 108.918 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.99 136.11 22.15 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.488 1.458 . . . . 0.0 108.403 166.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.1 mt -117.93 111.58 34.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 105.38 -2.081 . . . . 0.0 105.38 175.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -113.52 97.28 6.35 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.149 1.38 . . . . 0.0 108.488 -176.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 m -68.98 83.39 0.32 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.559 0.744 . . . . 0.0 109.234 170.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.4 p -55.07 -39.12 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 118.41 0.55 . . . . 0.0 111.159 -173.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -14.53 20.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.844 1.258 . . . . 0.0 113.98 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -126.64 2.87 6.81 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 126.318 1.847 . . . . 0.0 111.059 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 36.08 44.11 0.24 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.406 1.882 . . . . 0.0 111.665 -159.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.69 160.4 30.82 Favored 'General case' 0 C--N 1.349 0.559 0 C-N-CA 117.676 -1.609 . . . . 0.0 108.654 168.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 72.5 t -140.85 128.41 22.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 103.96 -2.607 . . . . 0.0 103.96 162.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -142.67 119.69 11.35 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.441 1.496 . . . . 0.0 107.62 169.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 28.9 ttp -83.58 142.98 30.45 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 172.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.5 t -140.94 177.23 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 129.42 3.088 . . . . 0.0 103.19 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 15.7 pt-20 -108.17 169.4 8.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 120.373 1.442 . . . . 0.0 114.052 174.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.97 171.24 1.28 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.636 0.774 . . . . 0.0 110.038 176.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.32 131.63 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.553 1.141 . . . . 0.0 111.416 -169.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -157.15 99.97 1.83 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.829 0.851 . . . . 0.0 109.357 173.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.6 mt -143.9 169.48 17.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.428 2.291 . . . . 0.0 108.612 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.503 ' H ' ' CG ' ' A' ' 30' ' ' GLU . 0.7 OUTLIER -90.35 164.23 14.41 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 127.098 2.159 . . . . 0.0 109.878 176.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.22 57.9 1.52 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 122.382 1.087 . . . . 0.0 110.055 160.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.06 -12.06 0.22 Allowed 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 124.694 1.198 . . . . 0.0 111.869 158.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.503 ' CG ' ' H ' ' A' ' 27' ' ' SER . 45.0 mm-40 -81.92 -49.09 10.71 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.545 -0.722 . . . . 0.0 109.976 -170.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.441 ' CE3' ' CD1' ' A' ' 35' ' ' LEU . 62.5 m95 -60.72 9.37 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.45 1.9 . . . . 0.0 114.9 -175.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.68 -0.66 4.33 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.441 1.497 . . . . 0.0 114.879 177.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.97 -23.11 2.01 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.592 173.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.4 pt -103.33 16.96 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 119.306 0.957 . . . . 0.0 110.517 170.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.461 HD22 ' CB ' ' A' ' 39' ' ' ALA . 3.4 mt -139.67 160.16 40.5 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.078 0.951 . . . . 0.0 112.138 -174.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.479 ' HB2' ' H ' ' A' ' 39' ' ' ALA . 2.4 m-20 -59.36 148.52 72.68 Favored Pre-proline 0 C--O 1.238 0.489 0 C-N-CA 124.353 1.061 . . . . 0.0 110.159 172.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -63.08 -18.37 64.79 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.749 1.633 . . . . 0.0 111.328 165.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -72.21 -50.68 25.67 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 119.323 -0.37 . . . . 0.0 110.119 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.479 ' H ' ' HB2' ' A' ' 36' ' ' ASP . . . -58.14 -44.17 87.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 119.068 0.849 . . . . 0.0 110.509 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -53.95 -51.84 62.55 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.034 1.334 . . . . 0.0 111.911 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.411 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 41.1 ptt180 -68.72 -51.11 45.01 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.376 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.7 t -61.15 -28.63 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 118.805 -0.617 . . . . 0.0 109.664 -170.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.5 -17.64 64.06 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -107.41 -32.37 7.77 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.435 1.016 . . . . 0.0 112.346 174.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 41' ' ' ARG . 17.0 ptpt -103.74 0.35 30.38 Favored 'General case' 0 C--N 1.343 0.292 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -174.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.29 45.57 7.28 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.031 1.332 . . . . 0.0 111.819 -170.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.87 -69.22 0.27 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 168.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.5 t -141.75 117.59 10.48 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -175.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 35.1 mt-10 -55.76 -57.49 21.17 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.929 170.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 49' ' ' GLU . 5.6 Cg_exo -83.95 160.58 13.83 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.919 1.746 . . . . 0.0 110.906 -172.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.75 66.23 5.8 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.504 2.803 . . . . 0.0 110.617 172.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -140.69 165.14 28.31 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.116 1.366 . . . . 0.0 108.787 170.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.3 p -126.47 160.9 29.23 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.726 1.21 . . . . 0.0 110.257 -173.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -169.52 113.83 0.53 Allowed Glycine 0 C--N 1.335 0.477 0 N-CA-C 107.13 -2.388 . . . . 0.0 107.13 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.33 167.18 22.65 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -137.07 123.39 20.65 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -167.44 175.13 7.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 128.327 2.651 . . . . 0.0 106.107 167.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -136.72 -89.78 0.27 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 171.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.5 pp -143.3 126.28 16.3 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.895 1.278 . . . . 0.0 108.213 163.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.91 161.52 42.54 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.991 0.916 . . . . 0.0 112.264 177.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -138.7 87.73 2.24 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 158.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -150.34 -179.94 7.61 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 166.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.75 -171.72 39.78 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 124.115 0.864 . . . . 0.0 112.644 171.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.2 pt -140.49 179.04 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 158.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -89.1 147.65 24.11 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.061 -1.024 . . . . 0.0 110.726 169.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -120.39 141.99 49.6 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.978 0.894 . . . . 0.0 111.207 158.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 25.5 t -92.6 93.96 8.79 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 113.48 -1.691 . . . . 0.0 107.214 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.458 HG22 ' HA ' ' A' ' 144' ' ' ALA . 4.2 tt -63.32 -29.81 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 123.861 0.864 . . . . 0.0 111.322 -164.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.9 m -77.44 0.53 22.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.118 1.767 . . . . 0.0 112.503 -178.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 6.6 p -132.0 -10.41 3.4 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.242 1.017 . . . . 0.0 112.92 163.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.7 6.13 84.49 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.002 1.286 . . . . 0.0 112.71 -172.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.2 m -106.17 132.1 52.63 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 118.442 1.121 . . . . 0.0 109.887 -164.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -75.92 165.23 25.29 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.325 1.85 . . . . 0.0 112.967 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 177.23 -171.96 0.1 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 129.048 2.939 . . . . 0.0 108.775 178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 27.3 95.19 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 129.964 3.305 . . . . 0.0 116.109 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -63.55 150.43 43.97 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.328 1.051 . . . . 0.0 111.692 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.6 m -62.19 -24.14 67.04 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -174.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.18 -16.99 63.75 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.3 t -98.64 -9.68 24.38 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.7 -0.625 . . . . 0.0 111.293 169.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.691 ' HE2' ' H ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -84.48 179.1 7.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.12 1.368 . . . . 0.0 108.682 172.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.691 ' H ' ' HE2' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -141.24 -173.57 3.78 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.013 1.725 . . . . 0.0 107.618 174.537 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -158.82 -86.97 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -158.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.6 t -58.39 129.96 44.51 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 166.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.48 -87.68 0.52 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -175.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 28.8 m -81.96 50.06 1.49 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 122.405 1.097 . . . . 0.0 111.408 -175.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.37 32.23 3.65 Favored Glycine 0 CA--C 1.524 0.649 0 O-C-N 120.025 -1.672 . . . . 0.0 112.07 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -122.33 166.68 16.31 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.764 2.026 . . . . 0.0 108.557 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.32 71.44 6.76 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.559 2.173 . . . . 0.0 113.752 -160.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.6 p -136.86 162.09 34.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.827 1.251 . . . . 0.0 111.236 166.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -145.19 178.45 8.06 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.922 2.489 . . . . 0.0 109.471 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -128.61 -4.64 5.29 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -157.78 178.81 9.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.119 2.167 . . . . 0.0 108.146 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.0 t -134.14 151.09 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 119.182 0.901 . . . . 0.0 110.846 -168.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.5 p -55.01 -47.4 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.349 1.86 . . . . 0.0 111.546 170.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.3 m 165.22 170.24 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 131.069 3.748 . . . . 0.0 106.593 -174.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -90.4 97.15 11.01 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 159.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -131.08 -60.36 0.96 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.292 0.637 . . . . 0.0 110.804 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -115.47 18.74 15.83 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.087 1.355 . . . . 0.0 111.388 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.3 tt -130.64 163.93 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.117 2.567 . . . . 0.0 106.98 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.485 ' HD3' ' N ' ' A' ' 101' ' ' LEU . 2.7 tmtm? -135.96 128.79 31.1 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.137 0.975 . . . . 0.0 109.028 174.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.485 ' N ' ' HD3' ' A' ' 100' ' ' LYS . 1.7 mp -114.15 143.95 43.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 128.792 2.837 . . . . 0.0 111.256 176.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.27 113.85 8.25 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.102 1.761 . . . . 0.0 109.107 168.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -81.31 125.22 30.08 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.423 0.689 . . . . 0.0 111.498 -176.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -130.62 -175.99 3.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.501 1.921 . . . . 0.0 108.753 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.95 19.62 17.72 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.518 1.527 . . . . 0.0 111.477 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.45 20.73 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 129.102 2.961 . . . . 0.0 118.155 -165.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.6 pp -132.06 -2.17 3.63 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.821 -1.174 . . . . 0.0 112.253 167.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.4 8.68 56.11 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 117.871 -1.516 . . . . 0.0 112.851 -168.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 16.1 tpt -142.23 -92.13 0.13 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 119.867 1.834 . . . . 0.0 108.507 174.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 81.5 t -143.01 114.77 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -119.09 113.8 21.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.646 1.178 . . . . 0.0 108.183 169.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.452 ' HB3' ' CG1' ' A' ' 126' ' ' VAL . 31.5 t -106.15 122.33 45.97 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 172.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -64.03 151.03 44.06 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 172.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 75.6 t -136.46 111.49 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 C-N-CA 125.016 1.326 . . . . 0.0 107.572 -178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 mp -127.8 164.97 21.02 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.28 1.032 . . . . 0.0 109.195 175.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 18.1 t -71.88 154.2 41.39 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.445 -0.785 . . . . 0.0 109.3 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -82.96 -20.96 34.21 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 122.055 -0.403 . . . . 0.0 112.05 172.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.22 -42.79 3.46 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.639 1.176 . . . . 0.0 112.496 -162.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 27.9 p -123.54 81.08 1.86 Allowed 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 167.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.49 40.77 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.014 1 C-N-CA 132.533 4.333 . . . . 0.0 114.888 -163.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -96.21 -174.44 3.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.154 2.582 . . . . 0.0 112.434 -170.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -30.4 -70.11 0.06 Allowed 'General case' 0 C--N 1.341 0.232 0 C-N-CA 130.012 3.325 . . . . 0.0 114.716 -164.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 mt 42.16 -111.13 0.15 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.277 2.231 . . . . 0.0 109.984 -170.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.59 -114.26 0.46 Allowed Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 118.884 0.765 . . . . 0.0 112.623 171.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -164.76 179.08 6.77 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.826 0.45 . . . . 0.0 110.298 -170.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.547 HG21 ' HE2' ' A' ' 136' ' ' LYS . 2.7 p -124.49 144.93 32.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 124.795 1.238 . . . . 0.0 108.463 167.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -131.48 147.23 52.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 124.109 0.881 . . . . 0.0 109.566 175.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -65.89 115.35 5.89 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.01 -34.36 0.15 Allowed 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -171.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -83.91 172.32 49.7 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -174.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.7 -84.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.685 2.256 . . . . 0.0 110.353 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.62 169.53 9.88 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 129.062 2.945 . . . . 0.0 104.887 176.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.3 -54.49 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.629 0 CA-C-N 121.572 1.597 . . . . 0.0 111.93 -2.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.8 p -69.35 -25.61 64.28 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.37 0.668 . . . . 0.0 112.442 -174.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 68.22 10.77 60.28 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.895 0.76 . . . . 0.0 113.453 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.547 ' HE2' HG21 ' A' ' 126' ' ' VAL . 14.7 ptmt -130.29 158.57 39.42 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 119.281 1.54 . . . . 0.0 111.561 -169.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.83 103.36 7.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.941 1.696 . . . . 0.0 108.499 -175.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -73.15 135.28 44.65 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 168.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 27.0 t -142.19 133.58 26.47 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.707 1.203 . . . . 0.0 108.5 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 6.9 ptm -133.16 156.25 47.81 Favored 'General case' 0 CA--C 1.528 0.098 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -137.4 97.82 3.56 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.5 m -157.74 158.38 35.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 173.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -77.22 -30.19 54.49 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.07 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -74.46 54.17 0.57 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.863 2.065 . . . . 0.0 113.183 -170.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.8 mt -120.0 63.59 0.83 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.014 0.926 . . . . 0.0 108.73 -176.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 2.1 tpmt? -79.63 101.84 8.57 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -57.8 133.8 55.72 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 165.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.3 pt -136.99 165.72 32.72 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.567 1.147 . . . . 0.0 108.888 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.32 170.94 2.71 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.484 2.123 . . . . 0.0 111.38 162.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -50.09 -11.51 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 128.814 2.846 . . . . 0.0 118.185 -166.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 32.4 t0 177.31 -61.19 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 128.675 2.79 . . . . 0.0 107.296 159.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.32 11.89 0.63 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.962 2.105 . . . . 0.0 112.0 -174.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.8 pp -71.71 -11.58 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 O-C-N 121.186 -0.946 . . . . 0.0 112.328 173.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.543 0 C-N-CA 127.888 2.661 . . . . 0.0 106.532 159.199 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.9 ttp . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 119.07 -0.49 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -133.51 109.02 8.98 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 176.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.87 173.73 11.24 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -159.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -137.22 160.91 37.64 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.024 2.13 . . . . 0.0 105.571 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.488 ' HB ' HD21 ' A' ' 98' ' ' ASN . 18.8 pt -136.24 137.28 24.17 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.147 0.979 . . . . 0.0 111.431 -171.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.12 114.31 3.88 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.51 2.14 . . . . 0.0 110.342 170.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.446 HD12 HG23 ' A' ' 72' ' ' THR . 5.5 mm -87.64 132.29 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 159.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -132.28 96.09 3.8 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 -175.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.5 m -68.56 61.26 0.09 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 167.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.8 t -52.21 -36.67 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 120.863 -1.148 . . . . 0.0 109.486 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.54 -18.52 65.06 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.83 -174.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -108.53 1.98 21.87 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 129.812 3.245 . . . . 0.0 111.581 169.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.0 t30 37.7 61.57 1.0 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.046 2.538 . . . . 0.0 113.164 -158.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.98 169.11 11.49 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.765 1.226 . . . . 0.0 108.949 169.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.2 t -148.39 124.35 2.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 126.401 1.88 . . . . 0.0 106.305 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -144.19 95.15 2.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.032 1.333 . . . . 0.0 107.948 -173.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 12.1 ttt -69.63 137.62 52.39 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.513 -1.367 . . . . 0.0 109.968 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.9 t -135.08 160.02 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.049 1.34 . . . . 0.0 107.385 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -68.22 155.76 39.02 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.045 -1.659 . . . . 0.0 110.961 170.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.548 HH12 ' CD ' ' A' ' 25' ' ' GLU . 41.6 ptt85 -74.93 154.11 38.3 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 121.749 -0.594 . . . . 0.0 109.421 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.61 134.53 25.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.548 ' CD ' HH12 ' A' ' 23' ' ' ARG . 0.3 OUTLIER -162.52 123.56 2.54 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 102.008 -3.33 . . . . 0.0 102.008 159.029 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.1 mt -140.49 -178.96 5.75 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.963 1.705 . . . . 0.0 106.821 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.1 t -161.58 -10.94 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -118.94 -144.22 0.37 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.58 1.082 . . . . 0.0 110.211 -172.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.24 3.02 0.69 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.603 1.161 . . . . 0.0 113.281 175.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -59.47 -46.5 88.6 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 125.994 1.718 . . . . 0.0 110.974 -163.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.414 ' CE3' HD13 ' A' ' 35' ' ' LEU . 93.2 m95 -69.29 45.64 0.06 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.32 2.248 . . . . 0.0 112.344 174.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.67 -36.25 0.05 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.084 2.154 . . . . 0.0 109.915 159.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -84.68 -25.85 28.16 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.109 -0.948 . . . . 0.0 112.309 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.5 pt -109.67 18.69 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 119.773 1.17 . . . . 0.0 112.176 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.414 HD13 ' CE3' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -145.51 174.91 10.74 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 124.478 1.111 . . . . 0.0 110.875 -169.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.91 141.78 96.96 Favored Pre-proline 0 C--O 1.237 0.417 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 169.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -68.57 -14.53 39.81 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.744 2.296 . . . . 0.0 111.589 171.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -79.14 -44.04 22.79 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 122.999 0.52 . . . . 0.0 109.97 168.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.98 -39.7 90.62 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.58 1.082 . . . . 0.0 110.64 -178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -46.9 -58.29 4.09 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.953 2.101 . . . . 0.0 111.175 171.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 8.3 ptp85 -72.73 -42.06 64.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.883 -177.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.469 HG13 ' HA2' ' A' ' 47' ' ' GLY . 44.5 t -52.56 -35.36 20.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 124.595 1.158 . . . . 0.0 110.405 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.71 -8.78 11.29 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -116.23 -38.68 3.53 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-N 119.376 0.989 . . . . 0.0 111.936 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 41' ' ' ARG . 19.3 ptpt -87.15 9.43 20.02 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.304 0.956 . . . . 0.0 113.151 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.58 -36.62 0.23 Allowed 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 129.143 2.977 . . . . 0.0 113.636 -167.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.469 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . 177.63 -73.4 0.07 OUTLIER Glycine 0 C--N 1.335 0.511 0 C-N-CA 127.023 2.249 . . . . 0.0 108.861 -166.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.7 p -132.9 127.89 35.35 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -47.04 -57.52 9.06 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 117.92 -1.038 . . . . 0.0 111.488 170.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.41 166.35 20.19 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.249 1.966 . . . . 0.0 110.962 166.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -74.64 58.01 4.5 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.806 3.004 . . . . 0.0 111.001 169.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -75.26 88.61 2.53 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.187 -0.946 . . . . 0.0 109.436 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.3 m -68.26 73.46 0.21 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.801 1.241 . . . . 0.0 109.935 171.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.98 72.26 0.71 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.437 1.494 . . . . 0.0 110.929 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 19.6 ttpp -73.97 65.09 1.06 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.121 1.368 . . . . 0.0 110.953 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -70.14 78.16 0.51 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.344 1.457 . . . . 0.0 109.069 174.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -89.18 2.62 53.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.621 1.569 . . . . 0.0 114.292 -165.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -73.55 148.67 42.79 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.917 0.78 . . . . 0.0 110.669 -174.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.6 mt -149.67 96.58 2.5 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 127.359 2.264 . . . . 0.0 105.163 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -126.92 -74.56 0.59 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.105 0.962 . . . . 0.0 109.641 -166.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -78.03 -178.28 5.47 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.334 1.854 . . . . 0.0 109.606 164.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -69.76 167.95 16.05 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.874 -0.516 . . . . 0.0 111.8 -176.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.39 162.83 12.82 Favored Glycine 0 C--N 1.34 0.759 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.875 174.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.423 HG22 ' HA ' ' A' ' 76' ' ' ASP . 38.5 pt -143.51 175.21 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 126.274 1.829 . . . . 0.0 109.131 -179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -93.35 122.51 35.84 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.295 0.569 . . . . 0.0 111.934 173.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.91 115.05 21.61 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 158.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.8 t -70.55 94.53 0.99 Allowed 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 166.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.455 HG22 ' HA ' ' A' ' 144' ' ' ALA . 2.0 tt -58.85 -33.0 48.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.599 1.16 . . . . 0.0 111.155 -165.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.4 t -82.48 5.14 21.62 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.949 1.3 . . . . 0.0 111.891 -169.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.7 p -143.72 18.63 1.83 Allowed 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.43 -0.794 . . . . 0.0 111.557 158.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 57.7 25.83 56.41 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 123.343 0.497 . . . . 0.0 112.744 174.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.446 HG23 HD12 ' A' ' 10' ' ' ILE . 28.4 m -120.55 124.54 45.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.863 1.265 . . . . 0.0 108.021 -164.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -64.63 145.27 56.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.408 1.083 . . . . 0.0 111.448 170.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.466 HD23 ' H ' ' A' ' 75' ' ' PHE 0.281 0.0 OUTLIER -148.88 -107.42 0.08 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.953 160.657 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.466 ' H ' HD23 ' A' ' 74' ' ' LEU . 19.4 m-85 -54.38 127.15 26.16 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.307 1.443 . . . . 0.0 112.416 -159.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.423 ' HA ' HG22 ' A' ' 64' ' ' ILE . 8.8 t70 -89.47 150.54 22.43 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.223 1.009 . . . . 0.0 109.494 -176.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.1 m -59.47 -26.83 65.57 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.088 172.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -70.1 -17.78 63.23 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.914 1.234 . . . . 0.0 112.449 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.8 p -96.44 -22.86 16.88 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.809 1.244 . . . . 0.0 112.196 170.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.477 ' HE2' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -125.56 79.09 1.79 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.566 1.946 . . . . 0.0 107.653 -170.482 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -127.43 118.64 24.45 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 172.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -135.68 163.65 29.67 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 104.71 -2.329 . . . . 0.0 104.71 159.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.6 t -136.48 135.89 38.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.385 0.993 . . . . 0.0 109.785 -164.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.99 -53.28 1.36 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 -164.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.92 -68.96 0.28 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.26 1.424 . . . . 0.0 110.021 168.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 53.7 12.31 2.43 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 126.177 1.846 . . . . 0.0 116.225 -170.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -51.19 155.04 2.44 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 127.021 2.128 . . . . 0.0 112.307 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -73.55 68.09 4.49 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.864 3.042 . . . . 0.0 111.532 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.2 p -131.04 143.76 50.94 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 125.238 1.415 . . . . 0.0 108.508 167.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.92 160.22 38.97 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.659 1.584 . . . . 0.0 108.035 -171.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -123.27 7.04 9.08 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.453 -171.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -159.61 176.65 11.77 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 159.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -100.64 157.91 4.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 119.1 0.864 . . . . 0.0 110.268 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.3 p -66.25 -45.63 89.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 169.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.6 m -179.81 161.46 0.98 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 129.73 3.212 . . . . 0.0 106.714 167.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -76.74 56.99 1.22 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.03 1.732 . . . . 0.0 110.085 175.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -111.56 -61.51 1.69 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 123.629 0.772 . . . . 0.0 109.251 -168.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.488 HD21 ' HB ' ' A' ' 8' ' ' ILE 0.25 0.8 OUTLIER -113.09 21.23 15.57 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 175.48 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.8 tt -111.74 153.21 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 167.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -122.22 145.26 48.38 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.482 1.113 . . . . 0.0 108.815 169.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.5 mt -149.52 133.34 16.96 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 128.87 2.868 . . . . 0.0 108.602 -159.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.56 101.9 4.47 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 129.105 2.962 . . . . 0.0 108.503 168.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -73.8 143.8 45.84 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.604 0.762 . . . . 0.0 111.899 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -154.94 178.0 10.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 129.407 3.083 . . . . 0.0 107.989 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.456 ' H ' ' HD2' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -103.13 25.12 9.84 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 120.366 -1.459 . . . . 0.0 113.135 178.05 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.45 19.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 117.247 2.314 . . . . 0.0 117.247 -166.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.14 2.03 2.76 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.985 -1.072 . . . . 0.0 112.449 165.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.05 -3.55 51.9 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.061 -1.41 . . . . 0.0 113.042 -169.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -139.11 -98.32 0.17 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.416 1.608 . . . . 0.0 109.175 -174.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.6 m -135.12 110.28 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.41 ' HE ' ' CD2' ' A' ' 125' ' ' HIS . 4.8 ttt180 -106.33 142.06 36.63 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 161.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.508 ' HB3' ' CG1' ' A' ' 126' ' ' VAL . 20.8 t -137.39 138.99 40.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 166.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -61.25 153.43 26.32 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 169.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.3 t -134.09 107.98 10.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -125.43 165.37 18.55 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 172.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 26.8 t -73.92 146.64 43.83 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 168.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.78 -45.46 86.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.745 -0.645 . . . . 0.0 109.337 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 19.3 tpt85 -84.41 -77.64 0.26 Allowed 'General case' 0 C--N 1.35 0.589 0 CA-C-O 116.257 -1.83 . . . . 0.0 111.775 162.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 28.6 p -78.34 75.32 4.87 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.859 1.209 . . . . 0.0 110.746 -158.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -59.76 77.22 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.509 1.924 . . . . 0.0 112.536 171.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.26 -155.62 0.45 Allowed 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 112.861 -1.972 . . . . 0.0 109.748 161.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -70.11 -60.6 2.19 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 125.525 1.53 . . . . 0.0 111.296 -168.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 50.24 -113.11 0.64 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.503 1.921 . . . . 0.0 108.511 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 174.11 -128.4 1.46 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 119.815 -1.183 . . . . 0.0 113.664 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.41 ' CD2' ' HE ' ' A' ' 111' ' ' ARG . 38.2 p-80 -157.78 175.65 13.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.01 0.524 . . . . 0.0 110.044 -174.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.508 ' CG1' ' HB3' ' A' ' 112' ' ' CYS . 3.0 p -122.06 143.86 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.288 1.435 . . . . 0.0 108.776 172.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -142.1 164.95 28.78 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.619 1.168 . . . . 0.0 111.516 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -72.06 102.93 3.11 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.468 1.907 . . . . 0.0 109.452 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -162.75 -50.8 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.709 2.004 . . . . 0.0 110.21 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -63.85 157.77 41.85 Favored Glycine 0 CA--C 1.533 1.174 0 O-C-N 123.311 0.382 . . . . 0.0 112.29 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.12 177.64 8.5 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.651 2.234 . . . . 0.0 112.684 -169.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -50.19 145.62 9.63 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.792 159.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -84.55 -25.36 9.03 Favored 'Cis proline' 0 N--CA 1.457 -0.619 0 CA-C-N 119.462 0.844 . . . . 0.0 113.253 18.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.261 0.9 OUTLIER -107.46 -14.01 14.95 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.463 0.705 . . . . 0.0 112.18 -159.182 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 78.23 16.66 79.31 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 121.465 -0.772 . . . . 0.0 114.974 159.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -146.98 159.37 43.64 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 118.579 1.189 . . . . 0.0 110.486 -175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 ttm105 -119.56 108.88 15.04 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 126.052 1.741 . . . . 0.0 107.18 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -73.77 138.72 44.74 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 163.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 19.3 t -141.29 133.47 27.91 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.081 0.855 . . . . 0.0 108.74 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 18.8 ptt? -130.18 105.11 7.71 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 122.15 0.976 . . . . 0.0 109.336 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -83.82 68.17 9.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 169.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 p -113.91 142.59 45.93 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.284 1.433 . . . . 0.0 110.463 -176.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.96 -40.59 91.44 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.036 0.934 . . . . 0.0 111.907 170.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.455 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -66.73 16.74 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.44 2.696 . . . . 0.0 116.649 -160.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 87.9 mt -92.61 75.68 5.05 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.419 1.088 . . . . 0.0 111.275 -162.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -86.14 110.94 19.9 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -62.83 144.41 56.61 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 164.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 4.9 pt -142.79 169.6 10.45 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 126.179 1.792 . . . . 0.0 108.111 171.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -56.96 177.2 0.19 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.903 2.402 . . . . 0.0 111.142 159.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -50.93 8.56 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 119.867 3.284 . . . . 0.0 119.867 -172.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.7 t70 145.08 -72.85 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.159 1 C-N-CA 133.549 4.739 . . . . 0.0 107.308 163.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -154.69 43.02 0.49 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 128.172 2.589 . . . . 0.0 107.083 -176.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.3 pt -77.19 -19.73 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.076 -1.015 . . . . 0.0 110.562 161.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 1 C-N-CA 130.849 4.071 . . . . 0.0 105.832 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 59.7 ttm . . . . . 0 CA--C 1.528 0.129 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.9 mttp -155.69 144.59 20.56 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.871 0.869 . . . . 0.0 108.909 168.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -78.77 32.58 0.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 129.937 3.295 . . . . 0.0 111.337 -172.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 4.2 mtt180 -143.5 -172.42 3.71 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 126.405 1.882 . . . . 0.0 109.225 -171.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 pt -138.93 140.56 27.35 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.801 2.04 . . . . 0.0 109.665 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.471 ' O ' HD13 ' A' ' 10' ' ' ILE . 90.1 Cg_endo -80.78 143.0 14.47 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.062 2.508 . . . . 0.0 111.015 174.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.808 HD12 HG23 ' A' ' 72' ' ' THR . 17.2 mm -135.86 122.02 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 C-N-CA 125.816 1.647 . . . . 0.0 107.254 -168.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -132.47 98.51 4.39 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.905 0.775 . . . . 0.0 110.299 -165.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.5 m -69.73 74.84 0.43 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.827 0.851 . . . . 0.0 109.602 170.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.86 -39.24 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.686 1.194 . . . . 0.0 112.074 -174.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.67 -15.64 8.33 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.162 2.185 . . . . 0.0 113.724 175.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.412 ' HE3' ' CD ' ' A' ' 17' ' ' ARG . 4.7 ttpt -133.1 15.58 4.19 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.738 2.415 . . . . 0.0 110.12 -178.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 24.38 45.58 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 131.133 3.773 . . . . 0.0 114.375 -163.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.412 ' CD ' ' HE3' ' A' ' 15' ' ' LYS . 19.2 mtp-105 -90.95 171.63 9.15 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.003 175.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.0 p -140.34 154.4 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 158.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -144.35 170.99 14.96 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 127.984 2.514 . . . . 0.0 106.903 158.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 43.6 ttm -127.46 92.3 3.47 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.757 0.823 . . . . 0.0 109.499 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.6 t -77.16 155.94 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 174.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 1.0 OUTLIER -79.13 174.24 11.77 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.06 -1.025 . . . . 0.0 112.476 175.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -77.86 163.24 26.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.533 0.733 . . . . 0.0 110.413 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.288 2.8 tp -89.15 69.12 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 123.324 1.535 . . . . 0.0 111.784 -169.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.9 89.87 3.2 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.018 1.727 . . . . 0.0 106.532 -173.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.8 mt -130.33 -176.21 3.88 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.107 2.163 . . . . 0.0 109.952 -175.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.0 t -112.91 162.66 15.58 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.741 1.617 . . . . 0.0 107.885 163.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -52.28 -36.89 54.06 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.14 0.882 . . . . 0.0 111.514 -177.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -46.87 -34.63 5.57 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 129.25 3.02 . . . . 0.0 111.714 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -81.92 -46.88 13.45 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.193 1.797 . . . . 0.0 111.212 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.418 ' C ' HD12 ' A' ' 35' ' ' LEU . 91.3 m95 -64.01 40.5 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 129.844 3.258 . . . . 0.0 113.503 -174.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -169.29 -18.68 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.166 2.187 . . . . 0.0 113.24 -170.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -127.24 -13.69 5.53 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 118.31 -0.852 . . . . 0.0 112.807 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pt -109.31 3.95 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 119.061 0.846 . . . . 0.0 111.906 170.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.418 HD12 ' C ' ' A' ' 31' ' ' TRP . 12.3 mt -97.74 170.67 8.83 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.423 1.489 . . . . 0.0 111.014 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -61.18 144.73 90.95 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 159.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -63.64 -15.01 46.17 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 121.889 1.726 . . . . 0.0 111.761 166.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -70.94 -41.9 70.53 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 122.523 0.329 . . . . 0.0 110.587 170.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.441 ' HB2' HG12 ' A' ' 68' ' ' ILE . . . -62.55 -40.51 97.06 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.29 0.566 . . . . 0.0 109.914 -172.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -53.48 -52.61 59.0 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.576 1.15 . . . . 0.0 112.057 172.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 42' ' ' VAL . 3.8 ptp180 -76.92 -47.07 22.07 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -172.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' A' ' 39' ' ' ALA . 4.1 p -62.52 -24.39 35.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -174.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.23 -9.51 32.97 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 115.157 1.539 . . . . 0.0 115.157 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.78 -41.28 2.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.881 1.219 . . . . 0.0 110.849 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.413 ' H ' ' HG2' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -89.08 3.44 51.77 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.623 1.169 . . . . 0.0 113.317 176.346 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.33 2.44 0.09 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.16 2.584 . . . . 0.0 115.663 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.88 -71.4 0.02 OUTLIER Glycine 0 C--N 1.344 1.022 0 N-CA-C 118.242 2.057 . . . . 0.0 118.242 -163.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 t -158.12 156.53 31.11 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -73.76 162.62 73.31 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 158.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -70.53 152.66 65.46 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.012 1.808 . . . . 0.0 111.241 177.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.0 168.26 25.22 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.913 2.409 . . . . 0.0 110.889 172.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -139.99 172.14 13.19 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.618 1.567 . . . . 0.0 108.418 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.0 p -63.51 107.61 1.17 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.819 1.248 . . . . 0.0 109.28 175.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -171.08 -165.71 28.82 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 108.219 -1.952 . . . . 0.0 108.219 -177.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -138.09 160.29 39.77 Favored 'General case' 0 C--N 1.338 0.094 0 CA-C-N 117.706 0.753 . . . . 0.0 110.023 174.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -154.53 149.33 26.6 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 127.034 2.133 . . . . 0.0 105.791 168.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -154.84 171.72 19.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 158.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -144.83 -160.14 1.09 Allowed 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 163.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.29 39.1 0.66 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.523 1.129 . . . . 0.0 110.556 170.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -114.18 162.28 16.73 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.154 0.582 . . . . 0.0 112.17 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -149.32 62.56 1.03 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.62 1.968 . . . . 0.0 106.139 170.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -153.23 169.02 24.05 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.111 2.164 . . . . 0.0 106.187 -175.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.96 169.5 14.76 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.909 1.242 . . . . 0.0 112.63 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.474 HG22 ' HA ' ' A' ' 76' ' ' ASP . 35.0 pt -138.49 172.41 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.794 1.638 . . . . 0.0 110.427 -172.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -86.6 137.51 32.43 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.893 0.477 . . . . 0.0 111.207 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.51 121.06 44.17 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.671 1.188 . . . . 0.0 109.765 164.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.424 ' HB2' HD11 ' A' ' 74' ' ' LEU . 16.9 t -70.16 87.64 0.59 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.309 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.463 HG22 ' HA ' ' A' ' 144' ' ' ALA . 2.6 tt -52.89 -26.28 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -171.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.0 t -75.5 -0.86 21.7 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.838 0.855 . . . . 0.0 111.684 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.3 p -149.37 20.29 0.95 Allowed 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.69 -1.256 . . . . 0.0 111.926 161.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.1 -4.93 0.45 Allowed Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.565 1.555 . . . . 0.0 116.021 177.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.808 HG23 HD12 ' A' ' 10' ' ' ILE . 97.3 m -71.03 142.9 50.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.778 1.631 . . . . 0.0 109.577 -171.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -89.87 135.4 33.65 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.687 0.795 . . . . 0.0 111.739 165.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' A' ' 67' ' ' CYS 0.326 0.0 OUTLIER -137.26 -92.91 0.23 Allowed 'General case' 0 C--N 1.344 0.336 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 178.17 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -61.59 118.01 6.51 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.554 0.615 . . . . 0.0 110.851 -165.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.474 ' HA ' HG22 ' A' ' 64' ' ' ILE . 22.2 t70 -70.5 152.41 44.03 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 168.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.3 m -55.94 -25.8 45.1 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.217 -1.373 . . . . 0.0 113.565 175.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.59 -25.17 64.38 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 121.426 1.921 . . . . 0.0 111.282 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 30.3 p -95.87 18.52 13.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.081 1.353 . . . . 0.0 112.129 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -151.27 35.57 0.58 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.82 1.248 . . . . 0.0 111.492 161.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -84.35 57.42 4.26 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.621 0.724 . . . . 0.0 111.421 -164.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -98.75 110.24 22.87 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.169 0.587 . . . . 0.0 109.988 -172.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.6 m -50.04 102.14 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.371 1.868 . . . . 0.0 112.951 -169.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.72 -49.69 3.95 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.6 1.095 . . . . 0.0 112.305 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.9 m -59.52 -45.88 90.46 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.246 1.018 . . . . 0.0 110.967 178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 49.58 26.43 7.52 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 128.034 2.73 . . . . 0.0 115.12 171.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -56.81 147.52 52.65 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.237 1.015 . . . . 0.0 111.139 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -78.97 57.62 6.54 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.163 3.242 . . . . 0.0 110.126 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.1 p -160.6 121.28 2.9 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -172.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.88 -160.78 1.1 Allowed 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 124.455 1.102 . . . . 0.0 109.082 -172.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -115.75 4.8 14.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 118.429 0.559 . . . . 0.0 112.074 -161.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -155.35 -179.18 7.84 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.144 0.578 . . . . 0.0 110.359 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 m -137.02 167.17 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 127.287 2.235 . . . . 0.0 110.114 178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.5 p -58.48 -51.1 75.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 124.52 1.128 . . . . 0.0 111.926 -178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.4 m 159.74 151.37 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 129.216 3.006 . . . . 0.0 108.038 -169.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -74.29 79.68 1.84 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.888 0.475 . . . . 0.0 109.842 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -118.92 -56.23 2.12 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.81 0.844 . . . . 0.0 110.919 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.51 HD22 HG21 ' A' ' 72' ' ' THR . 27.9 t-20 -128.28 33.07 4.77 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.14 0.976 . . . . 0.0 111.352 170.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.7 tt -118.78 144.29 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 163.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.423 ' HD3' ' H ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -127.81 141.07 51.67 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.889 1.276 . . . . 0.0 107.698 171.418 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.423 ' H ' ' HD3' ' A' ' 100' ' ' LYS . 1.8 mp -127.85 140.8 51.8 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.452 1.901 . . . . 0.0 107.629 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.516 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 5.6 mpt_? -120.86 125.68 48.11 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 171.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -106.9 126.94 52.96 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.237 0.615 . . . . 0.0 110.769 -167.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -132.45 178.59 6.71 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.714 2.006 . . . . 0.0 109.912 176.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -106.63 11.35 30.53 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.423 1.889 . . . . 0.0 112.992 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 m -46.9 -43.44 18.86 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.616 1.566 . . . . 0.0 115.182 -159.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 pp -68.5 -12.2 60.89 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.49 4.95 30.23 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 117.615 -1.659 . . . . 0.0 112.757 -169.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.2 ttp -147.88 -86.94 0.09 Allowed 'General case' 0 C--N 1.348 0.511 0 CA-C-N 120.258 2.029 . . . . 0.0 109.172 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.8 p -148.61 114.32 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -120.56 112.1 18.5 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.221 1.808 . . . . 0.0 107.822 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -115.01 134.79 54.89 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.516 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 9.1 pt-20 -71.41 165.67 23.29 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.495 1.043 . . . . 0.0 110.661 174.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.7 t -135.62 108.41 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 mp -131.17 167.47 19.1 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 167.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.1 t -66.53 149.2 50.8 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 98' ' ' ASN . . . -76.6 -17.4 59.21 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -174.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 44.8 tpt85 -111.74 -58.48 2.12 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 118.627 -0.701 . . . . 0.0 111.74 170.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 25.8 p -84.98 77.13 10.18 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.54 74.99 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.599 1.16 . . . . 0.0 110.01 172.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -97.61 -73.6 0.6 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.909 1.284 . . . . 0.0 112.323 -165.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.68 -80.95 0.17 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.54 1.136 . . . . 0.0 109.674 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.7 mt 45.56 -110.88 0.25 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.775 1.63 . . . . 0.0 111.15 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.95 -111.79 0.39 Allowed Glycine 0 C--N 1.332 0.318 0 CA-C-N 118.88 0.764 . . . . 0.0 112.843 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -164.02 -176.45 4.53 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -166.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.88 147.53 29.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 C-N-CA 127.163 2.185 . . . . 0.0 108.632 169.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -137.91 143.41 40.81 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.98 0.912 . . . . 0.0 108.63 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.95 111.81 9.46 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -167.82 -45.35 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.977 2.111 . . . . 0.0 110.776 -160.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -72.31 178.38 38.13 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.391 0.996 . . . . 0.0 113.606 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.76 162.0 42.35 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.664 2.243 . . . . 0.0 111.883 -175.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -60.72 154.37 57.79 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 163.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -70.66 -42.9 0.71 Allowed 'Cis proline' 0 C--N 1.346 0.432 0 CA-C-N 120.812 1.326 . . . . 0.0 113.693 12.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 27.2 p -70.88 -30.59 67.0 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.41 10.2 84.5 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 119.302 -0.721 . . . . 0.0 112.682 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.85 164.01 28.22 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.906 1.353 . . . . 0.0 112.81 -166.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.86 106.89 7.98 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.858 1.663 . . . . 0.0 107.963 -177.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -73.05 148.12 44.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.264 1.826 . . . . 0.0 107.235 167.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 49.7 t -156.16 115.79 3.57 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.399 1.479 . . . . 0.0 108.854 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.94 138.3 33.72 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 123.903 0.881 . . . . 0.0 109.771 -175.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -142.51 126.71 17.51 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.445 1.098 . . . . 0.0 109.416 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 85.2 p -162.7 176.63 10.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 167.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -53.6 -31.43 46.9 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.599 1.559 . . . . 0.0 112.065 163.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.463 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -87.62 47.8 1.55 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.237 1.415 . . . . 0.0 112.058 -175.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 88.1 mt -131.3 61.3 1.64 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.794 1.238 . . . . 0.0 108.31 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -88.56 127.09 35.54 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -68.59 144.87 54.38 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 169.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.3 pt -137.44 168.24 17.37 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 126.304 1.842 . . . . 0.0 108.765 171.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -57.87 174.07 0.71 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.78 1.653 . . . . 0.0 110.806 158.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 11.9 mtp85 -46.8 -33.71 4.67 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.126 1.771 . . . . 0.0 113.778 -172.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -151.8 -65.08 0.18 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.583 1.953 . . . . 0.0 108.156 158.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -151.85 1.97 0.37 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 129.546 3.138 . . . . 0.0 110.668 -171.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.7 pp -55.15 -29.94 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 119.665 1.12 . . . . 0.0 113.862 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 116.824 -2.098 . . . . 0.0 109.457 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 16.9 ptp . . . . . 0 C--O 1.239 0.531 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -58.51 164.87 2.39 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.27 1.028 . . . . 0.0 109.829 177.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -77.25 21.38 0.25 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 123.192 1.472 . . . . 0.0 114.379 -177.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -142.63 154.53 44.46 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 128.857 2.863 . . . . 0.0 106.724 -170.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 pt -131.38 107.69 14.67 Favored Pre-proline 0 C--N 1.324 -0.5 0 C-N-CA 125.813 1.645 . . . . 0.0 108.393 -165.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.85 103.57 1.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.415 2.743 . . . . 0.0 109.483 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.6 mt -85.28 97.65 5.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -75.47 95.67 3.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.5 m -67.86 67.71 0.1 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.637 0.775 . . . . 0.0 108.92 159.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.11 -34.95 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.584 -0.697 . . . . 0.0 110.822 -170.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.38 -11.72 17.25 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.685 1.194 . . . . 0.0 114.088 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' A' ' 151' ' ' ASP . 35.9 ttmt -123.32 12.81 9.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.184 1.394 . . . . 0.0 110.66 172.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 30.9 68.21 0.11 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 129.915 3.286 . . . . 0.0 113.157 -164.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 mtp85 -131.5 165.36 23.74 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 172.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.9 t -144.1 98.58 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -92.84 103.47 15.81 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.5 ttt -77.88 89.08 4.08 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.656 0.662 . . . . 0.0 109.665 171.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.2 t -86.06 168.31 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 176.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -92.16 161.66 14.65 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.532 -1.355 . . . . 0.0 108.884 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -60.27 151.78 26.63 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.49 -0.756 . . . . 0.0 110.141 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.523 ' H ' ' HG2' ' A' ' 118' ' ' ARG . 2.9 tp -65.87 130.4 31.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 172.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -153.95 120.03 5.37 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 129.109 2.964 . . . . 0.0 103.134 165.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.1 mt -143.89 175.29 10.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.542 1.537 . . . . 0.0 109.054 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.8 m -93.68 157.18 16.3 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 161.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.79 -36.24 64.69 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.137 0.975 . . . . 0.0 112.206 -174.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.35 -18.32 63.78 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -178.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -70.2 -43.75 70.09 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.609 1.164 . . . . 0.0 109.748 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -60.19 10.54 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.118 2.567 . . . . 0.0 115.542 -173.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.77 -9.89 3.95 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 172.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.82 -13.88 5.74 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 118.31 -0.853 . . . . 0.0 113.05 -176.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.3 pt -113.44 -2.67 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 119.168 0.895 . . . . 0.0 112.45 171.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.23 173.34 7.98 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.074 0.949 . . . . 0.0 111.29 -171.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.47 133.83 70.64 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 162.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.72 -21.1 45.54 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.382 2.055 . . . . 0.0 112.731 -172.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -74.76 -31.29 61.75 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.986 171.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.404 ' HB2' HG12 ' A' ' 68' ' ' ILE . . . -58.18 -41.89 84.87 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 120.063 1.301 . . . . 0.0 110.54 -174.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -57.13 -48.4 78.74 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.071 0.948 . . . . 0.0 111.272 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -69.8 -46.5 65.58 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.665 0.666 . . . . 0.0 110.917 175.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.493 HG13 ' HA2' ' A' ' 47' ' ' GLY 0.261 6.3 t -58.88 -23.64 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 125.593 1.557 . . . . 0.0 111.364 -177.214 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.76 -29.54 70.76 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 168.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.38 -36.46 13.8 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.906 1.23 . . . . 0.0 111.782 177.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -94.75 6.0 50.23 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.473 0.709 . . . . 0.0 112.876 -174.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.11 19.32 0.19 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.258 2.223 . . . . 0.0 113.857 -172.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.493 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . 112.65 -18.22 22.6 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.397 1.475 . . . . 0.0 114.652 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.6 m -163.99 115.61 1.35 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.708 2.254 . . . . 0.0 109.104 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -55.62 147.83 38.3 Favored Pre-proline 0 N--CA 1.47 0.534 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.806 168.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.2 121.38 8.67 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.207 1.938 . . . . 0.0 109.36 170.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -70.53 158.09 56.97 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.061 1.841 . . . . 0.0 110.499 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -146.62 -59.26 0.29 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.068 0.547 . . . . 0.0 109.756 176.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.6 p -118.09 67.84 0.76 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.007 0.923 . . . . 0.0 110.016 -172.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 155.37 171.97 22.5 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -151.0 157.79 43.32 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.115 1.366 . . . . 0.0 107.584 171.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -147.98 -179.26 6.78 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.796 2.038 . . . . 0.0 107.283 166.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -165.97 165.93 17.72 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.986 1.714 . . . . 0.0 108.397 160.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -126.56 168.49 14.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.294 1.438 . . . . 0.0 108.553 168.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.8 tt -156.08 114.11 3.34 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 170.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.27 168.85 19.44 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.473 1.909 . . . . 0.0 107.733 168.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -126.37 23.03 7.01 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 128.218 2.607 . . . . 0.0 111.242 -177.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -122.21 164.71 17.36 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.99 2.116 . . . . 0.0 110.077 -165.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.94 -175.57 36.85 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.024 1.297 . . . . 0.0 113.099 174.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.6 pt -125.91 160.24 33.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 165.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -72.96 155.54 39.75 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 122.424 1.107 . . . . 0.0 109.498 171.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -129.89 109.95 11.31 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 127.491 2.316 . . . . 0.0 106.228 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.1 t -75.76 73.85 2.72 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.193 1.397 . . . . 0.0 107.983 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.454 HD12 ' HD3' ' A' ' 146' ' ' LYS . 7.7 tt -58.57 -16.8 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 127.114 2.166 . . . . 0.0 113.002 -170.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 6.3 t -74.91 -0.51 18.83 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.432 1.493 . . . . 0.0 112.231 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 29.8 p -152.41 -13.66 0.17 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 158.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.99 10.99 57.03 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 119.805 1.184 . . . . 0.0 113.34 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 m -63.14 163.23 10.44 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.601 1.16 . . . . 0.0 108.936 160.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -129.2 153.65 47.53 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 169.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -169.33 -163.23 0.39 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.913 1.685 . . . . 0.0 109.426 -173.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 20.54 91.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 130.675 3.59 . . . . 0.0 114.632 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -57.61 137.27 56.56 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.0 1.32 . . . . 0.0 110.286 173.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.8 m -59.52 -21.34 60.05 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -169.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.92 -20.95 64.34 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.647 1.112 . . . . 0.0 112.448 173.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.6 p -75.72 -12.42 60.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.263 1.025 . . . . 0.0 112.549 172.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -133.67 85.34 2.2 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 125.146 1.379 . . . . 0.0 110.219 -165.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -142.8 45.31 1.59 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.639 -0.663 . . . . 0.0 112.454 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.8 98.04 0.06 Allowed 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 172.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.8 m -76.3 113.01 13.39 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.212 0.605 . . . . 0.0 110.57 -158.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.19 -60.61 0.49 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -175.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.25 -53.92 50.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.383 1.073 . . . . 0.0 111.306 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 37.35 35.43 0.18 Allowed Glycine 0 C--N 1.337 0.635 0 C-N-CA 130.632 3.968 . . . . 0.0 114.395 -167.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.9 158.07 13.74 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.728 0.811 . . . . 0.0 110.506 167.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.35 78.45 1.21 Allowed 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.531 2.821 . . . . 0.0 111.102 177.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.1 p -139.95 157.31 45.89 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.487 165.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -136.26 169.84 17.0 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.104 1.762 . . . . 0.0 108.55 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -122.4 -6.71 8.73 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.336 1.054 . . . . 0.0 112.274 174.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -152.25 -179.45 7.55 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.166 1.386 . . . . 0.0 107.676 173.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 m -119.25 164.9 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.853 1.661 . . . . 0.0 111.027 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.401 HG12 ' H ' ' A' ' 94' ' ' VAL . 2.4 p -61.81 -49.83 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.466 1.106 . . . . 0.0 109.492 160.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.0 m 168.95 159.94 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 130.515 3.526 . . . . 0.0 107.912 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -70.02 81.97 0.49 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.134 1.373 . . . . 0.0 108.812 162.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -128.08 -60.44 1.14 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.611 0.764 . . . . 0.0 110.99 -175.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.23 26.52 10.04 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.628 1.171 . . . . 0.0 110.599 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.0 tt -132.74 158.15 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.794 1.638 . . . . 0.0 108.677 -171.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.436 ' HE3' ' OE2' ' A' ' 113' ' ' GLU . 2.9 tmtm? -135.18 119.52 17.87 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.327 1.451 . . . . 0.0 108.323 -171.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.5 mp -136.45 137.37 40.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.89 1.276 . . . . 0.0 111.919 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.503 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 1.9 mpt_? -125.48 119.49 28.37 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.104 2.562 . . . . 0.0 108.666 168.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.07 143.71 41.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.945 0.898 . . . . 0.0 110.64 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -145.9 -178.21 5.99 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.953 2.101 . . . . 0.0 106.915 167.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.44 11.73 18.53 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.173 1.789 . . . . 0.0 110.985 177.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.8 t -55.37 -3.96 0.08 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.836 3.255 . . . . 0.0 118.322 -158.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.2 pp -101.82 -10.37 19.96 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.68 1.127 . . . . 0.0 111.977 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.41 8.8 34.81 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 117.554 -1.692 . . . . 0.0 113.197 -165.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 43.9 tpp -148.92 -85.96 0.09 Allowed 'General case' 0 C--N 1.349 0.581 0 CA-C-N 120.481 2.141 . . . . 0.0 109.641 176.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.7 t -143.43 115.54 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 176.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -128.7 114.02 16.11 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 124.939 1.296 . . . . 0.0 108.571 171.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.577 ' HB3' HG13 ' A' ' 126' ' ' VAL . 22.7 t -121.87 136.17 54.92 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.387 1.075 . . . . 0.0 108.378 -175.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.503 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 25.6 pt-20 -65.37 159.79 23.31 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.735 1.152 . . . . 0.0 111.098 175.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 90.0 t -142.14 111.68 2.63 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 C-N-CA 124.961 1.304 . . . . 0.0 107.835 172.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -124.97 165.72 17.61 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.776 1.23 . . . . 0.0 108.273 170.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 35.2 t -69.64 162.65 27.23 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 164.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -86.54 -2.92 58.88 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.523 ' HG2' ' H ' ' A' ' 24' ' ' ILE . 28.2 tpt85 -142.64 -52.39 0.39 Allowed 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.322 0.965 . . . . 0.0 112.83 171.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 22.6 p -84.01 65.79 8.87 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 120.181 1.355 . . . . 0.0 108.248 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.61 53.94 0.08 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.598 2.759 . . . . 0.0 112.535 -170.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.43 -178.39 4.6 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.745 1.618 . . . . 0.0 110.802 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -39.38 -60.68 0.89 Allowed 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 128.218 2.607 . . . . 0.0 112.587 -173.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 48.53 -118.31 1.02 Allowed 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.807 1.643 . . . . 0.0 107.559 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.54 -110.11 0.29 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-N 118.124 0.42 . . . . 0.0 112.189 168.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.33 176.99 8.61 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.575 -0.368 . . . . 0.0 111.806 -165.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.62 HG21 ' HE2' ' A' ' 136' ' ' LYS . 3.1 p -127.56 138.58 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 124.826 1.251 . . . . 0.0 109.341 168.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -138.29 161.11 37.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.386 1.074 . . . . 0.0 110.95 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -66.93 112.58 4.39 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.675 1.59 . . . . 0.0 110.527 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -156.1 -28.2 0.1 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -78.12 154.15 40.6 Favored Glycine 0 CA--C 1.535 1.294 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -173.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.21 -32.88 6.27 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 121.984 1.789 . . . . 0.0 112.15 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 164.07 166.0 0.06 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 131.511 3.925 . . . . 0.0 106.026 -170.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.12 -45.03 0.45 Allowed 'Cis proline' 0 C--N 1.349 0.57 0 CA-C-N 121.245 1.48 . . . . 0.0 112.005 -9.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.0 p -73.59 -22.18 60.12 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.863 1.265 . . . . 0.0 113.215 -172.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.54 -1.67 56.49 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.358 0.98 . . . . 0.0 113.356 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.62 ' HE2' HG21 ' A' ' 126' ' ' VAL . 12.7 ptmt -124.25 158.34 32.73 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 120.811 -1.405 . . . . 0.0 111.522 -162.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -125.98 108.8 11.75 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.824 2.05 . . . . 0.0 107.42 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -80.74 120.79 25.09 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 168.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 42.6 t -133.2 122.57 24.18 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.318 1.447 . . . . 0.0 107.794 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.7 ptp -141.94 161.87 36.88 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.309 1.044 . . . . 0.0 109.675 -176.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.99 132.68 16.87 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 126.816 2.047 . . . . 0.0 106.238 175.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 77.0 p -174.15 176.76 2.45 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.747 1.219 . . . . 0.0 108.604 165.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.478 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -63.95 -14.09 51.12 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.002 0.921 . . . . 0.0 112.972 162.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -75.84 6.71 4.68 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.005 1.275 . . . . 0.0 113.818 -171.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.1 mt -109.31 85.4 2.09 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.471 1.032 . . . . 0.0 110.407 -163.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.454 ' HD3' HD12 ' A' ' 68' ' ' ILE . 16.9 ttpt -112.75 167.13 10.74 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.804 0.842 . . . . 0.0 109.11 171.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -112.86 159.44 19.03 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.352 1.461 . . . . 0.0 108.44 168.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.0 pt -141.15 169.46 11.41 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 126.825 2.05 . . . . 0.0 107.595 163.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -58.26 174.07 0.82 Allowed 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.433 2.088 . . . . 0.0 111.588 160.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -47.02 -25.52 0.83 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 127.34 2.256 . . . . 0.0 116.744 -164.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.499 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -176.66 -60.03 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.965 1.706 . . . . 0.0 108.258 167.389 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -151.74 19.7 0.7 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.909 2.084 . . . . 0.0 110.266 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.26 -14.07 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 120.639 -1.288 . . . . 0.0 111.669 174.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.913 0 C-N-CA 128.006 2.717 . . . . 0.0 106.444 160.472 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.7 mtm . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -161.03 32.75 0.14 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.095 1.358 . . . . 0.0 110.634 -166.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.461 ' H ' HH21 ' A' ' 23' ' ' ARG . 1.2 p30 -150.8 -165.99 2.42 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.698 1.199 . . . . 0.0 113.275 -157.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.6 mtt85 -120.11 177.32 5.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 130.432 3.493 . . . . 0.0 108.452 -176.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.9 pt -134.42 152.06 77.3 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 119.574 1.079 . . . . 0.0 111.68 170.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.35 124.6 5.96 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.256 1.97 . . . . 0.0 109.734 164.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.4 mm -88.6 147.42 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 159.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -146.3 91.95 2.12 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -171.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 m -71.04 86.59 0.73 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 118.899 -1.12 . . . . 0.0 110.09 172.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.53 -34.78 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 124.002 0.921 . . . . 0.0 110.834 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.44 -15.22 2.46 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.826 2.05 . . . . 0.0 113.769 173.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -131.19 7.8 4.65 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.975 2.11 . . . . 0.0 111.084 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 27.6 66.9 0.08 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 128.258 2.623 . . . . 0.0 111.678 -158.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -112.45 162.07 16.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.927 1.691 . . . . 0.0 108.06 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.2 t -143.48 123.16 8.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -139.59 98.79 3.56 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.534 1.934 . . . . 0.0 107.265 -174.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.5 ttp -68.72 139.0 55.35 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.636 -1.29 . . . . 0.0 109.817 176.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 t -135.98 135.18 50.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 175.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -62.93 167.77 4.48 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 120.946 -1.096 . . . . 0.0 111.208 165.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.461 HH21 ' H ' ' A' ' 6' ' ' ASP . 12.8 mtm105 -78.01 -166.67 0.84 Allowed 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.448 -0.783 . . . . 0.0 113.031 -169.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.1 112.88 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 -178.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -142.43 98.41 3.3 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 -177.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.478 HD11 HD11 ' A' ' 34' ' ' ILE . 54.9 mt -136.19 172.76 12.53 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 126.652 1.981 . . . . 0.0 109.885 178.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.96 166.57 21.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.97 2.108 . . . . 0.0 107.936 160.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -62.99 -54.59 35.97 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.493 -0.754 . . . . 0.0 112.196 -175.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.45 -19.01 65.28 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -171.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -56.57 -40.7 75.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.041 0.936 . . . . 0.0 109.575 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -59.3 6.82 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.412 2.285 . . . . 0.0 116.599 -177.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.06 -8.88 3.03 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 120.756 -1.215 . . . . 0.0 114.184 173.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -117.87 -22.45 7.93 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.423 -178.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.478 HD11 HD11 ' A' ' 26' ' ' LEU . 1.1 pt -105.32 -9.5 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.456 1.025 . . . . 0.0 112.338 169.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.55 175.28 6.88 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.685 0.794 . . . . 0.0 111.135 -170.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.32 140.77 94.53 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 164.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.3 -12.25 27.41 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 123.337 2.691 . . . . 0.0 112.523 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -81.95 -38.97 24.39 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 126.76 2.024 . . . . 0.0 110.059 167.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.26 -44.5 96.4 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 119.776 1.171 . . . . 0.0 110.323 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -46.55 -57.23 4.94 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.202 1.401 . . . . 0.0 110.703 174.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 20.0 ptp180 -73.63 -49.52 25.61 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 118.084 -0.96 . . . . 0.0 108.784 -174.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.8 t -53.04 -32.85 18.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 119.08 0.854 . . . . 0.0 110.064 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.61 -28.4 68.49 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.81 -23.98 19.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.438 1.017 . . . . 0.0 112.128 175.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HE3' ' HB2' ' A' ' 41' ' ' ARG . 19.0 ptpt -111.26 -1.7 15.99 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -168.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 40.35 43.55 1.48 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.068 1.347 . . . . 0.0 111.002 -167.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.8 -26.27 23.83 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 125.781 1.658 . . . . 0.0 114.858 167.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.7 m -157.85 121.36 4.03 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 120.999 2.399 . . . . 0.0 110.204 176.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' CD ' ' HE2' ' A' ' 45' ' ' LYS . 18.3 mt-10 -57.03 -62.69 4.69 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.25 1.42 . . . . 0.0 112.13 172.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.43 166.65 29.17 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 121.687 1.591 . . . . 0.0 110.531 166.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -65.38 154.22 74.64 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.453 1.435 . . . . 0.0 110.031 168.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -72.95 168.16 19.56 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.495 0.664 . . . . 0.0 109.996 171.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.3 m -165.01 -51.74 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.529 1.532 . . . . 0.0 106.964 171.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.2 172.83 43.8 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 164.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -141.1 177.09 8.31 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.137 1.775 . . . . 0.0 108.654 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -66.6 153.2 43.68 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.399 0.619 . . . . 0.0 110.486 167.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -85.51 158.56 20.13 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.209 1.403 . . . . 0.0 109.122 164.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.12 135.86 56.37 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.929 1.692 . . . . 0.0 108.745 168.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.83 -171.69 2.79 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.719 1.208 . . . . 0.0 109.72 -166.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -72.47 66.92 0.71 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 160.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -77.67 59.63 2.03 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.952 1.701 . . . . 0.0 109.977 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -126.94 117.13 21.91 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 126.614 1.966 . . . . 0.0 107.616 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 161.32 -167.43 36.21 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -164.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.544 HG22 ' HA ' ' A' ' 76' ' ' ASP . 22.2 pt -130.76 162.55 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.317 1.047 . . . . 0.0 110.25 174.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -79.91 155.25 27.83 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.726 0.811 . . . . 0.0 111.243 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 43.8 ttt180 -139.93 152.81 46.67 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.534 1.134 . . . . 0.0 110.197 176.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.9 t -103.3 93.01 4.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.478 1.511 . . . . 0.0 107.817 169.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.504 HG22 ' HA ' ' A' ' 144' ' ' ALA . 4.0 tt -61.09 -33.91 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 125.426 1.49 . . . . 0.0 111.733 -175.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.0 t -75.77 5.95 5.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.595 1.158 . . . . 0.0 111.613 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 31.1 p -140.96 15.48 2.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.795 0.838 . . . . 0.0 110.811 158.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.65 11.29 35.05 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.009 1.766 . . . . 0.0 115.271 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.0 m -118.85 137.91 53.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.745 1.773 . . . . 0.0 110.849 -159.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 8.9 p-10 -79.62 164.17 24.01 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.516 1.527 . . . . 0.0 113.481 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.268 0.2 OUTLIER -161.28 -101.34 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.983 0.913 . . . . 0.0 112.402 174.46 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -61.89 129.32 40.4 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -158.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.544 ' HA ' HG22 ' A' ' 64' ' ' ILE . 9.9 t0 -74.07 134.19 42.93 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 170.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.7 m -62.51 -18.12 61.24 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.153 0.981 . . . . 0.0 113.439 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -30.68 66.25 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.012 1.278 . . . . 0.0 111.635 172.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.7 p -69.53 -17.13 63.55 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.229 1.012 . . . . 0.0 112.694 177.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 87' ' ' TRP . 16.7 tttt -102.17 -163.73 1.03 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.701 1.6 . . . . 0.0 109.723 -164.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.47 21.66 4.34 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.566 0.951 . . . . 0.0 113.566 -175.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -53.87 118.31 3.87 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.756 1.222 . . . . 0.0 109.015 164.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.2 m 111.0 -23.5 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 131.621 3.968 . . . . 0.0 110.585 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -99.16 -52.01 1.29 Allowed Glycine 0 C--N 1.34 0.786 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 176.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.4 t -155.43 -6.72 0.13 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 168.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.99 17.69 52.29 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 119.794 1.179 . . . . 0.0 115.351 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.407 ' O ' ' HE2' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -63.15 150.49 88.68 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 118.022 0.911 . . . . 0.0 110.864 176.193 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -77.89 51.01 3.45 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.747 2.964 . . . . 0.0 111.489 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.4 p -129.74 146.39 51.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.676 0.791 . . . . 0.0 109.785 168.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.72 166.05 25.79 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.004 1.722 . . . . 0.0 108.568 -170.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -116.63 -9.27 11.36 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -172.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -149.65 -174.03 4.57 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 168.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 m -130.79 165.48 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 124.511 1.124 . . . . 0.0 111.475 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.3 p -52.7 -44.95 48.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.452 1.501 . . . . 0.0 110.877 168.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.4 m 157.14 158.33 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 130.258 3.423 . . . . 0.0 108.76 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -72.8 72.78 1.09 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 164.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -121.41 -56.19 1.9 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.379 1.072 . . . . 0.0 109.191 -174.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -118.01 13.41 13.91 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.363 1.865 . . . . 0.0 110.644 170.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.31 142.3 44.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 O-C-N 119.962 -1.711 . . . . 0.0 107.236 171.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -122.53 145.97 47.84 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.085 1.754 . . . . 0.0 107.963 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mp -128.12 157.37 40.94 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 125.092 1.357 . . . . 0.0 111.771 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.49 133.53 27.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 127.934 2.493 . . . . 0.0 106.094 167.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.461 ' CD ' HH21 ' A' ' 105' ' ' ARG . 6.8 tm-20 -76.94 144.49 38.8 Favored 'General case' 0 N--CA 1.459 0.021 0 C-N-CA 123.245 0.618 . . . . 0.0 110.878 177.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -150.9 177.73 9.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.044 2.138 . . . . 0.0 105.409 158.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.461 HH21 ' CD ' ' A' ' 103' ' ' GLU . 1.1 ptp180 -120.36 27.98 8.28 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.667 1.987 . . . . 0.0 111.072 -177.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.03 21.3 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.961 2.905 . . . . 0.0 116.372 -168.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.64 0.57 3.29 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.539 1.136 . . . . 0.0 112.435 166.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.35 -0.13 55.79 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-O 117.696 -1.613 . . . . 0.0 112.842 -170.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -139.11 -88.97 0.21 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 119.854 1.827 . . . . 0.0 108.495 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 64.5 t -145.2 107.2 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -176.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -113.56 88.62 2.88 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.892 1.277 . . . . 0.0 108.757 167.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 53.5 m -86.06 133.32 33.9 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.05 159.58 30.55 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.311 0.96 . . . . 0.0 111.285 174.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.7 t -141.65 102.79 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 126.385 1.874 . . . . 0.0 107.163 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mp -133.09 159.66 39.45 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.551 0.614 . . . . 0.0 111.248 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 43.1 t -79.27 115.32 18.85 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.532 0.733 . . . . 0.0 111.021 -173.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.51 -24.83 65.61 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.671 1.188 . . . . 0.0 113.463 -171.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -59.2 -26.97 65.29 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.73 1.15 . . . . 0.0 112.749 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 2.8 p -137.71 -94.73 0.2 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -174.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 176.42 16.45 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.99 2.516 . . . . 0.0 112.238 -174.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.83 148.36 44.55 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -158.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -41.18 -65.65 0.41 Allowed 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 128.985 2.914 . . . . 0.0 113.99 -159.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 52.66 -108.1 0.38 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.868 1.667 . . . . 0.0 108.916 176.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.06 -115.51 0.5 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.145 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -160.21 177.15 10.95 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 122.762 -0.257 . . . . 0.0 110.792 -168.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.683 HG21 ' HE2' ' A' ' 136' ' ' LYS . 5.0 p -125.68 137.35 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 125.265 1.426 . . . . 0.0 108.888 173.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -132.25 159.11 40.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.098 0.959 . . . . 0.0 112.133 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -72.78 84.36 1.2 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.917 2.487 . . . . 0.0 110.942 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -160.04 7.22 0.09 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.355 1.062 . . . . 0.0 112.818 -172.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -97.71 170.36 25.28 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 119.872 -1.768 . . . . 0.0 112.755 -173.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -73.04 165.09 33.71 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.631 2.221 . . . . 0.0 110.146 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -62.45 151.92 81.57 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 162.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.05 -44.74 0.51 Allowed 'Cis proline' 0 C--N 1.347 0.452 0 CA-C-N 119.992 1.033 . . . . 0.0 113.806 8.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 26.9 p -72.8 -25.72 61.25 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -165.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.58 3.5 62.9 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 124.094 0.854 . . . . 0.0 113.552 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.683 ' HE2' HG21 ' A' ' 126' ' ' VAL . 9.7 ptmt -128.97 156.76 43.26 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.327 1.563 . . . . 0.0 111.877 -165.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.7 ttm105 -125.11 101.13 6.88 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.675 1.99 . . . . 0.0 107.399 -177.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -67.26 135.48 53.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 162.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 20.9 t -143.81 141.34 30.33 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.704 1.138 . . . . 0.0 108.609 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -141.09 158.61 43.68 Favored 'General case' 0 C--O 1.231 0.079 0 C-N-CA 123.09 0.556 . . . . 0.0 111.494 -173.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -151.17 125.56 9.45 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.95 1.7 . . . . 0.0 108.093 161.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.8 t -149.5 148.97 30.03 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 158.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.24 -19.93 63.7 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.571 166.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.504 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -65.78 -12.26 52.62 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 124.755 1.222 . . . . 0.0 113.436 172.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 89.5 mt -75.45 106.09 6.82 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.946 1.248 . . . . 0.0 109.992 -176.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -109.82 167.62 10.02 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.31 1.444 . . . . 0.0 107.923 170.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -124.39 147.12 48.45 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 23.6 pt -138.77 166.66 23.53 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.287 1.435 . . . . 0.0 107.85 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -54.82 170.24 0.67 Allowed 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 122.497 2.132 . . . . 0.0 111.652 167.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -52.92 -27.15 17.4 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -171.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -165.05 -83.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 158.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -123.55 12.25 9.3 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.489 1.116 . . . . 0.0 110.597 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 154' ' ' GLY . 2.2 pp -65.12 -24.57 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -169.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.43 ' N ' HD12 ' A' ' 153' ' ' ILE . . . . . . . . 0 C--O 1.247 0.935 0 CA-C-O 116.939 -2.034 . . . . 0.0 109.597 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -142.52 153.46 43.63 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.033 1.333 . . . . 0.0 109.057 174.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.03 25.99 0.21 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 128.48 2.712 . . . . 0.0 112.344 -177.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.5 mtt180 -142.26 157.87 44.35 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 127.588 2.355 . . . . 0.0 109.3 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.0 pt -116.14 113.45 41.51 Favored Pre-proline 0 CA--C 1.536 0.418 0 C-N-CA 126.882 2.073 . . . . 0.0 106.829 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.66 101.0 1.11 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.03 1.82 . . . . 0.0 107.652 168.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.18 147.01 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 170.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -141.75 160.98 39.07 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.302 1.841 . . . . 0.0 107.228 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.5 t -136.63 113.64 10.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 160.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.8 p -56.91 -45.34 83.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 119.148 0.885 . . . . 0.0 110.046 170.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.37 -31.02 61.43 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.36 1.864 . . . . 0.0 113.057 -174.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -118.75 0.41 11.44 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.059 1.344 . . . . 0.0 112.181 -175.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 41.43 41.12 1.46 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.648 1.579 . . . . 0.0 112.41 -159.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -74.46 150.92 39.7 Favored 'General case' 0 C--N 1.345 0.39 0 O-C-N 121.15 -0.969 . . . . 0.0 109.138 174.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.2 t -142.37 137.84 29.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 159.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -155.49 110.15 2.93 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.052 1.741 . . . . 0.0 109.61 173.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.2 ttt -79.79 129.34 34.4 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 120.34 -1.475 . . . . 0.0 110.192 174.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 90.0 t -122.8 155.24 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -79.58 162.55 25.26 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.401 -0.812 . . . . 0.0 110.61 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -75.28 160.6 30.16 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.582 -0.699 . . . . 0.0 110.688 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.6 tt -90.92 67.97 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 122.745 1.259 . . . . 0.0 112.133 -161.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -101.38 47.22 0.91 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.393 -169.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.5 mt -78.61 172.72 13.29 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.785 1.278 . . . . 0.0 110.984 -178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.23 153.57 28.45 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 127.205 2.202 . . . . 0.0 107.011 161.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -59.37 -39.05 82.06 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.216 1.371 . . . . 0.0 111.877 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.61 -22.73 62.24 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -174.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.79 -38.84 83.88 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.481 1.112 . . . . 0.0 109.563 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.6 m95 -62.85 8.3 0.06 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.731 2.412 . . . . 0.0 115.994 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.22 -2.05 3.98 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -129.7 -19.73 3.3 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.456 -0.783 . . . . 0.0 112.617 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 pt -107.31 1.78 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 119.033 0.833 . . . . 0.0 111.645 167.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -108.55 167.19 10.23 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.17 0.988 . . . . 0.0 110.894 -176.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.39 140.04 79.77 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 166.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.17 -18.16 55.74 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.018 1.812 . . . . 0.0 111.49 168.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -70.37 -44.14 68.7 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 118.83 -0.605 . . . . 0.0 109.713 170.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.48 -43.82 93.18 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.18 0.9 . . . . 0.0 110.049 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -59.81 -45.22 93.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.84 0.856 . . . . 0.0 112.007 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -70.19 -48.38 57.44 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 119.095 0.862 . . . . 0.0 108.788 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 36.1 t -53.92 -32.58 22.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 124.871 1.269 . . . . 0.0 110.065 -177.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.67 -26.35 67.97 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 175.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.5 ptt-85 -88.8 -27.62 20.99 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.752 1.16 . . . . 0.0 111.912 174.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -110.93 2.64 18.24 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -168.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.04 36.29 1.93 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.479 1.511 . . . . 0.0 111.621 -171.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.27 -31.87 8.17 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-O 117.967 -1.463 . . . . 0.0 113.411 174.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.7 t -153.4 118.27 5.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 119.443 1.621 . . . . 0.0 111.192 -175.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -55.31 -57.55 19.77 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.641 1.176 . . . . 0.0 112.023 167.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.39 138.88 36.8 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 CA-C-N 121.399 1.535 . . . . 0.0 108.981 169.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.32 -14.38 22.89 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.74 2.293 . . . . 0.0 112.956 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -65.65 123.74 20.51 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.228 1.011 . . . . 0.0 109.08 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.1 t -145.75 -176.57 5.18 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.866 1.266 . . . . 0.0 108.779 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.82 77.37 1.37 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 -167.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -145.19 171.92 13.86 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.164 1.385 . . . . 0.0 108.123 -177.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -137.64 167.01 22.53 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.205 2.202 . . . . 0.0 106.424 170.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -134.05 17.04 3.81 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.978 0.894 . . . . 0.0 110.655 174.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -145.46 151.93 38.98 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 128.79 2.836 . . . . 0.0 107.631 -158.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.9 tp -154.14 20.86 0.5 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.588 0.755 . . . . 0.0 111.094 -174.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -147.16 145.11 29.42 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.64 35.65 0.15 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 128.214 2.606 . . . . 0.0 112.356 -170.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -137.96 176.57 8.58 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.718 0.807 . . . . 0.0 111.807 -173.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.19 178.31 38.59 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -159.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.509 HG22 ' HA ' ' A' ' 76' ' ' ASP . 37.6 pt -136.82 160.63 36.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.427 0.691 . . . . 0.0 109.555 173.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.71 158.28 28.36 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.132 0.967 . . . . 0.0 110.693 178.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 73' ' ' ASP . 5.2 ttt180 -143.51 134.18 25.08 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.481 1.512 . . . . 0.0 110.057 -170.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.7 t -87.03 92.71 9.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.239 -1.764 . . . . 0.0 106.239 174.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.7 tt -62.01 -25.61 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 O-C-N 122.265 -0.272 . . . . 0.0 110.994 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 57.8 m -70.12 -0.35 7.59 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.267 1.827 . . . . 0.0 113.589 176.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 25.0 p -139.56 15.2 2.54 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.918 0.887 . . . . 0.0 110.606 158.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.11 9.43 5.77 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 118.031 -1.427 . . . . 0.0 114.201 -177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.1 m -110.29 141.57 43.1 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 119.308 1.554 . . . . 0.0 108.851 -164.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 7.8 p-10 -65.82 163.84 15.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.51 1.124 . . . . 0.0 113.679 176.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.309 0.2 OUTLIER -154.29 -110.01 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.604 165.214 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -52.83 115.65 1.93 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.319 1.448 . . . . 0.0 112.617 -162.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.509 ' HA ' HG22 ' A' ' 64' ' ' ILE . 13.2 t70 -65.96 151.16 47.41 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 170.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.37 -16.67 64.26 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 176.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -63.61 -13.4 41.73 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.787 1.631 . . . . 0.0 111.828 163.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.449 ' HA ' ' CD2' ' A' ' 90' ' ' PHE . 67.5 p -119.58 12.4 12.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.813 2.445 . . . . 0.0 111.703 172.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -156.16 91.97 1.31 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.021 0.929 . . . . 0.0 110.396 178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -141.68 147.69 37.88 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.988 1.715 . . . . 0.0 106.456 166.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -149.96 136.93 19.47 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 166.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.2 p -55.47 98.39 0.02 OUTLIER 'General case' 0 C--O 1.235 0.302 0 C-N-CA 126.805 2.042 . . . . 0.0 112.96 -158.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.9 11.95 26.75 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.832 1.206 . . . . 0.0 113.7 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.3 m -136.02 -34.45 0.8 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.218 1.007 . . . . 0.0 110.507 -159.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 58.7 25.82 59.25 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.428 -1.206 . . . . 0.0 114.659 172.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 25.8 t90 -59.5 140.65 88.6 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 119.223 1.511 . . . . 0.0 109.677 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -78.82 67.8 8.38 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.154 2.569 . . . . 0.0 113.301 -167.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.2 p -145.61 145.48 30.98 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.485 162.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.449 ' CD2' ' HA ' ' A' ' 79' ' ' THR . 4.7 t80 -141.94 -156.56 0.69 Allowed 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 123.464 0.706 . . . . 0.0 110.195 171.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -133.14 4.33 3.75 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 119.036 0.835 . . . . 0.0 112.184 -172.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.569 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 1.1 t0 -151.38 -176.95 5.79 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.177 -0.439 . . . . 0.0 110.22 158.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.8 m -134.26 164.1 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 126.594 1.958 . . . . 0.0 109.23 173.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -73.1 -17.71 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -167.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.3 m 160.43 171.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 131.121 3.768 . . . . 0.0 108.253 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -91.65 100.67 13.35 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 158.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.5 ' CG ' ' H ' ' A' ' 98' ' ' ASN . 10.6 p80 -141.84 -60.83 0.46 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.334 0.654 . . . . 0.0 109.92 -171.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.5 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 63.1 t30 -114.37 10.72 17.12 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.468 2.307 . . . . 0.0 110.005 171.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.57 150.22 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 127.5 2.32 . . . . 0.0 107.497 -177.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.461 ' HD3' ' H ' ' A' ' 101' ' ' LEU . 14.4 tppt? -142.16 147.54 36.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.18 1.792 . . . . 0.0 110.517 -174.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.461 ' H ' ' HD3' ' A' ' 100' ' ' LYS . 1.8 mp -127.17 150.67 49.41 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 127.839 2.456 . . . . 0.0 111.78 177.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.568 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 1.3 mpt_? -131.4 152.89 50.24 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 129.927 3.291 . . . . 0.0 104.46 162.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -125.69 135.94 52.66 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 119.015 0.825 . . . . 0.0 111.008 -168.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.434 ' CG ' ' H ' ' A' ' 105' ' ' ARG . 33.4 t0 -144.82 -176.43 5.07 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.228 2.211 . . . . 0.0 108.863 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.434 ' H ' ' CG ' ' A' ' 104' ' ' ASP . 17.5 ptt-85 -112.73 15.87 19.79 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 128.734 2.814 . . . . 0.0 111.894 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.31 -33.28 41.65 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -158.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.1 pp -78.22 -10.36 59.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.045 0.839 . . . . 0.0 112.966 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.3 -1.44 26.66 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 117.431 -1.761 . . . . 0.0 112.885 -169.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.7 mmt -143.41 -88.05 0.13 Allowed 'General case' 0 C--N 1.347 0.463 0 CA-C-N 120.026 1.913 . . . . 0.0 108.215 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.2 t -138.55 112.09 7.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 CA-C-N 120.25 1.386 . . . . 0.0 107.604 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.5 ttt85 -121.95 117.45 26.46 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.525 0.73 . . . . 0.0 109.723 168.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.94 141.92 47.92 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 177.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.568 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 10.0 pt-20 -72.36 159.62 33.71 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.32 0.964 . . . . 0.0 109.981 176.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 89.9 t -138.6 103.51 2.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 170.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.7 mp -124.69 175.37 7.26 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 11.5 t -64.9 166.66 8.79 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.463 0.649 . . . . 0.0 110.136 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -100.42 -4.99 27.84 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.29 1.036 . . . . 0.0 110.808 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 34.7 tpt85 -131.85 -71.03 0.56 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 116.978 -1.487 . . . . 0.0 111.603 159.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 30.2 p -75.22 94.54 2.99 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 119.95 1.25 . . . . 0.0 109.148 -168.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -37.86 30.08 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.286 1 C-N-CA 133.965 4.906 . . . . 0.0 118.945 174.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.1 175.39 2.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.186 2.195 . . . . 0.0 111.895 174.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -71.14 -57.89 4.08 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 126.104 1.761 . . . . 0.0 111.171 -163.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.55 -112.06 0.64 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.014 1.726 . . . . 0.0 107.372 177.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.7 -104.88 0.2 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 119.051 0.841 . . . . 0.0 112.339 165.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -161.85 -177.26 5.72 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.751 0.31 . . . . 0.0 111.452 -163.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.15 140.71 43.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 126.575 1.95 . . . . 0.0 107.349 169.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -139.29 153.61 47.8 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.715 0.806 . . . . 0.0 110.768 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -64.12 119.74 10.76 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.694 0.679 . . . . 0.0 109.298 167.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -154.28 -28.74 0.12 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.253 1.021 . . . . 0.0 113.204 -177.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -95.97 -179.78 35.72 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.821 1.201 . . . . 0.0 111.428 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.64 -87.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.141 2.56 . . . . 0.0 112.085 -175.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.73 163.1 1.64 Allowed Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 127.277 2.231 . . . . 0.0 107.4 -176.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.11 -39.94 1.12 Allowed 'Cis proline' 0 C--N 1.35 0.627 0 CA-C-N 120.241 1.122 . . . . 0.0 109.817 -13.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.3 p -73.66 79.83 1.52 Allowed 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.611 1.565 . . . . 0.0 108.945 165.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -109.93 -3.05 30.15 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 126.832 2.158 . . . . 0.0 110.659 170.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 138.88 39.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 164.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -117.37 109.8 17.26 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.291 1.836 . . . . 0.0 108.303 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.569 ' CE1' ' HA ' ' A' ' 92' ' ' ASP . 50.2 m-85 -78.23 129.6 35.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 23.2 t -140.0 120.38 13.99 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.915 1.686 . . . . 0.0 108.771 -170.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 20.5 ptp -133.74 155.16 50.26 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.558 0.743 . . . . 0.0 109.854 -170.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -152.14 93.66 1.85 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.958 2.103 . . . . 0.0 107.003 -173.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.7 p -143.3 152.94 42.24 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.09 -35.66 81.0 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.66 0.743 . . . . 0.0 109.421 165.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.4 75.87 0.26 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.874 1.67 . . . . 0.0 110.416 165.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 96.1 mt -144.83 46.97 1.35 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.009 2.524 . . . . 0.0 108.655 164.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -72.31 157.24 38.05 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -97.14 145.86 25.61 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.64 0.776 . . . . 0.0 109.711 164.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.497 ' HB ' ' HD2' ' A' ' 149' ' ' PRO . 0.1 OUTLIER -134.65 174.96 4.03 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 160.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 148' ' ' ILE . 57.0 Cg_endo -64.46 172.29 6.85 Favored 'Trans proline' 0 C--N 1.352 0.734 0 CA-C-N 121.504 1.573 . . . . 0.0 112.061 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -38.84 -44.26 1.02 Allowed 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 127.433 2.293 . . . . 0.0 114.012 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -144.34 -78.32 0.21 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.606 1.962 . . . . 0.0 107.945 172.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -144.55 2.62 1.1 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 128.692 2.797 . . . . 0.0 111.195 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.4 pp -55.3 -24.48 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 -174.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 116.901 -2.055 . . . . 0.0 110.702 176.107 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 60.3 mtt . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -88.78 124.41 34.12 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 170.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 52.8 p30 -145.0 -157.73 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.264 1.426 . . . . 0.0 110.927 -159.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -133.04 159.35 40.32 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 127.511 2.324 . . . . 0.0 107.272 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.4 pt -123.13 108.89 31.89 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.013 1.725 . . . . 0.0 107.406 -169.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.22 104.26 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.932 2.421 . . . . 0.0 109.12 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.9 mm -84.15 154.59 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -134.69 152.25 51.63 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -176.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.2 m -129.08 77.99 1.82 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.3 p -54.11 -38.8 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.34 1.056 . . . . 0.0 111.89 -171.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.18 -14.57 11.04 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.237 1.415 . . . . 0.0 113.65 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.04 10.57 4.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.984 2.114 . . . . 0.0 110.608 175.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 34.53 40.99 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.776 2.83 . . . . 0.0 113.434 -164.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -83.07 164.17 20.46 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.275 -0.89 . . . . 0.0 108.995 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.5 t -136.32 132.42 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 168.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -135.63 103.6 5.49 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.534 1.534 . . . . 0.0 107.129 -179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 42.5 ttm -71.05 122.02 19.29 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 120.967 -1.083 . . . . 0.0 108.81 175.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.9 t -109.9 156.32 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 173.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -88.79 164.74 15.09 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 120.898 -1.126 . . . . 0.0 110.199 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.479 ' HG3' ' HD3' ' A' ' 118' ' ' ARG . 39.4 ttt-85 -65.87 144.25 56.93 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.769 -0.582 . . . . 0.0 110.506 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 tt -83.89 121.81 36.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -156.99 118.0 3.67 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 169.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.2 mt -135.73 177.54 7.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.987 2.515 . . . . 0.0 108.811 -172.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 p -85.62 178.7 7.29 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 164.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -60.1 -38.45 83.0 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.62 0.768 . . . . 0.0 111.083 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -18.46 59.26 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -166.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -71.07 -45.89 62.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.399 1.08 . . . . 0.0 110.154 -169.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -63.79 21.52 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 128.321 2.648 . . . . 0.0 114.805 -176.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.99 -10.82 2.01 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 166.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -120.77 -18.05 7.78 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 119.223 0.919 . . . . 0.0 112.824 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 pt -111.08 24.97 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 119.226 0.921 . . . . 0.0 111.27 170.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mt -124.87 169.47 12.02 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.832 1.253 . . . . 0.0 110.903 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -62.65 144.08 96.24 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 168.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -68.37 -12.04 33.75 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.418 2.079 . . . . 0.0 111.741 168.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -78.84 -41.08 30.96 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 118.476 -0.773 . . . . 0.0 111.065 166.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.72 -39.42 80.78 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 120.231 1.378 . . . . 0.0 111.472 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -61.21 -37.74 84.06 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.799 0.84 . . . . 0.0 113.048 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.0 ptt-85 -78.15 -49.47 13.79 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.599 HG12 ' HB1' ' A' ' 143' ' ' ALA . 3.2 t -60.2 -24.16 29.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 O-C-N 121.396 -0.815 . . . . 0.0 111.488 -173.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.21 -24.26 67.3 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 171.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -105.69 -37.63 6.67 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.392 1.077 . . . . 0.0 111.548 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -90.47 10.68 24.31 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.251 0.932 . . . . 0.0 112.819 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 42.36 50.74 4.67 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.701 1.6 . . . . 0.0 111.564 -177.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.421 ' HA2' HG22 ' A' ' 42' ' ' VAL . . . 80.08 -6.89 58.29 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-O 118.257 -1.302 . . . . 0.0 113.903 173.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 p -140.83 106.3 5.07 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.19 1.495 . . . . 0.0 111.211 -160.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -63.59 -49.84 75.41 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-O 117.594 -1.193 . . . . 0.0 112.974 175.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.61 155.93 49.59 Favored 'Trans proline' 0 C--N 1.353 0.802 0 CA-C-N 121.258 1.485 . . . . 0.0 111.456 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.75 -1.32 10.99 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.658 2.905 . . . . 0.0 113.848 -178.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -141.94 160.36 40.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 125.783 1.633 . . . . 0.0 107.859 176.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.4 p -63.79 113.13 3.21 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.169 0.988 . . . . 0.0 110.022 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.27 173.2 6.78 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 160.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.57 160.95 29.18 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -147.96 166.97 26.1 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.555 1.542 . . . . 0.0 107.293 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.47 146.36 25.86 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.467 1.507 . . . . 0.0 107.465 176.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -139.83 171.03 14.8 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.326 0.584 . . . . 0.0 112.031 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.5 mt -135.72 2.72 2.93 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.822 2.449 . . . . 0.0 111.161 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -133.47 106.06 7.26 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.153 1.381 . . . . 0.0 108.386 -175.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -70.25 39.83 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.279 2.232 . . . . 0.0 112.836 -177.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -87.78 168.68 12.73 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.76 1.224 . . . . 0.0 111.001 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.31 163.36 30.69 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 126.017 1.77 . . . . 0.0 111.763 168.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.7 pt -133.8 155.85 40.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 165.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -79.23 146.99 32.75 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.659 0.743 . . . . 0.0 109.489 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -110.93 110.92 21.7 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 128.613 2.765 . . . . 0.0 107.067 169.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.65 88.65 0.06 Allowed 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 165.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.6 tt -62.36 -28.13 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.591 0.71 . . . . 0.0 110.461 -170.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.91 -9.15 57.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 128.107 2.563 . . . . 0.0 113.129 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 26.1 p -139.5 15.29 2.55 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.754 0.821 . . . . 0.0 111.594 166.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.87 37.9 53.45 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 118.912 0.778 . . . . 0.0 112.045 176.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.0 m -132.18 146.39 51.99 Favored 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 125.971 1.708 . . . . 0.0 107.27 -171.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.3 173.52 12.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.36 0.982 . . . . 0.0 111.675 176.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -168.2 -118.15 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.689 1.995 . . . . 0.0 110.392 170.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -48.25 132.32 16.21 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.83 1.652 . . . . 0.0 114.306 -159.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -80.73 145.3 31.62 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.725 0.81 . . . . 0.0 110.068 172.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 70.6 m -54.6 -26.39 32.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 117.572 -1.204 . . . . 0.0 113.719 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -62.63 -21.25 65.52 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.798 1.635 . . . . 0.0 112.361 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.8 p -79.25 -10.64 59.86 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.547 0.739 . . . . 0.0 112.059 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -117.96 -177.97 3.39 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.327 1.451 . . . . 0.0 110.98 -161.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -140.76 25.24 2.17 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -162.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -56.06 -34.92 66.38 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 120.531 -1.356 . . . . 0.0 112.431 173.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.09 77.93 3.63 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 163.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 155.84 -68.02 0.29 Allowed Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.601 1.096 . . . . 0.0 111.287 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.8 t -153.5 -11.58 0.15 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.455 1.279 . . . . 0.0 114.455 -173.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.06 18.5 57.6 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 119.781 1.173 . . . . 0.0 115.337 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.86 136.91 96.69 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 118.221 1.01 . . . . 0.0 110.708 -177.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.95 51.34 3.81 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.904 3.069 . . . . 0.0 111.771 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.3 p -138.38 117.64 12.73 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 168.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -104.33 179.77 4.18 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.62 1.968 . . . . 0.0 107.894 -170.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -119.37 -12.96 9.31 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 118.309 -0.853 . . . . 0.0 113.209 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -154.38 -178.49 7.18 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.897 1.226 . . . . 0.0 108.222 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.4 t -133.74 153.8 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.727 1.211 . . . . 0.0 110.061 -165.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -65.81 -56.72 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.154 0.982 . . . . 0.0 109.909 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.0 m 175.63 158.88 0.24 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 127.276 2.231 . . . . 0.0 107.656 -173.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -76.36 85.23 3.12 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 160.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -119.7 -58.18 1.92 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.647 0.779 . . . . 0.0 109.561 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.71 -1.72 24.15 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.262 1.025 . . . . 0.0 111.296 169.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.06 153.86 32.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 126.393 1.877 . . . . 0.0 108.571 -169.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -140.39 134.54 30.99 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.324 1.449 . . . . 0.0 110.273 -167.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 pp -141.96 144.95 33.98 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 124.305 1.003 . . . . 0.0 113.258 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.544 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 1.5 mpt_? -137.24 123.95 21.13 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 129.522 3.129 . . . . 0.0 107.747 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -84.35 148.44 26.63 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.776 1.23 . . . . 0.0 111.206 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -153.99 173.32 16.15 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.21 2.604 . . . . 0.0 107.49 168.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.93 20.19 11.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.599 1.159 . . . . 0.0 112.763 173.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.97 -43.48 63.57 Favored 'General case' 0 C--N 1.342 0.28 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -158.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 pp -73.36 -7.58 52.23 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.84 3.69 45.8 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.485 1.517 . . . . 0.0 112.512 -169.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 92.0 mtp -142.07 -98.36 0.13 Allowed 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.091 1.445 . . . . 0.0 108.474 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.7 t -139.4 106.35 2.71 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.3 ttt-85 -110.42 113.69 26.54 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 42.7 t -119.77 124.32 45.87 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.544 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 16.8 pt-20 -62.54 162.26 10.68 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.221 0.464 . . . . 0.0 110.812 -174.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.8 t -137.24 106.28 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 169.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.36 168.88 15.62 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 170.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 30.4 t -70.6 138.93 51.25 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -66.54 -12.93 60.03 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.191 0.996 . . . . 0.0 112.297 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.479 ' HD3' ' HG3' ' A' ' 23' ' ' ARG . 38.4 tpt85 -123.26 -73.79 0.64 Allowed 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 117.088 -1.434 . . . . 0.0 112.904 167.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 19.9 p -69.71 17.58 0.05 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.631 2.086 . . . . 0.0 116.631 -158.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 68.09 -19.69 0.14 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.911 2.484 . . . . 0.0 116.087 162.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -68.06 165.33 18.24 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -161.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -37.12 -62.65 0.48 Allowed 'General case' 0 C--N 1.342 0.28 0 C-N-CA 129.247 3.019 . . . . 0.0 113.846 -169.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mt 46.43 -109.12 0.21 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 127.225 2.21 . . . . 0.0 110.604 -172.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.78 -126.47 1.03 Allowed Glycine 0 CA--C 1.521 0.456 0 CA-C-N 119.144 0.884 . . . . 0.0 113.913 175.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -167.08 168.39 13.71 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.967 0.907 . . . . 0.0 110.415 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.647 HG21 ' HE2' ' A' ' 136' ' ' LYS . 4.0 p -105.5 142.87 17.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 123.78 0.832 . . . . 0.0 110.152 170.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -140.72 166.32 25.07 Favored 'General case' 0 C--N 1.344 0.328 0 O-C-N 124.006 0.816 . . . . 0.0 111.569 172.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -74.24 67.94 1.43 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.056 1.742 . . . . 0.0 112.19 -172.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -142.7 25.38 1.82 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.439 1.096 . . . . 0.0 111.52 -174.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -103.2 167.43 16.91 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 120.971 -1.081 . . . . 0.0 111.637 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.7 167.81 25.6 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.509 2.139 . . . . 0.0 110.564 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 52.3 ptt85 -58.23 147.36 67.08 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 160.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.21 -54.28 0.15 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.525 0 CA-C-N 120.557 1.235 . . . . 0.0 113.764 7.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.1 t -79.21 -13.46 59.68 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -161.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.65 -1.36 45.42 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 119.963 1.256 . . . . 0.0 114.424 169.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.647 ' HE2' HG21 ' A' ' 126' ' ' VAL . 15.6 ptmt -119.44 156.11 30.79 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 119.084 1.442 . . . . 0.0 111.434 -169.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -128.03 98.91 5.29 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 126.089 1.755 . . . . 0.0 110.128 -169.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -75.58 92.96 2.97 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 127.685 2.394 . . . . 0.0 109.367 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 31.3 t -92.57 140.24 29.75 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.021 0.928 . . . . 0.0 109.963 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 9.1 ttp -144.37 146.92 32.81 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.981 0.912 . . . . 0.0 109.204 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -143.13 119.12 10.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.458 1.903 . . . . 0.0 107.756 174.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 80.3 p -172.86 -175.14 1.2 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.524 1.13 . . . . 0.0 107.963 165.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.599 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -57.77 -21.25 40.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.615 1.566 . . . . 0.0 114.0 163.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.27 25.76 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.09 2.156 . . . . 0.0 115.751 -164.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 95.5 mt -124.63 41.58 3.47 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.157 0.89 . . . . 0.0 112.258 -160.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -78.67 145.34 34.64 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 170.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -95.31 159.16 15.14 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.777 0.717 . . . . 0.0 109.546 167.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 14.2 pt -138.53 170.98 8.99 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 125.077 1.351 . . . . 0.0 107.663 158.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -46.47 167.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.524 3.482 . . . . 0.0 113.702 162.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -15.66 -49.01 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 129.284 3.034 . . . . 0.0 116.023 163.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -170.08 -156.63 0.14 Allowed 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 131.326 3.85 . . . . 0.0 101.255 -161.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -88.05 16.02 6.6 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 129.331 3.053 . . . . 0.0 110.133 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.2 pp -76.03 -10.69 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.121 1.768 . . . . 0.0 114.171 -162.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 CA-C-O 116.964 -2.02 . . . . 0.0 111.066 177.886 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.414 ' C ' ' H ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 121.474 0.654 . . . . 0.0 111.326 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -69.56 43.53 0.05 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.808 1.643 . . . . 0.0 110.334 163.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 4' ' ' MET . 3.2 p30 -80.24 -169.79 2.23 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 127.322 2.249 . . . . 0.0 110.085 -178.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -138.33 154.13 48.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.825 2.45 . . . . 0.0 106.649 -169.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 pt -108.91 114.97 57.87 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 125.66 1.584 . . . . 0.0 111.041 -175.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.91 126.13 12.25 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.238 1.959 . . . . 0.0 109.287 164.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.9 mt -110.21 93.58 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -88.76 112.21 22.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.0 m -83.41 75.56 9.98 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 166.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.4 m -57.58 -30.14 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -170.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.21 -17.9 22.29 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.104 1.362 . . . . 0.0 113.059 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.27 15.76 5.05 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.811 1.644 . . . . 0.0 111.201 166.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 36.67 44.47 0.33 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.604 2.762 . . . . 0.0 112.638 -166.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.5 mtm105 -84.09 156.67 22.06 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 168.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.0 t -143.64 122.03 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 -177.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -130.39 114.72 15.93 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.515 1.126 . . . . 0.0 108.064 171.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.5 ttm -81.96 135.19 35.4 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 121.173 -0.954 . . . . 0.0 109.197 172.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.3 t -135.46 159.17 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 126.024 1.73 . . . . 0.0 106.611 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -69.53 166.13 19.54 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.743 -1.223 . . . . 0.0 113.559 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.95 170.62 12.33 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 163.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.55 138.52 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -168.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -156.96 92.14 1.25 Allowed 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 174.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.5 mt -126.57 -178.17 4.27 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 127.487 2.315 . . . . 0.0 108.436 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.8 p -87.45 -92.64 0.1 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.232 1.013 . . . . 0.0 109.95 176.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -150.41 -62.02 0.2 Allowed 'General case' 0 C--O 1.231 0.117 0 C-N-CA 126.564 1.946 . . . . 0.0 107.947 174.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -58.53 -21.89 53.7 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -175.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -53.2 -46.12 68.9 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.789 0.836 . . . . 0.0 110.658 173.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -68.2 40.91 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.338 2.255 . . . . 0.0 112.935 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.27 -44.42 0.13 Allowed 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 125.623 1.569 . . . . 0.0 109.351 159.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.4 -24.0 34.63 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 117.94 -1.029 . . . . 0.0 112.549 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.1 pt -105.65 21.99 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 119.936 1.244 . . . . 0.0 112.443 172.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.9 mt -108.22 166.01 11.07 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-O 122.036 0.922 . . . . 0.0 113.272 -177.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -56.15 151.01 28.18 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.942 1.297 . . . . 0.0 109.111 163.227 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.9 22.18 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.121 1 C-N-CA 125.331 4.021 . . . . 0.0 111.981 168.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.473 ' H ' ' C ' ' A' ' 36' ' ' ASP . 7.2 tt0 -133.32 -48.72 0.84 Allowed 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 126.867 2.067 . . . . 0.0 109.317 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.55 -37.21 75.24 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 120.31 1.413 . . . . 0.0 111.9 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -56.18 -46.06 79.52 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 175.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -80.83 -51.06 9.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -175.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.627 HG13 ' HA2' ' A' ' 47' ' ' GLY 0.269 2.1 t -59.52 -23.92 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.413 1.085 . . . . 0.0 110.374 -178.102 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.47 -25.51 68.03 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 170.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -100.68 -34.79 9.72 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.035 1.288 . . . . 0.0 111.566 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -89.0 5.79 42.63 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.892 0.877 . . . . 0.0 112.092 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.42 51.29 16.65 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.852 1.661 . . . . 0.0 110.568 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.627 ' HA2' HG13 ' A' ' 42' ' ' VAL . . . 69.75 -1.54 15.32 Favored Glycine 0 C--N 1.338 0.644 0 CA-C-O 118.778 -1.012 . . . . 0.0 114.513 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.1 m -119.5 86.96 2.65 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 118.467 1.133 . . . . 0.0 108.606 -159.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -78.13 155.61 79.68 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.899 -173.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.81 154.35 73.29 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 121.989 1.793 . . . . 0.0 110.802 174.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.31 151.7 48.88 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.648 2.232 . . . . 0.0 111.879 -174.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -144.66 171.94 13.69 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.89 2.076 . . . . 0.0 107.26 170.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.3 t -77.16 172.83 12.61 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 164.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.55 85.37 0.79 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -173.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.09 169.5 17.5 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.285 1.034 . . . . 0.0 109.815 -177.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -131.31 178.46 6.69 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.805 1.642 . . . . 0.0 109.327 -175.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -136.12 -68.36 0.5 Allowed 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -81.36 160.22 24.17 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.254 1.822 . . . . 0.0 109.185 158.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.2 tp -149.52 -176.75 5.52 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.889 1.676 . . . . 0.0 108.603 170.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -67.83 120.53 14.3 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.293 -0.879 . . . . 0.0 108.742 165.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -71.09 110.41 5.75 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 163.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -159.71 178.71 9.54 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.098 1.759 . . . . 0.0 106.83 -173.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.39 -172.78 52.63 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 125.463 1.506 . . . . 0.0 111.96 162.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.517 HG22 ' HA ' ' A' ' 76' ' ' ASP . 36.4 pt -138.28 166.47 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 158.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -78.48 149.16 33.24 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.259 -0.901 . . . . 0.0 110.237 173.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.17 120.26 24.26 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.636 1.974 . . . . 0.0 107.002 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.0 t -73.76 86.6 1.7 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.832 1.653 . . . . 0.0 106.924 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.6 tt -66.35 -30.6 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.032 0.933 . . . . 0.0 111.099 -161.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.3 m -73.61 4.88 4.4 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.863 2.065 . . . . 0.0 112.462 177.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.553 ' HB3' ' HE ' ' A' ' 118' ' ' ARG . 30.7 p -148.47 16.54 1.02 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.878 1.271 . . . . 0.0 112.048 163.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.32 9.55 24.1 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.218 0.913 . . . . 0.0 115.172 176.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.2 m -108.53 122.54 47.28 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.928 1.364 . . . . 0.0 110.13 -159.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -64.94 151.85 44.74 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.486 0.715 . . . . 0.0 111.852 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.01 -101.43 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.863 0.865 . . . . 0.0 111.632 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -62.9 130.25 43.99 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.947 0.794 . . . . 0.0 111.15 -163.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.517 ' HA ' HG22 ' A' ' 64' ' ' ILE . 11.7 t70 -76.73 145.09 38.87 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 174.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 68.1 m -54.57 -27.59 39.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.152 -0.927 . . . . 0.0 112.549 176.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.99 -19.9 65.5 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.353 1.433 . . . . 0.0 112.96 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.4 p -79.95 -12.52 59.72 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.83 0.852 . . . . 0.0 112.046 174.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.446 ' HG2' ' H ' ' A' ' 81' ' ' PHE . 9.4 tttt -123.06 -171.36 2.28 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.408 1.883 . . . . 0.0 109.054 -166.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.446 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 74.0 m-85 -145.21 -179.79 6.87 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.668 1.987 . . . . 0.0 109.548 -177.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -155.94 -71.35 0.11 Allowed 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 127.499 2.319 . . . . 0.0 107.854 -168.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.63 53.33 2.65 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.863 0.839 . . . . 0.0 111.598 -159.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.99 -78.82 0.2 Allowed Glycine 0 CA--C 1.524 0.602 0 C-N-CA 127.083 2.277 . . . . 0.0 107.869 -173.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.2 m -77.07 53.66 0.98 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.389 1.076 . . . . 0.0 110.003 173.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -88.82 52.75 3.95 Favored Glycine 0 N--CA 1.45 -0.42 0 O-C-N 120.201 -1.562 . . . . 0.0 110.913 -176.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.9 p-90 -135.11 164.67 42.28 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.673 1.189 . . . . 0.0 109.453 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.37 76.31 3.16 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.883 2.389 . . . . 0.0 112.191 -173.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.3 p -135.95 154.97 50.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.021 1.728 . . . . 0.0 109.399 167.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -143.75 168.71 19.27 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.22 1.408 . . . . 0.0 108.268 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -115.08 -13.83 11.83 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.001 -0.999 . . . . 0.0 113.14 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -158.16 176.65 12.22 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.39 1.45 . . . . 0.0 107.992 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.9 t -121.18 149.39 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 118.523 0.601 . . . . 0.0 111.46 -158.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.1 p -51.93 -58.72 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.114 1.766 . . . . 0.0 110.268 168.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.4 m 169.39 156.45 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 130.832 3.653 . . . . 0.0 105.205 -176.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -79.33 79.87 5.74 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 119.826 1.194 . . . . 0.0 108.599 173.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -125.63 -53.65 1.56 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 122.994 0.518 . . . . 0.0 110.414 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -115.01 14.37 17.13 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.746 1.218 . . . . 0.0 112.347 171.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.1 tt -119.2 153.54 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 170.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.27 128.11 48.67 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 125.973 1.709 . . . . 0.0 106.899 168.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.68 146.94 51.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.921 1.289 . . . . 0.0 110.758 177.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.63 152.14 47.85 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 128.446 2.699 . . . . 0.0 105.064 174.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -131.79 130.39 41.76 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.807 0.843 . . . . 0.0 109.556 -169.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -137.06 -178.49 5.22 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 128.07 2.548 . . . . 0.0 107.355 -175.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -103.39 9.53 37.79 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.345 1.458 . . . . 0.0 111.045 174.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.4 t -59.81 14.46 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 129.669 3.188 . . . . 0.0 119.079 -161.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 pp -118.87 -9.61 10.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.501 1.52 . . . . 0.0 111.809 168.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 122.11 -23.36 7.32 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 126.94 2.21 . . . . 0.0 112.091 -166.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 28.0 ttm -136.25 -74.39 0.44 Allowed 'General case' 0 C--N 1.348 0.519 0 CA-C-N 119.541 1.67 . . . . 0.0 112.352 -168.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.9 p -155.24 100.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -111.71 128.78 56.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.616 ' SG ' HG13 ' A' ' 126' ' ' VAL . 0.0 OUTLIER -128.78 144.59 51.2 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -178.495 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -79.05 156.57 28.31 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 63.3 t -134.87 109.03 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 171.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.72 161.34 29.95 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 169.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.2 t -70.96 150.58 45.54 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 173.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.21 -52.14 44.76 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 172.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.553 ' HE ' ' HB3' ' A' ' 70' ' ' CYS . 0.1 OUTLIER -65.12 -57.51 8.41 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 124.965 1.306 . . . . 0.0 112.667 177.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 13.0 p -121.11 77.53 1.32 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.548 1.139 . . . . 0.0 109.742 -158.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.31 20.62 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.005 1 C-N-CA 133.612 4.765 . . . . 0.0 115.572 -174.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.92 -58.08 6.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.333 1.853 . . . . 0.0 114.146 -159.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -158.37 -73.66 0.09 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.2 mt 49.62 -105.27 0.16 Allowed 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.403 1.881 . . . . 0.0 110.462 -170.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.23 -115.55 0.54 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.481 172.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -149.47 177.05 10.06 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.195 0.522 . . . . 0.0 111.745 -167.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.616 HG13 ' SG ' ' A' ' 112' ' ' CYS . 0.5 OUTLIER -132.49 149.63 32.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.998 1.719 . . . . 0.0 109.029 161.263 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -147.0 161.47 40.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.797 1.239 . . . . 0.0 109.961 174.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -67.35 121.4 15.65 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.327 0.651 . . . . 0.0 109.767 171.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -160.91 -31.61 0.05 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -74.29 148.34 38.96 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -173.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.93 -14.35 19.21 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.323 2.015 . . . . 0.0 113.205 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 175.27 168.4 0.36 Allowed Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 131.568 3.947 . . . . 0.0 106.607 -176.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.98 -71.77 0.02 OUTLIER 'Cis proline' 0 C--N 1.35 0.635 0 CA-C-N 121.136 1.441 . . . . 0.0 110.709 -13.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.8 t -70.28 -9.29 55.56 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.196 0.998 . . . . 0.0 113.623 -176.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 84.14 -14.88 41.95 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.25 1.405 . . . . 0.0 113.704 172.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -97.58 152.26 19.22 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 120.942 -1.328 . . . . 0.0 110.493 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -126.14 109.65 12.6 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 127.474 2.309 . . . . 0.0 106.335 -171.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -85.03 141.76 30.07 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.479 1.512 . . . . 0.0 107.737 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' CYS . . . . . . . . . . . . . 18.5 t -146.29 144.77 30.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.883 0.873 . . . . 0.0 109.774 172.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 16.7 ptm -142.22 152.31 42.96 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.178 0.991 . . . . 0.0 110.351 -171.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -144.25 138.27 27.88 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.848 1.259 . . . . 0.0 108.371 164.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 63.5 p -179.21 175.11 0.98 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.18 1.392 . . . . 0.0 109.549 172.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -71.65 2.96 4.46 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.456 1.102 . . . . 0.0 113.139 160.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -81.84 -6.16 58.84 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 120.409 1.459 . . . . 0.0 112.837 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.93 113.3 21.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.125 0.97 . . . . 0.0 111.881 -170.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -141.34 156.85 45.79 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 158.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -92.24 162.68 14.2 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 163.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 18.3 pt -135.86 171.11 9.38 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.456 1.903 . . . . 0.0 106.966 159.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.56 171.82 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.392 2.062 . . . . 0.0 111.977 162.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -34.97 -38.23 0.08 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 128.843 2.857 . . . . 0.0 114.857 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -159.28 -102.83 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -115.21 8.75 15.62 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.534 1.134 . . . . 0.0 111.265 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.3 pp -69.41 -16.46 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -159.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 116.357 -2.357 . . . . 0.0 109.75 -172.925 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_